01072000000000421000450099100020000070000020000270600020000470100020000609100090
00081300038000174210024000551510026000792300038001050350010001434800038001530300
02400191031000300215032000200218036000700220930000500227042000200232117000600234
08500030024020000020024306500090024512200030025404800140025704900250027104900350
02960490028003310480014003590480024003730490024003970490031004210430065004520430
06500517043006800582#1#0#i#1#20080128#Revista Panamericana de Salud Pública#Rev 
Panam Salud Publica#Rev. panam. salud pública#Pan American Journal of Public Hea
lth#1020-4989#Organización Panamericana de la Salud#Rev Panam Salud Publica#22#5
#200710#RPSP#1#other#nd#1#20071100#14#^les^hSumario#^les^cRPSP020^tArtículos#^le
s^cRPSP330^tInformes Especiales#^les^cRPSP030^tInstantáneas#^lpt^hSumário#^len^h
Table of Contents#^len^cRPSP020^tArticles#^len^cRPSP330^tSpecial Reports#^les^tR
ev Panam Salud Publica^vv.22^nn.5^cWashington^mnov.^a2007#^lpt^tRev Panam Salud 
Publica^vv.22^nn.5^cWashington^mnov.^a2007#^len^tRev Panam Salud Publica^vvol.22
^nno.5^cWashington^mNov.^a2007##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#o#1#1#article#1
#20080121#151808#a01v22n5.htm#165##
05758000000000661000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000500090038000400095121000300099049000800102158000300110
03000240011303100030013703200020014006500090014201400110015103500100016201201490
01720120144003210100027004650100034004920100035005260700127005610700131006880832
03700819085000802856085002702864085003702891085002802928085003202956085001902988
08318240300708500080483108500280483908500240486708500230489108500190491405800370
49330580042049701170006050120720003050181120009050211110023050301140009050531130
02105062002001305083#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#h#2
#1#article#1#oa#es#br1.1#1#3.1#ILUS#TAB#01#RPSP020#nd#Rev Panam Salud Publica#22
#5#20071100#^f295^l303#1020-4989#Instrumento para la evaluación de variables psi
cológicas y comportamientos sexuales de riesgo en jóvenes de dos centros univers
itarios de México^les#A survey instrument for evaluating psychological variables
 and risky sexual behavior among young adults at two university centers in Mexic
o^len#^rND^nJulio A.^sPiña López#^rND^1A02^nSusana^sRobles Montijo#^rND^1A03^nBl
anca M.^sRivera Icedo#Universidad Nacional Autónoma de México^iA02^1Facultad de 
Estudios Superiores-Iztacala^cTlalnepantla^sEstado de México^pMéxico#Instituto M
exicano del Seguro Social^iA03^1Unidad de Investigación Epidemiológica y Servici
os de Salud^cHermosillo^sSonora^pMéxico#^les^aOBJETIVO: Probar las propiedades p
sicométricas de un instrumento de encuesta destinado a evaluar algunas variables
 históricas y de contexto que facilitan el comportamiento sexual de riesgo en un
a muestra de estudiantes de dos centros universitarios de México. MÉTODOS: Estud
io transversal con una muestra compuesta por 1 346 estudiantes universitarios de
 México: 784 del Centro de Estudios Superiores del Estado de Sonora, Hermosillo,
 Sonora, (33,2% del total de la matrícula de ese centro) y 562 de la Universidad
 Nacional Autónoma de México, campus Tlalnepantla, Estado de México (23,5% del t
otal de estudiantes de ese centro). El trabajo se realizó en octubre de 2006 en 
Hermosillo y entre los meses de enero y marzo de 2006 en Tlalnepantla. La encues
ta contenía 11 preguntas sobre datos sociodemográficos, 7 sobre comportamientos 
sexuales de riesgo, 22 sobre motivos subyacentes, 8 sobre las situaciones social
es y 6 sobre el estado biológico previo a la relación. Se evaluó la capacidad de
 comprensión de las preguntas, la validez conceptual y la confiabilidad del inst
rumento. RESULTADOS: La versión definitiva del instrumento quedó constituida por
 44 preguntas. En el análisis de confiabilidad se obtuvo un valor a de Cronbach 
global de 0,821, considerando todas las variables en su conjunto y agrupadas por
 factores. Se encontraron tres factores (motivos para no usar preservativos en l
a primera relación sexual y a lo largo de la vida, motivos del uso inconsistente
 de preservativos con parejas ocasionales y disposición hacia la primera relació
n sexual y hacia la relación con parejas ocasionales) que en su conjunto explica
ron 38,36% de la varianza total. CONCLUSIÓN: Las propiedades psicométricas del i
nstrumento de encuesta evaluado fueron satisfactorias. Los interesados en aplica
r este instrumento deben familiarizarse con el modelo teórico que lo sustenta, y
a que la interpretación de los resultados se basa en las definiciones de las dif
erentes variables históricas y de contexto contempladas y en su interacción.#^dn
d^i1#^tm^les^kComportamiento^i1#^tm^les^kconducta del adolescente^i1#^tm^les^kco
nducta sexual^i1#^tm^les^kasunción de riesgos^i1#^tm^les^kMéxico^i1#^len^aOBJECT
IVES: To measure the psychometric attributes of a survey instrument designed to 
evaluate historical and context variables that lead to high-risk sexual behavior
s among a sample of university students in Mexico. METHODS: Cross-sectional stud
y of a sample of 1 346 university students in Mexico: 784 from the Sonora State 
Center for Higher Education in Hermosillo, Sonora, or 33.2% of its total enrollm
ent; and 562 from the National Autonomous University of Mexico, at Tlalnepantla 
campus in Mexico State, or 23.5% of its total enrollment. The study took place i
n Hermosillo during the month of October 2006 and in Tlalnepantla from January t
o March 2006. The survey had 11 questions on sociodemographics, 7 on risky sexua
l behaviors, 22 on related motives, 8 on social context, and 6 on physical statu
s prior to sexual relations. The survey was evaluated in terms of how well the q
uestions were understood, its conceptual validity, and reliability. RESULTS: The
 final version of the survey instrument was composed of 44 questions. The reliab
ility analysis produced an overall Cronbach a value of 0.821, taking into accoun
t all the variables combined and grouped by factor. Three factors were found tha
t together accounted for 38.36% of the total variance: reasons for not using a c
ondom in the first sexual relationship or throughout life, reasons for inconsist
ent use of a condom with a casual sex partner, and willingness to become sexuall
y active and to engage in casual sex. CONCLUSIONS: The psychometric attributes o
f this survey instrument were found to be satisfactory. Those interested in usin
g this instrument should become familiar with the theoretical model on which it 
is based, since understanding the results depends on properly defining the histo
rical and context variables, and their interaction.#^dnd^i2#^tm^len^kSexual beha
vior^i2#^tm^len^krisk taking^i2#^tm^len^kunsafe sex^i2#^tm^len^kMexico^i2#Instit
uto Mexicano del Seguro Social#Fondo para el Fomento de la Investigación#other#3
5#20061208#8 de diciembre de 2006#20070813#13 de agosto de 2007#a01v22n5.htm##
05828000000000661000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000500090038000400095121000300099049000800102158000300110
03000240011303100030013703200020014006500090014201400110015103500100016201201560
01720120151003280100027004790100034005060100035005400700127005750700131007020832
06500833085000802898085002702906085003702933085002802970085003202998085001903030
08318520304908500080490108500280490908500240493708500230496108500190498405800370
50030580042050401170006050820720003050881120009050911110023051001140009051231130
02105132002001305153#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#f#3
#1#article#1#oa#es#br1.1#1#3.1#ILUS#TAB#01#RPSP020#nd#Rev Panam Salud Publica#22
#5#20071100#^f295^l303#1020-4989#<B>Instrumento para la evaluación de variables 
psicológicas y comportamientos sexuales de riesgo en jóvenes de dos centros univ
ersitarios de México</B>^les#<B>A survey instrument for evaluating psychological
 variables and risky sexual behavior among young adults at two university center
s in Mexico</B>^len#^rND^nJulio A.^sPiña López#^rND^1A02^nSusana^sRobles Montijo
#^rND^1A03^nBlanca M.^sRivera Icedo#Universidad Nacional Autónoma de México^iA02
^1Facultad de Estudios Superiores-Iztacala^cTlalnepantla^sEstado de México^pMéxi
co#Instituto Mexicano del Seguro Social^iA03^1Unidad de Investigación Epidemioló
gica y Servicios de Salud^cHermosillo^sSonora^pMéxico#^les^a<B>OBJETIVO:</B> Pro
bar las propiedades psicométricas de un instrumento de encuesta destinado a eval
uar algunas variables históricas y de contexto que facilitan el comportamiento s
exual de riesgo en una muestra de estudiantes de dos centros universitarios de M
éxico. <B>MÉTODOS:</B> Estudio transversal con una muestra compuesta por 1 346 e
studiantes universitarios de México: 784 del Centro de Estudios Superiores del E
stado de Sonora, Hermosillo, Sonora, (33,2% del total de la matrícula de ese cen
tro) y 562 de la Universidad Nacional Autónoma de México, campus Tlalnepantla, E
stado de México (23,5% del total de estudiantes de ese centro). El trabajo se re
alizó en octubre de 2006 en Hermosillo y entre los meses de enero y marzo de 200
6 en Tlalnepantla. La encuesta contenía 11 preguntas sobre datos sociodemográfic
os, 7 sobre comportamientos sexuales de riesgo, 22 sobre motivos subyacentes, 8 
sobre las situaciones sociales y 6 sobre el estado biológico previo a la relació
n. Se evaluó la capacidad de comprensión de las preguntas, la validez conceptual
 y la confiabilidad del instrumento. <B>RESULTADOS:</B> La versión definitiva de
l instrumento quedó constituida por 44 preguntas. En el análisis de confiabilida
d se obtuvo un valor a de Cronbach global de 0,821, considerando todas las varia
bles en su conjunto y agrupadas por factores. Se encontraron tres factores (moti
vos para no usar preservativos en la primera relación sexual y a lo largo de la 
vida, motivos del uso inconsistente de preservativos con parejas ocasionales y d
isposición hacia la primera relación sexual y hacia la relación con parejas ocas
ionales) que en su conjunto explicaron 38,36% de la varianza total. <B>CONCLUSIÓ
N:</B> Las propiedades psicométricas del instrumento de encuesta evaluado fueron
 satisfactorias. Los interesados en aplicar este instrumento deben familiarizars
e con el modelo teórico que lo sustenta, ya que la interpretación de los resulta
dos se basa en las definiciones de las diferentes variables históricas y de cont
exto contempladas y en su interacción.#^dnd^i1#^tm^les^kComportamiento^i1#^tm^le
s^kconducta del adolescente^i1#^tm^les^kconducta sexual^i1#^tm^les^kasunción de 
riesgos^i1#^tm^les^kMéxico^i1#^len^a<B>OBJECTIVES:</B> To measure the psychometr
ic attributes of a survey instrument designed to evaluate historical and context
 variables that lead to high-risk sexual behaviors among a sample of university 
students in Mexico. <B>METHODS:</B> Cross-sectional study of a sample of 1 346 u
niversity students in Mexico: 784 from the Sonora State Center for Higher Educat
ion in Hermosillo, Sonora, or 33.2% of its total enrollment; and 562 from the Na
tional Autonomous University of Mexico, at Tlalnepantla campus in Mexico State, 
or 23.5% of its total enrollment. The study took place in Hermosillo during the 
month of October 2006 and in Tlalnepantla from January to March 2006. The survey
 had 11 questions on sociodemographics, 7 on risky sexual behaviors, 22 on relat
ed motives, 8 on social context, and 6 on physical status prior to sexual relati
ons. The survey was evaluated in terms of how well the questions were understood
, its conceptual validity, and reliability. <B>RESULTS:</B> The final version of
 the survey instrument was composed of 44 questions. The reliability analysis pr
oduced an overall Cronbach a value of 0.821, taking into account all the variabl
es combined and grouped by factor. Three factors were found that together accoun
ted for 38.36% of the total variance: reasons for not using a condom in the firs
t sexual relationship or throughout life, reasons for inconsistent use of a cond
om with a casual sex partner, and willingness to become sexually active and to e
ngage in casual sex. <B>CONCLUSIONS:</B> The psychometric attributes of this sur
vey instrument were found to be satisfactory. Those interested in using this ins
trument should become familiar with the theoretical model on which it is based, 
since understanding the results depends on properly defining the historical and 
context variables, and their interaction.#^dnd^i2#^tm^len^kSexual behavior^i2#^t
m^len^krisk taking^i2#^tm^len^kunsafe sex^i2#^tm^len^kMexico^i2#Instituto Mexica
no del Seguro Social#Fondo para el Fomento de la Investigación#other#35#20061208
#8 de diciembre de 2006#20070813#13 de agosto de 2007#a01v22n5.htm##
05942000000000685000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000500103038000400108121000300112049000800115
15800030012303000260012603100030015203200020015506500090015701400110016603500100
01770120149001870120144003360100026004800100034005060100034005400700129005740700
13300703083206700836085000802903085002702911085003702938085002802975085003203003
08500190303508318450305408500080489908500280490708500240493508500230495908500190
49820580037050010580042050381170006050800720003050861120009050891110023050981140
00905121113002105130002001305151008009205164#v22n5#v:\scielo\serial\rpsp\v22n5\m
arkup\a01v22n5.htm#S#l#4#1#article#1#^mnov.^a2007#oa#es#br1.1#1#3.1#ilus#tab#01#
RPSP020#nd#Rev. panam. salud pública#22#5#20071100#^f295^l303#1020-4989#Instrume
nto para la evaluación de variables psicológicas y comportamientos sexuales de r
iesgo en jóvenes de dos centros universitarios de México^les#A survey instrument
 for evaluating psychological variables and risky sexual behavior among young ad
ults at two university centers in Mexico^len#^rND^nJulio A^sPiña López#^rND^1A02
^nSusana^sRobles Montijo#^rND^1A03^nBlanca M^sRivera Icedo#^iA02^1Universidad Na
cional Autónoma de México^2Facultad de Estudios Superiores-Iztacala^cTlalnepantl
a^sEstado de México^pMéxico#^iA03^1Instituto Mexicano del Seguro Social^2Unidad 
de Investigación Epidemiológica y Servicios de Salud^cHermosillo^sSonora^pMéxico
#^les^aOBJETIVO: Probar las propiedades psicométricas de un instrumento de encue
sta destinado a evaluar algunas variables históricas y de contexto que facilitan
 el comportamiento sexual de riesgo en una muestra de estudiantes de dos centros
 universitarios de México. MÉTODOS: Estudio transversal con una muestra compuest
a por 1 346 estudiantes universitarios de México: 784 del Centro de Estudios Sup
eriores del Estado de Sonora, Hermosillo, Sonora, (33,2 por ciento del total de 
la matrícula de ese centro) y 562 de la Universidad Nacional Autónoma de México,
 campus Tlalnepantla, Estado de México (23,5 por ciento del total de estudiantes
 de ese centro). El trabajo se realizó en octubre de 2006 en Hermosillo y entre 
los meses de enero y marzo de 2006 en Tlalnepantla. La encuesta contenía 11 preg
untas sobre datos sociodemográficos, 7 sobre comportamientos sexuales de riesgo,
 22 sobre motivos subyacentes, 8 sobre las situaciones sociales y 6 sobre el est
ado biológico previo a la relación. Se evaluó la capacidad de comprensión de las
 preguntas, la validez conceptual y la confiabilidad del instrumento. RESULTADOS
: La versión definitiva del instrumento quedó constituida por 44 preguntas. En e
l análisis de confiabilidad se obtuvo un valor a de Cronbach global de 0,821, co
nsiderando todas las variables en su conjunto y agrupadas por factores. Se encon
traron tres factores (motivos para no usar preservativos en la primera relación 
sexual y a lo largo de la vida, motivos del uso inconsistente de preservativos c
on parejas ocasionales y disposición hacia la primera relación sexual y hacia la
 relación con parejas ocasionales) que en su conjunto explicaron 38,36 por cient
o de la varianza total. CONCLUSIÓN: Las propiedades psicométricas del instrument
o de encuesta evaluado fueron satisfactorias. Los interesados en aplicar este in
strumento deben familiarizarse con el modelo teórico que lo sustenta, ya que la 
interpretación de los resultados se basa en las definiciones de las diferentes v
ariables históricas y de contexto contempladas y en su interacción.#^dnd^i1#^tm^
les^kComportamiento^i1#^tm^les^kconducta del adolescente^i1#^tm^les^kconducta se
xual^i1#^tm^les^kasunción de riesgos^i1#^tm^les^kMéxico^i1#^len^aOBJECTIVES: To 
measure the psychometric attributes of a survey instrument designed to evaluate 
historical and context variables that lead to high-risk sexual behaviors among a
 sample of university students in Mexico. METHODS: Cross-sectional study of a sa
mple of 1 346 university students in Mexico: 784 from the Sonora State Center fo
r Higher Education in Hermosillo, Sonora, or 33.2 percent of its total enrollmen
t; and 562 from the National Autonomous University of Mexico, at Tlalnepantla ca
mpus in Mexico State, or 23.5 percent of its total enrollment. The study took pl
ace in Hermosillo during the month of October 2006 and in Tlalnepantla from Janu
ary to March 2006. The survey had 11 questions on sociodemographics, 7 on risky 
sexual behaviors, 22 on related motives, 8 on social context, and 6 on physical 
status prior to sexual relations. The survey was evaluated in terms of how well 
the questions were understood, its conceptual validity, and reliability. RESULTS
: The final version of the survey instrument was composed of 44 questions. The r
eliability analysis produced an overall Cronbach a value of 0.821, taking into a
ccount all the variables combined and grouped by factor. Three factors were foun
d that together accounted for 38.36 percent of the total variance: reasons for n
ot using a condom in the first sexual relationship or throughout life, reasons f
or inconsistent use of a condom with a casual sex partner, and willingness to be
come sexually active and to engage in casual sex. CONCLUSIONS: The psychometric 
attributes of this survey instrument were found to be satisfactory. Those intere
sted in using this instrument should become familiar with the theoretical model 
on which it is based, since understanding the results depends on properly defini
ng the historical and context variables, and their interaction.#^dnd^i2#^tm^len^
kSexual behavior^i2#^tm^len^krisk taking^i2#^tm^len^kunsafe sex^i2#^tm^len^kMexi
co^i2#Instituto Mexicano del Seguro Social#Fondo para el Fomento de la Investiga
ción#other#35#20061208#8 de diciembre de 2006#20070813#13 de agosto de 2007#a01v
22n5.htm#Internet^ihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S10
20-49892007001000001##
00357000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012400074002001300198#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#5#1#article#126#<p align="right"><fon
t size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEA
RCH</font></p>     ^cY#a01v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#6#2#article#126#<p>&nbsp;</p>     ^cY
#a01v22n5.htm##
00488000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704025500074002001300329#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#7#3#article#126#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>Instrumento para la evaluaci&oacute;n    de vari
ables psicol&oacute;gicas y comportamientos sexuales de riesgo en j&oacute;venes
    de dos centros universitarios de M&eacute;xico</b></font></p>     ^cY#a01v22
n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#8#4#article#126#<p>&nbsp;</p>     ^cY
#a01v22n5.htm##
00438000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704020500074002001300279#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#9#5#article#126#<p><font size="3" fac
e="verdana"><b>A survey instrument for evaluating psychological    variables and
 risky sexual behavior among young adults at two university centers    in Mexico
</b></font></p>     ^cY#a01v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#10#6#article#126#<p>&nbsp;</p>     ^c
Y#a01v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#11#7#article#126#<p>&nbsp;</p>     ^c
Y#a01v22n5.htm##
00448000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704021400075002001300289#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#12#8#article#126#<p><font size="2" fa
ce="Verdana"><b>Julio A. Pi&ntilde;a L&oacute;pez<sup>I, </sup><a href="#nt"><su
p>*</sup></a>;    Susana Robles Montijo<SUP>II</SUP>; Blanca M. Rivera Icedo<SUP
>III</sup></b></font></p>     ^cY#a01v22n5.htm##
00524000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704029000075002001300365#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#13#9#article#126#<p><FONT SIZE="2" fa
ce="Verdana"><SUP>I</sup>Investigador independiente, Hermosillo,    Sonora, M&ea
cute;xico. La correspondencia se debe dirigir a Julio A. Pi&ntilde;a    L&oacute
;pez, Guillermo Prieto No. 18, Col. Constituci&oacute;n, Hermosillo,    Sonora C
P 83150, M&eacute;xico    ^cY#a01v22n5.htm##
00418000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018300076002001300259#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#14#10#article#126#<br>   <SUP>II</sup
>Facultad de Estudios Superiores-Iztacala,    Universidad Nacional Aut&oacute;no
ma de M&eacute;xico, Tlalnepantla, Estado    de M&eacute;xico, M&eacute;xico    
^cY#a01v22n5.htm##
00428000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704019300076002001300269#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#15#11#article#126#<br>   <SUP>III</su
p>Unidad de Investigaci&oacute;n    Epidemiol&oacute;gica y Servicios de Salud, 
Instituto Mexicano del Seguro Social,    Hermosillo, Sonora, M&eacute;xico</font
></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#16#12#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#17#13#article#126#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a01v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#18#14#article#126#<p><font size="2" f
ace="VERDANA"><b>RESUMEN</b></font></p>     ^cY#a01v22n5.htm##
00572000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704033700076002001300413#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#19#15#article#126#<p><font size="2" f
ace="Verdana"><b>OBJETIVO:</b> Probar las propiedades psicom&eacute;tricas    de
 un instrumento de encuesta destinado a evaluar algunas variables hist&oacute;ri
cas    y de contexto que facilitan el comportamiento sexual de riesgo en una mue
stra    de estudiantes de dos centros universitarios de M&eacute;xico.    ^cY#a0
1v22n5.htm##
01203000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704096800076002001301044#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#20#16#article#126#<br>   <b>M&Eacute;
TODOS:</b> Estudio transversal con una muestra compuesta por 1 346    estudiante
s universitarios de M&eacute;xico: 784 del Centro de Estudios Superiores    del 
Estado de Sonora, Hermosillo, Sonora, (33,2% del total de la matr&iacute;cula   
 de ese centro) y 562 de la Universidad Nacional Aut&oacute;noma de M&eacute;xic
o,    campus Tlalnepantla, Estado de M&eacute;xico (23,5% del total de estudiant
es    de ese centro). El trabajo se realiz&oacute; en octubre de 2006 en Hermosi
llo    y entre los meses de enero y marzo de 2006 en Tlalnepantla. La encuesta c
onten&iacute;a    11 preguntas sobre datos sociodemogr&aacute;ficos, 7 sobre com
portamientos sexuales    de riesgo, 22 sobre motivos subyacentes, 8 sobre las si
tuaciones sociales y    6 sobre el estado biol&oacute;gico previo a la relaci&oa
cute;n. Se evalu&oacute;    la capacidad de comprensi&oacute;n de las preguntas,
 la validez conceptual y    la confiabilidad del instrumento.    ^cY#a01v22n5.ht
m##
00913000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704067800076002001300754#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#21#17#article#126#<br>   <b>RESULTADO
S:</b> La versi&oacute;n definitiva del instrumento qued&oacute;    constituida 
por 44 preguntas. En el an&aacute;lisis de confiabilidad se obtuvo    un valor a
 de Cronbach global de 0,821, considerando todas las variables en    su conjunto
 y agrupadas por factores. Se encontraron tres factores (motivos    para no usar
 preservativos en la primera relaci&oacute;n sexual y a lo largo    de la vida, 
motivos del uso inconsistente de preservativos con parejas ocasionales    y disp
osici&oacute;n hacia la primera relaci&oacute;n sexual y hacia la relaci&oacute;
n    con parejas ocasionales) que en su conjunto explicaron 38,36% de la varianz
a    total.    ^cY#a01v22n5.htm##
00689000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704045400076002001300530#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#22#18#article#126#<br>   <b>CONCLUSI&
Oacute;N:</b> Las propiedades psicom&eacute;tricas del instrumento    de encuest
a evaluado fueron satisfactorias. Los interesados en aplicar este    instrumento
 deben familiarizarse con el modelo te&oacute;rico que lo sustenta,    ya que la
 interpretaci&oacute;n de los resultados se basa en las definiciones    de las d
iferentes variables hist&oacute;ricas y de contexto contempladas y en    su inte
racci&oacute;n.</font></p>     ^cY#a01v22n5.htm##
00437000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704020200076002001300278#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#23#19#article#126#<p><font size="2" f
ace="Verdana"><b>Palabras clave:</b> Comportamiento, conducta    del adolescente
, conducta sexual, asunci&oacute;n de riesgos, M&eacute;xico.</font></p> <hr siz
e="1" noshade>     ^cY#a01v22n5.htm##
00304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006900076002001300145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#24#20#article#126#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font> </p>     ^cY#a01v22n5.htm##
00508000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704027300076002001300349#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#25#21#article#126#<p><font size="2" f
ace="Verdana"><b>OBJECTIVES:</b> To measure the psychometric    attributes of a 
survey instrument designed to evaluate historical and context    variables that 
lead to high-risk sexual behaviors among a sample of university    students in M
exico.    ^cY#a01v22n5.htm##
01020000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704078500076002001300861#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#26#22#article#126#<br>   <b>METHODS:<
/b> Cross-sectional study of    a sample of 1 346 university students in Mexico:
 784 from the Sonora State Center    for Higher Education in Hermosillo, Sonora,
 or 33.2% of its total enrollment;    and 562 from the National Autonomous Unive
rsity of Mexico, at Tlalnepantla campus    in Mexico State, or 23.5% of its tota
l enrollment. The study took place in Hermosillo    during the month of October 
2006 and in Tlalnepantla from January to March 2006.    The survey had 11 questi
ons on sociodemographics, 7 on risky sexual behaviors,    22 on related motives,
 8 on social context, and 6 on physical status prior to    sexual relations. The
 survey was evaluated in terms of how well the questions    were understood, its
 conceptual validity, and reliability.    ^cY#a01v22n5.htm##
00804000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056900076002001300645#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#27#23#article#126#<br>   <b>RESULTS:<
/b> The final version of the survey instrument was composed of 44    questions. 
The reliability analysis produced an overall Cronbach a value of    0.821, takin
g into account all the variables combined and grouped by factor.    Three factor
s were found that together accounted for 38.36% of the total variance:    reason
s for not using a condom in the first sexual relationship or throughout    life,
 reasons for inconsistent use of a condom with a casual sex partner, and    will
ingness to become sexually active and to engage in casual sex.    ^cY#a01v22n5.h
tm##
00614000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037900076002001300455#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#28#24#article#126#<br>   <b>CONCLUSIO
NS:</b> The psychometric attributes of this survey instrument were    found to b
e satisfactory. Those interested in using this instrument should become    famil
iar with the theoretical model on which it is based, since understanding    the 
results depends on properly defining the historical and context variables,    an
d their interaction.</font></p>     ^cY#a01v22n5.htm##
00379000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704014400076002001300220#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#29#25#article#126#<p><font size="2" f
ace="Verdana"><b>Keywords:</b> Sexual behavior, risk taking,    unsafe sex, Mexi
co.</font></p> <hr size="1" noshade>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#30#26#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#31#27#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00865000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704063000076002001300706#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#32#28#article#126#<p><font size="2" f
ace="Verdana">En M&eacute;xico, las autoridades sanitarias    ten&iacute;an regi
strados cerca de 105 000 casos de sida hasta noviembre de    2006, de los cuales
 alrededor de 89% adquirieron la infecci&oacute;n por la    v&iacute;a sexual (1
). Esto hace que el estudio de los factores y variables    que facilitan o previ
enen los comportamientos de riesgo en las relaciones sexuales    sea una tarea o
bligada y necesaria para dise&ntilde;ar e implementar programas    eficaces de i
ntervenci&oacute;n dirigidos a modificar esos comportamientos y    adoptar pr&aa
cute;cticas m&aacute;s seguras.</font></p>     ^cY#a01v22n5.htm##
00878000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704064300076002001300719#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#33#29#article#126#<p><font size="2" f
ace="Verdana">Varias investigaciones basadas en diferentes    modelos te&oacute;
ricos han demostrado que a pesar de los conocimientos sobre    el sida, el virus
 de inmunodeficiencia humana (VIH), los mecanismos de transmisi&oacute;n    de e
sa infecci&oacute;n y las formas de prevenirla, los adolescentes y los adultos  
  j&oacute;venes contin&uacute;an practicando comportamientos de riesgo. Entre  
  estos comportamientos destacan iniciar la vida sexual a edades tempranas, tene
r    relaciones sexuales con m&uacute;ltiples parejas y no utilizar preservativo
s    de manera consistente y correcta (2–6).</font></p>     ^cY#a01v22n5.htm##
01738000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704150300076002001301579#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#34#30#article#126#<p><font size="2" f
ace="Verdana">Para dar soluci&oacute;n a este problema es necesario    identific
ar las variables que pueden ayudar a predecir la tendencia a adoptar    comporta
mientos de riesgo, de manera que las autoridades y los profesionales    de la sa
lud puedan incidir eficazmente y reducir el riesgo de adquirir enfermedades    d
e transmisi&oacute;n sexual (7–8). A pesar de que los psic&oacute;logos mexicano
s    han emprendido m&uacute;ltiples esfuerzos en esa direcci&oacute;n, los resu
ltados    alcanzados hasta ahora han sido insuficientes. Esto puede deberse a la
s caracter&iacute;sticas    y las propias limitaciones de los modelos te&oacute;
ricos utilizados en las    investigaciones realizadas, en particular el de creen
cias en salud (9), el de    la acci&oacute;n razonada (10) y el de la autoeficac
ia (11). En estos modelos    se suele sobreestimar el papel de las variables cog
noscitivas —como los conocimientos,    actitudes, creencias, intenciones y autoe
ficacia, entre otras—, lo que implica    que se le confiera poca importancia a o
tras variables, como la personalidad,    la motivaci&oacute;n y el contexto soci
al en el que acaece la relaci&oacute;n    sexual. Como se sabe, en la interacci&
oacute;n entre dos o m&aacute;s personas    influyen la circunstancia social en 
la que ocurre esa interacci&oacute;n —de    amistad, de recreaci&oacute;n, de tr
abajo, de aprendizaje, etc&eacute;tera—    y el lugar en el que las personas ent
ran en contacto (12–15).</font></p>     ^cY#a01v22n5.htm##
00608000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037300076002001300449#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#35#31#article#126#<p><font size="2" f
ace="Verdana">Se requiere, por tanto, que las investigaciones    se apoyen en mo
delos te&oacute;ricos basados en variables concebidas de manera    interdependie
nte, que abarquen el an&aacute;lisis de los antecedentes y del    contexto socia
l y que se puedan evaluar de manera confiable y v&aacute;lida,    al igual que l
os resultados.</font></p>     ^cY#a01v22n5.htm##
01812000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704157700076002001301653#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#36#32#article#126#<p><font size="2" f
ace="Verdana">En un modelo psicol&oacute;gico orientado a la    prevenci&oacute;
n de las enfermedades (16) se se&ntilde;ala que la descripci&oacute;n    psicol&
oacute;gica en el proceso salud-enfermedad corresponde a la dimensi&oacute;n    
individualizada de las variables relacionadas con la interacci&oacute;n entre   
 los aspectos biol&oacute;gicos y socioculturales (<a href="#fig01">figura 1</a>
).    Los estilos de interacci&oacute;n —es decir, las maneras consistentes de c
omportamiento    en circunstancias sociales en las que no se especifica un crite
rio sobre c&oacute;mo    responder, referidas en la literatura especializada com
o personalidad— constituyen    la primera de esas variables. Un ejemplo de estil
o de interacci&oacute;n es    la tendencia al riesgo, que se manifiesta cuando u
na persona en una circunstancia    social espec&iacute;fica enfrenta dos opcione
s de respuesta: la primera, tener    una relaci&oacute;n sexual no protegida por
que espera una consecuencia positiva    inmediata —por ejemplo, gratificaci&oacu
te;n o placer sexual—, y la segunda,    evitar la relaci&oacute;n sexual aunque 
no se obtengan los beneficios esperados,    porque as&iacute; reduce la probabil
idad de obtener en el mediano o largo plazo    una consecuencia negativa —por ej
emplo, una infecci&oacute;n de transmisi&oacute;n    sexual o por el VIH—. Se ha
bla de una persona con tendencia al riesgo si en    circunstancias similares inv
ariablemente opta por la primera respuesta y se    comporta consistentemente de 
manera arriesgada.</font></p>     ^cY#a01v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#37#33#article#126#<p><a name="fig01">
</a></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#38#34#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#39#35#article#126#<p ALIGN="center"><
img src="/img/revistas/rpsp/v22n5/a01fig01.gif"></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#40#36#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00902000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704066700076002001300743#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#41#37#article#126#<p><font size="2" f
ace="Verdana">Otra de las variables que responden a la interacci&oacute;n    ent
re los aspectos biol&oacute;gicos del organismo y los socioculturales es    la h
istoria de competencias conductuales de la persona, que le permitieron en    el 
pasado, en contextos y circunstancias sociales diversas, cumplir con determinado
s    criterios que favorecieron o entorpecieron el cuidado y el mantenimiento de
    su salud. Por ejemplo, una persona que sab&iacute;a que el preservativo evit
a    enfermedades, lo utiliz&oacute; de manera consistente y eficaz en todas las
    relaciones sexuales en las que se involucr&oacute; en el pasado.</font></p> 
    ^cY#a01v22n5.htm##
01020000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704078500076002001300861#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#42#38#article#126#<p><font size="2" f
ace="Verdana">Los motivos —o motivaciones, seg&uacute;n el    lenguaje com&uacut
e;n— constituyen la tercera variable que define la elecci&oacute;n    o preferen
cia que tiene una persona por objetos, eventos u otras personas en    determinad
as situaciones sociales. La caracter&iacute;stica principal de esta    variable 
es que le da direccionalidad al comportamiento, es decir, hace m&aacute;s    o m
enos probable la pr&aacute;ctica de un comportamiento dado, en correspondencia  
  con situaciones o circunstancias sociales en las que dicho comportamiento es  
  valorado de cierta manera por la sociedad, por ejemplo, cuando una persona uti
liza    el cond&oacute;n en correspondencia con su uso y aceptaci&oacute;n por s
u grupo    social o pares.</font></p>     ^cY#a01v22n5.htm##
01326000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704109100076002001301167#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#43#39#article#126#<p><font size="2" f
ace="Verdana">Las tres variables expuestas son de tipo hist&oacute;rico    (refl
ejan los antecedentes). Sin embargo, ning&uacute;n comportamiento ocurre    fuer
a de un contexto determinado, ya que, por ejemplo, la decisi&oacute;n de    evit
ar una relaci&oacute;n sexual o involucrarse en ella, o de utilizar preservativo
s    siempre o no utilizarlos nunca, se toma en contextos y circunstancias socia
les    concretas. De esta forma, todo comportamiento se ve afectado por los ante
cedentes    aludidos —estilos de interacci&oacute;n o personalidad, historia de 
competencias    y motivos—, pero tambi&eacute;n por variables de contexto —de am
istad, recreaci&oacute;n,    aprendizaje, etc.— relacionadas con el lugar y las 
personas participantes. Finalmente,    se debe tener en cuenta el estado biol&oa
cute;gico previo a la relaci&oacute;n    sexual, que puede estar determinado por
 la excitaci&oacute;n o inhibici&oacute;n    producida por la privaci&oacute;n o
 la saciedad, o por el consumo de sustancias    como el alcohol o algunas drogas
 (8, 16–17).</font></p>     ^cY#a01v22n5.htm##
00607000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037200076002001300448#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#44#40#article#126#<p><font size="2" f
ace="Verdana">El objetivo del presente trabajo fue probar las    propiedades psi
com&eacute;tricas de un instrumento de encuesta destinado a evaluar    algunas v
ariables hist&oacute;ricas y de contexto que facilitan el comportamiento    sexu
al de riesgo en una muestra de estudiantes de dos centros universitarios    de M
&eacute;xico.</font></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#45#41#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00322000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008700076002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#46#42#article#126#<p><font size="3" f
ace="Verdana"><b>MATERIALES Y M&Eacute;TODOS</b></font></p>     ^cY#a01v22n5.htm
##
01183000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704094800076002001301024#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#47#43#article#126#<p><font size="2" f
ace="Verdana">Se realiz&oacute; un estudio transversal con    una muestra repres
entativa de los 4 601 estudiantes inscritos en dos centros    universitarios mex
icanos: el Centro de Estudios Superiores del Estado de Sonora,    en Hermosillo,
 Sonora, y la Universidad Nacional Aut&oacute;noma de M&eacute;xico,    campus T
lalnepantla, Estado de M&eacute;xico. Se realiz&oacute; un muestreo    estratifi
cado multiet&aacute;pico por planteles, a&ntilde;os de estudio (del    primero a
l quinto) y turnos de clases (matutino y vespertino). La poblaci&oacute;n    tot
al de estudiantes inscritos en ambas instituciones, seg&uacute;n los registros  
  oficiales proporcionados por los responsables de Servicios Escolares, era de  
  2 365 estudiantes en Hermosillo y de 2 236 en Tlalnepantla. El trabajo se real
iz&oacute;    en octubre de 2006 en Hermosillo y entre los meses de enero y marz
o de 2006    en Tlalnepantla.</font></p>     ^cY#a01v22n5.htm##
01536000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704130100076002001301377#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#48#44#article#126#<p><font size="2" f
ace="Verdana">Los criterios de inclusi&oacute;n fueron: estar    inscrito oficia
lmente en una de las carreras profesionales que se ofertaban    en las dos insti
tuciones, tener m&aacute;s de 17 y menos de 32 a&ntilde;os,    aceptar voluntari
amente participar en la investigaci&oacute;n y responder al    menos a 80,0% de 
las preguntas de la encuesta. En total, 146 estudiantes no    cumplieron con alg
uno de los criterios, por lo que la muestra definitiva qued&oacute;    conformad
a por 1 346 estudiantes: 784 de Hermosillo, pertenecientes a 39 de    los 78 gru
pos (33,2% del total de la matr&iacute;cula de ese centro) y 562 de    Tlalnepan
tla, de 25 de los 104 grupos (23,5% del total de estudiantes de ese    centro). 
La edad promedio fue de 20,3 a&ntilde;os (desviaci&oacute;n est&aacute;ndar    =
 2,3; edad m&iacute;nima: 17 a&ntilde;os; edad m&aacute;xima: 31 a&ntilde;os).  
  En el <a href="#qdr01">cuadro 1</a> se presentan las caracter&iacute;sticas   
 sociodemogr&aacute;ficas de la muestra de estudio. Como no se encontraron difer
encias    significativas entre ambas muestras, para efectos de este trabajo amba
s se consideraron    como una muestra &uacute;nica representativa de un mismo un
iverso. Ning&uacute;n    estudiante rechaz&oacute; participar.</font></p>     ^c
Y#a01v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#49#45#article#126#<p><a name="qdr01">
</a></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#50#46#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#51#47#article#126#<p ALIGN="center"><
img src="/img/revistas/rpsp/v22n5/a01qdr01.gif"></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#52#48#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00306000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007100076002001300147#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#53#49#article#126#<p><font size="2" f
ace="Verdana"><b>Instrumento</b></font></p>     ^cY#a01v22n5.htm##
01977000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704174200076002001301818#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#54#50#article#126#<p><font size="2" f
ace="Verdana">Dos autores del presente art&iacute;culo (JAPL    y SRM) elaboraro
n el instrumento de encuesta a partir de los supuestos te&oacute;ricos    de un 
modelo psicol&oacute;gico orientado a la prevenci&oacute;n de las enfermedades  
  (16). Originalmente, el instrumento constaba de 27 preguntas sobre las caracte
r&iacute;sticas    sociodemogr&aacute;ficas de los entrevistados, los comportami
entos de riesgo    y sus motivos (19). Luego se le a&ntilde;adieron otras 27 pre
guntas para abundar    sobre los comportamientos de riesgo —por ejemplo, las rel
aciones sexuales con    parejas ocasionales y el uso de preservativos con estas 
parejas—, los motivos,    las situaciones sociales y el estado biol&oacute;gico 
previo a cada relaci&oacute;n    sexual. La versi&oacute;n definitiva de la encu
esta qued&oacute; entonces conformada    por 11 preguntas sobre la informaci&oac
ute;n sociodemogr&aacute;fica, 7 sobre    los comportamientos sexuales de riesgo
, 22 sobre los motivos subyacentes, 8    sobre las situaciones sociales y 6 sobr
e el estado biol&oacute;gico previo a    la relaci&oacute;n. Entre las preguntas
 sobre los comportamientos de riesgo    estaban: la experiencia sexual, la edad 
a la que ocurri&oacute; la primera relaci&oacute;n    sexual con penetraci&oacut
e;n, el uso de preservativo en la primera relaci&oacute;n    sexual, el n&uacute
;mero de parejas sexuales a lo largo de la vida, las relaciones    con parejas o
casionales —parejas a las que no se conoc&iacute;a en el momento    de involucra
rse en una relaci&oacute;n sexual con penetraci&oacute;n— y el uso    inconsiste
nte de preservativos con las diferentes parejas a lo largo de la vida    y con l
as parejas ocasionales.</font></p>     ^cY#a01v22n5.htm##
00835000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704060000076002001300676#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#55#51#article#126#<p><font size="2" f
ace="Verdana">Las preguntas —sobre los motivos, las situaciones    sociales, el 
estado biol&oacute;gico antes de la relaci&oacute;n sexual y el    peso (seg&uac
ute;n una escala de Likert ascendente, de 4 puntos) que cada una    de las pregu
ntas tuvo en la decisi&oacute;n de proceder al acto sexual con penetraci&oacute;
n—    se formularon de manera independiente para la primera relaci&oacute;n sexu
al,    para las relaciones sexuales que hab&iacute;a tenido en su vida y para la
s relaciones    sexuales con parejas ocasionales (<a href="#qdr02">cuadro 2</a>)
.</font></p>     ^cY#a01v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#56#52#article#126#<p><a name="qdr02">
</a></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#57#53#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#58#54#article#126#<p ALIGN="center"><
img src="/img/revistas/rpsp/v22n5/a01qdr02.gif"></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#59#55#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00345000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011000076002001300186#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#60#56#article#126#<p><font size="2" f
ace="Verdana"><b>An&aacute;lisis estad&iacute;stico de los    datos</b></font></
p>     ^cY#a01v22n5.htm##
01266000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704103100076002001301107#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#61#57#article#126#<p><font size="2" f
ace="Verdana">Los datos se procesaron mediante el paquete estad&iacute;stico    
SPSS para Windows v. 12.0. En una primera fase se emple&oacute; la prueba de    
la t de Student para evaluar la capacidad de comprensi&oacute;n de cada una    d
e las preguntas. Estas se agruparon de acuerdo con su concepto central: los    m
otivos, las situaciones sociales y el estado biol&oacute;gico previo a la relaci
&oacute;n    sexual con penetraci&oacute;n y se sumaron las puntuaciones recibid
as por cada    grupo de preguntas, seg&uacute;n la escala de Likert, y se extraj
eron los valores    m&aacute;s bajos en el grupo 1 —inferiores o iguales al prim
er cuartil (percentil    25)— y m&aacute;s altos en el grupo 2 —superiores o igu
ales al tercer cuartil    (percentil 75)— seg&uacute;n el an&aacute;lisis de fre
cuencia. Se consider&oacute;    que se comprend&iacute;a una pregunta si la dife
rencia entre las puntuaciones    de ambos grupos era estad&iacute;sticamente sig
nificativa (<i>P</i> &lt; 0,05).</font></p>     ^cY#a01v22n5.htm##
01095000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704086000076002001300936#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#62#58#article#126#<p><font size="2" f
ace="Verdana">Posteriormente se comprob&oacute; la validez    conceptual del ins
trumento mediante el an&aacute;lisis factorial exploratorio    (m&eacute;todo de
 componentes principales) con rotaci&oacute;n varimax (normalizaci&oacute;n    d
e Kaiser). Para ello se parti&oacute; de tres criterios: que las puntuaciones   
 de las preguntas de cada uno de los grupos difirieran significativamente entre 
   s&iacute;; que cada pregunta obtuviera pesos factoriales iguales o superiores
    a 0,40; y que las preguntas no se repitieran en dos o m&aacute;s factores. P
or    &uacute;ltimo, se estim&oacute; la confiabilidad del instrumento mediante 
el    coeficiente <font face="Symbol">a</font> de Cronbach, para lo cual se cons
ideraron    los valores de cada uno de los factores y variables, y del instrumen
to en su    conjunto.</font></p>     ^cY#a01v22n5.htm##
00777000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704054200076002001300618#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#63#59#article#126#<p><font size="2" f
ace="Verdana">Se solicit&oacute; el consentimiento informado    por escrito de c
ada participante. El proyecto de investigaci&oacute;n fue aprobado    por los Co
mit&eacute;s de Investigaci&oacute;n y de &Eacute;tica del Hospital    Regional 
No. 2 del Instituto Mexicano del Seguro Social, en Hermosillo, Sonora,    y por 
el Comit&eacute; de Bio&eacute;tica de la Facultad de Estudios Superiores-Iztaca
la,    Universidad Nacional Aut&oacute;noma de M&eacute;xico, Tlalnepantla, Esta
do    de M&eacute;xico.</font></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#64#60#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#65#61#article#126#<p><font size="3" f
ace="Verdana"><b>RESULTADOS</b></font></p>     ^cY#a01v22n5.htm##
00339000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010400076002001300180#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#66#62#article#126#<p><font size="2" f
ace="Verdana"><b>Nivel de comprensi&oacute;n de las preguntas</b></font></p>    
 ^cY#a01v22n5.htm##
01499000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704126400076002001301340#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#67#63#article#126#<p><font size="2" f
ace="Verdana">Seg&uacute;n el an&aacute;lisis de la comprensi&oacute;n    de las
 preguntas con la prueba de la t de Student, solamente 4 de las 36 preguntas    
sobre motivos, situaciones sociales y estados biol&oacute;gicos moment&aacute;ne
os    no alcanzaron la significaci&oacute;n estad&iacute;stica esperada, lo que 
indic&oacute;    que no se comprendieron correctamente (<a href="#qdr02">cuadro 
2</a>). Estas    preguntas fueron: "porque exist&iacute;a una relaci&oacute;n af
ectiva con    la otra persona" (<i>t</i> = –0,683; <i>P</i> = 0,498) correspondi
ente    a la variable "motivos que subyacen a la primera relaci&oacute;n sexual 
   con penetraci&oacute;n"; "porque en ese momento no dispon&iacute;a    de uno"
 (<i>t</i> = –1,131; <i>P</i> = 0,265) de la variable "no us&oacute;    preserva
tivo en la primera relaci&oacute;n sexual con penetraci&oacute;n";    "porque en
 ese momento no dispon&iacute;a de uno" (<i>t</i> = –1,031;    <i>P</i> = 0,309)
 de la variable "motivo del uso inconsistente de preservativos    en toda la vid
a"; y "porque se present&oacute; la oportunidad de tenerlas"    (<i>t</i> = –0,9
67; <i>P</i> = 0,339) de la variable "motivos para tener    relaciones sexuales 
con parejas ocasionales".</font></p>     ^cY#a01v22n5.htm##
00329000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009400076002001300170#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#68#64#article#126#<p><font size="2" f
ace="Verdana"><b>Validez conceptual y confiabilidad</b></font></p>     ^cY#a01v2
2n5.htm##
01505000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704127000076002001301346#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#69#65#article#126#<p><font size="2" f
ace="Verdana">Seg&uacute;n los resultados del an&aacute;lisis    factorial explo
ratorio se eliminaron otras cinco preguntas por obtener pesos    factoriales men
ores que 0,40: "excitaci&oacute;n en la primera relaci&oacute;n    sexual" corre
spondiente a la variable "estado biol&oacute;gico";    "encontrarme paseando con
 la pareja", de la variable "situaciones    sociales previas a la primera relaci
&oacute;n sexual"; "encontrarme    con la pareja en una reuni&oacute;n" y "encon
trarme paseando con la    pareja", correspondientes a la variable "situaciones s
ociales previas    a tener relaciones con parejas ocasionales"; y "porque no dis
pon&iacute;a    de uno en ese momento" de la variable "motivo del uso inconsiste
nte    de preservativos con parejas ocasionales" (<a href="#qdr03">cuadro 3</a>)
.    Se encontraron tres factores (motivos para no usar preservativos en la prim
era    relaci&oacute;n sexual y a lo largo de la vida, motivos del uso inconsist
ente    del preservativos con parejas ocasionales y disposici&oacute;n hacia la 
primera    relaci&oacute;n sexual y hacia la relaci&oacute;n con parejas ocasion
ales) con    valores individuales superiores a 1, que en su conjunto explicaron 
38,36% de    la varianza total.</font></p>     ^cY#a01v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#70#66#article#126#<p><a name="qdr03">
</a></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#71#67#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#72#68#article#126#<p ALIGN="center"><
img src="/img/revistas/rpsp/v22n5/a01qdr03.gif"></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#73#69#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00761000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704052600076002001300602#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#74#70#article#126#<p><font size="2" f
ace="Verdana">Por &uacute;ltimo, en el an&aacute;lisis de confiabilidad    se ob
tuvo un valor <font face="Symbol">a</font> de Cronbach global de 0,821,    consi
derando todas las variables en su conjunto y agrupadas por factores. Como    res
ultado de este an&aacute;lisis y seg&uacute;n las previsiones del m&eacute;todo 
   se elimin&oacute; la pregunta "porque se present&oacute; la oportunidad"    c
orrespondiente a la variable "motivos para tener la primera relaci&oacute;n    s
exual".</font></p>     ^cY#a01v22n5.htm##
00492000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704025700076002001300333#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#75#71#article#126#<p><font size="2" f
ace="Verdana">En consecuencia, la versi&oacute;n definitiva    del instrumento q
ued&oacute; constituida por 44 preguntas. El instrumento validado    est&aacute;
 disponible libremente y se puede solicitar a los autores.</font></p>     ^cY#a0
1v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#76#72#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00311000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007600076002001300152#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#77#73#article#126#<p><font size="3" f
ace="Verdana"><b>DISCUSI&Oacute;N</b></font></p>     ^cY#a01v22n5.htm##
00665000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704043000076002001300506#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#78#74#article#126#<p><font size="2" f
ace="Verdana">Al aplicar las t&eacute;cnicas de la psicolog&iacute;a    a proble
mas relevantes de salud es necesario apoyarse en modelos te&oacute;ricos    que 
garanticen una mejor comprensi&oacute;n de la forma en que operan las diferentes
    variables psicol&oacute;gicas y de c&oacute;mo se relacionan con los comport
amientos    de riesgo que comprometen la salud de las personas (20–22).</font></
p>     ^cY#a01v22n5.htm##
00712000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704047700076002001300553#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#79#75#article#126#<p><font size="2" f
ace="Verdana">A partir de ese razonamiento, en este estudio    se demostraron la
s propiedades psicom&eacute;tricas de confiabilidad y validez    de un nuevo ins
trumento de encuesta, con un valor &oacute;ptimo global del coeficiente    a de 
Cronbach (0,821) y una adecuada relaci&oacute;n entre los diferentes comportamie
ntos    y las variables psicol&oacute;gicas estudiadas (motivos, estados biol&oa
cute;gicos    y situaciones sociales).</font></p>     ^cY#a01v22n5.htm##
01289000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704105400076002001301130#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#80#76#article#126#<p><font size="2" f
ace="Verdana">El instrumento empleado en este estudio tiene    algunas ventajas 
con respecto a otros elaborados y validados en M&eacute;xico    basados en presu
puestos te&oacute;ricos diferentes (23–25). En primer lugar,    la inclusi&oacut
e;n de variables hist&oacute;ricas y de contexto (motivos, estados    biol&oacut
e;gicos y situaciones sociales) debe permitir describir y explicar    m&aacute;s
 acertadamente los comportamientos de riesgo sexual. En segundo lugar,    este i
nstrumento se apoya en un modelo te&oacute;rico de tipo interactivo y    funcion
al, por lo que toma en cuenta el hecho de que las variables psicol&oacute;gicas 
   que determinan el comportamiento sexual de riesgo en las personas no operan  
  en un mismo nivel de complejidad. Entre las variables que pueden influir en   
 el comportamiento sexual de una persona en una situaci&oacute;n social determin
ada    est&aacute;n las motivaciones, el consumo de sustancias —como el alcohol 
y algunas    drogas— y la influencia de otras personas.</font></p>     ^cY#a01v2
2n5.htm##
01226000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704099100076002001301067#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#81#77#article#126#<p><font size="2" f
ace="Verdana">En ese sentido, no se trata tan solo de evaluar    si una persona 
practica un comportamiento de riesgo o de prevenci&oacute;n,    sino de identifi
car las variables asociadas con ese comportamiento tomando en    consideraci&oac
ute;n su nivel de complejidad. No es lo mismo cuando una persona    responde que
 ha tenido relaciones sexuales con penetraci&oacute;n con diferentes    parejas 
por la satisfacci&oacute;n o la gratificaci&oacute;n sexuales que experimenta,  
  que cuando responde que no ha tenido relaciones sexuales con penetraci&oacute;
n    por sus creencias religiosas (16–17, 26). En el primer caso, su comportamie
nto    se encuentra regulado por variables de contexto presentes en la situaci&o
acute;n    dada —variables situacionales o contextuales—, mientras que en el seg
undo caso,    la respuesta depende de variables que no inciden en la situaci&oac
ute;n, las    llamadas variables extrasituacionales o transituacionales.</font><
/p>     ^cY#a01v22n5.htm##
01198000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704096300076002001301039#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#82#78#article#126#<p><font size="2" f
ace="Verdana">Otro aspecto valioso del instrumento empleado    es que tanto las 
variables de contexto social como las relacionadas con los    estados biol&oacut
e;gicos se analizan seg&uacute;n el mismo modelo te&oacute;rico.    En numerosos
 estudios se informa que el uso de sustancias, como el alcohol o    las drogas, 
facilita la pr&aacute;ctica de diferentes comportamientos sexuales    de riesgo 
(27–30). Sin embargo, los estados biol&oacute;gicos deben entenderse    como eve
ntos que interact&uacute;an con otros, por ejemplo, los motivos y las    circuns
tancias sociales. Adem&aacute;s intervienen eventos relacionados con    la situa
ci&oacute;n previa a la relaci&oacute;n sexual, entre los que se encuentran    e
l lugar en el que ocurre el comportamiento de riesgo y las personas con las    q
ue se entra en contacto. Todos estos eventos contribuyen a hacer m&aacute;s    o
 menos probable un comportamiento de riesgo.</font></p>     ^cY#a01v22n5.htm##
00827000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704059200076002001300668#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#83#79#article#126#<p><font size="2" f
ace="Verdana">Como se muestra en la <a href="#fig01">figura    1</a>, los estado
s biol&oacute;gicos pueden interferir con el desempe&ntilde;o    de las competen
cias (fase del pasado) en situaciones sociales en las que se    acepta que el co
nsumo de sustancias antes de una relaci&oacute;n sexual puede    dar como result
ado momentos gratificantes en lo inmediato, al margen de la valoraci&oacute;n   
 que se haga de las posibles consecuencias negativas a mediano plazo, como la   
 adquisici&oacute;n de una infecci&oacute;n de transmisi&oacute;n sexual.</font>
</p>     ^cY#a01v22n5.htm##
01489000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704125400076002001301330#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#84#80#article#126#<p><font size="2" f
ace="Verdana">Este trabajo presenta algunas limitaciones. En    primer t&eacute;
rmino, si bien es cierto que se trabaj&oacute; con muestras    representativas d
e dos instituciones del noroeste y del centro del pa&iacute;s,    las conclusion
es pueden no reflejar las respuestas de los estudiantes de otras    institucione
s y de otras regiones, donde los patrones de comportamiento sexual    en diverso
s grupos de adolescentes son diferentes, en particular en lo relativo    al debu
t sexual y al uso de preservativo en la primera relaci&oacute;n con penetraci&oa
cute;n    (31). En segundo lugar, llama la atenci&oacute;n que se hayan eliminad
o algunas    variables relacionadas con los motivos y las situaciones sociales q
ue en otros    estudios desempe&ntilde;aron un papel clave en la predicci&oacute
;n de diversos    comportamientos de riesgo relacionados con el uso de preservat
ivos (32–35).    Es posible, sin embargo, que esta contradicci&oacute;n se deba 
a que estos resultados    se obtuvieron en una muestra de estudiantes de univers
idades p&uacute;blicas,    donde no necesariamente se responde igual a las misma
s motivaciones y situaciones    que en otras instituciones de otros municipios d
el pa&iacute;s.</font></p>     ^cY#a01v22n5.htm##
00752000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704051700076002001300593#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#85#81#article#126#<p><font size="2" f
ace="Verdana">En conclusi&oacute;n, los resultados del presente    estudio demos
traron las propiedades psicom&eacute;tricas satisfactorias del    instrumento de
 encuesta evaluado. Los interesados en aplicar este instrumento    deben familia
rizarse con el modelo te&oacute;rico que lo sustenta, ya que la    interpretaci&
oacute;n de los resultados se basa en las definiciones de las diferentes    vari
ables hist&oacute;ricas y de contexto contempladas y en su interacci&oacute;n.</
font></p>     ^cY#a01v22n5.htm##
00686000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704045100076002001300527#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#86#82#article#126#<p><font size="2" f
ace="Verdana"><b>Agradecimientos. </b>El presente trabajo cont&oacute;    con fi
nanciamiento del Instituto Mexicano del Seguro Social a trav&eacute;s    del Fon
do para el Fomento de la Investigaci&oacute;n (FOFOI, clave 2006/ 1A)1/017).    
Se agradece al M.C. Luis Enrique Fierros D&aacute;vila, de la Escuela de Psicolo
g&iacute;a    de la Universidad de Sonora, M&eacute;xico, por sus comentarios y 
sugerencias.</font></p>     ^cY#a01v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#87#83#article#126#<p>&nbsp;</p>     ^
cY#a01v22n5.htm##
00306000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007100076002001300147#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#88#84#article#126#<p><font size="3" f
ace="Verdana"><b>REFERENCIAS</b></font></p>     ^cY#a01v22n5.htm##
00452000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704020300078002001300281#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#89#85#article#126#1#<p><f
ont size="2" face="Verdana">1. Centro Nacional de SIDA. Registro de casos    de 
SIDA en M&eacute;xico hasta noviembre de 2006. M&eacute;xico: Secretar&iacute;a 
   de Salud; 2007.</font> </p>    ^cY#a01v22n5.htm##
00451000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704020200078002001300280#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#90#86#article#126#2#<p><f
ont size="2" face="Verdana"> 2. Nieto B, Izazola JA. Uso del cond&oacute;n    en
 hombres con pareja no estable de la ciudad de M&eacute;xico. Salud Publica    M
ex. 1999;41:85–94.</font></p>    ^cY#a01v22n5.htm##
00519000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704027000078002001300348#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#91#87#article#126#3#<p><f
ont size="2" face="Verdana"> 3. Villase&ntilde;or A, Caballero R, Hidalgo    A, 
Santos JL. Conocimiento objetivo y subjetivo sobre el VIH/SIDA como predictor   
 del uso de cond&oacute;n en adolescentes. Salud Publica Mex. 2003; 45(Supl.1):S
73–80.</font></p>    ^cY#a01v22n5.htm##
00598000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704034900078002001300427#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#92#88#article#126#4#<p><f
ont size="2" face="Verdana"> 4. Alfaro LB, Harada E, D&iacute;az-Loving R.    Fa
ctores psicosociales que determinan la intenci&oacute;n y uso del cond&oacute;n 
   en adolescentes. En: La psicolog&iacute;a social en M&eacute;xico. M&eacute;x
ico,    DF.: Asociaci&oacute;n Mexicana de Psicolog&iacute;a Social; 2000. Pp. 7
11–7.</font></p>    ^cY#a01v22n5.htm##
00483000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704023400078002001300312#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#93#89#article#126#5#<p><f
ont size="2" face="Verdana"> 5. Pi&ntilde;a JA, Corral V. Conocimientos y    mot
ivos asociados a comportamientos de riesgo y prevenci&oacute;n relacionados    c
on el SIDA. Av Psicol Clin Latinoam. 2001;19:7–24.</font></p>    ^cY#a01v22n5.ht
m##
00535000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704028600078002001300364#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#94#90#article#126#6#<p><f
ont size="2" face="Verdana"> 6. Robles S, Pi&ntilde;a JA, Fr&iacute;as B,    Rod
r&iacute;guez M, Barroso R, Moreno D. Predictores de conductas relacionadas    c
on el uso inconsistente de cond&oacute;n en estudiantes universitarios. Psicol  
  Salud. 2006;16:71–8.</font></p>    ^cY#a01v22n5.htm##
00548000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704029900078002001300377#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#95#91#article#126#7#<p><f
ont size="2" face="Verdana"> 7. Bay&eacute;s R. Aspectos psicol&oacute;gicos    
relacionados con el problema de la prevenci&oacute;n del SIDA. En: N&aacute;jera
    R. SIDA: de la biomedicina a la sociedad. Madrid: Ediciones de la Universida
d    Complutense; 1990. Pp. 377–90.</font></p>    ^cY#a01v22n5.htm##
00584000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704033500078002001300413#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#96#92#article#126#8#<p><f
ont size="2" face="Verdana"> 8. Bay&eacute;s R, Ribes E. Un modelo psicol&oacute
;gico    de prevenci&oacute;n de enfermedad: su aplicaci&oacute;n al caso del SI
DA. En:    Pi&ntilde;a JA. Psicolog&iacute;a y salud: aportes del an&aacute;lisi
s de la    conducta. Hermosillo, M&eacute;xico: UNISON; 1992. Pp. 1–21.</font></
p>    ^cY#a01v22n5.htm##
00405000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704015600078002001300234#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#97#93#article#126#9#<p><f
ont size="2" face="Verdana"> 9. Rosenstock IM. Historical origins of the    heal
th belief model. Health Educ Monogr. 1974;2: 328–35.</font></p>    ^cY#a01v22n5.
htm##
00461000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704021100079002001300290#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#98#94#article#126#10#<p><
font size="2" face="Verdana">10. Fishbein M, Azjen I. Belief, attitude, intentio
n    and behavior: an introduction to theory and research. Reading, Massachusset
ts:    Addison-Wesley; 1975.</font></p>    ^cY#a01v22n5.htm##
00410000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704016000079002001300239#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#99#95#article#126#11#<p><
font size="2" face="Verdana">11. Bandura A. Self-efficacy: toward a unifying    
theory of behavior change. Psychol Rev. 1977; 84:191–215.</font></p>    ^cY#a01v
22n5.htm##
00586000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704033500080002001300415#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#100#96#article#126#12#<p>
<font size="2" face="Verdana">12. Moreno San Pedro E, Roales-Nieto JJ. El modelo
    de creencias de salud: revisi&oacute;n te&oacute;rica, consideraci&oacute;n 
   cr&iacute;tica y propuesta alternativa. I: Hacia un an&aacute;lisis funcional
    de las creencias en salud. Rev Int Psicol Ter Psicol. 2003;3: 91–109.</font>
</p>    ^cY#a01v22n5.htm##
00434000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704018300080002001300263#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#101#97#article#126#13#<p>
<font size="2" face="Verdana">13. Pi&ntilde;a JA. Psicolog&iacute;a y VIH/SIDA: 
   aportaciones y asignaturas pendientes en M&eacute;xico. Higiene. 2003;5:184–9
.</font></p>    ^cY#a01v22n5.htm##
00462000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704021100080002001300291#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#102#98#article#126#14#<p>
<font size="2" face="Verdana">14. De Visser RO, Smith AMA. Which intention?    W
hose intention? Condom use and theories of individual decision making. Psychol  
  Health Med. 2004;9:193–204.</font></p>    ^cY#a01v22n5.htm##
00405000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704015400080002001300234#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#103#99#article#126#15#<p>
<font size="2" face="Verdana">15. Baranowski T. Integration of two models,    or
 dominance of one? J Health Psychol. 2005;10: 19–21.</font></p>    ^cY#a01v22n5.
htm##
00479000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022700081002001300308#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#104#100#article#126#16#<p
><font size="2" face="Verdana">16. Pi&ntilde;a JA. Variaciones sobre un modelo  
  psicol&oacute;gico de salud biol&oacute;gica: justificaci&oacute;n y desarroll
o.    Universitas Psychol. 2007;6 (en prensa).</font></p>    ^cY#a01v22n5.htm##
00416000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704016400081002001300245#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#105#101#article#126#17#<p
><font size="2" face="Verdana">17. Ribes E. Psicolog&iacute;a y salud: un an&aac
ute;lisis    conceptual. Barcelona: Mart&iacute;nez Roca; 1990.</font></p>    ^c
Y#a01v22n5.htm##
00652000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704040000081002001300481#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#106#102#article#126#18#<p
><font size="2" face="Verdana">18. Banco de M&eacute;xico. Informe anual 2006.  
  M&eacute;xico, D.F.: Banco de M&eacute;xico; 2007. Hallado en <a href="http://
www.banxico.org.mx/documents/{4EF1BFA3-67A1-F187-0DB0-1243591806B5}.pdf" target=
"_blank">http://www.banxico.org.mx/documents/    %7B4EF1BFA3-67A1-F187-0DB0-1243
591806 B5%7D.pdf</a>. Acceso el 2 de septiembre    de 2007.</font></p>    ^cY#a0
1v22n5.htm##
00486000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704023400081002001300315#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#107#103#article#126#19#<p
><font size="2" face="Verdana">19. Rodr&iacute;guez ML, Moreno D, Robles S,    D
&iacute;az-Gonz&aacute;lez E. El sida desde el modelo psicol&oacute;gico de    s
alud biol&oacute;gica. Psicol Salud. 2001;10: 161–75.</font></p>    ^cY#a01v22n5
.htm##
00661000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704040900081002001300490#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#108#104#article#126#20#<p
><font size="2" face="Verdana">20. Pi&ntilde;a JA, Molina C, Cota M. Validaci&oa
cute;n    de un instrumento que mide variables psicol&oacute;gicas y comportamie
ntos de    riesgo/prevenci&oacute;n para el SIDA. En: Vera-Villaroel P, Oblitas 
LA. Manual    de escalas y cuestionarios iberoamericanos en psicolog&iacute;a cl
&iacute;nica    y de la salud. Bogot&aacute;: PSICOM Editores; 2005.</font></p> 
   ^cY#a01v22n5.htm##
00518000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704026600081002001300347#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#109#105#article#126#21#<p
><font size="2" face="Verdana">21. Pi&ntilde;a JA, Robles S. Psicolog&iacute;a  
  y VIH/SIDA en M&eacute;xico: su prevenci&oacute;n con base en un modelo psicol
&oacute;gico    de salud biol&oacute;gica. Rev Psicopatol Psicol Clin. 2005;10:7
1–83.</font></p>    ^cY#a01v22n5.htm##
00481000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022900081002001300310#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#110#106#article#126#22#<p
><font size="2" face="Verdana">22. Pi&ntilde;a JA, Rivera BM. Psicolog&iacute;a 
   y salud: algunas reflexiones cr&iacute;ticas sobre su qu&eacute; y su para qu
&eacute;.    Universitas Psychol. 2006;5:669–79.</font></p>    ^cY#a01v22n5.htm#
#
00630000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704037800081002001300459#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#111#107#article#126#23#<p
><font size="2" face="Verdana">23. Alfaro LB, D&iacute;az-Loving R. An&aacute;li
sis    de conductas sexuales de riesgo ante el VIH, a trav&eacute;s del modelo d
e la    acci&oacute;n razonada en adolescentes. En: La psicolog&iacute;a social 
en M&eacute;xico.    M&eacute;xico, D.F.: Asociaci&oacute;n Mexicana de Psicolog
&iacute;a Social;    1996. Pp. 525–9.</font></p>    ^cY#a01v22n5.htm##
00493000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024100081002001300322#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#112#108#article#126#24#<p
><font size="2" face="Verdana">24. L&oacute;pez-Rosales F, Moral-de la Rubia    
J. Validaci&oacute;n de una escala de autoeficacia para la prevenci&oacute;n    
del SIDA en adolescentes. Salud Publica Mex. 2001;43:421–32.</font></p>    ^cY#a
01v22n5.htm##
00660000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704040800081002001300489#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#113#109#article#126#25#<p
><font size="2" face="Verdana">25. Sald&iacute;var A, Cedillo DE. Creencias    s
obre el uso del cond&oacute;n con pareja regular. En: S&aacute;nchez S, D&iacute
;az-Loving    R, Rivera S. La psicolog&iacute;a social en M&eacute;xico. M&eacut
e;xico, D.F.:    Asociaci&oacute;n Mexicana de Psicolog&iacute;a Social, Univers
idad Ju&aacute;rez    Aut&oacute;noma de Tabasco; 2006. Pp. 227–33.</font></p>  
  ^cY#a01v22n5.htm##
00576000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704032400081002001300405#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#114#110#article#126#26#<p
><font size="2" face="Verdana">26. D&iacute;az-Gonz&aacute;lez E, Rodr&iacute;gu
ez    ML, Moreno D, Fr&iacute;as B, Rodr&iacute;guez M, Barroso R, et al. Descri
pci&oacute;n    de un instrumento de evaluaci&oacute;n de competencias funcional
es relacionadas    con el VIH-SIDA. Psicol Salud. 2005;15:5–12.</font></p>    ^c
Y#a01v22n5.htm##
00520000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704026800081002001300349#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#115#111#article#126#27#<p
><font size="2" face="Verdana">27. Flores-Ortiz YG. The role of cultural and    
gender values in alcohol use patterns among Chicana/Latina high school and unive
rsity    students: implications for AIDS prevention. Int J Addictions. 1994;29:1
149–71.</font></p>    ^cY#a01v22n5.htm##
00558000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704030600081002001300387#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#116#112#article#126#28#<p
><font size="2" face="Verdana">28. Villagr&aacute;n VG, Alfaro ML, Torres MK.   
 Asociaci&oacute;n alcohol-sexo y autoconcepto en HSH. En: La psicolog&iacute;a 
   social en M&eacute;xico. M&eacute;xico, D.F.: Asociaci&oacute;n Mexicana de  
  Psicolog&iacute;a Social; 2004. Pp. 453–60.</font></p>    ^cY#a01v22n5.htm##
00471000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704021900081002001300300#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#117#113#article#126#29#<p
><font size="2" face="Verdana">29. Cook RL, Duncan C. Is there an association   
 between alcohol consumption and sexually transmitted diseases? A systematic    
review. Sex Trans Dis. 2005;32:156–64.</font></p>    ^cY#a01v22n5.htm##
00469000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704021700081002001300298#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#118#114#article#126#30#<p
><font size="2" face="Verdana">30. Stein JA, Rotheram-Borus MJ, Swenderman D,   
 Milburn NG. Predictors of sexual transmission behaviors among HIV-positive youn
g    men. AIDS Care. 2005;17:433–42.</font></p>    ^cY#a01v22n5.htm##
00533000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704028100081002001300362#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#119#115#article#126#31#<p
><font size="2" face="Verdana">31. Gayet C, Ju&aacute;rez F, Pedrosa LA, Magis  
  C. Uso del cond&oacute;n entre adolescentes mexicanos para la prevenci&oacute;
n    de las infecciones de transmisi&oacute;n sexual. Salud Publica Mex. 2003;45
    (Supl.5):S32–40.</font></p>    ^cY#a01v22n5.htm##
00456000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020400081002001300285#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#120#116#article#126#32#<p
><font size="2" face="Verdana">32. Pi&ntilde;a JA. Eventos disposicionales que  
  probabilizan la pr&aacute;ctica de conductas de riesgo para el VIH/SIDA. An   
 Psicol. 2004;20:23–32.</font></p>    ^cY#a01v22n5.htm##
00480000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022800081002001300309#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#121#117#article#126#33#<p
><font size="2" face="Verdana">33. Urquidi LE, Pi&ntilde;a JA. Efecto de los    
conocimientos, creencias y motivos sobre el uso de cond&oacute;n en hombres.    
Ense&ntilde;anza Invest Psicol. 2005;10:369–80.</font></p>    ^cY#a01v22n5.htm##
00493000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024100081002001300322#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#122#118#article#126#34#<p
><font size="2" face="Verdana">34. Pi&ntilde;a JA, Urquidi LE. Determinantes    
psicol&oacute;gicos del uso de cond&oacute;n en estudiantes de educaci&oacute;n 
   superior. Ense&ntilde;anza Invest Psicol. 2006;11:333–45.</font></p>    ^cY#a
01v22n5.htm##
00478000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022600081002001300307#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#123#119#article#126#35#<p
><font size="2" face="Verdana">35. Robles S, Pi&ntilde;a JA, Moreno D. Determina
ntes    del uso inconsistente del cond&oacute;n en mujeres que tienen sexo vagin
al,    oral y anal. An Psicol. 2006;22:200–4.</font></p>    ^cY#a01v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#124#120#article#126#<p>&nbsp;</p>    
 ^cY#a01v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#125#121#article#126#<p>&nbsp;</p>    
 ^cY#a01v22n5.htm##
00324000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008700078002001300165#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#126#122#article#126#<p><font size="2"
 face="Verdana">Manuscrito recibido el 8 de diciembre de 2006.    ^cY#a01v22n5.h
tm##
00344000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010700078002001300185#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#127#123#article#126#<br>   Aceptado p
ara publicaci&oacute;n, tras revisi&oacute;n, el 13 de agosto de 2007.</font></p
>     ^cY#a01v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#128#124#article#126#<p>&nbsp;</p>    
 ^cY#a01v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#129#125#article#126#<p>&nbsp;</p>    
 ^cY#a01v22n5.htm##
00417000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704018000078002001300258#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a01v22n5.htm#S#p#130#126#article#126#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> Correo electr&oacute;nico: 
   <a href="mailto:ja_pina@hotmail.com">ja_pina@hotmail.com</a></font></p>     ^
cY#a01v22n5.htm##
00458000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170024000770180064001010660
00700165062002000172065000900192064000500201865000900206002001300215#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#131#1#article#35#1#Centro Naciona
l de SIDA#Registro de casos de SIDA en México hasta noviembre de 2006^les#México
#Secretaría de Salud#20070000#2007#20071100#a01v22n5.htm##
00517000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100018000920120
07500110030001900185710000200204065000900206064000500215031000300220014000600223
865000900229002001300238#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#132#2#article#35#2#^rND^sNieto^nB#^rND^sIzazola^nJA#Uso del condón en hombres
 con pareja no estable de la ciudad de México^les#Salud Publica Mex.#2#19990000#
1999#41#85-94#20071100#a01v22n5.htm##
00628000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100019000970100
01700116010001700133012010500150030001900255710000200274065000900276064000500285
031000300290032000400293014000700297865000900304002001300313#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a01v22n5.htm#S#c#133#3#article#35#3#^rND^sVillaseñor^nA#^r
ND^sCaballero^nR#^rND^sHidalgo^nA#^rND^sSantos^nJL#Conocimiento objetivo y subje
tivo sobre el VIH/SIDA como predictor del uso de condón en adolescentes^les#Salu
d Publica Mex.#2#20030000#2003#45#^s1#S73-80#20071100#a01v22n5.htm##
00626000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100016000940100
02100110012008800131018003500219066001100254062004100265065000900306064000500315
014000600320865000900326002001300335#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
1v22n5.htm#S#c#134#4#article#35#4#^rND^sAlfaro^nLB#^rND^sHarada^nE#^rND^sDíaz-Lo
ving^nR#Factores psicosociales que determinan la intención y uso del condón en a
dolescentes^les#La psicología social en México^les#México^eDF#Asociación Mexican
a de Psicología Social#20000000#2000#711-7#20071100#a01v22n5.htm##
00549000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100016000920120
10400108030002500212710000200237065000900239064000500248031000300253014000500256
865000900261002001300270#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#135#5#article#35#5#^rND^sPiña^nJA#^rND^sCorral^nV#Conocimientos y motivos aso
ciados a comportamientos de riesgo y prevención relacionados con el SIDA^les#Av 
Psicol Clin Latinoam.#2#20010000#2001#19#7-24#20071100#a01v22n5.htm##
00656000000000313000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100016000770100015000930100
01500108010001900123010001700142010001600159012010700175030001400282710000200296
065000900298064000500307031000300312014000500315865000900320002001300329#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#136#6#article#35#6#^rND^sRobl
es^nS#^rND^sPiña^nJA#^rND^sFrías^nB#^rND^sRodríguez^nM#^rND^sBarroso^nR#^rND^sMo
reno^nD#Predictores de conductas relacionadas con el uso inconsistente de condón
 en estudiantes universitarios^les#Psicol Salud.#2#20060000#2006#16#71-8#2007110
0#a01v22n5.htm##
00587000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770120081000920160
01600173018004200189066000700231062004000238065000900278064000500287014000700292
865000900299002001300308#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#137#7#article#35#7#^rND^sBayés^nR#Aspectos psicológicos relacionados con el p
roblema de la prevención del SIDA^les#^rND^sNájera^nR#SIDA: de la biomedicina a 
la sociedad^les#Madrid#Ediciones de la Universidad Complutense#19900000#1990#377
-90#20071100#a01v22n5.htm##
00624000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100015000920120
08600107016001500193018006000208066001100268067000700279062000700286065000900293
064000500302014000500307865000900312002001300321#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a01v22n5.htm#S#c#138#8#article#35#8#^rND^sBayés^nR#^rND^sRibes^nE#Un m
odelo psicológico de prevención de enfermedad: su aplicación al caso del SIDA^le
s#^rND^sPiña^nJA#Psicología y salud: aportes del análisis de la conducta^les#Her
mosillo#México#UNISON#19920000#1992#1-21#20071100#a01v22n5.htm##
00469000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100021000770120050000980300
02000148710000200168065000900170064000500179031000200184014000700186865000900193
002001300202#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#139#9#art
icle#35#9#^rND^sRosenstock^nIM#Historical origins of the health belief model^len
#Health Educ Monogr.#2#19740000#1974#2#328-35#20071100#a01v22n5.htm##
00514000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160018000790160015000970180
08500112066002400197062001500221065000900236064000500245865000900250002001300259
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#140#10#article#35#10#
^rND^sFishbein^nM#^rND^sAzjen^nI#Belief, attitude, intention and behavior: an in
troduction to theory and research^len#Reading^eMassachussetts#Addison-Wesley#197
50000#1975#20071100#a01v22n5.htm##
00475000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790120063000960300
01300159710000200172065000900174064000500183031000300188014000800191865000900199
002001300208#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#141#11#ar
ticle#35#11#^rND^sBandura^nA#Self-efficacy: toward a unifying theory of behavior
 change^len#Psychol Rev.#2#19770000#1977#84#191-215#20071100#a01v22n5.htm##
00627000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100026000790100023001050120
15900128030002700287710000200314065000900316064000500325031000200330014000700332
865000900339002001300348#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#142#12#article#35#12#^rND^sMoreno San Pedro^nE#^rND^sRoales-Nieto^nJJ#El mode
lo de creencias de salud: revisión teórica, consideración crítica y propuesta al
ternativa. I: Hacia un análisis funcional de las creencias en salud^les#Rev Int 
Psicol Ter Psicol.#2#20030000#2003#3#91-109#20071100#a01v22n5.htm##
00505000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790120075000940300
00800169065000900177064000500186031000200191014000600193865000900199002001300208
035001000221801000800231#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#143#13#article#35#13#^rND^sPiña^nJA#Psicología y VIH/SIDA: aportaciones y asi
gnaturas pendientes en México^les#Higiene#20030000#2003#5#184-9#20071100#a01v22n
5.htm#0437-4495#HIGIENE##
00543000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100017000990120
09300116030002000209710000200229065000900231064000500240031000200245014000800247
865000900255002001300264#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#144#14#article#35#14#^rND^sDe Visser^nRO#^rND^sSmith^nAMA#Which intention?: W
hose intention? Condom use and theories of individual decision making^len#Psycho
l Health Med.#2#20040000#2004#9#193-204#20071100#a01v22n5.htm##
00470000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790120052000990300
01800151710000200169065000900171064000500180031000300185014000600188865000900194
002001300203#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#145#15#ar
ticle#35#15#^rND^sBaranowski^nT#Integration of two models, or dominance of one?^
len#J Health Psychol.#2#20050000#2005#10#19-21#20071100#a01v22n5.htm##
00510000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790120091000940300
02100185710000200206065000900208064000500217031000200222061001000224865000900234
002001300243#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#146#16#ar
ticle#35#16#^rND^sPiña^nJA#Variaciones sobre un modelo psicológico de salud biol
ógica: justificación y desarrollo^les#Universitas Psychol.#2#20070000#2007#6#en 
prensa#20071100#a01v22n5.htm##
00431000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160015000790180047000940660
01000141062001400151065000900165064000500174865000900179002001300188#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#147#17#article#35#17#^rND^sRibes^
nE#Psicología y salud: un análisis conceptual^les#Barcelona#Martínez Roca#199000
00#1990#20071100#a01v22n5.htm##
00567000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170016000790180023000950660
01300118062001600131065000900147064000500156037008500161110000900246109002400255
865000900279002001300288#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#148#18#article#35#18#Banco de México#Informe anual 2006^les#México^eD.F.#Banc
o de México#20070000#2007#http://www.banxico.org.mx/documents/ %7B4EF1BFA3-67A1-
F187-0DB0-1243591806 B5%7D.pdf#20070902#2 de septiembre de 2007#20071100#a01v22n
5.htm##
00565000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100016000990100
01600115010002300131012005900154030001400213710000200227065000900229064000500238
031000300243014000700246865000900253002001300262#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a01v22n5.htm#S#c#149#19#article#35#19#^rND^sRodríguez^nML#^rND^sMoreno
^nD#^rND^sRobles^nS#^rND^sDíaz-González^nE#El sida desde el modelo psicológico d
e salud biológica^les#Psicol Salud.#2#20010000#2001#10#161-75#20071100#a01v22n5.
htm##
00722000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100016000940100
01400110012011700124016002400241016001800265018009000283066000700373062001600380
065000900396064000500405865000900410002001300419#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a01v22n5.htm#S#c#150#20#article#35#20#^rND^sPiña^nJA#^rND^sMolina^nC#^
rND^sCota^nM#Validación de un instrumento que mide variables psicológicas y comp
ortamientos de riesgo/prevención para el SIDA^les#^rND^sVera-Villaroel^nP#^rND^s
Oblitas^nLA#Manual de escalas y cuestionarios iberoamericanos en psicología clín
ica y de la salud^les#Bogotá#PSICOM Editores#20050000#2005#20071100#a01v22n5.htm
##
00555000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100016000940120
10400110030002800214710000200242065000900244064000500253031000300258014000600261
865000900267002001300276#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#151#21#article#35#21#^rND^sPiña^nJA#^rND^sRobles^nS#Psicología y VIH/SIDA en 
México: su prevención con base en un modelo psicológico de salud biológica^les#R
ev Psicopatol Psicol Clin.#2#20050000#2005#10#71-83#20071100#a01v22n5.htm##
00525000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100017000940120
08000111030002100191710000200212065000900214064000500223031000200228014000700230
865000900237002001300246#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#152#22#article#35#22#^rND^sPiña^nJA#^rND^sRivera^nBM#Psicología y salud: algu
nas reflexiones críticas sobre su qué y su para qué^les#Universitas Psychol.#2#2
0060000#2006#5#669-79#20071100#a01v22n5.htm##
00630000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100021000960120
11600117018003500233066001300268062004100281065000900322064000500331014000600336
865000900342002001300351#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#153#23#article#35#23#^rND^sAlfaro^nLB#^rND^sDíaz-Loving^nR#Análisis de conduc
tas sexuales de riesgo ante el VIH, a través del modelo de la acción razonada en
 adolescentes^les#La psicología social en México^les#México^eD.F.#Asociación Mex
icana de Psicología Social#19960000#1996#525-9#20071100#a01v22n5.htm##
00551000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100027001020120
08900129030001900218710000200237065000900239064000500248031000300253014000700256
865000900263002001300272#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#154#24#article#35#24#^rND^sLópez-Rosales^nF#^rND^sMoral-de la Rubia^nJ#Valida
ción de una escala de autoeficacia para la prevención del SIDA en adolescentes^l
es#Salud Publica Mex.#2#20010000#2001#43#421-32#20071100#a01v22n5.htm##
00711000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100018000970120
05700115016001700172016002100189016001600210018003500226066001300261062004100274
062003900315065000900354064000500363014000700368865000900375002001300384#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#155#25#article#35#25#^rND^sSa
ldívar^nA#^rND^sCedillo^nDE#Creencias sobre el uso del condón con pareja regular
^les#^rND^sSánchez^nS#^rND^sDíaz-Loving^nR#^rND^sRivera^nS#La psicología social 
en México^les#México^eD.F.#Asociación Mexicana de Psicología Social#Universidad 
Juárez Autónoma de Tabasco#20060000#2006#227-33#20071100#a01v22n5.htm##
00686000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100020001020100
01600122010001500138010001900153010001700172810000600189012010500195030001400300
71000020031406500090031606400050032503100030033001400050033386500090033800200130
0347#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#156#26#article#35
#26#^rND^sDíaz-González^nE#^rND^sRodríguez^nML#^rND^sMoreno^nD#^rND^sFrías^nB#^r
ND^sRodríguez^nM#^rND^sBarroso^nR#et al#Descripción de un instrumento de evaluac
ión de competencias funcionales relacionadas con el VIH-SIDA^les#Psicol Salud.#2
#20050000#2005#15#5-12#20071100#a01v22n5.htm##
00581000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790120158001020300
01800260710000200278065000900280064000500289031000300294014000800297865000900305
002001300314#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#157#27#ar
ticle#35#27#^rND^sFlores-Ortiz^nYG#The role of cultural and gender values in alc
ohol use patterns among Chicana/Latina high school and university students: impl
ications for AIDS prevention^len#Int J Addictions.#2#19940000#1994#29#1149-71#20
071100#a01v22n5.htm##
00593000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100017000990100
01700116012005000133018003500183066001300218062004100231065000900272064000500281
014000700286865000900293002001300302#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
1v22n5.htm#S#c#158#28#article#35#28#^rND^sVillagrán^nVG#^rND^sAlfaro^nML#^rND^sT
orres^nMK#Asociación alcohol-sexo y autoconcepto en HSH^les#La psicología social
 en México^les#México^eD.F.#Asociación Mexicana de Psicología Social#20040000#20
04#453-60#20071100#a01v22n5.htm##
00551000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100016000940120
11200110030001500222710000200237065000900239064000500248031000300253014000700256
865000900263002001300272#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#159#29#article#35#29#^rND^sCook^nRL#^rND^sDuncan^nC#Is there an association b
etween alcohol consumption and sexually transmitted diseases?: A systematic revi
ew^len#Sex Trans Dis.#2#20050000#2005#32#156-64#20071100#a01v22n5.htm##
00584000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100025000950100
02000120010001800140012007700158030001100235710000200246065000900248064000500257
031000300262014000700265865000900272002001300281#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a01v22n5.htm#S#c#160#30#article#35#30#^rND^sStein^nJA#^rND^sRotheram-B
orus^nMJ#^rND^sSwenderman^nD#^rND^sMilburn^nNG#Predictors of sexual transmission
 behaviors among HIV-positive young men^len#AIDS Care.#2#20050000#2005#17#433-42
#20071100#a01v22n5.htm##
00624000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100016000940100
01800110010001500128012010800143030001900251710000200270065000900272064000500281
031000300286032000400289014000700293865000900300002001300309#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a01v22n5.htm#S#c#161#31#article#35#31#^rND^sGayet^nC#^rND^
sJuárez^nF#^rND^sPedrosa^nLA#^rND^sMagis^nC#Uso del condón entre adolescentes me
xicanos para la prevención de las infecciones de transmisión sexual^les#Salud Pu
blica Mex.#2#20030000#2003#45#^s5#S32-40#20071100#a01v22n5.htm##
00503000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790120097000940300
01100191710000200202065000900204064000500213031000300218014000600221865000900227
002001300236#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S#c#162#32#ar
ticle#35#32#^rND^sPiña^nJA#Eventos disposicionales que probabilizan la práctica 
de conductas de riesgo para el VIH/SIDA^les#An Psicol.#2#20040000#2004#20#23-32#
20071100#a01v22n5.htm##
00538000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100015000970120
08700112030002500199710000200224065000900226064000500235031000300240014000700243
865000900250002001300259#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#163#33#article#35#33#^rND^sUrquidi^nLE#^rND^sPiña^nJA#Efecto de los conocimie
ntos, creencias y motivos sobre el uso de condón en hombres^les#Enseñanza Invest
 Psicol.#2#20050000#2005#10#369-80#20071100#a01v22n5.htm##
00537000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100018000940120
08600112030002500198710000200223065000900225064000500234031000300239014000700242
865000900249002001300258#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a01v22n5.htm#S
#c#164#34#article#35#34#^rND^sPiña^nJA#^rND^sUrquidi^nLE#Determinantes psicológi
cos del uso de condón en estudiantes de educación superior^les#Enseñanza Invest 
Psicol.#2#20060000#2006#11#333-45#20071100#a01v22n5.htm##
00561000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100015000950100
01600110012009900126030001100225710000200236065000900238064000500247031000300252
014000600255865000900261002001300270#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
1v22n5.htm#S#c#165#35#article#35#35#^rND^sRobles^nS#^rND^sPiña^nJA#^rND^sMoreno^
nD#Determinantes del uso inconsistente del condón en mujeres que tienen sexo vag
inal, oral y anal^les#An Psicol.#2#20060000#2006#22#200-4#20071100#a01v22n5.htm#
#
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#o#1#1#article#1
#20080121#151811#a02v22n5.htm#123##
05062000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201030016701201160
02700100032003860100029004180100032004470110044004790700054005230831591005770850
00802168085003002176085002902206085002102235085002102256085003002277085002202307
08500220232908317220235108500080407308500300408108500260411108500420413708500420
41790850024042210850022042450580008042670580023042751170006042980720003043041120
00904307111001304316114000904329113001304338002001304351#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a02v22n5.htm#S#h#2#1#article#1#oa#en#br1.1#1#3.1#TAB#02#RPSP02
0#nd#Rev Panam Salud Publica#22#5#20071100#^f304^l307#1020-4989#The diabetes-rel
ated attitudes of health care professionals and persons with diabetes in Argenti
na^len#Actitudes relacionadas con la diabetes en los profesionales sanitarios y 
las personas con diabetes en Argentina^les#^rND^1A01^nJuan J.^sGagliardino#^rND^
1A01^nClaudio^sGonzález#^rND^1A01^nJoaquín E.^sCaporale#Diabetes Education Study
 Group of Argentina#Center of Experimental and Applied Endocrinology^iA01#^len^a
OBJECTIVE: To test diabetes-related attitudes of health care team members (HCTMs
) and people with diabetes in a developing country, in this case, Argentina. MET
HODS: The third version of the Diabetes Attitudes Scale (DAS-3) was randomly adm
inistered, in person, to 252 HCTMs (nurses, nutritionists, physicians, podiatris
ts, and social workers) and 279 people with type 1 or type 2 diabetes mellitus i
n several provinces of Argentina in 2004. Data from 531 completed questionnaires
 were included in the study. The data were statistically analyzed using analysis
 of variance, covariance, chi-square, and t-tests. RESULTS: Although few, the di
fferences in attitudes of HCTMs and people with diabetes were significant. The t
wo groups expressed only slight agreement on DAS-3 statements such as "seriousne
ss of type 2 diabetes," "value of tight control," and "psychosocial impact of di
abetes;" and disagreed completely on "patient autonomy." No significant differen
ces were recorded between people with type 1 or type 2 diabetes regarding "serio
usness of the disease," but from both groups, those individuals who had previous
ly attended a diabetes education course assigned this statement a higher score (
P < 0.01). CONCLUSIONS: The unfavorable trend among the participants, similar to
 that recorded in developed countries, would contribute to the poor treatment ou
tcomes observed in people with type 2 diabetes. Changing these attitudes by mean
s of education could contribute to improving the quality of care and of life for
 people with diabetes and to decreasing the cost of the disease.#^dnd^i1#^tm^len
^kDiabetes mellitus^i1#^tm^len^khealth knowledge^i1#^tm^len^kattitude^i1#^tm^len
^kpractice^i1#^tm^len^kpatient care team^i1#^tm^len^kself care^i1#^tm^len^kArgen
tina^i1#^les^aOBJETIVO: Analizar las actitudes relacionadas con la diabetes en l
os miembros del equipo de salud (MES) y las personas con diabetes en un país en 
desarrollo, Argentina. MÉTODOS: Se administró de forma aleatoria la tercera vers
ión de la Escala de Actitudes en la Diabetes (DAS-3) a 252 MES (enfermeros, nutr
iólogos, médicos, podólogos y trabajadores sociales) y a 279 personas con diabet
es mellitus tipos 1 ó 2 en varias provincias de Argentina en 2004. Los datos de 
531 cuestionarios respondidos se evaluaron mediante análisis de varianza y covar
ianza, y las pruebas de la t y de la ji al cuadrado. RESULTADOS: Aunque pocas, l
as diferencias entre las actitudes de los MES y de las personas con diabetes fue
ron significativas. Los dos grupos mostraron solamente una ligera coincidencia e
n algunos aspectos del DAS-3, como "importancia de la diabetes tipo 2", "el valo
r de un riguroso control" y "el impacto psicosocial de la diabetes" y difirieron
 totalmente en cuanto a "la autonomía del paciente". No se encontraron diferenci
as significativas entre los pacientes con diabetes tipos 1 y 2 en cuanto a "impo
rtancia de la diabetes", sin embargo, en ambos grupos las personas que habían as
istido a algún curso educativo sobre diabetes le asignaron una mayor puntuación 
a este aspecto (P < 0,01). CONCLUSIONES: La tendencia desfavorable encontrada en
 los participantes de este estudio, similar a la observada en otros países en de
sarrollo, puede haber contribuido a los insatisfactorios resultados del tratamie
nto en las personas con diabetes tipo 2. Cambiar estas actitudes mediante la edu
cación puede ayudar a mejorar la calidad de la atención y de la vida de los diab
éticos y a reducir los costos de esta enfermedad.#^dnd^i2#^tm^les^kDiabetes mell
itus^i2#^tm^les^kconocimientos^i2#^tm^les^kactitudes y práctica en salud^i2#^tm^
les^kgrupo de atención al paciente^i2#^tm^les^kautocuidado^i2#^tm^les^kArgentina
^i2#CONICET#Novo Nordisk Argentina#other#27#20060308#8 March 2006#20070628#28 Ju
ne 2007#a02v22n5.htm##
05166000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201100016701201230
02770100032004000100029004320100032004610110051004930700054005440831636005980850
00802234085003002242085002902272085002102301085002102322085003002343085002202373
08500220239508317600241708500080417708500300418508500260421508500420424108500420
42830850024043250850022043490580008043710580023043791170006044020720003044081120
00904411111001304420114000904433113001304442002001304455#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a02v22n5.htm#S#f#3#1#article#1#oa#en#br1.1#1#3.1#TAB#02#RPSP02
0#nd#Rev Panam Salud Publica#22#5#20071100#^f304^l307#1020-4989#<B>The diabetes-
related attitudes of health care professionals and persons with diabetes in Arge
ntina</B>^len#<B>Actitudes relacionadas con la diabetes en los profesionales san
itarios y las personas con diabetes en Argentina</B>^les#^rND^1A01^nJuan J.^sGag
liardino#^rND^1A01^nClaudio^sGonzález#^rND^1A01^nJoaquín E.^sCaporale#<B>Diabete
s Education Study Group of Argentina</B>#Center of Experimental and Applied Endo
crinology^iA01#^len^a<B>OBJECTIVE:</B> To test diabetes-related attitudes of hea
lth care team members (HCTMs) and people with diabetes in a developing country, 
in this case, Argentina. <B>METHODS:</B> The third version of the Diabetes Attit
udes Scale (DAS-3) was randomly administered, in person, to 252 HCTMs (nurses, n
utritionists, physicians, podiatrists, and social workers) and 279 people with t
ype 1 or type 2 diabetes mellitus in several provinces of Argentina in 2004. Dat
a from 531 completed questionnaires were included in the study. The data were st
atistically analyzed using analysis of variance, covariance, chi-square, and <I>
t</I>-tests. <B>RESULTS:</B> Although few, the differences in attitudes of HCTMs
 and people with diabetes were significant. The two groups expressed only slight
 agreement on DAS-3 statements such as "seriousness of type 2 diabetes," "value 
of tight control," and "psychosocial impact of diabetes;" and disagreed complete
ly on "patient autonomy." No significant differences were recorded between peopl
e with type 1 or type 2 diabetes regarding "seriousness of the disease," but fro
m both groups, those individuals who had previously attended a diabetes educatio
n course assigned this statement a higher score (<I>P</I> &lt; 0.01). <B>CONCLUS
IONS:</B> The unfavorable trend among the participants, similar to that recorded
 in developed countries, would contribute to the poor treatment outcomes observe
d in people with type 2 diabetes. Changing these attitudes by means of education
 could contribute to improving the quality of care and of life for people with d
iabetes and to decreasing the cost of the disease.#^dnd^i1#^tm^len^kDiabetes mel
litus^i1#^tm^len^khealth knowledge^i1#^tm^len^kattitude^i1#^tm^len^kpractice^i1#
^tm^len^kpatient care team^i1#^tm^len^kself care^i1#^tm^len^kArgentina^i1#^les^a
<B>OBJETIVO:</B> Analizar las actitudes relacionadas con la diabetes en los miem
bros del equipo de salud (MES) y las personas con diabetes en un país en desarro
llo, Argentina. <B>MÉTODOS: </B>Se administró de forma aleatoria la tercera vers
ión de la Escala de Actitudes en la Diabetes (DAS-3) a 252 MES (enfermeros, nutr
iólogos, médicos, podólogos y trabajadores sociales) y a 279 personas con diabet
es mellitus tipos 1 ó 2 en varias provincias de Argentina en 2004. Los datos de 
531 cuestionarios respondidos se evaluaron mediante análisis de varianza y covar
ianza, y las pruebas de la t y de la ji al cuadrado. <B>RESULTADOS:</B> Aunque p
ocas, las diferencias entre las actitudes de los MES y de las personas con diabe
tes fueron significativas. Los dos grupos mostraron solamente una ligera coincid
encia en algunos aspectos del DAS-3, como "importancia de la diabetes tipo 2", "
el valor de un riguroso control" y "el impacto psicosocial de la diabetes" y dif
irieron totalmente en cuanto a "la autonomía del paciente". No se encontraron di
ferencias significativas entre los pacientes con diabetes tipos 1 y 2 en cuanto 
a "importancia de la diabetes", sin embargo, en ambos grupos las personas que ha
bían asistido a algún curso educativo sobre diabetes le asignaron una mayor punt
uación a este aspecto (<I>P</I> &lt; 0,01). <B>CONCLUSIONES:</B> La tendencia de
sfavorable encontrada en los participantes de este estudio, similar a la observa
da en otros países en desarrollo, puede haber contribuido a los insatisfactorios
 resultados del tratamiento en las personas con diabetes tipo 2. Cambiar estas a
ctitudes mediante la educación puede ayudar a mejorar la calidad de la atención 
y de la vida de los diabéticos y a reducir los costos de esta enfermedad.#^dnd^i
2#^tm^les^kDiabetes mellitus^i2#^tm^les^kconocimientos^i2#^tm^les^kactitudes y p
ráctica en salud^i2#^tm^les^kgrupo de atención al paciente^i2#^tm^les^kautocuida
do^i2#^tm^les^kArgentina^i2#CONICET#Novo Nordisk Argentina#other#27#20060308#8 M
arch 2006#20070628#28 June 2007#a02v22n5.htm##
05193000000000721000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201201030
01820120116002850100031004010100029004320100031004610110044004920700056005360831
59100592085000802183085003002191085002902221085002102250085002102271085003002292
08500220232208500220234408317220236608500080408808500300409608500260412608500420
41520850042041940850024042360850022042600580008042820580023042901170006043130720
00304319112000904322111001304331114000904344113001304353002001304366008009204379
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#l#4#1#article#1#^mNov.^
a2007#oa#en#br1.1#1#3.1#tab#02#RPSP020#nd#Rev. panam. salud pública#22#5#2007110
0#^f304^l307#1020-4989#The diabetes-related attitudes of health care professiona
ls and persons with diabetes in Argentina^len#Actitudes relacionadas con la diab
etes en los profesionales sanitarios y las personas con diabetes en Argentina^le
s#^rND^1A01^nJuan J^sGagliardino#^rND^1A01^nClaudio^sGonzález#^rND^1A01^nJoaquín
 E^sCaporale#Diabetes Education Study Group of Argentina#^iA01^1Center of Experi
mental and Applied Endocrinology#^len^aOBJECTIVE: To test diabetes-related attit
udes of health care team members (HCTMs) and people with diabetes in a developin
g country, in this case, Argentina. METHODS: The third version of the Diabetes A
ttitudes Scale (DAS-3) was randomly administered, in person, to 252 HCTMs (nurse
s, nutritionists, physicians, podiatrists, and social workers) and 279 people wi
th type 1 or type 2 diabetes mellitus in several provinces of Argentina in 2004.
 Data from 531 completed questionnaires were included in the study. The data wer
e statistically analyzed using analysis of variance, covariance, chi-square, and
 t-tests. RESULTS: Although few, the differences in attitudes of HCTMs and peopl
e with diabetes were significant. The two groups expressed only slight agreement
 on DAS-3 statements such as "seriousness of type 2 diabetes," "value of tight c
ontrol," and "psychosocial impact of diabetes;" and disagreed completely on "pat
ient autonomy." No significant differences were recorded between people with typ
e 1 or type 2 diabetes regarding "seriousness of the disease," but from both gro
ups, those individuals who had previously attended a diabetes education course a
ssigned this statement a higher score (P < 0.01). CONCLUSIONS: The unfavorable t
rend among the participants, similar to that recorded in developed countries, wo
uld contribute to the poor treatment outcomes observed in people with type 2 dia
betes. Changing these attitudes by means of education could contribute to improv
ing the quality of care and of life for people with diabetes and to decreasing t
he cost of the disease.#^dnd^i1#^tm^len^kDiabetes mellitus^i1#^tm^len^khealth kn
owledge^i1#^tm^len^kattitude^i1#^tm^len^kpractice^i1#^tm^len^kpatient care team^
i1#^tm^len^kself care^i1#^tm^len^kArgentina^i1#^les^aOBJETIVO: Analizar las acti
tudes relacionadas con la diabetes en los miembros del equipo de salud (MES) y l
as personas con diabetes en un país en desarrollo, Argentina. MÉTODOS: Se admini
stró de forma aleatoria la tercera versión de la Escala de Actitudes en la Diabe
tes (DAS-3) a 252 MES (enfermeros, nutriólogos, médicos, podólogos y trabajadore
s sociales) y a 279 personas con diabetes mellitus tipos 1 ó 2 en varias provinc
ias de Argentina en 2004. Los datos de 531 cuestionarios respondidos se evaluaro
n mediante análisis de varianza y covarianza, y las pruebas de la t y de la ji a
l cuadrado. RESULTADOS: Aunque pocas, las diferencias entre las actitudes de los
 MES y de las personas con diabetes fueron significativas. Los dos grupos mostra
ron solamente una ligera coincidencia en algunos aspectos del DAS-3, como "impor
tancia de la diabetes tipo 2", "el valor de un riguroso control" y "el impacto p
sicosocial de la diabetes" y difirieron totalmente en cuanto a "la autonomía del
 paciente". No se encontraron diferencias significativas entre los pacientes con
 diabetes tipos 1 y 2 en cuanto a "importancia de la diabetes", sin embargo, en 
ambos grupos las personas que habían asistido a algún curso educativo sobre diab
etes le asignaron una mayor puntuación a este aspecto (P < 0,01). CONCLUSIONES: 
La tendencia desfavorable encontrada en los participantes de este estudio, simil
ar a la observada en otros países en desarrollo, puede haber contribuido a los i
nsatisfactorios resultados del tratamiento en las personas con diabetes tipo 2. 
Cambiar estas actitudes mediante la educación puede ayudar a mejorar la calidad 
de la atención y de la vida de los diabéticos y a reducir los costos de esta enf
ermedad.#^dnd^i2#^tm^les^kDiabetes mellitus^i2#^tm^les^kconocimientos^i2#^tm^les
^kactitudes y práctica en salud^i2#^tm^les^kgrupo de atención al paciente^i2#^tm
^les^kautocuidado^i2#^tm^les^kArgentina^i2#CONICET#Novo Nordisk Argentina#other#
27#20060308#8 March 2006#20070628#28 June 2007#a02v22n5.htm#Internet^ihttp://www
.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001000002##
00356000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704012400073002001300197#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#5#1#article#92#<p align="right"><font
 size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEAR
CH</font></p>     ^cY#a02v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704002200073002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#6#2#article#92#<p>&nbsp;</p>     ^cY#
a02v22n5.htm##
00410000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704017800073002001300251#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#7#3#article#92#<p><font size="4" face
="verdana"><b><a name="tx"></a>The diabetes-related attitudes    of health care 
professionals and persons with diabetes in Argentina</b></font></p>     ^cY#a02v
22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704002200073002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#8#4#article#92#<p>&nbsp;</p>     ^cY#
a02v22n5.htm##
00406000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704017400073002001300247#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#9#5#article#92#<p><font size="3" face
="verdana"><b>Actitudes relacionadas con la diabetes en    los profesionales san
itarios y las personas con diabetes en Argentina</b></font></p>     ^cY#a02v22n5
.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#10#6#article#92#<p>&nbsp;</p>     ^cY
#a02v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#11#7#article#92#<p>&nbsp;</p>     ^cY
#a02v22n5.htm##
00501000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704026800074002001300342#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#12#8#article#92#<p><font size="2" fac
e="Verdana"><b>Juan J. Gagliardino<sup>I, </sup><a href="#nt"><sup>*</sup></a>; 
   Claudio Gonz&aacute;lez<sup>I</sup>; Joaqu&iacute;n E. Caporale<sup>I</sup>; 
   the Diabetes Education Study Group of Argentina<SUP>II</SUP></b></font></p>  
   ^cY#a02v22n5.htm##
00547000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704031400074002001300388#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#13#9#article#92#<p><FONT SIZE="2" fac
e="Verdana"><SUP>I</sup>Center of Experimental and Applied    Endocrinology (CEN
EXA–PAHO/WHO Collaborating Center for Diabetes Research, Education,    and Care)
 and National Council on Scientific and Technical Research (CONICET),    Nationa
l University of La Plata, La Plata, Argentina    ^cY#a02v22n5.htm##
00515000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704028100075002001300356#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#14#10#article#92#<br>   <SUP>II</sup>
Mirta Centeno, Patricia Chalabe,    Mar&iacute;a Charad&iacute;o, V&iacute;ctor 
Commendatore, Silvia Lapertosa,    Guillermo Marcucci, V&iacute;ctor Previtera, 
Rosa L. Raineri, Graciela Rubin,    Mar&iacute;a O. Szykowsky, and Mirta Villagr
a</font></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#15#11#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00278000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704004400075002001300119#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#16#12#article#92#<p>&nbsp;</p> <hr si
ze="1" noshade>     ^cY#a02v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704006800075002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#17#13#article#92#<p><font size="2" fa
ce="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a02v22n5.htm##
00444000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704021000075002001300285#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#18#14#article#92#<p><font size="2" fa
ce="Verdana"><b>OBJECTIVE:</b> To test diabetes-related attitudes    of health c
are team members (HCTMs) and people with diabetes in a developing    country, in
 this case, Argentina.    ^cY#a02v22n5.htm##
00731000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704049700075002001300572#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#19#15#article#92#<br>   <b>METHODS:</
b> The third version of the Diabetes Attitudes Scale (DAS-3) was    randomly adm
inistered, in person, to 252 HCTMs (nurses, nutritionists, physicians,    podiat
rists, and social workers) and 279 people with type 1 or type 2 diabetes    mell
itus in several provinces of Argentina in 2004. Data from 531 completed    quest
ionnaires were included in the study. The data were statistically analyzed    us
ing analysis of variance, covariance, chi-square, and <i>t</i>-tests.    ^cY#a02
v22n5.htm##
00889000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704065500075002001300730#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#20#16#article#92#<br>   <b>RESULTS:</
b> Although few, the differences in attitudes of HCTMs and people    with diabet
es were significant. The two groups expressed only slight agreement    on DAS-3 
statements such as "seriousness of type 2 diabetes," "value    of tight control,
" and "psychosocial impact of diabetes;" and    disagreed completely on "patient
 autonomy." No significant differences    were recorded between people with type
 1 or type 2 diabetes regarding "seriousness    of the disease," but from both g
roups, those individuals who had previously    attended a diabetes education cou
rse assigned this statement a higher score    (<i>P</i> &lt; 0.01).    ^cY#a02v2
2n5.htm##
00653000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704041900075002001300494#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#21#17#article#92#<br>   <b>CONCLUSION
S:</b> The unfavorable trend among the participants, similar to    that recorded
 in developed countries, would contribute to the poor treatment    outcomes obse
rved in people with type 2 diabetes. Changing these attitudes by    means of edu
cation could contribute to improving the quality of care and of    life for peop
le with diabetes and to decreasing the cost of the disease.</font></p>     ^cY#a
02v22n5.htm##
00427000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704019300075002001300268#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#22#18#article#92#<p><font size="2" fa
ce="Verdana"><b>Keywords:</b> Diabetes mellitus; health knowledge,    attitude, 
practice; patient care team; self care; Argentina. </font></p> <hr size="1" nosh
ade>     ^cY#a02v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704006800075002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#23#19#article#92#<p><font size="2" fa
ce="VERDANA"><b>RESUMEN</b></font> </p>     ^cY#a02v22n5.htm##
00463000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704022900075002001300304#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#24#20#article#92#<p><font size="2" fa
ce="Verdana"><b>OBJETIVO:</b> Analizar las actitudes relacionadas    con la diab
etes en los miembros del equipo de salud (MES) y las personas con    diabetes en
 un pa&iacute;s en desarrollo, Argentina.    ^cY#a02v22n5.htm##
00759000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704052500075002001300600#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#25#21#article#92#<br>   <b>M&Eacute;T
ODOS: </b>Se administr&oacute; de    forma aleatoria la tercera versi&oacute;n d
e la Escala de Actitudes en la Diabetes    (DAS-3) a 252 MES (enfermeros, nutri&
oacute;logos, m&eacute;dicos, pod&oacute;logos    y trabajadores sociales) y a 2
79 personas con diabetes mellitus tipos 1 &oacute;    2 en varias provincias de 
Argentina en 2004. Los datos de 531 cuestionarios    respondidos se evaluaron me
diante an&aacute;lisis de varianza y covarianza,    y las pruebas de la t y de l
a ji al cuadrado.    ^cY#a02v22n5.htm##
01017000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704078300075002001300858#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#26#22#article#92#<br>   <b>RESULTADOS
:</b> Aunque pocas, las diferencias    entre las actitudes de los MES y de las p
ersonas con diabetes fueron significativas.    Los dos grupos mostraron solament
e una ligera coincidencia en algunos aspectos    del DAS-3, como "importancia de
 la diabetes tipo 2", "el valor    de un riguroso control" y "el impacto psicoso
cial de la diabetes"    y difirieron totalmente en cuanto a "la autonom&iacute;a
 del paciente".    No se encontraron diferencias significativas entre los pacien
tes con diabetes    tipos 1 y 2 en cuanto a "importancia de la diabetes", sin em
bargo,    en ambos grupos las personas que hab&iacute;an asistido a alg&uacute;n
 curso    educativo sobre diabetes le asignaron una mayor puntuaci&oacute;n a es
te aspecto    (<i>P</i> &lt; 0,01).    ^cY#a02v22n5.htm##
00733000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704049900075002001300574#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#27#23#article#92#<br>   <b>CONCLUSION
ES:</b> La tendencia desfavorable encontrada en los participantes    de este est
udio, similar a la observada en otros pa&iacute;ses en desarrollo,    puede habe
r contribuido a los insatisfactorios resultados del tratamiento en    las person
as con diabetes tipo 2. Cambiar estas actitudes mediante la educaci&oacute;n    
puede ayudar a mejorar la calidad de la atenci&oacute;n y de la vida de los    d
iab&eacute;ticos y a reducir los costos de esta enfermedad.</font></p>     ^cY#a
02v22n5.htm##
00471000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704023700075002001300312#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#28#24#article#92#<p><font size="2" fa
ce="Verdana"><b>Palabras clave:</b> Diabetes mellitus; conocimientos,    actitud
es y pr&aacute;ctica en salud; grupo de atenci&oacute;n al paciente;    autocuid
ado, Argentina.</font></p> <hr size="1" noshade>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#29#25#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#30#26#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
01810000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704157600075002001301651#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#31#27#article#92#<p><font size="2" fa
ce="Verdana">Although the chronic complications of diabetes    can be effectivel
y prevented or delayed (1–4), most people with diabetes still    suffer from the
m. Poor quality of diabetes care may be responsible for the disconnect    betwee
n scientific knowledge and real world results. In fact, the quality of    care f
requently falls far short of the standards recommended by the American    Diabet
es Association (5) and what is considered "optimal" care in    the United States
 of America (6), as well as in countries in Latin America (7).    It has been sh
own that poor diabetes care is partly due to the prevalent, misguided    attitud
es of both health care providers and people with diabetes (8). Alternatively,   
 patients who report high levels of adherence to diabetes care and control have 
   more positive attitudes toward disease management (9). Since these conclusion
s    were obtained mainly from studies in developed countries, they could not be
    strictly applied to developing countries where the health scenario can be qu
ite    different. Therefore, a diabetes-related attitudes study in a developing 
country    was needed. Based on this need and the assumption that the study woul
d explain    the poor results of diabetes treatment in Argentina (10) and help d
efine appropriate    strategies for overcoming the issues identified, we surveye
d health care team    members (HCTMs) and people with diabetes. The questionnair
e employed for the    survey was the third version of the Diabetes Attitudes Sca
le (DAS-3) (11).</font></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#32#28#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008100075002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#33#29#article#92#<p><font size="3" fa
ce="Verdana"><b>MATERIALS AND METHODS</b></font></p>     ^cY#a02v22n5.htm##
00607000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704037300075002001300448#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#34#30#article#92#<p><font size="2" fa
ce="Verdana">In 2003, the Diabetes Education Study Group of    Argentina (DESGA)
 decided to evaluate diabetes-related attitudes of HCTMs and    people with diab
etes. Eleven of the 15 DESGA members, each with extensive experience    in diabe
tes treatment and control and with numerous diabetes patients, participated    i
n the study. </font></p>     ^cY#a02v22n5.htm##
01541000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704130700075002001301382#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#35#31#article#92#<p><font size="2" fa
ce="Verdana">The evaluation tool, DAS-3, has improved internal    reliability sc
ores and is shorter than earlier versions, thus becoming a valid    and reliable
 tool to measure diabetes-related attitudes. Further, it is suitable    for perf
orming comparisons across different groups, i.e. HCTM and/or people    with diab
etes. DAS-3 includes 33 statements that by different combinations are    resolve
d into five discrete subscales, namely, attitude toward (1) need for    special 
training to provide diabetes care, (2) seriousness of type 2 diabetes,    (3) va
lue of tight glucose control, (4) psychosocial impact of diabetes, and    (5) pa
tient autonomy. Each subscale is classified according to the following    possib
le scores: strongly agree = 5, agree = 4, neutral = 3, disagree = 2, and    stro
ngly disagree = 1. Consequently, while a score of 3 indicates almost no    clear
 definition, values above or below represent agreement or disagreement    with t
he corresponding statement of the subscale. DAS-3 was translated into    Spanish
, with the permission of Dr. Anderson, and validated in our population    (Cronb
ach’s <font face="Symbol">a</font>-coefficient 0.987, unpublished<a name="tx01">
</a><a href="#nt01"><SUP>1</SUP></a>)    before its implementation.</font></p>  
   ^cY#a02v22n5.htm##
00906000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704067200075002001300747#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#36#32#article#92#<p><font size="2" fa
ce="Verdana">Eleven DESGA members personally and sequentially    delivered appro
ximately 50 DAS-3 questionnaires each to HCTMs and people with    diabetes (simp
le access order), within their respective organizations, along    with an explan
ation of the study aims. The completed surveys were collected,    preserving the
 anonymity of those surveyed. Diabetes type was defined by the    patient’s clin
ical records. Since members of the DESGA belong to different regions    of the c
ountry and work in different health sectors (Public Health, Social Security,    
and Prepaid System), data were collected from all three health sectors. </font><
/p>     ^cY#a02v22n5.htm##
01194000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704096000075002001301035#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#37#33#article#92#<p><font size="2" fa
ce="Verdana">From a total of 542 questionnaires distributed,    531 (98%) were c
ollected from 252 HCTMs (46% physicians, 27% nurses, 12% nutritionists,    7% so
cial workers, 3% podiatrists, 5% educators), and 279 people with diabetes.    Th
irty-two percent of the patients had type 1 diabetes and the remaining 68%    ha
d type 2 diabetes. This percentage does not correspond to the low values of    p
eople with type 1 diabetes described in the adult general population, however,  
  similar figures to ours were found in diabetes-treated population databases   
 (7, 12). This difference is due to the large number of people with type 2 diabe
tes    who ignore their disease and to those who know it but do not receive any 
type    of treatment, while the opposite situation occurs among people with type
 1 diabetes    (13). Thirty percent of the patients had previously attended stru
ctured, educational    diabetes courses.</font></p>     ^cY#a02v22n5.htm##
00381000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704014700075002001300222#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#38#34#article#92#<p><font size="2" fa
ce="Verdana">The data collected were statistically evaluated    using ANOVA, cov
ariance, and <i>t</i>-test.</font></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#39#35#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00301000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704006700075002001300142#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#40#36#article#92#<p><font size="3" fa
ce="Verdana"><b>RESULTS</b></font></p>     ^cY#a02v22n5.htm##
00483000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704024900075002001300324#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#41#37#article#92#<p><font size="2" fa
ce="Verdana"><a href="#tab01">Table 1</a> summarizes the characteristics    of t
he population sample. Most HCTMs worked in the public sector and were physicians
.    The predominant form of diabetes was type 2.</font></p>     ^cY#a02v22n5.ht
m##
00270000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704003600075002001300111#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#42#38#article#92#<p><a name="tab01"><
/a></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#43#39#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008000075002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#44#40#article#92#<p align="center"><i
mg src="/img/revistas/rpsp/v22n5/a02tab01.gif"></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#45#41#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00819000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704058500075002001300660#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#46#42#article#92#<p><font size="2" fa
ce="Verdana">Results of the survey (<a href="#tab02">Table    2</a>) are quite s
triking. Scales whose importance has strong reported evidence    such as "seriou
sness of type 2 diabetes," "value of tight control,"    and "psychosocial impact
 of diabetes," received only a slight agreement    from the participants (border
line to the neutral level of 3); it was even worse    for "patient autonomy." In
 the case of "patient autonomy,"    neither HCTMs nor people with diabetes consi
dered it an important issue (score    below neutral level of 3). </font></p>    
 ^cY#a02v22n5.htm##
00270000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704003600075002001300111#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#47#43#article#92#<p><a name="tab02"><
/a></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#48#44#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008000075002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#49#45#article#92#<p align="center"><i
mg src="/img/revistas/rpsp/v22n5/a02tab02.gif"></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#50#46#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00803000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704056900075002001300644#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#51#47#article#92#<p><font size="2" fa
ce="Verdana">Although initially we conducted separate evaluations    of the data
 collected from the different types of HCTMs, we finally analyzed    all data to
gether because no significant differences were recorded among those    subgroups
 when comparing the different scale items. Conversely, when we analyzed    the d
ata collected from HCTMs in Argentina’s different health care sectors,    profes
sionals working in the public health sector generally had lower scores    than t
hose of the prepaid sector (<i>P</i> &lt; 0.05). </font></p>     ^cY#a02v22n5.ht
m##
00745000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704051100075002001300586#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#52#48#article#92#<p><font size="2" fa
ce="Verdana">We recorded no significant differences between    people with type 
1 or type 2 diabetes, but those who had previously attended    diabetes educatio
n courses had higher scores regarding "seriousness of    the disease" (<i>P</i> 
&lt; 0.01). There were significant differences between    HCTMs and people with 
diabetes at scales 1, 2, and 5. In the first two scales,    HCTMs recorded highe
r score values, while the opposite occurred with "patient    autonomy."</font></
p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#53#49#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007000075002001300145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#54#50#article#92#<p><font size="3" fa
ce="Verdana"><b>DISCUSSION</b></font></p>     ^cY#a02v22n5.htm##
01946000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704171200075002001301787#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#55#51#article#92#<p><font size="2" fa
ce="Verdana">Our results show that among the study population    (HCTMs and peop
le with diabetes in the different health care sectors of a developing    country
), attitudes toward different aspects of type 2 diabetes are not exactly    the 
same. A similar difference was previously recorded by other authors and    in di
fferent health settings using the DAS-1 (14) and DAS-3 (15). This statistical   
 difference between the two groups would not have the same significance or impac
t    from the clinical point of view; in fact, both groups showed a close decrea
sing    trend in the subscale scores, with low agreement values in the items "se
riousness    of type 2 diabetes" and "value of tight control," and disagreement 
   with regard to "patient autonomy." Such a trend represents a clear    misconc
eption considering the strong available evidence on the highly negative    socio
economic impact of type 2 diabetes and the positive preventive effect of    bloo
d glucose control (1–4, 16–19). Similar consideration is merited by the    low i
mportance given to the role of patient participation, patient-provider    consen
sus on treatment goals, and specific strategies designed to meet the goals    an
d to improve patient outcomes (20–25). This misconception does not represent    
a minor point considering that type 2 diabetes is the predominant form of the   
 disease in the general population, as well as in the diabetes-treated populatio
n.    Since in most cases, patients are informed by their physicians about the c
haracteristics    of their disease, our results could reflect the negative influ
ence of HCTMs    on patient attitudes rather than a merely casual fact. </font><
/p>     ^cY#a02v22n5.htm##
00810000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704057600075002001300651#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#56#52#article#92#<p><font size="2" fa
ce="Verdana">All in all, these attitudes could be partly responsible    for the 
poor quality of care received by people with type 2 diabetes in Argentina    (10
), as well as in other countries. Consequently, it is crucial to identify    and
 correct the attitudes of HCTMs toward the "seriousness of type 2 diabetes"    a
nd among people with diabetes, attitudes toward "keeping a tight control    of t
he disease" and the value of "patient autonomy." Appropriate    interventions fo
r the redirection of such attitudes must be implemented.</font></p>     ^cY#a02v
22n5.htm##
01061000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704082700075002001300902#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#57#53#article#92#<p><font size="2" fa
ce="Verdana">Evidence in the literature shows that education    is a useful tool
 for achieving better results in diabetes care quality, namely:    (1) continuin
g medical and patient education not only improves diabetes knowledge    but also
 attitudes toward the disease (14, 22); (2) in Argentina, the implementation    
of a diabetes education program for general practitioners significantly improved
    their diabetes-related knowledge and prescriptive attitudes, leading to a pa
rallel    improvement of clinical and biochemical indicators of care quality (26
); and    (3) a similar reported improvement was obtained with the implementatio
n of a    patient education program for people with type 2 diabetes in 10 Latin 
American    countries (27), as well as in other countries (20–25). </font></p>  
   ^cY#a02v22n5.htm##
01002000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704076800075002001300843#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#58#54#article#92#<p><font size="2" fa
ce="Verdana">On account of these results and of the low technological    level r
equired, a wide implementation of diabetes education programs for both    HCTMs 
and people with diabetes would be an efficient tool for improving the    quality
 of care and decreasing disease costs in both developed and developing    countr
ies. Thus, health decision makers, particularly those from developing    countri
es where economic resources are frequently scarce, should be aware of    these r
esults and seriously consider the benefits of testing health provider    and con
sumer attitudes, and of incorporating education as part of diabetes care,    not
 only for economic reasons, but also for the quality of life of people with    d
iabetes.</font></p>     ^cY#a02v22n5.htm##
00472000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704023800075002001300313#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#59#55#article#92#<p><font size="2" fa
ce="Verdana"><b>Acknowledgments. </b>The authors are grateful    to Adriana Di M
aggio for careful assistance in manuscript preparation. This    work was funded 
by CONICET and Novo Nordisk Argentina.</font></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#60#56#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007000075002001300145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#61#57#article#92#<p><font size="3" fa
ce="Verdana"><b>REFERENCES</b></font></p>     ^cY#a02v22n5.htm##
00552000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704030400077002001300381#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#62#58#article#92#1#<p><fo
nt size="2" face="Verdana"> 1. The effect of intensive treatment of diabetes    
on the development and progression of long term complications in insulin-depende
nt    diabetes mellitus. The Diabetes Control and Complications Trial Research G
roup.    N Engl J Med. 1993;329:977–86.</font></p>    ^cY#a02v22n5.htm##
00553000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704030500077002001300382#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#63#59#article#92#2#<p><fo
nt size="2" face="Verdana"> 2. Intensive blood-glucose control with sulphonylure
as    or insulin compared with conventional treatment and risk of complications 
in    patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (U
KPDS)    Group. Lancet. 1998;352:837–53.</font></p>    ^cY#a02v22n5.htm##
00486000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704023800077002001300315#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#64#60#article#92#3#<p><fo
nt size="2" face="Verdana"> 3. UK Prospective Diabetes Study Group. Tight    blo
od pressure control and risk of macrovascular and microvascular complications   
 in type 2 diabetes (UKPDS 38). BMJ 1998;317: 703–13.</font></p>    ^cY#a02v22n5
.htm##
00493000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704024500077002001300322#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#65#61#article#92#4#<p><fo
nt size="2" face="Verdana"> 4. Gaede P, Vedel P, Larsen N, Jensen GV, Parving   
 HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patie
nts    with type 2 diabetes. N Engl J Med. 2003;348: 383–93.</font></p>    ^cY#a
02v22n5.htm##
00413000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704016500077002001300242#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#66#62#article#92#5#<p><fo
nt size="2" face="Verdana"> 5. American Diabetes Association. Clinical practice 
   recommendations. Diabetes Care. 2007; 30(Suppl 1):S1–103.</font></p>    ^cY#a
02v22n5.htm##
00482000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704023400077002001300311#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#67#63#article#92#6#<p><fo
nt size="2" face="Verdana"> 6. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks    
J, DeCristofaro A, et al. The quality of health care delivered to adults in    t
he United States. N Engl J Med. 2003;348:2635–45.</font></p>    ^cY#a02v22n5.htm
##
00553000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704030500077002001300382#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#68#64#article#92#7#<p><fo
nt size="2" face="Verdana"> 7. Gagliardino JJ, De La Hera M, Siri F, Grupo    de
 Investigaci&oacute;n de la Red QUALIDIAB. Evaluaci&oacute;n de la calidad    de
 la asistencia al paciente diab&eacute;tico en Am&eacute;rica Latina. Rev    Pan
am Salud P&uacute;blica. 2001;10:309–17.</font></p>    ^cY#a02v22n5.htm##
00456000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704020800077002001300285#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#69#65#article#92#8#<p><fo
nt size="2" face="Verdana"> 8. Weinberger M, Cohen SJ, Mazzuca SA. The role    o
f physicians’ knowledge and attitudes in effective diabetes management. Soc    S
ci Med. 1984;19:965–69.</font></p>    ^cY#a02v22n5.htm##
00466000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704021800077002001300295#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#70#66#article#92#9#<p><fo
nt size="2" face="Verdana"> 9. Anderson RM, Fitzgerald JT, Oh MS. The relationsh
ip    between diabetes-related attitudes and patients’ self-reported adherence. 
Diabetes    Educ. 1993;19:287–92.</font></p>    ^cY#a02v22n5.htm##
00489000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704024000078002001300318#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#71#67#article#92#10#<p><f
ont size="2" face="Verdana">10. Gagliardino JJ, De La Hera M, Siri F. Evaluaci&o
acute;n    preliminar de la calidad de atenci&oacute;n de personas con diabetes 
en Argentina.    Rev Soc Arg Diabetes. 2001;35: 121–33. </font></p>    ^cY#a02v2
2n5.htm##
00445000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704019600078002001300274#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#72#68#article#92#11#<p><f
ont size="2" face="Verdana">11. Anderson RM, Fitzgerald JT, Funnell MM, Gruppen 
   LD. The third version of the Diabetes Attitude Scale. Diabetes Care. 1998;21:
    1403–7. </font></p>    ^cY#a02v22n5.htm##
00512000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704026300078002001300341#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#73#69#article#92#12#<p><f
ont size="2" face="Verdana">12. Gagliardino JJ, Olivera E, Etchegoyen GS,    Gui
di ML, Caporale JE, Martella A, et al. PROPAT: A study to improve the quality   
 and reduce the cost of diabetes care. Diabetes Res Clin Pract. 2006;72:284–91.<
/font></p>    ^cY#a02v22n5.htm##
00565000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704031600078002001300394#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#74#70#article#92#13#<p><f
ont size="2" face="Verdana">13. Gagliardino J, Olivera E. The regions and    the
ir health care systems: Latin American. In: Economics of Diabetes and Diabetes  
  Care. A report of the Diabetes Health Economics Study Group. Gruber W, Lander 
   T, Leese B, Songer T, Williams H, Eds. 1997;51–9.</font></p>    ^cY#a02v22n5.
htm##
00475000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704022600078002001300304#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#75#71#article#92#14#<p><f
ont size="2" face="Verdana">14. Sharp LK, Lipsky MS. The short-term impact    of
 continuing medical education program on providers’ attitudes toward treating   
 diabetes. Diabetes Care. 1999;22:1929–32.</font></p>    ^cY#a02v22n5.htm##
00467000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704021800078002001300296#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#76#72#article#92#15#<p><f
ont size="2" face="Verdana">15. Clark M, Hampson SE. Comparison of patients’    
and healthcare professionals’ beliefs about and attitudes towards type 2 diabete
s.    Diabetic Med. 2003;20:152–4.</font></p>    ^cY#a02v22n5.htm##
00614000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704036500078002001300443#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#77#73#article#92#16#<p><f
ont size="2" face="Verdana">16. Gray A, Raikou M, McGuire A, Fenn P, Stevens    
R, Cull C, et al. Cost effectiveness of an intensive blood glucose control polic
y    inn patients with type 2 diabetes: economic analysis alongside randomized c
ontrolled    trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. 
BMJ. 2000;320:1373–8.</font></p>    ^cY#a02v22n5.htm##
00557000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704030800078002001300386#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#78#74#article#92#17#<p><f
ont size="2" face="Verdana">17. Gray A, Clarke P, Farmer A, Holman R; United    
Kingdom Prospective Diabetes Study Group. Implementing intensive control of    b
lood glucose concentration and blood pressure in type 2 diabetes in England:    
cost analysis (UKPDS 63). BMJ. 2002;325:860.</font></p>    ^cY#a02v22n5.htm##
00416000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704016700078002001300245#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#79#75#article#92#18#<p><f
ont size="2" face="Verdana">18. Klonoff DC, Schwartz DM. An economic analysis   
 of interventions for diabetes. Diabetes Care. 2000;23:390–404.</font></p>    ^c
Y#a02v22n5.htm##
00516000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704026700078002001300345#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#80#76#article#92#19#<p><f
ont size="2" face="Verdana">19. CDC Diabetes Cost-effectiveness Group. Cost-effe
ctiveness    of intensive glycemic control, intensified hypertension control, an
d serum cholesterol    level reduction for type 2 diabetes. JAMA. 2002;287:2542–
51.</font></p>    ^cY#a02v22n5.htm##
00418000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704016900078002001300247#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#81#77#article#92#20#<p><f
ont size="2" face="Verdana">20. Muhlhauser I, Berger M. Patient education-evalua
tion    of a complex intervention. Diabetologia. 2002;45:1723–33.</font></p>    
^cY#a02v22n5.htm##
00536000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704028700078002001300365#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#82#78#article#92#21#<p><f
ont size="2" face="Verdana">21. Heisler M, Vijan S, Anderson RM, Ubel PA,    Ber
nstein SJ, Hofer TP. When do patients and their physicians agree on diabetes    
treatment goals and strategies, and what difference does it make? J Gen Intern  
  Med. 2003;18:893–902.</font></p>    ^cY#a02v22n5.htm##
00557000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704030800078002001300386#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#83#79#article#92#22#<p><f
ont size="2" face="Verdana">22. De Berardis G, Pellegrini F, Franciosi M,    Bel
figlio M, Di Nardo B, Greenfield S et al.; QuED Study. Physician attitudes    to
ward foot care education and foot examination and their correlation with patient
    practice. Diabetes Care. 2004; 27:286–7.</font></p>    ^cY#a02v22n5.htm##
00502000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704025300078002001300331#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#84#80#article#92#23#<p><f
ont size="2" face="Verdana">23. Pavlic-Renar I, Metelko Z. Effects of an    empo
werment-based psychosocial intervention on quality of life and metabolic    cont
rol in type 2 diabetic patients. Patient Educ Couns. 2004; 52:193–9. </font></p>
    ^cY#a02v22n5.htm##
00437000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704018800078002001300266#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#85#81#article#92#24#<p><f
ont size="2" face="Verdana">24. Funnell MM, Kruger DF, Spencer M. Self-managemen
t    support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004;30: 274
–80.</font></p>    ^cY#a02v22n5.htm##
00630000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704038100078002001300459#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#86#82#article#92#25#<p><f
ont size="2" face="Verdana">25. Philis-Tsimikas A, Walker C, Rivard L, Talavera 
   G, Reimann JO, Salmon M, Araujo R; Project Dulce. Improvement in diabetes car
e    of underinsured patients enrolled in project dulce: a community-based, cult
urally    appropriate, nurse case management and peer education diabetes care mo
del. Diabetes    Care. 2004;27:110–5.</font></p>    ^cY#a02v22n5.htm##
00524000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704027500078002001300353#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#87#83#article#92#26#<p><f
ont size="2" face="Verdana">26. Gagliardino JJ, Jadzinsky MN, Alvari&ntilde;as  
  JH, Fabiano A, de Sereday M, Sinay IR. Training program for general practition
ers    (PROCAMEG): Preliminary results, Diabetes Res Clin Practice. 2000;50(Supp
l.2):1.    </font></p>    ^cY#a02v22n5.htm##
00507000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704025800078002001300336#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#88#84#article#92#27#<p><f
ont size="2" face="Verdana">27. Gagliardino J, Etchegoyen G; PEDNID-LA Research 
   Group. A model education program for people with type 2 diabetes: a cooperati
ve    Latin-American implementation study. Diabetes Care. 2001;24:1001–7. </font
></p>    ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#89#85#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#90#86#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00312000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007800075002001300153#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#91#87#article#92#<p><font size="2" fa
ce="Verdana">Manuscript received on 8 March 2006.     ^cY#a02v22n5.htm##
00318000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008400075002001300159#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#92#88#article#92#<br>   Revised versi
on accepted for publication on 28 June 2007.</font></p>     ^cY#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#93#89#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#94#90#article#92#<p>&nbsp;</p>     ^c
Y#a02v22n5.htm##
00609000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704037500075002001300450#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#95#91#article#92#<p><font size="2" fa
ce="Verdana"><a name="nt"></a><a href="#tx">*</a> Send correspondence    to: Jua
n Jos&eacute; Gagliardino, CENEXA (UNLP, CONICET), Facultad de Ciencias    M&eac
ute;dicas, Calles 60 y 120, (1900) La Plata, Argentina; telephone: +54    221 42
3-6712; fax: +54 221 422-2081; e-mail: <a href="mailto:direccion@cenexa.org.ar">
direccion@cenexa.org.ar</a>    ^cY#a02v22n5.htm##
00604000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704037000075002001300445#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a02v22n5.htm#S#p#96#92#article#92#<br>   <a name="nt01
"></a><a href="#tx01">1</a> We have evaluated the internal consistency    of the
 DAS-3 in a population of HCTMs and diabetic patients with similar characteristi
cs    of those studied here in two hospitals of our country (<i>n</i> <font face
="Symbol">&raquo;</font>    160). The results are available upon request from th
e authors.</font></p>     ^cY#a02v22n5.htm##
00593000000000241000450000400060000070200480000670500020005470600020005670000030
00587010002000617090008000637080003000711180002000740120212000760300014002887100
00200302065000900304064000500313031000400318014000700322865000900329002001300338
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#97#1#article#27#1#The
 effect of intensive treatment of diabetes on the development and progression of
 long term complications in insulin-dependent diabetes mellitus: The Diabetes Co
ntrol and Complications Trial Research Group^len#N Engl J Med.#2#19930000#1993#3
29#977-86#20071100#a02v22n5.htm##
00595000000000241000450000400060000070200480000670500020005470600020005670000030
00587010002000617090008000637080003000711180002000740120213000760300015002897100
00200304065000900306064000500315031000400320014000700324865000900331002001300340
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#98#2#article#27#2#Int
ensive blood-glucose control with sulphonylureas or insulin compared with conven
tional treatment and risk of complications in patients with type 2 diabetes (UKP
DS 33): UK Prospective Diabetes Study (UKPDS)^len#Group. Lancet.#2#19980000#1998
#352#837-53#20071100#a02v22n5.htm##
00553000000000253000450000400060000070200480000670500020005470600020005670000030
00587010002000617090008000637080003000711180002000740120158000760300004002340650
00900238064000500247031000400252014000700256865000900263002001300272035001000285
801000400295#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#99#3#arti
cle#27#3#UK Prospective Diabetes Study Group: Tight blood pressure control and r
isk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 3
8)^len#BMJ#19980000#1998#317#703-13#20071100#a02v22n5.htm#0959-8138#BMJ##
00645000000000313000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100015000920100
01600107010001700123010001800140010001800158012009200176030001400268710000200282
065000900284064000500293031000400298014000700302865000900309002001300318#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#100#4#article#27#4#^rND^sGaed
e^nP#^rND^sVedel^nP#^rND^sLarsen^nN#^rND^sJensen^nGV#^rND^sParving^nHH#^rND^sPed
ersen^nO#Multifactorial intervention and cardiovascular disease in patients with
 type 2 diabetes^len#N Engl J Med.#2#20030000#2003#348#383-93#20071100#a02v22n5.
htm##
00511000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750110030000770120038001070300
01400145065000900159064000500168031000300173032000400176014000700180865000900187
002001300196035001000209801001400219#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#101#5#article#27#5#American Diabetes Association#Clinical practic
e recommendations^len#Diabetes Care#20070000#2007#30#^s1#S1-103#20071100#a02v22n
5.htm#0149-5992#Diabetes Care##
00646000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100015000950100
01500110010001600125010001500141010002200156810000600178012007200184030001400256
71000020027006500090027206400050028103100040028601400080029086500090029800200130
0307#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#102#6#article#27#
6#^rND^sMcGlynn^nEA#^rND^sAsch^nSM#^rND^sAdams^nJ#^rND^sKeesey^nJ#^rND^sHicks^nJ
#^rND^sDeCristofaro^nA#et al#The quality of health care delivered to adults in t
he United States^len#N Engl J Med.#2#20030000#2003#348#2635-45#20071100#a02v22n5
.htm##
00624000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100022000770100020000990100
01400119011004300133012008600176030002400262710000200286065000900288064000500297
031000300302014000700305865000900312002001300321#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a02v22n5.htm#S#c#103#7#article#27#7#^rND^sGagliardino^nJJ#^rND^sDe La 
Hera^nM#^rND^sSiri^nF#Grupo de Investigación de la Red QUALIDIAB#Evaluación de l
a calidad de la asistencia al paciente diabético en América Latina^les#Rev Panam
 Salud Pública#2#20010000#2001#10#309-17#20071100#a02v22n5.htm##
00555000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100016000970100
01800113012008500131030001300216710000200229065000900231064000500240031000300245
014000700248865000900255002001300264#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#104#8#article#27#8#^rND^sWeinberger^nM#^rND^sCohen^nSJ#^rND^sMazz
uca^nSA#The role of physicians’ knowledge and attitudes in effective diabetes ma
nagement^len#Soc Sci Med.#2#19840000#1984#19#965-69#20071100#a02v22n5.htm##
00565000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100019000770100021000960100
01300117012009400130030001500224710000200239065000900241064000500250031000300255
014000700258865000900265002001300274#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#105#9#article#27#9#^rND^sAnderson^nRM#^rND^sFitzgerald^nJT#^rND^s
Oh^nMS#The relationship between diabetes-related attitudes and patients’ self-re
ported adherence^len#Diabetes Educ.#2#19930000#1993#19#287-92#20071100#a02v22n5.
htm##
00572000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100020001010100
01400121012009000135030002100225710000200246065000900248064000500257031000300262
014000700265865000900272002001300281#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#106#10#article#27#10#^rND^sGagliardino^nJJ#^rND^sDe La Hera^nM#^r
ND^sSiri^nF#Evaluación preliminar de la calidad de atención de personas con diab
etes en Argentina^les#Rev Soc Arg Diabetes#2#20010000#2001#35#121-33#20071100#a0
2v22n5.htm##
00594000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100021000980100
01800119010001800137012005300155030001400208065000900222064000500231031000300236
014000700239865000900246002001300255035001000268801001400278#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a02v22n5.htm#S#c#107#11#article#27#11#^rND^sAnderson^nRM#^
rND^sFitzgerald^nJT#^rND^sFunnell^nMM#^rND^sGruppen^nLD#The third version of the
 Diabetes Attitude Scale^len#Diabetes Care#19980000#1998#21#1403-7#20071100#a02v
22n5.htm#0149-5992#Diabetes Care##
00677000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100017001010100
02100118010001600139010001900155010001800174810000600192012008000198030002500278
71000020030306500090030506400050031403100030031901400070032286500090032900200130
0338#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#108#12#article#27
#12#^rND^sGagliardino^nJJ#^rND^sOlivera^nE#^rND^sEtchegoyen^nGS#^rND^sGuidi^nML#
^rND^sCaporale^nJE#^rND^sMartella^nA#et al#PROPAT: A study to improve the qualit
y and reduce the cost of diabetes care^len#Diabetes Res Clin Pract.#2#20060000#2
006#72#284-91#20071100#a02v22n5.htm##
00702000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100021000790100017001000120
06200117018009900179016001600278016001600294016001500310016001600325016001800341
065000900359064000500368014000500373865000900378002001300387#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a02v22n5.htm#S#c#109#13#article#27#13#^rND^sGagliardino^nJ
#^rND^sOlivera^nE#The regions and their health care systems: Latin American^len#
Economics of Diabetes and Diabetes Care: A report of the Diabetes Health Economi
cs Study Group^len#^rED^sGruber^nW#^rED^sLander^nT#^rED^sLeese^nB#^rED^sSonger^n
T#^rED^sWilliams^nH#19970000#1997#51-9#20071100#a02v22n5.htm##
00590000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100017000950120
11500112030001400227065000900241064000500250031000300255014000800258865000900266
002001300275035001000288801001400298#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#110#14#article#27#14#^rND^sSharp^nLK#^rND^sLipsky^nMS#The short-t
erm impact of continuing medical education program on providers’ attitudes towar
d treating diabetes^len#Diabetes Care#19990000#1999#22#1929-32#20071100#a02v22n5
.htm#0149-5992#Diabetes Care##
00549000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100018000940120
11000112030001400222710000200236065000900238064000500247031000300252014000600255
865000900261002001300270#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S
#c#111#15#article#27#15#^rND^sClark^nM#^rND^sHampson^nSE#Comparison of patients’
 and healthcare professionals’ beliefs about and attitudes towards type 2 diabet
es^len#Diabetic Med.#2#20030000#2003#20#152-4#20071100#a02v22n5.htm##
00799000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100014000790100016000930100
01700109010001400126010001700140010001400157810000600171012021900177030000400396
06500090040006400050040903100040041401400070041886500090042500200130043403500100
0447801000400457#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#112#1
6#article#27#16#^rND^sGray^nA#^rND^sRaikou^nM#^rND^sMcGuire^nA#^rND^sFenn^nP#^rN
D^sStevens^nR#^rND^sCull^nC#et al#Cost effectiveness of an intensive blood gluco
se control policy inn patients with type 2 diabetes: economic analysis alongside
 randomized controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Stu
dy Group^len#BMJ#20000000#2000#320#1373-8#20071100#a02v22n5.htm#0959-8138#BMJ##
00706000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100014000790100016000930100
01600109010001600125011004800141012014100189030000400330065000900334064000500343
031000400348020000400352865000900356002001300365035001000378801000400388#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#113#17#article#27#17#^rND^sGr
ay^nA#^rND^sClarke^nP#^rND^sFarmer^nA#^rND^sHolman^nR#United Kingdom Prospective
 Diabetes Study Group#Implementing intensive control of blood glucose concentrat
ion and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)^l
en#BMJ#20020000#2002#325#860#20071100#a02v22n5.htm#0959-8138#BMJ##
00534000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100019000970120
05500116030001400171065000900185064000500194031000300199014000800202865000900210
002001300219035001000232801001400242#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#114#18#article#27#18#^rND^sKlonoff^nDC#^rND^sSchwartz^nDM#An econ
omic analysis of interventions for diabetes^len#Diabetes Care#20000000#2000#23#3
90-404#20071100#a02v22n5.htm#0149-5992#Diabetes Care##
00597000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760110038000790120146001170300
00500263065000900268064000500277031000400282014000800286865000900294002001300303
035001000316801000500326#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S
#c#115#19#article#27#19#CDC Diabetes Cost-effectiveness Group#Cost-effectiveness
 of intensive glycemic control, intensified hypertension control, and serum chol
esterol level reduction for type 2 diabetes^len#JAMA#20020000#2002#287#2542-51#2
0071100#a02v22n5.htm#0098-7484#JAMA##
00535000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100016000990120
05900115030001300174065000900187064000500196031000300201014000800204865000900212
002001300221035001000234801001300244#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#116#20#article#27#20#^rND^sMuhlhauser^nI#^rND^sBerger^nM#Patient 
education-evaluation of a complex intervention^len#Diabetologia#20020000#2002#45
#1723-33#20071100#a02v22n5.htm#0012-186X#Diabetologia##
00688000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100015000960100
01900111010001500130010002000145010001600165012012600181030001800307710000200325
065000900327064000500336031000300341014000800344865000900352002001300361#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#117#21#article#27#21#^rND^sHe
isler^nM#^rND^sVijan^nS#^rND^sAnderson^nRM#^rND^sUbel^nPA#^rND^sBernstein^nSJ#^r
ND^sHofer^nTP#When do patients and their physicians agree on diabetes treatment 
goals and strategies, and what difference does it make?^len#J Gen Intern Med.#2#
20030000#2003#18#893-902#20071100#a02v22n5.htm##
00751000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100021000790100020001000100
01900120010001900139010001800158010002000176810000600196012012800202030001400330
06500090034406400050035303100030035801400060036186500090036700200130037603500100
0389801001400399#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#118#2
2#article#27#22#^rND^sDe Berardis^nG#^rND^sPellegrini^nF#^rND^sFranciosi^nM#^rND
^sBelfiglio^nM#^rND^sDi Nardo^nB#^rND^sGreenfield^nS#et al#QuED Study: Physician
 attitudes toward foot care education and foot examination and their correlation
 with patient practice^len#Diabetes Care#20040000#2004#27#286-7#20071100#a02v22n
5.htm#0149-5992#Diabetes Care##
00582000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100017001010120
13100118030002000249710000200269065000900271064000500280031000300285014000600288
865000900294002001300303#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S
#c#119#23#article#27#23#^rND^sPavlic-Renar^nI#^rND^sMetelko^nZ#Effects of an emp
owerment-based psychosocial intervention on quality of life and metabolic contro
l in type 2 diabetic patients^len#Patient Educ Couns.#2#20040000#2004#52#193-9#2
0071100#a02v22n5.htm##
00539000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100017000970100
01700114012006700131030001500198710000200213065000900215064000500224031000300229
014000700232865000900239002001300248#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
2v22n5.htm#S#c#120#24#article#27#24#^rND^sFunnell^nMM#^rND^sKruger^nDF#^rND^sSpe
ncer^nM#Self-management support for insulin therapy in type 2 diabetes^len#Diabe
tes Educ.#2#20040000#2004#30#274-80#20071100#a02v22n5.htm##
00829000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100025000790100016001040100
01600120010001800136010001800154010001600172010001600188012020400204030001400408
06500090042206400050043103100030043601400060043986500090044500200130045403500100
0467801001400477#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#121#2
5#article#27#25#^rND^sPhilis-Tsimikas^nA#^rND^sWalker^nC#^rND^sRivard^nL#^rND^sT
alavera^nG#^rND^sReimann^nJO#^rND^sSalmon^nM#^rND^sAraujo^nR#Project Dulce: Impr
ovement in diabetes care of underinsured patients enrolled in project dulce: a c
ommunity-based, culturally appropriate, nurse case management and peer education
 diabetes care model^len#Diabetes Care#20040000#2004#27#110-5#20071100#a02v22n5.
htm#0149-5992#Diabetes Care##
00673000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100020001010100
02000121010001700141010002000158010001600178012007900194030002700273710000200300
06500090030206400050031103100030031603200040031902000020032386500090032500200130
0334#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a02v22n5.htm#S#c#122#26#article#27
#26#^rND^sGagliardino^nJJ#^rND^sJadzinsky^nMN#^rND^sAlvariñas^nJH#^rND^sFabiano^
nA#^rND^sde Sereday^nM#^rND^sSinay^nIR#Training program for general practitioner
s (PROCAMEG): Preliminary results^len#Diabetes Res Clin Practice#2#20000000#2000
#50#^s2#1#20071100#a02v22n5.htm##
00632000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100021000790100020001000110
02500120012011300145030001400258065000900272064000500281031000300286014000700289
865000900296002001300305035001000318801001400328#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a02v22n5.htm#S#c#123#27#article#27#27#^rND^sGagliardino^nJ#^rND^sEtche
goyen^nG#PEDNID-LA Research Group#A model education program for people with type
 2 diabetes: a cooperative Latin-American implementation study^len#Diabetes Care
#20010000#2001#24#1001-7#20071100#a02v22n5.htm#0149-5992#Diabetes Care##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#o#1#1#article#1
#20080121#151814#a03v22n5.htm#161##
05326000000000637000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200590016701200630
02260100058002890100033003470100036003800700088004160700130005040700142006340831
69900776085000802475085004902483085003502532085002402567085001902591083182002610
08500080443008500330443808500320447108500240450308500190452705800620454611700060
4608072000304614112000904617111002004626114000904646113002004655002001304675#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#h#2#1#article#1#oa#pt#br1.1
#1#3.1#TAB#03#RPSP020#nd#Rev Panam Salud Publica#22#5#20071100#^f308^l316#1020-4
989#Uso de serviços odontológicos entre idosos brasileiros^lpt#Utilization of de
ntal services among the elderly in Brazil^len#^rND^1A01^nAndréa Maria Eleutério 
de Barros Lima^sMartins#^rND^1A02^nSandhi Maria^sBarreto#^rND^1A03^nIsabela Alme
ida^sPordeus#Universidade Estadual de Montes Claros^iA01^1Curso de Odontologia^s
Minas Gerais^pBrasil#Universidade Federal de Minas Gerais^iA02^1Faculdade de Med
icina^2Departamento de Medicina Preventiva^cBelo Horizonte^sMG^pBrasil#Universid
ade Federal de Minas Gerais^iA03^1Faculdade de Odontologia^2Departamento de Odon
topediatria e Ortodontia^cBelo Horizonte^sMG^pBrasil#^lpt^aOBJETIVO: Investigar 
a utilização de serviços odontológicos e seus determinantes entre idosos brasile
iros. MÉTODO: Foram incluídos os idosos participantes do inquérito de saúde buca
l do Ministério da Saúde realizado em 2002 e 2003 que usaram algum serviço odont
ológico pelo menos uma vez na vida. Dentados e edentados foram comparados e anal
isados separadamente, utilizando regressão logística múltipla. RESULTADOS: Dos 5
 009 participantes, 46,0% eram dentados e 54,0% edentados. A prevalência de uso 
de serviço odontológico no último ano foi 26,6 e 10,4%, respectivamente. Entre d
entados, o uso foi maior entre aqueles com maior escolaridade, que percebiam sua
 mastigação como péssima/ruim e que relataram sensibilidade dolorosa; e menor en
tre os que não receberam informações sobre saúde bucal, que percebiam sua saúde 
bucal como ruim/péssima, que tinham menor renda per capita, que precisavam de pr
ótese e já a usavam, que precisavam de prótese e não a usavam, que tinham proble
mas periodontais e maior número de dentes extraídos. Entre edentados, o uso foi 
maior entre aqueles com maior escolaridade e os que relataram sensibilidade dolo
rosa; e menor entre os idosos identificados como não-brancos e os que não recebe
ram informações sobre saúde bucal. CONCLUSÃO: A saúde bucal dos idosos brasileir
os é precária e o uso de serviços odontológicos foi menor entre os que mais nece
ssitavam. Diferentes fatores estiveram associados ao uso entre dentados e edenta
dos. Apenas a escolaridade, o acesso a informações sobre saúde bucal e a dor nos
 dentes ou gengiva nos últimos 3 meses foram comuns aos dois estratos. São neces
sários investimentos públicos em saúde bucal para reverter esse quadro.#^dnd^i1#
^tm^lpt^kAssistência odontológica para idosos^i1#^tm^lpt^kdesigualdades em saúde
^i1#^tm^lpt^ksaúde bucal^i1#^tm^lpt^kBrasil^i1#^len^aOBJECTIVE: To investigate t
he pattern of dental services use and its determinants among the elderly in Braz
il. METHODS: The study included the elderly participating in the Ministry of Hea
lth of Brazil’s oral health survey carried out in 2002 and 2003 who had used den
tal services at least once in their lifetime. Dentulous and edentulous individua
ls were compared and analyzed separately using multiple logistic regression. RES
ULTS: Of 5 009 participants, 46.0% were dentulous and 54.0% edentulous. The prev
alence of dental services use in the year right before the survey was 26.6% and 
10.4%, respectively. Among dentulous participants, the utilization rate was high
er in those with more years of schooling, those who perceived their chewing as p
oor/very poor, and those who reported feeling oral pain; and lower in those who 
did not have information on oral health, who perceived their oral health as poor
/very poor, those with lower per capita income, those who required prostheses an
d used them, and who required prostheses and did not use them, those with period
ontal problems, and with a higher number of extracted teeth. Among edentulous pa
rticipants, the utilization rate was higher in those with more years of schoolin
g and those reporting oral pain; and lower in non-whites and in those who did no
t have information on oral health. CONCLUSIONS: The oral health of the elderly i
n Brazil is deficient and the use of dental services was lower among those who n
eeded them most. The factors associated with dental services utilization differ 
for dentulous and edentulous individuals. The only similarities are schooling, h
aving information on oral health, and having experienced pain in the teeth and g
ums in the previous three months. Public investment in oral health is needed to 
turn around this scenario.#^dnd^i2#^tm^len^kDental care for aged^i2#^tm^len^khea
lth inequalities^i2#^tm^len^koral health^i2#^tm^len^kBrazil^i2#Conselho Nacional
 de Desenvolvimento Científico e Tecnológico#other#31#20070316#16 de março de 20
07#20070801#1 de agosto de 2007#a03v22n5.htm##
05410000000000637000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200660016701200700
02330100058003030100033003610100036003940700088004300700130005180700142006480831
73400790085000802524085004902532085003502581085002402616085001902640083185502659
08500080451408500330452208500320455508500240458708500190461105800620463011700060
4692072000304698112000904701111002004710114000904730113002004739002001304759#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#f#3#1#article#1#oa#pt#br1.1
#1#3.1#TAB#03#RPSP020#nd#Rev Panam Salud Publica#22#5#20071100#^f308^l316#1020-4
989#<B>Uso de serviços odontológicos entre idosos brasileiros</B>^lpt#<B>Utiliza
tion of dental services among the elderly in Brazil</B>^len#^rND^1A01^nAndréa Ma
ria Eleutério de Barros Lima^sMartins#^rND^1A02^nSandhi Maria^sBarreto#^rND^1A03
^nIsabela Almeida^sPordeus#Universidade Estadual de Montes Claros^iA01^1Curso de
 Odontologia^sMinas Gerais^pBrasil#Universidade Federal de Minas Gerais^iA02^1Fa
culdade de Medicina^2Departamento de Medicina Preventiva^cBelo Horizonte^sMG^pBr
asil#Universidade Federal de Minas Gerais^iA03^1Faculdade de Odontologia^2Depart
amento de Odontopediatria e Ortodontia^cBelo Horizonte^sMG^pBrasil#^lpt^a<B>OBJE
TIVO:</B> Investigar a utilização de serviços odontológicos e seus determinantes
 entre idosos brasileiros. <B>MÉTODO:</B> Foram incluídos os idosos participante
s do inquérito de saúde bucal do Ministério da Saúde realizado em 2002 e 2003 qu
e usaram algum serviço odontológico pelo menos uma vez na vida. Dentados e edent
ados foram comparados e analisados separadamente, utilizando regressão logística
 múltipla. <B>RESULTADOS:</B> Dos 5 009 participantes, 46,0% eram dentados e 54,
0% edentados. A prevalência de uso de serviço odontológico no último ano foi 26,
6 e 10,4%, respectivamente. Entre dentados, o uso foi maior entre aqueles com ma
ior escolaridade, que percebiam sua mastigação como péssima/ruim e que relataram
 sensibilidade dolorosa; e menor entre os que não receberam informações sobre sa
úde bucal, que percebiam sua saúde bucal como ruim/péssima, que tinham menor ren
da <I>per capita</I>, que precisavam de prótese e já a usavam, que precisavam de
 prótese e não a usavam, que tinham problemas periodontais e maior número de den
tes extraídos. Entre edentados, o uso foi maior entre aqueles com maior escolari
dade e os que relataram sensibilidade dolorosa; e menor entre os idosos identifi
cados como não-brancos e os que não receberam informações sobre saúde bucal. <B>
CONCLUSÃO:</B> A saúde bucal dos idosos brasileiros é precária e o uso de serviç
os odontológicos foi menor entre os que mais necessitavam. Diferentes fatores es
tiveram associados ao uso entre dentados e edentados. Apenas a escolaridade, o a
cesso a informações sobre saúde bucal e a dor nos dentes ou gengiva nos últimos 
3 meses foram comuns aos dois estratos. São necessários investimentos públicos e
m saúde bucal para reverter esse quadro.#^dnd^i1#^tm^lpt^kAssistência odontológi
ca para idosos^i1#^tm^lpt^kdesigualdades em saúde^i1#^tm^lpt^ksaúde bucal^i1#^tm
^lpt^kBrasil^i1#^len^a<B>OBJECTIVE:</B> To investigate the pattern of dental ser
vices use and its determinants among the elderly in Brazil. <B>METHODS:</B> The 
study included the elderly participating in the Ministry of Health of Brazil’s o
ral health survey carried out in 2002 and 2003 who had used dental services at l
east once in their lifetime. Dentulous and edentulous individuals were compared 
and analyzed separately using multiple logistic regression. <B>RESULTS:</B> Of 5
 009 participants, 46.0% were dentulous and 54.0% edentulous. The prevalence of 
dental services use in the year right before the survey was 26.6% and 10.4%, res
pectively. Among dentulous participants, the utilization rate was higher in thos
e with more years of schooling, those who perceived their chewing as poor/very p
oor, and those who reported feeling oral pain; and lower in those who did not ha
ve information on oral health, who perceived their oral health as poor/very poor
, those with lower <I>per capita</I> income, those who required prostheses and u
sed them, and who required prostheses and did not use them, those with periodont
al problems, and with a higher number of extracted teeth. Among edentulous parti
cipants, the utilization rate was higher in those with more years of schooling a
nd those reporting oral pain; and lower in non-whites and in those who did not h
ave information on oral health. <B>CONCLUSIONS:</B> The oral health of the elder
ly in Brazil is deficient and the use of dental services was lower among those w
ho needed them most. The factors associated with dental services utilization dif
fer for dentulous and edentulous individuals. The only similarities are schoolin
g, having information on oral health, and having experienced pain in the teeth a
nd gums in the previous three months. Public investment in oral health is needed
 to turn around this scenario.#^dnd^i2#^tm^len^kDental care for aged^i2#^tm^len^
khealth inequalities^i2#^tm^len^koral health^i2#^tm^len^kBrazil^i2#Conselho Naci
onal de Desenvolvimento Científico e Tecnológico#other#31#20070316#16 de março d
e 2007#20070801#1 de agosto de 2007#a03v22n5.htm##
05518000000000661000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201200590
01820120063002410100058003040100033003620100036003950700090004310700132005210700
14400653083172600797085000802523085004902531085003502580085002402615085001902639
08318480265808500080450608500330451408500320454708500240457908500190460305800620
46221170006046840720003046901120009046931110020047021140009047221130020047310020
01304751008009204764#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#l#4
#1#article#1#^mnov.^a2007#oa#pt#br1.1#1#3.1#tab#03#RPSP020#nd#Rev. panam. salud 
pública#22#5#20071100#^f308^l316#1020-4989#Uso de serviços odontológicos entre i
dosos brasileiros^lpt#Utilization of dental services among the elderly in Brazil
^len#^rND^1A01^nAndréa Maria Eleutério de Barros Lima^sMartins#^rND^1A02^nSandhi
 Maria^sBarreto#^rND^1A03^nIsabela Almeida^sPordeus#^iA01^1Universidade Estadual
 de Montes Claros^2Curso de Odontologia^sMinas Gerais^pBrasil#^iA02^1Universidad
e Federal de Minas Gerais^2Faculdade de Medicina^3Departamento de Medicina Preve
ntiva^cBelo Horizonte^sMG^pBrasil#^iA03^1Universidade Federal de Minas Gerais^2F
aculdade de Odontologia^3Departamento de Odontopediatria e Ortodontia^cBelo Hori
zonte^sMG^pBrasil#^lpt^aOBJETIVO: Investigar a utilização de serviços odontológi
cos e seus determinantes entre idosos brasileiros. MÉTODO: Foram incluídos os id
osos participantes do inquérito de saúde bucal do Ministério da Saúde realizado 
em 2002 e 2003 que usaram algum serviço odontológico pelo menos uma vez na vida.
 Dentados e edentados foram comparados e analisados separadamente, utilizando re
gressão logística múltipla. RESULTADOS: Dos 5 009 participantes, 46,0 por cento 
eram dentados e 54,0 por cento edentados. A prevalência de uso de serviço odonto
lógico no último ano foi 26,6 e 10,4 por cento, respectivamente. Entre dentados,
 o uso foi maior entre aqueles com maior escolaridade, que percebiam sua mastiga
ção como péssima/ruim e que relataram sensibilidade dolorosa; e menor entre os q
ue não receberam informações sobre saúde bucal, que percebiam sua saúde bucal co
mo ruim/péssima, que tinham menor renda per capita, que precisavam de prótese e 
já a usavam, que precisavam de prótese e não a usavam, que tinham problemas peri
odontais e maior número de dentes extraídos. Entre edentados, o uso foi maior en
tre aqueles com maior escolaridade e os que relataram sensibilidade dolorosa; e 
menor entre os idosos identificados como não-brancos e os que não receberam info
rmações sobre saúde bucal. CONCLUSÃO: A saúde bucal dos idosos brasileiros é pre
cária e o uso de serviços odontológicos foi menor entre os que mais necessitavam
. Diferentes fatores estiveram associados ao uso entre dentados e edentados. Ape
nas a escolaridade, o acesso a informações sobre saúde bucal e a dor nos dentes 
ou gengiva nos últimos 3 meses foram comuns aos dois estratos. São necessários i
nvestimentos públicos em saúde bucal para reverter esse quadro.#^dnd^i1#^tm^lpt^
kAssistência odontológica para idosos^i1#^tm^lpt^kdesigualdades em saúde^i1#^tm^
lpt^ksaúde bucal^i1#^tm^lpt^kBrasil^i1#^len^aOBJECTIVE: To investigate the patte
rn of dental services use and its determinants among the elderly in Brazil. METH
ODS: The study included the elderly participating in the Ministry of Health of B
razil’s oral health survey carried out in 2002 and 2003 who had used dental serv
ices at least once in their lifetime. Dentulous and edentulous individuals were 
compared and analyzed separately using multiple logistic regression. RESULTS: Of
 5 009 participants, 46.0 percent were dentulous and 54.0 percent edentulous. Th
e prevalence of dental services use in the year right before the survey was 26.6
 percent and 10.4 percent, respectively. Among dentulous participants, the utili
zation rate was higher in those with more years of schooling, those who perceive
d their chewing as poor/very poor, and those who reported feeling oral pain; and
 lower in those who did not have information on oral health, who perceived their
 oral health as poor/very poor, those with lower per capita income, those who re
quired prostheses and used them, and who required prostheses and did not use the
m, those with periodontal problems, and with a higher number of extracted teeth.
 Among edentulous participants, the utilization rate was higher in those with mo
re years of schooling and those reporting oral pain; and lower in non-whites and
 in those who did not have information on oral health. CONCLUSIONS: The oral hea
lth of the elderly in Brazil is deficient and the use of dental services was low
er among those who needed them most. The factors associated with dental services
 utilization differ for dentulous and edentulous individuals. The only similarit
ies are schooling, having information on oral health, and having experienced pai
n in the teeth and gums in the previous three months. Public investment in oral 
health is needed to turn around this scenario.#^dnd^i2#^tm^len^kDental care for 
aged^i2#^tm^len^khealth inequalities^i2#^tm^len^koral health^i2#^tm^len^kBrazil^
i2#Conselho Nacional de Desenvolvimento Científico e Tecnológico#other#31#200703
16#16 de março de 2007#20070801#1 de agosto de 2007#a03v22n5.htm#Internet^ihttp:
//www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001000003##
00357000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012400074002001300198#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#5#1#article#126#<p align="right"><fon
t size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEA
RCH</font></p>     ^cY#a03v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#6#2#article#126#<p>&nbsp;</p>     ^cY
#a03v22n5.htm##
00381000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704014800074002001300222#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#7#3#article#126#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>Uso de servi&ccedil;os odontol&oacute;gicos    e
ntre idosos brasileiros</b></font></p>     ^cY#a03v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#8#4#article#126#<p>&nbsp;</p>     ^cY
#a03v22n5.htm##
00354000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012100074002001300195#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#9#5#article#126#<p><font size="3" fac
e="verdana"><b>Utilization of dental services among the elderly    in Brazil</b>
</font></p>     ^cY#a03v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#10#6#article#126#<p>&nbsp;</p>     ^c
Y#a03v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#11#7#article#126#<p>&nbsp;</p>     ^c
Y#a03v22n5.htm##
00477000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704024300075002001300318#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#12#8#article#126#<p><font size="2" fa
ce="Verdana"><b>Andr&eacute;a Maria Eleut&eacute;rio de Barros    Lima Martins<s
up>I, </sup><a href="#nt"><sup>*</sup></a>; Sandhi Maria Barreto<SUP>II</SUP>;  
  Isabela Almeida Pordeus<SUP>III</sup></b></font></p>     ^cY#a03v22n5.htm##
00515000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704028100075002001300356#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#13#9#article#126#<p><FONT SIZE=2 face
="Verdana"><SUP>I</sup>Universidade Estadual de Montes Claros    (UNIMONTES), Cu
rso de Odontologia, e Faculdades Unidas do Norte de Minas (FUNORTE)/    Associa&
ccedil;&atilde;o Educativa do Brasil (SOEBRAS), Curso de Odontologia,    Minas G
erais, Brasil    ^cY#a03v22n5.htm##
00398000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704016300076002001300239#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#14#10#article#126#<br>   <sup>II</sup
>Universidade Federal de Minas Gerais (UFMG), Faculdade de Medicina,    Departam
ento de Medicina Preventiva, Belo Horizonte (MG), Brasil    ^cY#a03v22n5.htm##
00423000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018800076002001300264#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#15#11#article#126#<br>   <SUP>III</su
p>Universidade Federal de Minas Gerais (UFMG), Faculdade de Odontologia,    Depa
rtamento de Odontopediatria e Ortodontia, Belo Horizonte (MG), Brasil</font></p>
     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#16#12#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#17#13#article#126#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a03v22n5.htm##
00301000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006600076002001300142#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#18#14#article#126#<p><font size="2" f
ace="VERDANA"><b>RESUMO</b></font></p>     ^cY#a03v22n5.htm##
00420000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018500076002001300261#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#19#15#article#126#<p><font size="2" f
ace="Verdana"><b>OBJETIVO:</b> Investigar a utiliza&ccedil;&atilde;o    de servi
&ccedil;os odontol&oacute;gicos e seus determinantes entre idosos brasileiros.  
  ^cY#a03v22n5.htm##
00642000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704040700076002001300483#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#20#16#article#126#<br>   <b>M&Eacute;
TODO:</b> Foram inclu&iacute;dos os idosos participantes do inqu&eacute;rito    
de sa&uacute;de bucal do Minist&eacute;rio da Sa&uacute;de realizado em 2002    
e 2003 que usaram algum servi&ccedil;o odontol&oacute;gico pelo menos uma vez   
 na vida. Dentados e edentados foram comparados e analisados separadamente, util
izando    regress&atilde;o log&iacute;stica m&uacute;ltipla.    ^cY#a03v22n5.htm
##
01318000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704108300076002001301159#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#21#17#article#126#<br>   <b>RESULTADO
S:</b> Dos 5 009 participantes, 46,0% eram dentados e 54,0% edentados.    A prev
al&ecirc;ncia de uso de servi&ccedil;o odontol&oacute;gico no &uacute;ltimo    a
no foi 26,6 e 10,4%, respectivamente. Entre dentados, o uso foi maior entre    a
queles com maior escolaridade, que percebiam sua mastiga&ccedil;&atilde;o como  
  p&eacute;ssima/ruim e que relataram sensibilidade dolorosa; e menor entre os  
  que n&atilde;o receberam informa&ccedil;&otilde;es sobre sa&uacute;de bucal,  
  que percebiam sua sa&uacute;de bucal como ruim/p&eacute;ssima, que tinham meno
r    renda <i>per capita</i>, que precisavam de pr&oacute;tese e j&aacute; a usa
vam,    que precisavam de pr&oacute;tese e n&atilde;o a usavam, que tinham probl
emas    periodontais e maior n&uacute;mero de dentes extra&iacute;dos. Entre ede
ntados,    o uso foi maior entre aqueles com maior escolaridade e os que relatar
am sensibilidade    dolorosa; e menor entre os idosos identificados como n&atild
e;o-brancos e os    que n&atilde;o receberam informa&ccedil;&otilde;es sobre sa&
uacute;de bucal.    ^cY#a03v22n5.htm##
00822000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704058700076002001300663#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#22#18#article#126#<br>   <b>CONCLUS&A
tilde;O:</b> A sa&uacute;de bucal dos idosos brasileiros &eacute;    prec&aacute
;ria e o uso de servi&ccedil;os odontol&oacute;gicos foi menor entre    os que m
ais necessitavam. Diferentes fatores estiveram associados ao uso entre    dentad
os e edentados. Apenas a escolaridade, o acesso a informa&ccedil;&otilde;es    s
obre sa&uacute;de bucal e a dor nos dentes ou gengiva nos &uacute;ltimos 3    me
ses foram comuns aos dois estratos. S&atilde;o necess&aacute;rios investimentos 
   p&uacute;blicos em sa&uacute;de bucal para reverter esse quadro. </font></p> 
    ^cY#a03v22n5.htm##
00445000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704021000076002001300286#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#23#19#article#126#<p><font size="2" f
ace="Verdana"><b>Palavras-chave:</b> Assist&ecirc;ncia odontol&oacute;gica    pa
ra idosos, desigualdades em sa&uacute;de, sa&uacute;de bucal, Brasil.</font></p>
 <hr size="1" noshade>     ^cY#a03v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#24#20#article#126#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a03v22n5.htm##
00396000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704016100076002001300237#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#25#21#article#126#<p><font size="2" f
ace="Verdana"><b>OBJECTIVE:</b> To investigate the pattern    of dental services
 use and its determinants among the elderly in Brazil.    ^cY#a03v22n5.htm##
00578000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704034300076002001300419#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#26#22#article#126#<br>   <b>METHODS:<
/b> The study included the elderly participating in the Ministry    of Health of
 Brazil’s oral health survey carried out in 2002 and 2003 who had    used dental
 services at least once in their lifetime. Dentulous and edentulous    individua
ls were compared and analyzed separately using multiple logistic regression.    
^cY#a03v22n5.htm##
01214000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704097900076002001301055#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#27#23#article#126#<br>   <b>RESULTS:<
/b> Of 5 009 participants, 46.0% were dentulous and 54.0% edentulous.    The pre
valence of dental services use in the year right before the survey was    26.6% 
and 10.4%, respectively. Among dentulous participants, the utilization    rate w
as higher in those with more years of schooling, those who perceived their    ch
ewing as poor/very poor, and those who reported feeling oral pain; and lower    
in those who did not have information on oral health, who perceived their oral  
  health as poor/very poor, those with lower <i>per capita</i> income, those who
    required prostheses and used them, and who required prostheses and did not u
se    them, those with periodontal problems, and with a higher number of extract
ed    teeth. Among edentulous participants, the utilization rate was higher in t
hose    with more years of schooling and those reporting oral pain; and lower in
 non-whites    and in those who did not have information on oral health.    ^cY#
a03v22n5.htm##
00755000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704052000076002001300596#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#28#24#article#126#<br>   <b>CONCLUSIO
NS:</b> The oral health of the elderly in Brazil is deficient and    the use of 
dental services was lower among those who needed them most. The factors    assoc
iated with dental services utilization differ for dentulous and edentulous    in
dividuals. The only similarities are schooling, having information on oral    he
alth, and having experienced pain in the teeth and gums in the previous three   
 months. Public investment in oral health is needed to turn around this scenario
.</font></p>     ^cY#a03v22n5.htm##
00394000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704015900076002001300235#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#29#25#article#126#<p><font size="2" f
ace="Verdana"><b>Key words:</b> Dental care for aged, health    inequalities, or
al health, Brazil.</font></p> <hr size="1" noshade>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#30#26#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#31#27#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
01291000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704105600076002001301132#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#32#28#article#126#<p><font size="2" f
ace="Verdana">As doen&ccedil;as bucais comprometem a qualidade    de vida e rest
ringem as atividades cotidianas dos indiv&iacute;duos    (1–3). A preocupa&ccedi
l;&atilde;o com a sa&uacute;de bucal dos idosos est&aacute;    crescendo devido 
ao envelhecimento da popula&ccedil;&atilde;o mundial, especialmente    nos pa&ia
cute;ses desenvolvidos (4). Os danos causados pelas doen&ccedil;as    bucais aum
entam com a idade e comprometem a qualidade de vida, ocasionando o    cresciment
o da demanda por pr&oacute;teses, geralmente n&atilde;o oferecidas    pelos serv
i&ccedil;os p&uacute;blicos no Brasil (5). Nesse pa&iacute;s, o quadro    de sa&
uacute;de bucal dos idosos &eacute; cr&iacute;tico: em 2003, apenas 10%    tinha
m mais de 20 dentes na boca, propor&ccedil;&atilde;o muito inferior &agrave;    
meta proposta pela Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de (OMS) na   
 qual se preconizava que 50% da popula&ccedil;&atilde;o idosa deveriam apresenta
r    mais de 20 dentes na boca at&eacute; o ano 2000 (6).</font></p>     ^cY#a03
v22n5.htm##
01436000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704120100076002001301277#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#33#29#article#126#<p><font size="2" f
ace="Verdana">A sa&uacute;de bucal, assim como a sa&uacute;de    em geral, est&a
acute; correlacionada ao uso de servi&ccedil;os odontol&oacute;gicos    (1, 3). 
O uso desses servi&ccedil;os com a periodicidade e a freq&uuml;&ecirc;ncia    ap
ropriadas contribui para a preven&ccedil;&atilde;o de doen&ccedil;as em todas   
 as idades e permite o tratamento precoce dos problemas identificados (7). O    
edentulismo &eacute; uma condi&ccedil;&atilde;o extrema e est&aacute;, geralment
e,    associado ao menor uso de servi&ccedil;os odontol&oacute;gicos nos estudos
 epidemiol&oacute;gicos    (8–11). Entretanto, mesmo para os edentados, o uso de
 servi&ccedil;os    odontol&oacute;gicos &eacute; importante para avaliar a nece
ssidade de utiliza&ccedil;&atilde;o    ou substitui&ccedil;&atilde;o de pr&oacut
e;teses dent&aacute;rias e para o diagn&oacute;stico    precoce de les&otilde;es
 potencialmente cancer&iacute;genas (12). Dessa forma,    o acesso aos servi&cce
dil;os odontol&oacute;gicos deve ser garantido n&atilde;o    apenas para preveni
r o edentulismo, como tamb&eacute;m para melhorar a qualidade    de vida e a sa&
uacute;de bucal dos edentados e dentados. </font></p>     ^cY#a03v22n5.htm##
01387000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704115200076002001301228#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#34#30#article#126#<p><font size="2" f
ace="Verdana">O modelo te&oacute;rico de Andersen e Davidson    &eacute; o mais 
difundido para analisar os determinantes do uso de servi&ccedil;os    odontol&oa
cute;gicos. Uma vers&atilde;o expandida desse modelo foi utilizada    em 1997 pa
ra a avalia&ccedil;&atilde;o do uso de servi&ccedil;os odontol&oacute;gicos    n
os Estados Unidos (13). Nesse estudo, a ra&ccedil;a e a idade foram consideradas
    como vari&aacute;veis ex&oacute;genas, enquanto que as caracter&iacute;stica
s    sociodemogr&aacute;ficas e o sistema de aten&ccedil;&atilde;o &agrave; sa&u
acute;de    bucal foram considerados como vari&aacute;veis contextuais. As vari&
aacute;veis    relacionadas &agrave;s caracter&iacute;sticas da popula&ccedil;&a
tilde;o foram    reunidas em tr&ecirc;s grupos: disponibilidade de recursos, pre
disposi&ccedil;&atilde;o    ao uso e necessidade de tratamento. Segundo os autor
es, as caracter&iacute;sticas    de predisposi&ccedil;&atilde;o e de necessidade
 de tratamento, al&eacute;m de    importantes determinantes do uso, s&atilde;o m
ut&aacute;veis frente &agrave;s    pol&iacute;ticas de sa&uacute;de (14).</font>
</p>     ^cY#a03v22n5.htm##
00722000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048700076002001300563#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#35#31#article#126#<p><font size="2" f
ace="Verdana">Sendo assim, o presente estudo utilizou a vers&atilde;o    expandi
da do modelo de Andersen e Davidson (13) para investigar as caracter&iacute;stic
as    associadas ao uso de servi&ccedil;os odontol&oacute;gicos entre os idosos 
brasileiros    dentados e edentados que participaram do inqu&eacute;rito de sa&u
acute;de bucal    realizado pelo Minist&eacute;rio da Sa&uacute;de em todo o ter
rit&oacute;rio    nacional em 2002 e 2003 (15). </font></p>     ^cY#a03v22n5.htm
##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#36#32#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008600076002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#37#33#article#126#<p><font size="3" f
ace="Verdana"><b>MATERIAIS E M&Eacute;TODOS</b></font></p>     ^cY#a03v22n5.htm#
#
02723000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704248800076002001302564#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#38#34#article#126#<p><FONT SIZE=2 fac
e="Verdana">O presente trabalho utilizou os dados coletados    no inqu&eacute;ri
to Sa&uacute;de Bucal do Brasil, anteriormente denominado Projeto    SB 2000 e a
tualmente denominado Projeto SB Brasil (15), realizado pelo Minist&eacute;rio   
 da Sa&uacute;de, conforme proposta da OMS (16). No projeto, foi avaliada a cond
i&ccedil;&atilde;o    de sa&uacute;de bucal e coletadas informa&ccedil;&otilde;e
s sociodemogr&aacute;ficas    assim como informa&ccedil;&otilde;es sobre o uso d
e servi&ccedil;os odontol&oacute;gicos    e a autopercep&ccedil;&atilde;o da sa&
uacute;de bucal dos participantes. O inqu&eacute;rito    incluiu 108 921 indiv&i
acute;duos residentes em 250 munic&iacute;pios em 2002    e 2003. A amostra foi 
desenhada para garantir a representatividade das cinco    macrorregi&otilde;es b
rasileiras (Norte, Nordeste, Centro-Oeste, Sudeste e Sul)    em duas idades &iac
ute;ndices (5 e 12 anos) e nos quatro estratos et&aacute;rios    (18 a 36 meses,
 15 a 19 anos, 35 a 44 anos e 65 a 74 anos) (17). Foram feitas    entrevistas e 
exames nos domic&iacute;lios, escolas e creches por dentistas    treinados e cal
ibrados, de acordo com os crit&eacute;rios propostos pela OMS    em 1997 (16) e 
seguindo os princ&iacute;pios &eacute;ticos estabelecidos pelo    Conselho Nacio
nal de Sa&uacute;de (CNS) (6). Os dentistas foram calibrados quanto    ao exame 
das condi&ccedil;&otilde;es bucais a partir do c&aacute;lculo da concord&acirc;n
cia    Kappa ou da concord&acirc;ncia percentual. Os calibradores foram treinado
s para    aferir a concord&acirc;ncia intra e interexaminadores. Quando os resul
tados    do teste Kappa ou percentual n&atilde;o eram satisfat&oacute;rios, os e
xaminadores    recebiam um novo treinamento, at&eacute; que o resultado do teste
 de concord&acirc;ncia    atingisse n&iacute;veis satisfat&oacute;rios &#91;conc
ord&acirc;ncia intra-examinadores:    condi&ccedil;&atilde;o da coroa, condi&cce
dil;&atilde;o da raiz e necessidade    de tratamento, &gt; 97,5%; &iacute;ndice 
periodontal comunit&aacute;rio (CPI)    e &iacute;ndice de perda de inser&ccedil
;&atilde;o (PIP), &gt; 95,0%. Concord&acirc;ncia    interexaminadores: condi&cce
dil;&atilde;o da coroa, condi&ccedil;&atilde;o da    raiz e necessidade de trata
mento, &gt; 90,0%; CPI e PIP, &gt; 80,0%&#93;. Maiores    informa&ccedil;&otilde
;es sobre a metodologia adotada no projeto SB Brasil est&atilde;o    dispon&iacu
te;veis em outras publica&ccedil;&otilde;es (18).</font></p>     ^cY#a03v22n5.ht
m##
00781000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704054600076002001300622#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#39#35#article#126#<p><font size="2" f
ace="Verdana">Apesar de, comumente, nos estudos epidemiol&oacute;gicos    no Bra
sil, considerar-se como idoso o indiv&iacute;duo com 60 anos ou mais (19),    a 
OMS prop&ocirc;s, em 1997, investigar o estrato de 65 a 74 anos como representat
ivo    da popula&ccedil;&atilde;o de idosos em levantamentos epidemiol&oacute;gi
cos    de sa&uacute;de bucal (16). Essa orienta&ccedil;&atilde;o foi acatada no 
projeto    SB Brasil, de modo a facilitar a compara&ccedil;&atilde;o com resulta
dos internacionais    (15).</font></p>     ^cY#a03v22n5.htm##
00480000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704024500076002001300321#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#40#36#article#126#<p><font size="2" f
ace="Verdana">A vari&aacute;vel dependente foi definida como    "uso de servi&cc
edil;os odontol&oacute;gicos no &uacute;ltimo ano"    e foi constru&iacute;da pe
la agrega&ccedil;&atilde;o de duas perguntas: </font></p>     ^cY#a03v22n5.htm##
00362000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704012700076002001300203#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#41#37#article#126#<p><font size="2" f
ace="Verdana">• j&aacute; foi ao dentista alguma vez na vida?    (sim ou n&atild
e;o); e </font></p>     ^cY#a03v22n5.htm##
00394000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704015900076002001300235#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#42#38#article#126#<p><font size="2" f
ace="Verdana">• h&aacute; quanto tempo? (nunca foi ao dentista,    h&aacute; men
os de 1 ano, de 1 a 2 anos, 3 ou mais). </font></p>     ^cY#a03v22n5.htm##
00588000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704035300076002001300429#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#43#39#article#126#<p><font size="2" f
ace="Verdana">Todos os que usaram servi&ccedil;os odontol&oacute;gicos    pelo m
enos uma vez na vida foram eleg&iacute;veis para o presente estudo. A    vari&aa
cute;vel foi agrupada em duas categorias: os que usaram esses servi&ccedil;os   
 no &uacute;ltimo ano e os que n&atilde;o os usaram no &uacute;ltimo ano. </font
></p>     ^cY#a03v22n5.htm##
01304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704106900076002001301145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#44#40#article#126#<p><font size="2" f
ace="Verdana">As vari&aacute;veis independentes, conforme o    modelo de Anderse
n e Davidson (13), foram reclassificadas em cinco    subgrupos: ex&oacute;genas,
 contextuais, de predisposi&ccedil;&atilde;o, de    disponibilidade de recursos 
e de necessidade de tratamento. A vari&aacute;vel    "ra&ccedil;a", autodeclarad
a pelo indiv&iacute;duo conforme cinco    categorias (branco, amarelo, &iacute;n
dio, negro ou pardo), foi a &uacute;nica    vari&aacute;vel ex&oacute;gena e foi
 categorizada em dois grupos (branco, n&atilde;o    branco). As vari&aacute;veis
 contextuais inclu&iacute;ram: macrorregi&otilde;es    do Brasil (Sudeste, Sul, 
Centro-Oeste, Norte, Nordeste), local de resid&ecirc;ncia    (urbano ou rural), 
escolaridade em anos de estudo (<u>&lt;</u>4, 5 a 8, <u>&gt;</u>9),    tipo de s
ervi&ccedil;o odontol&oacute;gico (gratuito ou p&uacute;blico/filantr&oacute;pic
o,    n&atilde;o gratuito ou privado/conv&ecirc;nios) e acesso a informa&ccedil;
&otilde;es    sobre como evitar problemas bucais (sim ou n&atilde;o). </font></p
>     ^cY#a03v22n5.htm##
01243000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704100800076002001301084#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#45#41#article#126#<p><font size="2" f
ace="Verdana">As vari&aacute;veis de predisposi&ccedil;&atilde;o,    que engloba
ram as caracter&iacute;sticas individuais, foram: sexo (feminino    ou masculino
), autopercep&ccedil;&atilde;o da sa&uacute;de bucal (&oacute;tima/boa,    regul
ar, ruim/p&eacute;ssima), autopercep&ccedil;&atilde;o da mastiga&ccedil;&atilde;
o    (&oacute;tima/ boa, regular, ruim/p&eacute;ssima), percep&ccedil;&atilde;o 
sobre    se a sa&uacute;de bucal afeta o relacionamento social (n&atilde;o afeta
 ou afeta),    autopercep&ccedil;&atilde;o da apar&ecirc;ncia dos dentes e gengi
vas (&oacute;tima/boa,    regular, ruim/ p&eacute;ssima) e autopercep&ccedil;&at
ilde;o da influ&ecirc;ncia    dos dentes e das gengivas na fala (&oacute;tima/bo
a, regular, ruim/p&eacute;ssima).    A renda domiciliar <i>per capita</i> distri
bu&iacute;da em tercis (201,00 a    12 750,00 reais; 117,00 a 200,00 reais; 0,00
 a 116,00 reais) foi considerada    como vari&aacute;vel de disponibilidade de r
ecursos. </font></p>     ^cY#a03v22n5.htm##
01574000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704133900076002001301415#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#46#42#article#126#<p><font size="2" f
ace="Verdana">As vari&aacute;veis de necessidade de tratamento    inclu&iacute;r
am relato de dor de dentes e/ou gengivas nos &uacute;ltimos 3    meses (n&atilde
;o ou sim), a autopercep&ccedil;&atilde;o da necessidade de tratamento    (n&ati
lde;o ou sim), o uso e a necessidade de confec&ccedil;&atilde;o ou substitui&cce
dil;&atilde;o    de pr&oacute;tese entre dentados (n&atilde;o usa e n&atilde;o n
ecessita, usa    e n&atilde;o necessita, usa e necessita, n&atilde;o usa e neces
sita), o uso    e a necessidade de confec&ccedil;&atilde;o ou substitui&ccedil;&
atilde;o de    pr&oacute;tese entre edentados (usa e n&atilde;o necessita, usa e
 necessita,    n&atilde;o usa e necessita), a altera&ccedil;&atilde;o de tecido 
mole (n&atilde;o    ou sim), o n&uacute;mero de dentes cariados, perdidos e obtu
rados (CPOD) em    tercis (0 a 19, 20 a 26, 27 a 32), a necessidade de tratament
o periodontal (n&atilde;o    ou sim), a necessidade de tratamento por c&aacute;r
ie (n&atilde;o ou sim) e    o n&uacute;mero de dentes extra&iacute;dos (0 a 15, 
16 a 24, 25 a 31). As vari&aacute;veis    CPOD, necessidade de tratamento period
ontal, necessidade de tratamento por c&aacute;rie    e n&uacute;mero de dentes e
xtra&iacute;dos foram avaliadas apenas entre dentados    por n&atilde;o se aplic
arem aos edentados. </font></p>     ^cY#a03v22n5.htm##
01924000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704168900076002001301765#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#47#43#article#126#<p><font size="2" f
ace="Verdana">Inicialmente, a popula&ccedil;&atilde;o idosa    brasileira dentad
a foi comparada &agrave; edentada quanto &agrave;s vari&aacute;veis    propostas
 por Andersen e Davidson utilizando-se o teste do qui-quadrado (<font face="Symb
ol">c</font><SUP>2</SUP>)    e o valor de <i>P</i> &lt; 0,05. Posteriormente, em
 cada estrato, os idosos    dentados e edentados que usaram os servi&ccedil;os o
dontol&oacute;gicos no &uacute;ltimo    ano foram comparados aos que n&atilde;o 
usaram esses servi&ccedil;os, segundo    cada grupo de vari&aacute;veis de inter
esse. A signific&acirc;ncia estat&iacute;stica    das diferen&ccedil;as encontra
das foi aferida pelo teste do <font face="Symbol">c</font><SUP>2</SUP>    com n&
iacute;vel de signific&acirc;ncia de 5,0%. A seguir, todos os fatores    associa
dos significativamente ao uso, com <i>P</i> <u>&lt;</u> 0,20, foram inclu&iacute
;dos    no modelo multivariado (20) utilizando regress&atilde;o log&iacute;stica
    m&uacute;ltipla, sendo retidos os fatores que permaneceram associados ao n&i
acute;vel    de <i>P</i> <u>&lt;</u> 0,05. Cada subgrupo definido pelo modelo de
 Andersen    e Davidson foi analisado separadamente. Ao final, foi constru&iacut
e;do um modelo    &uacute;nico para cada estrato, a partir dos fatores retidos n
os modelos multivariados.    As magnitudes das associa&ccedil;&otilde;es entre a
 vari&aacute;vel dependente    e os fatores de interesse foram estimadas pela ra
z&atilde;o de chances (<i>odds    ratio</i>, OR) com intervalo de confian&ccedil
;a de 95% (IC95%). A an&aacute;lise    foi feita com o programa <i>Statistical P
ackage for the Social Sciences</i>    (SPSS) 11.0.</font></p>     ^cY#a03v22n5.h
tm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#48#44#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#49#45#article#126#<p><font size="3" f
ace="Verdana"><b>RESULTADOS</b></font></p>     ^cY#a03v22n5.htm##
01066000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704083100076002001300907#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#50#46#article#126#<p><font size="2" f
ace="Verdana">Um total de 5 349 idosos (65 a 74 anos) participou    do inqu&eacu
te;rito. Desses, 30 n&atilde;o responderam as perguntas referentes    &agrave; u
tiliza&ccedil;&atilde;o de servi&ccedil;os odontol&oacute;gicos. Entre    os 5 3
19 que responderam, 310 (5,8%) nunca haviam usado servi&ccedil;os odontol&oacute
;gicos,    4 114 (77,4%) haviam usado esses servi&ccedil;os h&aacute; mais de 1 
ano e 895    (16,8%) haviam usado os servi&ccedil;os no &uacute;ltimo ano. Entre
 os 5 009    idosos inclu&iacute;dos na an&aacute;lise, 2 305 (46,0%) eram denta
dos e 2 704    (54,0%), edentados. Dos dentados, 614 (26,6%) haviam usado servi&
ccedil;os odontol&oacute;gicos    no &uacute;ltimo ano. Entre os edentados, some
nte 281 (10,4%) haviam usado os    servi&ccedil;os no &uacute;ltimo ano.</font><
/p>     ^cY#a03v22n5.htm##
00688000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704045300076002001300529#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#51#47#article#126#<p><font size="2" f
ace="Verdana">A <a href="#tab01">tabela 1</a> apresenta a distribui&ccedil;&atil
de;o    dos participantes dentados e edentados segundo as caracter&iacute;sticas
 de    interesse para o presente trabalho, agrupadas conforme o modelo de Anders
en    e Davidson. Dentados e edentados s&oacute; n&atilde;o diferiram significat
ivamente    com rela&ccedil;&atilde;o &agrave; ra&ccedil;a e ao local de resid&e
circ;ncia.    </font></p>     ^cY#a03v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#52#48#article#126#<p><a name="tab01">
</a></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#53#49#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#54#50#article#126#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a03tab01.gif"></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#55#51#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
01638000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704140300076002001301479#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#56#52#article#126#<p><font size="2" f
ace="Verdana">As <a href="#tab02">tabelas 2</a>, <a href="#tab03">3</a>    e <a 
href="#tab04">4</a> apresentam os resultados das an&aacute;lises univariadas    
considerando o uso de servi&ccedil;os odontol&oacute;gicos no &uacute;ltimo    a
no como vari&aacute;vel dependente. Os resultados s&atilde;o apresentados separa
damente    para dentados e edentados. As vari&aacute;veis local de resid&ecirc;n
cia, autopercep&ccedil;&atilde;o    da influ&ecirc;ncia da fala em fun&ccedil;&a
tilde;o da condi&ccedil;&atilde;o    dos dentes e da gengiva, autopercep&ccedil;
&atilde;o da necessidade de tratamento    e altera&ccedil;&otilde;es de tecidos 
moles n&atilde;o foram estatisticamente    associadas ao uso de servi&ccedil;os 
odontol&oacute;gicos no &uacute;ltimo ano    entre dentados. J&aacute; entre ede
ntados, as seguintes vari&aacute;veis n&atilde;o    apresentaram associa&ccedil;
&atilde;o estat&iacute;stica com o uso de servi&ccedil;os    odontol&oacute;gico
s no &uacute;ltimo ano: local de resid&ecirc;ncia, servi&ccedil;o    odontol&oac
ute;gico, sexo, autopercep&ccedil;&atilde;o da mastiga&ccedil;&atilde;o,    auto
percep&ccedil;&atilde;o da influ&ecirc;ncia dos dentes e das gengivas no    rela
cionamento e na fala, autopercep&ccedil;&atilde;o da apar&ecirc;ncia de    dente
s e gengivas, renda <i>per capita</i> e altera&ccedil;&atilde;o de tecidos    mo
les.</font></p>     ^cY#a03v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#57#53#article#126#<p><a name="tab02">
</a></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#58#54#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#59#55#article#126#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a03tab02.gif"></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#60#56#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00282000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004700076002001300123#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#61#57#article#126#<p><a name="tab03" 
id="tab03"></a></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#62#58#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#63#59#article#126#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a03tab03.gif"></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#64#60#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#65#61#article#126#<p><a name="tab04">
</a></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#66#62#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#67#63#article#126#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a03tab04.gif"></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#68#64#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
01338000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704110300076002001301179#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#69#65#article#126#<p><font size="2" f
ace="Verdana">Os resultados da an&aacute;lise multivariada    com os fatores que
 permaneceram associados ao uso de servi&ccedil;os odontol&oacute;gicos    no &u
acute;ltimo ano s&atilde;o apresentados na <a href="#tab05">tabela 5</a>.    Ent
re dentados, a preval&ecirc;ncia de uso foi maior entre aqueles com maior    esc
olaridade, que perceberam sua mastiga&ccedil;&atilde;o como regular e p&eacute;s
sima    ou ruim, e entre os que relataram sensibilidade dolorosa nos dentes ou g
engivas    nos &uacute;ltimos 3 meses. J&aacute; a menor preval&ecirc;ncia de us
o foi evidenciada    entre os que n&atilde;o receberam informa&ccedil;&otilde;es
 sobre sa&uacute;de    bucal, entre os que percebiam sua sa&uacute;de bucal como
 regular e ruim ou    p&eacute;ssima, entre os com menor renda <i>per capita</i>
, entre os que usavam    e necessitavam de pr&oacute;teses, entre os que n&atild
e;o usavam e necessitavam    de pr&oacute;teses, entre os que apresentavam neces
sidade de tratamento periodontal    e entre aqueles com maior n&uacute;mero de d
entes extra&iacute;dos. </font></p>     ^cY#a03v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#70#66#article#126#<p><a name="tab05">
</a></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#71#67#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#72#68#article#126#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a03tab05.gif"></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#73#69#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00723000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048800076002001300564#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#74#70#article#126#<p><font size="2" f
ace="Verdana">Entre os edentados, a an&aacute;lise multivariada    mostrou uma m
aior preval&ecirc;ncia de uso entre os idosos com maior escolaridade    e entre 
os que relataram sensibilidade dolorosa nos dentes ou gengivas nos &uacute;ltimo
s    3 meses. A menor preval&ecirc;ncia de uso foi verificada entre os n&atilde;
o    brancos e os que n&atilde;o receberam informa&ccedil;&otilde;es sobre sa&ua
cute;de    bucal (<a href="#tab05">tabela 5</a>).</font></p>     ^cY#a03v22n5.ht
m##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#75#71#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00311000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007600076002001300152#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#76#72#article#126#<p><font size="3" f
ace="Verdana"><b>DISCUSS&Atilde;O</b></font></p>     ^cY#a03v22n5.htm##
00791000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704055600076002001300632#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#77#73#article#126#<p><font size="2" f
ace="Verdana">O presente trabalho evidenciou que, no Brasil,    a preval&ecirc;n
cia de uso dos servi&ccedil;os odontol&oacute;gicos por idosos    no &uacute;lti
mo ano foi muito baixa (16,8%). Esse resultado denota uma prov&aacute;vel    dif
iculdade de acesso, especialmente considerando que 5,8% dos idosos relataram    
nunca ter ido ao dentista. A baixa preval&ecirc;ncia de uso explica, em parte,  
  as prec&aacute;rias condi&ccedil;&otilde;es de sa&uacute;de bucal dos idosos  
  identificadas no inqu&eacute;rito. </font></p>     ^cY#a03v22n5.htm##
01430000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704119500076002001301271#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#78#74#article#126#<p><font size="2" f
ace="Verdana">A preval&ecirc;ncia de uso no presente trabalho    foi considerave
lmente inferior &agrave;s preval&ecirc;ncias de uso dos servi&ccedil;os    odont
ol&oacute;gicos no ano anterior observadas na d&eacute;cada de 1980 nos    Estad
os Unidos (75,6 e 58,5%) (21, 22) e na d&eacute;cada de 1990    no Canad&aacute;
 (35,2%) e Gr&atilde;-Bretanha (55,8%) (9, 23). Na maior parte    dos estudos, a
s propor&ccedil;&otilde;es dos que nunca usaram foram bem menores    do que os 5
,8% encontrados na presente investiga&ccedil;&atilde;o: 2,0% na Finl&acirc;ndia 
   em 1971 (24), 1,0% na Noruega em 1975 (25), 2,0% na Fl&oacute;rida, Estados  
  Unidos, na d&eacute;cada de 1990 (26), 0,7% na Gr&atilde;- Bretanha em 2002   
 (23). J&aacute; outro estudo, realizado em 1989, nos Estados Unidos, constatou 
   que 5,0% de idosos nunca haviam usado servi&ccedil;os odontol&oacute;gicos,  
  propor&ccedil;&atilde;o semelhante &agrave; observada na presente investiga&cc
edil;&atilde;o    (27), enquanto que um estudo realizado no sul da China verific
ou 10,0% de n&atilde;o    uso de servi&ccedil;os odontol&oacute;gicos na zona ur
bana e 22,0% na zona rural    (28). </font></p>     ^cY#a03v22n5.htm##
01683000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704144800076002001301524#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#79#75#article#126#<p><font size="2" f
ace="Verdana">Os resultados mostraram que os dentados e os    edentados comparti
lham duas importantes vari&aacute;veis contextuais associadas    ao uso de servi
&ccedil;os odontol&oacute;gicos —escolaridade e informa&ccedil;&otilde;es    sob
re sa&uacute;de bucal—, mas mostraram tamb&eacute;m diferen&ccedil;as importante
s    entre os dois estratos com rela&ccedil;&atilde;o aos demais conjuntos de va
ri&aacute;veis    analisados pelo modelo de Davidson e Andersen. Entre os edenta
dos, nenhuma vari&aacute;vel    de predisposi&ccedil;&atilde;o de uso ou disponi
bilidade de recursos permaneceu    associada ao uso de servi&ccedil;os no &uacut
e;ltimo ano. Entre os dentados,    entretanto, a renda <i>per capita</i>, a auto
percep&ccedil;&atilde;o da mastiga&ccedil;&atilde;o    e da sa&uacute;de bucal m
antiveram-se associadas ao uso de servi&ccedil;os odontol&oacute;gicos.    Com r
ela&ccedil;&atilde;o &agrave;s vari&aacute;veis de necessidade de tratamento,   
 apenas o relato de dor em dentes ou gengivas foi associada ao uso nos dois estr
atos.    As especificidades observadas em cada estrato analisado s&atilde;o impo
rtantes    para orientar pol&iacute;ticas p&uacute;blicas voltadas para a preven
&ccedil;&atilde;o    do edentulismo, a melhoria da condi&ccedil;&atilde;o de sa&
uacute;de bucal e    a redu&ccedil;&atilde;o de desigualdades no uso de servi&cc
edil;os odontol&oacute;gicos    entre os idosos. </font></p>     ^cY#a03v22n5.ht
m##
01346000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704111100076002001301187#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#80#76#article#126#<p><font size="2" f
ace="Verdana">As consultas ao dentista, diferentemente do que    ocorre com as v
isitas ao m&eacute;dico, parecem se tornar menos freq&uuml;entes    com o envelh
ecimento (4), sendo esperada uma baixa preval&ecirc;ncia de uso    de servi&cced
il;os odontol&oacute;gicos entre os idosos quando comparados a    popula&ccedil;
&otilde;es mais jovens (7, 12, 29). O menor uso parece ser explicado,    em gran
de parte, pela alta freq&uuml;&ecirc;ncia de idosos edentados, uma vez    que es
te fator est&aacute; associado &agrave; menor preval&ecirc;ncia de uso    de ser
vi&ccedil;os odontol&oacute;gicos em v&aacute;rios estudos (10, 11, 29).    H&aa
cute; ind&iacute;cios de que os edentados acreditam que a visita regular    ao d
entista &eacute; importante apenas para quem ainda tem dentes (30). No presente 
   estudo, a preval&ecirc;ncia de uso de servi&ccedil;os odontol&oacute;gicos fo
i    cerca de 3 vezes maior entre os idosos dentados quando comparados aos enden
tados,    sendo evidente a necessidade de conhecer as cren&ccedil;as dos idosos 
edentados    sobre esse aspecto.</font></p>     ^cY#a03v22n5.htm##
01034000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704079900076002001300875#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#81#77#article#126#<p><font size="2" f
ace="Verdana">A associa&ccedil;&atilde;o inversa entre a escolaridade    e o uso
 de servi&ccedil;os, observada nos dois estratos, j&aacute; foi verificada    em
 estudos conduzidos no Brasil (12) e em outros pa&iacute;ses (29–31).    O menor
 uso entre os que n&atilde;o tiveram acesso a informa&ccedil;&otilde;es    sobre
 sa&uacute;de bucal &eacute; um resultado interessante e sugere a necessidade   
 de difundir as informa&ccedil;&otilde;es relacionadas &agrave; sa&uacute;de    
bucal entre os idosos. Resultados semelhantes tamb&eacute;m foram encontrados   
 na Dinamarca e nos Estados Unidos (21, 31). Chama aten&ccedil;&atilde;o e merec
e    investiga&ccedil;&atilde;o o menor uso de servi&ccedil;os pelos edentados i
dentificados    como n&atilde;o brancos.</font></p>     ^cY#a03v22n5.htm##
01166000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704093100076002001301007#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#82#78#article#126#<p><font size="2" f
ace="Verdana">A influ&ecirc;ncia da renda no acesso &agrave;    consulta odontol
&oacute;gica tende a ser maior nos pa&iacute;ses em que esses    servi&ccedil;os
 s&atilde;o predominantemente pagos. No Brasil, 44% dos idosos    utilizaram ser
vi&ccedil;os odontol&oacute;gicos gratuitos, o que reflete um    acesso ainda li
mitado ao servi&ccedil;o odontol&oacute;gico p&uacute;blico.    Verificou-se uma
 rela&ccedil;&atilde;o direta entre a renda e o uso de servi&ccedil;os    em inq
u&eacute;ritos feitos nos Estados Unidos (21), Canad&aacute; (9–11)    e Dinamar
ca (31). O fato de a renda n&atilde;o ter aparecido como vari&aacute;vel    asso
ciada ao uso no &uacute;ltimo ano entre os edentados pode ser devido &agrave;   
 homogeneidade de renda nesse estrato, que concentra uma popula&ccedil;&atilde;o
    pobre, ou mesmo a um problema de acesso desse estrato aos servi&ccedil;os gr
atuitos.    </font></p>     ^cY#a03v22n5.htm##
01017000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704078200076002001300858#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#83#79#article#126#<p><font size="2" f
ace="Verdana">A dor em dentes ou na gengiva nos &uacute;ltimos    3 meses foi a 
&uacute;nica vari&aacute;vel de necessidade associada ao uso dos    servi&ccedil
;os odontol&oacute;gicos no &uacute;ltimo ano comum aos dois estratos.    Essa a
ssocia&ccedil;&atilde;o tamb&eacute;m foi encontrada por Davidson e Andersen    
(29) e sugere que a procura por assist&ecirc;ncia odontol&oacute;gica se d&aacut
e;    quando a sa&uacute;de bucal declina consideravelmente (4). Entre os edenta
dos,    n&atilde;o &eacute; poss&iacute;vel afirmar, mas n&atilde;o se pode desc
artar,    a possibilidade de essa associa&ccedil;&atilde;o indicar que o uso tev
e como    finalidade a realiza&ccedil;&atilde;o de extra&ccedil;&atilde;o dos de
ntes remanescentes.    </font></p>     ^cY#a03v22n5.htm##
01173000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704093800076002001301014#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#84#80#article#126#<p><font size="2" f
ace="Verdana">O maior uso de servi&ccedil;os entre os idosos    dentados que per
ceberam a sua mastiga&ccedil;&atilde;o como regular e ruim/    p&eacute;ssima su
gere que a limita&ccedil;&atilde;o ou defici&ecirc;ncia mastigat&oacute;ria    p
rediz o uso de servi&ccedil;os entre os dentados. O fato de n&atilde;o aparecer 
   como vari&aacute;vel relacionada ao uso entre edentados pode indicar acomoda&
ccedil;&atilde;o    a uma pior qualidade de mastiga&ccedil;&atilde;o ou defici&e
circ;ncia de acesso    aos servi&ccedil;os nesse estrato. &Eacute; surpreendente
 a menor freq&uuml;&ecirc;ncia    de uso entre os dentados que autopercebiam a s
ua sa&uacute;de bucal como regular    ou p&eacute;ssima/ruim. Problemas de acess
o a servi&ccedil;os odontol&oacute;gicos,    assim como uma certa resigna&ccedil
;&atilde;o com a condi&ccedil;&atilde;o de    sa&uacute;de bucal n&atilde;o pode
m ser descartados. </font></p>     ^cY#a03v22n5.htm##
00964000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704072900076002001300805#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#85#81#article#126#<p><font size="2" f
ace="Verdana">Nos dois estratos analisados no presente trabalho,    diferentemen
te de outros estudos, n&atilde;o foram verificadas associa&ccedil;&otilde;es    
entre o uso de servi&ccedil;os odontol&oacute;gicos no &uacute;ltimo ano e o    
sexo (29), a macrorregi&atilde;o de resid&ecirc;ncia ou a resid&ecirc;ncia em   
 zona urbana e rural (11, 12, 31). A autopercep&ccedil;&atilde;o da apar&ecirc;n
cia,    da fala e do relacionamento social em fun&ccedil;&atilde;o das condi&cce
dil;&otilde;es    bucais n&atilde;o estiveram associadas ao uso de servi&ccedil;
os odontol&oacute;gicos,    indicando a necessidade de avaliar melhor o papel de
ssas vari&aacute;veis no    cuidado com os dentes.</font></p>     ^cY#a03v22n5.h
tm##
01345000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704111000076002001301186#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#86#82#article#126#<p><font size="2" f
ace="Verdana">O uso e a necessidade de pr&oacute;tese n&atilde;o    estiveram as
sociados ao uso de servi&ccedil;os odontol&oacute;gicos entre os    edentados no
 presente estudo. A literatura mostra resultados inconsistentes    sobre o tema 
(21, 29, 31). &Eacute; poss&iacute;vel que os edentados brasileiros    n&atilde;
o tenham informa&ccedil;&atilde;o satisfat&oacute;ria sobre a necessidade    de 
consultas regulares ao dentista para avalia&ccedil;&atilde;o e manuten&ccedil;&a
tilde;o    de suas pr&oacute;teses. A menor preval&ecirc;ncia de uso entre os id
osos dentados    que necessitam de pr&oacute;tese ou de tratamento periodontal, 
assim como a    associa&ccedil;&atilde;o inversa com o n&uacute;mero de dentes e
xtra&iacute;dos    e a forte associa&ccedil;&atilde;o entre as visitas ao dentis
ta e a dor —uma    express&atilde;o da necessidade de tratamento— podem retratar
 a iniq&uuml;idade    (pois os que mais necessitam s&atilde;o os que menos usam)
 ou uma tend&ecirc;ncia    &agrave; procura pelo dentista somente em situa&ccedi
l;&otilde;es de urg&ecirc;ncia.</font></p>     ^cY#a03v22n5.htm##
01519000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704128400076002001301360#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#87#83#article#126#<p><font size="2" f
ace="Verdana">Tais resultados preocupam, pois a piora na sa&uacute;de    bucal t
ende a levar ao edentulismo se n&atilde;o for tratada a tempo e adequadamente.  
  Chama aten&ccedil;&atilde;o o fato de a maioria dos idosos dentados no present
e    estudo estar pr&oacute;xima da condi&ccedil;&atilde;o de edentulismo pela p
recariedade    da sua condi&ccedil;&atilde;o bucal e pelo pequeno n&uacute;mero 
de dentes remanescentes    na boca. Um fator que pode concorrer para explicar a 
associa&ccedil;&atilde;o    negativa entre a necessidade de pr&oacute;tese e o u
so de servi&ccedil;os &eacute;    o custo elevado do tratamento prot&eacute;tico
. Vale salientar que a rela&ccedil;&atilde;o    entre o uso de servi&ccedil;os o
dontol&oacute;gicos e as vari&aacute;veis investigadas    &eacute; din&acirc;mic
a, portanto causas e efeitos certamente variam ao longo    da vida. Sendo este u
m estudo seccional, n&atilde;o &eacute; poss&iacute;vel    estabelecer uma rela&
ccedil;&atilde;o temporal entre as associa&ccedil;&otilde;es    observadas. Quem
 menos usa os servi&ccedil;os para tratamento restaurador e    preventivo tende 
a perder mais dentes e ter uma pior condi&ccedil;&atilde;o    geral de sa&uacute
;de bucal em decorr&ecirc;ncia do menor uso. </font></p>     ^cY#a03v22n5.htm##
01322000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704108700076002001301163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#88#84#article#126#<p><font size="2" f
ace="Verdana">Dentados e edentados mostraram diferen&ccedil;as    importante com
 rela&ccedil;&atilde;o &agrave;s vari&aacute;veis associadas ao    uso de servi&
ccedil;os odontol&oacute;gicos. Apenas a escolaridade, o relato    de ter recebi
do informa&ccedil;&otilde;es sobre sa&uacute;de bucal e o relato    de dor de de
nte ou gengiva nos &uacute;ltimos 3 meses foram vari&aacute;veis    comuns aos d
ois estratos. Este trabalho tamb&eacute;m evidenciou um menor uso    de servi&cc
edil;os entre os idosos com sa&uacute;de bucal mais prec&aacute;ria,    ou seja,
 entre os que mais necessitavam de tratamento, o que sugere iniq&uuml;idade    n
o acesso aos servi&ccedil;os odontol&oacute;gicos. A menor preval&ecirc;ncia    
de uso entre aqueles que n&atilde;o receberam informa&ccedil;&otilde;es sobre   
 sa&uacute;de bucal sugere a necessidade de melhorar a qualidade dos servi&ccedi
l;os    preventivos, que devem passar a oferecer orienta&ccedil;&otilde;es sobre
 o auto-exame    bucal para a identifica&ccedil;&atilde;o precoce dos problemas 
bucais. </font></p>     ^cY#a03v22n5.htm##
01340000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704110500076002001301181#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#89#85#article#126#<p><font size="2" f
ace="Verdana">A necessidade de tratamento e de revis&atilde;o    das pr&oacute;t
eses e a suspeita da neoplasia s&atilde;o raz&otilde;es para    a procura dos se
rvi&ccedil;os odontol&oacute;gicos. No presente estudo, importantes    vari&aacu
te;veis de necessidade de tratamento dent&aacute;rio estiveram associadas    ao 
menor uso de servi&ccedil;os, o que pode levar a um ciclo vicioso de deteriora&c
cedil;&atilde;o    da sa&uacute;de bucal. A popula&ccedil;&atilde;o idosa est&aa
cute; crescendo    e necessita de pol&iacute;ticas de sa&uacute;de bucal espec&i
acute;ficas para    reduzir o edentulismo e melhorar as condi&ccedil;&otilde;es 
gerais de sa&uacute;de    e de vida. Para tanto, s&atilde;o necess&aacute;rios i
nvestimentos em sa&uacute;de    bucal que possam garantir o acesso e aumentar a 
motiva&ccedil;&atilde;o para    o uso de servi&ccedil;os odontol&oacute;gicos pr
eventivos e regulares, tanto    entre os dentados quanto entre os edentados, rev
ertendo, assim, o prec&aacute;rio    quadro de sa&uacute;de bucal e reduzindo as
 desigualdades observadas.</font></p>     ^cY#a03v22n5.htm##
00937000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704070200076002001300778#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#90#86#article#126#<p><font size="2" f
ace="Verdana"><b>Agradecimentos.</b> Agradecemos &agrave; Coordena&ccedil;&atild
e;o    de Sa&uacute;de Bucal do Minist&eacute;rio da Sa&uacute;de e &agrave; equ
ipe    de campo do inqu&eacute;rito, bem como aos participantes do estudo. Andr&
eacute;a    Maria Eleut&eacute;rio de Barros Lima Martins recebeu bolsa das Facu
ldades Unidas    de Norte de Minas (FUNORTE)/Associa&ccedil;&atilde;o Educativa 
do Brasil (SOEBRAS)    durante a realiza&ccedil;&atilde;o deste trabalho. Sandhi
 Maria Barreto e Isabela    Almeida Pordeus s&atilde;o bolsistas de produtividad
e em pesquisa do Conselho    Nacional de Desenvolvimento Cient&iacute;fico e Tec
nol&oacute;gico (CNPq).</font></p>     ^cY#a03v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#91#87#article#126#<p>&nbsp;</p>     ^
cY#a03v22n5.htm##
00313000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007800076002001300154#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#92#88#article#126#<p><font size="3" f
ace="Verdana"><b>REFER&Ecirc;NCIAS</b></font> </p>     ^cY#a03v22n5.htm##
00521000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704027200078002001300350#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#93#89#article#126#1#<p><f
ont size="2" face="Verdana">1. Petersen PE. The Word Oral Health Report 2003.   
 Continuous improvement of oral health in the 21st century—the approach of the  
  WHO Global Oral Health Programme. Community Dent Oral Epidemiol. 2003;31(1):3–
24.    </font> </p>    ^cY#a03v22n5.htm##
00382000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704013300078002001300211#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#94#90#article#126#2#<p><f
ont size="2" face="Verdana">2. Reisine ST. Dental disease and work loss.    J De
nt Res. 1984;63(9): 1158–61.</font> </p>    ^cY#a03v22n5.htm##
00436000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704018700078002001300265#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#95#91#article#126#3#<p><f
ont size="2" face="Verdana">3. Reisine ST. The impact of dental conditions    on
 social functioning and the quality of life. Annual Rev Public Health. 1988;9:1–
19.</font></p>    ^cY#a03v22n5.htm##
00418000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704016900078002001300247#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#96#92#article#126#4#<p><f
ont size="2" face="Verdana">4. Kiyak HA. Explaining patterns of dental service  
  utilization among the elderly. J Dent Educ. 1986;50(11):679–87.</font></p>    
^cY#a03v22n5.htm##
00445000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704019600078002001300274#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#97#93#article#126#5#<p><f
ont size="2" face="Verdana"> 5. Colussi CF, Freitas SFT. Aspectos epidemiol&oacu
te;gicos    da sa&uacute;de bucal do idoso no Brasil. Cad Saude Publica. 2002;18
(5):1313–20.</font></p>    ^cY#a03v22n5.htm##
00619000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704037000078002001300448#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#98#94#article#126#6#<p><f
ont size="2" face="Verdana"> 6. Brasil, Minist&eacute;rio da Sa&uacute;de,    Co
ordena&ccedil;&atilde;o Nacional de Sa&uacute;de Bucal. Resultados principais   
 do projeto SB Brasil 2003: condi&ccedil;&otilde;es de sa&uacute;de bucal da    
popula&ccedil;&atilde;o brasileira 2002–2003. Bras&iacute;lia: Minist&eacute;rio
    da Sa&uacute;de; 2004.</font></p>    ^cY#a03v22n5.htm##
00429000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704018000078002001300258#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#99#95#article#126#7#<p><f
ont size="2" face="Verdana"> 7. Newman JF, Gift HC. Regular pattern of preventiv
e    dental services—a measure of access. Soc Sci Med. 1992;35(38):997–1001.</fo
nt></p>    ^cY#a03v22n5.htm##
00430000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000200077704018000079002001300259#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#100#96#article#126#8#<p><
font size="2" face="Verdana"> 8. Gilbert GH, Branch LG, Longmate J. Dental    ca
re use by U.S. veterans eligible for VA Care. Soc Sci Med. 1993;36(3):361–70.</f
ont></p>    ^cY#a03v22n5.htm##
00461000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000200077704021100079002001300290#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#101#97#article#126#9#<p><
font size="2" face="Verdana"> 9. Locker D, Ford J. Evaluation of an area-based  
  measure as an indicator of inequalities in oral health. Community Dent Oral   
 Epidemiol. 1994;22(2):80–5.</font></p>    ^cY#a03v22n5.htm##
00457000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704020600080002001300286#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#102#98#article#126#10#<p>
<font size="2" face="Verdana">10. Locker D, Ford J. Using area-based measures   
 of socioeconomic status in dental health services research. J Public Health    
Dent. 1996;56 (2):69–75.</font></p>    ^cY#a03v22n5.htm##
00483000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704023200080002001300312#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#103#99#article#126#11#<p>
<font size="2" face="Verdana">11. Locker D, Leake JL, Lee J, Main PA, Hicks    T
, Hamilton M. Utilization of dental services by older adults in four Ontario    
communities. J Can Dent Assoc. 1991;57(11):879–86.</font></p>    ^cY#a03v22n5.ht
m##
00587000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704033500081002001300416#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#104#100#article#126#12#<p
><font size="2" face="Verdana">12. Matos DL, Giatt, L, Lima Costa MF. Fatores   
 s&oacute;cio-demogr&aacute;ficos associados ao uso de servi&ccedil;os odontol&o
acute;gicos    entre idosos brasileiros: um estudo baseado na Pesquisa Nacional 
por amostras    de domic&iacute;lio. Cad Saude Publica. 2004;20(5):1290–7.</font
></p>    ^cY#a03v22n5.htm##
00436000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704018400081002001300265#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#105#101#article#126#13#<p
><font size="2" face="Verdana">13. Andersen RM, Davidson PL. Ethnicity, aging,  
  and oral health outcomes: a conceptual framework. Adv Dent Res. 1997;11(2):203
–9.</font></p>    ^cY#a03v22n5.htm##
00453000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020100081002001300282#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#106#102#article#126#14#<p
><font size="2" face="Verdana">14. Gift HC, Atchison KA, Drury TF. Perceptions  
  of the natural dentition in the context of multiple variables. J Dent Res. 199
8;77(7):    1529–38.</font></p>    ^cY#a03v22n5.htm##
00522000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704027000081002001300351#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#107#103#article#126#15#<p
><font size="2" face="Verdana">15. Brasil, Minist&eacute;rio da Sa&uacute;de.   
 Projeto SB 2000: Condi&ccedil;&otilde;es da sa&uacute;de bucal da popula&ccedil
;&atilde;o    brasileira, 2000. Bras&iacute;lia: Minist&eacute;rio da Sa&uacute;
de; 2000.</font></p>    ^cY#a03v22n5.htm##
00401000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704014900081002001300230#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#108#104#article#126#16#<p
><font size="2" face="Verdana">16. World Health Organization. Oral health survey
s:    basic methods. 4th ed. Genebra: WHO; 1997.</font></p>    ^cY#a03v22n5.htm#
#
00616000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704036400081002001300445#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#109#105#article#126#17#<p
><font size="2" face="Verdana">17. Brasil, Minist&eacute;rio da Sa&uacute;de,   
 Secretaria de Aten&ccedil;&atilde;o &agrave; Sa&uacute;de. Projeto SB 2000:    
condi&ccedil;&otilde;es de sa&uacute;de bucal da popula&ccedil;&atilde;o brasile
ira    no ano 2000. Manual do coordenador. Bras&iacute;lia: Minist&eacute;rio da
 Sa&uacute;de;    2001.</font></p>    ^cY#a03v22n5.htm##
00645000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704039300081002001300474#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#110#106#article#126#18#<p
><font size="2" face="Verdana">18. Brasil, Minist&eacute;rio da Sa&uacute;de,   
 Secretaria de Aten&ccedil;&atilde;o &agrave; Sa&uacute;de. Projeto SB 2000:    
condi&ccedil;&otilde;es de sa&uacute;de bucal da popula&ccedil;&atilde;o brasile
ira    no ano 2000. Manual de calibra&ccedil;&atilde;o de examinadores. Bras&iac
ute;lia:    Minist&eacute;rio da Sa&uacute;de; 2001.</font></p>    ^cY#a03v22n5.
htm##
00509000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704025700081002001300338#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#111#107#article#126#19#<p
><font size="2" face="Verdana">19. Lima-Costa MF, Barreto SM. Tipos de estudos  
  epidemiol&oacute;gicos: conceitos b&aacute;sicos e aplica&ccedil;&otilde;es   
 na &aacute;rea do envelhecimento. Epidemiol Serv Saude. 2003;12(4):189–201.</fo
nt></p>    ^cY#a03v22n5.htm##
00421000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704016900081002001300250#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#112#108#article#126#20#<p
><font size="2" face="Verdana">20. Greenland S. Modeling and variable selec-tion
    in epidemiologic analysis. Am J Public Health. 1989;79(3):340–9.</font></p> 
   ^cY#a03v22n5.htm##
00535000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704028300081002001300364#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#113#109#article#126#21#<p
><font size="2" face="Verdana">21. Atchison KA, Mayer-Oakes SA, Schweitzer SO,  
  Lubben JE, De Jong FJ, Mathias RE. The relationship between dental utilization
    and preventive participation among a well-elderly sample. J Publ Health Dent
.    1993;53(2):88–95.</font></p>    ^cY#a03v22n5.htm##
00420000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704016800081002001300249#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#114#110#article#126#22#<p
><font size="2" face="Verdana">22. Ettinger RL. The unique oral health needs    
of an aging population. Dent Clin North America. 1997;41(4):633–49.</font></p>  
  ^cY#a03v22n5.htm##
00431000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704017900081002001300260#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#115#111#article#126#23#<p
><font size="2" face="Verdana">23. Mc Grath C, Bedi R. Influences of social    s
upport on the oral health of older people in Britain. J Rehab. 2002;29:918–22.</
font></p>    ^cY#a03v22n5.htm##
00476000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022400081002001300305#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#116#112#article#126#24#<p
><font size="2" face="Verdana">24. Murtoma AH, Markulla J. Utilization and hindr
ances    to utilization of dental services in Finland prior to the public health
. Proc    Finn Dent Soc. 1977;73(3):138–43.</font></p>    ^cY#a03v22n5.htm##
00439000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704018700081002001300268#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#117#113#article#126#25#<p
><font size="2" face="Verdana">25. Heloe LA, Trostand L. The use of dental servi
ces    among Norwegian adults in 1973. Community Dent Oral Epidemiol. 1975;3(3):
120–5.</font></p>    ^cY#a03v22n5.htm##
00444000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019200081002001300273#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#118#114#article#126#26#<p
><font size="2" face="Verdana">26. Gilbert GH, Heft MN, Duncan RP, Ringelberg   
 ML. Perceived need for dental care in dentate older adults. Int Dent J. 1994;44
(2):145–52.</font></p>    ^cY#a03v22n5.htm##
00522000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704027000081002001300351#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#119#115#article#126#27#<p
><font size="2" face="Verdana">27. Bolden AD, Joseph L, Henry JL, Allukian M.   
 Implications of access, utilization and need for oral health care by low income
    groups and minorities on the dental delivery system. J Dent Educ. 1993;57(12
):888–98.</font></p>    ^cY#a03v22n5.htm##
00435000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704018300081002001300264#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#120#116#article#126#28#<p
><font size="2" face="Verdana">28. Lo EC, Lin HC, Wang ZJ, Wong MC, Schwarz    E
. Utilization of dental services in Southern China. J Dent Res. 2001;80(5):1471–
4.</font></p>    ^cY#a03v22n5.htm##
00448000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019600081002001300277#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#121#117#article#126#29#<p
><font size="2" face="Verdana">29. Davidson PL, Andersen RM. Determinants of    
dental care utilization for diverse ethnic and age groups. Adv Dent Res. 1997;11
(2):    254–62.</font></p>    ^cY#a03v22n5.htm##
00475000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022300081002001300304#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#122#118#article#126#30#<p
><font size="2" face="Verdana">30. Tennstedt SL, Brambilla DL, Jette AM. Underst
anding    dental service use by older adults: sociobehavioral factors vs. need. 
J Public    Health Dent. 1994;54(4):211–9.</font></p>    ^cY#a03v22n5.htm##
00423000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704017100081002001300252#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#123#119#article#126#31#<p
><font size="2" face="Verdana">31. Schwarz E. Changes in demand for dental care 
   among Danish adults, 1975–90. Acta Odontol Scand. 1996;54(1):36–43.</font></p
>    ^cY#a03v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#124#120#article#126#<p>&nbsp;</p>    
 ^cY#a03v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#125#121#article#126#<p>&nbsp;</p>    
 ^cY#a03v22n5.htm##
00331000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009400078002001300172#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#126#122#article#126#<p><font size="2"
 face="Verdana">Manuscrito recebido em 16 de mar&ccedil;o de    2007.    ^cY#a03
v22n5.htm##
00320000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008300078002001300161#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#127#123#article#126#<br>   Aceito em 
vers&atilde;o revisada em 1 de agosto de 2007.</font></p>     ^cY#a03v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#128#124#article#126#<p>&nbsp;</p>    
 ^cY#a03v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#129#125#article#126#<p>&nbsp;</p>    
 ^cY#a03v22n5.htm##
00564000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704032700078002001300405#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a03v22n5.htm#S#p#130#126#article#126#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> Correspond&ecirc;ncia:    A
venida Cula Mangabeira 210, Bairro Santo Expedito, CEP 39401-001, Montes Claros,
    MG, Brasil. Fone: +55-38-3214. 2672; e-mail: <a href="mailto:andrea martins@
viamoc.com.br">andrea    martins@viamoc.com.br</a></font></p>     ^cY#a03v22n5.h
tm##
00590000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100019000770120149000960300
03100245710000200276065000900278064000500287031000300292032000200295014000500297
865000900302002001300311#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#131#1#article#31#1#^rND^sPetersen^nPE#The Word Oral Health Report 2003: Conti
nuous improvement of oral health in the 21st century-the approach of the WHO Glo
bal Oral Health Programme^len#Community Dent Oral Epidemiol.#2#20030000#2003#31#
1#3-24#20071100#a03v22n5.htm##
00457000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120033000950300
01200128710000200140065000900142064000500151031000300156032000200159014000800161
865000900169002001300178#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#132#2#article#31#2#^rND^sReisine^nST#Dental disease and work loss^len#J Dent 
Res.#2#19840000#1984#63#9#1158-61#20071100#a03v22n5.htm##
00501000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120082000950300
02500177710000200202065000900204064000500213031000200218014000500220865000900225
002001300234#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#133#3#art
icle#31#3#^rND^sReisine^nST#The impact of dental conditions on social functionin
g and the quality of life^len#Annual Rev Public Health#2#19880000#1988#9#1-19#20
071100#a03v22n5.htm##
00495000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100016000770120072000930300
01300165710000200178065000900180064000500189031000300194032000300197014000700200
865000900207002001300216#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#134#4#article#31#4#^rND^sKiyak^nHA#Explaining patterns of dental service util
ization among the elderly^len#J Dent Educ.#2#19860000#1986#50#11#679-87#20071100
#a03v22n5.htm##
00562000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100019000950120
06300114030001800177065000900195064000500204031000300209032000200212014000800214
865000900222002001300231035001000244801001800254#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a03v22n5.htm#S#c#135#5#article#31#5#^rND^sColussi^nCF#^rND^sFreitas^nS
FT#Aspectos epidemiológicos da saúde bucal do idoso no Brasil^lpt#Cad Saude Publ
ica#20020000#2002#18#5#1313-20#20071100#a03v22n5.htm#0102-311X#Cad Saude Publica
##
00549000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170065000770180112001420660
00900254062002000263065000900283064000500292865000900297002001300306#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#136#6#article#31#6#Brasil^dMinist
ério da Saúde, Coordenação Nacional de Saúde Bucal#Resultados principais do proj
eto SB Brasil 2003: condições de saúde bucal da população brasileira 2002-2003^l
pt#Brasília#Ministério da Saúde#20040000#2004#20071100#a03v22n5.htm##
00523000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100015000940120
07000109030001300179710000200192065000900194064000500203031000300208032000300211
014000900214865000900223002001300232#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#137#7#article#31#7#^rND^sNewman^nJF#^rND^sGift^nHC#Regular patter
n of preventive dental services-a measure of access^len#Soc Sci Med.#2#19920000#
1992#35#38#997-1001#20071100#a03v22n5.htm##
00541000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100017000950100
01800112012005800130030001300188710000200201065000900203064000500212031000300217
032000200220014000700222865000900229002001300238#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a03v22n5.htm#S#c#138#8#article#31#8#^rND^sGilbert^nGH#^rND^sBranch^nLG
#^rND^sLongmate^nJ#Dental care use by U.S. veterans eligible for VA Care^len#Soc
 Sci Med.#2#19930000#1993#36#3#361-70#20071100#a03v22n5.htm##
00551000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100016000770100014000930120
08700107030003100194710000200225065000900227064000500236031000300241032000200244
014000500246865000900251002001300260#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#139#9#article#31#9#^rND^sLocker^nD#^rND^sFord^nJ#Evaluation of an
 area-based measure as an indicator of inequalities in oral health^len#Community
 Dent Oral Epidemiol.#2#19940000#1994#22#2#80-5#20071100#a03v22n5.htm##
00547000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100014000950120
08900109030002200198710000200220065000900222064000500231031000300236032000200239
014000600241865000900247002001300256#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#140#10#article#31#10#^rND^sLocker^nD#^rND^sFord^nJ#Using area-bas
ed measures of socioeconomic status in dental health services research^len#J Pub
lic Health Dent.#2#19960000#1996#56#2#69-75#20071100#a03v22n5.htm##
00646000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100016000950100
01300111010001500124010001500139010001800154012007900172030001800251710000200269
06500090027106400050028003100030028503200030028801400070029186500090029800200130
0307#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#141#11#article#31
#11#^rND^sLocker^nD#^rND^sLeake^nJL#^rND^sLee^nJ#^rND^sMain^nPA#^rND^sHicks^nT#^
rND^sHamilton^nM#Utilization of dental services by older adults in four Ontario 
communities^len#J Can Dent Assoc.#2#19910000#1991#57#11#879-86#20071100#a03v22n5
.htm##
00693000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100015000950100
02100110012016600131030001800297065000900315064000500324031000300329032000200332
014000700334865000900341002001300350035001000363801001800373#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a03v22n5.htm#S#c#142#12#article#31#12#^rND^sMatos^nDL#^rND
^sGiatt^nL#^rND^sLima Costa^nMF#Fatores sócio-demográficos associados ao uso de 
serviços odontológicos entre idosos brasileiros: um estudo baseado na Pesquisa N
acional por amostras de domicílio^lpt#Cad Saude Publica#20040000#2004#20#5#1290-
7#20071100#a03v22n5.htm#0102-311X#Cad Saude Publica##
00529000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100019000980120
07100117030001400188710000200202065000900204064000500213031000300218032000200221
014000600223865000900229002001300238#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#143#13#article#31#13#^rND^sAndersen^nRM#^rND^sDavidson^nPL#Ethnic
ity, aging, and oral health outcomes: a conceptual framework^len#Adv Dent Res.#2
#19970000#1997#11#2#203-9#20071100#a03v22n5.htm##
00560000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100019000940100
01600113012007800129030001200207710000200219065000900221064000500230031000300235
032000200238014000800240865000900248002001300257#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a03v22n5.htm#S#c#144#14#article#31#14#^rND^sGift^nHC#^rND^sAtchison^nK
A#^rND^sDrury^nTF#Perceptions of the natural dentition in the context of multipl
e variables^len#J Dent Res.#2#19980000#1998#77#7#1529-38#20071100#a03v22n5.htm##
00478000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170028000790180076001070660
00900183062002000192065000900212064000500221865000900226002001300235#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#145#15#article#31#15#Brasil^dMini
stério da Saúde#Projeto SB 2000: Condições da saúde bucal da população brasileir
a, 2000^lpt#Brasília#Ministério da Saúde#20000000#2000#20071100#a03v22n5.htm##
00436000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170026000790180039001050630
00200144066000800146062000400154065000900158064000500167865000900172002001300181
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#146#16#article#31#16#
World Health Organization#Oral health surveys: basic methods^len#4#Genebra#WHO#1
9970000#1997#20071100#a03v22n5.htm##
00549000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170059000790180082001380610
02200220066000900242062002000251065000900271064000500280865000900285002001300294
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#147#17#article#31#17#
Brasil^dMinistério da Saúde, Secretaria de Atenção à Saúde#Projeto SB 2000: cond
ições de saúde bucal da população brasileira no ano 2000^lpt#Manual do coordenad
or#Brasília#Ministério da Saúde#20010000#2001#20071100#a03v22n5.htm##
00564000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170059000790180082001380610
03700220066000900257062002000266065000900286064000500295865000900300002001300309
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#148#18#article#31#18#
Brasil^dMinistério da Saúde, Secretaria de Atenção à Saúde#Projeto SB 2000: cond
ições de saúde bucal da população brasileira no ano 2000^lpt#Manual de calibraçã
o de examinadores#Brasília#Ministério da Saúde#20010000#2001#20071100#a03v22n5.h
tm##
00563000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100021000790100018001000120
09500118030002100213710000200234065000900236064000500245031000300250032000200253
014000800255865000900263002001300272#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#149#19#article#31#19#^rND^sLima-Costa^nMF#^rND^sBarreto^nSM#Tipos
 de estudos epidemiológicos: conceitos básicos e aplicações na área do envelheci
mento^lpt#Epidemiol Serv Saude#2#20030000#2003#12#4#189-201#20071100#a03v22n5.ht
m##
00534000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790120063000980300
01900161065000900180064000500189031000300194032000200197014000600199865000900205
002001300214035001000227801001900237#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#150#20#article#31#20#^rND^sGreenland^nS#Modeling and variable sel
ec-tion in epidemiologic analysis^len#Am J Public Health#19890000#1989#79#3#340-
9#20071100#a03v22n5.htm#0090-0036#Am J Public Health##
00694000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100022000980100
02100120010001700141010001800158010001800176012010500194030002000299710000200319
06500090032106400050033003100030033503200020033801400060034086500090034600200130
0355#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#151#21#article#31
#21#^rND^sAtchison^nKA#^rND^sMayer-Oakes^nSA#^rND^sSchweitzer^nSO#^rND^sLubben^n
JE#^rND^sDe Jong^nFJ#^rND^sMathias^nRE#The relationship between dental utilizati
on and preventive participation among a well-elderly sample^len#J Publ Health De
nt.#2#19930000#1993#53#2#88-95#20071100#a03v22n5.htm##
00494000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790120056000980300
02400154710000200178065000900180064000500189031000300194032000200197014000700199
865000900206002001300215#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#152#22#article#31#22#^rND^sEttinger^nRL#The unique oral health needs of an ag
ing population^len#Dent Clin North America#2#19970000#1997#41#4#633-49#20071100#
a03v22n5.htm##
00513000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100014000970120
07900111030000900190710000200199065000900201064000500210031000300215014000700218
865000900225002001300234#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#153#23#article#31#23#^rND^sMc Grath^nC#^rND^sBedi^nR#Influences of social sup
port on the oral health of older people in Britain^len#J Rehab.#2#20020000#2002#
29#918-22#20071100#a03v22n5.htm##
00566000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100018000970120
10300115030002000218710000200238065000900240064000500249031000300254032000200257
014000700259865000900266002001300275#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#154#24#article#31#24#^rND^sMurtoma^nAH#^rND^sMarkulla^nJ#Utilizat
ion and hindrances to utilization of dental services in Finland prior to the pub
lic health^len#Proc Finn Dent Soc.#2#19770000#1977#73#3#138-43#20071100#a03v22n5
.htm##
00532000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100018000950120
06200113030003100175710000200206065000900208064000500217031000200222032000200224
014000600226865000900232002001300241#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#155#25#article#31#25#^rND^sHeloe^nLA#^rND^sTrostand^nL#The use of
 dental services among Norwegian adults in 1973^len#Community Dent Oral Epidemio
l.#2#19750000#1975#3#3#120-5#20071100#a03v22n5.htm##
00573000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100015000970100
01700112010002100129012005900150030001200209710000200221065000900223064000500232
031000300237032000200240014000700242865000900249002001300258#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a03v22n5.htm#S#c#156#26#article#31#26#^rND^sGilbert^nGH#^r
ND^sHeft^nMN#^rND^sDuncan^nRP#^rND^sRingelberg^nML#Perceived need for dental car
e in dentate older adults^len#Int Dent J.#2#19940000#1994#44#2#145-52#20071100#a
03v22n5.htm##
00648000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100016000960100
01600112010001800128012013600146030001300282710000200295065000900297064000500306
031000300311032000300314014000700317865000900324002001300333#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a03v22n5.htm#S#c#157#27#article#31#27#^rND^sBolden^nAD#^rN
D^sJoseph^nL#^rND^sHenry^nJL#^rND^sAllukian^nM#Implications of access, utilizati
on and need for oral health care by low income groups and minorities on the dent
al delivery system^len#J Dent Educ.#2#19930000#1993#57#12#888-98#20071100#a03v22
n5.htm##
00582000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100013000790100014000920100
01500106010001500121010001700136012005300153030001200206710000200218065000900220
064000500229031000300234032000200237014000700239865000900246002001300255#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S#c#158#28#article#31#28#^rND^sLo
^nEC#^rND^sLin^nHC#^rND^sWang^nZJ#^rND^sWong^nMC#^rND^sSchwarz^nE#Utilization of
 dental services in Southern China^len#J Dent Res.#2#20010000#2001#80#5#1471-4#2
0071100#a03v22n5.htm##
00537000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100019000980120
07800117030001400195710000200209065000900211064000500220031000300225032000200228
014000700230865000900237002001300246#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
3v22n5.htm#S#c#159#29#article#31#29#^rND^sDavidson^nPL#^rND^sAndersen^nRM#Determ
inants of dental care utilization for diverse ethnic and age groups^len#Adv Dent
 Res.#2#19970000#1997#11#2#254-62#20071100#a03v22n5.htm##
00583000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100020000990100
01600119012008700135030002200222710000200244065000900246064000500255031000300260
032000200263014000600265865000900271002001300280#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a03v22n5.htm#S#c#160#30#article#31#30#^rND^sTennstedt^nSL#^rND^sBrambi
lla^nDL#^rND^sJette^nAM#Understanding dental service use by older adults: sociob
ehavioral factors vs. need^len#J Public Health Dent.#2#19940000#1994#54#4#211-9#
20071100#a03v22n5.htm##
00498000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790120067000960300
02000163710000200183065000900185064000500194031000300199032000200202014000600204
865000900210002001300219#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a03v22n5.htm#S
#c#161#31#article#31#31#^rND^sSchwarz^nE#Changes in demand for dental care among
 Danish adults, 1975-90^len#Acta Odontol Scand.#2#19960000#1996#54#1#36-43#20071
100#a03v22n5.htm##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#o#1#1#article#1
#20080121#151816#a04v22n5.htm#128##
04926000000000685000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000500090038000400095121000300099049000800102158000300110
03000240011303100030013703200020014006500090014201400110015103500100016201201250
01720120153002970100033004500100025004830100027005080100028005350100025005630700
10000588070010500688070011700793070009500910070010301005083127401108085000802382
08500340239008500380242408500320246208314550249408500080394908500340395708500480
39910850030040390580071040690580033041401170006041730720003041791120009041821110
01204191114000904203113001504212002001304227#v22n5#v:\scielo\serial\rpsp\v22n5\m
arkup\a04v22n5.htm#S#h#2#1#article#1#oa#en#br1.1#1#3.1#ILUS#TAB#04#RPSP020#nd#Re
v Panam Salud Publica#22#5#20071100#^f317^l322#1020-4989#In-house polymerase cha
in reaction for affordable and sustainable Chlamydia trachomatis detection in Tr
inidad and Tobago^len#Sistema autóctono para la detección asequible y sustentabl
e de Chlamydia trachomatis por la reacción en cadena de la polimerasa en Trinida
d y Tobago^les#^rND^1A01 A05^nJoanne^sRampersad#^rND^1A02^nXiaohui^sWang#^rND^1A
03^nHelen^sGayadeen#^rND^1A03^nSamuel^sRamsewak#^rND^1A04^nDavid^sAmmons#Univers
ity of the West Indies^iA01^1Department of Life Sciences^cSt. Augustine^pTrinida
d and Tobago#University of Texas-Pan American^iA02^1Mathematics Department^cEdin
burg^sTexas^pUnited States of America#University of the West Indies^iA03^1Facult
y of Medical Sciences^2School of Medicine^cMount Hope^pTrinidad and Tobago#Unive
rsity of the West Indies^iA04^1Faculty of Medical Sciences^2School of Veterinary
 Medicine#University of Texas-Pan American^iA05^1Chemistry Department^cEdinburg^
sTexas^pUnited States of America#^len^aOBJECTIVES: To provide a preliminary asse
ssment of in-house polymerase chain reaction (PCR) as an alternative to the more
 costly commercial test for detection of asymptomatic infection by Chlamydia tra
chomatis and to provide much needed demographic data on infection indicators wit
hin the Trinidad and Tobago public health care system. METHODS: An inexpensive i
n-house nested-PCR with an Internal Amplification Control was used to detect C. 
trachomatis and Neisseria gonorrhoeae in urine samples collected from 273 appare
ntly healthy, pregnant women from March-September 2004 in Trinidad, West Indies.
 Demographic information on participants was collected and subjected to statisti
cal analyses. RESULTS: C. trachomatis was detected in 57/273 (21%) samples, of w
hich 5 (2%) were also positive for N. gonorrhoeae. Infection correlated well wit
h certain demographic parameters, with the highest incidence of C. trachomatis i
nfection found among pregnant women that were single or of African descent. CONC
LUSIONS: Given the lack of commercial tests in Trinidad, in-house PCR is an inex
pensive alternative that can be used to detect asymptomatic infections of C. tra
chomatis and to provide demographic information needed for interventions by the 
public health care system.#^dnd^i1#^tm^len^kChlamydia trachomatis^i1#^tm^len^kpo
lymerase chain reaction^i1#^tm^len^kTrinidad and Tobago^i1#^les^aOBJETIVOS: Hace
r una evaluación preliminar de un sistema autóctono para la detección de la infe
cción asintomática por Chlamydia trachomatis mediante la reacción en cadena de l
a polimerasa (RCP), como alternativa a los costosos sistemas comerciales, y ofre
cer datos demográficos muy necesarios relacionados con los indicadores de esta i
nfección en el sistema de salud pública de Trinidad y Tobago. MÉTODOS: Se empleó
 un sistema autóctono y económico de RCP anidada con control interno de la ampli
ficación para la detección de C. trachomatis y Neisseria gonorrhoeae en muestras
 de orina de 273 mujeres embarazadas asintomáticas, entre marzo y septiembre de 
2004 en Trinidad y Tobago, Indias Occidentales. Se obtuvo la información demográ
fica de las participantes y se sometió a análisis estadístico. RESULTADOS: Se de
tectó C. trachomatis en 57/273 (21%) muestras, de las cuales 5 (2%) fueron tambi
én positivas para N. gonorrhoeae. La infección se correlacionó bien con algunos 
parámetros demográficos; la mayor incidencia de la infección por C. trachomatis 
se observó en las mujeres embarazadas solteras o de ascendencia africana. CONCLU
SIONES: Debido al déficit de sistemas de diagnóstico comerciales en Trinidad, la
 RCP autóctona es una alternativa económica que puede emplearse para detectar la
 infección asintomática por C. trachomatis y obtener la información demográfica 
necesaria para que el sistema de salud pública implemente intervenciones.#^dnd^i
2#^tm^les^kChlamydia trachomatis^i2#^tm^les^kreacción en cadena de la polimerasa
^i2#^tm^les^kTrinidad y Tobago^i2#University of the West Indies’ Research and Pu
blication Fund Committee#University of Texas-Pan American#other#20#20060707#7 Ju
ly 2006#20071003#3 October 2007#a04v22n5.htm##
05122000000000685000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000500090038000400095121000300099049000800102158000300110
03000240011303100030013703200020014006500090014201400110015103500100016201201390
01720120167003110100033004780100025005110100027005360100028005630100025005910700
10000616070010500716070011700821070009500938070010301033083135101136085000802487
08500410249508500380253608500320257408315320260608500080413808500410414608500480
41870850030042350580071042650580033043361170006043690720003043751120009043781110
01204387114000904399113001504408002001304423#v22n5#v:\scielo\serial\rpsp\v22n5\m
arkup\a04v22n5.htm#S#f#3#1#article#1#oa#en#br1.1#1#3.1#ILUS#TAB#04#RPSP020#nd#Re
v Panam Salud Publica#22#5#20071100#^f317^l322#1020-4989#<B>In-house polymerase 
chain reaction for affordable and sustainable <I>Chlamydia trachomatis</I> detec
tion in Trinidad and Tobago</B>^len#<B>Sistema autóctono para la detección asequ
ible y sustentable de <I>Chlamydia trachomatis</I> por la reacción en cadena de 
la polimerasa en Trinidad y Tobago</B>^les#^rND^1A01 A05^nJoanne^sRampersad#^rND
^1A02^nXiaohui^sWang#^rND^1A03^nHelen^sGayadeen#^rND^1A03^nSamuel^sRamsewak#^rND
^1A04^nDavid^sAmmons#University of the West Indies^iA01^1Department of Life Scie
nces^cSt. Augustine^pTrinidad and Tobago#University of Texas-Pan American^iA02^1
Mathematics Department^cEdinburg^sTexas^pUnited States of America#University of 
the West Indies^iA03^1Faculty of Medical Sciences^2School of Medicine^cMount Hop
e^pTrinidad and Tobago#University of the West Indies^iA04^1Faculty of Medical Sc
iences^2School of Veterinary Medicine#University of Texas-Pan American^iA05^1Che
mistry Department^cEdinburg^sTexas^pUnited States of America#^len^a<B>OBJECTIVES
:</B> To provide a preliminary assessment of in-house polymerase chain reaction 
(PCR) as an alternative to the more costly commercial test for detection of asym
ptomatic infection by <I>Chlamydia trachomatis</I> and to provide much needed de
mographic data on infection indicators within the Trinidad and Tobago public hea
lth care system. <B>METHODS:</B> An inexpensive in-house nested-PCR with an Inte
rnal Amplification Control was used to detect <I>C. trachomatis</I> and <I>Neiss
eria gonorrhoeae</I> in urine samples collected from 273 apparently healthy, pre
gnant women from March-September 2004 in Trinidad, West Indies. Demographic info
rmation on participants was collected and subjected to statistical analyses. <B>
RESULTS:</B> <I>C. trachomatis</I> was detected in 57/273 (21%) samples, of whic
h 5 (2%) were also positive for <I>N. gonorrhoeae</I>. Infection correlated well
 with certain demographic parameters, with the highest incidence of <I>C. tracho
matis</I> infection found among pregnant women that were single or of African de
scent. <B>CONCLUSIONS:</B> Given the lack of commercial tests in Trinidad, in-ho
use PCR is an inexpensive alternative that can be used to detect asymptomatic in
fections of <I>C. trachomatis</I> and to provide demographic information needed 
for interventions by the public health care system.#^dnd^i1#^tm^len^k<I>Chlamydi
a trachomatis</I>^i1#^tm^len^kpolymerase chain reaction^i1#^tm^len^kTrinidad and
 Tobago^i1#^les^a<B>OBJETIVOS:</B> Hacer una evaluación preliminar de un sistema
 autóctono para la detección de la infección asintomática por <I>Chlamydia trach
omatis</I> mediante la reacción en cadena de la polimerasa (RCP), como alternati
va a los costosos sistemas comerciales, y ofrecer datos demográficos muy necesar
ios relacionados con los indicadores de esta infección en el sistema de salud pú
blica de Trinidad y Tobago. <B>MÉTODOS:</B> Se empleó un sistema autóctono y eco
nómico de RCP anidada con control interno de la amplificación para la detección 
de <I>C. trachomatis</I> y <I>Neisseria gonorrhoeae</I> en muestras de orina de 
273 mujeres embarazadas asintomáticas, entre marzo y septiembre de 2004 en Trini
dad y Tobago, Indias Occidentales. Se obtuvo la información demográfica de las p
articipantes y se sometió a análisis estadístico. <B>RESULTADOS:</B> Se detectó 
<I>C. trachomatis</I> en 57/273 (21%) muestras, de las cuales 5 (2%) fueron tamb
ién positivas para <I>N. gonorrhoeae</I>. La infección se correlacionó bien con 
algunos parámetros demográficos; la mayor incidencia de la infección por <I>C. t
rachomatis</I> se observó en las mujeres embarazadas solteras o de ascendencia a
fricana. <B>CONCLUSIONES:</B> Debido al déficit de sistemas de diagnóstico comer
ciales en Trinidad, la RCP autóctona es una alternativa económica que puede empl
earse para detectar la infección asintomática por <I>C. trachomatis</I> y obtene
r la información demográfica necesaria para que el sistema de salud pública impl
emente intervenciones.#^dnd^i2#^tm^les^k<I>Chlamydia trachomatis</I>^i2#^tm^les^
kreacción en cadena de la polimerasa^i2#^tm^les^kTrinidad y Tobago^i2#University
 of the West Indies’ Research and Publication Fund Committee#University of Texas
-Pan American#other#20#20060707#7 July 2006#20071003#3 October 2007#a04v22n5.htm
##
05137000000000709000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000500103038000400108121000300112049000800115
15800030012303000260012603100030015203200020015506500090015701400110016603500100
01770120125001870120153003120100033004650100025004980100027005230100028005500100
02500578070010200603070010700705070011900812070013300931070010501064083128801169
08500080245708500340246508500380249908500320253708314750256908500080404408500340
40520850048040860850030041340580071041640580033042351170006042680720003042741120
00904277111001204286114000904298113001504307002001304322008009204335#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#l#4#1#article#1#^mNov.^a2007#oa#en#
br1.1#1#3.1#ilus#tab#04#RPSP020#nd#Rev. panam. salud pública#22#5#20071100#^f317
^l322#1020-4989#In-house polymerase chain reaction for affordable and sustainabl
e Chlamydia trachomatis detection in Trinidad and Tobago^len#Sistema autóctono p
ara la detección asequible y sustentable de Chlamydia trachomatis por la reacció
n en cadena de la polimerasa en Trinidad y Tobago^les#^rND^1A01 A05^nJoanne^sRam
persad#^rND^1A02^nXiaohui^sWang#^rND^1A03^nHelen^sGayadeen#^rND^1A03^nSamuel^sRa
msewak#^rND^1A04^nDavid^sAmmons#^iA01^1University of the West Indies^2Department
 of Life Sciences^cSt. Augustine^pTrinidad and Tobago#^iA02^1University of Texas
-Pan American^2Mathematics Department^cEdinburg^sTexas^pUnited States of America
#^iA03^1University of the West Indies^2Faculty of Medical Sciences^3School of Me
dicine^cMount Hope^pTrinidad and Tobago#^iA04^1University of the West Indies^2Fa
culty of Medical Sciences^3School of Veterinary Medicine^cSt. Augustine^pTrinida
d and Tobago#^iA05^1University of Texas-Pan American^2Chemistry Department^cEdin
burg^sTexas^pUnited States of America#^len^aOBJECTIVES: To provide a preliminary
 assessment of in-house polymerase chain reaction (PCR) as an alternative to the
 more costly commercial test for detection of asymptomatic infection by Chlamydi
a trachomatis and to provide much needed demographic data on infection indicator
s within the Trinidad and Tobago public health care system. METHODS: An inexpens
ive in-house nested-PCR with an Internal Amplification Control was used to detec
t C. trachomatis and Neisseria gonorrhoeae in urine samples collected from 273 a
pparently healthy, pregnant women from March-September 2004 in Trinidad, West In
dies. Demographic information on participants was collected and subjected to sta
tistical analyses. RESULTS: C. trachomatis was detected in 57/273 (21 percent) s
amples, of which 5 (2 percent) were also positive for N. gonorrhoeae. Infection 
correlated well with certain demographic parameters, with the highest incidence 
of C. trachomatis infection found among pregnant women that were single or of Af
rican descent. CONCLUSIONS: Given the lack of commercial tests in Trinidad, in-h
ouse PCR is an inexpensive alternative that can be used to detect asymptomatic i
nfections of C. trachomatis and to provide demographic information needed for in
terventions by the public health care system.#^dnd^i1#^tm^len^kChlamydia trachom
atis^i1#^tm^len^kpolymerase chain reaction^i1#^tm^len^kTrinidad and Tobago^i1#^l
es^aOBJETIVOS: Hacer una evaluación preliminar de un sistema autóctono para la d
etección de la infección asintomática por Chlamydia trachomatis mediante la reac
ción en cadena de la polimerasa (RCP), como alternativa a los costosos sistemas 
comerciales, y ofrecer datos demográficos muy necesarios relacionados con los in
dicadores de esta infección en el sistema de salud pública de Trinidad y Tobago.
 MÉTODOS: Se empleó un sistema autóctono y económico de RCP anidada con control 
interno de la amplificación para la detección de C. trachomatis y Neisseria gono
rrhoeae en muestras de orina de 273 mujeres embarazadas asintomáticas, entre mar
zo y septiembre de 2004 en Trinidad y Tobago, Indias Occidentales. Se obtuvo la 
información demográfica de las participantes y se sometió a análisis estadístico
. RESULTADOS: Se detectó C. trachomatis en 57/273 (21 por ciento) muestras, de l
as cuales 5 (2 por ciento) fueron también positivas para N. gonorrhoeae. La infe
cción se correlacionó bien con algunos parámetros demográficos; la mayor inciden
cia de la infección por C. trachomatis se observó en las mujeres embarazadas sol
teras o de ascendencia africana. CONCLUSIONES: Debido al déficit de sistemas de 
diagnóstico comerciales en Trinidad, la RCP autóctona es una alternativa económi
ca que puede emplearse para detectar la infección asintomática por C. trachomati
s y obtener la información demográfica necesaria para que el sistema de salud pú
blica implemente intervenciones.#^dnd^i2#^tm^les^kChlamydia trachomatis^i2#^tm^l
es^kreacción en cadena de la polimerasa^i2#^tm^les^kTrinidad y Tobago^i2#Univers
ity of the West Indies’ Research and Publication Fund Committee#University of Te
xas-Pan American#other#20#20060707#7 July 2006#20071003#3 October 2007#a04v22n5.
htm#Internet^ihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49
892007001000004##
00357000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012400074002001300198#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#5#1#article#104#<p align="right"><fon
t size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEA
RCH</font></p>     ^cY#a04v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#6#2#article#104#<p>&nbsp;</p>     ^cY
#a04v22n5.htm##
00443000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704021000074002001300284#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#7#3#article#104#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>In-house polymerase chain    reaction for afford
able and sustainable <i>Chlamydia trachomatis</i> detection    in Trinidad and T
obago</b></font></p>     ^cY#a04v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#8#4#article#104#<p>&nbsp;</p>     ^cY
#a04v22n5.htm##
00476000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704024300074002001300317#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#9#5#article#104#<p><font size="3" fac
e="verdana"><b>Sistema aut&oacute;ctono para la detecci&oacute;n    asequible y 
sustentable de <i>Chlamydia trachomatis</i> por la reacci&oacute;n    en cadena 
de la polimerasa en Trinidad y Tobago</b></font> </p>     ^cY#a04v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#10#6#article#104#<p>&nbsp;</p>     ^c
Y#a04v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#11#7#article#104#<p>&nbsp;</p>     ^c
Y#a04v22n5.htm##
00478000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704024400075002001300319#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#12#8#article#104#<p><font size="2" fa
ce="Verdana"><b>Joanne Rampersad<sup>I, V, </sup><a href="#nt"><sup>*</sup></a>;
    Xiaohui Wang<sup>II</sup>; Helen Gayadeen<sup>III</sup>; Samuel Ramsewak<sup
>III</sup>;    David Ammons<SUP>IV</SUP></b></font></p>     ^cY#a04v22n5.htm##
00384000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704015000075002001300225#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#13#9#article#104#<p><font size="2" fa
ce="Verdana"><SUP>I</sup>Department of Life Sciences, University    of the West 
Indies, St. Augustine, Trinidad and Tobago    ^cY#a04v22n5.htm##
00365000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704013000076002001300206#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#14#10#article#104#<br>   <SUP>II</sup
>Mathematics Department, University    of Texas—Pan American, Edinburg, Texas, U
nited States of America    ^cY#a04v22n5.htm##
00381000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704014600076002001300222#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#15#11#article#104#<br>   <SUP>III</su
p>Faculty of Medical Sciences,    School of Medicine, University of the West Ind
ies, Mount Hope, Trinidad and    Tobago    ^cY#a04v22n5.htm##
00391000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704015600076002001300232#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#16#12#article#104#<br>   <SUP>IV</sup
>Faculty of Medical Sciences,    School of Veterinary Medicine, University of th
e West Indies, Mount Hope, Trinidad    and Tobago    ^cY#a04v22n5.htm##
00374000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704013900076002001300215#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#17#13#article#104#<br>   <SUP>V</sup>
Chemistry Department, University    of Texas—Pan American, Edinburg, Texas, Unit
ed States of America</font></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#18#14#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#19#15#article#104#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a04v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#20#16#article#104#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a04v22n5.htm##
00637000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704040200076002001300478#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#21#17#article#104#<p><font size="2" f
ace="Verdana"><b>OBJECTIVES:</b> To provide a preliminary assessment    of in-ho
use polymerase chain reaction (PCR) as an alternative to the more costly    comm
ercial test for detection of asymptomatic infection by <i>Chlamydia trachomatis<
/i>    and to provide much needed demographic data on infection indicators withi
n the    Trinidad and Tobago public health care system.    ^cY#a04v22n5.htm##
00641000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704040600076002001300482#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#22#18#article#104#<br>   <b>METHODS:<
/b> An inexpensive in-house nested-PCR with an Internal Amplification    Control
 was used to detect <i>C. trachomatis</i> and <i>Neisseria gonorrhoeae</i>    in
 urine samples collected from 273 apparently healthy, pregnant women from    Mar
ch–September 2004 in Trinidad, West Indies. Demographic information on participa
nts    was collected and subjected to statistical analyses.    ^cY#a04v22n5.htm#
#
00591000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704035600076002001300432#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#23#19#article#104#<br>   <b>RESULTS:<
/b> <i>C. trachomatis</i> was detected in 57/273 (21%) samples,    of which 5 (2
%) were also positive for <i>N. gonorrhoeae</i>. Infection correlated    well wi
th certain demographic parameters, with the highest incidence of <i>C.    tracho
matis</i> infection found among pregnant women that were single or of    African
 descent.    ^cY#a04v22n5.htm##
00555000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704032000076002001300396#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#24#20#article#104#<br>   <b>CONCLUSIO
NS:</b> Given the lack of commercial tests in Trinidad, in-house    PCR is an in
expensive alternative that can be used to detect asymptomatic infections    of <
i>C. trachomatis</i> and to provide demographic information needed for intervent
ions    by the public health care system.</font></p>     ^cY#a04v22n5.htm##
00407000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704017200076002001300248#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#25#21#article#104#<p><font size="2" f
ace="Verdana"><b>Keywords:</b> <i>Chlamydia trachomatis</i>,    polymerase chain
 reaction, Trinidad and Tobago.</font></p> <hr size="1" noshade>     ^cY#a04v22n
5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#26#22#article#104#<p><font size="2" f
ace="VERDANA"><b>RESUMEN</b></font></p>     ^cY#a04v22n5.htm##
00767000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704053200076002001300608#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#27#23#article#104#<p><font size="2" f
ace="Verdana"><b>OBJETIVOS:</b> Hacer una evaluaci&oacute;n    preliminar de un 
sistema aut&oacute;ctono para la detecci&oacute;n de la infecci&oacute;n    asin
tom&aacute;tica por <i>Chlamydia trachomatis</i> mediante la reacci&oacute;n    
en cadena de la polimerasa (RCP), como alternativa a los costosos sistemas comer
ciales,    y ofrecer datos demogr&aacute;ficos muy necesarios relacionados con l
os indicadores    de esta infecci&oacute;n en el sistema de salud p&uacute;blica
 de Trinidad y    Tobago.    ^cY#a04v22n5.htm##
00773000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704053800076002001300614#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#28#24#article#104#<br>   <b>M&Eacute;
TODOS:</b> Se emple&oacute; un sistema aut&oacute;ctono y econ&oacute;mico    de
 RCP anidada con control interno de la amplificaci&oacute;n para la detecci&oacu
te;n    de <i>C. trachomatis</i> y <i>Neisseria gonorrhoeae</i> en muestras de o
rina    de 273 mujeres embarazadas asintom&aacute;ticas, entre marzo y septiembr
e de    2004 en Trinidad y Tobago, Indias Occidentales. Se obtuvo la informaci&o
acute;n    demogr&aacute;fica de las participantes y se someti&oacute; a an&aacu
te;lisis    estad&iacute;stico.    ^cY#a04v22n5.htm##
00676000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704044100076002001300517#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#29#25#article#104#<br>   <b>RESULTADO
S:</b> Se detect&oacute; <i>C. trachomatis</i> en 57/273 (21%) muestras,    de l
as cuales 5 (2%) fueron tambi&eacute;n positivas para <i>N. gonorrhoeae</i>.    
La infecci&oacute;n se correlacion&oacute; bien con algunos par&aacute;metros   
 demogr&aacute;ficos; la mayor incidencia de la infecci&oacute;n por <i>C. trach
omatis</i>    se observ&oacute; en las mujeres embarazadas solteras o de ascende
ncia africana.    ^cY#a04v22n5.htm##
00673000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704043800076002001300514#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#30#26#article#104#<br>   <b>CONCLUSIO
NES:</b> Debido al d&eacute;ficit    de sistemas de diagn&oacute;stico comercial
es en Trinidad, la RCP aut&oacute;ctona    es una alternativa econ&oacute;mica q
ue puede emplearse para detectar la infecci&oacute;n    asintom&aacute;tica por 
<i>C. trachomatis</i> y obtener la informaci&oacute;n    demogr&aacute;fica nece
saria para que el sistema de salud p&uacute;blica implemente    intervenciones.<
/font></p>     ^cY#a04v22n5.htm##
00431000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704019600076002001300272#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#31#27#article#104#<p><font size="2" f
ace="Verdana"><b>Palabras clave:</b>    <i>Chlamydia trachomatis</i>, reacci&oac
ute;n en cadena de la polimerasa, Trinidad    y Tobago.</font></p> <hr size="1" 
noshade>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#32#28#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#33#29#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
01620000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704138500076002001301461#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#34#30#article#104#<p><font size="2" f
ace="Verdana"><i>Chlamydia trachomatis</i> and <i>Neisseria    gonorrhoeae</i> a
re sexually transmitted bacteria known to cause a range of    diseases in both m
en and women, with women being at particular risk of serious    complications (1
, 2). Neonates infected at birth by their mothers can suffer    from ailments su
ch as pneumonia and conjunctivitis (3, 4). Most importantly,    both bacteria ar
e capable of establishing subclinical infections whereby unsuspecting    carrier
s can pass on the infection through sexual contact. Testing has been    shown ef
fective for the identification of infected, asymptomatic individuals    (5) and 
economic gains by the health care system have been attributed to testing    (6).
 Testing is recommended by the Centers for Disease Control and Prevention    (CD
C, Atlanta, Georgia, United States of America) (7). Commercial diagnostic    sys
tems, based on nucleic acid amplification, have been developed to serve this    
need and are now considered to be the preferred method (7). However, these syste
ms    are expensive, though efforts have been made to reduce their cost (8). For
 the    Republic of Trinidad and Tobago, and other countries in the developing w
orld    where resources are relatively limited, the cost to purchase, use, and m
aintain    these commercial diagnostic systems can be prohibitive.</font></p>   
  ^cY#a04v22n5.htm##
01289000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704105400076002001301130#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#35#31#article#104#<p><font size="2" f
ace="Verdana">Studies have indicated that <i>C. trachomatis</i>    infection may
 represent a serious health threat to the Trinidadian population    (9). It is a
lso an important factor in pregnancy and fertility-related problems    in Trinid
ad (10). However, despite the need for testing (11), to date, <i>C.    trachomat
is</i> screening has not been made available by the Government’s health    care 
system. Recognizing the importance of and need for <i>C. trachomatis</i>    scre
ening and the prohibitive cost of commercial systems, the Diagnostic Laboratory 
   Services at the Government’s Mt. Hope Hospital, in collaboration with the Uni
versity    of the West Indies, undertook a preliminary study. The study would de
termine    if a less expensive, in-house diagnostic test could serve the health 
care needs    of the nation by achieving two desired objectives: the detection o
f asymptomatic    infections and the collection of demographic information neede
d for intervention    by the public health care system.</font></p>     ^cY#a04v2
2n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#36#32#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00316000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008100076002001300157#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#37#33#article#104#<p><font size="3" f
ace="Verdana"><b>MATERIALS AND METHODS</b></font></p>     ^cY#a04v22n5.htm##
00592000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704035700076002001300433#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#38#34#article#104#<p><font size="2" f
ace="Verdana">The ethics committees of the Faculty of Medical    Sciences of the
 University of the West Indies and the General Hospital in Port-of-Spain,    Tri
nidad and Tobago, approved this study. Administrative approval was obtained    f
rom the Principal Medical Officer, Ministry of Health, Government of Trinidad.</
font></p>     ^cY#a04v22n5.htm##
00327000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009200076002001300168#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#39#35#article#104#<p><font size="2" f
ace="Verdana"><b>Sample collection and processing</b></font></p>     ^cY#a04v22n
5.htm##
00903000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704066800076002001300744#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#40#36#article#104#<p><font size="2" f
ace="Verdana">Samples were collected in March– September 2004    from 273 appare
ntly healthy, pregnant women at private as well as government    clinics. Any an
d all pregnant women present in the respective clinics at the    time of samplin
g were invited to participate. A 15–20 mL sample of first-void    urine was coll
ected, held at 4°C until transported (within 24 hours of collection),    and sto
red at –20°C until DNA was prepared from the sample (within two months).    DNA 
from both urine and vulvular swabs was prepared using Chelex 100 resin (Sigma   
 Chemical Co., St. Louis, United States) according to Jurstrand (12).</font></p>
     ^cY#a04v22n5.htm##
00326000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009100076002001300167#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#41#37#article#104#<p><font size="2" f
ace="Verdana"><b>Polymerase chain reaction (PCR)</b></font></p>     ^cY#a04v22n5
.htm##
01789000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704155400076002001301630#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#42#38#article#104#<p><font size="2" f
ace="Verdana">Primary and nested multiplex-PCR reactions were    optimized by te
sting 1.5, 2, and 3 mM MgCl<SUB>2</SUB> in the reaction, each    at 12 temperatu
res ranging from 45°C – 65°C using a Gradient Master Cycler (Eppendorf    Inc., 
Westbury, New York, United States). Primers utilized in this work are    present
ed in <a href="#tab01">Table 1</a> and target the cryptic plasmids in    <i>C. t
rachomatis</i> (for example, GenBank X06707) or <i>N. gonorrhoeae</i>    (for ex
ample, GenBank M10316). In order to minimize contamination, four separate    roo
ms were used; one for creating the PCR reaction mix, a second for template    pr
eparation and primary PCR, a third for performing nested reactions, and a    fou
rth for gel electrophoresis. Nested reactions were performed in a biosafety    h
ood where 1 mL of primary reaction was delivered to a nested tube with a 1    mL
 platinum urine loop. The end of the loop was then washed briefly in a 10%    bl
each solution, rinsed in water, and flamed before reusing. Amplification product
s    from 15 mL of the PCR reaction were separated on a 2% agarose gel, stained 
with    ethidium bromide, and visualized under a 302 nm ultraviolet light. DNA m
arkers    were created by PCR amplification of virulence genes from <i>E. coli</
i> generating    calculated-sized base pair (bp) fragments of 881, 520, 337, 274
, and 171, and    their relative sizes confirmed using a commercial DNA size sta
ndard (100 bp    ladder, Promega Corp., Madison, Wisconsin, United States).</fon
t></p>     ^cY#a04v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#43#39#article#104#<p><a name="tab01">
</a></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#44#40#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#45#41#article#104#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a04tab01.gif"></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#46#42#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00936000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704070100076002001300777#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#47#43#article#104#<p><font size="2" f
ace="Verdana">Primary reactions contained 0.2 mM each dNTP,    reaction buffer w
ith MgCl<SUB>2</SUB> at 3 mM, 0.5 pmoles/mL each of primers    HO1, HO3, Chlam5 
(5'-cattatgtcggagtctgagc), and Chlam3 (5'-ggatgactcaaggaatagtcg),    1 mL of Int
ernal Amplification Control (IAC) template (a DNA amplicon randomly    amplified
 from the genome of a chicken with primer IAC whose concentration was    undeter
mined), 0.4 pmoles/mL primer IAC (5'-tgtttgacagcttatcat), 5 mL DNA template    p
reparation, 0.5 units of <i>Taq</i> polymerase, and water to 25 mL. Amplificatio
n    conditions were 94°C for 15 seconds, 60°C for 30 seconds, 72°C for 60 secon
ds,    for 40 cycles. </font></p>     ^cY#a04v22n5.htm##
00724000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048900076002001300565#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#48#44#article#104#<p><font size="2" f
ace="Verdana">Nested reactions contained 0.2 mM each dNTP,    reaction buffer co
ntaining MgCl<SUB>2</SUB> at 2 mM, 0.5 pmoles/mL each of primers    KL-1, KL-2, 
Gon5 (5'-gttcttgacgctccatatcg) and Gon3 (5'-acgaggcattgaagcaaagc),    0.4 pmoles
/mL IAC, 1 mL of the primary reaction, 0.5 units of <i>Taq</i> polymerase,    an
d water to 25 mL. Amplification conditions were 94°C for 15 seconds, 58.5°C    f
or 30 seconds, 72°C for 30 seconds, for 40 cycles.</font></p>     ^cY#a04v22n5.h
tm##
00309000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007400076002001300150#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#49#45#article#104#<p><font size="2" f
ace="Verdana"><b>DNA sequencing</b></font></p>     ^cY#a04v22n5.htm##
01006000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704077100076002001300847#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#50#46#article#104#<p><font size="2" f
ace="Verdana">DNA sequence was determined for <i>C. trachomatis</i>    and <i>N.
 gonorrhoeae</i> from amplicons generated in the nested reaction. Amplification 
   products were electrophoresed through a 1% agarose gel, and the agar containi
ng    the amplified DNA was then cut from the gel, briefly frozen, thawed, and s
pun    at 12 000 rpm through a polypropylene fiber to remove the DNA-containing 
liquid.    Lastly it was ethanol precipitated. An ABI Big Dye (Applied Biosystem
s Group,    Foster City, California, United States) sequencing kit was used acco
rding to    the manufacturer’s instructions, using the nested primers individual
ly in separate    reactions, and the reactions resolved on an ABI377 DNA sequenc
ing machine.</font></p>     ^cY#a04v22n5.htm##
00327000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009200076002001300168#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#51#47#article#104#<p><font size="2" f
ace="Verdana"><b>Digene’s Hybrid Capture II CT-ID</b></font></p>     ^cY#a04v22n
5.htm##
00625000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039000076002001300466#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#52#48#article#104#<p><font size="2" f
ace="Verdana">DNA from 10 swabs and 10 urine samples were sent    to the Barbado
s Reference Laboratory for <i>C. trachomatis</i> testing using    Digene’s Hybri
d Capture II CT-ID test (Digene Corp., Gaithersburg, Maryland,    United States)
. Samples shown by PCR to be either positive or negative for <i>C.    trachomati
s</i> were chosen for analysis.</font></p>     ^cY#a04v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#53#49#article#104#<p><font size="2" f
ace="Verdana"><b>Statistical analysis</b></font></p>     ^cY#a04v22n5.htm##
01032000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704079700076002001300873#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#54#50#article#104#<p><font size="2" f
ace="Verdana">Statistical analyses were performed using the    Statistical Packa
ge for the Social Sciences, version 15.0 (SPSS Inc., Chicago,    Illinois, Unite
d States), and R for Windows (The R Foundation, Vienna, Austria)    (15). The Ch
i-square test was used to assess the association of pairs of categorical    vari
ables. Multidimensional log-linear analyses were used to analyze a three-way    
contingency table consisting of marital status, ethnicity, and infection status.
    Because the log-linear models indicated that a three-way interaction effect 
   of marital status, ethnicity, and infection status was not significant, analy
ses    of two-way contingency tables were performed. A significance level of 0.0
5 was    used throughout the analyses.</font></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#55#51#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#56#52#article#104#<p><font size="3" f
ace="Verdana"><b>RESULTS</b></font></p>     ^cY#a04v22n5.htm##
00813000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704057800076002001300654#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#57#53#article#104#<p><font size="2" f
ace="Verdana">The in-house test provided clear and easy to    interpret results 
(<a href="#fig01">Figure 1</a>). Of 273 urine samples from    apparently healthy
, pregnant women, the primary PCR detected <i>C. trachomatis</i>    in 21 sample
s and both <i>C. trachomatis</i> and <i>N. gonorrhoeae</i> in 1    sample. The n
ested PCR detected <i>C. trachomatis</i> in a total of 57 samples,    5 of which
 also contained <i>N. gonorrhoeae</i>. None of the samples contained    <i>N. go
norrhoeae</i> without a <i>C. trachomatis</i> co-infection.</font></p>     ^cY#a
04v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#58#54#article#104#<p><a name="fig01">
</a></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#59#55#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#60#56#article#104#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a04fig01.gif"></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#61#57#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00718000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048300076002001300559#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#62#58#article#104#<p><font size="2" f
ace="Verdana">As expected, all samples that tested positive    in the primary re
action for either bacterium were also positive for the same    bacterium in the 
more sensitive, nested reaction. DNA sequence analysis of amplicons    generated
 in the nested reaction for both a positive <i>C. trachomatis</i> sample    (Gen
Bank DQ005492), and a positive <i>N. gonorrhoeae</i> sample, (GenBank DQ005493),
    confirmed the origin of amplified DNAs. </font></p>     ^cY#a04v22n5.htm##
00823000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704058800076002001300664#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#63#59#article#104#<p><font size="2" f
ace="Verdana">Results using the in-house test compared well    with results obta
ined by the Barbados Reference Laboratory using Digene’s Hybrid    Capture II CT
-ID (<a href="#tab02">Table 2</a>). In all instances, where the    commercial te
st was either positive or equivocal, the in-house test was positive;    however,
 two samples, negative by the commercial test, were positive by the    in-house 
test. These two samples were tested twice by the in-house test, and    both time
s the results were positive in both the primary and nested reactions.</font></p>
     ^cY#a04v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#64#60#article#104#<p><a name="tab02">
</a></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#65#61#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#66#62#article#104#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a04tab02.gif"></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#67#63#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
01175000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704094000076002001301016#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#68#64#article#104#<p><font size="2" f
ace="Verdana">The association of four demographic parameters    with <i>C. trach
omatis</i> infection is presented in <a href="#tab03">Table    3</a>. A statisti
cally significant association was not observed between either    trimester and i
nfection status (<i>P</i> = 0.462), nor the type of health facility    and infec
tion status (<i>P</i> = 0.104). Therefore, the probability of being    either po
sitive (79.1%) or negative (20.9%) was estimated with 95% confidence    levels (
<a href="#tab03">Table 3</a>), regardless of the trimester and facility    subgr
oups. Alternatively, the associations between both marital status and ethnicity 
   and the infection status were very strong, indicated by extremely small <i>P<
/i>    values (near zero). Infection probability and 95% confidence intervals fo
r each    subgroup of ethnicity and marital status are also given in <a href="#t
ab03">Table    3</a>.</font></p>     ^cY#a04v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#69#65#article#104#<p><a name="tab03">
</a></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#70#66#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#71#67#article#104#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a04tab03.gif"></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#72#68#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#73#69#article#104#<p><font size="3" f
ace="Verdana"><b>DISCUSSION</b></font></p>     ^cY#a04v22n5.htm##
01097000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704086200076002001300938#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#74#70#article#104#<p><font size="2" f
ace="Verdana">Although routine testing for <i>C. trachomatis</i>    has never be
en available within the public health care system in Trinidad and    Tobago, stu
dies have indicated both a high rate of exposure to the organism    (9) and its 
involvement in disease within the Trinidadian population (10). The    need for r
outine testing for <i>C. trachomatis</i> in Trinidad has been reported    (11) a
nd numerous reports can be found in the literature on the use of commercial    t
ests for the detection of <i>C. trachomatis</i> (16–18). However, for developing
    countries like Trinidad and Tobago, these reports are of little use since th
e    tests described are prohibitively expensive. Therefore, an economical alter
native    to commercial tests was sought for use within the Trinidad and Tobago 
health    care system. </font></p>     ^cY#a04v22n5.htm##
02062000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704182700076002001301903#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#75#71#article#104#<p><font size="2" f
ace="Verdana">The first objective of this study was to determine    if an in-hou
se, PCR could detect subclinical infection in individuals. This    was necessary
 for purposes of routine testing and treatment. The decision was    made to use 
a nested-PCR because it is known to be highly sensitive. In fact,    one potenti
al concern was the false-positive results that the nested PCR might    produce d
ue to its high sensitivity. However, in this study, positive samples    were non
-random regarding both race and marital status (<a href="#tab02">Table    2</a>)
, and thus consistent with few or no false-positive reactions from random    con
tamination. Attesting to the sensitivity of a nested-PCR, it detected approximat
ely    2.5 times more infected samples from asymptomatic individuals than did th
e primary    PCR. The nested PCR also performed well compared to Digene’s Captur
e Hybrid    II CT-ID, used by the Barbados Reference Laboratory for the detectio
n of Chlamydia    (<a href="#tab02">Table 2</a>). Although financial constraints
 limited the sample    size (<i>n</i> = 20), results suggested that the commerci
al test had no obvious    advantage over the in-house test (<a href="#tab02">Tab
le 2</a>). The two samples    positive by the in-house test and negative with th
e commercial test were tested    twice, both times giving positive reactions for
 <i>C. trachomatis</i> in both    the primary and nested reactions. These result
s suggest that the two samples    contained the bacterium and that the reactions
 using Digene’s Capture Hybrid    II CT-ID may have been falsely negative (19). 
False-negatives are, in fact,    a recognized problem with PCR tests, and intern
al amplification controls, such    as the one incorporated in the in-house test,
 have been recommended (20).</font></p>     ^cY#a04v22n5.htm##
00803000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056800076002001300644#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#76#72#article#104#<p><font size="2" f
ace="Verdana">Although the in-house test utilized in this study    was primarily
 for the detection of <i>C. trachomatis, N. gonorrhoeae</i> was    included, as 
in commercial systems, due to its importance as an STD. However,    unlike <i>C.
 trachomatis</i>, the culture and diagnosis of <i>N. gonorrhoeae</i>    are avai
lable within the public health care system of Trinidad and Tobago; its    inclus
ion in this preliminary study was mainly in anticipation of the future    develo
pment of the test and not a focus of this study. </font></p>     ^cY#a04v22n5.ht
m##
01606000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704137100076002001301447#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#77#73#article#104#<p><font size="2" f
ace="Verdana">Because routine screening for <i>C. trachomatis</i>    has never b
een available in Trinidad and Tobago, the second objective of this    study was 
to determine if the test could provide the health authorities in Trinidad    and
 Tobago with much needed data on infection demographics. In this regard,    the 
test performed well identifying non-random infection within the population    an
d indicating that marital status and ethnicity may serve as indicators of    inf
ection; that is, pregnant women who are single and/or of African/mixed-African  
  descent may have a higher probability of <i>C. trachomatis</i> infection (<a h
ref="#tab03">Table    3</a>). Aside from health consequences to the mother, thes
e results indicate    that a relatively large number of infants of African desce
nt are being born    from infected mothers—with unknown consequences to the chil
d. Although infection    status may seem higher among women at public health fac
ilities, a significant    association between infection and facility type was no
t observed using a significance    level of 0.05. However, the P value of 0.104 
was marginal, indicating that <i>C.    trachomatis</i> infection may be more pre
valent among patients at public health    facilities and should be examined furt
her as a potential indicator of infection    status.</font></p>     ^cY#a04v22n5
.htm##
01049000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704081400076002001300890#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#78#74#article#104#<p><font size="2" f
ace="Verdana">Because Trinidad and Tobago has not been able    to afford commerc
ial tests for routine detection of <i>C. trachomatis</i>, the    government heal
th care system has not been able to provide this basic service    to clients. Al
though in-house PCR tests may not be as rigorously characterized    as commercia
l tests, the nested PCR has been shown useful in Trinidad for the    detection o
f sub-clinical infection and for identifying demographic parameters    indicativ
e of higher infection rates. With a calculated cost in reagents of    less than 
US$ 1.50 per test, in Trinidad and Tobago, and perhaps other countries    with s
imilar challenges, in-house PCR tests may represent a useful tool for    the det
ection and control of <i>C. trachomatis</i> infection. </font></p>     ^cY#a04v2
2n5.htm##
00755000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704052000076002001300596#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#79#75#article#104#<p><font size="2" f
ace="Verdana"><b>Acknowledgements.</b> We thank the University    of the West In
dies’ Research and Publication Fund Committee for financial support    of this w
ork and the Barbados Reference Laboratory for assistance in analyzing    samples
 with Digene’s Hybrid Capture II CT-ID. JR and DA thank the Wellness    Project 
for its support. Xiaohui Wang’s research is partially supported by a    2006–200
7 Faculty Development Council Award from the University of Texas-Pan    American
.</font></p>     ^cY#a04v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#80#76#article#104#<p>&nbsp;</p>     ^
cY#a04v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#81#77#article#104#<p><font size="3" f
ace="Verdana"><b>REFERENCES</b></font></p>     ^cY#a04v22n5.htm##
00539000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704029000078002001300368#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#82#78#article#104#1#<p><f
ont size="2" face="Verdana">1. Hillis SD, Owens LM, Marchbanks PA, Amsterdam    
LF, MacKenzie WR. Recurrent chlamydial infections increase the risks of hospital
ization    for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gy
necol.    1997;176:103–7.</font> </p>    ^cY#a04v22n5.htm##
00570000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704032100078002001300399#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#83#79#article#104#2#<p><f
ont size="2" face="Verdana"> 2. Westrom L, Joesoef R, Reynolds G, Hadgu,    A, T
hompson SE. Pelvic inflammatory disease and fertility. a cohort study of    1,84
4 women with laparoscopically verified disease and 657 control women with    nor
mal laparoscopy results. Sex Transm Dis. 1992;19: 185–92.</font></p>    ^cY#a04v
22n5.htm##
00419000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704017000078002001300248#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#84#80#article#104#3#<p><f
ont size="2" face="Verdana">3. Numazaki K, Wainberg MA, McDonald J. <i>Chlamydia
    trachomatis</i> infections in infants. CMAJ 1989;140: 615–22. </font></p>   
 ^cY#a04v22n5.htm##
00429000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704018000078002001300258#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#85#81#article#104#4#<p><f
ont size="2" face="Verdana">4. Numazaki K, Asanuma H, Niida Y. <i>Chlamydia    t
rachomatis</i> infection in early neonatal period. BMC Infect Dis. 2003;3:2.</fo
nt></p>    ^cY#a04v22n5.htm##
00479000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704023000078002001300308#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#86#82#article#104#5#<p><f
ont size="2" face="Verdana"> 5. Sherrard J, Rings M, Hall C. Where has all    th
e chlamydia come from? The clinical impact of the introduction of an improved   
 Chlamydia test. Int J STD AIDS 2005;16:163–5.</font></p>    ^cY#a04v22n5.htm##
00480000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704023100078002001300309#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#87#83#article#104#6#<p><f
ont size="2" face="Verdana"> 6. Hu D, Hook EW 3rd, Goldie SJ. Screening for    <
i>Chlamydia trachomatis</i> in women 15 to 29 years of age: a cost-effectiveness
    analysis. Ann Intern Med. 2004;141:501–13. </font></p>    ^cY#a04v22n5.htm##
00434000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704018500078002001300263#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#88#84#article#104#7#<p><f
ont size="2" face="Verdana"> 7. Centers for Disease Control and Prevention.    S
exually transmitted diseases treatment guidelines 2002; MMWR. 251(No. RR-6).2–34
.</font></p>    ^cY#a04v22n5.htm##
00477000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704022800078002001300306#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#89#85#article#104#8#<p><f
ont size="2" face="Verdana"> 8. Currie MJ, McNiven M, Yee T, Schiemer U,    Bowd
en FJ. Pooling of Clinical Specimens Prior to Testing for <i>Chlamydia trachomat
is</i>.    J Clin Microbiol. 2004;42:4866–7.</font></p>    ^cY#a04v22n5.htm##
00499000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704025000078002001300328#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#90#86#article#104#9#<p><f
ont size="2" face="Verdana"> 9. Eley A, Hemeg H A, Geary I, Ramsewak S, Herring 
   A, Caul EO. Prevalence of <i>Chlamydia trachomatis</i> IgG antibodies in ante
natal    patients from Trinidad. Sex. Transm. Inf. 2001;77:30–302.</font></p>   
 ^cY#a04v22n5.htm##
00573000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704032300079002001300402#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#91#87#article#104#10#<p><
font size="2" face="Verdana">10. Barlow REL, Cooke ID, Odukoya O, et al. The    
prevalence of <i>Chlamydia trachomatis</i> in fresh tissue specimens from patien
ts    with ectopic pregnancy or tubal factor infertility as determined by PCR an
d    insitu hybridization. J. Med. Microbiol. 2001;50:902–8.</font></p>    ^cY#a
04v22n5.htm##
00598000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704034800079002001300427#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#92#88#article#104#11#<p><
font size="2" face="Verdana">11. Swanston WH, Prabhakar P, Barrow L, Mahabir    
BS, Furlonge C. Single dose (direct observed) azithromycin therapy for <i>Neisse
ria    gonorrhoeae</i> and <i>Chlamydia trachomatis</i> in STD clinic attenders 
with    genital discharge in Trinidad and Tobago. West Indian Med J. 2001;50:198
–202.</font></p>    ^cY#a04v22n5.htm##
00505000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704025500079002001300334#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#93#89#article#104#12#<p><
font size="2" face="Verdana">12. Jurstrand M, Falk L, Fredlund H, et al. Charact
erization    of <i>Chlamydia trachomatis</i> omp1 genotypes among sexually trans
mitted disease    patients in Sweden. J Clin Microbiol. 2001;39: 3915–9.</font><
/p>    ^cY#a04v22n5.htm##
00480000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704023000079002001300309#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#94#90#article#104#13#<p><
font size="2" face="Verdana">13. Ho BS, Feng WG, Wong BK, Egglestone SI. Polymer
ase    chain reaction for the detection of <i>Neisseria gonorrhoeae</i> in clini
cal    samples. J Clin Pathol. 1992;45:439–42. </font></p>    ^cY#a04v22n5.htm##
00546000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704029600079002001300375#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#95#91#article#104#14#<p><
font size="2" face="Verdana">14. Mahony JB, Luinstra KE, Sellors JW, Jang    D, 
Chernesky MA. Confirmatory polymerase chain reaction testing for <i>Chlamydia   
 trachomatis</i> in first-void urine from asymptomatic and symptomatic men. J   
 Clin Microbiol. 1992;30: 2241–5.</font></p>    ^cY#a04v22n5.htm##
00574000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704032400079002001300403#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#96#92#article#104#15#<p><
font size="2" face="Verdana">15. R Development Core Team. R: a language and    e
nvironment for statistical computing. R Foundation for Statistical Computing:   
 Vienna, Austria. Available from: <a href="http://www.R-project.org" target="_bl
ank">www.R-project.org</a>.    Accessed on: 12 December 2006.</font></p>    ^cY#
a04v22n5.htm##
00551000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704030100079002001300380#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#97#93#article#104#16#<p><
font size="2" face="Verdana">16. Leslie DE, Azzato F, Ryan N, Fyfe J. An assessm
ent    of the Roche Amplicor <i>Chlamydia trachomatis/Neisseria gonorrhoeae</i> 
multiplex    PCR assay in routine diagnostic use on a variety of specimen types.
 Commun Dis    Intell. 2003;27:373–9. </font></p>    ^cY#a04v22n5.htm##
00660000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704041000079002001300489#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#98#94#article#104#17#<p><
font size="2" face="Verdana">17. Moncada J, Schachter J, Hook EW 3rd, et al.    
The effect of urine testing in evaluations of the sensitivity of the Gen-Probe  
  Aptima Combo 2 assay on endocervical swabs for <i>Chlamydia trachomatis</i>   
 and <i>Neisseria gonorrhoeae</i>: the infected patient standard reduces sensiti
vity    of single site evaluation. Sex Transm Dis. 2004; 31:273–7. </font></p>  
  ^cY#a04v22n5.htm##
00575000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704032500079002001300404#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#99#95#article#104#18#<p><
font size="2" face="Verdana">18. Bang D, Angelso L, Schirakow B, Westh H.    Com
parison of the Becton Dickinson strand displacement amplification and Cobas    A
mplicor Roche PCR for the detection of <i>Chlamydia trachomatis</i>: pooling    
versus individual tests. Clin Microbiol Infect. 2003;9:1020–3.</font></p>    ^cY
#a04v22n5.htm##
00538000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704028700080002001300367#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#100#96#article#104#19#<p>
<font size="2" face="Verdana">19. Girdner JL, Cullen AP, Salama TG, He L, Lorinc
z    A, Quinn TC. Evaluation of the Digene Hybrid Capture II CT-ID test for dete
ction    of <i>Chlamydia trachomatis</i> in Endocervical Specimens. J Clin Micro
biol.    1999;37:1579–81.</font></p>    ^cY#a04v22n5.htm##
00445000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704019400080002001300274#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#101#97#article#104#20#<p>
<font size="2" face="Verdana">20. Hoofar J, Cook N, Malorny, et al. Making    in
ternal amplification control mandatory for diagnostic PCR. J Clin Microbiol.    
2003;4:5835.</font></p>    ^cY#a04v22n5.htm##
00258000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704002200077002001300099#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#102#98#article#104#<p>&nbsp;</p>     
^cY#a04v22n5.htm##
00258000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704002200077002001300099#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#103#99#article#104#<p>&nbsp;</p>     
^cY#a04v22n5.htm##
00313000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007600078002001300154#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#104#100#article#104#<p><font size="2"
 face="Verdana">Manuscript received on 7 July 2006.    ^cY#a04v22n5.htm##
00323000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008600078002001300164#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#105#101#article#104#<br>   Revised ve
rsion accepted for publication on 3 October 2007.</font></p>     ^cY#a04v22n5.ht
m##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#106#102#article#104#<p>&nbsp;</p>    
 ^cY#a04v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#107#103#article#104#<p>&nbsp;</p>    
 ^cY#a04v22n5.htm##
00627000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704039000078002001300468#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a04v22n5.htm#S#p#108#104#article#104#<p><font size="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> Send correspondence    to: 
David Ammons, Chemistry Department, University of Texas—Pan American, 1201    We
st University Drive, Edinburg, Texas, 78539, United States of America; telephone
:    956-381-2097; fax: 956-384-5006; e-mail: <a href="mailto:ammonstt@ hotmail.
com">ammonstt@    hotmail.com</a></font></p>     ^cY#a04v22n5.htm##
00670000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100016000940100
02100110010002000131010002000151012012800171030002100299710000200320065000900322
064000500331031000400336014000600340865000900346002001300355#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a04v22n5.htm#S#c#109#1#article#20#1#^rND^sHillis^nSD#^rND^
sOwens^nLM#^rND^sMarchbanks^nPA#^rND^sAmsterdam^nLF#^rND^sMacKenzie^nWR#Recurren
t chlamydial infections increase the risks of hospitalization for ectopic pregna
ncy and pelvic inflammatory disease^len#Am J Obstet Gynecol.#2#19970000#1997#176
#103-7#20071100#a04v22n5.htm##
00699000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100017000940100
01800111010001500129010001900144012017000163030001600333710000200349065000900351
064000500360031000300365014000700368865000900375002001300384#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a04v22n5.htm#S#c#110#2#article#20#2#^rND^sWestrom^nL#^rND^
sJoesoef^nR#^rND^sReynolds^nG#^rND^sHadgu^nA#^rND^sThompson^nSE#Pelvic inflammat
ory disease and fertility: a cohort study of 1,844 women with laparoscopically v
erified disease and 657 control women with normal laparoscopy results^len#Sex Tr
ansm Dis.#2#19920000#1992#19#185-92#20071100#a04v22n5.htm##
00479000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100019000950100
01800114012004800132030001000180710000200190031000400192014000700196865000900203
002001300212#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#c#111#3#art
icle#20#3#^rND^sNumazaki^nK#^rND^sWainberg^nMA#^rND^sMcDonald^nJ#Chlamydia trach
omatis infections in infants^len#CMAJ 1989#2#140#615-22#20071100#a04v22n5.htm##
00524000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100017000950100
01500112012006100127030001600188710000200204065000900206064000500215031000200220
020000200222865000900224002001300233#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
4v22n5.htm#S#c#112#4#article#20#4#^rND^sNumazaki^nK#^rND^sAsanuma^nH#^rND^sNiida
^nY#Chlamydia trachomatis infection in early neonatal period^len#BMC Infect Dis.
#2#20030000#2003#3#2#20071100#a04v22n5.htm##
00613000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100015000950100
01400110012011400124030001500238065000900253064000500262031000300267014000600270
865000900276002001300285035001000298801001500308#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#113#5#article#20#5#^rND^sSherrard^nJ#^rND^sRings^nM#^
rND^sHall^nC#Where has all the chlamydia come from?: The clinical impact of the 
introduction of an improved Chlamydia test^len#Int J STD AIDS#20050000#2005#16#1
63-5#20071100#a04v22n5.htm#0956-4624#Int J STD AIDS##
00570000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100012000770100019000890100
01700108012010200125030001600227710000200243065000900245064000500254031000400259
014000700263865000900270002001300279#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
4v22n5.htm#S#c#114#6#article#20#6#^rND^sHu^nD#^rND^sHook^nEW 3rd#^rND^sGoldie^nS
J#Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-eff
ectiveness analysis^len#Ann Intern Med.#2#20040000#2004#141#501-13#20071100#a04v
22n5.htm##
00490000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750110043000770120060001200300
00500180031000400185032000500189014000500194865000900199002001300208035001000221
801000500231#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#c#115#7#art
icle#20#7#Centers for Disease Control and Prevention#Sexually transmitted diseas
es treatment guidelines 2002^len#MMWR#251#RR-6#2-34#20071100#a04v22n5.htm#0149-2
195#MMWR##
00604000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100017000940100
01300111010001800124010001700142012007700159030001800236710000200254065000900256
064000500265031000300270014000700273865000900280002001300289#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a04v22n5.htm#S#c#116#8#article#20#8#^rND^sCurrie^nMJ#^rND^
sMcNiven^nM#^rND^sYee^nT#^rND^sSchiemer^nU#^rND^sBowden^nFJ#Pooling of Clinical 
Specimens Prior to Testing for Chlamydia trachomatis^len#J Clin Microbiol.#2#200
40000#2004#42#4866-7#20071100#a04v22n5.htm##
00644000000000313000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100014000770100017000910100
01500108010001800123010001700141010001500158012009100173030001800264710000200282
065000900284064000500293031000300298014000700301865000900308002001300317#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#c#117#9#article#20#9#^rND^sEley
^nA#^rND^sHemeg^nH A#^rND^sGeary^nI#^rND^sRamsewak^nS#^rND^sHerring^nA#^rND^sCau
l^nEO#Prevalence of Chlamydia trachomatis IgG antibodies in antenatal patients f
rom Trinidad^len#Sex. Transm. Inf.#2#20010000#2001#77#30-302#20071100#a04v22n5.h
tm##
00673000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100016000970100
01700113810000600130012018100136030001900317710000200336065000900338064000500347
031000300352014000600355865000900361002001300370#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#118#10#article#20#10#^rND^sBarlow^nREL#^rND^sCooke^nI
D#^rND^sOdukoya^nO#et al#The prevalence of Chlamydia trachomatis in fresh tissue
 specimens from patients with ectopic pregnancy or tubal factor infertility as d
etermined by PCR and insitu hybridization^len#J. Med. Microbiol.#2#20010000#2001
#50#902-8#20071100#a04v22n5.htm##
00716000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100019000980100
01600117010001800133010001800151012017700169030001900346710000200365065000900367
064000500376031000300381014000800384865000900392002001300401#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a04v22n5.htm#S#c#119#11#article#20#11#^rND^sSwanston^nWH#^
rND^sPrabhakar^nP#^rND^sBarrow^nL#^rND^sMahabir^nBS#^rND^sFurlonge^nC#Single dos
e (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia
 trachomatis in STD clinic attenders with genital discharge in Trinidad and Toba
go^len#West Indian Med J.#2#20010000#2001#50#198-202#20071100#a04v22n5.htm##
00607000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100014000980100
01800112810000600130012011500136030001800251710000200269065000900271064000500280
031000300285014000700288865000900295002001300304#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#120#12#article#20#12#^rND^sJurstrand^nM#^rND^sFalk^nL
#^rND^sFredlund^nH#et al#Characterization of Chlamydia trachomatis omp1 genotype
s among sexually transmitted disease patients in Sweden^len#J Clin Microbiol.#2#
20010000#2001#39#3915-9#20071100#a04v22n5.htm##
00589000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100013000790100015000920100
01500107010002100122012009300143030001500236710000200251065000900253064000500262
031000300267014000700270865000900277002001300286#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#121#13#article#20#13#^rND^sHo^nBS#^rND^sFeng^nWG#^rND
^sWong^nBK#^rND^sEgglestone^nSI#Polymerase chain reaction for the detection of N
eisseria gonorrhoeae in clinical samples^len#J Clin Pathol.#2#19920000#1992#45#4
39-42#20071100#a04v22n5.htm##
00670000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100019000960100
01800115010001400133010002000147012013500167030001800302710000200320065000900322
064000500331031000300336014000700339865000900346002001300355#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a04v22n5.htm#S#c#122#14#article#20#14#^rND^sMahony^nJB#^rN
D^sLuinstra^nKE#^rND^sSellors^nJW#^rND^sJang^nD#^rND^sChernesky^nMA#Confirmatory
 polymerase chain reaction testing for Chlamydia trachomatis in first-void urine
 from asymptomatic and symptomatic men^len#J Clin Microbiol.#2#19920000#1992#30#
2241-5#20071100#a04v22n5.htm##
00537000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170024000790180060001030620
03900163066000700202067000800209037001800217110000900235109001700244865000900261
002001300270#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#c#123#15#ar
ticle#20#15#R Development Core Team#R: a language and environment for statistica
l computing^len#R Foundation for Statistical Computing#Vienna#Austria#www.R-proj
ect.org#20061212#12 December 2006#20071100#a04v22n5.htm##
00657000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100016000960100
01400112010001400126012016100140030001900301710000200320065000900322064000500331
031000300336014000600339865000900345002001300354#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#124#16#article#20#16#^rND^sLeslie^nDE#^rND^sAzzato^nF
#^rND^sRyan^nN#^rND^sFyfe^nJ#An assessment of the Roche Amplicor Chlamydia trach
omatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a 
variety of specimen types^len#Commun Dis Intell.#2#20030000#2003#27#373-9#200711
00#a04v22n5.htm##
00748000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100019000960100
01900115810000600134012025500140030001600395710000200411065000900413064000500422
031000300427014000600430865000900436002001300445#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#125#17#article#20#17#^rND^sMoncada^nJ#^rND^sSchachter
^nJ#^rND^sHook^nEW 3rd#et al#The effect of urine testing in evaluations of the s
ensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlam
ydia trachomatis and Neisseria gonorrhoeae: the infected patient standard reduce
s sensitivity of single site evaluation^len#Sex Transm Dis.#2#20040000#2004#31#2
73-7#20071100#a04v22n5.htm##
00682000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100014000790100017000930100
01900110010001500129012017800144030002300322710000200345065000900347064000500356
031000200361014000700363865000900370002001300379#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#126#18#article#20#18#^rND^sBang^nD#^rND^sAngelso^nL#^
rND^sSchirakow^nB#^rND^sWesth^nH#Comparison of the Becton Dickinson strand displ
acement amplification and Cobas Amplicor Roche PCR for the detection of Chlamydi
a trachomatis: pooling versus individual tests^len#Clin Microbiol Infect.#2#2003
0000#2003#9#1020-3#20071100#a04v22n5.htm##
00680000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100017000970100
01700114010001200131010001700143010001600160012012300176030001800299710000200317
065000900319064000500328031000300333014000800336865000900344002001300353#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a04v22n5.htm#S#c#127#19#article#20#19#^rND^sGi
rdner^nJL#^rND^sCullen^nAP#^rND^sSalama^nTG#^rND^sHe^nL#^rND^sLorincz^nA#^rND^sQ
uinn^nTC#Evaluation of the Digene Hybrid Capture II CT-ID test for detection of 
Chlamydia trachomatis in Endocervical Specimens^len#J Clin Microbiol.#2#19990000
#1999#37#1579-81#20071100#a04v22n5.htm##
00553000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100014000950100
01400109810000600123012007100129030001800200710000200218065000900220064000500229
031000200234020000500236865000900241002001300250#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a04v22n5.htm#S#c#128#20#article#20#20#^rND^sHoofar^nJ#^rND^sCook^nN#^r
ND^sMalorny#et al#Making internal amplification control mandatory for diagnostic
 PCR^len#J Clin Microbiol.#2#20030000#2003#4#5835#20071100#a04v22n5.htm##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#o#1#1#article#1
#20080121#151818#a05v22n5.htm#119##
04164000000000601000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200980016701200800
02650100028003450100028003730100029004010700123004300831456005530850008020090850
03202017085004802049085002202097085001802119083124302137085000803380085002503388
08500250341308500210343808500180345911700060347707200030348311200090348611100200
3495114000903515113002503524002001303549#v22n5#v:\scielo\serial\rpsp\v22n5\marku
p\a05v22n5.htm#S#h#2#1#article#1#oa#es#br1.1#1#3.1#TAB#05#RPSP020#nd#Rev Panam S
alud Publica#22#5#20071100#^f323^l328#1020-4989#Conocimientos y actitudes hacia 
la donación de sangre en una población universitaria de Chile^les#Blood donation
: knowledge and attitudes of a university population in Chile^len#^rND^1A01^nMar
cela^sVásquez#^rND^1A01^nPatricia^sIbarra#^rND^1A01^nMónica^sMaldonado#Universid
ad de Talca^iA01^1Facultad de Ciencias de la Salud^2Departamento de Bioquímica C
línica e Inmunohematología^pChile#^les^aOBJETIVOS: Evaluar los conocimientos y a
ctitudes hacia la donación de sangre voluntaria entre estudiantes, académicos y 
no académicos de la Universidad de Talca, Chile. MÉTODOS: Entre junio y julio de
 2002, se aplicó una encuesta, previamente validada, a 487 personas de la comuni
dad universitaria, para indagar acerca de su percepción con respecto a algunos a
spectos de la donación de sangre, tales como: conocimientos y motivaciones sobre
 la donación, y desmotivaciones y mitos asociados a la donación de sangre. Para 
el análisis de los datos se usaron estadígrafos descriptivos. RESULTADOS: De los
 encuestados sólo 14% habían donado sangre y correspondían mayoritariamente al g
rupo de académicos (43,3%). Los estudiantes fueron quienes, en mayor medida, man
ifestaron su intención de donar sangre en el futuro (88,1%). Al comparar la pred
isposición a donar sangre en el futuro entre hombres y mujeres, se obtuvieron po
rcentajes de 90% y 84,2% respectivamente; sin embargo, esta diferencia no fue es
tadísticamente significativa. Dentro de las desmotivaciones para donar sangre, 7
3,4% de los encuestados dijo desconfiar de la esterilidad del material empleado 
en la colección de sangre. CONCLUSIONES: La población universitaria es un grupo 
muy deseable para convertirlo en donantes voluntarios; una adecuada campaña de i
nformación y motivación podría transformar a 87,3% de las personas con intención
 de donar sangre, en donantes voluntarios reales.#^dnd^i1#^tm^les^kDonadores de 
sangre^i1#^tm^les^kinstituciones de enseñanza superior^i1#^tm^les^kactitudes^i1#
^tm^les^kChile^i1#^len^aOBJECTIVES: To evaluate the knowledge and attitudes of s
tudents, professors, and other staff at the University of Talca, Chile, regardin
g voluntary blood donation. METHODS: From June to July 2002 a previously-validat
ed survey was administered to 487 individuals in the university community. The s
urvey sought to measure their understanding of blood donation, i.e., motivators 
and reasons for becoming a blood donor and the myths and fears that might deter 
blood donation. Descriptive statistics were used to analyze the data. RESULTS: O
nly 14% of survey participants had donated blood in the past, and most of these 
(43.3%) were professors or other academics. Of the participants who were plannin
g to donate blood in the future, students were the majority (88.1%). When the ma
les in the group that was planning to donate were compared to the females, the d
ifference was not statistically significant (90.0% vs. 84.2%, respectively). Of 
the deterrents to blood donation, 73.4% said the collection instruments might no
t be sterile. CONCLUSIONS: The university population represents a pool of desira
ble donors; an informative and motivating campaign could successfully convert th
e 87.3% potential donors into actual volunteer blood donors.#^dnd^i2#^tm^len^kBl
ood donors^i2#^tm^len^kuniversities^i2#^tm^len^kattitude^i2#^tm^len^kChile^i2#ot
her#16#20060720#20 de julio de 2006#20070918#18 de septiembre de 2007#a05v22n5.h
tm##
04234000000000601000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201050016701200870
02720100028003590100028003870100029004150700123004440831484005670850008020510850
03202059085004802091085002202139085001802161083127102179085000803450085002503458
08500250348308500210350808500180352911700060354707200030355311200090355611100200
3565114000903585113002503594002001303619#v22n5#v:\scielo\serial\rpsp\v22n5\marku
p\a05v22n5.htm#S#f#3#1#article#1#oa#es#br1.1#1#3.1#TAB#05#RPSP020#nd#Rev Panam S
alud Publica#22#5#20071100#^f323^l328#1020-4989#<B>Conocimientos y actitudes hac
ia la donación de sangre en una población universitaria de Chile</B>^les#<B>Bloo
d donation: knowledge and attitudes of a university population in Chile</B>^len#
^rND^1A01^nMarcela^sVásquez#^rND^1A01^nPatricia^sIbarra#^rND^1A01^nMónica^sMaldo
nado#Universidad de Talca^iA01^1Facultad de Ciencias de la Salud^2Departamento d
e Bioquímica Clínica e Inmunohematología^pChile#^les^a<B>OBJETIVOS:</B> Evaluar 
los conocimientos y actitudes hacia la donación de sangre voluntaria entre estud
iantes, académicos y no académicos de la Universidad de Talca, Chile. <B>MÉTODOS
: </B>Entre junio y julio de 2002, se aplicó una encuesta, previamente validada,
 a 487 personas de la comunidad universitaria, para indagar acerca de su percepc
ión con respecto a algunos aspectos de la donación de sangre, tales como: conoci
mientos y motivaciones sobre la donación, y desmotivaciones y mitos asociados a 
la donación de sangre. Para el análisis de los datos se usaron estadígrafos desc
riptivos. <B>RESULTADOS: </B>De los encuestados sólo 14% habían donado sangre y 
correspondían mayoritariamente al grupo de académicos (43,3%). Los estudiantes f
ueron quienes, en mayor medida, manifestaron su intención de donar sangre en el 
futuro (88,1%). Al comparar la predisposición a donar sangre en el futuro entre 
hombres y mujeres, se obtuvieron porcentajes de 90% y 84,2% respectivamente; sin
 embargo, esta diferencia no fue estadísticamente significativa. Dentro de las d
esmotivaciones para donar sangre, 73,4% de los encuestados dijo desconfiar de la
 esterilidad del material empleado en la colección de sangre. <B>CONCLUSIONES: <
/B>La población universitaria es un grupo muy deseable para convertirlo en donan
tes voluntarios; una adecuada campaña de información y motivación podría transfo
rmar a 87,3% de las personas con intención de donar sangre, en donantes voluntar
ios reales.#^dnd^i1#^tm^les^kDonadores de sangre^i1#^tm^les^kinstituciones de en
señanza superior^i1#^tm^les^kactitudes^i1#^tm^les^kChile^i1#^len^a<B>OBJECTIVES:
 </B>To evaluate the knowledge and attitudes of students, professors, and other 
staff at the University of Talca, Chile, regarding voluntary blood donation. <B>
METHODS: </B>From June to July 2002 a previously-validated survey was administer
ed to 487 individuals in the university community. The survey sought to measure 
their understanding of blood donation, i.e., motivators and reasons for becoming
 a blood donor and the myths and fears that might deter blood donation. Descript
ive statistics were used to analyze the data. <B>RESULTS: </B>Only 14% of survey
 participants had donated blood in the past, and most of these (43.3%) were prof
essors or other academics. Of the participants who were planning to donate blood
 in the future, students were the majority (88.1%). When the males in the group 
that was planning to donate were compared to the females, the difference was not
 statistically significant (90.0% vs. 84.2%, respectively). Of the deterrents to
 blood donation, 73.4% said the collection instruments might not be sterile. <B>
CONCLUSIONS: </B>The university population represents a pool of desirable donors
; an informative and motivating campaign could successfully convert the 87.3% po
tential donors into actual volunteer blood donors.#^dnd^i2#^tm^len^kBlood donors
^i2#^tm^len^kuniversities^i2#^tm^len^kattitude^i2#^tm^len^kChile^i2#other#16#200
60720#20 de julio de 2006#20070918#18 de septiembre de 2007#a05v22n5.htm##
04416000000000625000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201200980
01820120080002800100028003600100028003880100029004160700125004450831526005700850
00802096085003202104085004802136085002202184085001802206083129202224085000803516
08500250352408500250354908500210357408500180359511700060361307200030361911200090
3622111002003631114000903651113002503660002001303685008009203698#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#l#4#1#article#1#^mnov.^a2007#oa#es#br1.
1#1#3.1#tab#05#RPSP020#nd#Rev. panam. salud pública#22#5#20071100#^f323^l328#102
0-4989#Conocimientos y actitudes hacia la donación de sangre en una población un
iversitaria de Chile^les#Blood donation: knowledge and attitudes of a university
 population in Chile^len#^rND^1A01^nMarcela^sVásquez#^rND^1A01^nPatricia^sIbarra
#^rND^1A01^nMónica^sMaldonado#^iA01^1Universidad de Talca^2Facultad de Ciencias 
de la Salud^3Departamento de Bioquímica Clínica e Inmunohematología^pChile#^les^
aOBJETIVOS: Evaluar los conocimientos y actitudes hacia la donación de sangre vo
luntaria entre estudiantes, académicos y no académicos de la Universidad de Talc
a, Chile. MÉTODOS: Entre junio y julio de 2002, se aplicó una encuesta, previame
nte validada, a 487 personas de la comunidad universitaria, para indagar acerca 
de su percepción con respecto a algunos aspectos de la donación de sangre, tales
 como: conocimientos y motivaciones sobre la donación, y desmotivaciones y mitos
 asociados a la donación de sangre. Para el análisis de los datos se usaron esta
dígrafos descriptivos. RESULTADOS: De los encuestados sólo 14 por ciento habían 
donado sangre y correspondían mayoritariamente al grupo de académicos (43,3 por 
ciento). Los estudiantes fueron quienes, en mayor medida, manifestaron su intenc
ión de donar sangre en el futuro (88,1 por ciento). Al comparar la predisposició
n a donar sangre en el futuro entre hombres y mujeres, se obtuvieron porcentajes
 de 90 por ciento y 84,2 por ciento respectivamente; sin embargo, esta diferenci
a no fue estadísticamente significativa. Dentro de las desmotivaciones para dona
r sangre, 73,4 por ciento de los encuestados dijo desconfiar de la esterilidad d
el material empleado en la colección de sangre. CONCLUSIONES: La población unive
rsitaria es un grupo muy deseable para convertirlo en donantes voluntarios; una 
adecuada campaña de información y motivación podría transformar a 87,3 por cient
o de las personas con intención de donar sangre, en donantes voluntarios reales.
#^dnd^i1#^tm^les^kDonadores de sangre^i1#^tm^les^kinstituciones de enseñanza sup
erior^i1#^tm^les^kactitudes^i1#^tm^les^kChile^i1#^len^aOBJECTIVES: To evaluate t
he knowledge and attitudes of students, professors, and other staff at the Unive
rsity of Talca, Chile, regarding voluntary blood donation. METHODS: From June to
 July 2002 a previously-validated survey was administered to 487 individuals in 
the university community. The survey sought to measure their understanding of bl
ood donation, i.e., motivators and reasons for becoming a blood donor and the my
ths and fears that might deter blood donation. Descriptive statistics were used 
to analyze the data. RESULTS: Only 14 percent of survey participants had donated
 blood in the past, and most of these (43.3 percent) were professors or other ac
ademics. Of the participants who were planning to donate blood in the future, st
udents were the majority (88.1 percent). When the males in the group that was pl
anning to donate were compared to the females, the difference was not statistica
lly significant (90.0 percent vs. 84.2 percent, respectively). Of the deterrents
 to blood donation, 73.4 percent said the collection instruments might not be st
erile. CONCLUSIONS: The university population represents a pool of desirable don
ors; an informative and motivating campaign could successfully convert the 87.3 
percent potential donors into actual volunteer blood donors.#^dnd^i2#^tm^len^kBl
ood donors^i2#^tm^len^kuniversities^i2#^tm^len^kattitude^i2#^tm^len^kChile^i2#ot
her#16#20060720#20 de julio de 2006#20070918#18 de septiembre de 2007#a05v22n5.h
tm#Internet^ihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-498
92007001000005##
00356000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704012400073002001300197#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#5#1#article#99#<p align="right"><font
 size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEAR
CH</font></p>     ^cY#a05v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704002200073002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#6#2#article#99#<p>&nbsp;</p>     ^cY#
a05v22n5.htm##
00422000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704019000073002001300263#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#7#3#article#99#<p><font size="4" face
="verdana"><b><a name="tx"></a>Conocimientos y actitudes    hacia la donaci&oacu
te;n de sangre en una poblaci&oacute;n universitaria de    Chile</b></font></p> 
    ^cY#a05v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704002200073002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#8#4#article#99#<p>&nbsp;</p>     ^cY#
a05v22n5.htm##
00370000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000300070704013800073002001300211#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#9#5#article#99#<p><font size="3" face
="verdana"><b>Blood donation: knowledge and attitudes of    a university populat
ion in Chile</b></font></p>     ^cY#a05v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#10#6#article#99#<p>&nbsp;</p>     ^cY
#a05v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#11#7#article#99#<p>&nbsp;</p>     ^cY
#a05v22n5.htm##
00390000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704015700074002001300231#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#12#8#article#99#<p><font size="2" fac
e="Verdana"><b>Marcela V&aacute;squez<a href="#nt"><sup>*</sup></a>;    Patricia
 Ibarra; M&oacute;nica Maldonado</b></font></p>     ^cY#a05v22n5.htm##
00428000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000300071704019500074002001300269#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#13#9#article#99#<p><FONT SIZE=2 face=
"Verdana">Departamento de Bioqu&iacute;mica Cl&iacute;nica    e Inmunohematolog&
iacute;a, Facultad de Ciencias de la Salud, Universidad de    Talca, Chile</font
></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#14#10#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00278000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704004400075002001300119#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#15#11#article#99#<p>&nbsp;</p> <hr si
ze="1" noshade>     ^cY#a05v22n5.htm##
00301000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704006700075002001300142#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#16#12#article#99#<p><font size="2" fa
ce="VERDANA"><b>RESUMEN</b></font></p>     ^cY#a05v22n5.htm##
00477000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704024300075002001300318#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#17#13#article#99#<p><font size="2" fa
ce="Verdana"><b>OBJETIVOS:</b> Evaluar los conocimientos y    actitudes hacia la
 donaci&oacute;n de sangre voluntaria entre estudiantes, acad&eacute;micos    y 
no acad&eacute;micos de la Universidad de Talca, Chile.    ^cY#a05v22n5.htm##
00739000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704050500075002001300580#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#18#14#article#99#<br>   <b>M&Eacute;T
ODOS: </b>Entre junio y julio de 2002, se aplic&oacute; una encuesta,    previam
ente validada, a 487 personas de la comunidad universitaria, para indagar    ace
rca de su percepci&oacute;n con respecto a algunos aspectos de la donaci&oacute;
n    de sangre, tales como: conocimientos y motivaciones sobre la donaci&oacute;
n,    y desmotivaciones y mitos asociados a la donaci&oacute;n de sangre. Para e
l    an&aacute;lisis de los datos se usaron estad&iacute;grafos descriptivos.   
 ^cY#a05v22n5.htm##
00940000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704070600075002001300781#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#19#15#article#99#<br>   <b>RESULTADOS
: </b>De los encuestados s&oacute;lo 14% hab&iacute;an donado sangre    y corres
pond&iacute;an mayoritariamente al grupo de acad&eacute;micos (43,3%).    Los es
tudiantes fueron quienes, en mayor medida, manifestaron su intenci&oacute;n    d
e donar sangre en el futuro (88,1%). Al comparar la predisposici&oacute;n a    d
onar sangre en el futuro entre hombres y mujeres, se obtuvieron porcentajes    d
e 90% y 84,2% respectivamente; sin embargo, esta diferencia no fue estad&iacute;
sticamente    significativa. Dentro de las desmotivaciones para donar sangre, 73
,4% de los    encuestados dijo desconfiar de la esterilidad del material emplead
o en la colecci&oacute;n    de sangre.    ^cY#a05v22n5.htm##
00584000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704035000075002001300425#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#20#16#article#99#<br>   <b>CONCLUSION
ES: </b>La poblaci&oacute;n    universitaria es un grupo muy deseable para conve
rtirlo en donantes voluntarios;    una adecuada campa&ntilde;a de informaci&oacu
te;n y motivaci&oacute;n podr&iacute;a    transformar a 87,3% de las personas co
n intenci&oacute;n de donar sangre, en    donantes voluntarios reales.</font></p
>     ^cY#a05v22n5.htm##
00420000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704018600075002001300261#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#21#17#article#99#<p><font size="2" fa
ce="Verdana"><b>Palabras clave:</b>    Donadores de sangre, instituciones    de 
ense&ntilde;anza superior, actitudes, Chile.</font></p> <hr size="1" noshade>   
  ^cY#a05v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704006800075002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#22#18#article#99#<p><font size="2" fa
ce="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a05v22n5.htm##
00451000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704021700075002001300292#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#23#19#article#99#<p><font size="2" fa
ce="Verdana"><b>OBJECTIVES: </b>To evaluate the knowledge    and attitudes of st
udents, professors, and other staff at the University of    Talca, Chile, regard
ing voluntary blood donation.    ^cY#a05v22n5.htm##
00629000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704039500075002001300470#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#24#20#article#99#<br>   <b>METHODS: <
/b>From June to July 2002 a previously-validated survey was administered    to 4
87 individuals in the university community. The survey sought to measure    thei
r understanding of blood donation, i.e., motivators and reasons for becoming    
a blood donor and the myths and fears that might deter blood donation. Descripti
ve    statistics were used to analyze the data.    ^cY#a05v22n5.htm##
00777000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704054300075002001300618#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#25#21#article#99#<br>   <b>RESULTS: <
/b>Only 14% of survey participants had donated blood in the past,    and most of
 these (43.3%) were professors or other academics. Of the participants    who we
re planning to donate blood in the future, students were the majority    (88.1%)
. When the males in the group that was planning to donate were compared    to th
e females, the difference was not statistically significant (90.0% vs.    84.2%,
 respectively). Of the deterrents to blood donation, 73.4% said the collection  
  instruments might not be sterile.    ^cY#a05v22n5.htm##
00480000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704024600075002001300321#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#26#22#article#99#<br>   <b>CONCLUSION
S: </b>The university population represents a pool of desirable    donors; an in
formative and motivating campaign could successfully convert the    87.3% potent
ial donors into actual volunteer blood donors.</font></p>     ^cY#a05v22n5.htm##
00374000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704014000075002001300215#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#27#23#article#99#<p><font size="2" fa
ce="Verdana"><b>Key words: </b>Blood donors, universities,    attitude, Chile.</
font></p> <hr size="1" noshade>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#28#24#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#29#25#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00950000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704071600075002001300791#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#30#26#article#99#<p><font size="2" fa
ce="Verdana">Al inicio de los a&ntilde;os noventa se hizo    un diagn&oacute;sti
co de la situaci&oacute;n de los bancos de sangre en Chile,    que permiti&oacut
e; constatar la existencia de 180 instituciones de ese tipo,    de las cuales 68
,5% eran p&uacute;blicas; tan s&oacute;lo en 23% de los bancos    de sangre se l
levaban a cabo 90% de las transfusiones; hab&iacute;a una eliminaci&oacute;n    
por obsolescencia de 12% de los productos y un bajo &iacute;ndice de fraccionami
ento;    asimismo, se comprob&oacute; la falta de control de calidad y que 98% d
e las    donaciones de sangre se realizaban a trav&eacute;s del sistema intrafam
iliar    o de reposici&oacute;n (1).</font></p>     ^cY#a05v22n5.htm##
00916000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704068200075002001300757#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#31#27#article#99#<p><font size="2" fa
ce="Verdana">Los resultados de este diagn&oacute;stico motivaron    a las autori
dades a estudiar la factibilidad de centralizar la producci&oacute;n    de hemoc
omponentes, tal como se hace en pa&iacute;ses industrializados como    Inglaterr
a, Francia y Espa&ntilde;a, entre otros (2). De esta forma, se aprob&oacute;    
un proyecto que plantea la centralizaci&oacute;n en cuatro sitios productores   
 que deber&iacute;an atender las necesidades de sangre de las unidades de medici
na    transfusional de cada hospital. Este proyecto favorecer&iacute;a la equida
d,    calidad, oportunidad y eficiencia de la medicina transfusional en Chile (1
).</font></p>     ^cY#a05v22n5.htm##
00824000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704059000075002001300665#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#32#28#article#99#<p><font size="2" fa
ce="Verdana">Uno de los pilares fundamentales para el funcionamiento    de un si
stema centralizado es la donaci&oacute;n de sangre altruista y, en la    medida 
de lo posible, a repetici&oacute;n, es decir, personas que donan sangre    a otr
as que la necesitan, y que lo hacen con el &uacute;nico fin de servir a    la hu
manidad sin buscar retribuci&oacute;n alguna. Cabe destacar que en Chile    las 
cifras indicaban que en el a&ntilde;o 2000 los donantes de sangre altruistas    
representaban &uacute;nicamente 2,6 % del total de donaciones anuales.</font></p
>     ^cY#a05v22n5.htm##
00870000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704063600075002001300711#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#33#29#article#99#<p><font size="2" fa
ce="Verdana">Existen dos grandes debilidades en el sistema    de donantes de san
gre de reposici&oacute;n: por un lado, la alta prevalencia    de pat&oacute;geno
s de transmisi&oacute;n sangu&iacute;nea y, por el otro, el    cuestionamiento &
eacute;tico que surge de la "obligatoriedad" de este    sistema. En el plano int
ernacional, se ha demostrado que la donaci&oacute;n    voluntaria y repetida de 
sangre hace de la transfusi&oacute;n sangu&iacute;nea    un proceso m&aacute;s s
eguro, por la menor tasa de transmisi&oacute;n de agentes    infecciosos vincula
dos con la transfusi&oacute;n (3–5).</font></p>     ^cY#a05v22n5.htm##
01705000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704147100075002001301546#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#34#30#article#99#<p><font size="2" fa
ce="Verdana">Para implementar estrategias tendentes a incrementar    la donaci&o
acute;n, es necesario iniciar el proceso recabando informaci&oacute;n,    en la 
comunidad respectiva, acerca de sus actitudes y motivaciones hacia la    donaci&
oacute;n de sangre, as&iacute; como sobre los conocimientos que tiene    sobre l
a sangre, la donaci&oacute;n y la utilizaci&oacute;n. Se han realizado    divers
os estudios en este sentido, en poblaci&oacute;n hispana de la localidad    de R
io Grande Valley, en el estado de Texas, en los Estados Unidos de Am&eacute;rica
,    donde se determin&oacute; que las personas con un mayor nivel de educaci&oa
cute;n,    que hablasen ingl&eacute;s y pertenecieran a un nivel socioecon&oacut
e;mico    m&aacute;s elevado, tendr&iacute;an m&aacute;s probabilidades de donar
 sangre.    Los resultados de otros dos trabajos fueron congruentes con lo anter
ior, pues    se encontr&oacute; que las personas con un menor nivel de educaci&o
acute;n tienen    menos probabilidades de donar sangre, en comparaci&oacute;n co
n aquellas que    poseen un nivel de instrucci&oacute;n m&aacute;s alto (6–8). P
or su parte, a    fines de 1999 la Organizaci&oacute;n Panamericana de la Salud 
(OPS) expres&oacute;,    en la resoluci&oacute;n CD4 R15/9 (3), la necesidad de 
que los "Programas    Nacionales de Sangre y Servicios de Transfusi&oacute;n, tu
viesen como base la    donaci&oacute;n altruista y repetida de sangre".</font></
p>     ^cY#a05v22n5.htm##
00867000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704063300075002001300708#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#35#31#article#99#<p><font size="2" fa
ce="Verdana">De todo lo se&ntilde;alado previamente, se desprende    la urgencia
 de incrementar los esfuerzos para aumentar el porcentaje de donaci&oacute;n    
de sangre altruista. Para lograr esto, es necesario elaborar un diagn&oacute;sti
co    que permita saber acerca de las percepciones y conocimientos de la poblaci
&oacute;n    local, con relaci&oacute;n a este tema. A partir de los datos que s
e obtengan,    podr&aacute; incrementarse la informaci&oacute;n necesaria para e
structurar    las campa&ntilde;as y estrategias de promoci&oacute;n de la donaci
&oacute;n    de sangre altruista.</font></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#36#32#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008700075002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#37#33#article#99#<p><font size="3" fa
ce="Verdana"><b>MATERIALES Y M&Eacute;TODOS</b></font></p>     ^cY#a05v22n5.htm#
#
01571000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704133700075002001301412#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#38#34#article#99#<p><FONT SIZE=2 face
="Verdana"><b>Poblaci&oacute;n.</b> El estudio de tipo descriptivo,    transvers
al, se desarroll&oacute; en junio y julio de 2002 en los <i>campus</i>    Lircay
 y Los Niches<a name="tx01"></a><a href="#nt01"><sup>1</sup></a> de la    Univer
sidad de Talca, en Chile, con una poblaci&oacute;n de 4 800 personas agrupadas  
  en 4 300 estudiantes, 270 acad&eacute;micos y 230 funcionarios no acad&eacute;
micos.    La muestra definida, correspondiente a 500 personas, se estratific&oac
ute; de    acuerdo con los grupos indicados anteriormente; para el estrato estud
iantes    se consider&oacute; una subestratificaci&oacute;n proporcional por car
reras,    a fin de garantizar que todas estuviesen representadas. El muestreo se
 realiz&oacute;    por conveniencia, para el caso de los estudiantes, mediante c
ontacto con los    directores de cada escuela y reclutando al n&uacute;mero pred
efinido de alumnos    en las clases a cargo de ese profesor. Para el caso de los
 acad&eacute;micos    y no acad&eacute;micos, el muestreo se realiz&oacute; medi
ante invitaci&oacute;n    en sus lugares de trabajo. Del total de encuestas toma
das, hubo 13 documentos    que no pudieron incorporarse al an&aacute;lisis por e
star incompletos, de tal    manera que la muestra final qued&oacute; conformada 
por 487 personas.</font></p>     ^cY#a05v22n5.htm##
01351000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704111700075002001301192#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#39#35#article#99#<p><font size="2" fa
ce="Verdana"><b>Encuesta.</b> Para la recolecci&oacute;n de    los datos se apli
c&oacute; una encuesta que inclu&iacute;a preguntas sobre caracter&iacute;sticas
    demogr&aacute;ficas como sexo, edad, actividad y estado civil, junto a las 1
3    preguntas orientadas a detectar la percepci&oacute;n y conocimientos de los
    encuestados con respecto a la donaci&oacute;n de sangre. Las preguntas se ag
ruparon    en cuatro conglomerados: I) Conocimientos sobre la donaci&oacute;n de
 sangre;    II) Motivaci&oacute;n de las personas para donar sangre; III) Razone
s que desmotivan    a las personas a donar, y IV) Mitos asociados a la donaci&oa
cute;n de sangre.    Las escalas empleadas para medir las variables fueron de ti
po nominal y ordinal    (<a href="#anx01">anexo 1</a>). La encuesta fue autoadmi
nistrada con posterioridad    a una explicaci&oacute;n dada por uno de los inves
tigadores, para el caso de    los estudiantes, al grupo reunido en una sala de c
lases y, para el caso de acad&eacute;micos    y no acad&eacute;micos, a grupos q
ue no superaban las cuatro personas. </font></p>     ^cY#a05v22n5.htm##
01015000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704078100075002001300856#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#40#36#article#99#<p><font size="2" fa
ce="Verdana"><b>Validaci&oacute;n del cuestionario.</b> El    cuestionario usado
 en este estudio se someti&oacute; a prueba con grupos de    10 personas represe
ntantes de cada uno de los estratos definidos anteriormente,    adem&aacute;s de
 cinco personas que ten&iacute;an conocimientos sobre el tema:    tres tecn&oacu
te;logos m&eacute;dicos de banco de sangre y dos estad&iacute;sticos.    Las pre
guntas fueron evaluadas como "Buena", "Regular" o    "Mala" con respecto al cong
lomerado al cual pertenec&iacute;an, de    tal manera que la que ten&iacute;a un
 m&iacute;nimo de calificaci&oacute;n de    90% se clasific&oacute; como "Buena"
; por otra parte, se eliminaron    las preguntas con m&aacute;s de 10% de califi
caci&oacute;n "Mala".</font></p>     ^cY#a05v22n5.htm##
00876000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704064200075002001300717#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#41#37#article#99#<p><font size="2" fa
ce="Verdana"><b>An&aacute;lisis estad&iacute;stico.</b> Los    datos del estudio
 se analizaron descriptivamente, expresados en porcentaje por    el tipo de preg
unta utilizada. Las escalas empleadas en el cuestionario fueron    de tipo nomin
al y ordinal, de tal manera que el an&aacute;lisis se realiz&oacute;    con base
 en frecuencias absolutas y relativas. Asimismo se aplic&oacute; an&aacute;lisis
    de <font face="Symbol">c</font><SUP>2</SUP> para determinar la significancia
    estad&iacute;stica de algunos resultados, mediante la utilizaci&oacute;n del
    programa EpiInfo versi&oacute;n 3.3.2.</font></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#42#38#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007000075002001300145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#43#39#article#99#<p><font size="3" fa
ce="Verdana"><b>RESULTADOS</b></font></p>     ^cY#a05v22n5.htm##
00659000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704042500075002001300500#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#44#40#article#99#<p><font size="2" fa
ce="Verdana">De las 487 personas que respondieron toda la    encuesta, 87,7% (42
7) representaban el estrato de estudiantes, 6,2% (30) el    de acad&eacute;micos
 y 6,2% (30) el de no acad&eacute;micos; 53,1% eran del    sexo masculino y el r
ango de edad de 88,6% de la poblaci&oacute;n fluctuaba    entre los 17 y 30 a&nt
ilde;os y 89,6% eran solteros (<a href="#qdr01">cuadro    1</a>).</font></p>    
 ^cY#a05v22n5.htm##
00270000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704003600075002001300111#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#45#41#article#99#<p><a name="qdr01"><
/a></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#46#42#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008000075002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#47#43#article#99#<p align="center"><i
mg src="/img/revistas/rpsp/v22n5/a05qdr01.gif"></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#48#44#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00883000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704064900075002001300724#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#49#45#article#99#<p><font size="2" fa
ce="Verdana"><b>Conocimientos sobre la donaci&oacute;n de    sangre.</b> &Uacute
;nicamente 14% de los encuestados afirmaron haber donado    sangre, de los cuale
s 89,3% manifestaron tener conocimientos generales sobre    las necesidades, uti
lizaci&oacute;n y an&aacute;lisis de la sangre y lugar de    donaci&oacute;n, au
nque s&oacute;lo 23,3 % pose&iacute;an conocimientos m&aacute;s    espec&iacute;
ficos acerca de los requisitos de edad, peso e intervalos entre    donaciones. C
abe hacer notar el hecho de que casi la mitad de los encuestados    cre&iacute;a
 que se comercializar&iacute;a la sangre (49,6%).</font></p>     ^cY#a05v22n5.ht
m##
01224000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704099000075002001301065#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#50#46#article#99#<p><font size="2" fa
ce="Verdana"><b>Motivaci&oacute;n para donar sangre.</b> Con    respecto a la pr
edisposici&oacute;n hacia la donaci&oacute;n de sangre, se encontr&oacute;    qu
e del total de encuestados, 425 (87,3%) estar&iacute;an dispuestos a donar    sa
ngre en el futuro. El estrato de los estudiantes encabez&oacute; la lista    con
 88,1% de personas predispuestas, seguido de los acad&eacute;micos con 83,3%    
y de los no acad&eacute;micos, con 80%, aunque estas diferencias no fueron estad
&iacute;sticamente    significativas (<a href="#qdr02">cuadro 2</a>). Al analiza
r la distribuci&oacute;n    por sexo, considerando el total de hombre y mujeres 
que participaron en el estudio,    se observa que s&oacute;lo 84,2% (192/228) de
 las mujeres estar&iacute;an dispuestas    a donar sangre, en comparaci&oacute;n
 con 90% (233/259) de los hombres, pero    estos porcentajes tampoco fueron esta
d&iacute;sticamente significativos (<a href="#qdr03">cuadro    3</a>).</font></p
>     ^cY#a05v22n5.htm##
00270000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704003600075002001300111#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#51#47#article#99#<p><a name="qdr02"><
/a></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#52#48#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008000075002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#53#49#article#99#<p align="center"><i
mg src="/img/revistas/rpsp/v22n5/a05qdr02.gif"></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#54#50#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00270000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704003600075002001300111#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#55#51#article#99#<p><a name="qdr03"><
/a></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#56#52#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008000075002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#57#53#article#99#<p align="center"><i
mg src="/img/revistas/rpsp/v22n5/a05qdr03.gif"></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#58#54#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00547000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704031300075002001300388#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#59#55#article#99#<p><font size="2" fa
ce="Verdana">Destacan como razones principales que motivan    a donar sangre en 
el futuro el inter&eacute;s de ayudar a un familiar o a un    amigo enfermo (97,
6%), o bien en el caso de una cat&aacute;strofe nacional (62,8%),    ambas se&nt
ilde;aladas como muy importantes.</font></p>     ^cY#a05v22n5.htm##
00651000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704041700075002001300492#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#60#56#article#99#<p><font size="2" fa
ce="Verdana">Al preguntar sobre el medio de comunicaci&oacute;n    por el cual l
es gustar&iacute;a recibir informaci&oacute;n acerca de la donaci&oacute;n,    6
2,3% de los encuestados prefirieron la televisi&oacute;n; la radio obtuvo el    
menor porcentaje (3,6%) de preferencia. Por otra parte, a 4,7% de los encuestado
s    no les interesaba recibir informaci&oacute;n alguna.</font></p>     ^cY#a05
v22n5.htm##
00722000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704048800075002001300563#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#61#57#article#99#<p><font size="2" fa
ce="Verdana"><b>Razones que desmotivan a la donaci&oacute;n    sangu&iacute;nea.
</b> Al sumar las valoraciones "Muy importante" y    "Regularmente importante", 
las principales razones que desmotivan    a los encuestados a donar son: las cau
sas m&eacute;dicas (75,7%); la desconfianza    en la esterilidad del material (7
3,4%), y haber tenido hepatitis (64,2%). Por    otra parte, tambi&eacute;n es no
table el rechazo al ambiente hospitalario (48%).</font></p>     ^cY#a05v22n5.htm
##
00620000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704038600075002001300461#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#62#58#article#99#<p><font size="2" fa
ce="Verdana"><b>Mitos asociados a la donaci&oacute;n de sangre.</b>    Del total
 de encuestados, s&oacute;lo 7,8% consideraban que donar sangre es    da&ntilde;
ino para la salud, y que las dos principales causas para esto son    el riesgo d
e contraer alguna enfermedad (94,6%) y la anemia (73%), ambas catalogadas    com
o razones muy importantes.</font></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#63#59#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00310000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007600075002001300151#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#64#60#article#99#<p><font size="3" fa
ce="Verdana"><b>DISCUSI&Oacute;N</b></font></p>     ^cY#a05v22n5.htm##
00899000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704066500075002001300740#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#65#61#article#99#<p><font size="2" fa
ce="Verdana">Cuatrocientas ochenta y siete personas de la    Universidad de Talc
a, en Chile, respondieron satisfactoriamente una encuesta    para indagar acerca
 del nivel de conocimiento y la percepci&oacute;n que ten&iacute;an    sobre la 
donaci&oacute;n de sangre. M&aacute;s de 85% de los encuestados ten&iacute;an   
 menos de 30 a&ntilde;os y eran solteros, lo que se explica por la alta proporci
&oacute;n    de estudiantes que conformaron la muestra en estudio. De las person
as encuestadas,    86% nunca hab&iacute;an donado sangre, lo que concuerda con o
tros estudios realizados    en poblaciones universitarias (9–11).</font></p>    
 ^cY#a05v22n5.htm##
01029000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704079500075002001300870#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#66#62#article#99#<p><font size="2" fa
ce="Verdana">En relaci&oacute;n con los conocimientos sobre    la donaci&oacute;
n de sangre, se detect&oacute; que la poblaci&oacute;n tiene    informaci&oacute
;n general sobre el tema, pero que carece de un manejo preciso    de aspectos m&
aacute;s espec&iacute;ficos: sabe que la sangre es un recurso    necesario y que
 se somete a an&aacute;lisis antes de ser utilizada, pero desconoce    con qu&ea
cute; frecuencia se puede donar, as&iacute; como los requisitos y limitaciones  
  para hacerlo. Estos datos son similares a los encontrados en universitarios   
 de Bangladesh (10) y en la poblaci&oacute;n representante de los 15 pa&iacute;s
es    de Am&eacute;rica que formaron parte del estudio que realizaran en 2003 Ga
rc&iacute;a    y colaboradores (3).</font></p>     ^cY#a05v22n5.htm##
01596000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704136200075002001301437#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#67#63#article#99#<p><font size="2" fa
ce="Verdana">Por otro lado, m&aacute;s de 80% de la poblaci&oacute;n    encuesta
da ten&iacute;a una actitud positiva hacia la donaci&oacute;n de sangre    y est
ar&iacute;a dispuesta a hacerlo en el futuro. Esta tendencia tambi&eacute;n    s
e ha detectado en una investigaci&oacute;n efectuada en Inglaterra en 1991    (1
2), en estudiantes de Bangladesh (10) y de Tailandia (11), y donde se concluy&oa
cute;    que la imagen que se ten&iacute;a hacia la donaci&oacute;n era muy posi
tiva.    Sin embargo, en el presente estudio se encontr&oacute; que las razones 
que manifest&oacute;    la poblaci&oacute;n para donar ser&iacute;an la necesida
d de un familiar o amigo    enfermo, seguida de una cat&aacute;strofe nacional. 
Esta es una actitud similar    a la encontrada en otras personas de Am&eacute;ri
ca, y una posible explicaci&oacute;n    ser&iacute;a que en estas regiones se pi
ensa que la sangre es un recurso escaso    y que, por ende, hay que reservar la 
donaci&oacute;n para una situaci&oacute;n    espec&iacute;fica. En la cultura la
tinoamericana est&aacute; muy arraigada la    idea de que s&oacute;lo se debe do
nar sangre por motivos de fuerza mayor, y    no hay conciencia de las necesidade
s permanentes de sangre (3). De esta forma,    la actitud positiva no repercute 
en un incremento de donantes voluntarios. </font></p>     ^cY#a05v22n5.htm##
01091000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704085700075002001300932#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#68#64#article#99#<p><font size="2" fa
ce="Verdana">La mayor&iacute;a de las personas (95,3%) estuvo    de acuerdo en r
ecibir informaci&oacute;n sobre la donaci&oacute;n de sangre    y 62,3% optaron 
por la televisi&oacute;n como medio de comunicaci&oacute;n.    Este dato debe co
nsiderarse en las estrategias de promoci&oacute;n, ya que la    televisi&oacute;
n es un medio masivo y de gran alcance, aunque de costo elevado.    Estudios rea
lizados en Espa&ntilde;a se&ntilde;alan que para los no donantes,    la mayor de
smotivaci&oacute;n es justamente la falta de informaci&oacute;n (43,6%)    (13, 
14). De lo anterior se desprende que deben dise&ntilde;arse estrategias    de co
municaci&oacute;n social eficaces que contemplen informaci&oacute;n, educaci&oac
ute;n    y comunicaci&oacute;n, orientadas a promover la donaci&oacute;n volunta
ria de    sangre.</font></p>     ^cY#a05v22n5.htm##
00889000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704065500075002001300730#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#69#65#article#99#<p><font size="2" fa
ce="Verdana">Al igual que en los trabajos de Thompson (6),    Hosain y colaborad
ores (10) y Wiwanitkit (11), una de las razones m&aacute;s    importantes que de
smotivan a la donaci&oacute;n sangu&iacute;nea es la desconfianza    hacia la es
terilidad del material y, por ende, el miedo a contagiarse de alguna    enfermed
ad infecciosa como el SIDA. Dicha percepci&oacute;n se detect&oacute;    tambi&e
acute;n en poblaci&oacute;n inglesa a inicios de los a&ntilde;os noventa    (15)
. Estos tab&uacute;es y mitos sobre la donaci&oacute;n de sangre influyen    neg
ativamente en el reclutamiento de donantes voluntarios.</font></p>     ^cY#a05v2
2n5.htm##
01842000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704160800075002001301683#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#70#66#article#99#<p><font size="2" fa
ce="Verdana">Por otra parte, se detect&oacute; una leve diferencia    entre homb
res (90%) y mujeres (84,2%) respecto de la actitud positiva hacia    una futura 
donaci&oacute;n de sangre. A pesar de que esa diferencia no fue estad&iacute;sti
camente    significativa, s&iacute; concuerda con los resultados obtenidos en es
tudios    de Boulware y colaboradores (16), quienes concluyeron que las mujeres 
est&aacute;n    menos dispuestas a donar sangre, en este caso por el miedo que l
es ocasiona    el ambiente hospitalario. Existen diversas razones que pueden exp
licar la tasa    m&aacute;s baja de donaci&oacute;n entre las mujeres y, por end
e, su menor predisposici&oacute;n    a donar sangre, y que incluyen la preocupac
i&oacute;n por su salud con respecto    a aspectos tales como la anemia, los emb
arazos, la p&eacute;rdida de peso o    el antecedente de haber sido rechazadas c
omo donantes (12). En el presente estudio    se podr&iacute;a asumir que razones
 similares justifican la menor predisposici&oacute;n    a donar sangre detectada
 en mujeres considerando, adem&aacute;s, que en la actualidad    la proporci&oac
ute;n de mujeres que donan sangre en el sistema de reposici&oacute;n    tambi&ea
cute;n es inferior respecto de los hombres. No obstante, la realizaci&oacute;n  
  de estudios adicionales para conocer las causas espec&iacute;ficas de este fen
&oacute;meno    permitir&iacute;a detectar los aspectos potencialmente modificab
les en estos    grupos y orientar de mejor forma las campa&ntilde;as de promoci&
oacute;n de    donaci&oacute;n sangu&iacute;nea.</font></p>     ^cY#a05v22n5.htm
##
00851000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704061700075002001300692#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#71#67#article#99#<p><font size="2" fa
ce="Verdana">Para promover la donaci&oacute;n de sangre voluntaria,    la OPS co
nsidera que, en cada pa&iacute;s, deben trabajar activamente las instituciones  
  acad&eacute;micas, las asociaciones profesionales, las sociedades cient&iacute
;ficas    y los medios de comunicaci&oacute;n, adem&aacute;s de los bancos de sa
ngre.    Para que esto se logre, es indispensable terminar con la obligatoriedad
 de familiares    y amigos de reponer la sangre transfundida, porque de lo contr
ario las poblaciones    seguir&aacute;n pensando en guardar el recurso sangre pa
ra las urgencias.</font></p>     ^cY#a05v22n5.htm##
01085000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704085100075002001300926#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#72#68#article#99#<p><font size="2" fa
ce="Verdana">En resumen, los resultados del presente estudio    permiten sugerir
 que las campa&ntilde;as de promoci&oacute;n de la donaci&oacute;n    voluntaria
 de sangre, en la poblaci&oacute;n de la Universidad de Talca, deber&iacute;an  
  centrarse en la difusi&oacute;n de informaci&oacute;n m&aacute;s precisa sobre
    los requisitos para ser aceptado como donante de sangre, recalcando la segur
idad    del proceso desde el punto de vista del contagio de enfermedades infecci
osas    como el SIDA, e incorporando una motivaci&oacute;n especial para las muj
eres,    haciendo &eacute;nfasis en el hecho de que, en el proceso de selecci&oa
cute;n    de donantes, se realizan una entrevista y un examen f&iacute;sico para
 definir    si la persona est&aacute; o no en condiciones de hacer una donaci&oa
cute;n.    </font></p>     ^cY#a05v22n5.htm##
00833000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704059900075002001300674#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#73#69#article#99#<p><font size="2" fa
ce="Verdana">Los aspectos relacionados con el efecto negativo    que ejerce la c
oexistencia de la donaci&oacute;n por reposici&oacute;n y la    voluntaria sobre
 la predisposici&oacute;n a donar sangre, as&iacute; como la    necesidad de dif
usi&oacute;n masiva v&iacute;a televisi&oacute;n, son cuestiones    m&aacute;s c
ompleja s de abordar, que requieren de una inversi&oacute;n econ&oacute;mica    
y de cambios en las pol&iacute;ticas. Los resultados de este estudio posiblement
e    podr&iacute;an extrapolarse a otras universidades regionales y nacionales.<
/font></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#74#70#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704007100075002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#75#71#article#99#<p><font size="3" fa
ce="Verdana"><b>REFERENCIAS</b></font></p>     ^cY#a05v22n5.htm##
00587000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704033900077002001300416#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#76#72#article#99#1#<p><fo
nt size="2" face="Verdana">1. Astorga I, Amaya S. 2000. Proyecto de Regionalizac
i&oacute;n    de los Bancos de Sangre. Hallado en: <a href="http://www.ias-uchil
e.cl/files/biblioteca/BancosdeSangre.pdf" target="_blank">http://www.ias-uchile.
cl/    files/biblioteca/BancosdeSangre.pdf</a>. Acceso el 3 de abril 2006.</font
></p>    ^cY#a05v22n5.htm##
00446000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704019800077002001300275#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#77#73#article#99#2#<p><fo
nt size="2" face="Verdana"> 2. Sullivan P. Developing an administrative    plan 
for transfusion medicine-a global perspective. Transfusi&oacute;n. 2005(45)(4sup
pl):224S–40S.</font></p>    ^cY#a05v22n5.htm##
00525000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704027700077002001300354#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#78#74#article#99#3#<p><fo
nt size="2" face="Verdana"> 3. Garc&iacute;a M, Saenz de Tejada E, Cruz    J. Es
tudio de factores socioculturales relacionados con la donaci&oacute;n voluntaria
    de sangre en la Am&eacute;ricas. Rev Panam Salud P&uacute;blica. 2003;13(2–3
):    85–90.</font></p>    ^cY#a05v22n5.htm##
00436000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704018800077002001300265#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#79#75#article#99#4#<p><fo
nt size="2" face="Verdana"> 4. Eastlund T. Monetary blood donation incentives   
 and the risk of transfusion-transmitted infection. Transfusion. 1998;38(9):874–
82.</font></p>    ^cY#a05v22n5.htm##
00428000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704018000077002001300257#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#80#76#article#99#5#<p><fo
nt size="2" face="Verdana"> 5. Barker L, Westphal R. Voluntary, nonremunerated  
  blood donation: still a world health goal. Transfusion. 1998;38(9):803–6.</fon
t></p>    ^cY#a05v22n5.htm##
00418000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704017000077002001300247#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#81#77#article#99#6#<p><fo
nt size="2" face="Verdana"> 6. Thompson W. Blood donation behavior of Hispanics 
   in the lower Rio Grande Valley. Transfusion. 1993;33(4):333–5.</font></p>    
^cY#a05v22n5.htm##
00447000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704019900077002001300276#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#82#78#article#99#7#<p><fo
nt size="2" face="Verdana"> 7. Ownby H, Kong F, Watanabe K. Analysis of    donor
 return behavior. Retrovirus Epidemiology Donor Study. Transfusion. 1999;39    (
10): 1128–35. </font></p>    ^cY#a05v22n5.htm##
00478000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704023000077002001300307#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#83#79#article#99#8#<p><fo
nt size="2" face="Verdana"> 8. Thomson R, Bethel J, Lo AY, Ownby HE, Nass    CC,
 Williams AE. Retention of "safe" blood donors. The Retrovirus    Epidemiology D
onor Study. Transfusion. 1998;38(9): 359–67. </font></p>    ^cY#a05v22n5.htm##
00449000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000200075704020100077002001300278#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#84#80#article#99#9#<p><fo
nt size="2" face="Verdana"> 9. Mwaba K, Keikelame MJ. Blood donation behaviour  
  and beliefs among a sample of high school students in Mmabatho. Curationis.   
 1995;18(3):2–3.</font></p>    ^cY#a05v22n5.htm##
00484000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704023500078002001300313#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#85#81#article#99#10#<p><f
ont size="2" face="Verdana">10. Hosain GM, Anisuzzaman M, Begur A. Knowledge    
and attitude towards voluntary blood donation among Dhaka University students   
 in Bangladesh. East Afr Med J. 1997; 74(9):549–53.</font></p>    ^cY#a05v22n5.h
tm##
00422000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704017300078002001300251#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#86#82#article#99#11#<p><f
ont size="2" face="Verdana">11. Wiwanikit V. Knowledge about blood donation    a
mong a sample of Thai university students. Vox Sang. 2002;83(2):97–9.</font></p>
    ^cY#a05v22n5.htm##
00457000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704020800078002001300286#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#87#83#article#99#12#<p><f
ont size="2" face="Verdana">12. Moore RJ. Promoting blood donation: a study    o
f the social profile, attitudes, motivations and experience of donors. Transfus 
   Med. 1991;1(4):201–7.</font></p>    ^cY#a05v22n5.htm##
00504000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704025500078002001300333#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#88#84#article#99#13#<p><f
ont size="2" face="Verdana">13. Fern&aacute;ndez-Montoya A, L&oacute;pez-Berr&ia
cute;o    A, Luna del Castillo JD. How some attitudes, beliefs and motivations o
f Spanish    blood donors evolve over time. Vox Sang. 1998;74(3):140–7.</font></
p>    ^cY#a05v22n5.htm##
00536000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704028700078002001300365#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#89#85#article#99#14#<p><f
ont size="2" face="Verdana">14. Fern&aacute;ndez-Montoya A, de Dios Luna    del 
Castillo J,L&oacute;pez Berr&iacute;o A, Rodr&iacute;guez Fern&aacute;ndez    A.
 Attitudes, beliefs and motivations in blood donors and non-donors. Sangre    (B
arc). 1996;41(6):413–6.</font></p>    ^cY#a05v22n5.htm##
00507000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704025800078002001300336#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#90#86#article#99#15#<p><f
ont size="2" face="Verdana">15. Bhopal RS, McEwan RT, Madhok R, McCallum    A. P
erceptions about blood donation, transfusion and the risk of HIV infection:    i
mplications for the blood transfusion service. AIDS Care. 1992;4(1):43–52.</font
></p>    ^cY#a05v22n5.htm##
00540000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072888000300075704029100078002001300369#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#91#87#article#99#16#<p><f
ont size="2" face="Verdana">16. Boulware LE, Ratner LE, Ness PM, Cooper LA,    C
ampbell-Lee S, LaVeist TA, et al. The contribution of sociodemographic, medical,
    and attitudinal factors to blood donation among the general public. Transfus
ion.    2002; 42(6):669–78.</font></p>    ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#92#88#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#93#89#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00318000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704008400075002001300159#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#94#90#article#99#<p><font size="2" fa
ce="Verdana">Manuscrito recibido el 20 de julio de 2006.    ^cY#a05v22n5.htm##
00348000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704011400075002001300189#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#95#91#article#99#<br>   Aceptado para
 publicaci&oacute;n, tras revisi&oacute;n, el 18 de septiembre    de 2007.</font
></p>     ^cY#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#96#92#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#97#93#article#99#<p>&nbsp;</p>     ^c
Y#a05v22n5.htm##
00604000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704037000075002001300445#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#98#94#article#99#<p><FONT SIZE="2" fa
ce="Verdana"><a name="nt"></a><a href="#tx">*</a> La correspondencia    se debe 
enviar a Marcela V&aacute;squez Rojas, Profesora, Facultad de Ciencias    de la 
Salud, Universidad de Talca, 2 Norte No. 685, Talca, Chile. T: 56-71-200494.    
F: 56-71-200488. Correo electr&oacute;nico: <a href="mailto:mvasquro@utalca.cl">
mvasquro@utalca.cl</a>    ^cY#a05v22n5.htm##
00783000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000300072704054900075002001300624#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#99#95#article#99#<br>   <a name="nt01
"></a><a href="#tx01">1</a> En 2002 la Universidad de Talca ten&iacute;a    dos 
<i>campus</i> con 13 carreras de pregrado. En el <i>campus</i> Lircay se    impa
rt&iacute;an las licenciaturas correspondientes a las facultades de ciencias:   
 Jur&iacute;dicas y Sociales; Forestales; Agrarias; Empresariales y de la Salud,
    mientras que en el <i>campus </i>Los Niches funcionaba la Facultad de Ingeni
er&iacute;a;    en este <i>campus </i>radicaba s&oacute;lo 19% de la poblaci&oac
ute;n universitaria    total.</font></p>     ^cY#a05v22n5.htm##
00278000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000300073704004300076002001300119#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#100#96#article#99#<p>&nbsp;</p> <a na
me="anx01"></a>     ^cY#a05v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000300073704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#101#97#article#99#<p>&nbsp;</p>     ^
cY#a05v22n5.htm##
00403000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000300073704016800076002001300244#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#102#98#article#99#<p align="center"><
font size="2" face="Verdana"><a href="/img/revistas/rpsp/v22n5/a05anx01.gif"><im
g src="/img/revistas/rpsp/v22n5/a05anxtb.gif" border="0"></a>    ^cY#a05v22n5.ht
m##
00348000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000300073704011300076002001300189#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a05v22n5.htm#S#p#103#99#article#99#<br>   <a href="/im
g/revistas/rpsp/v22n5/a05anx01.gif">ANEXO 1 - Clique aqui para ampliar</a></font
></p>     ^cY#a05v22n5.htm##
00542000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750160017000770160015000940650
00900109064000500118018005600123037006200179110000900241109001600250865000900266
002001300275#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#c#104#1#art
icle#16#1#^rND^sAstorga^nI#^rND^sAmaya^nS#20000000#2000#Proyecto de Regionalizac
ión de los Bancos de Sangre^les#http://www.ias-uchile.cl/ files/biblioteca/Banco
sdeSangre.pdf#20060403#3 de abril 2006#20071100#a05v22n5.htm##
00511000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120084000950300
01200179710000200191065000900193064000500202031000300207032000400210014000900214
865000900223002001300232#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S
#c#105#2#article#16#2#^rND^sSullivan^nP#Developing an administrative plan for tr
ansfusion medicine-a global perspective^len#Transfusión#2#20050000#2005#45#^s4#2
24S-40S#20071100#a05v22n5.htm##
00602000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100016000770100025000930100
01400118012010500132030002400237710000200261065000900263064000500272031000300277
032000400280014000600284865000900290002001300299#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a05v22n5.htm#S#c#106#3#article#16#3#^rND^sGarcía^nM#^rND^sSaenz de Tej
ada^nE#^rND^sCruz^nJ#Estudio de factores socioculturales relacionados con la don
ación voluntaria de sangre en la Américas^les#Rev Panam Salud Pública#2#20030000
#2003#13#2-3#85-90#20071100#a05v22n5.htm##
00544000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120089000950300
01200184065000900196064000500205031000300210032000200213014000700215865000900222
002001300231035001000244801001200254#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
5v22n5.htm#S#c#107#4#article#16#4#^rND^sEastlund^nT#Monetary blood donation ince
ntives and the risk of transfusion-transmitted infection^len#Transfusion#1998000
0#1998#38#9#874-82#20071100#a05v22n5.htm#0041-1132#Transfusion##
00554000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100016000770100018000930120
07200111030001200183065000900195064000500204031000300209032000200212014000600214
865000900220002001300229035001000242801001200252#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a05v22n5.htm#S#c#108#5#article#16#5#^rND^sBarker^nL#^rND^sWestphal^nR#
Voluntary, nonremunerated blood donation: still a world health goal^len#Transfus
ion#19980000#1998#38#9#803-6#20071100#a05v22n5.htm#0041-1132#Transfusion##
00526000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120072000950300
01200167065000900179064000500188031000300193032000200196014000600198865000900204
002001300213035001000226801001200236#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
5v22n5.htm#S#c#109#6#article#16#6#^rND^sThompson^nW#Blood donation behavior of H
ispanics in the lower Rio Grande Valley^len#Transfusion#19930000#1993#33#4#333-5
#20071100#a05v22n5.htm#0041-1132#Transfusion##
00585000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100014000920100
01800106012007500124030001200199065000900211064000500220031000300225032000300228
014000800231865000900239002001300248035001000261801001200271#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a05v22n5.htm#S#c#110#7#article#16#7#^rND^sOwnby^nH#^rND^sK
ong^nF#^rND^sWatanabe^nK#Analysis of donor return behavior: Retrovirus Epidemiol
ogy Donor Study^len#Transfusion#19990000#1999#39#10#1128-35#20071100#a05v22n5.ht
m#0041-1132#Transfusion##
00671000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100016000940100
01300110010001600123010001500139010001900154012007800173030001200251065000900263
06400050027203100030027703200020028001400070028286500090028900200130029803500100
0311801001200321#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#c#111#8
#article#16#8#^rND^sThomson^nR#^rND^sBethel^nJ#^rND^sLo^nAY#^rND^sOwnby^nHE#^rND
^sNass^nCC#^rND^sWilliams^nAE#Retention of "safe" blood donors: The Retrovirus E
pidemiology Donor Study^len#Transfusion#19980000#1998#38#9#359-67#20071100#a05v2
2n5.htm#0041-1132#Transfusion##
00571000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100020000920120
09200112030001100204065000900215064000500224031000300229032000200232014000400234
865000900238002001300247035001000260801001100270#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a05v22n5.htm#S#c#112#9#article#16#9#^rND^sMwaba^nK#^rND^sKeikelame^nMJ
#Blood donation behaviour and beliefs among a sample of high school students in 
Mmabatho^len#Curationis#19950000#1995#18#3#2-3#20071100#a05v22n5.htm#0379-8577#C
urationis##
00594000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100021000960100
01500117012010600132030001600238710000200254065000900256064000500265031000300270
032000200273014000700275865000900282002001300291#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a05v22n5.htm#S#c#113#10#article#16#10#^rND^sHosain^nGM#^rND^sAnisuzzam
an^nM#^rND^sBegur^nA#Knowledge and attitude towards voluntary blood donation amo
ng Dhaka University students in Bangladesh^len#East Afr Med J.#2#19970000#1997#7
4#9#549-53#20071100#a05v22n5.htm##
00528000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790120078000980300
00900176065000900185064000500194031000300199032000200202014000500204865000900209
002001300218035001000231801000900241#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
5v22n5.htm#S#c#114#11#article#16#11#^rND^sWiwanikit^nV#Knowledge about blood don
ation among a sample of Thai university students^len#Vox Sang#20020000#2002#83#2
#97-9#20071100#a05v22n5.htm#0042-9007#Vox sang##
00532000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790120109000950300
01400204710000200218065000900220064000500229031000200234032000200236014000600238
865000900244002001300253#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S
#c#115#12#article#16#12#^rND^sMoore^nRJ#Promoting blood donation: a study of the
 social profile, attitudes, motivations and experience of donors^len#Transfus Me
d.#2#19910000#1991#1#4#201-7#20071100#a05v22n5.htm##
00622000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100027000790100022001060100
02800128012008900156030000900245065000900254064000500263031000300268032000200271
014000600273865000900279002001300288035001000301801000900311#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a05v22n5.htm#S#c#116#13#article#16#13#^rND^sFernández-Mont
oya^nA#^rND^sLópez-Berrío^nA#^rND^sLuna del Castillo^nJD#How some attitudes, bel
iefs and motivations of Spanish blood donors evolve over time^len#Vox Sang#19980
000#1998#74#3#140-7#20071100#a05v22n5.htm#0042-9007#Vox sang##
00664000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100027000790100035001060100
02200141010002900163012007000192030000700262066000500269065000900274064000500283
03100030028803200020029101400060029386500090029900200130030803500100032180100070
0331#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#c#117#14#article#16
#14#^rND^sFernández-Montoya^nA#^rND^sde Dios Luna del Castillo^nJ#^rND^sLópez Be
rrío^nA#^rND^sRodríguez Fernández^nA#Attitudes, beliefs and motivations in blood
 donors and non-donors^len#Sangre#Barc#19960000#1996#41#6#413-6#20071100#a05v22n
5.htm#0036-4355#SANGRE##
00665000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100017000960100
01600113010001800129012012800147030001000275065000900285064000500294031000200299
032000200301014000600303865000900309002001300318035001000331801001000341#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a05v22n5.htm#S#c#118#15#article#16#15#^rND^sBh
opal^nRS#^rND^sMcEwan^nRT#^rND^sMadhok^nR#^rND^sMcCallum^nA#Perceptions about bl
ood donation, transfusion and the risk of HIV infection: implications for the bl
ood transfusion service^len#AIDS Care#19920000#1992#4#1#43-52#20071100#a05v22n5.
htm#0954-0121#AIDS care##
00743000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100017000980100
01500115010001700130010002200147010001800169810000600187012011800193030001200311
06500090032306400050033203100030033703200020034001400070034286500090034900200130
0358035001000371801001200381#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a05v22n5.h
tm#S#c#119#16#article#16#16#^rND^sBoulware^nLE#^rND^sRatner^nLE#^rND^sNess^nPM#^
rND^sCooper^nLA#^rND^sCampbell-Lee^nS#^rND^sLaVeist^nTA#et al#The contribution o
f sociodemographic, medical, and attitudinal factors to blood donation among the
 general public^len#Transfusion#20020000#2002#42#6#669-78#20071100#a05v22n5.htm#
0041-1132#Transfusion##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#o#1#1#article#1
#20080121#151821#a06v22n5.htm#215##
07134000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201280016701200970
02950100045003920100032004370100037004690100045005060700133005510700108006840700
12800792070010000920083247201020085000803492085002903500085003303529085003703562
08500190359908324780361808500080609608500280610408500240613208500290615608500360
61850850019062210580053062400600012062930580051063051170006063560720003063621120
00906365111002106374114000906395113001906404002001306423#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a06v22n5.htm#S#h#2#1#article#1#oa#pt#br1.1#1#3.1#TAB#06#RPSP02
0#nd#Rev Panam Salud Publica#22#5#20071100#^f329^l339#1020-4989#Padrões alimenta
res associados a fatores de risco para doenças cardiovasculares entre residentes
 de um município brasileiro^lpt#Dietary patterns associated with risk factors fo
r cardiovascular disease in a Brazilian city^len#^rND^1A01^nAfrica Isabel Cruz P
erez^sNeumann#^rND^1A02^nIgnez Salas^sMartins#^rND^1A03^nLuiz Francisco^sMarcopi
to#^rND^1A04^nEutalia Aparecida Candido^sAraujo#Secretaria de Estado da Saúde de
 São Paulo^iA01^1Centro de Vigilância Epidemiológica^2Divisão de Doenças Crônica
s Não-Transmissíveis#Universidade de São Paulo^iA02^1Faculdade de Saúde Pública^
2Departamento de Nutrição^cSão Paulo^sSP^pBrasil#Universidade Federal de São Pau
lo^iA03^1Departamento de Medicina Preventiva^2Disciplina de Epidemiologia^cSão P
aulo^sSP^pBrasil#Universidade de São Paulo^iA04^1Escola de Enfermagem^2Departame
nto de Clínica Cirúrgica^sSP^pBrasil#^lpt^aOBJETIVO: Identificar os padrões de c
onsumo alimentar dos residentes da área urbana do Município de São Paulo, Brasil
, e investigar a associação desses padrões com fatores de risco biológicos, soci
odemográficos e comportamentais para doenças cardiovasculares (DCV). MÉTODO: Rea
lizou-se um inquérito epidemiológico de delineamento transversal, com amostra pr
obabilística de base populacional. Os 2 100 participantes de ambos os sexos tinh
am entre 15 e 59 anos. Em uma sub-amostra sistemática de 700 pessoas, aplicou-se
 um inquérito sociodemográfico, comportamental, clínico e alimentar. Obtiveram-s
e os padrões alimentares por análise fatorial a partir de um questionário de fre
qüência alimentar. As associações dos padrões alimentares com as variáveis socio
demográficas e comportamentais foram determinadas por meio de análise de covariâ
ncia; e com os fatores biológicos, por regressão linear múltipla. RESULTADOS: Id
entificaram-se quatro padrões alimentares: "cafeteria" (açúcares simples e gordu
ras saturadas) associou-se com área de homogeneidade sociodemográfica e ambienta
l média, escolaridade média e superior e consumo de álcool. Associou-se ainda po
sitivamente com a pressão sistólica (PAS), diastólica (PAD), índice de massa cor
poral (IMC) e relação cintura-quadril (RCQ) e negativamente com o HDL. O segundo
 padrão, "tradicional" (cereais, feijões e infusões), predominou entre mulheres 
e na idade superior a 50 anos; associou-se com consumo de álcool, renda superior
 e área de homogeneidade média. Associou-se de modo positivo com glicemia e IMC 
e de modo negativo com triglicérides e RCQ. O padrão "moderno" (baixos teores de
 gordura de açúcares simples; consumo de peixes), predominou entre os indivíduos
 de áreas de homogeneidade alta, com maior renda e escolaridade superior. Associ
ou-se negativamente com PAD, colesterol total, glicemia e LDL. O padrão "aterogê
nico" (gorduras saturadas, adição de sal na comida depois de pronta e bebidas al
coólicas) predominou entre os homens. Associou-se com escolaridade fundamental, 
tabagismo, consumo de álcool e áreas de homogeneidade média e baixa. Associou-se
 de modo positivo com colesterol total, triglicérides, glicemia, IMC e RCQ. CONC
LUSÕES: Os resultados apontam para tendências desfavoráveis do padrão alimentar 
na população estudada, visto que três dos quatro padrões de consumo identificado
s (cafeteria, tradicional e aterogênico) associaram-se de forma significativa co
m fatores de risco para DCV.#^dnd^i1#^tm^lpt^kAnálise fatorial^i1#^tm^lpt^kconsu
mo de alimentos^i1#^tm^lpt^kdoenças cardiovasculares^i1#^tm^lpt^kBrasil^i1#^len^
aOBJECTIVE: To identify the dietary patterns of individuals living in the urban 
area of São Paulo, Brazil, and to investigate the association between these patt
erns and biological, sociodemographic, and behavioral risk factors for cardiovas
cular disease (CVD). METHOD: A cross-sectional epidemiological survey was carrie
d out with a population-based probabilistic sample. The 2 100 participants of bo
th sexes were from 15 to 59 years of age. A sociodemographic, behavioral, clinic
al, and dietary survey was applied to a systematic subsample of 700 people. Diet
ary patterns were determined using factor analysis based on a food frequency que
stionnaire. Covariance analysis was used to determine the associations between d
ietary patterns and sociodemographic and behavioral variables, and multilinear r
egression to determine the association between dietary patterns and biological f
actors. RESULTS: Four patterns were identified: (1) the "cafeteria" pattern (sim
ple sugars and saturated fat), associated with areas of medium sociodemographic 
and environmental homogeneity, high school and university-level schooling, and a
lcohol consumption; positively associated with systolic (SAP) and diastolic (DAP
) arterial pressure, body mass index (BMI) and waist-to-hip ratio (WHR); and neg
atively associated with HDL. (2) The "traditional" pattern (including cereals, b
eans, and infusion beverages) was predominant among women and in the age group o
ver 50 years;associated with alcohol consumption, higher income, and areas of me
dium homogeneity; positively associated with glucose levels and BMI; and negativ
ely associated with triglycerides and WHR. (3) The "modern" pattern (low intake 
of fat and simple sugars; fish) was predominant among individuals from high homo
geneity areas, with higher income and university schooling;negatively associated
 with DAP, total cholesterol, glucose levels, and LDL. (4) The "atherogenic" pat
tern (saturated fat, addition of salt to cooked foods and alcohol consumption) w
as predominant among males; associated with elementary schooling, smoking, alcoh
ol consumption, and areas of medium and low homogeneity; and positively associat
ed with total cholesterol, triglycerides, glucose levels, BMI, and WHR. CONCLUSI
ONS: The results indicate an unfavorable trend in the dietary patterns of this p
opulation, since three of the four patterns identified (cafeteria, traditional, 
and atherogenic) are significantly associated with risk factors for CVD.#^dnd^i2
#^tm^len^kFactor analysis^i2#^tm^len^kstatistical^i2#^tm^len^kfood consumption^i
2#^tm^len^kcardiovascular diseases^i2#^tm^len^kBrazil^i2#Fundação de Amparo à Pe
squisa do Estado de São Paulo#99/06187-60#Brasil^dSecretaria de Estado da Saúde 
de São Paulo#other#35#20060820#20 de agosto de 2006#20070709#9 de julho de 2007#
a06v22n5.htm##
07239000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201350016701201040
03020100045004060100032004510100037004830100045005200700133005650700108006980700
12800806070010000934083250001034085000803534085002903542085003303571085003703604
08500190364108325060366008500080616608500280617408500240620208500290622608500360
62550850019062910580053063100600047063630580051064101170006064610720003064671120
00906470111002106479114000906500113001906509002001306528#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a06v22n5.htm#S#f#3#1#article#1#oa#pt#br1.1#1#3.1#TAB#06#RPSP02
0#nd#Rev Panam Salud Publica#22#5#20071100#^f329^l339#1020-4989#<B>Padrões alime
ntares associados a fatores de risco para doenças cardiovasculares entre residen
tes de um município brasileiro</B>^lpt#<B>Dietary patterns associated with risk 
factors for cardiovascular disease in a Brazilian city</B>^len#^rND^1A01^nAfrica
 Isabel Cruz Perez^sNeumann#^rND^1A02^nIgnez Salas^sMartins#^rND^1A03^nLuiz Fran
cisco^sMarcopito#^rND^1A04^nEutalia Aparecida Candido^sAraujo#Secretaria de Esta
do da Saúde de São Paulo^iA01^1Centro de Vigilância Epidemiológica^2Divisão de D
oenças Crônicas Não-Transmissíveis#Universidade de São Paulo^iA02^1Faculdade de 
Saúde Pública^2Departamento de Nutrição^cSão Paulo^sSP^pBrasil#Universidade Fede
ral de São Paulo^iA03^1Departamento de Medicina Preventiva^2Disciplina de Epidem
iologia^cSão Paulo^sSP^pBrasil#Universidade de São Paulo^iA04^1Escola de Enferma
gem^2Departamento de Clínica Cirúrgica^sSP^pBrasil#^lpt^a<B>OBJETIVO: </B>Identi
ficar os padrões de consumo alimentar dos residentes da área urbana do Município
 de São Paulo, Brasil, e investigar a associação desses padrões com fatores de r
isco biológicos, sociodemográficos e comportamentais para doenças cardiovascular
es (DCV). <B>MÉTODO: </B>Realizou-se um inquérito epidemiológico de delineamento
 transversal, com amostra probabilística de base populacional. Os 2 100 particip
antes de ambos os sexos tinham entre 15 e 59 anos. Em uma sub-amostra sistemátic
a de 700 pessoas, aplicou-se um inquérito sociodemográfico, comportamental, clín
ico e alimentar. Obtiveram-se os padrões alimentares por análise fatorial a part
ir de um questionário de freqüência alimentar. As associações dos padrões alimen
tares com as variáveis sociodemográficas e comportamentais foram determinadas po
r meio de análise de covariância; e com os fatores biológicos, por regressão lin
ear múltipla. <B>RESULTADOS: </B>Identificaram-se quatro padrões alimentares: "c
afeteria" (açúcares simples e gorduras saturadas) associou-se com área de homoge
neidade sociodemográfica e ambiental média, escolaridade média e superior e cons
umo de álcool. Associou-se ainda positivamente com a pressão sistólica (PAS), di
astólica (PAD), índice de massa corporal (IMC) e relação cintura-quadril (RCQ) e
 negativamente com o HDL. O segundo padrão, "tradicional" (cereais, feijões e in
fusões), predominou entre mulheres e na idade superior a 50 anos; associou-se co
m consumo de álcool, renda superior e área de homogeneidade média. Associou-se d
e modo positivo com glicemia e IMC e de modo negativo com triglicérides e RCQ. O
 padrão "moderno" (baixos teores de gordura de açúcares simples; consumo de peix
es), predominou entre os indivíduos de áreas de homogeneidade alta, com maior re
nda e escolaridade superior. Associou-se negativamente com PAD, colesterol total
, glicemia e LDL. O padrão "aterogênico" (gorduras saturadas, adição de sal na c
omida depois de pronta e bebidas alcoólicas) predominou entre os homens. Associo
u-se com escolaridade fundamental, tabagismo, consumo de álcool e áreas de homog
eneidade média e baixa. Associou-se de modo positivo com colesterol total, trigl
icérides, glicemia, IMC e RCQ. <B>CONCLUSÕES: </B>Os resultados apontam para ten
dências desfavoráveis do padrão alimentar na população estudada, visto que três 
dos quatro padrões de consumo identificados (cafeteria, tradicional e aterogênic
o) associaram-se de forma significativa com fatores de risco para DCV.#^dnd^i1#^
tm^lpt^kAnálise fatorial^i1#^tm^lpt^kconsumo de alimentos^i1#^tm^lpt^kdoenças ca
rdiovasculares^i1#^tm^lpt^kBrasil^i1#^len^a<B>OBJECTIVE: </B>To identify the die
tary patterns of individuals living in the urban area of São Paulo, Brazil, and 
to investigate the association between these patterns and biological, sociodemog
raphic, and behavioral risk factors for cardiovascular disease (CVD). <B>METHOD:
</B> A cross-sectional epidemiological survey was carried out with a population-
based probabilistic sample. The 2 100 participants of both sexes were from 15 to
 59 years of age. A sociodemographic, behavioral, clinical, and dietary survey w
as applied to a systematic subsample of 700 people. Dietary patterns were determ
ined using factor analysis based on a food frequency questionnaire. Covariance a
nalysis was used to determine the associations between dietary patterns and soci
odemographic and behavioral variables, and multilinear regression to determine t
he association between dietary patterns and biological factors. <B>RESULTS: </B>
Four patterns were identified: (1) the "cafeteria" pattern (simple sugars and sa
turated fat), associated with areas of medium sociodemographic and environmental
 homogeneity, high school and university-level schooling, and alcohol consumptio
n; positively associated with systolic (SAP) and diastolic (DAP) arterial pressu
re, body mass index (BMI) and waist-to-hip ratio (WHR); and negatively associate
d with HDL. (2) The "traditional" pattern (including cereals, beans, and infusio
n beverages) was predominant among women and in the age group over 50 years;asso
ciated with alcohol consumption, higher income, and areas of medium homogeneity;
 positively associated with glucose levels and BMI; and negatively associated wi
th triglycerides and WHR. (3) The "modern" pattern (low intake of fat and simple
 sugars; fish) was predominant among individuals from high homogeneity areas, wi
th higher income and university schooling;negatively associated with DAP, total 
cholesterol, glucose levels, and LDL. (4) The "atherogenic" pattern (saturated f
at, addition of salt to cooked foods and alcohol consumption) was predominant am
ong males; associated with elementary schooling, smoking, alcohol consumption, a
nd areas of medium and low homogeneity; and positively associated with total cho
lesterol, triglycerides, glucose levels, BMI, and WHR. <B>CONCLUSIONS: </B>The r
esults indicate an unfavorable trend in the dietary patterns of this population,
 since three of the four patterns identified (cafeteria, traditional, and athero
genic) are significantly associated with risk factors for CVD.#^dnd^i2#^tm^len^k
Factor analysis^i2#^tm^len^kstatistical^i2#^tm^len^kfood consumption^i2#^tm^len^
kcardiovascular diseases^i2#^tm^len^kBrazil^i2#Fundação de Amparo à Pesquisa do 
Estado de São Paulo#<FONT FACE="Verdana" SIZE=2>99/06187-60</FONT>#Brasil^dSecre
taria de Estado da Saúde de São Paulo#other#35#20060820#20 de agosto de 2006#200
70709#9 de julho de 2007#a06v22n5.htm##
07273000000000721000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201201280
01820120097003100100045004070100032004520100037004840100045005210700135005660700
11000701070013000811070010200941083247201043085000803515085002903523085003303552
08500370358508500190362208324780364108500080611908500280612708500240615508500290
61790850036062080850019062440580053062630600012063160580051063281170006063790720
00306385112000906388111002106397114000906418113001906427002001306446008009206459
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#l#4#1#article#1#^mnov.^
a2007#oa#pt#br1.1#1#3.1#tab#06#RPSP020#nd#Rev. panam. salud pública#22#5#2007110
0#^f329^l339#1020-4989#Padrões alimentares associados a fatores de risco para do
enças cardiovasculares entre residentes de um município brasileiro^lpt#Dietary p
atterns associated with risk factors for cardiovascular disease in a Brazilian c
ity^len#^rND^1A01^nAfrica Isabel Cruz Perez^sNeumann#^rND^1A02^nIgnez Salas^sMar
tins#^rND^1A03^nLuiz Francisco^sMarcopito#^rND^1A04^nEutalia Aparecida Candido^s
Araujo#^iA01^1Secretaria de Estado da Saúde de São Paulo^2Centro de Vigilância E
pidemiológica^3Divisão de Doenças Crônicas Não-Transmissíveis#^iA02^1Universidad
e de São Paulo^2Faculdade de Saúde Pública^3Departamento de Nutrição^cSão Paulo^
sSP^pBrasil#^iA03^1Universidade Federal de São Paulo^2Departamento de Medicina P
reventiva^3Disciplina de Epidemiologia^cSão Paulo^sSP^pBrasil#^iA04^1Universidad
e de São Paulo^2Escola de Enfermagem^3Departamento de Clínica Cirúrgica^sSP^pBra
sil#^lpt^aOBJETIVO: Identificar os padrões de consumo alimentar dos residentes d
a área urbana do Município de São Paulo, Brasil, e investigar a associação desse
s padrões com fatores de risco biológicos, sociodemográficos e comportamentais p
ara doenças cardiovasculares (DCV). MÉTODO: Realizou-se um inquérito epidemiológ
ico de delineamento transversal, com amostra probabilística de base populacional
. Os 2 100 participantes de ambos os sexos tinham entre 15 e 59 anos. Em uma sub
-amostra sistemática de 700 pessoas, aplicou-se um inquérito sociodemográfico, c
omportamental, clínico e alimentar. Obtiveram-se os padrões alimentares por anál
ise fatorial a partir de um questionário de freqüência alimentar. As associações
 dos padrões alimentares com as variáveis sociodemográficas e comportamentais fo
ram determinadas por meio de análise de covariância; e com os fatores biológicos
, por regressão linear múltipla. RESULTADOS: Identificaram-se quatro padrões ali
mentares: "cafeteria" (açúcares simples e gorduras saturadas) associou-se com ár
ea de homogeneidade sociodemográfica e ambiental média, escolaridade média e sup
erior e consumo de álcool. Associou-se ainda positivamente com a pressão sistóli
ca (PAS), diastólica (PAD), índice de massa corporal (IMC) e relação cintura-qua
dril (RCQ) e negativamente com o HDL. O segundo padrão, "tradicional" (cereais, 
feijões e infusões), predominou entre mulheres e na idade superior a 50 anos; as
sociou-se com consumo de álcool, renda superior e área de homogeneidade média. A
ssociou-se de modo positivo com glicemia e IMC e de modo negativo com triglicéri
des e RCQ. O padrão "moderno" (baixos teores de gordura de açúcares simples; con
sumo de peixes), predominou entre os indivíduos de áreas de homogeneidade alta, 
com maior renda e escolaridade superior. Associou-se negativamente com PAD, cole
sterol total, glicemia e LDL. O padrão "aterogênico" (gorduras saturadas, adição
 de sal na comida depois de pronta e bebidas alcoólicas) predominou entre os hom
ens. Associou-se com escolaridade fundamental, tabagismo, consumo de álcool e ár
eas de homogeneidade média e baixa. Associou-se de modo positivo com colesterol 
total, triglicérides, glicemia, IMC e RCQ. CONCLUSÕES: Os resultados apontam par
a tendências desfavoráveis do padrão alimentar na população estudada, visto que 
três dos quatro padrões de consumo identificados (cafeteria, tradicional e atero
gênico) associaram-se de forma significativa com fatores de risco para DCV.#^dnd
^i1#^tm^lpt^kAnálise fatorial^i1#^tm^lpt^kconsumo de alimentos^i1#^tm^lpt^kdoenç
as cardiovasculares^i1#^tm^lpt^kBrasil^i1#^len^aOBJECTIVE: To identify the dieta
ry patterns of individuals living in the urban area of São Paulo, Brazil, and to
 investigate the association between these patterns and biological, sociodemogra
phic, and behavioral risk factors for cardiovascular disease (CVD). METHOD: A cr
oss-sectional epidemiological survey was carried out with a population-based pro
babilistic sample. The 2 100 participants of both sexes were from 15 to 59 years
 of age. A sociodemographic, behavioral, clinical, and dietary survey was applie
d to a systematic subsample of 700 people. Dietary patterns were determined usin
g factor analysis based on a food frequency questionnaire. Covariance analysis w
as used to determine the associations between dietary patterns and sociodemograp
hic and behavioral variables, and multilinear regression to determine the associ
ation between dietary patterns and biological factors. RESULTS: Four patterns we
re identified: (1) the "cafeteria" pattern (simple sugars and saturated fat), as
sociated with areas of medium sociodemographic and environmental homogeneity, hi
gh school and university-level schooling, and alcohol consumption; positively as
sociated with systolic (SAP) and diastolic (DAP) arterial pressure, body mass in
dex (BMI) and waist-to-hip ratio (WHR); and negatively associated with HDL. (2) 
The "traditional" pattern (including cereals, beans, and infusion beverages) was
 predominant among women and in the age group over 50 years;associated with alco
hol consumption, higher income, and areas of medium homogeneity; positively asso
ciated with glucose levels and BMI; and negatively associated with triglycerides
 and WHR. (3) The "modern" pattern (low intake of fat and simple sugars; fish) w
as predominant among individuals from high homogeneity areas, with higher income
 and university schooling;negatively associated with DAP, total cholesterol, glu
cose levels, and LDL. (4) The "atherogenic" pattern (saturated fat, addition of 
salt to cooked foods and alcohol consumption) was predominant among males; assoc
iated with elementary schooling, smoking, alcohol consumption, and areas of medi
um and low homogeneity; and positively associated with total cholesterol, trigly
cerides, glucose levels, BMI, and WHR. CONCLUSIONS: The results indicate an unfa
vorable trend in the dietary patterns of this population, since three of the fou
r patterns identified (cafeteria, traditional, and atherogenic) are significantl
y associated with risk factors for CVD.#^dnd^i2#^tm^len^kFactor analysis^i2#^tm^
len^kstatistical^i2#^tm^len^kfood consumption^i2#^tm^len^kcardiovascular disease
s^i2#^tm^len^kBrazil^i2#Fundação de Amparo à Pesquisa do Estado de São Paulo#99/
06187-60#Brasil^dSecretaria de Estado da Saúde de São Paulo#other#35#20060820#20
 de agosto de 2006#20070709#9 de julho de 2007#a06v22n5.htm#Internet^ihttp://www
.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001000006##
00357000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012400074002001300198#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#5#1#article#176#<p align="right"><fon
t size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEA
RCH</font></p>     ^cY#a06v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#6#2#article#176#<p>&nbsp;</p>     ^cY
#a06v22n5.htm##
00460000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704022700074002001300301#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#7#3#article#176#<p><font size="4" fac
e="verdana"><a name="tx"></a><b>Padr&otilde;es alimentares    associados a fator
es de risco para doen&ccedil;as cardiovasculares entre residentes    de um munic
&iacute;pio brasileiro</b></font></p>     ^cY#a06v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#8#4#article#176#<p>&nbsp;</p>     ^cY
#a06v22n5.htm##
00388000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704015500074002001300229#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#9#5#article#176#<p><font size="3" fac
e="verdana"><b>Dietary patterns associated with risk factors    for cardiovascul
ar disease in a Brazilian city</b></font></p>     ^cY#a06v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#10#6#article#176#<p>&nbsp;</p>     ^c
Y#a06v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#11#7#article#176#<p>&nbsp;</p>     ^c
Y#a06v22n5.htm##
00497000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704026300075002001300338#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#12#8#article#176#<p><font size="2" fa
ce="Verdana"><b>Africa Isabel Cruz Perez Neumann<sup>I, </sup><a href="#nt"><sup
>*</sup></a>;    Ignez Salas Martins<sup>II</sup>; Luiz Francisco Marcopito<SUP>
III</SUP>; Eutalia    Aparecida Candido Araujo<SUP>IV</sup></b></font></p>     ^
cY#a06v22n5.htm##
00481000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704024700075002001300322#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#13#9#article#176#<p><FONT SIZE="2" fa
ce="Verdana"><SUP>I</sup>Secretaria de Estado da Sa&uacute;de    de S&atilde;o P
aulo, Centro de Vigil&acirc;ncia Epidemiol&oacute;gica, Divis&atilde;o    de Doe
n&ccedil;as Cr&ocirc;nicas N&atilde;o-Transmiss&iacute;veis    ^cY#a06v22n5.htm#
#
00420000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018500076002001300261#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#14#10#article#176#<br>   <SUP>II</sup
>Universidade de S&atilde;o Paulo (USP), Faculdade de Sa&uacute;de    P&uacute;b
lica, Departamento de Nutri&ccedil;&atilde;o, S&atilde;o Paulo (SP),    Brasil  
  ^cY#a06v22n5.htm##
00417000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018200076002001300258#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#15#11#article#176#<br>   <SUP>III</su
p>Universidade Federal de S&atilde;o Paulo (UNIFESP), Departamento    de Medicin
a Preventiva, Disciplina de Epidemiologia, S&atilde;o Paulo (SP),    Brasil    ^
cY#a06v22n5.htm##
00422000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018700076002001300263#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#16#12#article#176#<br>   <SUP>IV</sup
>Universidade de S&atilde;o    Paulo (USP), S&atilde;o Paulo, Escola de Enfermag
em, Departamento de Cl&iacute;nica    Cir&uacute;rgica, (SP), Brasil</font></p> 
    ^cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#17#13#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#18#14#article#176#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a06v22n5.htm##
00301000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006600076002001300142#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#19#15#article#176#<p><font size="2" f
ace="VERDANA"><b>RESUMO</b></font></p>     ^cY#a06v22n5.htm##
00630000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039500076002001300471#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#20#16#article#176#<p><font size="2" f
ace="Verdana"><b>OBJETIVO: </b>Identificar os padr&otilde;es    de consumo alime
ntar dos residentes da &aacute;rea urbana do Munic&iacute;pio    de S&atilde;o P
aulo, Brasil, e investigar a associa&ccedil;&atilde;o desses    padr&otilde;es c
om fatores de risco biol&oacute;gicos, sociodemogr&aacute;ficos    e comportamen
tais para doen&ccedil;as cardiovasculares (DCV).    ^cY#a06v22n5.htm##
01077000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704084200076002001300918#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#21#17#article#176#<br>   <b>M&Eacute;
TODO: </b>Realizou-se um inqu&eacute;rito epidemiol&oacute;gico    de delineamen
to transversal, com amostra probabil&iacute;stica de base populacional.    Os 2 
100 participantes de ambos os sexos tinham entre 15 e 59 anos. Em uma sub-amostr
a    sistem&aacute;tica de 700 pessoas, aplicou-se um inqu&eacute;rito sociodemo
gr&aacute;fico,    comportamental, cl&iacute;nico e alimentar. Obtiveram-se os p
adr&otilde;es alimentares    por an&aacute;lise fatorial a partir de um question
&aacute;rio de freq&uuml;&ecirc;ncia    alimentar. As associa&ccedil;&otilde;es 
dos padr&otilde;es alimentares com as    vari&aacute;veis sociodemogr&aacute;fic
as e comportamentais foram determinadas    por meio de an&aacute;lise de covari&
acirc;ncia; e com os fatores biol&oacute;gicos,    por regress&atilde;o linear m
&uacute;ltipla.    ^cY#a06v22n5.htm##
01847000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704161200076002001301688#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#22#18#article#176#<br>   <b>RESULTADO
S: </b>Identificaram-se quatro padr&otilde;es alimentares: "cafeteria"    (a&cce
dil;&uacute;cares simples e gorduras saturadas) associou-se com &aacute;rea    d
e homogeneidade sociodemogr&aacute;fica e ambiental m&eacute;dia, escolaridade  
  m&eacute;dia e superior e consumo de &aacute;lcool. Associou-se ainda positiva
mente    com a press&atilde;o sist&oacute;lica (PAS), diast&oacute;lica (PAD), &
iacute;ndice    de massa corporal (IMC) e rela&ccedil;&atilde;o cintura-quadril 
(RCQ) e negativamente    com o HDL. O segundo padr&atilde;o, "tradicional" (cere
ais, feij&otilde;es    e infus&otilde;es), predominou entre mulheres e na idade 
superior a 50 anos;    associou-se com consumo de &aacute;lcool, renda superior 
e &aacute;rea de homogeneidade    m&eacute;dia. Associou-se de modo positivo com
 glicemia e IMC e de modo negativo    com triglic&eacute;rides e RCQ. O padr&ati
lde;o "moderno" (baixos    teores de gordura de a&ccedil;&uacute;cares simples; 
consumo de peixes), predominou    entre os indiv&iacute;duos de &aacute;reas de 
homogeneidade alta, com maior    renda e escolaridade superior. Associou-se nega
tivamente com PAD, colesterol    total, glicemia e LDL. O padr&atilde;o "aterog&
ecirc;nico" (gorduras    saturadas, adi&ccedil;&atilde;o de sal na comida depois
 de pronta e bebidas    alco&oacute;licas) predominou entre os homens. Associou-
se com escolaridade    fundamental, tabagismo, consumo de &aacute;lcool e &aacut
e;reas de homogeneidade    m&eacute;dia e baixa. Associou-se de modo positivo co
m colesterol total, triglic&eacute;rides,    glicemia, IMC e RCQ.    ^cY#a06v22n
5.htm##
00613000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037800076002001300454#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#23#19#article#176#<br>   <b>CONCLUS&O
tilde;ES: </b>Os resultados    apontam para tend&ecirc;ncias desfavor&aacute;vei
s do padr&atilde;o alimentar    na popula&ccedil;&atilde;o estudada, visto que t
r&ecirc;s dos quatro padr&otilde;es    de consumo identificados (cafeteria, trad
icional e aterog&ecirc;nico) associaram-se    de forma significativa com fatores
 de risco para DCV.</font></p>     ^cY#a06v22n5.htm##
00423000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018800076002001300264#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#24#20#article#176#<p><font size="2" f
ace="Verdana"><b>Palavras-chave:</b> An&aacute;lise    fatorial, consumo de alim
entos, doen&ccedil;as cardiovasculares, Brasil.</font></p> <hr size="1" noshade>
     ^cY#a06v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#25#21#article#176#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a06v22n5.htm##
00558000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704032300076002001300399#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#26#22#article#176#<p><font size="2" f
ace="Verdana"><b>OBJECTIVE: </b>To identify the dietary patterns    of individua
ls living in the urban area of S&atilde;o Paulo, Brazil, and to    investigate t
he association between these patterns and biological, sociodemographic,    and b
ehavioral risk factors for cardiovascular disease (CVD).    ^cY#a06v22n5.htm##
00904000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704066900076002001300745#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#27#23#article#176#<br>   <b>METHOD:</
b> A cross-sectional epidemiological survey was carried out with    a population
-based probabilistic sample. The 2 100 participants of both sexes    were from 1
5 to 59 years of age. A sociodemographic, behavioral, clinical, and    dietary s
urvey was applied to a systematic subsample of 700 people. Dietary    patterns w
ere determined using factor analysis based on a food frequency questionnaire.   
 Covariance analysis was used to determine the associations between dietary patt
erns    and sociodemographic and behavioral variables, and multilinear regressio
n to    determine the association between dietary patterns and biological factor
s.    ^cY#a06v22n5.htm##
01651000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704141600076002001301492#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#28#24#article#176#<br>   <b>RESULTS: 
</b>Four patterns were identified: (1) the "cafeteria"    pattern (simple sugars
 and saturated fat), associated with areas of medium sociodemographic    and env
ironmental homogeneity, high school and university-level schooling, and    alcoh
ol consumption; positively associated with systolic (SAP) and diastolic    (DAP)
 arterial pressure, body mass index (BMI) and waist-to-hip ratio (WHR);    and n
egatively associated with HDL. (2) The "traditional" pattern    (including cerea
ls, beans, and infusion beverages) was predominant among women    and in the age
 group over 50 years;associated with alcohol consumption, higher    income, and 
areas of medium homogeneity; positively associated with glucose    levels and BM
I; and negatively associated with triglycerides and WHR. (3) The    "modern" pat
tern (low intake of fat and simple sugars; fish) was predominant    among indivi
duals from high homogeneity areas, with higher income and university    schoolin
g;negatively associated with DAP, total cholesterol, glucose levels,    and LDL.
 (4) The "atherogenic" pattern (saturated fat, addition of    salt to cooked foo
ds and alcohol consumption) was predominant among males; associated    with elem
entary schooling, smoking, alcohol consumption, and areas of medium    and low h
omogeneity; and positively associated with total cholesterol, triglycerides,    
glucose levels, BMI, and WHR.    ^cY#a06v22n5.htm##
00518000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704028300076002001300359#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#29#25#article#176#<br>   <b>CONCLUSIO
NS: </b>The results indicate an unfavorable trend in the dietary    patterns of 
this population, since three of the four patterns identified (cafeteria,    trad
itional, and atherogenic) are significantly associated with risk factors    for 
CVD.</font></p>     ^cY#a06v22n5.htm##
00411000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704017600076002001300252#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#30#26#article#176#<p><font size="2" f
ace="Verdana"><b>Key words:</b> Factor analysis, statistical;    food consumptio
n; cardiovascular diseases; Brazil.</font></p> <hr size="1" noshade>     ^cY#a06
v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#31#27#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#32#28#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
01093000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704085800076002001300934#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#33#29#article#176#<p><font size="2" f
ace="Verdana">Cerca de 17 milh&otilde;es dos &oacute;bitos    ocorridos anualmen
te (1) s&atilde;o causados por doen&ccedil;as cardiovasculares    (DCV), princip
almente cardiopatias e acidentes vasculares cerebrais. No Brasil,    entre 1930 
e 1985, a propor&ccedil;&atilde;o de mortes por DCV aumentou em mais    de 200%.
 Apesar de ter sido observado, nas &uacute;ltimas quatro d&eacute;cadas,    um d
ecl&iacute;nio na mortalidade por DCV, essas doen&ccedil;as continuam sendo    a
s principais causas de morte no Estado e Munic&iacute;pio de S&atilde;o Paulo   
 (2). No Munic&iacute;pio de S&atilde;o Paulo, a primeira causa de &oacute;bitos
    no ano de 2002 foram as doen&ccedil;as isqu&ecirc;micas do cora&ccedil;&atil
de;o    (8 452, ou 13,6%) e a segunda, as doen&ccedil;as cerebrovasculares (5 48
4, ou    8,8%) (3).</font></p>     ^cY#a06v22n5.htm##
00908000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704067300076002001300749#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#34#30#article#176#<p><font size="2" f
ace="Verdana">Os elementos mais importantes no processo de    determina&ccedil;&
atilde;o das DCV e de suas inter-rela&ccedil;&otilde;es s&atilde;o    complexos.
 Admite-se que os fatores de risco tenham efeito sin&eacute;rgico    quando ocor
rem concomitantemente (4). Entretanto, sabe-se que a alimenta&ccedil;&atilde;o  
  contribui de v&aacute;rias formas para a determina&ccedil;&atilde;o do risco  
  cardiovascular. H&aacute; estudos demonstrando que as DCV podem ser reduzidas 
   em 30% com modifica&ccedil;&otilde;es na dieta, cuja composi&ccedil;&atilde;o
    pode constituir um fator de risco ou de prote&ccedil;&atilde;o (1, 5).</font
></p>     ^cY#a06v22n5.htm##
01550000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704131500076002001301391#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#35#31#article#176#<p><font size="2" f
ace="Verdana">Uma recente publica&ccedil;&atilde;o da Organiza&ccedil;&atilde;o 
   Mundial da Sa&uacute;de (OMS) (4) sobre a rela&ccedil;&atilde;o entre a alime
nta&ccedil;&atilde;o,    a atividade f&iacute;sica e as doen&ccedil;as cr&ocirc;
nicas n&atilde;o transmiss&iacute;veis    mostra que alguns componentes da dieta
 podem provocar efeitos adversos ao organismo.    Esses componentes aumentam o r
isco de DCV quando consumidos em periodicidade    e quantidades inadequadas. S&a
tilde;o os alimentos ou prepara&ccedil;&otilde;es    que cont&ecirc;m colesterol
, &aacute;cidos graxos saturados, &aacute;cidos graxos    trans e s&oacute;dio. 
Por outro lado, h&aacute; elementos diet&eacute;ticos    associados &agrave; dim
inui&ccedil;&atilde;o do risco de DCV, tais como os &aacute;cidos    graxos poli
insaturados (derivados do &ocirc;mega-3 e do &ocirc;mega-6) e os    monoinsatura
dos, encontrados nos &oacute;leos vegetais e nos peixes, entre outros.    Estudo
s epidemiol&oacute;gicos tamb&eacute;m sugerem que os vegetais —cereais,    legu
minosas, frutas em geral, verduras e legumes— podem reduzir os riscos para    do
en&ccedil;as n&atilde;o transmiss&iacute;veis (4, 6, 7) por conter fibras    ali
mentares, pot&aacute;ssio e componentes antioxidantes e fotoqu&iacute;micos.</fo
nt></p>     ^cY#a06v22n5.htm##
00946000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704071100076002001300787#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#36#32#article#176#<p><font size="2" f
ace="Verdana">A maioria das avalia&ccedil;&otilde;es do consumo    alimentar de 
popula&ccedil;&otilde;es no &acirc;mbito da epidemiologia nutricional    baseia-
se no c&ocirc;mputo de micro e macronutrientes e no respectivo consumo    cal&oa
cute;rico (5, 8). Mais recentemente, a OMS vem sugerindo que tais avalia&ccedil;
&otilde;es    deveriam ser baseadas em perfis alimentares, ao inv&eacute;s de nu
trientes (9),    pois a variedade de alimentos de uma dieta resulta em uma compl
exa combina&ccedil;&atilde;o    de compostos qu&iacute;micos que podem ser antag
&ocirc;nicos, competir ou alterar    a biodisponibilidade de outros compostos qu
&iacute;micos ou nutrientes (5).</font></p>     ^cY#a06v22n5.htm##
01014000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704077900076002001300855#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#37#33#article#176#<p><font size="2" f
ace="Verdana">Assim, &eacute; importante caracterizar os padr&otilde;es    alime
ntares de popula&ccedil;&otilde;es a partir de um rol de alimentos obtidos    po
r meio de inqu&eacute;ritos sobre freq&uuml;&ecirc;ncia de consumo. A distribui&
ccedil;&atilde;o    do consumo desses alimentos na popula&ccedil;&atilde;o e os 
seus poss&iacute;veis    efeitos na indu&ccedil;&atilde;o ou prote&ccedil;&atild
e;o contra as morbidades    s&atilde;o aspectos de fundamental import&acirc;ncia
 para os programas de interven&ccedil;&atilde;o    (8, 10–15). V&aacute;rios est
udos em diferentes partes do mundo t&ecirc;m utilizado    o m&eacute;todo de an&
aacute;lise fatorial para investigar as rela&ccedil;&otilde;es    entre a dieta 
e as doen&ccedil;as.</font></p>     ^cY#a06v22n5.htm##
00628000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039300076002001300469#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#38#34#article#176#<p><font size="2" f
ace="Verdana">O presente estudo teve como objetivo identificar    os padr&otilde
;es de consumo alimentar dos residentes da &aacute;rea urbana    do Munic&iacute
;pio de S&atilde;o Paulo, Brasil, e investigar a associa&ccedil;&atilde;o    des
ses padr&otilde;es com fatores de risco biol&oacute;gicos, sociodemogr&aacute;fi
cos    e comportamentais para DCV.</font></p>     ^cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#39#35#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008600076002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#40#36#article#176#<p><font size="3" f
ace="Verdana"><b>MATERIAIS E M&Eacute;TODOS</b></font></p>     ^cY#a06v22n5.htm#
#
00518000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704028300076002001300359#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#41#37#article#176#<p><font size="2" f
ace="Verdana">Esta pesquisa, de delineamento transversal, foi    realizada na &a
acute;rea urbana do Munic&iacute;pio de S&atilde;o Paulo entre    2001 e 2002. O
s presentes resultados se referem &agrave; subamostra de um estudo    anterior (
16).</font></p>     ^cY#a06v22n5.htm##
01555000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704132000076002001301396#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#42#38#article#176#<p><font size="2" f
ace="Verdana">O estudo teve como base uma amostra probabil&iacute;stica    por c
onglomerados em duas fases, constitu&iacute;da a partir de seis &aacute;reas    
socioambientais homog&ecirc;neas, selecionadas intencionalmente, e 100 setores  
  censit&aacute;rios, conforme a recomenda&ccedil;&atilde;o dos &oacute;rg&atild
e;os    respons&aacute;veis pelos censos nos Estados Unidos e no Brasil (17, 18)
. As    &aacute;reas socioambientais s&atilde;o recortes territoriais nos quais 
os dados    sobre a popula&ccedil;&atilde;o tendem a ser mais homog&ecirc;neos e
m rela&ccedil;&atilde;o    &agrave;s caracter&iacute;sticas sociodemogr&aacute;f
icas e ao meio ambiente.    Foram escolhidas a partir das &aacute;reas apresenta
das no mapa da inclus&atilde;o/exclus&atilde;o    social da Cidade de S&atilde;o
 Paulo (19). Duas &aacute;reas homog&ecirc;neas    com popula&ccedil;&atilde;o d
e alto padr&atilde;o socioecon&ocirc;mico n&atilde;o    foram inclu&iacute;das p
orque o estudo piloto revelou recusa em participar de    cerca de 80%. Neste est
udo, as &aacute;reas foram definidas em quatro n&iacute;veis    de homogeneidade
 —alto, m&eacute;dio, baixo e muito baixo— de acordo com a distribui&ccedil;&ati
lde;o    de inclus&atilde;o/exclus&atilde;o social estabelecida no referido mapa
.</font></p>     ^cY#a06v22n5.htm##
01278000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704104300076002001301119#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#43#39#article#176#<p><font size="2" f
ace="Verdana">O processo de sele&ccedil;&atilde;o da amostra    probabil&iacute;
stica da popula&ccedil;&atilde;o foi feito por amostragem estratificada    por c
onglomerados em dois est&aacute;gios. No primeiro est&aacute;gio, foram    selec
ionados os setores censit&aacute;rios dentro de cada &aacute;rea homog&ecirc;nea
    (conglomerado prim&aacute;rio) de forma sistem&aacute;tica, com probabilidad
e    proporcional ao n&uacute;mero atual de domic&iacute;lios (conforme censo de
    1991) (20) do setor. No segundo est&aacute;gio, os domic&iacute;lios foram s
orteados    dentro de cada setor proporcionalmente ao n&uacute;mero de domic&iac
ute;lios    do setor, sendo sorteado um indiv&iacute;duo entre 15 e 59 anos (uni
dade amostral)    em cada resid&ecirc;ncia, por meio do sistema balanceado propo
sto por Marques    e Berqu&oacute; (21). Outras descri&ccedil;&otilde;es metodol
&oacute;gicas encontram-se    em uma publica&ccedil;&atilde;o anterior, referent
e &agrave; pesquisa tem&aacute;tica    (16).</font></p>     ^cY#a06v22n5.htm##
00958000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704072300076002001300799#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#44#40#article#176#<p><font size="2" f
ace="Verdana">Foram selecionados 2 277 domic&iacute;lios, sendo    exclu&iacute;
dos da amostra os indiv&iacute;duos acima de 59 anos, as gr&aacute;vidas    e as
 pu&eacute;rperas. O tamanho da amostra foi estipulado em 2 100 participantes,  
  n&uacute;mero suficiente para atingir o que havia sido planejado. Em uma subam
ostra    extra&iacute;da por amostragem sistem&aacute;tica, constitu&iacute;da p
or um    ter&ccedil;o dos indiv&iacute;duos (782 pessoas), foi realizado um inqu
&eacute;rito    cl&iacute;nico e alimentar. Houve perdas por recusa na coleta do
 sangue, entre    outros, que totalizaram 82 indiv&iacute;duos (10,5%), sendo qu
e a subamostra    final incluiu 700 pessoas.</font></p>     ^cY#a06v22n5.htm##
01864000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704162900076002001301705#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#45#41#article#176#<p><font size="2" f
ace="Verdana">As entrevistas ocorreram entre mar&ccedil;o de    2001 e outubro d
e 2002. As pessoas selecionadas responderam a um question&aacute;rio    aplicado
 por enfermeiros treinados e tiveram a press&atilde;o arterial, o peso,    a est
atura, e a circunfer&ecirc;ncia do abdome e do quadril medidos duas vezes.    A 
maioria das entrevistas (70,9%) foi realizada nos fins de semana (42,7% nos    s
&aacute;bados e 28,2% nos domingos), sendo 29,1% distribu&iacute;das igualmente 
   nos outros 5 dias da semana, devido ao fato de a popula&ccedil;&atilde;o amos
trada    possuir muitos trabalhadores. Essa pr&aacute;tica minimiza a interfer&e
circ;ncia    do entrevistador na sele&ccedil;&atilde;o da pessoa a ser entrevist
ada e a tend&ecirc;ncia    a selecionar mulheres, n&atilde;o pela maior disponib
ilidade da mulher no domic&iacute;lio,    mas sim devido ao fator humano (recusa
s, mudan&ccedil;as, casais sem filhos,    mulheres morando sem parceiros), que h
abitualmente n&atilde;o obedece ao princ&iacute;pio    estat&iacute;stico da ale
atoriedade. Entretanto, a coleta de sangue realizada    no domic&iacute;lio por 
um laborat&oacute;rio detentor de padr&atilde;o internacional    n&atilde;o foi 
marcada para os domingos e segundas-feiras para evitar a interfer&ecirc;ncia    
do excesso de alimenta&ccedil;&atilde;o na concentra&ccedil;&atilde;o dos consti
tuintes    sang&uuml;&iacute;neos. A integridade das entrevistas foi verificada 
por telefone    em uma amostra aleat&oacute;ria de 10%, n&atilde;o sendo observa
da discrep&acirc;ncia    em rela&ccedil;&atilde;o aos dados originais.</font></p
>     ^cY#a06v22n5.htm##
00316000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008100076002001300157#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#46#42#article#176#<p><font size="2" f
ace="Verdana"><b>Exames f&iacute;sicos</b></font></p>     ^cY#a06v22n5.htm##
01418000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704118300076002001301259#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#47#43#article#176#<p><font size="2" f
ace="Verdana">As medidas da press&atilde;o arterial foram feitas    com esfigmom
an&ocirc;metro de coluna de merc&uacute;rio, no meio e ao final    da aplica&cce
dil;&atilde;o do question&aacute;rio. A primeira e a quinta fases    de Korotkof
f foram utilizadas como indicadoras das press&otilde;es sist&oacute;lica    e di
ast&oacute;lica, respectivamente (22). A estatura foi medida com o indiv&iacute;
duo    sem sapatos, utilizando-se uma fita m&eacute;trica fixada &agrave; parede
 da    casa e um esquadro pl&aacute;stico. Determinou-se o peso com uma balan&cc
edil;a    port&aacute;til equipada com escala digital, estando o examinado com o
 m&iacute;nimo    de roupas. As circunfer&ecirc;ncias abdominal e do quadril for
am tomadas com    fita m&eacute;trica inextens&iacute;vel, sem apertar, em posi&
ccedil;&atilde;o    paralela &agrave; do solo. Todas as medidas citadas foram fe
itas duas vezes,    sendo a m&eacute;dia das duas utilizada na an&aacute;lise. O
 sangue foi processado    para a determina&ccedil;&atilde;o de glicose plasm&aac
ute;tica e do colesterol    total, colesterol LDL, colesterol HDL e triglic&eacu
te;rides s&eacute;ricos.</font></p>     ^cY#a06v22n5.htm##
00331000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009600076002001300172#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#48#44#article#176#<p><font size="2" f
ace="Verdana"><b>Crit&eacute;rios diagn&oacute;sticos</b></font></p>     ^cY#a06
v22n5.htm##
01414000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704117900076002001301255#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#49#45#article#176#<p><FONT SIZE="2" f
ace="Verdana">Para a press&atilde;o arterial, no caso de o entrevistado    n&ati
lde;o estar em uso de prescri&ccedil;&atilde;o anti-hipertensiva, as Diretrizes 
   Brasileiras de Hipertens&atilde;o Arterial foram utilizadas para a classifica
&ccedil;&atilde;o    de press&atilde;o arterial normal (23). Para a glicemia, no
 caso de o entrevistado    n&atilde;o estar em uso de prescri&ccedil;&atilde;o a
ntidiab&eacute;tica, foram    utilizados os crit&eacute;rios da <i>American Diab
etes Association</i> (24).    No caso do perfil lip&iacute;dico, a interpreta&cc
edil;&atilde;o dos resultados    das dosagens seguiu as Diretrizes Brasileiras s
obre Dislipidemias e a Diretriz    de Preven&ccedil;&atilde;o da Aterosclerose (
25). Na antropometria, os dados    de peso e estatura foram utilizados para o c&
aacute;lculo do &iacute;ndice de    massa corporal (IMC = peso em kg/altura em m
<SUP>2</SUP>) conforme os crit&eacute;rios    da OMS (26). A raz&atilde;o cintur
a/quadril (RCQ) foi estabelecida pela divis&atilde;o    do per&iacute;metro da c
intura pelo per&iacute;metro do quadril, tamb&eacute;m    com base nos crit&eacu
te;rios da OMS (27).</font></p>     ^cY#a06v22n5.htm##
00336000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010100076002001300177#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#50#46#article#176#<p><font size="2" f
ace="Verdana"><b>Vari&aacute;veis sociodemogr&aacute;ficas</b></font></p>     ^c
Y#a06v22n5.htm##
01358000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704112300076002001301199#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#51#47#article#176#<p><font size="2" f
ace="Verdana">As &aacute;reas homog&ecirc;neas foram escolhidas    a partir daqu
elas apresentadas no mapa da inclus&atilde;o/exclus&atilde;o social    da Cidade
 de S&atilde;o Paulo com base em crit&eacute;rios estabelecidos por    Sposati (
19) e nos seguintes indicadores: autonomia (renda do chefe de fam&iacute;lia,   
 emprego e indig&ecirc;ncia); qualidade de vida (qualidade ambiental, qualidade 
   dos domic&iacute;lios, propriedade dos domic&iacute;lios, investimento imobil
i&aacute;rio    e oferta de servi&ccedil;os b&aacute;sicos); desenvolvimento hum
ano (escolaridade    do chefe da fam&iacute;lia, educa&ccedil;&atilde;o infantil
, concentra&ccedil;&atilde;o    de renda, mortalidade e viol&ecirc;ncia) e eq&uu
ml;idade (trabalho feminino).    Quanto ao h&aacute;bito de fumar, foram classif
icados como tabagistas os que    declararam fumar diariamente, n&atilde;o import
ando a quantidade. O consumo    de &aacute;lcool foi quantificado em gramas por 
dia, de acordo com o consumo    relatado pelo indiv&iacute;duo no question&aacut
e;rio de freq&uuml;&ecirc;ncia    alimentar.</font></p>     ^cY#a06v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008600076002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#52#48#article#176#<p><font size="2" f
ace="Verdana"><b>H&aacute;bitos alimentares</b></font></p>     ^cY#a06v22n5.htm#
#
00631000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039600076002001300472#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#53#49#article#176#<p><font size="2" f
ace="Verdana">O inqu&eacute;rito alimentar foi realizado com    782 entrevistado
s utilizando um question&aacute;rio de freq&uuml;&ecirc;ncia    alimentar semiqu
antitativo, contendo 74 alimentos. Foram utilizadas as informa&ccedil;&otilde;es
    referentes &agrave; freq&uuml;&ecirc;ncia m&eacute;dia usual de consumo de c
ada    alimento no &uacute;ltimo ano.</font></p>     ^cY#a06v22n5.htm##
01077000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704084200076002001300918#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#54#50#article#176#<p><font size="2" f
ace="Verdana">O question&aacute;rio utilizado havia sido previamente    validado
 (28, 29) e adaptado para uso em estudos de interven&ccedil;&atilde;o    ou prog
ramas de preven&ccedil;&atilde;o de doen&ccedil;as cr&ocirc;nicas. Nessa    vali
da&ccedil;&atilde;o, os alimentos foram selecionados de forma a abranger    as p
rincipais fontes alimentares de alguns nutrientes, de acordo com a estimativa   
 de consumo para o grupo de indiv&iacute;duos estudado (obtida por meio de inqu&
eacute;rito    recordat&oacute;rio de 24 horas). Os 74 itens alimentares do ques
tion&aacute;rio    foram agrupados em 29 categorias, de acordo com a semelhan&cc
edil;a de conte&uacute;do    nutritivo ou a composi&ccedil;&atilde;o bot&acirc;n
ica, de modo a evitar algum    tipo de vi&eacute;s (<a href="#tab01">tabela 1</a
>).</font></p>     ^cY#a06v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#55#51#article#176#<p><a name="tab01">
</a></p>     ^cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#56#52#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#57#53#article#176#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a06tab01.gif"></p>     ^cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#58#54#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
01712000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704147700076002001301553#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#59#55#article#176#<p><font size="2" f
ace="Verdana">As freq&uuml;&ecirc;ncias de consumo dos alimentos    ou grupo de 
alimentos foram resumidas em um &uacute;nico valor para cada indiv&iacute;duo.  
  Para tanto, os alimentos foram inicialmente agrupados e codificados de acordo 
   com as freq&uuml;&ecirc;ncias individuais de consumo: nunca consumido = 0; de
    1 a 8 vezes ao ano = 1; de 1 a 4 vezes ao m&ecirc;s = 2; de 1 a 4 vezes na s
emana    = 3; de 5 a 7 vezes na semana e de 1 a 2 vezes ao dia = 4; 3 vezes ao d
ia ou    mais = 5. A seguir, foram somadas as freq&uuml;&ecirc;ncias codificadas
 correspondentes    aos alimentos efetivamente consumidos pelo indiv&iacute;duo 
em cada grupo alimentar,    o que constituiu o numerador da medida-resumo. O den
ominador correspondeu ao    n&uacute;mero m&aacute;ximo de alimentos que o indiv
&iacute;duo poderia consumir    em cada grupo de alimentos multiplicado por 5. P
or exemplo, para um determinado    indiv&iacute;duo, a somat&oacute;ria das freq
&uuml;&ecirc;ncias codificadas    para o grupo do arroz, outros cereais e ra&iac
ute;zes foi 20. Nesse grupo de    alimentos, o consumo m&aacute;ximo seria de 50
 (como mostra a <a href="#tab01">tabela    1</a>, o grupo cont&eacute;m 10 alime
ntos, n&uacute;mero que foi multiplicado    por 5). Desse modo, o escore de cons
umo de cereais para o indiv&iacute;duo em    quest&atilde;o foi 20/50 = 0,4. For
am obtidas medidas-resumo para cada indiv&iacute;duo    integrante da amostra.</
font></p>     ^cY#a06v22n5.htm##
00355000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704012000076002001300196#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#60#56#article#176#<p><font size="2" f
ace="Verdana"><b>Identifica&ccedil;&atilde;o de padr&otilde;es    alimentares</b
></font></p>     ^cY#a06v22n5.htm##
01154000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704091900076002001300995#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#61#57#article#176#<p><font size="2" f
ace="Verdana">Para identificar os padr&otilde;es alimentares,    utilizou-se a a
n&aacute;lise fatorial por componentes principais, visando a    obter padr&otild
e;es a partir das medidas-resumo derivadas do question&aacute;rio    de freq&uum
l;&ecirc;ncia alimentar. Essa t&eacute;cnica tem por objetivo transformar    uma
 s&eacute;rie de vari&aacute;veis correlacionadas em um conjunto menor de    var
i&aacute;veis n&atilde;o correlacionadas, que s&atilde;o os componentes principa
is,    reduzindo a dimensionalidade dos dados e permitindo a identifica&ccedil;&
atilde;o    de novas vari&aacute;veis subjacentes significativas. Nessa an&aacut
e;lise,    ao inv&eacute;s de se arbitrar um indicador da dieta, os dados mostra
m objetivamente    como os alimentos se agrupam. Alguns crit&eacute;rios devem s
er estabelecidos    para a aplica&ccedil;&atilde;o de tal an&aacute;lise:</font>
</p> <ul>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#62#58#article#176#<li>          ^cY#a
06v22n5.htm##
00578000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704034300076002001300419#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#63#59#article#176#<p><font size="2" f
ace="Verdana">a rela&ccedil;&atilde;o casos/n&uacute;mero        de vari&aacute;
veis deve ser igual ou maior do que 5 para 1. O presente        estudo enfocou 3
0 vari&aacute;veis, sendo a rela&ccedil;&atilde;o casos/        vari&aacute;veis
 igual a 26,1 (782 participantes/30 vari&aacute;veis).</font></p>   </li>       
^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#64#60#article#176#<li>          ^cY#a
06v22n5.htm##
00546000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704031100076002001300387#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#65#61#article#176#<p><font size="2" f
ace="Verdana">A matriz da correla&ccedil;&atilde;o de vari&aacute;veis        de
ve conter duas ou mais correla&ccedil;&otilde;es maiores ou iguais a 0,30.      
  Neste estudo obtiveram-se 26 vari&aacute;veis com correla&ccedil;&atilde;o    
    maior do que 0,30.</font></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#66#62#article#176#<li>          ^cY#a
06v22n5.htm##
00472000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704023700076002001300313#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#67#63#article#176#<p><font size="2" f
ace="Verdana">A matriz de correla&ccedil;&atilde;o anti-imagem        obtida par
a cada grupo de alimentos ou alimento apresentou valores maiores        do que 0
,50, considerados adequados.</font></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#68#64#article#176#<li>          ^cY#a
06v22n5.htm##
00681000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704044600076002001300522#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#69#65#article#176#<p><font size="2" f
ace="Verdana">Os testes de Kaiser-Meyer-Olkin (KMO) e Bartlett        (<i>Bartle
tt’s test of sphericity</i>, BTS), que indicam a adequa&ccedil;&atilde;o        
dos dados &agrave; an&aacute;lise fatorial (30), estabelecem como adequados     
   valores pr&oacute;ximos a 1,0 para o KMO e <i>P</i> &lt; 0,001 para o BTS.   
     Neste estudo, o valor do KMO foi de 0,84, e do BTS, <i>P</i> &lt; 0,001.</f
ont></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#70#66#article#176#<li>          ^cY#a
06v22n5.htm##
00414000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704017900076002001300255#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#71#67#article#176#<p><font size="2" f
ace="Verdana">O n&uacute;mero de fatores a serem extra&iacute;dos        na an&a
acute;lise foi definido pelo teste de Lebart (30).</font></p>   </li>       ^cY#
a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#72#68#article#176#<li>          ^cY#a
06v22n5.htm##
01003000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704076800076002001300844#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#73#69#article#176#<p><font size="2" f
ace="Verdana">A matriz dos componentes foi rotacionada        empregando-se rota
&ccedil;&atilde;o denominada varimax para melhor interpreta&ccedil;&atilde;o    
    dos fatores (31). Os valores variam de –1 a +1, pois se tratam de correla&cc
edil;&otilde;es.        Os valores inferiores a 0,200 foram eliminados, pois n&a
tilde;o contribu&iacute;am        significativamente para o modelo. Quanto maior
 a correla&ccedil;&atilde;o        dos componentes, maior a contribui&ccedil;&at
ilde;o do alimento para o fator.        Foram definidos quatro fatores, que repr
esentaram 35,6% da vari&acirc;ncia        total. Cada indiv&iacute;duo do estudo
 recebeu um escore fatorial para cada        um dos quatro fatores identificados
.</font></p>   </li>     ^cY#a06v22n5.htm##
00249000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001400076002001300090#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#74#70#article#176#</ul>     ^cY#a06v2
2n5.htm##
00323000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008800076002001300164#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#75#71#article#176#<p><font size="2" f
ace="Verdana"><b>Vari&aacute;veis de controle</b></font></p>     ^cY#a06v22n5.ht
m##
00969000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704073400076002001300810#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#76#72#article#176#<p><font size="2" f
ace="Verdana">As vari&aacute;veis sociodemogr&aacute;ficas    foram sexo (mascul
ino ou feminino), idade (15 a 29, 30 a 39, 40 a 49, e 50 a    59 anos), &aacute;
rea socioambiental homog&ecirc;nea (homogeneidade alta, m&eacute;dia,    baixa e
 muito baixa), estado civil (casado, vi&uacute;vo, separado/divorciado),    n&ua
cute;mero de pessoas na fam&iacute;lia (1 a 3, 4 a 7, 8 ou mais), escolaridade  
  (nenhuma, fundamental incompleta e completa, superior incompleta e completa), 
   renda em reais (at&eacute; R$ 500,00; R$ 501,00 a 1 000,00; R$ 1 001,00 a 2  
  000,00; superior a R$ 2 000,00) e ocupa&ccedil;&atilde;o (assalariado, profiss
ional    liberal, empregador, aut&ocirc;nomo e outros).</font></p>     ^cY#a06v2
2n5.htm##
01479000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704124400076002001301320#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#77#73#article#176#<p><font size="2" f
ace="Verdana">Quanto aos h&aacute;bitos comportamentais, foram    investigados o
 tabagismo (nunca fumou, n&atilde;o fuma, fuma) e o consumo de    &aacute;lcool 
(consome ou n&atilde;o consome). O estado nutricional foi determinado    pelo IM
C (baixo peso: <u>&lt;</u> 18,4; normal: entre 18,5 e 24,9; sobrepeso:    entre 
25,0 e 29,9; obesidade: <u>&gt;</u> 30) e RCQ (&gt; 102 cm para os homens    e &
gt; 88 cm para as mulheres). Investigou-se a presen&ccedil;a de hipertens&atilde
;o,    definida como press&atilde;o arterial sist&oacute;lica (PAS) <u>&gt;</u> 
130    mmHg e diast&oacute;lica (PAD) <u>&gt;</u> 85 mmHg. O colesterol total fo
i considerado    elevado para um valor s&eacute;rico <u>&gt;</u> 200 mg/ dL. A l
ipoprote&iacute;na    de baixa densidade (LDL) foi considerada elevada para valo
res <u>&gt;</u> 100    mg/dL. O HDL foi considerado diminu&iacute;do para valore
s &lt; 40 mg/ dL. Os    triglic&eacute;rides foram considerados elevados para va
lores <u>&gt;</u> 150    mg/dL. Foi considerada como alterada a glicose plasm&aa
cute;tica <u>&gt;</u>    99 mg/dL. Finalmente, foram investigados os antecedente
s familiares para hipertens&atilde;o,    doen&ccedil;a coronariana e diabetes me
lito.</font></p>     ^cY#a06v22n5.htm##
00328000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009300076002001300169#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#78#74#article#176#<p><font size="2" f
ace="Verdana"><b>An&aacute;lise estat&iacute;stica</b></font></p>     ^cY#a06v22
n5.htm##
01355000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704112000076002001301196#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#79#75#article#176#<p><font size="2" f
ace="Verdana">Utilizou-se o <i>Statistical Package for the    Social Sciences</i
> (SPSS) 10.0 para a constru&ccedil;&atilde;o do banco de    dados e as seguinte
s an&aacute;lises: 1) descritiva, a partir dos dados sociodemogr&aacute;ficos,  
  comportamentais e biol&oacute;gicos; 2) fatorial por componentes principais,  
  utilizando as medidas-resumo derivadas do question&aacute;rio de freq&uuml;&ec
irc;ncia    alimentar; 3) covari&acirc;ncia do c&aacute;lculo das m&eacute;dias,
 ajustadas    por sexo e idade, e dos escores fatoriais, derivados dos padr&otil
de;es alimentares    segundo vari&aacute;veis sociodemogr&aacute;ficas e comport
amentais. Os escores    fatoriais e a idade foram modelados como vari&aacute;vei
s cont&iacute;nuas;    4) regress&atilde;o linear m&uacute;ltipla para avaliar a
 associa&ccedil;&atilde;o    entre os escores fatoriais (combina&ccedil;&otilde;
es lineares dos padr&otilde;es    alimentares, atribu&iacute;dos a cada observa&
ccedil;&atilde;o) e os fatores    biol&oacute;gicos, considerando tr&ecirc;s mod
elagens, com os seguintes ajustes:</font></p> <ul>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#80#76#article#176#<li>          ^cY#a
06v22n5.htm##
00383000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704014800076002001300224#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#81#77#article#176#<p><font size="2" f
ace="Verdana">modelagem sociodemogr&aacute;fica: sexo,        idade, &aacute;rea
s homog&ecirc;neas;</font></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#82#78#article#176#<li>          ^cY#a
06v22n5.htm##
00459000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704022400076002001300300#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#83#79#article#176#<p><font size="2" f
ace="Verdana">modelagem multivariada: escolaridade, h&aacute;bito        de fuma
r, consumo de &aacute;lcool (g/dia), hist&oacute;ria de doen&ccedil;a        na 
fam&iacute;lia;</font></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#84#80#article#176#<li>          ^cY#a
06v22n5.htm##
00337000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010200076002001300178#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#85#81#article#176#<p><font size="2" f
ace="Verdana">modelagem multivariada mais o IMC ou RCQ.</font></p>   </li>     ^
cY#a06v22n5.htm##
00249000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001400076002001300090#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#86#82#article#176#</ul>     ^cY#a06v2
2n5.htm##
00692000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704045700076002001300533#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#87#83#article#176#<p><font size="2" f
ace="Verdana">O n&iacute;vel de signific&acirc;ncia adotado    foi 5%, sendo que
 todos os valores de <i>P</i> foram bicaudais. As vari&aacute;veis    qualitativ
as, como sexo, h&aacute;bito de fumar, &aacute;reas homog&ecirc;neas    e parent
e na fam&iacute;lia com hipertens&atilde;o ou com diabetes, foram transformadas 
   em vari&aacute;veis indicadoras, recebendo os valores 0 ou 1 para identificar
    as categorias.</font></p>     ^cY#a06v22n5.htm##
00633000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039800076002001300474#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#88#84#article#176#<p><font size="2" f
ace="Verdana">O estudo foi aprovado pelos Comit&ecirc;s de    &Eacute;tica em Pe
squisa da Universidade Federal de S&atilde;o Paulo (UNIFESP)    e da Faculdade d
e Sa&uacute;de P&uacute;blica da Universidade de S&atilde;o    Paulo (USP). Os d
ados foram coletados, ap&oacute;s consentimento livre e esclarecido    dos entre
vistados, entre os anos de 2001 e 2002.</font></p>     ^cY#a06v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#89#85#article#176#<p>&nbsp;</p>     ^
cY#a06v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#90#86#article#176#<p><font size="3" f
ace="Verdana"><b>RESULTADOS</b></font></p>     ^cY#a06v22n5.htm##
01465000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704123000076002001301306#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#91#87#article#176#<p><font size="2" f
ace="Verdana">A amostra foi composta por 54,3% de pessoas do    sexo feminino e 
45,7% do sexo masculino. Quanto &agrave; idade, 28,6% tinham    entre 15 e 29 an
os; 27,6% tinham entre 30 e 39 anos; 25,4% tinham entre 40 e    49 anos; e 18,3%
, entre 50 e 59 anos. Quanto ao n&iacute;vel de escolaridade,    predominou o n&
iacute;vel fundamental (46,0%); 32,4% apresentavam n&iacute;vel    m&eacute;dio 
e 18,0%, n&iacute;vel superior. A renda familiar foi de at&eacute;    R$ 500,00 
para 27,4%; entre R$ 500,00 e 1 000,00 para 19,8%; R$ 2 000,00 para    27,6%; e 
acima de R$ 2 000,00 para 25,2%. Os casados perfaziam 55,9%, enquanto    30,5% e
ram solteiros, 9,8% separados e 4,5% vi&uacute;vos. Em 44,7% dos domic&iacute;li
os    visitados, havia at&eacute; tr&ecirc;s pessoas na fam&iacute;lia, e em 52,
7%,    de 4 a 7 pessoas. Quanto &agrave; distribui&ccedil;&atilde;o por &aacute;
reas    socioambientais homog&ecirc;neas, o maior n&uacute;mero de pessoas (35,3
%) estava    concentrado em uma &aacute;rea definida como de homogeneidade m&eac
ute;dia.    Quanto &agrave;s &aacute;reas de homogeneidade baixa e muito baixa, 
o percentual    em cada uma delas foi de 24,5 e 24,7%, respectivamente.</font></
p>     ^cY#a06v22n5.htm##
01352000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704111700076002001301193#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#92#88#article#176#<p><font size="2" f
ace="Verdana">Quanto &agrave;s caracter&iacute;sticas gerais    da amostra estud
ada (estilo de vida, estado nutricional e presen&ccedil;a de    doen&ccedil;as),
 verificou-se que 71,5% nunca fumaram ou n&atilde;o fumavam    mais e 28,5% decl
araram ter h&aacute;bito de fumar. Quanto ao consumo de bebidas    alco&oacute;l
icas, 45,5% declararam n&atilde;o consumilas. O percentual de excesso    de peso
 dos indiv&iacute;duos foi de 48,5%. Baixo peso foi observado em 2,8%,    enquan
to 43,1% apresentaram RCQ acima dos par&acirc;metros desej&aacute;veis.    N&iac
ute;veis press&oacute;ricos normais foram observados em 58,6% dos indiv&iacute;d
uos,    enquanto que 41,4% apresentaram n&iacute;veis alterados. Quanto aos n&ia
cute;veis    de colesterol e fra&ccedil;&otilde;es, 35,5 e 34,5% apresentaram, r
espectivamente,    colesterol total e LDL acima dos n&iacute;veis normais, e 43,
4% apresentaram    HDL abaixo dos par&acirc;metros considerados adequados; 26,6%
 tiveram triglic&eacute;rides    <u>&gt;</u> 150 mg/dL e 25,0% apresentaram glic
emia de jejum <u>&gt;</u> 99    mg/dL.</font></p>     ^cY#a06v22n5.htm##
00595000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704036000076002001300436#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#93#89#article#176#<p><font size="2" f
ace="Verdana">Na an&aacute;lise fatorial, foram identificados    quatro padr&oti
lde;es alimentares, sendo que os alimentos ou grupo que contribu&iacute;ram    p
ara a sua composi&ccedil;&atilde;o, por obter valores superiores a 0,220, est&at
ilde;o    representados na <a href="#tab02">tabela 2</a>. S&atilde;o eles:</font
></p> <ul>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#94#90#article#176#<li>          ^cY#a
06v22n5.htm##
00531000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704029600076002001300372#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#95#91#article#176#<p><font size="2" f
ace="Verdana">Padr&atilde;o 1 (cafeteria): leite integral,        p&atilde;es, m
assas, salgados, doces, gorduras, presunto, sucos artificiais,        refrigeran
te comum e, em menor propor&ccedil;&atilde;o, feijoada, sucos        naturais e 
frango.</font></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#96#92#article#176#<li>          ^cY#a
06v22n5.htm##
00521000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704028600076002001300362#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#97#93#article#176#<p><font size="2" f
ace="Verdana">Padr&atilde;o 2 (tradicional): cereais, feij&otilde;es,        fol
hosos, n&atilde;o folhosos e sopas, maionese, infus&atilde;o (caf&eacute;,      
  ch&aacute;) e, em menor propor&ccedil;&atilde;o, gorduras, frutas e frango.</f
ont></p>   </li>       ^cY#a06v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#98#94#article#176#<li>          ^cY#a
06v22n5.htm##
00521000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704028600076002001300362#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#99#95#article#176#<p><font size="2" f
ace="Verdana">Padr&atilde;o 3 (moderno): leite desnatado,        frutas, sucos n
aturais, peixes, refrigerante diet, ado&ccedil;antes artificiais        e, em me
nor propor&ccedil;&atilde;o, p&atilde;es, n&atilde;o folhosos e        sopas.</f
ont></p>   </li>       ^cY#a06v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704001800077002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#100#96#article#176#<li>          ^cY#
a06v22n5.htm##
00461000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704022500077002001300302#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#101#97#article#176#<p><font size="2" 
face="Verdana">Padr&atilde;o 4 (aterog&ecirc;nico): feijoada,        carne de bo
i e mi&uacute;dos, porco, frango, ling&uuml;i&ccedil;a, ovo,        bebidas alco
&oacute;licas, sal.</font></p>   </li>     ^cY#a06v22n5.htm##
00250000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704001400077002001300091#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#102#98#article#176#</ul>     ^cY#a06v
22n5.htm##
00272000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704003600077002001300113#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#103#99#article#176#<p><a name="tab02"
></a></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#104#100#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#105#101#article#176#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a06tab02.gif"></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#106#102#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00379000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704014200078002001300220#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#107#103#article#176#<p><font size="2"
 face="Verdana"><b>Padr&otilde;es alimentares e fatores sociodemogr&aacute;ficos
    e comportamentais</b></font></p>     ^cY#a06v22n5.htm##
01777000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704154000078002001301618#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#108#104#article#176#<p><font size="2"
 face="Verdana">As m&eacute;dias dos escores fatoriais para os    quatro padr&ot
ilde;es alimentares, segundo vari&aacute;veis sociodemogr&aacute;ficas    e comp
ortamentais, s&atilde;o apresentadas na <a href="#tab03">tabela 3</a>.    Verifi
cou-se que o padr&atilde;o 1 predominou na &aacute;rea de homog&ecirc;nea    de 
n&iacute;vel m&eacute;dio, estando associado com escolaridade m&eacute;dia    e 
superior e com o consumo de &aacute;lcool. O padr&atilde;o 2 predominou entre   
 as mulheres e entre pessoas com idade superior a 50 anos; relacionou-se com    
o consumo de &aacute;lcool, com renda mais alta e com o n&iacute;vel m&eacute;di
o.    O padr&atilde;o 3 predominou entre os indiv&iacute;duos da &aacute;rea hom
og&ecirc;nea    de n&iacute;vel alto, com n&iacute;vel de renda familiar acima d
e R$ 2 000,00,    escolaridade superior e ocupa&ccedil;&atilde;o na categoria de
 empregador. O    padr&atilde;o 4 predominou entre os homens; associou-se com es
colaridade fundamental,    tabagismo, consumo de &aacute;lcool e com as &aacute;
reas de homogeneidade m&eacute;dia    e baixa. Observaram-se escores de consumo 
alimentar significativamente mais    baixos para todos os padr&otilde;es aliment
ares nas &aacute;reas homog&ecirc;neas    de n&iacute;vel baixo e muito baixo qu
ando comparadas com as de n&iacute;vel    m&eacute;dio e alto—ou seja, a freq&uu
ml;&ecirc;ncia de consumo alimentar das    pessoas residentes nas &aacute;reas c
itadas &eacute; muito baixo (<a href="#tab03">tabela    3</a>).</font></p>     ^
cY#a06v22n5.htm##
00273000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704003600078002001300114#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#109#105#article#176#<p><a name="tab03
"></a></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#110#106#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#111#107#article#176#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a06tab03.gif"></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#112#108#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00382000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704014500078002001300223#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#113#109#article#176#<p><font size="2"
 face="Verdana"><b>Padr&otilde;es alimentares e fatores de risco    para doen&cc
edil;as cardiovasculares</b></font></p>     ^cY#a06v22n5.htm##
01173000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704093600078002001301014#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#114#110#article#176#<p><font size="2"
 face="Verdana">A associa&ccedil;&atilde;o entre os padr&otilde;es    alimentare
s e os fatores de risco biol&oacute;gicos controlados por sexo, idade,    &aacut
e;reas homog&ecirc;neas, escolaridade, h&aacute;bito de fumar, consumo    de &aa
cute;lcool, hist&oacute;ria familiar de hipertens&atilde;o e diabetes    &eacute
; apresentada na <a href="#tab04">tabela 4</a>. O padr&atilde;o 1 associou-se,  
  nas tr&ecirc;s modelagens propostas e no modelo sem ajuste, positiva e signifi
cativamente    com a press&atilde;o sist&oacute;lica e diast&oacute;lica, o IMC 
e a RCQ; e    negativa e significativamente com o HDL e a glicemia (apenas quand
o ajustado    por sexo, idade e local de moradia). O padr&atilde;o 2 associou-se
 positiva    e significativamente com a glicemia e o IMC, e negativa e significa
tivamente    com os triglic&eacute;rides e a RCQ, em todas as modelagens e no mo
delo sem    ajuste.</font></p>     ^cY#a06v22n5.htm##
00273000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704003600078002001300114#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#115#111#article#176#<p><a name="tab04
"></a></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#116#112#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#117#113#article#176#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a06tab04.gif"></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#118#114#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00930000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704069300078002001300771#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#119#115#article#176#<p><font size="2"
 face="Verdana">O padr&atilde;o 3 associou-se negativa e significativamente,    
em todas as modelagens e no modelo sem ajuste, com a press&atilde;o diast&oacute
;lica,    o colesterol total, a glicemia e o LDL. Com a press&atilde;o sist&oacu
te;lica    a rela&ccedil;&atilde;o foi significativa e inversa em todas os model
os, exceto    no modelo sem ajuste. Com o IMC, a rela&ccedil;&atilde;o foi inver
sa e significativa    no modelo multivariado + RCQ. Por fim, o padr&atilde;o 4 a
ssociou-se significativamente,    de modo positivo, com o colesterol total, os t
riglic&eacute;rides, a glicemia,    o IMC e a RCQ em todas as modelagens e no mo
delo sem ajuste.</font></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#120#116#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00313000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007600078002001300154#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#121#117#article#176#<p><font size="3"
 face="Verdana"><b>DISCUSS&Atilde;O</b></font></p>     ^cY#a06v22n5.htm##
00864000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704062700078002001300705#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#122#118#article#176#<p><font size="2"
 face="Verdana">Falar de h&aacute;bitos alimentares num pa&iacute;s    como o Br
asil &eacute;, obviamente, uma tarefa complexa, n&atilde;o s&oacute;    pelas pr
ofundas diferen&ccedil;as existentes entre as diversas regi&otilde;es,    mas, t
amb&eacute;m, em raz&atilde;o de nossas origens. A Cidade de S&atilde;o    Paulo
 &eacute; o principal p&oacute;lo gastron&ocirc;mico do Brasil e oferece    aces
so a uma enorme variedade de ingredientes ou alimentos j&aacute; preparados,    
desde os mais refinados e ex&oacute;ticos &agrave;s mais simples prepara&ccedil;
&otilde;es    de rua (32, 33).</font></p>     ^cY#a06v22n5.htm##
00882000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704064500078002001300723#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#123#119#article#176#<p><font size="2"
 face="Verdana">V&aacute;rios fatores t&ecirc;m modificado o    ambiente social 
onde se consomem os alimentos. O desenvolvimento de novos sistemas    de vida na
s zonas urbanas, a incorpora&ccedil;&atilde;o da mulher &agrave; for&ccedil;a   
 de trabalho, as dist&acirc;ncias entre a casa e o trabalho, a relativa facilida
de    para a aquisi&ccedil;&atilde;o de alimentos processados, o efeito da m&iac
ute;dia    sobre a alimenta&ccedil;&atilde;o, com a populariza&ccedil;&atilde;o 
das informa&ccedil;&otilde;es,    foram determinantes conjunturais da oferta, do
 consumo e disponibilidade de    alimentos (34).</font></p>     ^cY#a06v22n5.htm
##
01057000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704082000078002001300898#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#124#120#article#176#<p><font size="2"
 face="Verdana">Tem-se verificado que o paulistano, quando est&aacute;    no tra
balho, dispensa pouco tempo ao almo&ccedil;o, que &eacute; feito fora    de casa
 (32). Em nosso estudo, o padr&atilde;o 1 (cafeteria), formado principalmente   
 por salgados, pastelaria, massas, produtos l&aacute;cteos e p&atilde;es, que   
 predominou entre aqueles com escolaridade m&eacute;dia e superior e que residem
    em locais com boas condi&ccedil;&otilde;es socioambientais, coincide com o t
ipo    de alimento que &eacute; amplamente oferecido em bares e lanchonetes, ond
e grande    parte dos trabalhadores realizam refei&ccedil;&otilde;es r&aacute;pi
das, que    muitas vezes constituem o seu almo&ccedil;o. As cadeias de <i>fast-f
ood</i>    j&aacute; foram incorporadas ao dia-a-dia da cidade.</font></p>     ^
cY#a06v22n5.htm##
01383000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704114600078002001301224#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#125#121#article#176#<p><font size="2"
 face="Verdana">O padr&atilde;o alimentar 4 (aterog&ecirc;nico),    constitu&iac
ute;do por carnes bovinas e su&iacute;nas, feijoada, embutidos,    ovos e bebida
s alco&oacute;licas, cujo consumo predominou entre os homens com    escolaridade
 fundamental completa/incompleta, tabagistas, consumidores de bebidas    alco&oa
cute;licas e residentes em &aacute;reas de homogeneidade m&eacute;dia    e baixa
, est&aacute; muito presente nos restaurantes do tipo <i>self-service</i>    por
 quilo, disseminados nos &uacute;ltimos anos e encontrados em todos os bairros. 
   Esses s&atilde;o escolhidos por pessoas que desejam fazer uma refei&ccedil;&a
tilde;o    r&aacute;pida e mais barata do que oferecem os restaurantes tradicion
ais. Outro    h&aacute;bito que se incorporou ao estilo de vida paulistano s&ati
lde;o as refei&ccedil;&otilde;es    em pra&ccedil;as de alimenta&ccedil;&atilde;
o ou restaurantes de <i>shopping    centers</i>. No ambiente familiar, a telentr
ega de alimentos substituiu o preparo    do almo&ccedil;o ou do jantar, sendo co
mum a solicita&ccedil;&atilde;o de pizzas    para comer em casa (32).</font></p>
     ^cY#a06v22n5.htm##
00998000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704076100078002001300839#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#126#122#article#176#<p><font size="2"
 face="Verdana">A identidade gastron&ocirc;mica paulistana, no    entanto, ainda
 resiste na mesa caseira. A cozinha trivial e familiar paulistana    inclui o ar
roz e o feij&atilde;o carioquinha (caldo marrom), a mistura, que    pode ser con
ter carne (bife, carne assada, mo&iacute;da, frango, salsicha, ling&uuml;i&ccedi
l;a)    ou ovo, batata frita e, como salada, alface e tomate (32, 33). No presen
te estudo,    identificou-se uma padr&atilde;o chamado de tradicional justamente
 por ser constitu&iacute;do    pelos alimentos descritos por Philippi e Colucci 
(32), com predomin&acirc;ncia    entre mulheres na faixa et&aacute;ria acima de 
40 anos pertencentes &agrave;s    &aacute;reas homog&ecirc;neas m&eacute;dia e a
lta.</font></p>     ^cY#a06v22n5.htm##
01088000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704085100078002001300929#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#127#123#article#176#<p><font size="2"
 face="Verdana">Verificou-se o predom&iacute;nio do padr&atilde;o    alimentar 3
 (moderno), apenas entre indiv&iacute;duos de n&iacute;vel superior,    empregad
ores e moradores da &aacute;rea homog&ecirc;nea alta. Segundo Mondini    e Monte
iro (35), uma hip&oacute;tese seria atribuir o decl&iacute;nio no consumo    de 
alimentos ricos em gorduras e a&ccedil;&uacute;cares simples a uma atitude    co
nsciente da popula&ccedil;&atilde;o das &aacute;reas mais desenvolvidas em    pr
ol de uma dieta mais saud&aacute;vel. A restri&ccedil;&atilde;o a frituras    e 
a redu&ccedil;&atilde;o no consumo de alimentos ricos em colesterol s&atilde;o  
  duas das mais freq&uuml;entes mensagens educativas que v&ecirc;m sendo divulga
das    por profissionais de sa&uacute;de e por meios de comunica&ccedil;&atilde;
o de    massa.</font></p>     ^cY#a06v22n5.htm##
01085000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704084800078002001300926#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#128#124#article#176#<p><font size="2"
 face="Verdana">Nota-se neste estudo que as &aacute;reas socioambientais    cate
gorizadas como de homogeneidade baixa (27,3% da popula&ccedil;&atilde;o,    comp
osta por 20 distritos) e muito baixa (10,8% da popula&ccedil;&atilde;o,    compo
sta por nove distritos) obtiveram os menores escores m&eacute;dios nos    padr&o
tilde;es de consumo. Tais &aacute;reas s&atilde;o compostas por grupos    sociai
s com menor possibilidade de escolha em raz&atilde;o da pobreza e da exclus&atil
de;o    social. Por outro lado, as duas &aacute;reas mais privilegiadas n&atilde
;o puderam    ser inclu&iacute;das no estudo, pois houve recusas sistem&aacute;t
icas por parte    dos entrevistados em participar do estudo piloto. A n&atilde;o
 inclus&atilde;o    dessas &aacute;reas &eacute; a maior limita&ccedil;&atilde;o
 do estudo.</font></p>     ^cY#a06v22n5.htm##
01405000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704116800078002001301246#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#129#125#article#176#<p><font size="2"
 face="Verdana">As associa&ccedil;&otilde;es observadas entre    os escores dos 
padr&otilde;es alimentares e os fatores de risco biol&oacute;gicos    foram, de 
forma geral, as esperadas. O conjunto dos resultados encontrados aponta    para 
tend&ecirc;ncias desfavor&aacute;veis do padr&atilde;o alimentar no Munic&iacute
;pio    de S&atilde;o Paulo, sobretudo do ponto de vista do aumento do peso corp
oral    e da altera&ccedil;&atilde;o do perfil lip&iacute;dico, principalmente q
uanto    aos padr&otilde;es 1 e 4, com alta densidade energ&eacute;tica, escasse
z de    fibras e micronutrientes, excesso de gorduras em geral e de gorduras sat
uradas    e alto &iacute;ndice glic&ecirc;mico (4). Sabe-se que o potencial de u
m alimento    ou de uma dieta para influenciar o aumento do colesterol total e L
DL est&aacute;    diretamente relacionado ao conte&uacute;do de colesterol e de 
gordura saturada    (4). Como era esperado, verificou-se que, quanto ao colester
ol total, os escores    fatoriais do padr&atilde;o 4, aterog&ecirc;nico, associa
ram-se positivamente,    e quanto ao padr&atilde;o 3, moderno, associaram-se neg
ativamente.</font></p>     ^cY#a06v22n5.htm##
00949000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704071200078002001300790#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#130#126#article#176#<p><font size="2"
 face="Verdana">O padr&atilde;o tradicional, embora apresente    uma variedade d
e alimentos considerados saud&aacute;veis, associou-se positivamente    com o au
mento dos indicadores da obesidade perif&eacute;rica (IMC) e da glicemia.    &Ea
cute; bem prov&aacute;vel que outros fatores relacionados aos h&aacute;bitos    
comportamentais, principalmente a inatividade f&iacute;sica, possam estar interf
erindo    na rela&ccedil;&atilde;o entre a alimenta&ccedil;&atilde;o, o peso cor
poral    e a glicemia. Este resultado enfatiza a import&acirc;ncia da ado&ccedil
;&atilde;o    de alimenta&ccedil;&atilde;o equilibrada, acompanhada de mudan&cce
dil;as no    estilo de vida (4, 7).</font></p>     ^cY#a06v22n5.htm##
01249000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704101200078002001301090#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#131#127#article#176#<p><font size="2"
 face="Verdana">Apenas o padr&atilde;o alimentar 3, caracterizado    por conter 
alimentos com baixos teores de gorduras e a&ccedil;&uacute;cares    simples, fru
tas e peixes, entre outros, mostrou estar em concord&acirc;ncia    com as atuais
 recomenda&ccedil;&otilde;es sobre alimenta&ccedil;&atilde;o saud&aacute;vel    
e preven&ccedil;&atilde;o de doen&ccedil;as (4, 7) e relacionou-se de forma    i
nversa com a press&atilde;o sist&oacute;lica e diast&oacute;lica, colesterol    
total, LDL e glicemia. Tais achados confirmam os resultados citados na literatur
a.    Por&eacute;m, tal padr&atilde;o alimentar est&aacute; restrito aos grupos 
com    n&iacute;vel de renda e educacional alto, residentes nas &aacute;reas soc
ioambientais    mais privilegiadas. Essa popula&ccedil;&atilde;o tem mais acesso
 &agrave; assist&ecirc;ncia    &agrave; sa&uacute;de por meio de uma medicina es
pecializada, muitas vezes inacess&iacute;vel    aos grupos de baixa renda e pouc
a escolaridade.</font></p>     ^cY#a06v22n5.htm##
01380000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704114300078002001301221#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#132#128#article#176#<p><font size="2"
 face="Verdana">V&aacute;rios estudos j&aacute; foram realizados    utilizando a
 an&aacute;lise fatorial para investigar a associa&ccedil;&atilde;o    dos padr&
otilde;es diet&eacute;ticos com fatores de risco comportamentais e    biol&oacut
e;gicos para doen&ccedil;as cardiovasculares (6, 11–14). Fung et al.    (12), ut
ilizando metodologia semelhante, identificaram, entre as enfermeiras    american
as, um padr&atilde;o de dieta chamado de "prudente" (grande    quantidade de fru
tas e vegetais, cereais integrais e aves) e outro chamado de    "ocidental" (con
sumo elevado de carnes vermelhas, produtos l&aacute;cteos    integrais e cereais
 refinados). Este &uacute;ltimo associou-se positivamente    com as DCV. No estu
do de van Dam et al. (14), os mais altos escores do padr&atilde;o    "cosmopolit
a" (consumo de grande quantidade de vegetais, saladas,    arroz, frango, peixe e
 vinho) estiveram significativamente associados com n&iacute;veis    press&oacut
e;ricos mais baixos e com concentra&ccedil;&otilde;es mais altas    de HDL, inde
pendentemente dos fatores relacionados ao estilo de vida e ao IMC.</font></p>   
  ^cY#a06v22n5.htm##
00876000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704063900078002001300717#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#133#129#article#176#<p><font size="2"
 face="Verdana">No estudo de Sichieri et al. (8), o IMC associou-se    positivam
ente ao padr&atilde;o alimentar "misto" (tub&eacute;rculos,    legumes, verduras
, frutas, p&atilde;es, bolos, macarr&atilde;o, biscoitos, a&ccedil;&uacute;car, 
   leite e derivados, frango, carnes). O padr&atilde;o de consumo "tradicional" 
   (arroz e outros cereais, feij&atilde;o, farinha de mandioca, a&ccedil;&uacute
;car,    macarr&atilde;o), que no Brasil &eacute;, em grande parte, determinado 
pelas    condi&ccedil;&otilde;es socioecon&ocirc;micas, mostrou-se como fator de
 prote&ccedil;&atilde;o    para sobrepeso.</font></p>     ^cY#a06v22n5.htm##
01250000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704101300078002001301091#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#134#130#article#176#<p><font size="2"
 face="Verdana">Kerver et al. (13) verificaram que o padr&atilde;o    alimentar 
denominado "ocidental" (consumo de grande quantidade de    carnes processadas, o
vos, carnes vermelhas e alto consumo de produtos l&aacute;cteos    integrais) as
sociou-se positivamente com n&iacute;veis s&eacute;ricos de insulina,    prote&i
acute;na-C, hemoglobina glicosilada e inversamente com concentra&ccedil;&otilde;
es    de folato em c&eacute;lulas vermelhas do sangue no modelo ajustado para as
 vari&aacute;veis    de confus&atilde;o. O padr&atilde;o chamado de "americano s
aud&aacute;vel"    (grande quantidade de vegetais verdes folhosos, molhos para s
alada, tomates    e outros vegetais, vegetais cruc&iacute;feros e ch&aacute;s) n
&atilde;o se correlacionou    com as vari&aacute;veis examinadas. Os autores con
clu&iacute;ram que a identifica&ccedil;&atilde;o    de padr&otilde;es de consumo
 alimentar mostrou-se adequada para caracterizar    grupos populacionais de alto
 risco para DCV.</font></p>     ^cY#a06v22n5.htm##
01144000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704090700078002001300985#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#135#131#article#176#<p><font size="2"
 face="Verdana">Em suma, o presente estudo identificou quatro    padr&otilde;es 
alimentares que est&atilde;o significativamente associados a    fatores sociodem
ogr&aacute;ficos, comportamentais e biol&oacute;gicos, mostrando    a necessidad
e de promover o acesso de um amplo contingente da popula&ccedil;&atilde;o    pau
listana aos servi&ccedil;os de sa&uacute;de e a programas de interven&ccedil;&at
ilde;o    cl&iacute;nico-educativos. A acessibilidade aos servi&ccedil;os de sa&
uacute;de    permite a apropria&ccedil;&atilde;o de conhecimentos fundamentais p
ara o controle    e a preven&ccedil;&atilde;o das morbidades e para embasar as m
udan&ccedil;as    necess&aacute;rias no estilo de vida. Outros fatores complexos
 envolvidos em    tais mudan&ccedil;as, muitos deles emocionais, tamb&eacute;m d
evem ser considerados    pelos programas de interven&ccedil;&atilde;o.</font></p
>     ^cY#a06v22n5.htm##
00800000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704056300078002001300641#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#136#132#article#176#<p><font size="2"
 face="Verdana"><b>Agradecimentos.</b> &Agrave; equipe t&eacute;cnica    da Divi
s&atilde;o de Doen&ccedil;as Cr&ocirc;nicas N&atilde;o-Transmiss&iacute;veis    
do Centro de Vigil&acirc;ncia Epidemiol&oacute;gica da Secretaria de Estado    d
a Sa&uacute;de de S&atilde;o Paulo (SP), Brasil. Este estudo foi parcialmente   
 financiado pela Funda&ccedil;&atilde;o de Amparo &agrave; Pesquisa do Estado   
 de S&atilde;o Paulo (Processo FAPESP 99/06187-60) e pela Secretaria de Estado  
  da Sa&uacute;de de S&atilde;o Paulo, Brasil.</font></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#137#133#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007700078002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#138#134#article#176#<p><font size="3"
 face="Verdana"><b>REFER&Ecirc;NCIAS</b></font></p>     ^cY#a06v22n5.htm##
00768000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704051700080002001300597#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#139#135#article#176#1#<p>
<font size="2" face="Verdana">1.  Organiza&ccedil;&atilde;o Pan-Americana    da 
Sa&uacute;de. Doen&ccedil;as cr&ocirc;nico-degenerativas e obesidade: estrat&eac
ute;gia    mundial sobre alimenta&ccedil;&atilde;o saud&aacute;vel, atividade f&
iacute;sica    e sa&uacute;de &#91;site na Internet&#93;. Dispon&iacute;vel em: 
<a href="http://www.opas.org.br/sistema/arquivos/d_cronic.pdf" target="_blank">h
ttp://www.opas.org.br/    sistema/arquivos/d_cronic.pdf</a>. Acessado em 10 de o
utubro de 2005.</font></p>    ^cY#a06v22n5.htm##
00659000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704040800080002001300488#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#140#136#article#176#2#<p>
<font size="2" face="Verdana">2.  Lotufo PA, Lolio CA. Tend&ecirc;ncias    de ev
olu&ccedil;&atilde;o da mortalidade por doen&ccedil;as cardiovasculares:    o ca
so do Estado de S&atilde;o Paulo. Em: Monteiro CA, ed. Velhos e novos males    d
a sa&uacute;de no Brasil. A evolu&ccedil;&atilde;o do pa&iacute;s e de suas    d
oen&ccedil;as. 2ª ed. S&atilde;o Paulo: Hucitec; 2000. Pp. 279–87.</font></p>   
 ^cY#a06v22n5.htm##
00618000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704036700080002001300447#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#141#137#article#176#3#<p>
<font size="2" face="Verdana">3.  Prefeitura da Cidade de S&atilde;o Paulo.    S
a&uacute;de &#91;site na Internet&#93;. Dispon&iacute;vel em: <a href="http://po
rtal.prefeitura.sp.gov.br/secretarias/saude/mortalidade/0001" target="_blank">ht
tp://portal.prefeitura.sp.gov.br/    secretarias/saude/mortalidade/0001</a>. Ace
ssado em outubro de 2007.</font></p>    ^cY#a06v22n5.htm##
00442000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704019100080002001300271#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#142#138#article#176#4#<p>
<font size="2" face="Verdana">4.  World Health Organization. Diet, nutrition    
and prevention of chronic diseases. Geneva: WHO; 2003. (Technical Report Series,
    916).</font></p>    ^cY#a06v22n5.htm##
00432000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704018100080002001300261#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#143#139#article#176#5#<p>
<font size="2" face="Verdana">5.  Willett WC. Nutritional epidemiology issues   
 in chronic disease at the turn of the century. Epidemiol Rev. 2000;22(1):82–6.<
/font></p>    ^cY#a06v22n5.htm##
00583000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704033200080002001300412#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#144#140#article#176#6#<p>
<font size="2" face="Verdana">6.  Bazzano LA, He J, Ogden LG, Loria CM,    Vuppu
turi S, Myers L, et al. Fruit and vegetable intake and risk of cardiovascular   
 disease in US adults: the first National Health and Nutrition Examination Surve
y    Epidemiologic Follow-up Study. Am J Clin Nutr. 2002;76(1): 93–9. </font></p
>    ^cY#a06v22n5.htm##
00613000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704036200080002001300442#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#145#141#article#176#7#<p>
<font size="2" face="Verdana">7.  Barreto SM, Pinheiro ARO, Sichieri R,    Monte
iro CA, Batista Filho M, Shimidt M, et al. An&aacute;lise da estrat&eacute;gia  
  global para alimenta&ccedil;&atilde;o, atividade f&iacute;sica e sa&uacute;de 
   da Organiza&ccedil;&atilde;o Mundial da Sa&uacute;de. Epidemiol Serv Saude.  
  2005; 14(1):41–68.</font></p>    ^cY#a06v22n5.htm##
00492000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704024100080002001300321#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#146#142#article#176#8#<p>
<font size="2" face="Verdana">8.  Sichieri R, Castro JFG, Moura AS. Fatores    a
ssociados ao padr&atilde;o de consumo alimentar da popula&ccedil;&atilde;o    br
asileira urbana. Cad Saude Publica. 2003;19(Supl 1):S47–53.</font></p>    ^cY#a0
6v22n5.htm##
00452000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704020100080002001300281#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#147#143#article#176#9#<p>
<font size="2" face="Verdana">9.  World Health Organization. Report of a    Join
t FAO/WHO Consultation. Preparation and use of food-based dietary guidelines.   
 Geneva: WHO; 1998.</font></p>    ^cY#a06v22n5.htm##
00443000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019100081002001300272#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#148#144#article#176#10#<p
><font size="2" face="Verdana">10.  Slattery ML, Boucher KM, Caan BJ, Potter    
JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998;148(1)
:4–16.    </font></p>    ^cY#a06v22n5.htm##
00504000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704025200081002001300333#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#149#145#article#176#11#<p
><font size="2" face="Verdana">11.  Hu FB, Rimm EB, Stampfer MJ, Ascherio    A, 
Spiegelman D, Willett WC. Prospective study of major dietary patterns and    ris
k of coronary heart disease in men. Am J Clin Nutr. 2000; 72(4):912–21.</font></
p>    ^cY#a06v22n5.htm##
00471000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704021900081002001300300#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#150#146#article#176#12#<p
><font size="2" face="Verdana">12.  Fung TT, Willett WC, Stampfer MJ, Manson    
JE, Hu FB. Dietary patterns and the risk of coronary heart disease in women.    
Arch Intern Med. 2001;161(15):1857–62.</font></p>    ^cY#a06v22n5.htm##
00485000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704023300081002001300314#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#151#147#article#176#13#<p
><font size="2" face="Verdana">13.  Kerver JM, Yang EJ, Bianchi L, Song WO.    D
ietary patterns associated with risk factors for cardiovascular disease in    he
althy US adults. Am J Clin Nutr. 2003;78(6):1103–10.</font></p>    ^cY#a06v22n5.
htm##
00470000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704021800081002001300299#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#152#148#article#176#14#<p
><font size="2" face="Verdana">14.  van Dam RM, Rimm EB, Willett WC, Stampfer   
 MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. 
   Ann Intern Med. 2002;136(3):201–9.</font></p>    ^cY#a06v22n5.htm##
00441000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704018900081002001300270#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#153#149#article#176#15#<p
><font size="2" face="Verdana">15.  Yang EJ, Kerver JM, Song WO. Dietary    patt
erns of Korean American described by factor analysis. J Am Coll Nutr. 2005;24(2)
:115–21.</font></p>    ^cY#a06v22n5.htm##
00545000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704029300081002001300374#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#154#150#article#176#16#<p
><font size="2" face="Verdana">16.  Marcopito LF, Rodrigues SSR, Pacheco    MA, 
Shirassu MM, Goldfeder AJ, Moraes MA. Preval&ecirc;ncia de alguns fatores    de 
risco para doen&ccedil;as cr&ocirc;nicas na cidade de S&atilde;o Paulo. Rev    S
aude Publica. 2005;39(5):738–45.</font></p>    ^cY#a06v22n5.htm##
00476000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022400081002001300305#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#155#151#article#176#17#<p
><font size="2" face="Verdana">17.  US Bureau of the Census. Atlantida: a    cas
e study in household surveys. Unit IV: sample design. Washington, DC: US    Cens
us Bureau; 1966. (Series ISPO 1, No. 1-E). </font></p>    ^cY#a06v22n5.htm##
00495000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024300081002001300324#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#156#152#article#176#18#<p
><font size="2" face="Verdana">18.  Instituto Brasileiro de Geografia e Estat&ia
cute;stica.    Metodologia da Pesquisa Nacional por Amostra de Domic&iacute;lios
 (PNAD) na    d&eacute;cada de 70. Rio de Janeiro: IGBE; 1981.</font></p>    ^cY
#a06v22n5.htm##
00502000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704025000081002001300331#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#157#153#article#176#19#<p
><font size="2" face="Verdana">19.  Sposati A, coord. Mapa da inclus&atilde;o/ex
clus&atilde;o    social da cidade de S&atilde;o Paulo. S&atilde;o Paulo: Pontif&
iacute;cia Universidade    Cat&oacute;lica de S&atilde;o Paulo; 1996.</font></p>
    ^cY#a06v22n5.htm##
00548000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704029600081002001300377#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#158#154#article#176#20#<p
><font size="2" face="Verdana">20.  Instituto Brasileiro de Geografia e Estat&ia
cute;stica.    Censos Demogr&aacute;ficos 1991. Resultados do universo relativo 
&agrave;s caracter&iacute;sticas    da popula&ccedil;&atilde;o e dos domic&iacut
e;lios. Rio de Janeiro: IBGE; 1993.</font></p>    ^cY#a06v22n5.htm##
00549000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704029700081002001300378#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#159#155#article#176#21#<p
><font size="2" face="Verdana">21.  Marques RM, Berqu&oacute; E. Sele&ccedil;&at
ilde;o    da unidade de informa&ccedil;&atilde;o em estudos de tipo "survey":   
 um m&eacute;todo para a constru&ccedil;&atilde;o das tabelas de sorteio. Rev   
 Saude Publica. 1976;37(145): 81–92.</font></p>    ^cY#a06v22n5.htm##
00545000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704029300081002001300374#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#160#156#article#176#22#<p
><font size="2" face="Verdana">22.  Folsom AR, Prineas RJ, Jacobs DR, Luepker   
 RV, Gillum RF. Measured differences between fourth and fifth phase diastolic   
 blood pressure in 4885 adults: implications for blood pressure surveys. Int    
J Epidemiol. 1984;13(4): 436–41.</font></p>    ^cY#a06v22n5.htm##
00489000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704023700081002001300318#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#161#157#article#176#23#<p
><font size="2" face="Verdana">23.  Gomes MAM, Nobre F, Amodeo C, Kohlmann    Jr
 O, Praxedes JN, Machado CA, et al. IV Diretrizes Brasileiras de Hipertens&atild
e;o    Arterial. Arq Bras Cardiol. 2004;82 Supl IV:7–14.</font></p>    ^cY#a06v2
2n5.htm##
00553000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704030100081002001300382#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#162#158#article#176#24#<p
><font size="2" face="Verdana">24.  Genuth S, Alberti KG, Bennett P, Buse    J, 
Defronzo R, Kahn R, et al.; Expert Committee on the Diagnosis and Classification
    of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus
.    Diabetes Care. 2003;26(11): 3160–7.</font></p>    ^cY#a06v22n5.htm##
00530000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704027800081002001300359#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#163#159#article#176#25#<p
><font size="2" face="Verdana">25.  III Diretrizes Brasileiras Sobre Dislipidemi
as    e Diretriz de Preven&ccedil;&atilde;o da Aterosclerose do Departamento de 
Aterosclerose    da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2001;
77 Supl III:1–48.</font></p>    ^cY#a06v22n5.htm##
00443000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019100081002001300272#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#164#160#article#176#26#<p
><font size="2" face="Verdana">26.  World Health Organization. Physical status: 
   the use and interpretation of anthropometry. Geneva: WHO; 1995.(Report Series
,    854).</font></p>    ^cY#a06v22n5.htm##
00453000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020100081002001300282#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#165#161#article#176#27#<p
><font size="2" face="Verdana">27.  World Health Organization. Obesity: preventi
ng    and managing the global epidemic. Report of WHO Consultation on Obesity. G
eneva:    WHO; 1997.</font></p>    ^cY#a06v22n5.htm##
00586000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704033400081002001300415#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#166#162#article#176#28#<p
><font size="2" face="Verdana">28.  Ribeiro AB, Cardoso MA. Constru&ccedil;&atil
de;o    de um question&aacute;rio de freq&uuml;&ecirc;ncia alimentar como subs&i
acute;dio    para programas de preven&ccedil;&atilde;o de doen&ccedil;as cr&ocir
c;nicas n&atilde;o    transmiss&iacute;veis. Rev Nutr. 2002;15(2):239–45.</font>
</p>    ^cY#a06v22n5.htm##
00459000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020700081002001300288#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#167#163#article#176#29#<p
><font size="2" face="Verdana">29.  Sweeting H, Anderson A, West P. Socio-demogr
aphic    correlates of dietary habits in mid to late adolescence. Eur J Clin Nut
r. 1994;    48(10):736–48.</font></p>    ^cY#a06v22n5.htm##
00483000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704023100081002001300312#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#168#164#article#176#30#<p
><font size="2" face="Verdana">30.  Lebart L, Dreyfus JF. Comment limiter    de 
fa&ccedil;on non arbitraire le nombre de facteurs dans une analyse en composante
s    principales. Rev Rech Fond Barth. 1972;2:7–9.</font></p>    ^cY#a06v22n5.ht
m##
00426000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704017400081002001300255#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#169#165#article#176#31#<p
><font size="2" face="Verdana">31.  Hair JF Jr, Anderson RE, Tatham RL, Black   
 WC. Multivariate data analysis. Upper Saddle River: Prentice Hall; 1998.</font>
</p>    ^cY#a06v22n5.htm##
00527000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704027500081002001300356#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#170#166#article#176#32#<p
><font size="2" face="Verdana">32.  Philippi ST, Colucci ACA. S&atilde;o    Paul
o. Em: Fisberg M, Weba J, Cozzolino SMF, eds. Um, dois, feij&atilde;o com    arr
oz: a alimenta&ccedil;&atilde;o no Brasil de norte a sul. S&atilde;o Paulo:    A
theneu; 2002. </font></p>    ^cY#a06v22n5.htm##
00394000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704014200081002001300223#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#171#167#article#176#33#<p
><font size="2" face="Verdana">33.  Putz C. Hist&oacute;ria da gastronomia    pa
ulistana. S&atilde;o Paulo: Guia D; 2004.</font></p>    ^cY#a06v22n5.htm##
00576000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704032400081002001300405#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#172#168#article#176#34#<p
><font size="2" face="Verdana">34.  Abreu ES. Restaurante "por quilo":    vale q
uanto pesa? Uma avalia&ccedil;&atilde;o do padr&atilde;o alimentar em    restaur
antes de Cerqueira C&eacute;sar, S&atilde;o Paulo, SP &#91;tese de doutorado&#93
;.    S&atilde;o Paulo: Universidade de S&atilde;o Paulo; 2000.</font></p>    ^c
Y#a06v22n5.htm##
00495000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024300081002001300324#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#173#169#article#176#35#<p
><font size="2" face="Verdana">35.  Mondini L, Monteiro CA. Mudan&ccedil;as    n
o padr&atilde;o de alimenta&ccedil;&atilde;o da popula&ccedil;&atilde;o urbana  
  brasileira (1962–1988). Rev Saude Publica. 1995;28(6):433–9.</font></p>    ^cY
#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#174#170#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#175#171#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00322000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008500078002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#176#172#article#176#<p><font size="2"
 face="Verdana">Manuscrito recebido em 20 de agosto de 2006.    ^cY#a06v22n5.htm
##
00319000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008200078002001300160#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#177#173#article#176#<br>   Aceito em 
vers&atilde;o revisada em 9 de julho de 2007.</font></p>     ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#178#174#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#179#175#article#176#<p>&nbsp;</p>    
 ^cY#a06v22n5.htm##
00558000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704032100078002001300399#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a06v22n5.htm#S#p#180#176#article#176#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> Correspond&ecirc;ncia:    A
venida Dr. Arnaldo 351, sala 609, CEP 01246-000, S&atilde;o Paulo, SP, Brasil.  
  E-mail: <a href="mailto:africaisabel@usp.br">africaisabel@usp.br</a>, <a href=
"mailto:imartins@usp.br">imartins@usp.br</a></font></p>     ^cY#a06v22n5.htm##
00585000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170035000770180119001120610
01700231037005400248110000900302109002200311865000900333002001300342#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#181#1#article#35#1#Organização Pa
n-Americana da Saúde#Doenças crônico-degenerativas e obesidade: estratégia mundi
al sobre alimentação saudável, atividade física e saúde^lpt#site na Internet#htt
p://www.opas.org.br/ sistema/arquivos/d_cronic.pdf#20051010#10 de outubro de 200
5#20071100#a06v22n5.htm##
00666000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100016000940120
10200110016001900212018008200231063000200313066001000315062000800325065000900333
064000500342014000700347865000900354002001300363#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#182#2#article#35#2#^rND^sLotufo^nPA#^rND^sLolio^nCA#T
endências de evolução da mortalidade por doenças cardiovasculares: o caso do Est
ado de São Paulo^lpt#^rED^sMonteiro^nCA#Velhos e novos males da saúde no Brasil:
 A evolução do país e de suas doenças^lpt#2#São Paulo#Hucitec#20000000#2000#279-
87#20071100#a06v22n5.htm##
00486000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170034000770180010001110610
01700121037007100138110000900209109001600218865000900234002001300243#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#183#3#article#35#3#Prefeitura da 
Cidade de São Paulo#Saúde^lpt#site na Internet#http://portal.prefeitura.sp.gov.b
r/ secretarias/saude/mortalidade/0001#20071000#outubro de 2007#20071100#a06v22n5
.htm##
00476000000000241000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170026000770180055001030660
00700158062000400165065000900169064000500178061002900183865000900212002001300221
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#184#4#article#35#4#Wo
rld Health Organization#Diet, nutrition and prevention of chronic diseases^len#G
eneva#WHO#20030000#2003#Technical Report Series, 916#20071100#a06v22n5.htm##
00506000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770120082000950300
01500177710000200192065000900194064000500203031000300208032000200211014000500213
865000900218002001300227#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S
#c#185#5#article#35#5#^rND^sWillett^nWC#Nutritional epidemiology issues in chron
ic disease at the turn of the century^len#Epidemiol Rev.#2#20000000#2000#22#1#82
-6#20071100#a06v22n5.htm##
00750000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100012000950100
01600107010001600123010001900139010001500158810000600173012016900179030001600348
71000020036406500090036606400050037503100030038003200020038301400050038586500090
0390002001300399#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#186#6
#article#35#6#^rND^sBazzano^nLA#^rND^sHe^nJ#^rND^sOgden^nLG#^rND^sLoria^nCM#^rND
^sVupputuri^nS#^rND^sMyers^nL#et al#Fruit and vegetable intake and risk of cardi
ovascular disease in US adults: the first National Health and Nutrition Examinat
ion Survey Epidemiologic Follow-up Study^len#Am J Clin Nutr.#2#20020000#2002#76#
1#93-9#20071100#a06v22n5.htm##
00714000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100020000950100
01800115010001900133010002300152010001700175810000600192012010800198030002100306
71000020032706500090032906400050033803100030034303200020034601400060034886500090
0354002001300363#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#187#7
#article#35#7#^rND^sBarreto^nSM#^rND^sPinheiro^nARO#^rND^sSichieri^nR#^rND^sMont
eiro^nCA#^rND^sBatista Filho^nM#^rND^sShimidt^nM#et al#Análise da estratégia glo
bal para alimentação, atividade física e saúde da Organização Mundial da Saúde^l
pt#Epidemiol Serv Saude#2#20050000#2005#14#1#41-68#20071100#a06v22n5.htm##
00612000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100018000770100018000950100
01600113012008500129030001800214065000900232064000500241031000300246032000400249
014000700253865000900260002001300269035001000282801001800292#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a06v22n5.htm#S#c#188#8#article#35#8#^rND^sSichieri^nR#^rND
^sCastro^nJFG#^rND^sMoura^nAS#Fatores associados ao padrão de consumo alimentar 
da população brasileira urbana^lpt#Cad Saude Publica#20030000#2003#19#^s1#S47-53
#20071100#a06v22n5.htm#0102-311X#Cad Saude Publica##
00477000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170026000770180097001030660
00700200062000400207065000900211064000500220865000900225002001300234#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#189#9#article#35#9#World Health O
rganization#Report of a Joint FAO/WHO Consultation: Preparation and use of food-
based dietary guidelines^len#Geneva#WHO#19980000#1998#20071100#a06v22n5.htm##
00585000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100018000980100
01500116010001700131010001300148012004500161030001600206710000200222065000900224
064000500233031000400238032000200242014000500244865000900249002001300258#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#190#10#article#35#10#^rND^sSl
attery^nML#^rND^sBoucher^nKM#^rND^sCaan^nBJ#^rND^sPotter^nJD#^rND^sMa^nKN#Eating
 patterns and risk of colon cancer^len#Am J Epidemiol.#2#19980000#1998#148#1#4-1
6#20071100#a06v22n5.htm##
00664000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100013000790100015000920100
01900107010001800126010002000144010001800164012009000182030001600272710000200288
06500090029006400050029903100030030403200020030701400070030986500090031600200130
0325#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#191#11#article#35
#11#^rND^sHu^nFB#^rND^sRimm^nEB#^rND^sStampfer^nMJ#^rND^sAscherio^nA#^rND^sSpieg
elman^nD#^rND^sWillett^nWC#Prospective study of major dietary patterns and risk 
of coronary heart disease in men^len#Am J Clin Nutr.#2#20000000#2000#72#4#912-21
#20071100#a06v22n5.htm##
00614000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100018000940100
01900112010001700131010001300148012006900161030001700230710000200247065000900249
064000500258031000400263032000300267014000800270865000900278002001300287#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#192#12#article#35#12#^rND^sFu
ng^nTT#^rND^sWillett^nWC#^rND^sStampfer^nMJ#^rND^sManson^nJE#^rND^sHu^nFB#Dietar
y patterns and the risk of coronary heart disease in women^len#Arch Intern Med.#
2#20010000#2001#161#15#1857-62#20071100#a06v22n5.htm##
00610000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100015000960100
01700111010001500128012009800143030001600241710000200257065000900259064000500268
031000300273032000200276014000800278865000900286002001300295#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a06v22n5.htm#S#c#193#13#article#35#13#^rND^sKerver^nJM#^rN
D^sYang^nEJ#^rND^sBianchi^nL#^rND^sSong^nWO#Dietary patterns associated with ris
k factors for cardiovascular disease in healthy US adults^len#Am J Clin Nutr.#2#
20030000#2003#78#6#1103-10#20071100#a06v22n5.htm##
00613000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100015000970100
01800112010001900130010001300149012007100162030001600233710000200249065000900251
064000500260031000400265032000200269014000600271865000900277002001300286#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#194#14#article#35#14#^rND^sva
n Dam^nRM#^rND^sRimm^nEB#^rND^sWillett^nWC#^rND^sStampfer^nMJ#^rND^sHu^nFB#Dieta
ry patterns and risk for type 2 diabetes mellitus in U.S. men^len#Ann Intern Med
.#2#20020000#2002#136#3#201-9#20071100#a06v22n5.htm##
00551000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100017000940100
01500111012006900126030001600195710000200211065000900213064000500222031000300227
032000200230014000700232865000900239002001300248#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#195#15#article#35#15#^rND^sYang^nEJ#^rND^sKerver^nJM#
^rND^sSong^nWO#Dietary patterns of Korean American described by factor analysis^
len#J Am Coll Nutr.#2#20050000#2005#24#2#115-21#20071100#a06v22n5.htm##
00714000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100021000990100
01800120010001900138010002000157010001700177012008800194030001800282065000900300
06400050030903100030031403200020031701400070031986500090032600200130033503500100
0348801001800358#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#196#1
6#article#35#16#^rND^sMarcopito^nLF#^rND^sRodrigues^nSSR#^rND^sPacheco^nMA#^rND^
sShirassu^nMM#^rND^sGoldfeder^nAJ#^rND^sMoraes^nMA#Prevalência de alguns fatores
 de risco para doenças crônicas na cidade de São Paulo^lpt#Rev Saude Publica#200
50000#2005#39#5#738-45#20071100#a06v22n5.htm#0034-8910#Rev Saude Publica##
00509000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170024000790180073001030660
01500176062001700191065000900208064000500217061002300222865000900245002001300254
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#197#17#article#35#17#
US Bureau of the Census#Atlantida: a case study in household surveys. Unit IV: s
ample design^len#Washington^eDC#US Census Bureau#19660000#1966#Series ISPO 1, No
. 1-E#20071100#a06v22n5.htm##
00499000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170048000790180086001270660
01500213062000500228065000900233064000500242865000900247002001300256#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#198#18#article#35#18#Instituto Br
asileiro de Geografia e Estatística#Metodologia da Pesquisa Nacional por Amostra
 de Domicílios (PNAD) na década de 70^lpt#Rio de Janeiro#IGBE#19810000#1981#2007
1100#a06v22n5.htm##
00481000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160020000790180060000990660
01000159062004600169065000900215064000500224865000900229002001300238#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#199#19#article#35#19#^rCOORD^sSpo
sati^nA#Mapa da inclusão/exclusão social da cidade de São Paulo^lpt#São Paulo#Po
ntifícia Universidade Católica de São Paulo#19960000#1996#20071100#a06v22n5.htm#
#
00524000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170048000790180111001270660
01500238062000500253065000900258064000500267865000900272002001300281#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#200#20#article#35#20#Instituto Br
asileiro de Geografia e Estatística#Censos Demográficos 1991: Resultados do univ
erso relativo às características da população e dos domicílios^lpt#Rio de Janeir
o#IBGE#19930000#1993#20071100#a06v22n5.htm##
00615000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100016000970120
11700113030001800230065000900248064000500257031000300262032000400265014000600269
865000900275002001300284035001000297801001800307#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#201#21#article#35#21#^rND^sMarques^nRM#^rND^sBerquó^n
E#Seleção da unidade de informação em estudos de tipo "survey": um método para a
 construção das tabelas de sorteio^lpt#Rev Saude Publica#19760000#1976#37#145#81
-92#20071100#a06v22n5.htm#0034-8910#Rev Saude Publica##
00684000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100018000960100
01700114010001800131010001700149012013700166030001700303710000200320065000900322
064000500331031000300336032000200339014000700341865000900348002001300357#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#202#22#article#35#22#^rND^sFo
lsom^nAR#^rND^sPrineas^nRJ#^rND^sJacobs^nDR#^rND^sLuepker^nRV#^rND^sGillum^nRF#M
easured differences between fourth and fifth phase diastolic blood pressure in 4
885 adults: implications for blood pressure surveys^len#Int J Epidemiol.#2#19840
000#1984#13#4#436-41#20071100#a06v22n5.htm##
00652000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100015000960100
01600111010002100127010001900148010001800167810000600185012005400191030001800245
71000020026306500090026506400050027403100030027903200050028201400050028786500090
0292002001300301#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#203#2
3#article#35#23#^rND^sGomes^nMAM#^rND^sNobre^nF#^rND^sAmodeo^nC#^rND^sKohlmann J
r^nO#^rND^sPraxedes^nJN#^rND^sMachado^nCA#et al#IV Diretrizes Brasileiras de Hip
ertensão Arterial^lpt#Arq Bras Cardiol.#2#20040000#2004#82#^sIV#7-14#20071100#a0
6v22n5.htm##
00753000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100018000950100
01700113010001400130010001800144010001400162810000600176012013400182030001400316
06500090033006400050033903100030034403200030034701400070035086500090035700200130
0366035001000379801001400389#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.h
tm#S#c#204#24#article#35#24#^rND^sGenuth^nS#^rND^sAlberti^nKG#^rND^sBennett^nP#^
rND^sBuse^nJ#^rND^sDefronzo^nR#^rND^sKahn^nR#et al#Expert Committee on the Diagn
osis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis 
of diabetes mellitus^len#Diabetes Care#20030000#2003#26#11#3160-7#20071100#a06v2
2n5.htm#0149-5992#Diabetes Care##
00574000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760120092000790110067001710300
01800238710000200256065000900258064000500267031000300272032000600275014000500281
865000900286002001300295#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S
#c#205#25#article#35#25#III Diretrizes Brasileiras Sobre Dislipidemias e Diretri
z de Prevenção da Aterosclerose^lpt#Sociedade Brasileira de Cardiologia^dDeparta
mento de Aterosclerose#Arq Bras Cardiol.#2#20010000#2001#77#^sIII#1-48#20071100#
a06v22n5.htm##
00478000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170026000790180065001050660
00700170062000400177065000900181064000500190061001900195865000900214002001300223
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#206#26#article#35#26#
World Health Organization#Physical status: the use and interpretation of anthrop
ometry^len#Geneva#WHO#19950000#1995#Report Series, 854#20071100#a06v22n5.htm##
00478000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170026000790180096001050660
00700201062000400208065000900212064000500221865000900226002001300235#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#207#27#article#35#27#World Health
 Organization#Obesity: preventing and managing the global epidemic. Report of WH
O Consultation on Obesity^len#Geneva#WHO#19970000#1997#20071100#a06v22n5.htm##
00592000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100018000970120
13900115030001000254710000200264065000900266064000500275031000300280032000200283
014000700285865000900292002001300301#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
6v22n5.htm#S#c#208#28#article#35#28#^rND^sRibeiro^nAB#^rND^sCardoso^nMA#Construç
ão de um questionário de freqüência alimentar como subsídio para programas de pr
evenção de doenças crônicas não transmissíveis^lpt#Rev Nutr.#2#20020000#2002#15#
2#239-45#20071100#a06v22n5.htm##
00565000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100018000970100
01400115012007800129030001700207710000200224065000900226064000500235031000300240
032000300243014000700246865000900253002001300262#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#209#29#article#35#29#^rND^sSweeting^nH#^rND^sAnderson
^nA#^rND^sWest^nP#Socio-demographic correlates of dietary habits in mid to late 
adolescence^len#Eur J Clin Nutr.#2#19940000#1994#48#10#736-48#20071100#a06v22n5.
htm##
00554000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100018000950120
11000113030002100223710000200244065000900246064000500255031000200260014000400262
865000900266002001300275#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S
#c#210#30#article#35#30#^rND^sLebart^nL#^rND^sDreyfus^nJF#Comment limiter de faç
on non arbitraire le nombre de facteurs dans une analyse en composantes principa
les^lfr#Rev Rech Fond Barth.#2#19720000#1972#2#7-9#20071100#a06v22n5.htm##
00515000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160018000790160019000970160
01700116016001600133018003100149066001900180062001400199065000900213064000500222
865000900227002001300236#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S
#c#211#31#article#35#31#^rND^sHair^nJF Jr#^rND^sAnderson^nRE#^rND^sTatham^nRL#^r
ND^sBlack^nWC#Multivariate data analysis^len#Upper Saddle River#Prentice Hall#19
980000#1998#20071100#a06v22n5.htm##
00598000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100019000980120
01400117016001700131016001400148016002100162018007100183066001000254062000800264
065000900272064000500281865000900286002001300295#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#212#32#article#35#32#^rND^sPhilippi^nST#^rND^sColucci
^nACA#São Paulo^lpt#^rED^sFisberg^nM#^rED^sWeba^nJ#^rED^sCozzolino^nSMF#Um, dois
, feijão com arroz: a alimentação no Brasil de norte a sul^lpt#São Paulo#Atheneu
#20020000#2002#20071100#a06v22n5.htm##
00415000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160014000790180039000930660
01000132062000700142065000900149064000500158865000900163002001300172#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#213#33#article#35#33#^rND^sPutz^n
C#História da gastronomia paulistana^lpt#São Paulo#Guia D#20040000#2004#20071100
#a06v22n5.htm##
00550000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160016000790180131000950510
01000226046001000236050002600246045000900272044000500281865000900286002001300295
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a06v22n5.htm#S#c#214#34#article#35#34#
^rND^sAbreu^nES#Restaurante "por quilo": vale quanto pesa? Uma avaliação do padr
ão alimentar em restaurantes de Cerqueira César, São Paulo, SP^lpt#doutorado#São
 Paulo#Universidade de São Paulo#20000000#2000#20071100#a06v22n5.htm##
00579000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100019000960120
08100115030001800196065000900214064000500223031000300228032000200231014000600233
865000900239002001300248035001000261801001800271#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a06v22n5.htm#S#c#215#35#article#35#35#^rND^sMondini^nL#^rND^sMonteiro^
nCA#Mudanças no padrão de alimentação da população urbana brasileira (1962-1988)
^lpt#Rev Saude Publica#19950000#1995#28#6#433-9#20071100#a06v22n5.htm#0034-8910#
Rev Saude Publica##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#o#1#1#article#1
#20080121#151824#a07v22n5.htm#174##
05986000000000637000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200990016701201120
02660100027003780100028004050100026004330100025004590100028004840700082005120700
15700594083197200751085000802723085002302731085004202754085003202796085002102828
08322910284908500080514008500250514808500480517308500370522108500210525811700060
5279072000305285112000905288111001305297114000905310113001605319002001305335#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#h#2#1#article#1#oa#en#br1.1
#1#3.1#TAB#07#RPSP020#nd#Rev Panam Salud Publica#22#5#20071100#^f340^l347#1020-4
989#Postpartum women in the Honduran health system: folic acid knowledge, attitu
des, and practices^len#Conocimientos, actitudes y prácticas relacionados con el 
ácido fólico en mujeres recién paridas en Honduras^les#^rND^1A01^nGayle R.^sMill
a#^rND^1A02^nAlina L.^sFlores#^rND^1A01^nEdgardo^sUmaña#^rND^1A01^sIleana^nMayes
#^rND^1A02^nJorge^sRosenthal#Proyecto Niños Saludables/Project Healthy Children^
iA01^cSan Pedro Sula^pHonduras#National Center on Birth Defects and Developmenta
l Disabilities^iA02^1Centers for Disease Control and Prevention^cAtlanta^sGeorgi
a^pUnited States of America#^len^aOBJECTIVES: This study had two purposes: first
, to determine the knowledge, attitudes, and practices related to folic acid and
 birth defects among a convenience sample of postpartum Honduran women; and seco
nd, to identify food consumption patterns in this population and determine high-
consumption staples for potential folic acid fortification. METHODS: Convenience
 sampling methodology was used to recruit potential study participants. Particip
ants for this study were 2 619 postpartum Honduran women who had had a normal, i
n-hospital delivery in one of 16 public hospitals located throughout the country
 or the two social security hospitals that provide services to the Honduran work
ing class population. Over a 10-month period, in-depth, face-to-face oral interv
iews, supervised by the research coordinator and staff, were conducted in-hospit
al prior to discharge. RESULTS: The majority of the women were between 16 and 29
 years of age. Approximately half of the respondents (46.4%) had heard of folic 
acid and over one-third (37.6%) knew that it was a vitamin related to preventing
 birth defects. Birth defects were most often attributed to drug and alcohol use
 (20.6%) and lack of vitamin intake (18.1%), but 23.0% related defects to mystic
al, mythical, or religious causes. Aside from red beans, oranges, and natural fr
uit juices, folate-rich foods are not widely consumed by this population. The hi
ghest consumption frequency of staple foods with the potential to be fortified w
ith folic acid were rice, white flour, corn flour, and pasta. CONCLUSIONS: Resul
ts from this study provide potential avenues for food fortification, as well as 
underscore the need for further education about the role of folic acid in the pr
evention of neural tube defects. Results highlight that standardized health educ
ation for Honduran women of reproductive age is needed if folic acid consumption
 through fortification and supplementation is to be successful and sustainable.#
^dnd^i1#^tm^len^kFolic acid^i1#^tm^len^kprenatal nutrition physiology^i1#^tm^len
^kneural tube defects^i1#^tm^len^kHonduras^i1#^les^aOBJETIVOS: Este estudio tuvo
 dos propósitos: primero, determinar los conocimientos, las actitudes y las prác
ticas relacionados con el ácido fólico y las malformaciones congénitas en una mu
estra de conveniencia de mujeres hondureñas recién paridas; y segundo, identific
ar los patrones de consumo de alimentos en esta población y determinar los produ
ctos básicos de alto consumo para su posible fortificación con ácido fólico. MÉT
ODOS: Se seleccionaron las posibles participantes mediante un muestreo de conven
iencia. Participaron 2 619 mujeres hondureñas que habían tenido un parto normal 
en alguno de los 16 hospitales públicos del país o de dos hospitales de la segur
idad social que prestan servicios a la clase trabajadora hondureña. En un períod
o de 10 meses se realizaron entrevistas personales directas, orales y exhaustiva
s en los propios hospitales antes del alta médica. El coordinador y el equipo de
 investigación supervisaron las entrevistas. RESULTADOS: La mayoría de las mujer
es tenían entre 16 y 29 años de edad. Aproximadamente la mitad de las encuestada
s (46,4%) habían oído sobre el ácido fólico y más de la tercera parte (37,6%) sa
bía que era una vitamina relacionada con la prevención de malformaciones congéni
tas. Las mujeres encuestadas atribuyeron estas malformaciones principalmente al 
consumo de drogas y alcohol (20,6%) y a la insuficiente ingesta de vitaminas (18
,1%); no obstante, 23,0% relacionó las malformaciones con causas místicas, mític
as o religiosas. En esta población no se consumen muchos alimentos ricos en fola
tos, excepto frijoles colorados, naranjas y jugos de frutas naturales. Los alime
ntos básicos más frecuentes que podrían fortificarse con ácido fólico fueron el 
arroz, las pastas y las harinas de trigo y de maíz. CONCLUSIONES: Los resultados
 de este estudio abren una posible vía para la fortificación de alimentos y, ade
más, subrayan la necesidad de una mayor educación sobre la importancia del ácido
 fólico en la prevención de malformaciones del tubo neural en los fetos. Los res
ultados destacan la necesidad de ofrecer una educación sanitaria estandarizada a
 las mujeres hondureñas en edad reproductiva si se implementa de manera exitosa 
y sostenible el consumo de ácido fólico mediante la fortificación y suplementaci
ón de alimentos.#^dnd^i2#^tm^les^kÁcido fólico^i2#^tm^les^kfisiología de la nutr
ición prenatal^i2#^tm^les^kdefectos del tubo neural^i2#^tm^les^kHonduras^i2#othe
r#39#20060731#31 July 2006#20071016#16 October 2007#a07v22n5.htm##
06063000000000637000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201130016701201190
02800100027003990100028004260100026004540100025004800100028005050700082005330700
15700615083200000772085000802772085002302780085004202803085003202845085002102877
08323190289808500080521708500250522508500480525008500370529808500210533511700060
5356072000305362112000905365111001305374114000905387113001605396002001305412#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#f#3#1#article#1#oa#en#br1.1
#1#3.1#TAB#07#RPSP020#nd#Rev Panam Salud Publica#22#5#20071100#^f340^l347#1020-4
989#<B>Postpartum women in the Honduran health system</B>: <B>folic acid knowled
ge, attitudes, and practices</B>^len#<B>Conocimientos, actitudes y prácticas rel
acionados con el ácido fólico en mujeres recién paridas en Honduras</B>^les#^rND
^1A01^nGayle R.^sMilla#^rND^1A02^nAlina L.^sFlores#^rND^1A01^nEdgardo^sUmaña#^rN
D^1A01^sIleana^nMayes#^rND^1A02^nJorge^sRosenthal#Proyecto Niños Saludables/Proj
ect Healthy Children^iA01^cSan Pedro Sula^pHonduras#National Center on Birth Def
ects and Developmental Disabilities^iA02^1Centers for Disease Control and Preven
tion^cAtlanta^sGeorgia^pUnited States of America#^len^a<B>OBJECTIVES: </B>This s
tudy had two purposes: first, to determine the knowledge, attitudes, and practic
es related to folic acid and birth defects among a convenience sample of postpar
tum Honduran women; and second, to identify food consumption patterns in this po
pulation and determine high-consumption staples for potential folic acid fortifi
cation. <B>METHODS: </B>Convenience sampling methodology was used to recruit pot
ential study participants. Participants for this study were 2 619 postpartum Hon
duran women who had had a normal, in-hospital delivery in one of 16 public hospi
tals located throughout the country or the two social security hospitals that pr
ovide services to the Honduran working class population. Over a 10-month period,
 in-depth, face-to-face oral interviews, supervised by the research coordinator 
and staff, were conducted in-hospital prior to discharge. <B>RESULTS: </B>The ma
jority of the women were between 16 and 29 years of age. Approximately half of t
he respondents (46.4%) had heard of folic acid and over one-third (37.6%) knew t
hat it was a vitamin related to preventing birth defects. Birth defects were mos
t often attributed to drug and alcohol use (20.6%) and lack of vitamin intake (1
8.1%), but 23.0% related defects to mystical, mythical, or religious causes. Asi
de from red beans, oranges, and natural fruit juices, folate-rich foods are not 
widely consumed by this population. The highest consumption frequency of staple 
foods with the potential to be fortified with folic acid were rice, white flour,
 corn flour, and pasta. <B>CONCLUSIONS: </B>Results from this study provide pote
ntial avenues for food fortification, as well as underscore the need for further
 education about the role of folic acid in the prevention of neural tube defects
. Results highlight that standardized health education for Honduran women of rep
roductive age is needed if folic acid consumption through fortification and supp
lementation is to be successful and sustainable.#^dnd^i1#^tm^len^kFolic acid^i1#
^tm^len^kprenatal nutrition physiology^i1#^tm^len^kneural tube defects^i1#^tm^le
n^kHonduras^i1#^les^a<B>OBJETIVOS: </B>Este estudio tuvo dos propósitos: primero
, determinar los conocimientos, las actitudes y las prácticas relacionados con e
l ácido fólico y las malformaciones congénitas en una muestra de conveniencia de
 mujeres hondureñas recién paridas; y segundo, identificar los patrones de consu
mo de alimentos en esta población y determinar los productos básicos de alto con
sumo para su posible fortificación con ácido fólico. <B>MÉTODOS: </B>Se seleccio
naron las posibles participantes mediante un muestreo de conveniencia. Participa
ron 2 619 mujeres hondureñas que habían tenido un parto normal en alguno de los 
16 hospitales públicos del país o de dos hospitales de la seguridad social que p
restan servicios a la clase trabajadora hondureña. En un período de 10 meses se 
realizaron entrevistas personales directas, orales y exhaustivas en los propios 
hospitales antes del alta médica. El coordinador y el equipo de investigación su
pervisaron las entrevistas. <B>RESULTADOS: </B>La mayoría de las mujeres tenían 
entre 16 y 29 años de edad. Aproximadamente la mitad de las encuestadas (46,4%) 
habían oído sobre el ácido fólico y más de la tercera parte (37,6%) sabía que er
a una vitamina relacionada con la prevención de malformaciones congénitas. Las m
ujeres encuestadas atribuyeron estas malformaciones principalmente al consumo de
 drogas y alcohol (20,6%) y a la insuficiente ingesta de vitaminas (18,1%); no o
bstante, 23,0% relacionó las malformaciones con causas místicas, míticas o relig
iosas. En esta población no se consumen muchos alimentos ricos en folatos, excep
to frijoles colorados, naranjas y jugos de frutas naturales. Los alimentos básic
os más frecuentes que podrían fortificarse con ácido fólico fueron el arroz, las
 pastas y las harinas de trigo y de maíz. <B>CONCLUSIONES: </B>Los resultados de
 este estudio abren una posible vía para la fortificación de alimentos y, además
, subrayan la necesidad de una mayor educación sobre la importancia del ácido fó
lico en la prevención de malformaciones del tubo neural en los fetos. Los result
ados destacan la necesidad de ofrecer una educación sanitaria estandarizada a la
s mujeres hondureñas en edad reproductiva si se implementa de manera exitosa y s
ostenible el consumo de ácido fólico mediante la fortificación y suplementación 
de alimentos.#^dnd^i2#^tm^les^kÁcido fólico^i2#^tm^les^kfisiología de la nutrici
ón prenatal^i2#^tm^les^kdefectos del tubo neural^i2#^tm^les^kHonduras^i2#other#3
9#20060731#31 July 2006#20071016#16 October 2007#a07v22n5.htm##
06204000000000661000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201200990
01820120112002810100026003930100027004190100026004460100025004720100028004970700
08400525070015900609083200700768085000802775085002302783085004202806085003202848
08500210288008323410290108500080524208500250525008500480527508500370532308500210
53601170006053810720003053871120009053901110013053991140009054121130016054210020
01305437008009205450#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#l#4
#1#article#1#^mNov.^a2007#oa#en#br1.1#1#3.1#tab#07#RPSP020#nd#Rev. panam. salud 
pública#22#5#20071100#^f340^l347#1020-4989#Postpartum women in the Honduran heal
th system: folic acid knowledge, attitudes, and practices^len#Conocimientos, act
itudes y prácticas relacionados con el ácido fólico en mujeres recién paridas en
 Honduras^les#^rND^1A01^nGayle R^sMilla#^rND^1A02^nAlina L^sFlores#^rND^1A01^nEd
gardo^sUmaña#^rND^1A01^sIleana^nMayes#^rND^1A02^nJorge^sRosenthal#^iA01^1Proyect
o Niños Saludables/Project Healthy Children^cSan Pedro Sula^pHonduras#^iA02^1Nat
ional Center on Birth Defects and Developmental Disabilities^2Centers for Diseas
e Control and Prevention^cAtlanta^sGeorgia^pUnited States of America#^len^aOBJEC
TIVES: This study had two purposes: first, to determine the knowledge, attitudes
, and practices related to folic acid and birth defects among a convenience samp
le of postpartum Honduran women; and second, to identify food consumption patter
ns in this population and determine high-consumption staples for potential folic
 acid fortification. METHODS: Convenience sampling methodology was used to recru
it potential study participants. Participants for this study were 2 619 postpart
um Honduran women who had had a normal, in-hospital delivery in one of 16 public
 hospitals located throughout the country or the two social security hospitals t
hat provide services to the Honduran working class population. Over a 10-month p
eriod, in-depth, face-to-face oral interviews, supervised by the research coordi
nator and staff, were conducted in-hospital prior to discharge. RESULTS: The maj
ority of the women were between 16 and 29 years of age. Approximately half of th
e respondents (46.4 percent) had heard of folic acid and over one-third (37.6 pe
rcent) knew that it was a vitamin related to preventing birth defects. Birth def
ects were most often attributed to drug and alcohol use (20.6 percent) and lack 
of vitamin intake (18.1 percent), but 23.0 percent related defects to mystical, 
mythical, or religious causes. Aside from red beans, oranges, and natural fruit 
juices, folate-rich foods are not widely consumed by this population. The highes
t consumption frequency of staple foods with the potential to be fortified with 
folic acid were rice, white flour, corn flour, and pasta. CONCLUSIONS: Results f
rom this study provide potential avenues for food fortification, as well as unde
rscore the need for further education about the role of folic acid in the preven
tion of neural tube defects. Results highlight that standardized health educatio
n for Honduran women of reproductive age is needed if folic acid consumption thr
ough fortification and supplementation is to be successful and sustainable.#^dnd
^i1#^tm^len^kFolic acid^i1#^tm^len^kprenatal nutrition physiology^i1#^tm^len^kne
ural tube defects^i1#^tm^len^kHonduras^i1#^les^aOBJETIVOS: Este estudio tuvo dos
 propósitos: primero, determinar los conocimientos, las actitudes y las práctica
s relacionados con el ácido fólico y las malformaciones congénitas en una muestr
a de conveniencia de mujeres hondureñas recién paridas; y segundo, identificar l
os patrones de consumo de alimentos en esta población y determinar los productos
 básicos de alto consumo para su posible fortificación con ácido fólico. MÉTODOS
: Se seleccionaron las posibles participantes mediante un muestreo de convenienc
ia. Participaron 2 619 mujeres hondureñas que habían tenido un parto normal en a
lguno de los 16 hospitales públicos del país o de dos hospitales de la seguridad
 social que prestan servicios a la clase trabajadora hondureña. En un período de
 10 meses se realizaron entrevistas personales directas, orales y exhaustivas en
 los propios hospitales antes del alta médica. El coordinador y el equipo de inv
estigación supervisaron las entrevistas. RESULTADOS: La mayoría de las mujeres t
enían entre 16 y 29 años de edad. Aproximadamente la mitad de las encuestadas (4
6,4 por ciento) habían oído sobre el ácido fólico y más de la tercera parte (37,
6 por ciento) sabía que era una vitamina relacionada con la prevención de malfor
maciones congénitas. Las mujeres encuestadas atribuyeron estas malformaciones pr
incipalmente al consumo de drogas y alcohol (20,6 por ciento) y a la insuficient
e ingesta de vitaminas (18,1 por ciento); no obstante, 23,0 por ciento relacionó
 las malformaciones con causas místicas, míticas o religiosas. En esta población
 no se consumen muchos alimentos ricos en folatos, excepto frijoles colorados, n
aranjas y jugos de frutas naturales. Los alimentos básicos más frecuentes que po
drían fortificarse con ácido fólico fueron el arroz, las pastas y las harinas de
 trigo y de maíz. CONCLUSIONES: Los resultados de este estudio abren una posible
 vía para la fortificación de alimentos y, además, subrayan la necesidad de una 
mayor educación sobre la importancia del ácido fólico en la prevención de malfor
maciones del tubo neural en los fetos. Los resultados destacan la necesidad de o
frecer una educación sanitaria estandarizada a las mujeres hondureñas en edad re
productiva si se implementa de manera exitosa y sostenible el consumo de ácido f
ólico mediante la fortificación y suplementación de alimentos.#^dnd^i2#^tm^les^k
Ácido fólico^i2#^tm^les^kfisiología de la nutrición prenatal^i2#^tm^les^kdefecto
s del tubo neural^i2#^tm^les^kHonduras^i2#other#39#20060731#31 July 2006#2007101
6#16 October 2007#a07v22n5.htm#Internet^ihttp://www.scielosp.org/scielo.php?scri
pt=sci_arttext&pid=S1020-49892007001000007##
00357000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704012400074002001300198#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#5#1#article#131#<p align="right"><fon
t size="2" face="Verdana"><b>INVESTIGACI&Oacute;N ORIGINAL</b>    ORIGINAL RESEA
RCH</font></p>     ^cY#a07v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#6#2#article#131#<p>&nbsp;</p>     ^cY
#a07v22n5.htm##
00407000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704017400074002001300248#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#7#3#article#131#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>Postpartum women in the Honduran    health syste
m: folic acid knowledge, attitudes, and practices</b></font></p>     ^cY#a07v22n
5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#8#4#article#131#<p>&nbsp;</p>     ^cY
#a07v22n5.htm##
00434000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704020100074002001300275#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#9#5#article#131#<p><font size="3" fac
e="verdana"><b>Conocimientos, actitudes y pr&aacute;cticas    relacionados con e
l &aacute;cido f&oacute;lico en mujeres reci&eacute;n paridas    en Honduras</b>
</font></p>     ^cY#a07v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#10#6#article#131#<p>&nbsp;</p>     ^c
Y#a07v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#11#7#article#131#<p>&nbsp;</p>     ^c
Y#a07v22n5.htm##
00478000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704024400075002001300319#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#12#8#article#131#<p><font size="2" fa
ce="Verdana"><b>Gayle R. Milla<sup>I, </sup><a href="#nt"><sup>*</sup></a>;    A
lina L. Flores<sup>II</sup>; Edgardo Uma&ntilde;a<sup>I</sup>; Ileana Mayes<sup>
I</sup>;    Jorge Rosenthal<SUP>II</SUP></b></font></p>     ^cY#a07v22n5.htm##
00373000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704013900075002001300214#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#13#9#article#131#<p><FONT SIZE="2" fa
ce="Verdana"><SUP>I</sup>Proyecto Ni&ntilde;os Saludables/Project    Healthy Chi
ldren, San Pedro Sula, Honduras    ^cY#a07v22n5.htm##
00432000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704019700076002001300273#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#14#10#article#131#<br>   <SUP>II</sup
>National Center on Birth Defects    and Developmental Disabilities, Centers for
 Disease Control and Prevention,    Atlanta, Georgia, United States of America</
font></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#15#11#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#16#12#article#131#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a07v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#17#13#article#131#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a07v22n5.htm##
00640000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704040500076002001300481#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#18#14#article#131#<p><font size="2" f
ace="Verdana"><b>OBJECTIVES: </b>This study had two purposes:    first, to deter
mine the knowledge, attitudes, and practices related to folic    acid and birth 
defects among a convenience sample of postpartum Honduran women;    and second, 
to identify food consumption patterns in this population and determine    high-c
onsumption staples for potential folic acid fortification.    ^cY#a07v22n5.htm##
00797000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056200076002001300638#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#19#15#article#131#<br>   <b>METHODS: 
</b>Convenience sampling methodology was used to recruit potential    study part
icipants. Participants for this study were 2 619 postpartum Honduran    women wh
o had had a normal, in-hospital delivery in one of 16 public hospitals    locate
d throughout the country or the two social security hospitals that provide    se
rvices to the Honduran working class population. Over a 10-month period, in-dept
h,    face-to-face oral interviews, supervised by the research coordinator and s
taff,    were conducted in-hospital prior to discharge.    ^cY#a07v22n5.htm##
00959000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704072400076002001300800#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#20#16#article#131#<br>   <b>RESULTS: 
</b>The majority of the women were between 16 and 29 years of age.    Approximat
ely half of the respondents (46.4%) had heard of folic acid and over    one-thir
d (37.6%) knew that it was a vitamin related to preventing birth defects.    Bir
th defects were most often attributed to drug and alcohol use (20.6%) and    lac
k of vitamin intake (18.1%), but 23.0% related defects to mystical, mythical,   
 or religious causes. Aside from red beans, oranges, and natural fruit juices,  
  folate-rich foods are not widely consumed by this population. The highest cons
umption    frequency of staple foods with the potential to be fortified with fol
ic acid    were rice, white flour, corn flour, and pasta.    ^cY#a07v22n5.htm##
00701000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704046600076002001300542#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#21#17#article#131#<br>   <b>CONCLUSIO
NS: </b>Results from this study provide potential avenues for food    fortificat
ion, as well as underscore the need for further education about the    role of f
olic acid in the prevention of neural tube defects. Results highlight    that st
andardized health education for Honduran women of reproductive age is    needed 
if folic acid consumption through fortification and supplementation is    to be 
successful and sustainable.</font></p>     ^cY#a07v22n5.htm##
00404000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704016900076002001300245#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#22#18#article#131#<p><font size="2" f
ace="Verdana"><b>Key words:</b> Folic    acid, prenatal nutrition physiology, ne
ural tube defects, Honduras.</font></p> <hr size="1" noshade>     ^cY#a07v22n5.h
tm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#23#19#article#131#<p><font size="2" f
ace="Verdana"><b>RESUMEN</b></font></p>     ^cY#a07v22n5.htm##
00809000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704057400076002001300650#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#24#20#article#131#<p><font size="2" f
ace="Verdana"><b>OBJETIVOS: </b>Este estudio tuvo dos prop&oacute;sitos:    prim
ero, determinar los conocimientos, las actitudes y las pr&aacute;cticas    relac
ionados con el &aacute;cido f&oacute;lico y las malformaciones cong&eacute;nitas
    en una muestra de conveniencia de mujeres hondure&ntilde;as reci&eacute;n pa
ridas;    y segundo, identificar los patrones de consumo de alimentos en esta po
blaci&oacute;n    y determinar los productos b&aacute;sicos de alto consumo para
 su posible fortificaci&oacute;n    con &aacute;cido f&oacute;lico.    ^cY#a07v2
2n5.htm##
00868000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704063300076002001300709#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#25#21#article#131#<br>   <b>M&Eacute;
TODOS: </b>Se seleccionaron las posibles participantes mediante    un muestreo d
e conveniencia. Participaron 2 619 mujeres hondure&ntilde;as que    hab&iacute;a
n tenido un parto normal en alguno de los 16 hospitales p&uacute;blicos    del p
a&iacute;s o de dos hospitales de la seguridad social que prestan servicios    a
 la clase trabajadora hondure&ntilde;a. En un per&iacute;odo de 10 meses se    r
ealizaron entrevistas personales directas, orales y exhaustivas en los propios  
  hospitales antes del alta m&eacute;dica. El coordinador y el equipo de investi
gaci&oacute;n    supervisaron las entrevistas.    ^cY#a07v22n5.htm##
01246000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704101100076002001301087#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#26#22#article#131#<br>   <b>RESULTADO
S: </b>La mayor&iacute;a de las mujeres ten&iacute;an entre 16 y    29 a&ntilde;
os de edad. Aproximadamente la mitad de las encuestadas (46,4%)    hab&iacute;an
 o&iacute;do sobre el &aacute;cido f&oacute;lico y m&aacute;s de    la tercera p
arte (37,6%) sab&iacute;a que era una vitamina relacionada con la    prevenci&oa
cute;n de malformaciones cong&eacute;nitas. Las mujeres encuestadas    atribuyer
on estas malformaciones principalmente al consumo de drogas y alcohol    (20,6%)
 y a la insuficiente ingesta de vitaminas (18,1%); no obstante, 23,0%    relacio
n&oacute; las malformaciones con causas m&iacute;sticas, m&iacute;ticas    o rel
igiosas. En esta poblaci&oacute;n no se consumen muchos alimentos ricos    en fo
latos, excepto frijoles colorados, naranjas y jugos de frutas naturales.    Los 
alimentos b&aacute;sicos m&aacute;s frecuentes que podr&iacute;an fortificarse  
  con &aacute;cido f&oacute;lico fueron el arroz, las pastas y las harinas de   
 trigo y de ma&iacute;z.    ^cY#a07v22n5.htm##
00908000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704067300076002001300749#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#27#23#article#131#<br>   <b>CONCLUSIO
NES: </b>Los resultados de    este estudio abren una posible v&iacute;a para la 
fortificaci&oacute;n de alimentos    y, adem&aacute;s, subrayan la necesidad de 
una mayor educaci&oacute;n sobre    la importancia del &aacute;cido f&oacute;lic
o en la prevenci&oacute;n de malformaciones    del tubo neural en los fetos. Los
 resultados destacan la necesidad de ofrecer    una educaci&oacute;n sanitaria e
standarizada a las mujeres hondure&ntilde;as    en edad reproductiva si se imple
menta de manera exitosa y sostenible el consumo    de &aacute;cido f&oacute;lico
 mediante la fortificaci&oacute;n y suplementaci&oacute;n    de alimentos.</font
></p>     ^cY#a07v22n5.htm##
00453000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704021800076002001300294#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#28#24#article#131#<p><font size="2" f
ace="Verdana"><b>Palabras clave: </b>&Aacute;cido f&oacute;lico,    fisiolog&iac
ute;a de la nutrici&oacute;n prenatal, defectos del tubo neural,    Honduras.</f
ont></p> <hr size="1" noshade>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#29#25#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#30#26#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
01338000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704110300076002001301179#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#31#27#article#131#<p><font size="2" f
ace="Verdana">In 1992, the United States Public Health Service    recommended th
at all women of childbearing age consume 400 micrograms of synthetic    folic ac
id daily to prevent neural tube defects (NTDs), namely spina bifida    and anenc
ephaly (1). Although the rates of NTDs in the United States have decreased    si
nce fortification of the food supply with folic acid, rates among Hispanics    i
n both Latin America and the U.S. have remained high compared to those of non-Hi
spanic    blacks and whites (2–4). The exact reasons for this disparity remain u
nclear,    but research conducted with Hispanic women in the United States has i
ndicated    that levels of folic acid awareness, knowledge, and consumption are 
lowest among    this population (5–10). A 1998 survey conducted by the Gallup Or
ganization (Washington,    DC, United States) for the March of Dimes Birth Defec
ts Foundation found that    English-speaking Hispanic women had lower folic acid
 awareness (53% vs. 72%)    and lower daily consumption (29% vs. 33%) than non-H
ispanic white women (5).</font></p>     ^cY#a07v22n5.htm##
00979000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704074400076002001300820#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#32#28#article#131#<p><font size="2" f
ace="Verdana">In Honduras, one of the poorest countries in    the Western Hemisp
here, the infant mortality rate is 30.8 per 1 000 live births    (2004 data), wi
th the highest number of deaths occurring in the neonatal period    (11). The cu
rrent prevalence of NTDs in Honduras is estimated to be 2.43 per    1 000 births
, with the highest rates occurring in the country’s poorest health    regions (1
2). Although there is no systematized monitoring system for NTDs in    Honduras,
 a 1-year retrospective review of patient records in four Honduran    specialize
d public health hospitals and the two social security hospitals showed    that 4
9% of deaths associated with birth defects were due to NTDs (13).</font></p>    
 ^cY#a07v22n5.htm##
00941000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704070600076002001300782#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#33#29#article#131#<p><font size="2" f
ace="Verdana">Socioeconomic factors contribute to the health    issues faced by 
many Hondurans. Forty-one percent of the population is under    15 years of age 
and almost one-half of births occur at home, without prenatal    care (11). Unde
rreporting of births and deaths is estimated to be 40% and 52%,    respectively 
(14). More than half of the population lives in rural areas. Seventy    percent 
of the population lives in poverty, with half of that cohort living    at the ex
treme poverty level (15). Furthermore, 1 in 5 people over 15 years    of age is 
illiterate (11). These factors challenge the success of even the best-designed  
  health education efforts.</font></p>     ^cY#a07v22n5.htm##
00946000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704071100076002001300787#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#34#30#article#131#<p><font size="2" f
ace="Verdana">Although a dietary intake study of Honduran women    was conducted
 by Holden and colleagues (16), a review of the literature indicates    that the
re are no published reports focusing solely on Honduran women’s levels    of fol
ic acid knowledge and awareness or synthetic folic acid consumption. In    Augus
t 2004, Proyecto Ni&ntilde;os Saludables/ Project Healthy Children surveyed    2
19 women of childbearing age in two public hospitals and four outpatient health 
   care centers in one health region. Of the women interviewed, 50% reported hav
ing    heard about folic acid and 25% of these connected it with the prevention 
of    congenital anomalies (17).</font></p>     ^cY#a07v22n5.htm##
01305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704107000076002001301146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#35#31#article#131#<p><font size="2" f
ace="Verdana">In the United States, folic acid fortification    has successfully
 increased folic acid consumption. Countries such as Chile and    Canada have al
so decreased NTDs though flour fortification programs (18, 19).    In January 20
03, mandatory fortification of wheat flour with folic acid at a    level of 1.8 
mg/kg was legislated in all Central America (20). Wheat flour had    been volunt
arily fortified with 1.4 mg/kg as part of a vitamin pre-mix recommended    by th
e Nutrition Institute of Central America and Panama (INCAP) since 1996    (21; D
r. Doris Chinchilla, personal communication, February 2006). Currently,    MASEC
A, one of four corn flour products in Honduras, voluntarily fortifies its    pro
duct with folic acid (22). The Honduran Ministry of Health is negotiating    wit
h all of the country’s corn flour and pasta producers in an effort to legislate 
   fortification with folic acid (Dr. Vilma Estrada, personal communication, Oct
ober    2005; Dr. Luis Medina, personal communication, September 2005).</font></
p>     ^cY#a07v22n5.htm##
01263000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704102800076002001301104#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#36#32#article#131#<p><font size="2" f
ace="Verdana">In 2003 the Ministry of Health of Honduras approved    the use of 
folic acid for all women of childbearing age for the prevention of    birth defe
cts; however, Public Health Norm 3.2, which regulated the recommended    use of 
folic acid for this population at 1.0 mg per day, was not published until    Aug
ust 2005 and has yet to be adopted throughout the health system (23). Currently,
    women who appear at a public health center for their first prenatal care vis
it    are given 1.0 mg tablets of folic acid for daily consumption (24). However
,    this first prenatal care visit most often occurs late in the pregnancy, wel
l    past the first trimester (25). Because NTDs occur very early in pregnancy, 
before    a woman knows she is pregnant, folic acid consumption must take place 
before    conception and throughout the first trimester to be effective (1). Giv
ing women    folic acid before conception provides the greatest window of opport
unity for    preventing NTDs.</font></p>     ^cY#a07v22n5.htm##
00671000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704043600076002001300512#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#37#33#article#131#<p><font size="2" f
ace="Verdana">The purpose of this study was twofold: (1) to    determine the lev
els of folic acid awareness, knowledge, and practices among    a sample of postp
artum Honduran women, so that a baseline for future educational    efforts might
 be established; and (2) to un-derstand the food consumption patterns    of this
 population so that staples for folic acid fortification might be identified.</f
ont></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#38#34#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00316000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008100076002001300157#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#39#35#article#131#<p><font size="3" f
ace="Verdana"><b>MATERIALS AND METHODS</b></font></p>     ^cY#a07v22n5.htm##
00307000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007200076002001300148#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#40#36#article#131#<p><font size="2" f
ace="Verdana"><b>Participants</b></font></p>     ^cY#a07v22n5.htm##
00903000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704066800076002001300744#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#41#37#article#131#<p><font size="2" f
ace="Verdana">Convenience sampling methodology was used to    recruit study part
icipants. Potential participants for this study were postpartum    Honduran wome
n who had delivered in 1 of 18 hospitals throughout the country    (<a href="#ta
b01">Table 1</a>). Eligible participants were defined as Honduran    postpartum 
women of any age who had had a normal in-hospital delivery without    complicati
ons. Interviews were conducted with participants just prior to discharge    from
 the hospital. Eligible participants had to be able to provide information    th
emselves; information volunteered by family members was not accepted.</font></p>
     ^cY#a07v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#42#38#article#131#<p><a name="tab01">
</a></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#43#39#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#44#40#article#131#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a07tab01.gif"></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#45#41#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00304000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006900076002001300145#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#46#42#article#131#<p><font size="2" f
ace="Verdana"><b>Procedure</b></font></p>     ^cY#a07v22n5.htm##
01432000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704119700076002001301273#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#47#43#article#131#<p><font size="2" f
ace="Verdana">The concept for the structure of the study was    derived from a t
elephone communication with Dr. Cathy R. Wasserman of the Washington    State De
partment of Health (United States) in August 2000. The Honduran Minister    of P
ublic Health gave the research coordinator permission to conduct interviews    i
n the public health and social security hospital systems. Study protocols were  
  approved by the Ethics Committee of the Scientific Research Unit at the Nation
al    Autonomous University of Honduras’ School of Medicine (Facultad de Ciencia
s    M&eacute;dicas, Universidad Nacional Aut&oacute;noma de Honduras (UNAH)). O
nce    permission was granted and the protocols approved, an interview schedule 
was    developed and interviewers were recruited from within the hospital system
. Sixteen    of the hospital sites were public hospitals dispersed throughout th
e country    and the remaining sites were the two social security hospitals that
 provide    services to the Honduran working class population. These sites repre
sent 64.3%    of the hospitals in the public health system and 100% of the hospi
tals in the    social security system.</font></p>     ^cY#a07v22n5.htm##
00312000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007700076002001300153#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#48#44#article#131#<p><font size="2" f
ace="Verdana"><b>Survey instrument</b></font></p>     ^cY#a07v22n5.htm##
00913000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704067800076002001300754#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#49#45#article#131#<p><font size="2" f
ace="Verdana">All items for the survey instrument, except sociodemographic    an
d food frequency items, were based on existing research related to congenital   
 anomalies, NTDs, and folic acid (26–37). Because no food frequency or diet asse
ssment    tool had been used before with Honduran women, the investigators devel
oped a    new instrument from tools previously used by experts in the United Sta
tes (Dr.    Catherine Hayes, personal communication, September 2000; Dr. Maria T
olarova,    personal communication, November 2000). Food consumption items were 
adapted    to include those foods commonly consumed by the Honduran population.<
/font></p>     ^cY#a07v22n5.htm##
01166000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704093100076002001301007#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#50#46#article#131#<p><font size="2" f
ace="Verdana">The initial instrument was tested in two Honduran    public health
 hospitals prior to initiation of survey. Once the appropriate    adjustments we
re made, in-depth, face-to-face oral interviews were conducted    by registered 
nurses, nursing assistants, nursing students, and medical doctors    completing 
their social service requirement for graduation. The research coordinator    and
 staff trained 164 interviewers to administer the survey in a manner that    wou
ld minimize interviewer bias and maximize consistency by reading questions    ex
actly as written, in a non-leading manner, and prompting when needed with    neu
tral statements. Each interviewer was assigned a finite number of interviews    
based on the estimated birth rate per hospital (3% of the estimated births for  
  each hospital for the study year) and number of interviewers assigned to each 
   hospital.</font></p>     ^cY#a07v22n5.htm##
00652000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704041700076002001300493#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#51#47#article#131#<p><font size="2" f
ace="Verdana">Interviews were conducted daily, one hour prior    to hospital dis
charge for each postpartum woman. The questionnaires were kept    in a secured s
ite in the hospital, collected weekly by the research coordinator,    and transp
orted to the Proyecto Ni&ntilde;os Saludables/Project Healthy Children    office
 to be stored in a secure site until data input initiated.</font></p>     ^cY#a0
7v22n5.htm##
00310000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007500076002001300151#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#52#48#article#131#<p><font size="2" f
ace="Verdana"><b>Data collection</b></font></p>     ^cY#a07v22n5.htm##
00562000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704032700076002001300403#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#53#49#article#131#<p><font size="2" f
ace="Verdana">A total of 2 619 women participated in the interviews.    Data fro
m the completed interviews were entered manually into EpiInfo 6 (CDC,    Atlanta
, Georgia, United States), and transferred into SPSS version 14.0 (SPSS    Inc.,
 Chicago, Illinois, United States) for analysis.</font></p>     ^cY#a07v22n5.htm
##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#54#50#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#55#51#article#131#<p><font size="3" f
ace="Verdana"><b>RESULTS</b></font></p>     ^cY#a07v22n5.htm##
00307000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007200076002001300148#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#56#52#article#131#<p><font size="2" f
ace="Verdana"><b>Demographics</b></font></p>     ^cY#a07v22n5.htm##
01330000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704109500076002001301171#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#57#53#article#131#<p><font size="2" f
ace="Verdana">Survey respondents were from 11 to 48 years of    age, with the ma
jority of respondents either 16–19 years of age (24.7%) or 20–24    years of age
 (33.3%). When asked their ethnicity, 97.1% of the respondents indicated    <i>m
estiza</i> (mixed heritage, Spanish/Indigenous/ African). More than three    qua
rters of respondents (80.5%) indicated sharing a home with the father of    thei
r newborn. The highest education level of most respondents was either incomplete
    primary school education (31.1%) or complete primary school education (39.2%
).    More than half (64.8%) indicated that they did not work outside the home. 
The    reported monthly income of 17.6% of respondents was from 100 to 1 200 Hon
duran    Lempiras (HNL) (US$ 3.00–80.00 in 2001); 68.0% from 1 201–6 000 HNL (US
$ 81–400);    5.8% from 6 001–12 000 HNL (US$ 401–800); and 0.9% from 1 201–35 0
00 HNL (US$    801–$2 333). Approximately 7% of respondents did not know their m
onthly income.    The majority of this cohort indicated that their income was su
bsistence based.</font></p>     ^cY#a07v22n5.htm##
00345000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011000076002001300186#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#58#54#article#131#<p><font size="2" f
ace="Verdana"><b>Prenatal care: knowledge, attitudes, and practices</b></font></
p>     ^cY#a07v22n5.htm##
00979000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704074400076002001300820#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#59#55#article#131#<p><font size="2" f
ace="Verdana">When asked whether they had received some kind    of prenatal care
, 88.5% of respondents indicated that they had. Of these, 50.2%    had 1–5 prena
tal care visits, while 47.1% had 6–10 visits. More than half (59.8%)    had pren
atal care at a public clinic. The majority of the respondents (90.2%)    indicat
ed they had been given vitamins; 72.6% said a doctor had told them to    take vi
tamins. Of those who had been given vitamins, the largest percentages    receive
d them in either the second (22.3%) or third (23.0%) month of pregnancy,    whil
e only a small number reported receiving vitamins either before pregnancy    (0.
2%) or in the first month (14.6%) (<a href="#tab02">Table 2</a>).</font></p>    
 ^cY#a07v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#60#56#article#131#<p><a name="tab02">
</a></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#61#57#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#62#58#article#131#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a07tab02.gif"></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#63#59#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00342000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010700076002001300183#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#64#60#article#131#<p><font size="2" f
ace="Verdana"><b>Folic acid: knowledge, attitudes, and practices</b></font></p> 
    ^cY#a07v22n5.htm##
01431000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704119600076002001301272#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#65#61#article#131#<p><font size="2" f
ace="Verdana">When asked specifically about folic acid, 46.4%    of respondents 
had heard of it, with the majority of those (68.6%) having heard    about it fro
m a health care provider. When asked what they had heard about folic    acid, th
e most common responses were that it helped avoid birth defects and/or    was go
od for the growth and development of the baby (37.6%), was a vitamin or    was r
elated to anemia or iron (24.1%), was good for the baby (22.9%), or good    for 
health in general (7.8%). When discussing folic acid consumption, 55.2%    of th
e respondents indicated they had received folic acid before or during pregnancy,
    while 44.5% indicated they had not received folic acid at all. The largest n
umber    of respondents who did receive folic acid had received it in their seco
nd (21.6%)    or third month (21.4%) of pregnancy (<a href="#tab02">Table 2</a>)
. Of those    who reported having received folic acid, 97.4% reported taking it 
daily. The    majority of respondents (87.7%) reported that a doctor told them t
o take folic    acid. Of the women surveyed, 62.3% indicated using some kind of 
medication during    their pregnancy.</font></p>     ^cY#a07v22n5.htm##
00345000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011000076002001300186#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#66#62#article#131#<p><font size="2" f
ace="Verdana"><b>Birth defects: knowledge, attitudes, and practices</b></font></
p>     ^cY#a07v22n5.htm##
01480000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704124500076002001301321#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#67#63#article#131#<p><font size="2" f
ace="Verdana">When asked why infants are born with birth defects,    23.0% of re
spondents related the causes to superstitious, mythical, or religious    beliefs
 such as watching an eclipse, laughing at people with disabilities or    the wil
l of God. Alcohol, drugs, or medications not prescribed by a physician    were m
entioned by 20.6% of respondents, while a lack of vitamins or improper    nutrit
ion was mentioned by 18.1% of respondents. Lack of prenatal care or not    takin
g care of oneself was mentioned by 16.3%, while 22.1% of respondents indicated  
  that they did not know or remember what causes birth defects. When asked wheth
er    birth defects could be prevented, 68.5% indicated that they could be. When
 asked    how they could be prevented, 36.6% of respondents indicated prenatal c
are and/or    taking care of oneself. Another 20.4% of respondents indicated con
suming vitamins    and eating well; 20.4% indicated avoidance of alcohol, drugs,
 and medications    not prescribed by a physician; and 15.4% believed that engag
ing in mystical,    mythical, and/or religious practices, such as wearing red du
ring an eclipse    or praying to God for a healthy child, could prevent birth de
fects.</font></p>     ^cY#a07v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#68#64#article#131#<p><font size="2" f
ace="Verdana"><b>Food frequency items</b></font></p>     ^cY#a07v22n5.htm##
00756000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704052100076002001300597#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#69#65#article#131#<p><font size="2" f
ace="Verdana">Although researchers asked women about their    consumption of a w
ide variety of food items, for the purposes of this report,    only those that h
ave the potential to be fortified or are naturally high sources    of folate hav
e been included. Respondents were asked how often and what serving    size of ea
ch food product they consumed, but for purposes of this data analysis,    food c
onsumption responses were categorized as "yes" to indicate consumption    or "no
."</font></p>     ^cY#a07v22n5.htm##
00856000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704062100076002001300697#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#70#66#article#131#<p><font size="2" f
ace="Verdana">Three quarters (77.5%) of respondents reported    drinking natural
 juice, 64.1% juice from concentrate, and 90.5% reported eating    oranges. Near
ly all (94.2%) reported eating red beans, but very few (10.8%)    consumed peas,
 garbanzo beans, or lentils. Regarding vegetable consumption,    24.5% of respon
dents indicated eating broccoli and only 4.9% eating spinach.    Half of the wom
en (50.6%) consumed lettuce. The type of lettuce was not specified    in the sur
vey because iceberg lettuce was the only type available in public    markets at 
the time of the study.</font></p>     ^cY#a07v22n5.htm##
01832000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704159700076002001301673#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#71#67#article#131#<p><font size="2" f
ace="Verdana">Both corn and white flour tortillas are widely    consumed in Hond
uras, but they are prepared in different ways. The <i>nixtamalizado</i>    torti
lla is made directly from corn variety. The kernels are first boiled with    lim
e, washed, ground in manual grinders, and then made into a tortilla. Corn    tor
tillas can also be made directly from packaged corn flour that is mixed with    
water and then made into a tortilla. White flour tortillas are either prepared  
  from a mixture of white flour, lard, salt, baking soda, and water or bought   
 pre-packaged. In all, 83.1% of respondents reported consuming <i>nixtamalizado<
/i>    corn tortillas, 34.4% reported consuming packaged corn-flour tortillas, a
nd    58% reported consuming white flour tortillas. When it came to other grain 
products,    62.5% of the respondents consumed white bread, while only 16.6% con
sumed whole    wheat bread. Other frequently consumed staple foods were spaghett
i (87.4%);    rice (95.2%); and crackers, pastries, and sweet breads (73.8%). In
 keeping with    a Honduran tradition used to stimulate the production of breast
 milk, approximately    54% of respondents indicated consuming an oatmeal-based 
beverage exclusively    during pregnancy and the postpartum months; however, ove
rall, breakfast cereals    were not widely consumed. Only 12.9% of women indicat
ed that they consumed cereals    such as granola, fiber, or ground wheat; 27.7% 
consumed Central American cereals    (less fortified); and only 4.7% consumed No
rth American cereals (more fortified).</font></p>     ^cY#a07v22n5.htm##
01057000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704082200076002001300898#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#72#68#article#131#<p><font size="2" f
ace="Verdana">The consumption frequency of selected staple    food items that ha
ve the potential to be fortified were analyzed in relation    to the respondents
’ monthly incomes (<a href="#tab03">Table 3</a>). Consumption    of rice and tor
tillas was high for all respondents regardless of income level.    There were di
fferences by income group, however, when further segmenting by    type of tortil
la product. Consumption of <i>nixtamalizado</i> corn tortillas    was highest am
ong the lower-income groups, while consumption of the packaged    corn-flour tor
tillas was highest among the higher-income groups. Spaghetti and    white bread 
were widely consumed regardless of income level. Consumption of    the more cost
ly whole wheat bread was higher among the higher-income groups.</font></p>     ^
cY#a07v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#73#69#article#131#<p><a name="tab03">
</a></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#74#70#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#75#71#article#131#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a07tab03.gif"></p>     ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#76#72#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#77#73#article#131#<p><font size="3" f
ace="Verdana"><b>DISCUSSION</b></font></p>     ^cY#a07v22n5.htm##
01236000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704100100076002001301077#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#78#74#article#131#<p><font size="2" f
ace="Verdana">It is of importance to note that at the time    of this study, the
 Ministry of Health’s Norm for folic acid consumption was    limited to pregnant
 women for the prevention of megaloblastic anemia (24). Although    more than ha
lf of the women reported receiving folic acid, only 0.2% of these    women repor
ted receiving it before pregnancy. Nearly three-quarters of the women    who rep
orted consuming vitamins during their pregnancy had received them from    a phys
ician. These data highlight the willingness of these women to consume    vitamin
s given to them by their physicians, and underscore the important role    that p
hysicians can play in educating female patients about folic acid and encouraging
    its consumption among this population. Educating women about folic acid and 
   the need to take it before conception is just as essential to a comprehensive
    folic acid initiative as is educating the providers about folic acid benefit
s.</font></p>     ^cY#a07v22n5.htm##
01431000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704119600076002001301272#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#79#75#article#131#<p><font size="2" f
ace="Verdana">More than one-half of the women in this study    reported that the
y had heard about folic acid. Of these, more than one-third    associated it wit
h preventing defects and/or good growth and development of    the baby; and one-
quarter identified it as a vitamin, associated it with anemia,    or associated 
it with iron. Given that birth defects are multicausal, it is    encouraging tha
t more women associated taking vitamins, eating well, and/or    avoiding alcohol
 and drugs with prevention of birth defects, rather than with    supernatural pr
actices such as wearing red during an eclipse. Understanding    the scientific c
auses of birth defects and being able to make a connection between    birth defe
cts and prevention is an important educational component that may    still be la
cking among the respondent population. Without knowing the rationale    for taki
ng folic acid, it could be less likely that women in this target population    w
ould sustain the behavior. Providing women with accurate folic acid education   
 is an important step to ensuring folic acid intake both before pregnancy and   
 throughout their reproductive years.</font></p>     ^cY#a07v22n5.htm##
01844000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704160900076002001301685#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#80#76#article#131#<p><font size="2" f
ace="Verdana">In Honduras, multiple social and economic factors    make the sust
ainability of a supplementation program more challenging. The combination    of 
a very young population, high poverty and illiteracy rates, and a primarily    r
ural population can be significant challenges to distributing the folic acid    
supplement and reaching an audience with a health message. Several possible    a
venues have been identified to overcome such barriers. One would be the use    o
f volunteer lay health workers known as <i>promotoras, madres guias</i>, or    <
i>madres maestros</i>. These volunteers could work within their own communities 
   as well as surrounding communities. The possibility of linking <i>promotora</
i>-led    folic acid supplementation and education efforts to existing successfu
l programs,    such as the country-wide immunization program, is another avenue 
worth exploring.    Religious and secular associations, both national and intern
ational, have built    trust with hard-to-reach communities and established infr
astructures that could    lend themselves to a sustainable combined education an
d supplementation program.    Rural communities and even <i>barrios</i> (neighbo
rhoods) within large cities    have their own <i>patronatos</i> (steering commit
tees) elected by community    members to oversee the well-being of the community
. Education directed at members    of these groups would allow for dissemination
 of education materials by those    who are already trusted, thereby increasing 
the likelihood of the program’s    sustainability.</font></p>     ^cY#a07v22n5.h
tm##
01830000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704159500076002001301671#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#81#77#article#131#<p><font size="2" f
ace="Verdana">As mentioned previously, a major concern of any    folic acid effo
rt in Honduras is reaching a population that is largely rural    and primarily s
ubsistence-based. Fortification of corn flour used to make tortillas    would al
low folic acid to reach a certain portion of the population. Findings    from th
is study indicate a higher consumption of packaged white-flour tortillas    than
 packaged corn-flour tortillas, underscoring the benefit of the 2003 Central    
American mandate requiring wheat flour fortification. White bread consumption   
 was widespread with the highest consumption among the highest income level,    
while whole wheat bread was less frequently consumed by the population regardles
s    of income level. Spaghetti was found to be a very highly consumed product a
mong    all income levels. Fortifying pasta products, then, could be a potential
 avenue    for reaching a large segment of the population. It is important to co
nsider,    however, that food consumption can potentially vary between regions o
f the country.    A study conducted by the Pediatric Medical Mission University 
of Armed Services    (38) suggests that the use of flour products is found more 
in urban than rural    areas. Researchers conducting home visits found no wheat 
flour or wheat flour    products in any of the homes in rural communities surrou
nding La Paz, Honduras    (38). Finding those food products that are staple to a
 country, regardless of    region, can help ensure that fortification efforts re
ach the widest possible    audience.</font></p>     ^cY#a07v22n5.htm##
01508000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704127300076002001301349#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#82#78#article#131#<p><font size="2" f
ace="Verdana">Holden and colleagues (16) found that given the    frequency of ri
ce and tortilla (non-specified type) consumption, fortifying    these staple pro
ducts with folic acid could prevent a high number of NTDs. Similarly,    the cur
rent study found very high consumption of rice and tortillas, although    a high
er percentage of women consumed the <i>nixtamalizado</i> tortillas than    any o
ther type. Because this type of tortilla is essentially hand processed    direct
ly from the corn kernel, fortification may be more challenging. Holden    (16) s
tated in his article that one potential method of fortification for the    <i>ni
xtamalizado</i> tortillas widely consumed in rural communities is adding    foli
c acid to the water used to wash the corn before grinding, because most    women
 use a community grinding machine for that purpose. A 2002 study by INCAP    (39
) explored this method of fortification in rural Guatemalan communities.    Whil
e fortification with this method was found to be successful, lack of funding    
to further explore quality control issues regarding over- or under- fortificatio
n    of the product have yet to be examined (Dr. Rub&eacute;n Grajeda, personal 
communication,    September 2004).</font></p>     ^cY#a07v22n5.htm##
00940000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704070500076002001300781#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#83#79#article#131#<p><font size="2" f
ace="Verdana">Given the socioeconomic challenges this country    faces, fortific
ation alone may not be effective in reaching all of the population    or in prov
iding the recommended daily levels needed for NTD prevention. Yet,    without th
e full implementation of a folic acid fortification program, it is    difficult 
to assess which avenues are most effective and where the gaps in reaching    the
 population exist. While Honduras has been included in some studies looking    a
t potential fortification efforts, these studies have primarily centered on    i
ron fortification (21). Research examining the impact of folic acid fortificatio
n    efforts is necessary.</font></p>     ^cY#a07v22n5.htm##
00745000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704051000076002001300586#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#84#80#article#131#<p><font size="2" f
ace="Verdana">Combining fortification and supplementation efforts    may be the 
most effective way to maximize resources and reach the largest number    of Hond
uran women. Developing and implementing a strong folic acid education    program
 and integrating this educational component with the fortification and    supple
mentation efforts can help to ensure awareness of folic acid, acceptance    of t
he folic acid message, and compliance with the program recommendations.</font></
p>     ^cY#a07v22n5.htm##
00894000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704065900076002001300735#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#85#81#article#131#<p><font size="2" f
ace="Verdana">In this study, nearly half of the women interviewed    were aware 
of folic acid due to the emphasis placed on the prevention of megaloblastic    a
nemia at that time by the Honduran Health System. However, fewer than half    as
sociated folic acid with fetal development. A strong foundation of folic acid   
 education would maximize the effects of a national supplementation campaign    
designed to increase folic acid consumption. Similarly, a nutrition education   
 component emphasizing natural folate sources and fortified food products could 
   increase the overall health of women of childbearing age.</font></p>     ^cY#
a07v22n5.htm##
01765000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704153000076002001301606#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#86#82#article#131#<p><font size="2" f
ace="Verdana">There are limitations to this study. Findings    are based on the 
responses of a convenience sample of postpartum women who agreed    to participa
te in the study. Having just been through a pregnancy, these women    may be mor
e knowledgeable about folic acid than the general population. Moreover,    findi
ngs of this study do not reflect the knowledge and behaviors of Honduran    wome
n who lack access to prenatal care and hospital delivery. The income level    of
 respondents is higher than the general population; therefore, the data cannot  
  be generalized to the most resource-poor populations of Honduras. Because medi
cal    personnel conducted the surveys, the respondents may have been more likel
y to    answer favorably to questions related to health care provider recommenda
tions.    Study respondents appear receptive to folic acid education and recomme
ndations    provided by their public health physicians; however, these physician
s are not    available to all Hondurans. Folic acid education and distribution s
trategies    must be implemented with the disadvantages of this latter segment o
f the population    in mind. Finally, for the food intake portion of the survey 
instrument, the    respondent had to recall the portion size of a particular foo
d item, as well    as the frequency of its consumption, but because this might h
ave led to inaccurate    estimations, this data analysis categorized responses a
s either "yes,"    indicating consumption, or "no."</font></p>     ^cY#a07v22n5.
htm##
01220000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704098500076002001301061#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#87#83#article#131#<p><font size="2" f
ace="Verdana">The findings of this study could be used to assist    the Honduran
 government in making decisions regarding the selection of adequate    vehicles 
for food fortification and how to proceed with a nationwide folic acid    educat
ion effort. In a country such as Honduras, where there are significant    challe
nges associated with socioeconomics, isolation due to rurality, and a    primari
ly subsistence-based lifestyle, achieving the goal of increasing folic    acid c
onsumption will require a three-pronged approach—combining folic acid    educati
on with supplementation and fortification efforts. Possibilities for    future r
esearch include the evaluation of the effectiveness of educational efforts,    a
nd alternative forms of folic acid supplements, such as sprinkles, or a combined
    folic acid and iron tablet. Furthermore, research related to NTD risk factor
s,    such as genetic mutations and fumonisin, are also warranted.</font></p>   
  ^cY#a07v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#88#84#article#131#<p>&nbsp;</p>     ^
cY#a07v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#89#85#article#131#<p><font size="3" f
ace="Verdana"><b>REFERENCES</b></font></p>     ^cY#a07v22n5.htm##
00499000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704025000078002001300328#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#90#86#article#131#1#<p><f
ont size="2" face="Verdana">1. Centers for Disease Control and Prevention.    Re
commendations for the use of folic acid to reduce the number of cases of spina  
  bifida and other neural tube defects. MMWR. 1992; 41(RR-14):1–7.</font></p>   
 ^cY#a07v22n5.htm##
00483000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704023400078002001300312#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#91#87#article#131#2#<p><f
ont size="2" face="Verdana"> 2. Williams LJ, Rasmussen S, Flores AL, Kirby    R,
 Edmonds L. Decline in the prevalence of spina bifida and anencephaly by race-et
hnicity,    1995-2002. Pediatrics. 2005;166:580–6.</font></p>    ^cY#a07v22n5.ht
m##
00517000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704026800078002001300346#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#92#88#article#131#3#<p><f
ont size="2" face="Verdana"> 3. Kirby R, Petrini J, Alter C, The Hispanic    Eth
nicity Birth Defects Workgroup. Collecting and interpreting birth defects    sur
veillance data by Hispanic ethnicity: A comparative study. Teratology. 2000;61:2
1–7.</font></p>    ^cY#a07v22n5.htm##
00592000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704034300078002001300421#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#93#89#article#131#4#<p><f
ont size="2" face="Verdana"> 4. Mutchinick OM, L&oacute;pez MA, Luna L, Waxman  
  J, Babinsky VE, RYVEMCE Collaborative Group. High prevalence of the thermolabi
le    methylenetetrahydrofolate reductase variant in Mexico: A country with a ve
ry    high prevalence of neural tube defects. Mol Gen and Metab. 1999;68:461–7.<
/font></p>    ^cY#a07v22n5.htm##
00629000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704038000078002001300458#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#94#90#article#131#5#<p><f
ont size="2" face="Verdana"> 5. The Gallup Organization for the National    Marc
h of Dimes Birth Defects Foundation. Preparing for pregnancy III: Third    natio
nal survey of women’s behavior and knowledge relative to consumption of    folic
 acid and other vitamins and pre-pregnancy care. 1998;March of Dimes: White    P
lains NY.(Report number 31-1154-98).</font></p>    ^cY#a07v22n5.htm##
00433000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704018400078002001300262#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#95#91#article#131#6#<p><f
ont size="2" face="Verdana"> 6. Ahluwalia IB, Lyon Daniel K. Are women with    r
ecent live births aware of the benefits of folic acid? MMWR. 2001;50(RR06):3–14.
</font></p>    ^cY#a07v22n5.htm##
00597000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704034800078002001300426#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#96#92#article#131#7#<p><f
ont size="2" face="Verdana"> 7. P&eacute;rez-Escamilla R, Himmelgreen D,    Segu
ra-Mill&aacute;n S, Gonz&aacute;lez A, M&eacute;ndez I, Haldeman L. Knowledge   
 of folic acid and neural tube defects among inner-city residents: Have they    
heard about it? Research and Professional Briefs. J Am Diet Assoc. 1999; 99(1):8
0–3.</font></p>    ^cY#a07v22n5.htm##
00537000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704028800078002001300366#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#97#93#article#131#8#<p><f
ont size="2" face="Verdana"> 8. Carmichael SL, Shaw GM, Yang W, Laurent C,    He
rring A, Royle H, et al. National birth defects prevention study: Correlate    o
f intake of folic acid-containing supplements among pregnant women. Am J Obst   
 Gyn. 2006; 194: 203–10.</font></p>    ^cY#a07v22n5.htm##
00491000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704024200078002001300320#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#98#94#article#131#9#<p><f
ont size="2" face="Verdana"> 9. Jasti S, Siega-Riz AM, Bentley ME. Dietary    su
pplement use in the context of health disparities: Cultural, ethnic and demograp
hic    determinants of use. J Nutr. 2003;133:2010S– 2013S.</font></p>    ^cY#a07
v22n5.htm##
00520000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027000079002001300349#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#99#95#article#131#10#<p><
font size="2" face="Verdana">10. Balluz LS, Kieszak SM, Philen RM, Mulinare    J
. Vitamin and mineral supplement use in the United States: Results from the    T
hird National Health and Nutrition Examination Survey. Arch Fam Med; 2000:9:258–
62.    </font></p>    ^cY#a07v22n5.htm##
00462000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704021100080002001300291#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#100#96#article#131#11#<p>
<font size="2" face="Verdana">11. Secretaria de Salud. Situaci&oacute;n de    sa
lud en Honduras: Indicadores b&aacute;sicos, 2004. Tegucigalpa Metro Distrito   
 Central: El Instituto; 2005.</font></p>    ^cY#a07v22n5.htm##
00516000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704026500080002001300345#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#101#97#article#131#12#<p>
<font size="2" face="Verdana">12. Milla G, Uma&ntilde;a E, Mayes I. Prevalencia 
   hospitalaria de anomal&iacute;as cong&eacute;nitas en Honduras &#91;data pres
entation&#93;.    San Pedro Sula, Honduras: Proyecto Ni&ntilde;os Saludables; 20
02.</font></p>    ^cY#a07v22n5.htm##
00534000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704028300080002001300363#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#102#98#article#131#13#<p>
<font size="2" face="Verdana">13. Milla G, Uma&ntilde;a E, &amp; Mayes I. Los   
 costos hospitalarios directos de anomal&iacute;as cong&eacute;nitas en Honduras
    &#91;data presentation&#93;. San Pedro Sula, Honduras: Proyecto Ni&ntilde;os
 Saludables;    2003.</font></p>    ^cY#a07v22n5.htm##
00459000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704020800080002001300288#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#103#99#article#131#14#<p>
<font size="2" face="Verdana">14. Instituto Nacional de Estad&iacute;sticas.    
Censo nacional de poblaci&oacute;n y vivienda. Tegucigalpa Metro Distrito Centra
l:    El Instituto; 2001. </font></p>    ^cY#a07v22n5.htm##
00471000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704021900081002001300300#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#104#100#article#131#15#<p
><font size="2" face="Verdana">15. Instituto Nacional de Estad&iacute;sticas.   
 Encuesta de hogares de prop&oacute;sitos m&uacute;ltiples. Tegucigalpa Metro   
 Distrito Central: El Instituto; 2004.</font></p>    ^cY#a07v22n5.htm##
00495000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024300081002001300324#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#105#101#article#131#16#<p
><font size="2" face="Verdana">16. Holden KR, Collins JS, Greene JF, Hinkle    S
, Nave AF, Portillo JM, et al. Dietary intake and blood folate levels in Hondura
n    women of childbearing age. J Child Neurol 2002;17: 341–6.</font></p>    ^cY
#a07v22n5.htm##
00540000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704028800081002001300369#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#106#102#article#131#17#<p
><font size="2" face="Verdana">17. Wu DY, Brat G, Milla G. Folic acid knowledge 
   and usage amongst region number 3 patients and health workers in Honduras &#9
1;data    presentation&#93;; San Pedro Sula, Honduras: Proyecto Ni&ntilde;os Sal
udables; September    2004.</font></p>    ^cY#a07v22n5.htm##
00532000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704028000081002001300361#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#107#103#article#131#18#<p
><font size="2" face="Verdana">18. Hertrampf E, Cort&eacute;s F, Erickson JD,   
 Cayazzo M, FreireW, Bailey LB, et al. Consumption of folic acid–fortified bread
    improves folate status in women of reproductive age in Chile. Jnl of Nutr. 2
003;133:3166–9.    </font></p>    ^cY#a07v22n5.htm##
00541000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704028900081002001300370#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#108#104#article#131#19#<p
><font size="2" face="Verdana">19. Ray JG, Cole DE, Boss SC. An Ontario-wide    
study of vitamin B12, serum folate, and red cell folate levels in relation to   
 plasma homocysteine: Is a preventable public health issue on the rise? Clin    
Biochem. 2000;33(5): 337–43.</font></p>    ^cY#a07v22n5.htm##
00489000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704023700081002001300318#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#109#105#article#131#20#<p
><font size="2" face="Verdana">20. Comisi&oacute;n de Ministros de econom&iacute
;a    de Centroam&eacute;rica. Reglamento t&eacute;cnico de la uni&oacute;n adua
nera    centroamericana 2002, XXIV. (R-UAC 67.01.15.12).</font></p>    ^cY#a07v2
2n5.htm##
00517000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704026500081002001300346#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#110#106#article#131#21#<p
><font size="2" face="Verdana">21. Darnton-Hill I, Mora JO, Weinstein H, Wilbur 
   S, Nalubola PR. Iron and folate fortification in the Americas to prevent and 
   control micronutrient malnutrition: An analysis. Nutrl Rev. 1999;57(1):25–31.
    </font></p>    ^cY#a07v22n5.htm##
00499000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704024700081002001300328#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#111#107#article#131#22#<p
><font size="2" face="Verdana">22. Secretaria de Salud Marca Registrada (MASECA 
   Registro Sanitario Hondure&ntilde;o RSA 3-0006187-02-2005) Departamento de Re
gulaci&oacute;n,    Secretaria de Salud. Tegucigalpa DC, Honduras.</font></p>   
 ^cY#a07v22n5.htm##
00446000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019400081002001300275#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#112#108#article#131#23#<p
><font size="2" face="Verdana">23. Secretaria de Salud. Normas nacionales de    
atenci&oacute;n materna-neonatal. Tegucigalpa Metro Distrito Central: El Institu
to;    2005. </font></p>    ^cY#a07v22n5.htm##
00477000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022500081002001300306#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#113#109#article#131#24#<p
><font size="2" face="Verdana">24. Secretaria de Salud de Honduras. Manual de   
 normas y procedimientos de atenci&oacute;n integral a la mujer. Tegucigalpa    
Metro Distrito Central: El Instituto; 1999. </font></p>    ^cY#a07v22n5.htm##
00593000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704034100081002001300422#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#114#110#article#131#25#<p
><font size="2" face="Verdana">25. Secretaria de Salud, Asociaci&oacute;n Hondur
e&ntilde;a    de Planificaci&oacute;n de Familia (ASHONPLAFA), la Agencia de los
 Estados Unidos    para el Desarrollo Internacional (USAID). Encuesta nacional d
e epidemiolog&iacute;a    y salud familiar. Tegucigalpa MDC: El Instituto; 2001.
</font></p>    ^cY#a07v22n5.htm##
00520000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704026800081002001300349#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#115#111#article#131#26#<p
><font size="2" face="Verdana">26. Al-Gazali LI, Szthriha L, Dawodu A, Bakir    
M, Varghese M, Varady E, et al. Patterns of central nervous system anomalies    
in a population with high rate of consanguineous marriage. Clin Gen. 1999;55(2):
95–102.</font></p>    ^cY#a07v22n5.htm##
00477000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022500081002001300306#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#116#112#article#131#27#<p
><font size="2" face="Verdana">27. Tolarova M. Genetics, Gene Carriers, and    E
nvironment. In: Bader JD (ed). Risk Assessment in Dentistry. Chapel Hill: Univer
sity    of North Carolina; 1990. Pp. 116–79.</font></p>    ^cY#a07v22n5.htm##
00503000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704025100081002001300332#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#117#113#article#131#28#<p
><font size="2" face="Verdana">28. Becerra, JE, Khoury,MJ, Cordero,JE, Erickson 
   JD. Diabetes mellitus during pregnancy and the risks for specific birth defec
ts:    A population based case-control study. Pediatrics. 1990;85:1–9.</font></p
>    ^cY#a07v22n5.htm##
00424000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704017200081002001300253#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#118#114#article#131#29#<p
><font size="2" face="Verdana">29. CDC. Valproate: A new cause of birth defect—R
eport    from Italy and follow-up from France. MMWR. 1983;32(33):438-9.</font></
p>    ^cY#a07v22n5.htm##
00417000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704016500081002001300246#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#119#115#article#131#30#<p
><font size="2" face="Verdana">30. Covani A, Gupta AK, Jeavons PM. Sodium valpro
ate:    monotherapy and polytherapy. Epilepsia. 1982;6:693–-720.</font></p>    ^
cY#a07v22n5.htm##
00401000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704014900081002001300230#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#120#116#article#131#31#<p
><font size="2" face="Verdana">31. Jeavons PM. Non dose related side effects    
of valproate. Epilepsia. 1984;25(Suppl 1):S50–5.</font></p>    ^cY#a07v22n5.htm#
#
00457000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020500081002001300286#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#121#117#article#131#32#<p
><font size="2" face="Verdana">32. Garcia AM, Fletcher T, Benavides FG, Orts    
E. Parental agricultural work and selected congenital malformations. Am J of    
Epi. 1999; 149(1):64–73.</font></p>    ^cY#a07v22n5.htm##
00476000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022400081002001300305#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#122#118#article#131#33#<p
><font size="2" face="Verdana">33. Goodman MR, Gorlin JR. Fetal environment    s
yndromes. In: Goodman MR, Gorlin JR. The malformed infant and child. New York:  
  Oxford University Press; 1983. Pp. 11–36.</font></p>    ^cY#a07v22n5.htm##
00480000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022800081002001300309#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#123#119#article#131#34#<p
><font size="2" face="Verdana">34. Reece EA, Homko CJ, Wu YK, Wiznitzer A. The  
  role of free radicals and membrane lipids in diabetes-induced congenital malfo
rmations.    J Soc Gyn Inves. 1988;5(4):178–87.</font></p>    ^cY#a07v22n5.htm##
00521000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704026900081002001300350#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#124#120#article#131#35#<p
><font size="2" face="Verdana">35. Restrepo M, Munoz N, Day N, Parra JE, Hernand
ez    C, Blettner M, et al. Birth defects among children born to a population oc
cupationally    exposed to pesticides in Columbia. Scand J Work Environ. 1990;(4
):232–8.</font></p>    ^cY#a07v22n5.htm##
00448000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704019600081002001300277#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#125#121#article#131#36#<p
><font size="2" face="Verdana">36. Shaw GM, Velie EM, Morland KB. Parental recre
ational    drug use and risk for neural tube defects. Am J. Epidemol. 1996;144(1
2):1155–60.    </font></p>    ^cY#a07v22n5.htm##
00481000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704022900081002001300310#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#126#122#article#131#37#<p
><font size="2" face="Verdana">37. Wasserman C, Shaw G, Selvin S, Gould J, Syme 
   S. Socioeconomic status, neighborhood social conditions, and neural tube defe
cts.    Amer J Public Health. 1998;(11):1674–80.</font></p>    ^cY#a07v22n5.htm#
#
00452000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704020000081002001300281#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#127#123#article#131#38#<p
><font size="2" face="Verdana">38. Lynch J, Kemmer T, Lougee D. Pediatric Nutrit
ion    Medicine Missions. San Antonio Texas: Armed Services University of Health
 Services.    2001.</font></p>    ^cY#a07v22n5.htm##
00714000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000300078704046200081002001300543#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#128#124#article#131#39#<p
><font size="2" face="Verdana">39. De Le&oacute;n L, Romero ME. Fortificaci&oacu
te;n    de ma&iacute;z nixtamalizado con hierro y &aacute;cido f&oacute;lico a n
ivel    de molinos comunitarios: Desarrollo de tecnolog&iacute;a y aceptabilidad
 al    consumidor. Available from: <a href="http://www.bvssan.incap.org.gt/bvs_i
ncap/E/pubtec.htm" target="_blank">http://www.bvssan.incap.org.gt/    bvs_incap/
E/pubtec.htm</a>. Accessed 13 March 2006.</font></p>    ^cY#a07v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#129#125#article#131#<p>&nbsp;</p>    
 ^cY#a07v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#130#126#article#131#<p>&nbsp;</p>    
 ^cY#a07v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007700078002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#131#127#article#131#<p><font size="2"
 face="Verdana">Manuscript received on 31 July 2006.    ^cY#a07v22n5.htm##
00324000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008700078002001300165#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#132#128#article#131#<br>   Revised ve
rsion accepted for publication on 16 October 2007.</font></p>     ^cY#a07v22n5.h
tm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#133#129#article#131#<p>&nbsp;</p>    
 ^cY#a07v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#134#130#article#131#<p>&nbsp;</p>    
 ^cY#a07v22n5.htm##
00582000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704034500078002001300423#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a07v22n5.htm#S#p#135#131#article#131#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> Send correspondence    to: 
Gayle R. Milla, 5 Avenida entre 7 y 8 Calle N.O. #80, Barrio Guamilito,    San P
edro Sula, Honduras; telephone/fax: 011 504 5504795 email: <a href="mailto:gmill
a@projecthealthychildren.org">gmilla@projecthealthychildren.org</a>.</font></p> 
    ^cY#a07v22n5.htm##
00589000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750110043000770120122001200300
00500242065000900247064000500256031000300261032000600264014000400270865000900274
002001300283035001000296801000500306#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#136#1#article#39#1#Centers for Disease Control and Prevention#Rec
ommendations for the use of folic acid to reduce the number of cases of spina bi
fida and other neural tube defects^len#MMWR#19920000#1992#41#RR-14#1-7#20071100#
a07v22n5.htm#0149-2195#MMWR##
00647000000000313000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100019000770100019000960100
01700115010001500132010001700147012009100164030001100255065000900266064000500275
031000400280014000600284865000900290002001300299035001000312801001100322#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#137#2#article#39#2#^rND^sWill
iams^nLJ#^rND^sRasmussen^nS#^rND^sFlores^nAL#^rND^sKirby^nR#^rND^sEdmonds^nL#Dec
line in the prevalence of spina bifida and anencephaly by race-ethnicity, 1995-2
002^len#Pediatrics#20050000#2005#166#580-6#20071100#a07v22n5.htm#0031-4005#Pedia
trics##
00645000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100017000920100
01500109012015500124030001100279065000900290064000500299031000300304014000500307
865000900312002001300321035001000334801001100344#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#138#3#article#39#3#^rND^sKirby^nR#^rND^sPetrini^nJ#^r
ND^sAlter^nC#The Hispanic Ethnicity Birth Defects Workgroup: Collecting and inte
rpreting birth defects surveillance data by Hispanic ethnicity: A comparative st
udy^len#Teratology#20000000#2000#61#21-7#20071100#a07v22n5.htm#0040-3709#Teratol
ogy##
00727000000000313000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100021000770100016000980100
01400114010001600128010001900144011002800163012015600191030001900347710000200366
065000900368064000500377031000300382014000600385865000900391002001300400#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#139#4#article#39#4#^rND^sMutc
hinick^nOM#^rND^sLópez^nMA#^rND^sLuna^nL#^rND^sWaxman^nJ#^rND^sBabinsky^nVE#RYVE
MCE Collaborative Group#High prevalence of the thermolabile methylenetetrahydrof
olate reductase variant in Mexico: A country with a very high prevalence of neur
al tube defects^len#Mol Gen and Metab.#2#19990000#1999#68#461-7#20071100#a07v22n
5.htm##
00662000000000241000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170081000770180169001580650
00900327064000500336062001500341066001700356061002500373865000900398002001300407
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#140#5#article#39#5#Th
e Gallup Organization for the National March of Dimes Birth Defects Foundation#P
reparing for pregnancy III: Third national survey of women’s behavior and knowle
dge relative to consumption of folic acid and other vitamins and pre-pregnancy c
are^len#19980000#1998#March of Dimes#White Plains^eNY#Report number 31-1154-98#2
0071100#a07v22n5.htm##
00552000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100021000970120
07500118030000500193065000900198064000500207031000300212032000500215014000500220
865000900225002001300234035001000247801000500257#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#141#6#article#39#6#^rND^sAhluwalia^nIB#^rND^sLyon Dan
iel^nK#Are women with recent live births aware of the benefits of folic acid?^le
n#MMWR#20010000#2001#50#RR06#3-14#20071100#a07v22n5.htm#0149-2195#MMWR##
00728000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100025000770100021001020100
02300123010001800146010001600164010001800180012013900198030001700337710000200354
06500090035606400050036503100030037003200020037301400050037586500090038000200130
0389#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#142#7#article#39#
7#^rND^sPérez-Escamilla^nR#^rND^sHimmelgreen^nD#^rND^sSegura-Millán^nS#^rND^sGon
zález^nA#^rND^sMéndez^nI#^rND^sHaldeman^nL#Knowledge of folic acid and neural tu
be defects among inner-city residents: Have they heard about it? Research and Pr
ofessional Briefs^len#J Am Diet Assoc.#2#19990000#1999#99#1#80-3#20071100#a07v22
n5.htm##
00695000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100021000770100015000980100
01400113010001700127010001700144010001500161810000600176012012300182030001500305
71000020032006500090032206400050033103100040033601400070034086500090034700200130
0356#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#143#8#article#39#
8#^rND^sCarmichael^nSL#^rND^sShaw^nGM#^rND^sYang^nW#^rND^sLaurent^nC#^rND^sHerri
ng^nA#^rND^sRoyle^nH#et al#National birth defects prevention study: Correlate of
 intake of folic acid-containing supplements among pregnant women^len#Am J Obst 
Gyn.#2#20060000#2006#194#203-10#20071100#a07v22n5.htm##
00589000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100015000770100020000920100
01800112012011800130030000800248710000200256065000900258064000500267031000400272
014001300276865000900289002001300298#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#144#9#article#39#9#^rND^sJasti^nS#^rND^sSiega-Riz^nAM#^rND^sBentl
ey^nME#Dietary supplement use in the context of health disparities: Cultural, et
hnic and demographic determinants of use^len#J Nutr.#2#20030000#2003#133#2010S- 
2013S#20071100#a07v22n5.htm##
00665000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100018000960100
01700114010001800131012013300149030001300282065000900295064000500304031000200309
014000700311865000900318002001300327035001000340801001300350#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a07v22n5.htm#S#c#145#10#article#39#10#^rND^sBalluz^nLS#^rN
D^sKieszak^nSM#^rND^sPhilen^nRM#^rND^sMulinare^nJ#Vitamin and mineral supplement
 use in the United States: Results from the Third National Health and Nutrition 
Examination Survey^len#Arch Fam Med#20000000#2000#9#258-62#20071100#a07v22n5.htm
#1063-3987#Arch Fam Med##
00476000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170020000790180062000990660
03600161062001300197065000900210064000500219865000900224002001300233#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#146#11#article#39#11#Secretaria d
e Salud#Situación de salud en Honduras: Indicadores básicos, 2004^les#Tegucigalp
a^eMetro Distrito Central#El Instituto#20050000#2005#20071100#a07v22n5.htm##
00571000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160015000790160015000940160
01500109018006500124061001800189066001500207067000900222062002600231065000900257
064000500266865000900271002001300280#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#147#12#article#39#12#^rND^sMilla^nG#^rND^sUmaña^nE#^rND^sMayes^nI
#Prevalencia hospitalaria de anomalías congénitas en Honduras^les#data presentat
ion#San Pedro Sula#Honduras#Proyecto Niños Saludables#20020000#2002#20071100#a07
v22n5.htm##
00580000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160015000790160015000940160
01500109018007400124061001800198066001500216067000900231062002600240065000900266
064000500275865000900280002001300289#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#148#13#article#39#13#^rND^sMilla^nG#^rND^sUmaña^nE#^rND^sMayes^nI
#Los costos hospitalarios directos de anomalías congénitas en Honduras^les#data 
presentation#San Pedro Sula#Honduras#Proyecto Niños Saludables#20030000#2003#200
71100#a07v22n5.htm##
00472000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170035000790180043001140660
03600157062001300193065000900206064000500215865000900220002001300229#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#149#14#article#39#14#Instituto Na
cional de Estadísticas#Censo nacional de población y vivienda^les#Tegucigalpa^eM
etro Distrito Central#El Instituto#20010000#2001#20071100#a07v22n5.htm##
00477000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170035000790180048001140660
03600162062001300198065000900211064000500220865000900225002001300234#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#150#15#article#39#15#Instituto Na
cional de Estadísticas#Encuesta de hogares de propósitos múltiples^les#Tegucigal
pa^eMetro Distrito Central#El Instituto#20040000#2004#20071100#a07v22n5.htm##
00691000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100018000960100
01700114010001600131010001500147010001900162810000600181012008100187030001500268
06500090028306400050029203100030029701400060030086500090030600200130031503500100
0328801001500338#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#151#1
6#article#39#16#^rND^sHolden^nKR#^rND^sCollins^nJS#^rND^sGreene^nJF#^rND^sHinkle
^nS#^rND^sNave^nAF#^rND^sPortillo^nJM#et al#Dietary intake and blood folate leve
ls in Honduran women of childbearing age^len#J Child Neurol#20020000#2002#17#341
-6#20071100#a07v22n5.htm#0883-0738#J Child Neurol##
00612000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160013000790160014000920160
01500106018009900121061001800220066001500238067000900253062002600262065000900288
064001500297865000900312002001300321#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#152#17#article#39#17#^rND^sWu^nDY#^rND^sBrat^nG#^rND^sMilla^nG#Fo
lic acid knowledge and usage amongst region number 3 patients and health workers
 in Honduras^len#data presentation#San Pedro Sula#Honduras#Proyecto Niños Saluda
bles#20070900#September 2004#20071100#a07v22n5.htm##
00684000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100016000980100
01900114010001700133010001600150010001700166810000600183012010700189030001300296
71000020030906500090031106400050032003100040032501400070032986500090033600200130
0345#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#153#18#article#39
#18#^rND^sHertrampf^nE#^rND^sCortés^nF#^rND^sErickson^nJD#^rND^sCayazzo^nM#^rND^
sFreire^nW#^rND^sBailey^nLB#et al#Consumption of folic acid-fortified bread impr
oves folate status in women of reproductive age in Chile^len#Jnl of Nutr.#2#2003
0000#2003#133#3166-9#20071100#a07v22n5.htm##
00646000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100014000790100015000930100
01500108012016900123030001400292710000200306065000900308064000500317031000300322
032000200325014000700327865000900334002001300343#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#154#19#article#39#19#^rND^sRay^nJG#^rND^sCole^nDE#^rN
D^sBoss^nSC#An Ontario-wide study of vitamin B12, serum folate, and red cell fol
ate levels in relation to plasma homocysteine: Is a preventable public health is
sue on the rise?^len#Clin Biochem.#2#20000000#2000#33#5#337-43#20071100#a07v22n5
.htm##
00435000000000193000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170051000790180071001300610
01800201865000900219002001300228#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22
n5.htm#S#c#155#20#article#39#20#Comisión de Ministros de economía de Centroaméri
ca#Reglamento técnico de la unión aduanera centroamericana 2002, XXIV^les#R-UAC 
67.01.15.12#20071100#a07v22n5.htm##
00657000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100015001010100
01900116010001600135010001900151012011300170030001100283710000200294065000900296
064000500305031000300310032000200313014000600315865000900321002001300330#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#156#21#article#39#21#^rND^sDa
rnton-Hill^nI#^rND^sMora^nJO#^rND^sWeinstein^nH#^rND^sWilbur^nS#^rND^sNalubola^n
PR#Iron and folate fortification in the Americas to prevent and control micronut
rient malnutrition: An analysis^len#Nutrl Rev.#2#19990000#1999#57#1#25-31#200711
00#a07v22n5.htm##
00493000000000217000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170020000790180081000990620
04800180066001600228067000900244865000900253002001300262#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a07v22n5.htm#S#c#157#22#article#39#22#Secretaria de Salud#Marc
a Registrada (MASECA Registro Sanitario Hondureño RSA 3-0006187-02-2005)^les#Dep
artamento de Regulación, Secretaria de Salud#Tegucigalpa^eDC#Honduras#20071100#a
07v22n5.htm##
00465000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170020000790180051000990660
03600150062001300186065000900199064000500208865000900213002001300222#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#158#23#article#39#23#Secretaria d
e Salud#Normas nacionales de atención materna-neonatal^les#Tegucigalpa^eMetro Di
strito Central#El Instituto#20050000#2005#20071100#a07v22n5.htm##
00494000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170030000790180070001090660
03600179062001300215065000900228064000500237865000900242002001300251#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#159#24#article#39#24#Honduras^dSe
cretaria de Salud#Manual de normas y procedimientos de atención integral a la mu
jer^les#Tegucigalpa^eMetro Distrito Central#El Instituto#19990000#1999#20071100#
a07v22n5.htm##
00587000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170020000790170049000990170
06300148018005600211066001700267062001300284065000900297064000500306865000900311
002001300320#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#160#25#ar
ticle#39#25#Secretaria de Salud#Asociación Hondureña de Planificación de Familia
#Agencia de los Estados Unidos para el Desarrollo Internacional#Encuesta naciona
l de epidemiología y salud familiar^les#Tegucigalpa^eMDC#El Instituto#20010000#2
001#20071100#a07v22n5.htm##
00693000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100018000990100
01600117010001500133010001800148010001600166810000600182012010700188030001000295
71000020030506500090030706400050031603100030032103200020032401400070032686500090
0333002001300342#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#161#2
6#article#39#26#^rND^sAl-Gazali^nLI#^rND^sSzthriha^nL#^rND^sDawodu^nA#^rND^sBaki
r^nM#^rND^sVarghese^nM#^rND^sVarady^nE#et al#Patterns of central nervous system 
anomalies in a population with high rate of consanguineous marriage^len#Clin Gen
.#2#19990000#1999#55#2#95-102#20071100#a07v22n5.htm##
00541000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790120045000970160
01600142018003300158066001200191062002900203065000900232064000500241014000700246
865000900253002001300262#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S
#c#162#27#article#39#27#^rND^sTolarova^nM#Genetics, Gene Carriers, and Environme
nt^len#^rED^sBader^nJD#Risk Assessment in Dentistry^len#Chapel Hill#University o
f North Carolina#19900000#1990#116-79#20071100#a07v22n5.htm##
00647000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100017000970100
01800114010001900132012011900151030001100270065000900281064000500290031000300295
014000400298865000900302002001300311035001000324801001100334#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a07v22n5.htm#S#c#163#28#article#39#28#^rND^sBecerra^nJE#^r
ND^sKhoury^nMJ#^rND^sCordero^nJE#^rND^sErickson^nJD#Diabetes mellitus during pre
gnancy and the risks for specific birth defects: A population based case-control
 study^len#Pediatrics#19900000#1990#85#1-9#20071100#a07v22n5.htm#0031-4005#Pedia
trics##
00516000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760110004000790120087000830300
00500170065000900175064000500184031000300189032000300192014000600195865000900201
002001300210035001000223801000500233#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#164#29#article#39#29#CDC#Valproate: A new cause of birth defect-R
eport from Italy and follow-up from France^len#MMWR#19830000#1983#32#33#438-9#20
071100#a07v22n5.htm#0149-2195#MMWR##
00546000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100016000950100
01800111012005000129030001000179065000900189064000500198031000200203014000900205
865000900214002001300223035001000236801001000246#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#165#30#article#39#30#^rND^sCovani^nA#^rND^sGupta^nAK#
^rND^sJeavons^nPM#Sodium valproate: monotherapy and polytherapy^len#Epilepsia#19
820000#1982#6#693--720#20071100#a07v22n5.htm#0013-9580#Epilepsia##
00501000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790120047000970300
01000144065000900154064000500163031000300168032000400171014000600175865000900181
002001300190035001000203801001000213#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
7v22n5.htm#S#c#166#31#article#39#31#^rND^sJeavons^nPM#Non dose related side effe
cts of valproate^len#Epilepsia#19840000#1984#25#^s1#S50-5#20071100#a07v22n5.htm#
0013-9580#Epilepsia##
00582000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100018000960100
02000114010001400134012006900148030001300217710000200230065000900232064000500241
031000400246032000200250014000600252865000900258002001300267#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a07v22n5.htm#S#c#167#32#article#39#32#^rND^sGarcia^nAM#^rN
D^sFletcher^nT#^rND^sBenavides^nFG#^rND^sOrts^nE#Parental agricultural work and 
selected congenital malformations^len#Am J of Epi.#2#19990000#1999#149#1#64-73#2
0071100#a07v22n5.htm##
00581000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100017000970120
03200114016001800146016001700164018003500181066000900216062002400225065000900249
064000500258014000600263865000900269002001300278#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#168#33#article#39#33#^rND^sGoodman^nMR#^rND^sGorlin^n
JR#Fetal environment syndromes^len#^rND^sGoodman^nMR#^rND^sGorlin^nJR#The malfor
med infant and child^len#New York#Oxford University Press#19830000#1983#11-36#20
071100#a07v22n5.htm##
00606000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100016000950100
01300111010001900124012009500143030001700238710000200255065000900257064000500266
031000200271032000200273014000700275865000900282002001300291#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a07v22n5.htm#S#c#169#34#article#39#34#^rND^sReece^nEA#^rND
^sHomko^nCJ#^rND^sWu^nYK#^rND^sWiznitzer^nA#The role of free radicals and membra
ne lipids in diabetes-induced congenital malformations^len#J Soc Gyn Inves.#2#19
880000#1988#5#4#178-87#20071100#a07v22n5.htm##
00681000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100015000970100
01300112010001600125010001900141010001800160810000600178012010300184030002200287
71000020030906500090031106400050032003200020032501400060032786500090033300200130
0342#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#170#35#article#39
#35#^rND^sRestrepo^nM#^rND^sMunoz^nN#^rND^sDay^nN#^rND^sParra^nJE#^rND^sHernande
z^nC#^rND^sBlettner^nM#et al#Birth defects among children born to a population o
ccupationally exposed to pesticides in Columbia^len#Scand J Work Environ.#2#1990
0000#1990#4#232-8#20071100#a07v22n5.htm##
00551000000000289000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100015000790100012000940100
01800106012006800124030001600192710000200208065000900210064000500219031000400224
032000300228014000800231865000900239002001300248#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a07v22n5.htm#S#c#171#36#article#39#36#^rND^sShaw^nGM#^rND^sVelie#^rND^
sMorland^nKB#Parental recreational drug use and risk for neural tube defects^len
#Am J. Epidemol.#2#19960000#1996#144#12#1155-60#20071100#a07v22n5.htm##
00611000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790100014000980100
01600112010001500128010001400143012008200157030002100239710000200260065000900262
064000500271032000300276014000800279865000900287002001300296#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a07v22n5.htm#S#c#172#37#article#39#37#^rND^sWasserman^nC#^
rND^sShaw^nG#^rND^sSelvin^nS#^rND^sGould^nJ#^rND^sSyme^nS#Socioeconomic status, 
neighborhood social conditions, and neural tube defects^len#Amer J Public Health
#2#19980000#1998#11#1674-80#20071100#a07v22n5.htm##
00522000000000253000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160015000790160016000940160
01600110018004200126066001900168062004500187065000900232064000500241865000900246
002001300255#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#173#38#ar
ticle#39#38#^rND^sLynch^nJ#^rND^sKemmer^nT#^rND^sLougee^nD#Pediatric Nutrition M
edicine Missions^len#San Antonio^eTexas#Armed Services University of Health Serv
ices#20010000#2001#20071100#a07v22n5.htm##
00597000000000229000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760160017000790160017000960180
15400113037005500267110000900322109001400331865000900345002001300354#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a07v22n5.htm#S#c#174#39#article#39#39#^rND^sDe Leó
n^nL#^rND^sRomero^nME#Fortificación de maíz nixtamalizado con hierro y ácido fól
ico a nivel de molinos comunitarios: Desarrollo de tecnología y aceptabilidad al
 consumidor^les#http://www.bvssan.incap.org.gt/ bvs_incap/E/pubtec.htm#20060313#
13 March 2006#20071100#a07v22n5.htm##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#o#1#1#article#1
#20080121#151825#a08v22n5.htm#249##
05672000000000781000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201180016701201010
02850100036003860100027004220100027004490100031004760100025005070100027005320700
10500559070014500664070009600809070005000905070015000955083172701105085000802832
08500250284008500380286508500450290308500240294808500220297208500220299408314400
30160850008044560850026044640850035044900850032045250850035045570850024045920850
02204616085002204638059000904660058003504669058009904704117000604803072000304809
112000904812111002204821114000904843113002504852002001304877#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a08v22n5.htm#S#h#2#1#article#1#tr#es#br1.1#1#3.1#TAB#08#RP
SP330#nd#Rev Panam Salud Publica#22#5#20071100#^f348^l357#1020-4989#Sistemas de 
salud mental en El Salvador, Guatemala y Nicaragua: resultados de una evaluación
 mediante el WHO-AIMS^les#Mental health systems in El Salvador, Guatemala, and N
icaragua: results of a WHO-AIMS evaluation^len#^rND^1A01^nJorge Jacinto^sRodrígu
ez#^rND^1A02^nThomas^sBarrett#^rND^1A03^nSilvia^sNarváez#^rND^1A04^nJosé Miguel^
sCaldas#^rND^1A05^nItzhak^sLevav#^rND^1A02^nShekhar^sSaxena#Organización Panamer
icana de la Salud^iA01^1Unidad de Salud Mental^2Abuso de Sustancias y Rehabilita
ción#World Health Organization^iA02^1Noncommunicable Diseases and Mental Health 
Cluster, Mental Health and Substance Abuse Department^cGinebra^pSuiza#Organizaci
ón Panamericana de la Salud/Organización Mundial de la Salud^iA03^cManagua^pNica
ragua#Universidad de Nova Lisboa^iA04^cLisboa^pPortugal#Organización Panamerican
a de la Salud^iA05^1Unidad de Salud Mental^2Abuso de Sustancias y Rehabilitación
^cWashington^sD.C.^pEstados Unidos de América#^les^aLos autores realizaron una e
valuación de los sistemas de salud mental en El Salvador, Guatemala y Nicaragua,
 por medio de un grupo de indicadores seleccionados. Para recopilar la informaci
ón en los países se utilizó el Instrumento de Evaluación para Sistemas de Salud 
Mental de la Organización Mundial de la Salud (WHO-AIMS, por su sigla en inglés)
. Nicaragua, Guatemala y El Salvador tienen serias limitaciones en sus sistemas 
nacionales de salud mental, en especial en la atención primaria, así como una ma
rcada insuficiencia de recursos humanos calificados. El presupuesto dedicado a l
a salud mental apenas representa 1% del presupuesto general de salud y los hospi
tales psiquiátricos situados en la capital de los países consumen más de 90% de 
los fondos de salud mental. Los limitados recursos (materiales y humanos) existe
ntes se concentran en las respectivas capitales de los países. No se han formula
do políticas ni legislaciones nacionales de salud mental. Sin embargo, las tres 
naciones cuentan con planes nacionales en ejecución. Asimismo, se ha avanzado en
 el diseño e implementación de programas de protección de la salud mental en sit
uaciones de desastre. Es necesario establecer acuerdos con las procuradurías de 
los derechos humanos para incrementar la vigilancia y protección de los derechos
 humanos en las personas afectadas por enfermedades mentales. En los últimos año
s se han logrado impulsar algunas experiencias innovadoras que requieren ser gen
eralizadas. La Organización Panamericana de la Salud (OPS/OMS) y el proyecto WHO
-AIMS han contribuido al desarrollo de modelos comunitarios de servicios de salu
d mental. También se identificaron prioridades y se plantean recomendaciones par
a la acción.#^dnd^i1#^tm^les^kSalud mental^i1#^tm^les^kservicios de salud mental
^i1#^tm^les^kevaluación de servicios de salud^i1#^tm^les^kEl Salvador^i1#^tm^les
^kGuatemala^i1#^tm^les^kNicaragua^i1#^len^aThe authors evaluated the mental heal
th systems of El Salvador, Guatemala, and Nicaragua, using a group of select ind
icators. The World Health Organization Assessment Instrument for Mental Health S
ystems (WHO-AIMS) was used to collect data from the nations. The national mental
 health systems of Nicaragua, Guatemala, and El Salvador have serious limitation
s, especially in primary care, and a marked lack of qualified human resources. B
udget allocations for mental health care are barely 1% of the total health care 
budgets; and the psychiatric hospitals located in the national capitals consume 
at least 90% of those funds. The limited human and material resources available 
are concentrated in the respective country capital cities. National mental healt
h policies and legislation have not been adopted; however, all three countries d
o have national plans in progress. Furthermore, all three have designed and impl
emented programs for mental health care in case of disaster. Agreements must be 
reached with offices for the defense of human rights to raise awareness and prot
ection of rights for the mentally ill. In recent years, new experiences have bee
n gained and these should be distributed more widely. The Pan American Health Or
ganization (PAHO/WHO) and the WHO-AIMS project have contributed toward developin
g community models for mental health services. Lastly, priorities have been iden
tified and action items recommended.#^dnd^i2#^tm^len^kMental health^i2#^tm^len^k
mental health services^i2#^tm^len^khealth care quality^i2#^tm^len^kaccess, and e
valuation^i2#^tm^len^kEl Salvador^i2#^tm^len^kGuatemala^i2#^tm^len^kNicaragua^i2
#WHO-AIMS#Instituto Nacional de Salud Mental#Administración de Servicios de Salu
d Mental y Abuso de Sustancias de los Estados Unidos de América#other#09#2007022
3#23 de febrero de 2007#20070925#25 de septiembre de 2007#a08v22n5.htm##
05735000000000781000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701201320016701201150
02990100036004140100027004500100027004770100031005040100025005350100027005600700
10500587070014500692070009600837070005000933070015000983083172701133085000802860
08500250286808500380289308500450293108500240297608500220300008500220302208314400
30440850008044840850026044920850035045180850032045530850035045850850024046200850
02204644085002204666059004404688058003504732058009904767117000604866072000304872
112000904875111002204884114000904906113002504915002001304940#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a08v22n5.htm#S#f#3#1#article#1#tr#es#br1.1#1#3.1#TAB#08#RP
SP330#nd#Rev Panam Salud Publica#22#5#20071100#^f348^l357#1020-4989#<B>Sistemas 
de salud mental en El Salvador, Guatemala y Nicaragua</B>: <B>resultados de una 
evaluación mediante el WHO-AIMS</B>^les#<B>Mental health systems in El Salvador,
 Guatemala, and Nicaragua</B>: <B>results of a WHO-AIMS evaluation</B>^len#^rND^
1A01^nJorge Jacinto^sRodríguez#^rND^1A02^nThomas^sBarrett#^rND^1A03^nSilvia^sNar
váez#^rND^1A04^nJosé Miguel^sCaldas#^rND^1A05^nItzhak^sLevav#^rND^1A02^nShekhar^
sSaxena#Organización Panamericana de la Salud^iA01^1Unidad de Salud Mental^2Abus
o de Sustancias y Rehabilitación#World Health Organization^iA02^1Noncommunicable
 Diseases and Mental Health Cluster, Mental Health and Substance Abuse Departmen
t^cGinebra^pSuiza#Organización Panamericana de la Salud/Organización Mundial de 
la Salud^iA03^cManagua^pNicaragua#Universidad de Nova Lisboa^iA04^cLisboa^pPortu
gal#Organización Panamericana de la Salud^iA05^1Unidad de Salud Mental^2Abuso de
 Sustancias y Rehabilitación^cWashington^sD.C.^pEstados Unidos de América#^les^a
Los autores realizaron una evaluación de los sistemas de salud mental en El Salv
ador, Guatemala y Nicaragua, por medio de un grupo de indicadores seleccionados.
 Para recopilar la información en los países se utilizó el Instrumento de Evalua
ción para Sistemas de Salud Mental de la Organización Mundial de la Salud (WHO-A
IMS, por su sigla en inglés). Nicaragua, Guatemala y El Salvador tienen serias l
imitaciones en sus sistemas nacionales de salud mental, en especial en la atenci
ón primaria, así como una marcada insuficiencia de recursos humanos calificados.
 El presupuesto dedicado a la salud mental apenas representa 1% del presupuesto 
general de salud y los hospitales psiquiátricos situados en la capital de los pa
íses consumen más de 90% de los fondos de salud mental. Los limitados recursos (
materiales y humanos) existentes se concentran en las respectivas capitales de l
os países. No se han formulado políticas ni legislaciones nacionales de salud me
ntal. Sin embargo, las tres naciones cuentan con planes nacionales en ejecución.
 Asimismo, se ha avanzado en el diseño e implementación de programas de protecci
ón de la salud mental en situaciones de desastre. Es necesario establecer acuerd
os con las procuradurías de los derechos humanos para incrementar la vigilancia 
y protección de los derechos humanos en las personas afectadas por enfermedades 
mentales. En los últimos años se han logrado impulsar algunas experiencias innov
adoras que requieren ser generalizadas. La Organización Panamericana de la Salud
 (OPS/OMS) y el proyecto WHO-AIMS han contribuido al desarrollo de modelos comun
itarios de servicios de salud mental. También se identificaron prioridades y se 
plantean recomendaciones para la acción.#^dnd^i1#^tm^les^kSalud mental^i1#^tm^le
s^kservicios de salud mental^i1#^tm^les^kevaluación de servicios de salud^i1#^tm
^les^kEl Salvador^i1#^tm^les^kGuatemala^i1#^tm^les^kNicaragua^i1#^len^aThe autho
rs evaluated the mental health systems of El Salvador, Guatemala, and Nicaragua,
 using a group of select indicators. The World Health Organization Assessment In
strument for Mental Health Systems (WHO-AIMS) was used to collect data from the 
nations. The national mental health systems of Nicaragua, Guatemala, and El Salv
ador have serious limitations, especially in primary care, and a marked lack of 
qualified human resources. Budget allocations for mental health care are barely 
1% of the total health care budgets; and the psychiatric hospitals located in th
e national capitals consume at least 90% of those funds. The limited human and m
aterial resources available are concentrated in the respective country capital c
ities. National mental health policies and legislation have not been adopted; ho
wever, all three countries do have national plans in progress. Furthermore, all 
three have designed and implemented programs for mental health care in case of d
isaster. Agreements must be reached with offices for the defense of human rights
 to raise awareness and protection of rights for the mentally ill. In recent yea
rs, new experiences have been gained and these should be distributed more widely
. The Pan American Health Organization (PAHO/WHO) and the WHO-AIMS project have 
contributed toward developing community models for mental health services. Lastl
y, priorities have been identified and action items recommended.#^dnd^i2#^tm^len
^kMental health^i2#^tm^len^kmental health services^i2#^tm^len^khealth care quali
ty^i2#^tm^len^kaccess, and evaluation^i2#^tm^len^kEl Salvador^i2#^tm^len^kGuatem
ala^i2#^tm^len^kNicaragua^i2#<FONT FACE="Verdana" SIZE=2>WHO-AIMS</FONT>#Institu
to Nacional de Salud Mental#Administración de Servicios de Salud Mental y Abuso 
de Sustancias de los Estados Unidos de América#other#09#20070223#23 de febrero d
e 2007#20070925#25 de septiembre de 2007#a08v22n5.htm##
05892000000000805000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201201180
01820120101003000100036004010100027004370100027004640100031004910100025005220100
02700547070015200574070014700726070009800873070005200971070015201023083174701175
08500080292208500250293008500380295508500450299308500240303808500220306208500220
30840831454031060850008045600850026045680850035045940850032046290850035046610850
02404696085002204720085002204742059000904764058003504773058009904808117000604907
07200030491311200090491611100220492511400090494711300250495600200130498100800920
4994#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#l#4#1#article#1#^mn
ov.^a2007#tr#es#br1.1#1#3.1#tab#08#RPSP330#nd#Rev. panam. salud pública#22#5#200
71100#^f348^l357#1020-4989#Sistemas de salud mental en El Salvador, Guatemala y 
Nicaragua: resultados de una evaluación mediante el WHO-AIMS^les#Mental health s
ystems in El Salvador, Guatemala, and Nicaragua: results of a WHO-AIMS evaluatio
n^len#^rND^1A01^nJorge Jacinto^sRodríguez#^rND^1A02^nThomas^sBarrett#^rND^1A03^n
Silvia^sNarváez#^rND^1A04^nJosé Miguel^sCaldas#^rND^1A05^nItzhak^sLevav#^rND^1A0
2^nShekhar^sSaxena#^iA01^1Organización Panamericana de la Salud^2Unidad de Salud
 Mental^3Abuso de Sustancias y Rehabilitación^cWashington^sD.C.^pEstados Unidos 
de América#^iA02^1World Health Organization^2Noncommunicable Diseases and Mental
 Health Cluster, Mental Health and Substance Abuse Department^cGinebra^pSuiza#^i
A03^1Organización Panamericana de la Salud/Organización Mundial de la Salud^cMan
agua^pNicaragua#^iA04^1Universidad de Nova Lisboa^cLisboa^pPortugal#^iA05^1Organ
ización Panamericana de la Salud^2Unidad de Salud Mental^3Abuso de Sustancias y 
Rehabilitación^cWashington^sD.C.^pEstados Unidos de América#^les^aLos autores re
alizaron una evaluación de los sistemas de salud mental en El Salvador, Guatemal
a y Nicaragua, por medio de un grupo de indicadores seleccionados. Para recopila
r la información en los países se utilizó el Instrumento de Evaluación para Sist
emas de Salud Mental de la Organización Mundial de la Salud (WHO-AIMS, por su si
gla en inglés). Nicaragua, Guatemala y El Salvador tienen serias limitaciones en
 sus sistemas nacionales de salud mental, en especial en la atención primaria, a
sí como una marcada insuficiencia de recursos humanos calificados. El presupuest
o dedicado a la salud mental apenas representa 1 por ciento del presupuesto gene
ral de salud y los hospitales psiquiátricos situados en la capital de los países
 consumen más de 90 por ciento de los fondos de salud mental. Los limitados recu
rsos (materiales y humanos) existentes se concentran en las respectivas capitale
s de los países. No se han formulado políticas ni legislaciones nacionales de sa
lud mental. Sin embargo, las tres naciones cuentan con planes nacionales en ejec
ución. Asimismo, se ha avanzado en el diseño e implementación de programas de pr
otección de la salud mental en situaciones de desastre. Es necesario establecer 
acuerdos con las procuradurías de los derechos humanos para incrementar la vigil
ancia y protección de los derechos humanos en las personas afectadas por enferme
dades mentales. En los últimos años se han logrado impulsar algunas experiencias
 innovadoras que requieren ser generalizadas. La Organización Panamericana de la
 Salud (OPS/OMS) y el proyecto WHO-AIMS han contribuido al desarrollo de modelos
 comunitarios de servicios de salud mental. También se identificaron prioridades
 y se plantean recomendaciones para la acción.#^dnd^i1#^tm^les^kSalud mental^i1#
^tm^les^kservicios de salud mental^i1#^tm^les^kevaluación de servicios de salud^
i1#^tm^les^kEl Salvador^i1#^tm^les^kGuatemala^i1#^tm^les^kNicaragua^i1#^len^aThe
 authors evaluated the mental health systems of El Salvador, Guatemala, and Nica
ragua, using a group of select indicators. The World Health Organization Assessm
ent Instrument for Mental Health Systems (WHO-AIMS) was used to collect data fro
m the nations. The national mental health systems of Nicaragua, Guatemala, and E
l Salvador have serious limitations, especially in primary care, and a marked la
ck of qualified human resources. Budget allocations for mental health care are b
arely 1 percent of the total health care budgets; and the psychiatric hospitals 
located in the national capitals consume at least 90 percent of those funds. The
 limited human and material resources available are concentrated in the respecti
ve country capital cities. National mental health policies and legislation have 
not been adopted; however, all three countries do have national plans in progres
s. Furthermore, all three have designed and implemented programs for mental heal
th care in case of disaster. Agreements must be reached with offices for the def
ense of human rights to raise awareness and protection of rights for the mentall
y ill. In recent years, new experiences have been gained and these should be dis
tributed more widely. The Pan American Health Organization (PAHO/WHO) and the WH
O-AIMS project have contributed toward developing community models for mental he
alth services. Lastly, priorities have been identified and action items recommen
ded.#^dnd^i2#^tm^len^kMental health^i2#^tm^len^kmental health services^i2#^tm^le
n^khealth care quality^i2#^tm^len^kaccess, and evaluation^i2#^tm^len^kEl Salvado
r^i2#^tm^len^kGuatemala^i2#^tm^len^kNicaragua^i2#WHO-AIMS#Instituto Nacional de 
Salud Mental#Administración de Servicios de Salud Mental y Abuso de Sustancias d
e los Estados Unidos de América#other#09#20070223#23 de febrero de 2007#20070925
#25 de septiembre de 2007#a08v22n5.htm#Internet^ihttp://www.scielosp.org/scielo.
php?script=sci_arttext&pid=S1020-49892007001000008##
00341000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704010800074002001300182#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#5#1#article#236#<p align="right"><fon
t size="2" face="Verdana"><b>INFORME ESPECIAL</b> SPECIAL    REPORT</font></p>  
   ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#6#2#article#236#<p>&nbsp;</p>     ^cY
#a08v22n5.htm##
00437000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704020400074002001300278#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#7#3#article#236#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>Sistemas de salud mental    en El Salvador, Guat
emala y Nicaragua. Resultados de una evaluaci&oacute;n mediante    el WHO-AIMS <
/b></font></p>     ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#8#4#article#236#<p>&nbsp;</p>     ^cY
#a08v22n5.htm##
00392000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704015900074002001300233#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#9#5#article#236#<p><font size="3" fac
e="verdana"><b>Mental health systems in El Salvador, Guatemala,    and Nicaragua
: results of a WHO-AIMS evaluation</b></font></p>     ^cY#a08v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#10#6#article#236#<p>&nbsp;</p>     ^c
Y#a08v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#11#7#article#236#<p>&nbsp;</p>     ^c
Y#a08v22n5.htm##
00535000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704030100075002001300376#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#12#8#article#236#<p><font size="2" fa
ce="Verdana"><b>Jorge Jacinto Rodr&iacute;guez<sup>I, </sup><a href="#nt"><sup>*
</sup></a>;    Thomas Barrett<sup>II</sup>; Silvia Narv&aacute;ez<sup>III</sup>;
 Jos&eacute;    Miguel Caldas<sup>IV</sup>; Itzhak Levav<SUP>V</SUP>; Shekhar Sa
xena<SUP>II</sup></b></font></p>     ^cY#a08v22n5.htm##
00403000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704016900075002001300244#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#13#9#article#236#<p><FONT SIZE="2" fa
ce="Verdana"><SUP>I</sup>Organizaci&oacute;n Panamericana de    la Salud, Unidad
 de Salud Mental, Abuso de Sustancias y Rehabilitaci&oacute;n    ^cY#a08v22n5.ht
m##
00451000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704021600076002001300292#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#14#10#article#236#<br>   <SUP>II</sup
>World Health Organization, Noncommunicable Diseases and Mental    Health Cluste
r, Mental Health and Substance Abuse Department, Mental Health:    Evidence and 
Research Team, Ginebra, Suiza    ^cY#a08v22n5.htm##
00411000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704017600076002001300252#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#15#11#article#236#<br>   <SUP>III</su
p>Organizaci&oacute;n Panamericana de la Salud/Organizaci&oacute;n    Mundial de
 la Salud, Oficina del Representante en Nicaragua, Managua, Nicaragua    ^cY#a08
v22n5.htm##
00307000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007200076002001300148#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#16#12#article#236#<br>   <SUP>IV</sup
>Universidad de Nova Lisboa, Lisboa, Portugal    ^cY#a08v22n5.htm##
00485000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704025000076002001300326#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#17#13#article#236#<br>   <SUP>V</sup>
Cuando se realiz&oacute; el    estudio, Organizaci&oacute;n Panamericana de la S
alud, Unidad de Salud Mental,    Abuso de Sustancias y Rehabilitaci&oacute;n, Wa
shington, D.C., Estados Unidos    de Am&eacute;rica</font></p>     ^cY#a08v22n5.
htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#18#14#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#19#15#article#236#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a08v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#20#16#article#236#<p><font size="2" f
ace="Verdana"><b>RESUMEN</b></font></p>     ^cY#a08v22n5.htm##
01842000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704160700076002001301683#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#21#17#article#236#<p><font size="2" f
ace="Verdana">Los autores realizaron una evaluaci&oacute;n    de los sistemas de
 salud mental en El Salvador, Guatemala y Nicaragua, por medio    de un grupo de
 indicadores seleccionados. Para recopilar la informaci&oacute;n    en los pa&ia
cute;ses se utiliz&oacute; el Instrumento de Evaluaci&oacute;n para    Sistemas 
de Salud Mental de la Organizaci&oacute;n Mundial de la Salud (WHO-AIMS,    por 
su sigla en ingl&eacute;s). Nicaragua, Guatemala y El Salvador tienen serias    
limitaciones en sus sistemas nacionales de salud mental, en especial en la atenc
i&oacute;n    primaria, as&iacute; como una marcada insuficiencia de recursos hu
manos calificados.    El presupuesto dedicado a la salud mental apenas represent
a 1% del presupuesto    general de salud y los hospitales psiqui&aacute;tricos s
ituados en la capital    de los pa&iacute;ses consumen m&aacute;s de 90% de los 
fondos de salud mental.    Los limitados recursos (materiales y humanos) existen
tes se concentran en las    respectivas capitales de los pa&iacute;ses. No se ha
n formulado pol&iacute;ticas    ni legislaciones nacionales de salud mental. Sin
 embargo, las tres naciones    cuentan con planes nacionales en ejecuci&oacute;n
. Asimismo, se ha avanzado    en el dise&ntilde;o e implementaci&oacute;n de pro
gramas de protecci&oacute;n    de la salud mental en situaciones de desastre. Es
 necesario establecer acuerdos    con las procuradur&iacute;as de los derechos h
umanos para incrementar la vigilancia    y protecci&oacute;n de los derechos hum
anos en las personas afectadas por enfermedades    mentales.    ^cY#a08v22n5.htm
##
00662000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704042700076002001300503#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#22#18#article#236#<br>   En los &uacu
te;ltimos a&ntilde;os se han    logrado impulsar algunas experiencias innovadora
s que requieren ser generalizadas.    La Organizaci&oacute;n Panamericana de la 
Salud (OPS/OMS) y el proyecto WHO-AIMS    han contribuido al desarrollo de model
os comunitarios de servicios de salud    mental. Tambi&eacute;n se identificaron
 prioridades y se plantean recomendaciones    para la acci&oacute;n.</font></p> 
    ^cY#a08v22n5.htm##
00455000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704022000076002001300296#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#23#19#article#236#<p><font size="2" f
ace="Verdana"><b>Palabras clave: </b>Salud    mental, servicios de salud mental,
 evaluaci&oacute;n de servicios de salud,    El Salvador, Guatemala, Nicaragua.<
/font></p> <hr size="1" noshade>     ^cY#a08v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#24#20#article#236#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a08v22n5.htm##
01433000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704119800076002001301274#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#25#21#article#236#<p><font size="2" f
ace="Verdana">The authors evaluated the mental health systems    of El Salvador,
 Guatemala, and Nicaragua, using a group of select indicators.    The World Heal
th Organization Assessment Instrument for Mental Health Systems    (WHO-AIMS) wa
s used to collect data from the nations. The national mental health    systems o
f Nicaragua, Guatemala, and El Salvador have serious limitations, especially    
in primary care, and a marked lack of qualified human resources. Budget allocati
ons    for mental health care are barely 1% of the total health care budgets; an
d the    psychiatric hospitals located in the national capitals consume at least
 90%    of those funds. The limited human and material resources available are c
oncentrated    in the respective country capital cities. National mental health 
policies and    legislation have not been adopted; however, all three countries 
do have national    plans in progress. Furthermore, all three have designed and 
implemented programs    for mental health care in case of disaster. Agreements m
ust be reached with    offices for the defense of human rights to raise awarenes
s and protection of    rights for the mentally ill.    ^cY#a08v22n5.htm##
00588000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704035300076002001300429#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#26#22#article#236#<br>   In recent ye
ars, new experiences have been gained and these should be distributed    more wi
dely. The Pan American Health Organization (PAHO/WHO) and the WHO-AIMS    projec
t have contributed toward developing community models for mental health    servi
ces. Lastly, priorities have been identified and action items recommended.</font
></p>     ^cY#a08v22n5.htm##
00452000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704021700076002001300293#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#27#23#article#236#<p><font size="2" f
ace="Verdana"><b>Key words: </b>Mental health; mental health    services; health
 care quality, access, and evaluation; El Salvador, Guatemala,    Nicaragua.</fo
nt></p> <hr size="1" noshade>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#28#24#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#29#25#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
01531000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704129600076002001301372#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#30#26#article#236#<p><font size="2" f
ace="Verdana">La situaci&oacute;n de la salud mental en Centroam&eacute;rica    
obedece a la presencia de factores complejos y la poblaci&oacute;n de estos    p
a&iacute;ses ha quedado marcada por m&uacute;ltiples y numerosos eventos traum&a
acute;ticos,    como son los desastres naturales y los sangrientos conflictos ar
mados. Estos    acontecimientos han dejado profundas heridas y cicatrices psicop
atol&oacute;gicas    y psicosociales tanto en el plano individual como en el com
unitario, adem&aacute;s    de haber generado discapacidad en las &aacute;reas de
l funcionamiento familiar    y laboral, y ocasionado importantes p&eacute;rdidas
 econ&oacute;micas (1–3).    El impacto de estos eventos se acrecienta en virtud
 de haberse producido, y    producirse, en un contexto de marcada pobreza. Estas
 condiciones adversas, sumadas    a la exclusi&oacute;n social de grupos poblaci
onales, en especial ind&iacute;genas    y comunidades rurales, perpet&uacute;an 
un ciclo vicioso de sufrimiento y pobreza.    Los trastornos psicopatol&oacute;g
icos, que aumentan en relaci&oacute;n inversa    con la clase socio-econ&oacute;
mica (1), obstaculizan los esfuerzos que los    grupos de poblaci&oacute;n m&aac
ute;s vulnerables puedan hacer para superar    ese ciclo.</font></p>     ^cY#a08
v22n5.htm##
01336000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704110100076002001301177#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#31#27#article#236#<p><font size="2" f
ace="Verdana">No obstante la situaci&oacute;n antes descrita,    en casi todos l
os pa&iacute;ses centroamericanos los sistemas de salud mental    (planes, progr
amas y servicios) distan de responder a las necesidades. A&uacute;n    subsiste 
el modelo hospitalario de tipo asilar que captura buena proporci&oacute;n    de 
los presupuestos de salud mental, mientras que la participaci&oacute;n de    la 
atenci&oacute;n primaria en la oferta de servicios de salud mental es limitada. 
   Por otro lado, los trabajadores de la atenci&oacute;n primaria est&aacute;n  
  insuficientemente preparados para manejar de manera eficaz los problemas psico
sociales    (2). La Organizaci&oacute;n Panamericana de la Salud (OPS/ OMS), ha 
incrementado    su apoyo t&eacute;cnico a los procesos de reforma en la regi&oac
ute;n, lo cual    se ha evidenciado en la Declaraci&oacute;n de Caracas (1990) (
4) y las Resoluciones    del Consejo del Directivo de OPS/OMS (en los a&ntilde;o
s 1997 y 2001) (5). Por    medio de &eacute;stas se ha estimulado a los Estados 
Miembros a que:</font></p> <ul>       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#32#28#article#236#<li>          ^cY#a
08v22n5.htm##
00354000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011900076002001300195#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#33#29#article#236#<p><font size="2" f
ace="Verdana">Desarrollen programas nacionales de salud        mental.</font></p
>   </li>       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#34#30#article#236#<li>          ^cY#a
08v22n5.htm##
00379000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704014400076002001300220#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#35#31#article#236#<p><font size="2" f
ace="Verdana">Reorienten los servicios de salud mental        (de manicomiales a
 comunitarios).</font></p>   </li>       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#36#32#article#236#<li>          ^cY#a
08v22n5.htm##
00425000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704019000076002001300266#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#37#33#article#236#<p><font size="2" f
ace="Verdana">Desarrollen acciones de control de los trastornos        afectivos
, las epilepsias y las psicosis, como problemas prioritarios.</font></p>   </li>
       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#38#34#article#236#<li>          ^cY#a
08v22n5.htm##
00416000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018100076002001300257#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#39#35#article#236#<p><font size="2" f
ace="Verdana">Fortalezcan las acciones de promoci&oacute;n        de la salud me
ntal y el desarrollo psicosocial de la ni&ntilde;ez.</font></p>   </li>       ^c
Y#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#40#36#article#236#<li>          ^cY#a
08v22n5.htm##
00382000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704014700076002001300223#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#41#37#article#236#<p><font size="2" f
ace="Verdana">Aumenten las asignaciones para programas        de formaci&oacute;
n en salud mental.</font></p>   </li>       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#42#38#article#236#<li>          ^cY#a
08v22n5.htm##
00437000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704020200076002001300278#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#43#39#article#236#<p><font size="2" f
ace="Verdana">Modernicen la legislaci&oacute;n y protecci&oacute;n        de los
 derechos humanos de las personas con trastornos mentales y sus familiares.</fon
t></p>   </li>     ^cY#a08v22n5.htm##
00249000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001400076002001300090#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#44#40#article#236#</ul>     ^cY#a08v2
2n5.htm##
01078000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704084300076002001300919#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#45#41#article#236#<p><font size="2" f
ace="Verdana">Los procesos de reforma en salud mental requieren    de informaci&
oacute;n veraz y precisa; aunque el Informe Atlas de Salud Mental    (OMS/2005) 
(6) provee de ciertos datos b&aacute;sicos, &eacute;stos no bastan    para una a
decuada planificaci&oacute;n. En este art&iacute;culo se presenta    un grupo de
 indicadores sobre el estado de los sistemas de salud mental en El    Salvador, 
Guatemala y Nicaragua; los mismos est&aacute;n basados en una evaluaci&oacute;n 
   que se llev&oacute; a cabo usando el Instrumento de Evaluaci&oacute;n de los 
   Sistemas de Salud Mental de la Organizaci&oacute;n Mundial de la Salud (WHO-A
IMS,    por sus siglas en ingl&eacute;s). Los resultados deben contribuir a prom
over    los cambios y servir como una l&iacute;nea basal para monitorear el proc
eso.</font></p>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#46#42#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00325000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009000076002001300166#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#47#43#article#236#<p><font size="3" f
ace="Verdana"><b>M&Eacute;TODO Y PROCEDIMIENTOS</b></font></p>     ^cY#a08v22n5.
htm##
00367000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704013200076002001300208#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#48#44#article#236#<p><font size="2" f
ace="Verdana"><b>El Instrumento de Evaluaci&oacute;n para los    Sistemas de Sal
ud Mental</b></font></p>     ^cY#a08v22n5.htm##
01025000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704079000076002001300866#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#49#45#article#236#<p><font size="2" f
ace="Verdana">El equipo de Evidencias e Investigaci&oacute;n    del Departamento
 de Salud Mental y Abuso de Sustancias de la OMS, conjuntamente    con un grupo 
de consultores, desarrollaron el Instrumento de Evaluaci&oacute;n    para Sistem
as de Salud Mental (WHO-AIMS) de la Organizaci&oacute;n Mundial de    la Salud (
OMS) (7), cuyo prop&oacute;sito es facilitar la recopilaci&oacute;n    de la inf
ormaci&oacute;n esencial sobre el sistema de salud mental de un pa&iacute;s    o
 regi&oacute;n. Para el WHO-AIMS, un sistema de salud mental se define como    t
odas aquellas actividades cuyos fines principales son promover, restaurar o    m
antener la salud mental, e incluye a todas las organizaciones y recursos orienta
dos    a lograr esos objetivos.</font></p>     ^cY#a08v22n5.htm##
00734000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704049900076002001300575#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#50#46#article#236#<p><font size="2" f
ace="Verdana">Las 10 recomendaciones destinadas a promover    el mejoramiento de
 los servicios, publicadas en el Informe sobre la Salud en    el Mundo-2001 (8),
 han servido como base para dise&ntilde;ar el WHO-AIMS. Este    instrumento perm
ite evaluar los componentes clave e identificar las principales    debilidades e
n los sistemas de salud mental, de tal manera que se obtiene informaci&oacute;n 
   esencial para una acci&oacute;n p&uacute;blica relevante.</font></p>     ^cY#
a08v22n5.htm##
00612000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037700076002001300453#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#51#47#article#236#<p><font size="2" f
ace="Verdana">El WHO-AIMS consta de seis secciones que contienen    28 apartados
 y 154 &iacute;tems. Las secciones son interdependientes; est&aacute;n    concep
tualmente relacionadas y, hasta cierto punto, superpuestas; todas deben    ser e
valuadas a fin de tener una visi&oacute;n relativamente completa de un    sistem
a de salud mental.</font></p>     ^cY#a08v22n5.htm##
00773000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704053800076002001300614#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#52#48#article#236#<p><font size="2" f
ace="Verdana">Al inicio de cada secci&oacute;n hay una lista    de fuentes de da
tos recomendadas, las cuales son ajustadas de acuerdo con las    caracter&iacute
;sticas de los pa&iacute;ses. En algunos casos pueden existir    otras fuentes r
elevantes de datos que no han sido enumeradas. En conjunto, se    usan todas las
 fuentes de datos pertinentes y disponibles en el &aacute;mbito    nacional, a n
ivel provincial/estatal/de distrito y al nivel de base (centro,    unidad, servi
cio o dispositivo).</font></p>     ^cY#a08v22n5.htm##
00744000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704050900076002001300585#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#53#49#article#236#<p><font size="2" f
ace="Verdana">Los hallazgos del WHO-AIMS sirven para abogar    por la introducci
&oacute;n de reformas en salud mental, desarrollar planes y    programas sustent
ados en par&aacute;metros iniciales claros y objetivos, monitorear    el cambio 
y evaluar el progreso de las pol&iacute;ticas de reforma, incluyendo    la provi
si&oacute;n de servicios comunitarios y la implicaci&oacute;n de los    usuarios
, familias y otras partes interesadas en las acciones en salud mental.</font></p
>     ^cY#a08v22n5.htm##
00338000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010300076002001300179#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#54#50#article#236#<p><font size="2" f
ace="Verdana"><b>Recolecci&oacute;n de la informaci&oacute;n</b></font></p>     
^cY#a08v22n5.htm##
00698000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704046300076002001300539#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#55#51#article#236#<p><font size="2" f
ace="Verdana">El WHO-AIMS (7) se us&oacute; para recopilar    informaci&oacute;n
 en El Salvador, Guatemala y Nicaragua. El trabajo se inici&oacute;    en mayo d
e 2005 con un taller celebrado en Managua, Nicaragua, donde se present&oacute;  
  el instrumento y se discuti&oacute; su aplicaci&oacute;n. Los respectivos mini
sterios    de salud dieron su anuencia para efectuar la exploraci&oacute;n y com
prometieron    su apoyo.</font></p>     ^cY#a08v22n5.htm##
00775000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704054000076002001300616#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#56#52#article#236#<p><font size="2" f
ace="Verdana">El siguiente paso fue capacitar a un equipo t&eacute;cnico    de c
ada pa&iacute;s en la aplicaci&oacute;n del WHO-AIMS. Los equipos estuvieron    
integrados por un consultor nacional contratado por la OPS/OMS, el coordinador  
  nacional de salud mental del Ministerio de Salud y el consultor de la Represen
taci&oacute;n    de OPS/OMS a cargo de salud mental. Adem&aacute;s, cada pa&iacu
te;s incorpor&oacute;    otros especialistas o funcionarios, seg&uacute;n lo con
siderara conveniente.</font></p>     ^cY#a08v22n5.htm##
00620000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704038500076002001300461#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#57#53#article#236#<p><font size="2" f
ace="Verdana">El consultor encargado de la recopilaci&oacute;n    de informaci&o
acute;n y ejecuci&oacute;n del WHO-AIMS cont&oacute; con tres    meses para real
izar su trabajo; a lo largo del mismo mantuvo contactos sistem&aacute;ticos    c
on el equipo t&eacute;cnico que monitore&oacute; y orient&oacute; el proceso    
en los tres pa&iacute;ses.</font></p>     ^cY#a08v22n5.htm##
01075000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704084000076002001300916#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#58#54#article#236#<p><font size="2" f
ace="Verdana">Al concluir la etapa de recolecci&oacute;n de    datos se convoc&o
acute; un taller nacional, con la participaci&oacute;n de funcionarios    y prof
esionales destacados provenientes del sector p&uacute;blico y otras organizacion
es,    para la discusi&oacute;n y validaci&oacute;n de los resultados. Las consi
deraciones    m&aacute;s importantes fueron incorpora-das al documento resumen d
e la situaci&oacute;n    diagn&oacute;stica. En octubre de 2005 se efectu&oacute
; en San Salvador, El    Salvador, un taller con asistencia de los tres pa&iacut
e;ses, as&iacute; como    del Asesor Subregional de Salud Mental de la OPS y un 
miembro del equipo de    la OMS en Ginebra. En esta actividad se presentaron los
 informes respectivos,    los cuales fueron objeto de una nueva discusi&oacute;n
.</font></p>     ^cY#a08v22n5.htm##
00818000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704058300076002001300659#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#59#55#article#236#<p><font size="2" f
ace="Verdana">El equipo del WHO-AIMS en la sede de la OMS de    Ginebra revis&oa
cute; todos los datos disponibles, y se hicieron aclaraciones    y sugerencias q
ue aseguraran una adecuada calidad de la informaci&oacute;n.    El trabajo de ca
mpo se llev&oacute; a cabo en 2005 y los datos corresponden    a 2004. La inform
aci&oacute;n obtenida proviene del sector p&uacute;blico, integrado    por los m
inisterios de salud e instituciones del seguro social en los pa&iacute;ses.    L
a informaci&oacute;n del sector privado no pudo ser recolectada.</font></p>     
^cY#a08v22n5.htm##
00348000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011300076002001300189#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#60#56#article#236#<p><font size="2" f
ace="Verdana"><b>Caracter&iacute;sticas generales de los pa&iacute;ses</b></font
></p>     ^cY#a08v22n5.htm##
00910000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704067500076002001300751#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#61#57#article#236#<p><font size="2" f
ace="Verdana">El Salvador, Guatemala y Nicaragua son pa&iacute;ses    contiguos 
ubicados en el Istmo Centroamericano. Los tres comparten elementos    comunes en
 su historia y en sus caracter&iacute;sticas econ&oacute;micas y sociales.    A 
inicios del siglo XIX, cuando obtuvieron la independencia de Espa&ntilde;a,    f
ormaban parte de la Federaci&oacute;n Centroamericana, la cual posteriormente   
 se disolvi&oacute;. No obstante, los deseos de unidad han persistido a lo largo
    de casi 200 a&ntilde;os; actualmente existen diferentes estructuras pol&iacu
te;ticas    dentro de marcos formales de integraci&oacute;n centroamericana.</fo
nt></p>     ^cY#a08v22n5.htm##
01240000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704100500076002001301081#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#62#58#article#236#<p><font size="2" f
ace="Verdana"><b>El Salvador.</b> Cuenta con un &aacute;rea    geogr&aacute;fica
 de 20 646 kil&oacute;metros cuadrados y una poblaci&oacute;n    estimada de 6,5
 millones de habitantes. El idioma oficial es el espa&ntilde;ol.    Los mestizos
 (mezcla de blancos e ind&iacute;genas de origen maya) constituyen    el princip
al grupo &eacute;tnico. Las religiones predominantes son la cat&oacute;lica    y
 otras denominaciones cristianas. De los habitantes, 34% tienen menos de 15    a
&ntilde;os y 8% m&aacute;s de 60 a&ntilde;os. Por otra parte, 40% de la poblaci&
oacute;n    es rural. La expectativa de vida al nacer es de 66,5 a&ntilde;os par
a los hombres    y de 72,8 para las mujeres. La tasa de alfabetizaci&oacute;n es
 de 82,4% para    los varones y de 77,2 % para las mujeres. La proporci&oacute;n
 del presupuesto    de salud en el PIB es de 3,5. El pa&iacute;s pertenece al gr
upo de ingresos    medio-bajo, de acuerdo con los criterios de 2004 del Banco Mu
ndial.</font></p>     ^cY#a08v22n5.htm##
01467000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704123200076002001301308#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#63#59#article#236#<p><font size="2" f
ace="Verdana"><b>Guatemala.</b> Posee una extensi&oacute;n    territorial de 108
 889 kil&oacute;metros cuadrados, con una poblaci&oacute;n    de 12,7 millones d
e habitantes. Es un pa&iacute;s pluricultural, multi&eacute;tnico    y multiling
&uuml;&iacute;stico, donde se identifican los siguientes grupos &eacute;tnicos: 
   blancos, ladinos (mestizos), mayas, xinkas y gar&iacute;funas. El idioma ofic
ial    es el espa&ntilde;ol, pero coexisten 21 lenguas mayas entre las que predo
minan    el K'iche, el Mam, el Kaqchikel y el Q'ueqch&iacute;, adem&aacute;s de 
los idiomas    Xinka y Gar&iacute;funa. Los grupos religiosos incluyen cat&oacut
e;licos, evang&eacute;licos    y mayas. De la poblaci&oacute;n, 43% reside en el
 &aacute;rea rural y 42% es    ind&iacute;gena. Por otra parte, 62,6% es menor d
e 24 a&ntilde;os y 18% corresponde    a poblaci&oacute;n adolescente; los mayore
s de 60 a&ntilde;os representan 4%    de la poblaci&oacute;n. La expectativa de 
vida es de 65,9 a&ntilde;os. En 2003,    el gasto p&uacute;blico en salud como p
orcentaje del PIB fue de 2,1. Esta naci&oacute;n    pertenece al grupo de ingres
os medio-bajo, de acuerdo con los criterios de 2004    del Banco Mundial.</font>
</p>     ^cY#a08v22n5.htm##
01685000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704145000076002001301526#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#64#60#article#236#<p><font size="2" f
ace="Verdana"><b>Nicaragua.</b> Su extensi&oacute;n geogr&aacute;fica    es de 1
30 682 kil&oacute;metros cuadrados y tiene 5,6 millones de habitantes.    Se div
ide, adem&aacute;s, en tres regiones geogr&aacute;ficas: Pac&iacute;fico,    Atl
&aacute;ntico y Central, aunque los habitantes no est&aacute;n distribuidos    h
omog&eacute;neamente sino que se concentran en la regi&oacute;n del Pac&iacute;f
ico    que ocupa 15,3% del territorio nacional y alberga a 61,5% de la poblaci&o
acute;n    total. El idioma oficial es el espa&ntilde;ol pero, adem&aacute;s, en
 la costa    atl&aacute;ntica se habla el ingl&eacute;s y el dialecto miskito. L
os principales    grupos &eacute;tnicos son mestizos, ind&iacute;genas, negros y
 blancos. Los    grupos religiosos m&aacute;s importantes incluyen cat&oacute;li
cos y diversas    denominaciones cristianas. De la poblaci&oacute;n, 41,2% tiene
 menos de 15 a&ntilde;os    y 4,7% m&aacute;s de 60 a&ntilde;os; 41% de la pobla
ci&oacute;n es rural. La    expectativa de vida al nacer es de 68,7 a&ntilde;os 
para los hombres y 69,1    para las mujeres. La tasa de alfabetizaci&oacute;n es
 de 64%. El &Iacute;ndice    de Desarrollo Humano es el segundo m&aacute;s bajo 
de la regi&oacute;n centroamericana.    Nicaragua pertenece al grupo de ingreso 
bajo, seg&uacute;n los criterios de    2004 del Banco Mundial. La proporci&oacut
e;n del presupuesto de salud en el    PIB es de 3%.</font></p>     ^cY#a08v22n5.
htm##
00329000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009400076002001300170#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#65#61#article#236#<p><font size="2" f
ace="Verdana"><b>Resultados de la evaluaci&oacute;n</b></font></p>     ^cY#a08v2
2n5.htm##
00337000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010200076002001300178#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#66#62#article#236#<p><font size="2" f
ace="Verdana"><b><i>Pol&iacute;tica y marco legislativo</i></b></font></p>     ^
cY#a08v22n5.htm##
00973000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704073800076002001300814#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#67#63#article#236#<p><font size="2" f
ace="Verdana"><b>Pol&iacute;tica y planes.</b> En ninguno de    los tres pa&iacu
te;ses evaluados existen pol&iacute;ticas nacionales de salud    mental expl&iac
ute;citas. Sin embargo, se han dise&ntilde;ado e implementado    planes nacional
es de salud mental, mismos que en el caso de Nicaragua y El Salvador    fueron r
evisados y actualizados recientemente (2004–2005), mientras que el plan    de Gu
atemala no ha sido objeto de revisi&oacute;n desde 1997. En 2004, con el    apoy
o t&eacute;cnico de la Organizaci&oacute;n Panamericana de la Salud (OPS/OMS),  
  en los tres pa&iacute;ses se dise&ntilde;aron planes de protecci&oacute;n de  
  la salud mental en situaciones de desastre y emergencias.</font></p>     ^cY#a
08v22n5.htm##
00813000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704057800076002001300654#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#68#64#article#236#<p><font size="2" f
ace="Verdana"><b>Legislaci&oacute;n.</b> Ninguna de las tres    naciones cuenta 
con una legislaci&oacute;n en materia de salud mental. No obstante,    existen a
lgunos elementos dispersos en la legislaci&oacute;n vigente (Constituci&oacute;n
    de la Rep&uacute;blica, C&oacute;digo o Ley de Salud, C&oacute;digo Penal, r
egulaciones    sobre alcohol y tabaco, leyes sobre violencia y discapacidad, etc
.), los cuales    no alcanzan a constituirse en un cuerpo legal coherente de acu
erdo con los modernos    est&aacute;ndares internacionales.</font></p>     ^cY#a
08v22n5.htm##
01082000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704084700076002001300923#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#69#65#article#236#<p><font size="2" f
ace="Verdana"><b>Financiamiento de los servicios de salud mental.</b>    El comp
ortamiento es similar en los tres pa&iacute;ses y distante de las recomendacione
s    de la OMS: "dada la carga de los trastornos mentales y neurol&oacute;gicos,
    la proporci&oacute;n del presupuesto general de salud destinado a la salud m
ental    deber&iacute;a estar entre el 5 y 15%" (7). En estas naciones s&oacute;
lo    se dedica alrededor de 1% del presupuesto general de salud a la salud ment
al    y, de &eacute;ste, aproximadamente 90% se destina a los hospitales psiqui&
aacute;tricos.    Es decir, los manicomios contin&uacute;an absorbiendo la gran 
mayor&iacute;a    de los recursos financieros destinados a la salud mental, en d
etrimento de los    servicios especializados ambulatorios y de atenci&oacute;n p
rimaria.</font></p>     ^cY#a08v22n5.htm##
00802000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056700076002001300643#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#70#66#article#236#<p><font size="2" f
ace="Verdana">Para las personas pobres o con bajos niveles    de ingreso, que ti
enen que pagar los medicamentos psicotr&oacute;picos, &eacute;stos    resultan p
r&aacute;cticamente inaccesibles. As&iacute;, la proporci&oacute;n    del salari
o m&iacute;nimo diario que dedicar&iacute;a un usuario a la compra    de la dosi
s diaria necesaria de un antipsic&oacute;tico y de un antidepresivo    en El Sal
vador, corresponder&iacute;a a 46% y 28%, respectivamente; en Guatemala    ser&i
acute;a de 29% y 17%, y en Nicaragua de 5% y 4%.</font></p>     ^cY#a08v22n5.htm
##
00851000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704061600076002001300692#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#71#67#article#236#<p><font size="2" f
ace="Verdana"><b>Pol&iacute;ticas sobre derechos humanos.</b>    En los tres pa&
iacute;ses existen instituciones estatales dedicadas a la vigilancia    y protec
ci&oacute;n de los derechos humanos (Procuradur&iacute;a de los Derechos    Huma
nos), que si bien pueden realizar inspecciones o auditor&iacute;as y atender    
quejas o reclamos, carecen de autoridad administrativa para aplicar sanciones,  
  cerrar instituciones, etc&eacute;tera. Sus recomendaciones no son vinculantes 
   sino que, en la mayor&iacute;a de los casos, s&oacute;lo implican una sanci&o
acute;n    moral.</font></p>     ^cY#a08v22n5.htm##
00963000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704072800076002001300804#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#72#68#article#236#<p><font size="2" f
ace="Verdana">Cabe destacar que no existe una pol&iacute;tica    de revisiones p
eri&oacute;dicas del estado de salvaguarda de los derechos humanos    en los ser
vicios hospitalarios de psiquiatr&iacute;a, como tampoco hay una capacitaci&oacu
te;n    sistem&aacute;tica para los trabajadores de los dispositivos de salud me
ntal.    En 1998, el Grupo de trabajo para el diagn&oacute;stico sobre el estado
 de los    derechos humanos de las personas con enfermedades mentales en pa&iacu
te;ses    de Centroam&eacute;rica, de la OPS/OMS, llev&oacute; a cabo una revisi
&oacute;n    del tema (9), y evaluaciones posteriores han hecho evidente el esca
so avance    logrado desde esa fecha hasta ahora.</font></p>     ^cY#a08v22n5.ht
m##
00320000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008500076002001300161#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#73#69#article#236#<p><font size="2" f
ace="Verdana"><b>Servicios de salud mental</b></font></p>     ^cY#a08v22n5.htm##
00547000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704031200076002001300388#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#74#70#article#236#<p><font size="2" f
ace="Verdana">A continuaci&oacute;n se describe la situaci&oacute;n    de los di
ferentes tipos de servicios de salud mental en los pa&iacute;ses evaluados.    E
n el <a href="#qdr01">cuadro 1</a> se detalla el n&uacute;mero de dispositivos  
  seg&uacute;n categor&iacute;as.</font></p>     ^cY#a08v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#75#71#article#236#<p><a name="qdr01">
</a></p>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#76#72#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#77#73#article#236#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a08qdr01.gif"></p>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#78#74#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00346000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704011100076002001300187#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#79#75#article#236#<p><font size="2" f
ace="Verdana"><b><i>Establecimientos de salud mental disponibles</i></b></font><
/p>     ^cY#a08v22n5.htm##
00676000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704044100076002001300517#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#80#76#article#236#<p><font size="2" f
ace="Verdana"><b>Servicios ambulatorios.</b> La situaci&oacute;n    que priva en
 los tres pa&iacute;ses en cuanto a la existencia de servicios ambulatorios    e
specializados dista de ser adecuada; esto es resultado de la distribuci&oacute;n
    presupuestaria que contin&uacute;a dando prioridad a los servicios hospitala
rios.    No obstante esta generalidad, se observan diferencias entre las nacione
s.</font></p>     ^cY#a08v22n5.htm##
00868000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704063300076002001300709#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#81#77#article#236#<p><font size="2" f
ace="Verdana">El Salvador cuenta con el mayor n&uacute;mero    de servicios ambu
latorios y, en los &uacute;ltimos a&ntilde;os, se han abierto    algunos Centros
 Polivalentes de Atenci&oacute;n Psicosocial que constituyen    una experiencia 
novedosa en relaci&oacute;n con la extensi&oacute;n de cobertura    y b&uacute;s
queda de alternativas al hospital psiqui&aacute;trico. Ejemplo importante    en 
este contexto lo constituye la experiencia del Distrito Italia (Ilopango    Nort
e), donde se desarrolla la integraci&oacute;n del servicio especializado    con 
el Sistema B&aacute;sico de Salud.</font></p>     ^cY#a08v22n5.htm##
00731000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704049600076002001300572#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#82#78#article#236#<p><font size="2" f
ace="Verdana">En Nicaragua han surgido los Centros de Atenci&oacute;n    Psicoso
cial (CAPs), que constituyen un modelo local de servicios comunitarios    de sal
ud mental. Su creaci&oacute;n se remonta a la d&eacute;cada de los a&ntilde;os  
  ochenta; empero, durante los noventa sufrieron un serio deterioro. Actualmente
    se est&aacute;n fortaleciendo algunos, como el de Chinandega que ha recibido
    el apoyo de la OPS/OMS mediante el proyecto WHO-AIMS.</font></p>     ^cY#a08
v22n5.htm##
01133000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704089800076002001300974#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#83#79#article#236#<p><font size="2" f
ace="Verdana">La situaci&oacute;n en Guatemala es cr&iacute;tica,    pues escase
an los establecimientos para una poblaci&oacute;n relativamente numerosa.    La 
mayor&iacute;a de esos dispositivos apenas cuentan con un psic&oacute;logo.    C
abe destacar que en este pa&iacute;s, desde 1997, el Ministerio de Salud, con   
 el apoyo de la Organizaci&oacute;n Panamericana de la Salud y otras agencias,  
  ha desarrollado acciones de atenci&oacute;n psicosocial a poblaciones ind&iacu
te;genas    que fueron afectadas por el conflicto armado. Recientemente, como pa
rte del    proyecto WHO-AIMS, se abrieron dos servicios ambulatorios de salud me
ntal en    las zonas 18 y 19 de la periferia de la ciudad capital. El valor agre
gado de    estos servicios radica en que constituyen la fase inicial de la desce
ntralizaci&oacute;n    de la consulta externa del hospital.</font></p>     ^cY#a
08v22n5.htm##
00464000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704022900076002001300305#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#84#80#article#236#<p><font size="2" f
ace="Verdana">Con respecto a los centros de d&iacute;a, El    Salvador no cuenta
 con ninguno, Guatemala tiene dos (en los hospitales psiqui&aacute;tricos    de 
la capital) y Nicaragua cinco.</font></p>     ^cY#a08v22n5.htm##
00719000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048400076002001300560#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#85#81#article#236#<p><font size="2" f
ace="Verdana">Existen muy pocos servicios o unidades de salud    mental en hospi
tales generales. El desarrollo de esta modalidad asistencial    es a&uacute;n mu
y limitado e incipiente en los tres pa&iacute;ses. Se trata,    en la mayor&iacu
te;a de los casos, de unidades muy peque&ntilde;as, con pocos    recursos, sin g
ran capacidad de respuesta y limitada cobertura. En El Salvador    no existen; G
uatemala cuenta con dos y Nicaragua con tres.</font></p>     ^cY#a08v22n5.htm##
01033000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704079800076002001300874#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#86#82#article#236#<p><font size="2" f
ace="Verdana">Los hospitales psiqui&aacute;tricos est&aacute;n    ubicados en la
s capitales de estos pa&iacute;ses y concentran la casi totalidad    de las cama
s psiqui&aacute;tricas. Contin&uacute;an, en gran medida, con modelos    de aten
ci&oacute;n de tipo asilar, pobres condiciones de vida de las personas    intern
adas y problemas con la protecci&oacute;n de los derechos humanos. Con    frecue
ncia, el promedio de estad&iacute;a de internamiento sigue siendo alto;    por e
jemplo, m&aacute;s de 40% de los pacientes internados en el Hospital Psiqui&aacu
te;trico    de Managua han estado all&iacute; por m&aacute;s de 10 a&ntilde;os. 
Estos hospitales,    generalmente, no responden a las necesidades crecientes de 
salud mental de la    poblaci&oacute;n.</font></p>     ^cY#a08v22n5.htm##
00635000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704040000076002001300476#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#87#83#article#236#<p><font size="2" f
ace="Verdana">Los establecimientos residenciales comunitarios    (o casas de med
io camino) destinados a enfermos con trastornos mentales de larga    evoluci&oac
ute;n, son casi inexistentes. Los que hay, son b&aacute;sicamente    centros de 
tipo asilar, del sector privado, dedicados a ancianos o a casos con    retraso m
ental y abuso de sustancias psicoactivas.</font></p>     ^cY#a08v22n5.htm##
00524000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704028900076002001300365#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#88#84#article#236#<p><font size="2" f
ace="Verdana">Las unidades psiqui&aacute;tricas forenses se    han desarrollado 
en los &uacute;ltimos a&ntilde;os como una respuesta emergente    a las demandas
 existentes en este campo. Nicaragua a&uacute;n no dispone de    un servicio de 
este tipo.</font></p>     ^cY#a08v22n5.htm##
00934000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704069900076002001300775#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#89#85#article#236#<p><font size="2" f
ace="Verdana"><b>Atenci&oacute;n en los servicios ambulatorios.</b>    El n&uacu
te;mero de contactos por usuario var&iacute;a desde 2,3 en El Salvador    hasta 
5,0 en Nicaragua. Guatemala no pudo notificar esta informaci&oacute;n.    Debe s
e&ntilde;alarse, sin embargo, que &eacute;ste es un dato obtenido mediante    un
 mejor estimado o la evaluaci&oacute;n de una muestra. Generalmente los sistemas
    registran de forma regular los contactos, pero no identifican el n&uacute;me
ro    de usuarios. La raz&oacute;n de usuarios atendidos por 100 000 habitantes 
es    de 782 en Guatemala, 627 en El Salvador y 145 en Nicaragua (<a href="#qdr0
2">cuadro    2</a>).</font></p>     ^cY#a08v22n5.htm##
00271000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704003600076002001300112#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#90#86#article#236#<p><a name="qdr02">
</a></p>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#91#87#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
00315000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704008000076002001300156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#92#88#article#236#<p align="center"><
img src="/img/revistas/rpsp/v22n5/a08qdr02.gif"></p>     ^cY#a08v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#93#89#article#236#<p>&nbsp;</p>     ^
cY#a08v22n5.htm##
01016000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704078100076002001300857#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#94#90#article#236#<p><font size="2" f
ace="Verdana"><b>Establecimientos ambulatorios dedicados exclusivamente    a la 
infancia y adolescencia.</b> El n&uacute;mero de servicios ambulatorios    dedic
ados exclusivamente a la atenci&oacute;n de salud mental de ni&ntilde;os,    ni&
ntilde;as y adolescentes, es s&oacute;lo una peque&ntilde;a fracci&oacute;n    d
e lo que realmente se necesita. Cabe pensar que una de las deudas pendientes    
en estos pa&iacute;ses es la necesidad de incrementar y mejorar la atenci&oacute
;n    infanto-juvenil en salud mental, dado que en El Salvador s&oacute;lo 2% de
 sus    servicios ambulatorios se dedican exclusivamente a la infancia y la adol
escencia    (1/49); en Guatemala esa proporci&oacute;n es de 3% (1/32) y en Nica
ragua de    8% (3/34).</font></p>     ^cY#a08v22n5.htm##
00386000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704015100076002001300227#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#95#91#article#236#<p><font size="2" f
ace="Verdana">Tipo de oferta disponible en los servicios ambulatorios    y calid
ad de la atenci&oacute;n:</font></p> <ul>       ^cY#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#96#92#article#236#<li>          ^cY#a
08v22n5.htm##
00496000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704026100076002001300337#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#97#93#article#236#<p><font size="2" f
ace="Verdana">Guatemala y Nicaragua carecen de psicof&aacute;rmacos        en lo
s servicios ambulatorios, en tanto que en El Salvador s&oacute;lo 49%        de 
los mismos tienen medicamentos psicotr&oacute;picos.</font></p>   </li>       ^c
Y#a08v22n5.htm##
00253000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704001800076002001300094#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#98#94#article#236#<li>          ^cY#a
08v22n5.htm##
00458000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704022300076002001300299#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#99#95#article#236#<p><font size="2" f
ace="Verdana">Se realizan intervenciones de tipo psicosocial        exclusivamen
te en algunos servicios ambulatorios (entre 21 y 50%), seg&uacute;n        un me
jor estimado. </font></p>   </li>       ^cY#a08v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704001800077002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#100#96#article#236#<li>          ^cY#
a08v22n5.htm##
00455000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704021900077002001300296#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#101#97#article#236#<p><font size="2" 
face="Verdana">El seguimiento de casos en la comunidad es        limitado o inex
istente (ning&uacute;n servicio en Guatemala, 6% en El Salvador        y 50% en 
Nicaragua).</font></p>   </li>       ^cY#a08v22n5.htm##
00254000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704001800077002001300095#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#102#98#article#236#<li>          ^cY#
a08v22n5.htm##
00354000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704011800077002001300195#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#103#99#article#236#<p><font size="2" 
face="Verdana">No existen equipos m&oacute;viles de salud        mental.</font><
/p>   </li>     ^cY#a08v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001400078002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#104#100#article#236#</ul>     ^cY#a08
v22n5.htm##
00328000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009100078002001300169#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#105#101#article#236#<p><font size="2"
 face="Verdana"><b>Hospitales psiqui&aacute;tricos</b></font></p>     ^cY#a08v22
n5.htm##
00708000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704047100078002001300549#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#106#102#article#236#<p><font size="2"
 face="Verdana">Los tres principales diagn&oacute;sticos en las    personas inte
rnadas en hospitales psiqui&aacute;tricos son: esquizofrenias,    trastornos afe
ctivos y trastornos asociados al consumo de sustancias psicoactivas.    En El Sa
lvador, los trastornos asociados al consumo de sustancias son los m&aacute;s    
frecuentes, en lo cual puede influir la existencia de un importante servicio    
de adicciones dentro del hospital.</font></p>     ^cY#a08v22n5.htm##
00485000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704024800078002001300326#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#107#103#article#236#<p><font size="2"
 face="Verdana">La reducci&oacute;n de camas en los hospitales    psiqui&aacute;
tricos en los &uacute;ltimos cinco a&ntilde;os ha sido poco significativa:    7%
 en El Salvador y ninguna en Nicaragua y Guatemala.</font></p>     ^cY#a08v22n5.
htm##
00838000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704060100078002001300679#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#108#104#article#236#<p><font size="2"
 face="Verdana">La admisi&oacute;n involuntaria de casos y la    restricci&oacut
e;n f&iacute;sica o aislamiento de casos no se controla ni registra    de manera
 sistem&aacute;tica. S&oacute;lo en El Salvador se hizo un estimado    al respec
to mediante revisi&oacute;n de expedientes cl&iacute;nicos, y se encontr&oacute;
    que 35% de las admisiones fueron involuntarias y alrededor de 8% de los caso
s    internados en los hospitales psiqui&aacute;tricos fueron sometidos a medida
s    de restricci&oacute;n f&iacute;sica o aislados (<a href="#qdr03">cuadro 3</
a>).</font></p>     ^cY#a08v22n5.htm##
00273000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704003600078002001300114#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#109#105#article#236#<p><a name="qdr03
"></a></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#110#106#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#111#107#article#236#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a08qdr03.gif"></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#112#108#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00352000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011500078002001300193#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#113#109#article#236#<p><font size="2"
 face="Verdana"><b>Equidad en el acceso a los servicios de salud    mental</b></
font></p>     ^cY#a08v22n5.htm##
00393000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015600078002001300234#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#114#110#article#236#<p><font size="2"
 face="Verdana">Los tres pa&iacute;ses informaron &iacute;ndices    evidentes de
 inequidad, como los siguientes:</font></p> <ul>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#115#111#article#236#<li>          ^cY
#a08v22n5.htm##
00665000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704042800078002001300506#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#116#112#article#236#<p><font size="2"
 face="Verdana">Las camas psiqui&aacute;tricas est&aacute;n        concentradas,
 casi en su totalidad, en las capitales, de tal manera que        en El Salvador
 la relaci&oacute;n entre la raz&oacute;n de camas psiqui&aacute;tricas        d
e todo el pa&iacute;s y las que se encuentran en la capital, es de 2,90,        
mientras que en Guatemala es de 3,34 y en Nicaragua de 5,39. </font></p>   </li>
       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#117#113#article#236#<li>          ^cY
#a08v22n5.htm##
00552000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704031500078002001300393#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#118#114#article#236#<p><font size="2"
 face="Verdana">Los usuarios de zonas rurales, los grupos        ind&iacute;gena
s y otras minor&iacute;as &eacute;tnicas y ling&uuml;&iacute;sticas,        est&
aacute;n significativamente subrepresentados en el uso de los servicios        a
mbulatorios de salud mental.</font></p>   </li>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#119#115#article#236#<li>          ^cY
#a08v22n5.htm##
00511000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704027400078002001300352#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#120#116#article#236#<p><font size="2"
 face="Verdana">No existen estrategias formales que garanticen        el acceso 
equitativo a los servicios de salud mental para los grupos ind&iacute;genas     
   y otras minor&iacute;as &eacute;tnicas y ling&uuml;&iacute;sticas.</font></p>
   </li>     ^cY#a08v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001400078002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#121#117#article#236#</ul>     ^cY#a08
v22n5.htm##
00352000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011500078002001300193#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#122#118#article#236#<p><font size="2"
 face="Verdana"><b>Salud mental en la atenci&oacute;n primaria    de salud</b></
font></p>     ^cY#a08v22n5.htm##
01315000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704107800078002001301156#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#123#119#article#236#<p><font size="2"
 face="Verdana">Para los efectos de este an&aacute;lisis, se    evaluaron los pr
ogramas educativos de formaci&oacute;n de m&eacute;dicos y enfermeras    a fin d
e determinar el tiempo dedicado a los temas de salud mental en la formaci&oacute
;n    de pregrado (universitaria). Para el estudio se incluyeron todas las unive
rsidades    de cada pa&iacute;s (p&uacute;blicas o privadas) donde se impart&iac
ute;an las    carreras de medicina y enfermer&iacute;a. Se destaca que, en Guate
mala, tanto    la asignatura de psiquiatr&iacute;a como otros contenidos de salu
d mental desaparecieron,    casi totalmente, del programa de estudios de la facu
ltad de medicina de la principal    universidad p&uacute;blica del pa&iacute;s, 
de tal manera que se les dedica    tan s&oacute;lo 1% del tiempo de formaci&oacu
te;n de los m&eacute;dicos, y 3%    del correspondiente a las enfermeras; en El 
Salvador se destina 7% en el caso    de los m&eacute;dicos y 4% para las enferme
ras y, finalmente, en Nicaragua las    proporciones son 2% y 7%, respectivamente
.</font></p>     ^cY#a08v22n5.htm##
00830000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704059300078002001300671#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#124#120#article#236#<p><font size="2"
 face="Verdana">En las tres naciones, los programas de capacitaci&oacute;n    y 
educaci&oacute;n continua de post-grado son impartidos, fundamentalmente,    por
 los ministerios de salud y, en menor medida, por las instituciones de seguridad
    social. El primer elemento que cabe destacar es que los datos no estaban dis
ponibles    en los sistemas regulares de informaci&oacute;n; por lo tanto, fue n
ecesario    realizar un mejor estimado mediante la recopilaci&oacute;n en divers
as fuentes.    En Guatemala no fue posible contar con la informaci&oacute;n.</fo
nt></p>     ^cY#a08v22n5.htm##
00893000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704065600078002001300734#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#125#121#article#236#<p><font size="2"
 face="Verdana">En sentido general, se evidencia la casi inexistencia    de prog
ramas regulares de capacitaci&oacute;n en temas de salud mental para    el perso
nal de atenci&oacute;n primaria de salud (APS). Los pocos resultados    que se m
uestran son producto de cursos aislados o procesos no sistem&aacute;ticos.    En
 El Salvador 16% de los m&eacute;dicos de APS, y 13% de las enfermeras, fueron  
  capacitados en salud mental; en Nicaragua ninguna enfermera y s&oacute;lo 4%  
  de los m&eacute;dicos de APS recibieron esa capacitaci&oacute;n. En Guatemala 
   no se dispon&iacute;a de informaci&oacute;n al respecto.</font></p>     ^cY#a
08v22n5.htm##
00842000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704060500078002001300683#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#126#122#article#236#<p><font size="2"
 face="Verdana">El Salvador es el pa&iacute;s que m&aacute;s    ha trabajado en 
el desarrollo de normas y protocolos de atenci&oacute;n en salud    mental dirig
idos a trabajadores de APS; &eacute;stos se encuentran validados    y se ha come
nzado su implementaci&oacute;n en algunos centros de APS (menos    de 20%). Guat
emala dispone de protocolos elaborados a finales de los a&ntilde;os    noventa q
ue no han sido revisados ni actualizados; se encuentran actualmente    implement
ados en menos de 20% de los centros de APS. En Nicaragua no se dispone    de pro
tocolos.</font></p>     ^cY#a08v22n5.htm##
00547000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704031000078002001300388#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#127#123#article#236#<p><font size="2"
 face="Verdana">La disponibilidad de psicof&aacute;rmacos en    la APS es cr&iac
ute;tica en Nicaragua y Guatemala, ya que no est&aacute;n disponibles    estos m
edicamentos. En El Salvador hay medicamentos disponibles en un grupo    de centr
os que se estima entre 21% y 50%.</font></p>     ^cY#a08v22n5.htm##
00618000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704038100078002001300459#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#128#124#article#236#<p><font size="2"
 face="Verdana">Las modalidades de prescripci&oacute;n de los    psicof&aacute;r
macos son similares en los tres pa&iacute;ses: pueden prescribir    sin limitaci
ones (o con muy pocas) los psiquiatras y otros m&eacute;dicos de    la APS. Est&
aacute; prohibido que las enfermeras u otro tipo de personal no    m&eacute;dico
 prescriba medicamentos.</font></p>     ^cY#a08v22n5.htm##
00313000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007600078002001300154#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#129#125#article#236#<p><font size="2"
 face="Verdana"><b>Recursos humanos</b></font></p>     ^cY#a08v22n5.htm##
00595000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704035800078002001300436#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#130#126#article#236#<p><font size="2"
 face="Verdana">Para evaluar la disponibilidad de recursos humanos    calificado
s en los establecimientos de salud mental (todos los tipos), se seleccionaron   
 tres categor&iacute;as de trabajadores; en el <a href="#qdr04">cuadro 4</a>    
se muestran las cifras num&eacute;ricas y la raz&oacute;n por 100 000 habitantes
.</font></p>     ^cY#a08v22n5.htm##
00273000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704003600078002001300114#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#131#127#article#236#<p><a name="qdr04
"></a></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#132#128#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#133#129#article#236#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a08qdr04.gif"></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#134#130#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00678000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704044100078002001300519#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#135#131#article#236#<p><font size="2"
 face="Verdana">Los psiquiatras son un integrante fundamental    de los equipos 
de salud mental; si son insuficientes, la atenci&oacute;n de    salud mental se 
afecta o limita sensiblemente El indicador de un psiquiatra    o menos por cien 
mil habitantes coloca a estos pa&iacute;ses en el grupo de    naciones con el m&
aacute;s bajo n&uacute;mero de psiquiatras por poblaci&oacute;n,    la raz&oacut
e;n.</font></p>     ^cY#a08v22n5.htm##
00750000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704051300078002001300591#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#136#132#article#236#<p><font size="2"
 face="Verdana">Por otra parte, la elevada concentraci&oacute;n    de los recurs
os humanos en las capitales afecta seriamente el acceso a los servicios    de la
 poblaci&oacute;n del interior de la naci&oacute;n, en especial de las    zonas 
rurales o de los ind&iacute;genas. En Guatemala, la relaci&oacute;n entre    la 
raz&oacute;n nacional de m&eacute;dicos psiquiatras y la de aquellos ubicados   
 en la capital es de 2,96; en El Salvador es de 2,59 y en Nicaragua de 3,48.</fo
nt></p>     ^cY#a08v22n5.htm##
00372000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704013500078002001300213#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#137#133#article#236#<p><font size="2"
 face="Verdana"><b>Educaci&oacute;n del p&uacute;blico y v&iacute;nculos    con 
otros sectores</b></font></p>     ^cY#a08v22n5.htm##
00933000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704069600078002001300774#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#138#134#article#236#<p><font size="2"
 face="Verdana"><b>Actividades de promoci&oacute;n de la salud    mental y preve
nci&oacute;n en escuelas.</b> En sentido general, se observa que    en los siste
mas p&uacute;blicos de educaci&oacute;n es muy bajo el n&uacute;mero    de escue
las que pueden contar con un profesional de salud mental. Sin embargo    algunos
 pa&iacute;ses, como El Salvador, han logrado capacitar a maestros y    trabajad
ores de APS para que desarrollen acciones de promoci&oacute;n y prevenci&oacute;
n    en las escuelas (entre 51% y 80%, seg&uacute;n el mejor estimado). El porce
ntaje    es mucho menor en Guatemala y Nicaragua (menos de 20%) (<a href="#qdr05
">cuadro    5</a>).</font></p>     ^cY#a08v22n5.htm##
00273000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704003600078002001300114#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#139#135#article#236#<p><a name="qdr05
"></a></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#140#136#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00317000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008000078002001300158#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#141#137#article#236#<p align="center"
><img src="/img/revistas/rpsp/v22n5/a08qdr05.gif"></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#142#138#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00894000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704065700078002001300735#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#143#139#article#236#<p><font size="2"
 face="Verdana"><b>Asociaciones de usuarios y familiares.</b>    En general, la 
presencia y el grado de desarrollo de las asociaciones de usuarios    y familiar
es son muy limitados en las tres naciones. La membres&iacute;a es    pobre num&e
acute;ricamente y, casi siempre, mixta (usuarios y familiares). No    reciben su
bsidios ni aportes econ&oacute;micos de los gobiernos y casi nunca    participan
 de manera significativa en los procesos de planificaci&oacute;n e    implementa
ci&oacute;n de pol&iacute;ticas, programas y legislaci&oacute;n. Su    interacci
&oacute;n con los servicios de salud mental es muy limitada.</font></p>     ^cY#
a08v22n5.htm##
00337000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010000078002001300178#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#144#140#article#236#<p><font size="2"
 face="Verdana"><b>Evaluaci&oacute;n e investigaci&oacute;n</b></font></p>     ^
cY#a08v22n5.htm##
00377000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704014000078002001300218#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#145#141#article#236#<p><font size="2"
 face="Verdana">Los sistemas de informaci&oacute;n adolecen de    m&uacute;ltipl
es deficiencias:</font></p> <ul>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#146#142#article#236#<li>          ^cY
#a08v22n5.htm##
00393000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015600078002001300234#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#147#143#article#236#<p><font size="2"
 face="Verdana">No todas las unidades o servicios de salud        mental informa
n a los ministerios de salud.</font></p>   </li>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#148#144#article#236#<li>          ^cY
#a08v22n5.htm##
00386000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704014900078002001300227#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#149#145#article#236#<p><font size="2"
 face="Verdana">Los datos que se recolectan son insuficientes        para un an&
aacute;lisis adecuado.</font></p>   </li>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#150#146#article#236#<li>          ^cY
#a08v22n5.htm##
00365000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704012800078002001300206#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#151#147#article#236#<p><font size="2"
 face="Verdana">Existe subregistro o mala calidad en el registro        primario
.</font></p>   </li>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#152#148#article#236#<li>          ^cY
#a08v22n5.htm##
00342000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010500078002001300183#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#153#149#article#236#<p><font size="2"
 face="Verdana">No se dispone de datos del sector privado.</font></p>   </li>   
    ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#154#150#article#236#<li>          ^cY
#a08v22n5.htm##
00366000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704012900078002001300207#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#155#151#article#236#<p><font size="2"
 face="Verdana">No hay publicaciones o informes anuales sobre        salud menta
l.</font></p>   </li>       ^cY#a08v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001800078002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#156#152#article#236#<li>          ^cY
#a08v22n5.htm##
00354000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011700078002001300195#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#157#153#article#236#<p><font size="2"
 face="Verdana">No existen sistemas de vigilancia epidemiol&oacute;gica.</font><
/p>   </li>     ^cY#a08v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704001400078002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#158#154#article#236#</ul>     ^cY#a08
v22n5.htm##
00918000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704068100078002001300759#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#159#155#article#236#<p><font size="2"
 face="Verdana">La falta de investigaci&oacute;n es, sin lugar    a dudas, una d
ebilidad de los pa&iacute;ses evaluados. En El Salvador 12% de    las investigac
iones notificadas formalmente (PubMed) correspondieron a salud    mental; en Nic
aragua ascendieron a 24%, y en Guatemala no se inform&oacute;    de ninguna. La 
opini&oacute;n generalizada es que no se dispone de recursos    para esta &aacut
e;rea que, adem&aacute;s, no es prioritaria para el sector p&uacute;blico.    Un
a excepci&oacute;n es Nicaragua, ya que ha tenido un cierto grado de desarrollo 
   con un equipo de investigadores en salud mental en la Universidad de Le&oacut
e;n.</font></p>     ^cY#a08v22n5.htm##
00334000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009700078002001300175#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#160#156#article#236#<p><font size="2"
 face="Verdana"><b>Recomendaciones para la acci&oacute;n</b></font></p>     ^cY#
a08v22n5.htm##
00590000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704035300078002001300431#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#161#157#article#236#<p><font size="2"
 face="Verdana">Existen tres documentos adicionales que pueden    ayudar a los p
a&iacute;ses como gu&iacute;a para la reforma de los servicios    de salud menta
l: las recomendaciones del Informe Mundial de Salud (OMS, 2001),    las resoluci
ones de la OPS/OMS y la declaraci&oacute;n final de Brasilia (OPS,    2005).</fo
nt></p>     ^cY#a08v22n5.htm##
00564000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704032700078002001300405#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#162#158#article#236#<p><font size="2"
 face="Verdana">Las 10 recomendaciones del Informe sobre la Salud    en el Mundo
 (7) pueden utilizarse como gu&iacute;a de acci&oacute;n; &eacute;stas,    tambi
&eacute;n, fueron el fundamento para el dise&ntilde;o del instrumento de    eval
uaci&oacute;n de los sistemas de salud (WHO-AIMS):</font></p>     ^cY#a08v22n5.h
tm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#163#159#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00328000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009100078002001300169#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#164#160#article#236#<p><font size="2"
 face="Verdana"> 1. Dispensar tratamiento en la APS.</font></p>       ^cY#a08v22
n5.htm##
00367000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704013000078002001300208#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#165#161#article#236#<p><font size="2"
 face="Verdana"> 2. Garantizar la disponibilidad de medicamentos      psicotr&oa
cute;picos.</font></p>       ^cY#a08v22n5.htm##
00331000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009400078002001300172#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#166#162#article#236#<p><font size="2"
 face="Verdana"> 3. Prestar asistencia en la comunidad.</font></p>       ^cY#a08
v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008400078002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#167#163#article#236#<p><font size="2"
 face="Verdana"> 4. Educar al p&uacute;blico.</font></p>       ^cY#a08v22n5.htm#
#
00363000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704012600078002001300204#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#168#164#article#236#<p><font size="2"
 face="Verdana"> 5. Involucrar a las comunidades, las familias      y los consum
idores.</font></p>       ^cY#a08v22n5.htm##
00379000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704014200078002001300220#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#169#165#article#236#<p><font size="2"
 face="Verdana"> 6. Establecer pol&iacute;ticas, programas      y legislaci&oacu
te;n a escala nacional.</font></p>       ^cY#a08v22n5.htm##
00329000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009200078002001300170#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#170#166#article#236#<p><font size="2"
 face="Verdana"> 7. Desarrollar los recursos humanos.</font></p>       ^cY#a08v2
2n5.htm##
00342000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010500078002001300183#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#171#167#article#236#<p><font size="2"
 face="Verdana"> 8. Establecer v&iacute;nculos con otros sectores.</font></p>   
    ^cY#a08v22n5.htm##
00339000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010200078002001300180#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#172#168#article#236#<p><font size="2"
 face="Verdana"> 9. Vigilar la salud mental de las comunidades.</font></p>      
 ^cY#a08v22n5.htm##
00338000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010100078002001300179#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#173#169#article#236#<p><font size="2"
 face="Verdana">10. Apoyar nuevas investigaciones.</font></p> </blockquote>     
^cY#a08v22n5.htm##
00932000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704069500078002001300773#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#174#170#article#236#<p><font size="2"
 face="Verdana">De otro lado, en noviembre de 2006 la Conferencia    Regional pa
ra la Reforma de los Servicios de Salud Mental: 15 a&ntilde;os despu&eacute;s   
 de Caracas, efectuada en Brasilia, aprob&oacute; los "Principios rectores    pa
ra el desarrollo de la atenci&oacute;n de salud mental en las Am&eacute;ricas". 
   En esa conferencia se reiter&oacute; la vigencia de los elementos fundamental
es    de la Declaraci&oacute;n de Caracas (1990) y se advirti&oacute; que los se
rvicios    de salud deben afrontar nuevos desaf&iacute;os t&eacute;cnicos y cult
urales.    La declaraci&oacute;n final constituye otro elemento de gu&iacute;a p
ara el    trabajo.</font></p>     ^cY#a08v22n5.htm##
00437000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704020000078002001300278#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#175#171#article#236#<p><font size="2"
 face="Verdana">A continuaci&oacute;n se mencionan algunas recomendaciones    pa
ra la acci&oacute;n en el corto, mediano y largo plazo para los tres pa&iacute;s
es.</font></p>     ^cY#a08v22n5.htm##
00308000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007100078002001300149#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#176#172#article#236#<p><font size="2"
 face="Verdana">En el corto plazo:</font></p>     ^cY#a08v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#177#173#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00448000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704021100078002001300289#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#178#174#article#236#<p><font size="2"
 face="Verdana">1. Formular una pol&iacute;tica nacional de      salud mental qu
e sirva de marco estrat&eacute;gico a los planes operativos      y focalice las 
prioridades.</font></p>       ^cY#a08v22n5.htm##
00562000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704032500078002001300403#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#179#175#article#236#<p><font size="2"
 face="Verdana">2. Incluir la salud mental en programas de      acceso a medicam
entos para la poblaci&oacute;n de bajos ingresos. Es necesario      dar priorida
d a la existencia de medicamentos gratuitos o subsidiados en los      centros de
 APS y servicios de salud mental ambulatorios.</font></p>       ^cY#a08v22n5.htm
##
00584000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704034700078002001300425#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#180#176#article#236#<p><font size="2"
 face="Verdana">3. Incrementar y fortalecer los modelos de      servicios comuni
tarios de salud mental, asign&aacute;ndoles los recursos humanos      y financie
ros adecuados. Como ilustraci&oacute;n se mencionan experiencias      positivas 
que se han desarrollado o fortalecido mediante el Proyecto WHO-AIMS:</font></p> 
      ^cY#a08v22n5.htm##
00263000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002600078002001300104#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#181#177#article#236#<blockquote>     
     ^cY#a08v22n5.htm##
00356000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011900078002001300197#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#182#178#article#236#<p><font size="2"
 face="Verdana">a. Centros de Atenci&oacute;n Psicosocial        en Nicaragua.</
font></p>         ^cY#a08v22n5.htm##
00371000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704013400078002001300212#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#183#179#article#236#<p><font size="2"
 face="Verdana">a. Centros Polivalentes de Atenci&oacute;n        Psicosocial en
 El Salvador.</font></p>         ^cY#a08v22n5.htm##
00411000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704017400078002001300252#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#184#180#article#236#<p><font size="2"
 face="Verdana">c. Unidades de Salud Mental en las Cl&iacute;nicas        Perif&
eacute;ricas de la Ciudad de Guatemala.</font></p>   </blockquote>       ^cY#a08
v22n5.htm##
00395000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015800078002001300236#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#185#181#article#236#<p><font size="2"
 face="Verdana">4. Movilizar o cambiar algunos recursos de      los hospitales h
acia los servicios de base comunitaria.</font></p>       ^cY#a08v22n5.htm##
00496000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704025900078002001300337#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#186#182#article#236#<p><font size="2"
 face="Verdana">5. Desarrollar la atenci&oacute;n de salud      mental a la infa
ncia y adolescencia. Se recomienda implementar un programa      espec&iacute;fic
o adecuado a las condiciones y recursos de cada pa&iacute;s.</font></p>       ^c
Y#a08v22n5.htm##
00496000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704025900078002001300337#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#187#183#article#236#<p><font size="2"
 face="Verdana">6. Dise&ntilde;ar e implementar un programa      regular de capa
citaci&oacute;n para trabajadores de la APS, que garantice      que en dos a&nti
lde;os se puede capacitar, al menos, a 80% de este personal.</font></p>       ^c
Y#a08v22n5.htm##
00393000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015600078002001300234#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#188#184#article#236#<p><font size="2"
 face="Verdana">7. Fortalecer los sistemas de informaci&oacute;n      y vigilanc
ia epidemiol&oacute;gica.</font></p> </blockquote>     ^cY#a08v22n5.htm##
00318000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008100078002001300159#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#189#185#article#236#<p><font size="2"
 face="Verdana">En el mediano y largo plazo:</font></p>     ^cY#a08v22n5.htm##
00332000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704009500078002001300173#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#190#186#article#236#<p><font size="2"
 face="Verdana"><b>Pol&iacute;tica y marco legislativo</b></font></p>     ^cY#a0
8v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#191#187#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00499000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704026200078002001300340#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#192#188#article#236#<p><font size="2"
 face="Verdana">1. Proponer a las instancias correspondientes      las reformas 
necesarias para actualizar la legislaci&oacute;n en el campo      de la salud me
ntal, de acuerdo con los est&aacute;ndares m&aacute;s modernos.</font></p>      
 ^cY#a08v22n5.htm##
00757000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704052000078002001300598#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#193#189#article#236#<p><font size="2"
 face="Verdana">2. Incrementar el presupuesto dedicado a la      salud mental, b
uscando en una primera etapa un m&iacute;nimo de 3% del presupuesto      general
 de salud (algunos pa&iacute;ses de Centroam&eacute;rica, como Panam&aacute;,   
   han alcanzado este objetivo) y cambiar la estructura del gasto dentro del    
  sistema de salud mental, garantizando que los servicios comunitarios y ambulat
orios      tengan la prioridad por encima de los hospitales psiqui&aacute;tricos
.</font></p>       ^cY#a08v22n5.htm##
00567000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704033000078002001300408#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#194#190#article#236#<p><font size="2"
 face="Verdana">3. Establecer convenios entre los ministerios      de salud y la
s procuradur&iacute;as de los derechos humanos, para regularizar      la inspecc
i&oacute;n y vigilancia de los derechos humanos de los enfermos      mentales, a
segurando la salvaguarda de los mismos.</font></p> </blockquote>     ^cY#a08v22n
5.htm##
00322000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008500078002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#195#191#article#236#<p><font size="2"
 face="Verdana"><b>Servicios de salud mental</b></font></p>     ^cY#a08v22n5.htm
##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#196#192#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00424000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704018700078002001300265#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#197#193#article#236#<p><font size="2"
 face="Verdana">4. Descentralizar la consulta externa de los      hospitales psi
qui&aacute;tricos hacia servicios ambulatorios en las tres naciones.</font></p> 
      ^cY#a08v22n5.htm##
00493000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704025600078002001300334#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#198#194#article#236#<p><font size="2"
 face="Verdana">5. Promover la apertura de servicios de psiquiatr&iacute;a      
en los hospitales generales m&aacute;s importantes de cada pa&iacute;s, en      
especial los de car&aacute;cter departamental y regional.</font></p>       ^cY#a
08v22n5.htm##
00457000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704022000078002001300298#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#199#195#article#236#<p><font size="2"
 face="Verdana">6. Desarrollar centros de d&iacute;a vinculados      a los servi
cios ambulatorios de salud mental o los servicios de psiquiatr&iacute;a      de 
hospitales generales.</font></p>       ^cY#a08v22n5.htm##
00394000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015700078002001300235#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#200#196#article#236#<p><font size="2"
 face="Verdana">7. Abrir una unidad forense en Nicaragua y      fortalecer las e
xistentes en Guatemala y El Salvador. </font></p>       ^cY#a08v22n5.htm##
00596000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704035900078002001300437#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#201#197#article#236#<p><font size="2"
 face="Verdana">8. Dise&ntilde;ar e implementar estrategias      y acciones espe
c&iacute;ficas que permi-tan el acceso equitativo a los servicios      a los usu
arios de zonas rurales, as&iacute; como a los ind&iacute;genas y      a otras mi
nor&iacute;as &eacute;tnicas, culturales y ling&uuml;&iacute;sticas.</font></p> 
</blockquote>     ^cY#a08v22n5.htm##
00352000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011500078002001300193#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#202#198#article#236#<p><font size="2"
 face="Verdana"><b>Salud mental en la atenci&oacute;n primaria    de salud</b></
font></p>     ^cY#a08v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#203#199#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00536000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704029900078002001300377#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#204#200#article#236#<p><font size="2"
 face="Verdana">9. Aprobar las normas y protocolos de atenci&oacute;n      en sa
lud mental para la APS. El Salvador puede aportar su experiencia en este      se
ntido. La meta debe ser su implementaci&oacute;n en no menos de 80% de los      
centros.</font></p> </blockquote>     ^cY#a08v22n5.htm##
00313000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007600078002001300154#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#205#201#article#236#<p><font size="2"
 face="Verdana"><b>Recursos humanos</b></font></p>     ^cY#a08v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#206#202#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00530000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704029300078002001300371#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#207#203#article#236#<p><font size="2"
 face="Verdana">10. Dise&ntilde;ar un programa de conjunto      universidades—mi
nisterio, para la formaci&oacute;n y recalificaci&oacute;n      de los recursos 
humanos especializados en salud mental; establecer metas de      corto, mediano 
y largo plazo.</font></p>       ^cY#a08v22n5.htm##
00500000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704026300078002001300341#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#208#204#article#236#<p><font size="2"
 face="Verdana">11. Establecer estrategias para la asignaci&oacute;n      de los
 recursos humanos, garantizando la cobertura de servicios de salud mental      e
n zonas rurales y del interior de los pa&iacute;ses.</font></p> </blockquote>   
  ^cY#a08v22n5.htm##
00372000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704013500078002001300213#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#209#205#article#236#<p><font size="2"
 face="Verdana"><b>Educaci&oacute;n del p&uacute;blico y v&iacute;nculos    con 
otros sectores</b></font></p>     ^cY#a08v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#210#206#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00794000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704055700078002001300635#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#211#207#article#236#<p><font size="2"
 face="Verdana">12. Establecer convenios entre los ministerios      de educaci&o
acute;n y salud, para asegurar la designaci&oacute;n progresiva      de profesio
nales de salud mental en las escuelas p&uacute;blicas primarias      y secundari
as; alentar, en el mismo sentido, al sector privado. En paralelo,      capacitar
 a maestros y trabajadores de APS para que, de manera conjunta, desarrollen     
 acciones de promoci&oacute;n de la salud y prevenci&oacute;n de los trastornos 
     ps&iacute;quicos en las escuelas.</font></p>       ^cY#a08v22n5.htm##
00535000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704029800078002001300376#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#212#208#article#236#<p><font size="2"
 face="Verdana">13. Apoyar las organizaciones de usuarios y      familiares, inc
entivando su participaci&oacute;n activa en los planes y programas      de salud
 mental y favoreciendo su interacci&oacute;n sistem&aacute;tica con      los ser
vicios.</font></p> </blockquote>     ^cY#a08v22n5.htm##
00337000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704010000078002001300178#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#213#209#article#236#<p><font size="2"
 face="Verdana"><b>Evaluaci&oacute;n e investigaci&oacute;n</b></font></p>     ^
cY#a08v22n5.htm##
00261000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002400078002001300102#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#214#210#article#236#<blockquote>     
   ^cY#a08v22n5.htm##
00651000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704041400078002001300492#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#215#211#article#236#<p><font size="2"
 face="Verdana">14. Formar grupos de trabajo en cada pa&iacute;s,      con parti
cipaci&oacute;n conjunta de las universidades y las instituciones      p&uacute;
blicas para impulsar la investigaci&oacute;n. La OPS/OMS puede apoyar      esta 
iniciativa y la Universidad de Le&oacute;n en Nicaragua puede desempe&ntilde;ar 
     un papel de liderazgo en este proceso.</font></p> </blockquote>     ^cY#a08
v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#216#212#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00309000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007200078002001300150#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#217#213#article#236#<p><font size="3"
 face="Verdana"><b>CONCLUSIONES</b></font></p>     ^cY#a08v22n5.htm##
00730000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704049300078002001300571#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#218#214#article#236#<p><font size="2"
 face="Verdana">Nicaragua, Guatemala y El Salvador tienen importantes    limitac
iones en sus sistemas nacionales de salud mental. Es clara la marcada    insufic
iencia de recursos humanos calificados. El presupuesto dedicado a la    salud me
ntal apenas representa 1% del presupuesto general de salud y los hospitales    p
siqui&aacute;tricos situados en la capital de los pa&iacute;ses consumen m&aacut
e;s    de 90% de los fondos asignados a la salud mental.</font></p>     ^cY#a08v
22n5.htm##
00627000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704039000078002001300468#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#219#215#article#236#<p><font size="2"
 face="Verdana">Un problema clave es el pobre desarrollo del    componente salud
 mental en la APS. Los hospitales psiqui&aacute;tri-cos contin&uacute;an    sien
do hegem&oacute;nicos a pesar de algunos avances logrados en la asistencia    am
bulatoria y de la positiva concepci&oacute;n de trabajo desarrollada en los    p
lanes nacionales de salud mental.</font></p>     ^cY#a08v22n5.htm##
00575000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704033800078002001300416#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#220#216#article#236#<p><font size="2"
 face="Verdana">La supervisi&oacute;n del respeto de los derechos    humanos de 
los enfermos mentales debe fortalecerse. Tambi&eacute;n se hace necesario    sis
tematizar los procesos de capacitaci&oacute;n y actualizaci&oacute;n de los    p
rofesionales de la salud mental y los trabajadores de la APS.</font></p>     ^cY
#a08v22n5.htm##
00676000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704043900078002001300517#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#221#217#article#236#<p><font size="2"
 face="Verdana">Se recomienda que los pa&iacute;ses definan un    grupo de prior
idades y se establezca un plan de acci&oacute;n de corto y mediano    plazo que 
permita avanzar en aspectos b&aacute;sicos de desarrollo de los servicios.    Co
mo un elemento positivo se destaca que, en los &uacute;ltimos a&ntilde;os,    se
 ha logrado impulsar algunas experiencias innovadoras que requieren generalizars
e.</font></p>     ^cY#a08v22n5.htm##
02619000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704238200078002001302460#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#222#218#article#236#<p><font size="2"
 face="Verdana"> <b>Reconocimientos. </b>La recopilaci&oacute;n    de informaci&
oacute;n en Nicaragua, El Salvador y Guatemala estuvo a cargo de    los equipos 
t&eacute;cnicos nacionales, con la participaci&oacute;n de los respectivos    mi
nisterios de salud. El proyecto cont&oacute; con el apoyo las Representaciones  
  de la OPS/OMS en los pa&iacute;ses, as&iacute; como de la Unidad Regional de  
  Salud Mental y Programas Especializados de la Organizaci&oacute;n Panamericana
    de la Salud (OPS/OMS). Asimismo recibi&oacute; el apoyo, desde la sede de la
    OMS en Ginebra, del Equipo de Evidencias e Investigaci&oacute;n del Departam
ento    de Salud Mental y Abuso de Sustancias. El equipo del WHO-AIMS incluye a:
 Benedetto    Saraceno, Shekhar Saxena (quien lo coordina), Tom Barrett, Antonio
 Lora, Mark    van Ommeren, Jodi Morris y Grazia Motturi. Los participantes dire
ctos en Centroam&eacute;rica    fueron: <i>Coordinaci&oacute;n y revisi&oacute;n
 t&eacute;cnica de los tres    informes:</i> Thomas Barrett, Asesor de la OMS, G
inebra; Jorge Rodr&iacute;guez,    Asesor en Salud Mental para Centroam&eacute;r
ica, OPS/OMS; Silvia Narv&aacute;ez,    OPS/OMS Nicaragua, y Carlos Manuel Fern&
aacute;ndez, Consultor. <i>Informe de    Nicaragua:</i> Carlos Manuel Fern&aacut
e;ndez, Consultor Nacional; Carlos Fletes,    Jefe del Programa Nacional de Salu
d Mental de Nicaragua, y la Silvia Narv&aacute;ez,    OPS/OMS Nicaragua. <i>Info
rme de Guatemala:</i> Jos&eacute; Antonio Flores,    Consultor Nacional; Aura Ma
rina L&oacute;pez, Marline Paz y Nadyezhda van Tullen,    del Programa Nacional 
de Salud Mental; Edgar R. V&aacute;squez, m&eacute;dico    psiquiatra, y Jos&eac
ute; Ad&aacute;n Montes, OPS/OMS Guatemala. <i>Informe    de El Salvador:</i> Ar
turo Carranza, Consultor Nacional; Roberto Rivas, Director    de Regulaci&oacute
;n del Ministerio de Salud P&uacute;blica y Asistencia Social    de El Salvador;
 Mois&eacute;s Guardado, Jefe del Programa Nacional de Salud    Mental; Ulises G
uti&eacute;rrez, Director del Hospital Psiqui&aacute;trico de    San Salvador y 
Amalia E. Ayala, OPS/ OMS El Salvador. El Proyecto WHO-AIMS est&aacute;    parci
almente financiado por el Instituto Nacional de Salud Mental y la Administraci&o
acute;n    de Servicios de Salud Mental y Abuso de Sustancias de los Estados Uni
dos de    Am&eacute;rica.</font></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#223#219#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00308000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007100078002001300149#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#224#220#article#236#<p><font size="3"
 face="Verdana"><b>REFERENCIAS</b></font></p>     ^cY#a08v22n5.htm##
00536000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704028500080002001300365#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#225#221#article#236#1#<p>
<font size="2" face="Verdana">1. Kohn R, Levav I, Donaire I, Machuca M,    Tamas
hiro R. Psychological and psychopathological reactions in Honduras following    
Hurricane Mitch: implications for services planning. Rev Panam Salud Publica.   
 2005;18(4/5): 287–95. </font></p>    ^cY#a08v22n5.htm##
00478000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704022700080002001300307#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#226#222#article#236#2#<p>
<font size="2" face="Verdana">2. Organizaci&oacute;n Panamericana de la    Salud
. Informe sobre los Sistemas de Salud Mental en Nicaragua, El Salvador    y Guat
emala. Documentaci&oacute;n de OPS/OMS, 2006.</font></p>    ^cY#a08v22n5.htm##
00458000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704020700080002001300287#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#227#223#article#236#3#<p>
<font size="2" face="Verdana">3. Rodr&iacute;guez J, Bergonzoli G, Levav    I. V
iolencia pol&iacute;tica y salud mental en Guatemala. Acta Psiquiatr Psicol    A
m Lat. 2002;48(1–4):43–9.</font></p>    ^cY#a08v22n5.htm##
00572000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704032100080002001300401#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#228#224#article#236#4#<p>
<font size="2" face="Verdana">4. Levav I, Gonz&aacute;lez R, eds. Reestructuraci
&oacute;n    de la atenci&oacute;n psiqui&aacute;trica: bases conceptuales y gu&
iacute;as    para su implementaci&oacute;n. Washington D.C.: Organizaci&oacute;n
 Panamericana    de la Salud - Instituto Mario Negri; 1991.</font></p>    ^cY#a0
8v22n5.htm##
00693000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704044200080002001300522#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#229#225#article#236#5#<p>
<font size="2" face="Verdana">5. Organizaci&oacute;n Panamericana de la    Salud
/ Organizaci&oacute;n Mundial de la Salud. Salud Mental. Resoluci&oacute;n    CD
43/ 15. 43 Consejo Directivo. Washington D.C., 24 al 28 de septiembre de 2001.  
  Hallado en URL: <a href="http://www.paho.org/spanish/gov/cd/cd43_15-s.pdf" tar
get="_blank">http://www.paho.org/    spanish/gov/cd/cd43_15-s.pdf</a> Acceso el 
24 de febrero 2007. </font></p>    ^cY#a08v22n5.htm##
00408000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704015700080002001300237#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#230#226#article#236#6#<p>
<font size="2" face="Verdana">6. World Health Organization. Mental Health    Atl
as—2005. Geneva: World Health Organization; 2005. WHO. </font></p>    ^cY#a08v22
n5.htm##
00448000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704019700080002001300277#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#231#227#article#236#7#<p>
<font size="2" face="Verdana">7. World Health Organization. Assessment Instrumen
t    for Mental Health Systems. Version 2.2. Geneva: WHO Document Production Ser
vices;    2005.</font></p>    ^cY#a08v22n5.htm##
00453000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704020200080002001300282#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#232#228#article#236#8#<p>
<font size="2" face="Verdana">8. World Health Organization. The World Health    
Report 2001. Mental Health: New Understanding, New Hope. Geneva: World Health   
 Organization; 2001.</font></p>    ^cY#a08v22n5.htm##
00571000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074888000200078704032000080002001300400#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#233#229#article#236#9#<p>
<font size="2" face="Verdana">9. Organizaci&oacute;n Panamericana de la    Salud
. Grupo de trabajo para el diagn&oacute;stico sobre el estado de los derechos   
 humanos de las personas con enfermedades mentales en pa&iacute;ses de Centroam&
eacute;rica.    Informe final. Tegucigalpa: OPS/OMS; 1998.</font></p>    ^cY#a08
v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#234#230#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#235#231#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00323000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008600078002001300164#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#236#232#article#236#<p><font size="2"
 face="Verdana">Manuscrito recibido el 23 de febrero de 2007.    ^cY#a08v22n5.ht
m##
00351000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704011400078002001300192#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#237#233#article#236#<br>   Aceptado p
ara publicaci&oacute;n, tras revisi&oacute;n, el 25 de septiembre    de 2007.</f
ont></p>     ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#238#234#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#239#235#article#236#<p>&nbsp;</p>    
 ^cY#a08v22n5.htm##
00630000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704039300078002001300471#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a08v22n5.htm#S#p#240#236#article#236#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> La correspondencia    se de
be enviar a Jorge Rodr&iacute;guez, Unit Chief, Mental Health, Substance    Abus
e &amp; Rehabilitation, PAHO, 525 23rd Street, NW, Washington, D.C., 20037,    E
stados Unidos de Am&eacute;rica. Correo electr&oacute;nico: <a href="mailto:rodr
igjo@paho.org">rodrigjo@paho.org</a></font></p>     ^cY#a08v22n5.htm##
00717000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740100014000760100015000900100
01700105010001700122010001900139012012500158030002400283065000900307064000500316
03100030032103200040032401400070032886500090033500200130034403500100035780100240
0367#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#241#1#article#9#1
#^rND^sKohn^nR#^rND^sLevav^nI#^rND^sDonaire^nI#^rND^sMachuca^nM#^rND^sTamashiro^
nR#Psychological and psychopathological reactions in Honduras following Hurrican
e Mitch: implications for services planning^len#Rev Panam Salud Publica#20050000
#2005#18#4/5#287-95#20071100#a08v22n5.htm#1020-4989#Rev Panam Salud Publica##
00461000000000217000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170038000760180085001140620
00800199065000900207064000500216865000900221002001300230#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a08v22n5.htm#S#c#242#2#article#9#2#Organización Panamericana d
e la Salud#Informe sobre los Sistemas de Salud Mental en Nicaragua, El Salvador 
y Guatemala^les#OPS/OMS#20060000#2006#20071100#a08v22n5.htm##
00551000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740100019000760100020000950100
01500115012005100130030003000181710000200211065000900213064000500222031000300227
032000400230014000500234865000900239002001300248#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a08v22n5.htm#S#c#243#3#article#9#3#^rND^sRodríguez^nJ#^rND^sBergonzoli
^nG#^rND^sLevav^nI#Violencia política y salud mental en Guatemala^les#Acta Psiqu
iatr Psicol Am Lat.#2#20020000#2002#48#1-4#43-9#20071100#a08v22n5.htm##
00576000000000253000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740160015000760160018000910180
10000109066001700209062003800226062002200264065000900286064000500295865000900300
002001300309#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#244#4#art
icle#9#4#^rED^sLevav^nI#^rED^sGonzález^nR#Reestructuración de la atención psiqui
átrica: bases conceptuales y guías para su implementación^les#Washington^eD.C.#O
rganización Panamericana de la Salud#Instituto Mario Negri#19910000#1991#2007110
0#a08v22n5.htm##
00630000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170038000760170033001140180
06000147066001700207065000900224064003100233037005000264110000900314109001900323
865000900342002001300351#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S
#c#245#5#article#9#5#Organización Panamericana de la Salud#Organización Mundial 
de la Salud#Salud Mental: Resolución CD43/ 15. 43 Consejo Directivo^les#Washingt
on^eD.C.#20010924#24 al 28 de septiembre de 2001#http://www.paho.org/ spanish/go
v/cd/cd43_15-s.pdf#20070224#24 de febrero 2007#20071100#a08v22n5.htm##
00446000000000241000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170026000760180029001020660
00700131062002600138065000900164064000500173062000400178865000900182002001300191
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#246#6#article#9#6#Wor
ld Health Organization#Mental Health Atlas-2005^len#Geneva#World Health Organiza
tion#20050000#2005#WHO#20071100#a08v22n5.htm##
00473000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170026000760180065001020660
00700167062003300174065000900207064000500216865000900221002001300230#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#247#7#article#9#7#World Health Or
ganization#Assessment Instrument for Mental Health Systems: Version 2.2^len#Gene
va#WHO Document Production Services#20050000#2005#20071100#a08v22n5.htm##
00478000000000229000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170026000760180077001020660
00700179062002600186065000900212064000500221865000900226002001300235#v22n5#v:\sc
ielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#248#8#article#9#8#World Health Or
ganization#The World Health Report 2001: Mental Health: New Understanding, New H
ope^len#Geneva#World Health Organization#20010000#2001#20071100#a08v22n5.htm##
00577000000000241000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080002000721180002000740170038000760180165001140660
01200279062000400291062000400295065000900299064000500308865000900313002001300322
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a08v22n5.htm#S#c#249#9#article#9#9#Org
anización Panamericana de la Salud#Grupo de trabajo para el diagnóstico sobre el
 estado de los derechos humanos de las personas con enfermedades mentales en paí
ses de Centroamérica: Informe final^les#Tegucigalpa#OPS#OMS#19980000#1998#200711
00#a08v22n5.htm##
00275000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700910009000720920007000810020013000887030
00400101#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#o#1#1#article#1
#20080131#111634#a09v22n5.htm#148##
03979000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200400016701200420
02070100040002490100043002890100041003320700123003730831093004960850008015890850
01901597085003301616085004001649085002201689085001901711085001901730083116101749
08500080291008500190291808500340293708500290297108500240300008500250302408500190
30490580062030680600012031300580055031420600018031971170006032150720003032211120
00903224111001303233114000903246113001303255002001303268#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a09v22n5.htm#S#h#2#1#article#1#tr#en#br1.1#1#3.1#GRA#09#RPSP33
0#nd#Rev Panam Salud Publica#22#5#20071100#^f358^l363#1020-4989#Dengue viruses i
n Brazil, 1986-2006^len#Virus del dengue en Brasil, 1986-2006^les#^rND^1A01^nRit
a Maria Ribeiro^sNogueira#^rND^1A01^nJosélio Maria Galvão de^sAraújo#^rND^1A01^n
Hermann Gonçalves^sSchatzmayr#FIOCRUZ^iA01^1Instituto Oswaldo Cruz^2Department o
f Virology^3Flavivirus Laboratory^z21040-190^cRio de Janeiro^sRJ^pBrasil#^len^aA
 total of 4 243 049 dengue cases have been reported in Brazil between 1981 and 2
006, including 5 817 cases of dengue hemorrhagic fever/dengue shock syndrome (DH
F/DSS) and a total of 338 fatal cases. Although all Brazilian regions have been 
affected, the Northeast and Southeast regions have registered the highest number
 of notifications. DENV-1 and DENV-4 were isolated for the first time in the Ama
zon region of Brazil in 1981 and 1982. The disease became a nationwide public he
alth problem following outbreaks of DENV-1 and DENV-2 in the state of Rio de Jan
eiro in 1986 and 1990, respectively. The introduction of DENV-3 in 2000, also in
 the state of Rio de Janeiro, led to a severe epidemic with 288 245 reported den
gue cases, including 91 deaths. Virus strains that were typed during the 2002 ep
idemic show that DENV-3 has displaced other dengue virus serotypes and entered n
ew areas, a finding that warrants closer evaluation. Unusual clinical symptoms, 
including central nervous system involvement, have been observed in dengue patie
nts in at least three regions of the country.#^dnd^i1#^tm^len^kDengue^i1#^tm^len
^kdengue^i1^sepidemiology#^tm^len^kdengue virus/classification^i1#^tm^len^kdiagn
osis^i1#^tm^len^kgenome^i1#^tm^len^kBrazil^i1#^les^aEn Brasil se han notificado 
4 243 049 casos de dengue entre 1981 y 2006, de ellos 5 817 casos de dengue hemo
rrágico/síndrome de choque por dengue (DH/SCD) y un total de 338 casos mortales.
 A pesar de que la enfermedad ha afectado a todas las regiones brasileñas, el ma
yor número de casos se ha notificado en las regiones nororiental y suroriental. 
Los virus del dengue (DENV) 1 y 4 se aislaron por primera vez en la región amazó
nica de Brasil en 1981 y 1982. La enfermedad se convirtió en un problema naciona
l de salud pública después de los brotes de DENV-1 y DENV-2 en el Estado de Río 
de Janeiro en 1986 y 1990, respectivamente. La introducción del DENV-3 en 2000, 
también en el Estado de Río de Janeiro, llevó a una grave epidemia con 288 245 c
asos notificados de dengue y 91 muertes. Las cepas del virus identificadas duran
te la epidemia de 2002 demostraron que el DENV-3 ha desplazado a los otros serot
ipos y se ha expandido a nuevas zonas, algo que merece una evaluación más profun
da. En los pacientes con dengue de al menos tres regiones del país se han observ
ado síntomas clínicos atípicos, entre ellos alteraciones del sistema nervioso ce
ntral.#^dnd^i2#^tm^les^kDengue^i2#^tm^les^kdengue^i2^sepidemiología#^tm^les^kvir
us del dengue^i2#^tm^les^kdiagnóstico^i2#^tm^les^kgenoma viral^i2#^tm^les^kBrasi
l^i2#Conselho Nacional de Desenvolvimento Científico e Tecnológico#501564/03-9#F
undação de Amparo a Pesquisa Científica e Tecnológica#E-26/152.490/2002#other#39
#20060628#28 June 2006#20070712#12 July 2007#a09v22n5.htm##
04063000000000697000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700710003000720400003000750010006000780420
00200084120000400086038000400090121000300094049000800097158000300105030002400108
03100030013203200020013506500090013701400110014603500100015701200470016701200490
02140100040002630100043003030100041003460700123003870831093005100850008016030850
01901611085003301630085004001663085002201703085001901725085001901744083116101763
08500080292408500190293208500340295108500290298508500240301408500250303808500190
30630580062030820600047031440580055031910600053032461170006032990720003033051120
00903308111001303317114000903330113001303339002001303352#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a09v22n5.htm#S#f#3#1#article#1#tr#en#br1.1#1#3.1#GRA#09#RPSP33
0#nd#Rev Panam Salud Publica#22#5#20071100#^f358^l363#1020-4989#<B>Dengue viruse
s in Brazil, 1986-2006</B>^len#<B>Virus del dengue en Brasil, 1986-2006</B>^les#
^rND^1A01^nRita Maria Ribeiro^sNogueira#^rND^1A01^nJosélio Maria Galvão de^sAraú
jo#^rND^1A01^nHermann Gonçalves^sSchatzmayr#FIOCRUZ^iA01^1Instituto Oswaldo Cruz
^2Department of Virology^3Flavivirus Laboratory^z21040-190^cRio de Janeiro^sRJ^p
Brasil#^len^aA total of 4 243 049 dengue cases have been reported in Brazil betw
een 1981 and 2006, including 5 817 cases of dengue hemorrhagic fever/dengue shoc
k syndrome (DHF/DSS) and a total of 338 fatal cases. Although all Brazilian regi
ons have been affected, the Northeast and Southeast regions have registered the 
highest number of notifications. DENV-1 and DENV-4 were isolated for the first t
ime in the Amazon region of Brazil in 1981 and 1982. The disease became a nation
wide public health problem following outbreaks of DENV-1 and DENV-2 in the state
 of Rio de Janeiro in 1986 and 1990, respectively. The introduction of DENV-3 in
 2000, also in the state of Rio de Janeiro, led to a severe epidemic with 288 24
5 reported dengue cases, including 91 deaths. Virus strains that were typed duri
ng the 2002 epidemic show that DENV-3 has displaced other dengue virus serotypes
 and entered new areas, a finding that warrants closer evaluation. Unusual clini
cal symptoms, including central nervous system involvement, have been observed i
n dengue patients in at least three regions of the country.#^dnd^i1#^tm^len^kDen
gue^i1#^tm^len^kdengue^i1^sepidemiology#^tm^len^kdengue virus/classification^i1#
^tm^len^kdiagnosis^i1#^tm^len^kgenome^i1#^tm^len^kBrazil^i1#^les^aEn Brasil se h
an notificado 4 243 049 casos de dengue entre 1981 y 2006, de ellos 5 817 casos 
de dengue hemorrágico/síndrome de choque por dengue (DH/SCD) y un total de 338 c
asos mortales. A pesar de que la enfermedad ha afectado a todas las regiones bra
sileñas, el mayor número de casos se ha notificado en las regiones nororiental y
 suroriental. Los virus del dengue (DENV) 1 y 4 se aislaron por primera vez en l
a región amazónica de Brasil en 1981 y 1982. La enfermedad se convirtió en un pr
oblema nacional de salud pública después de los brotes de DENV-1 y DENV-2 en el 
Estado de Río de Janeiro en 1986 y 1990, respectivamente. La introducción del DE
NV-3 en 2000, también en el Estado de Río de Janeiro, llevó a una grave epidemia
 con 288 245 casos notificados de dengue y 91 muertes. Las cepas del virus ident
ificadas durante la epidemia de 2002 demostraron que el DENV-3 ha desplazado a l
os otros serotipos y se ha expandido a nuevas zonas, algo que merece una evaluac
ión más profunda. En los pacientes con dengue de al menos tres regiones del país
 se han observado síntomas clínicos atípicos, entre ellos alteraciones del siste
ma nervioso central.#^dnd^i2#^tm^les^kDengue^i2#^tm^les^kdengue^i2^sepidemiologí
a#^tm^les^kvirus del dengue^i2#^tm^les^kdiagnóstico^i2#^tm^les^kgenoma viral^i2#
^tm^les^kBrasil^i2#Conselho Nacional de Desenvolvimento Científico e Tecnológico
#<FONT FACE="Verdana" SIZE=2>501564/03-9</FONT>#Fundação de Amparo a Pesquisa Ci
entífica e Tecnológica#<FONT FACE="Verdana" SIZE=2>E-26/152.490/2002</FONT>#othe
r#39#20060628#28 June 2006#20070712#12 July 2007#a09v22n5.htm##
04112000000000721000450000400060000070200480000670500020005470600020005670000020
00587010002000607090008000627080002000700640013000720710003000850400003000880010
00600091042000200097120000400099038000400103121000300107049000800110158000300118
03000260012103100030014703200020015006500090015201400110016103500100017201200400
01820120042002220100040002640100043003040100041003470700125003880831093005130850
00801606085001901614085003301633085004001666085002201706085001901728085001901747
08311610176608500080292708500190293508500340295408500290298808500240301708500250
30410850019030660580062030850600012031470580055031590600018032141170006032320720
00303238112000903241111001303250114000903263113001303272002001303285008009203298
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#l#4#1#article#1#^mNov.^
a2007#tr#en#br1.1#1#3.1#gra#09#RPSP330#nd#Rev. panam. salud pública#22#5#2007110
0#^f358^l363#1020-4989#Dengue viruses in Brazil, 1986-2006^len#Virus del dengue 
en Brasil, 1986-2006^les#^rND^1A01^nRita Maria Ribeiro^sNogueira#^rND^1A01^nJosé
lio Maria Galvão de^sAraújo#^rND^1A01^nHermann Gonçalves^sSchatzmayr#^iA01^1FIOC
RUZ^2Instituto Oswaldo Cruz^3Department of Virology. Flavivirus Laboratory^z2104
0-190^cRio de Janeiro^sRJ^pBrasil#^len^aA total of 4 243 049 dengue cases have b
een reported in Brazil between 1981 and 2006, including 5 817 cases of dengue he
morrhagic fever/dengue shock syndrome (DHF/DSS) and a total of 338 fatal cases. 
Although all Brazilian regions have been affected, the Northeast and Southeast r
egions have registered the highest number of notifications. DENV-1 and DENV-4 we
re isolated for the first time in the Amazon region of Brazil in 1981 and 1982. 
The disease became a nationwide public health problem following outbreaks of DEN
V-1 and DENV-2 in the state of Rio de Janeiro in 1986 and 1990, respectively. Th
e introduction of DENV-3 in 2000, also in the state of Rio de Janeiro, led to a 
severe epidemic with 288 245 reported dengue cases, including 91 deaths. Virus s
trains that were typed during the 2002 epidemic show that DENV-3 has displaced o
ther dengue virus serotypes and entered new areas, a finding that warrants close
r evaluation. Unusual clinical symptoms, including central nervous system involv
ement, have been observed in dengue patients in at least three regions of the co
untry.#^dnd^i1#^tm^len^kDengue^i1#^tm^len^kdengue^i1^sepidemiology#^tm^len^kdeng
ue virus/classification^i1#^tm^len^kdiagnosis^i1#^tm^len^kgenome^i1#^tm^len^kBra
zil^i1#^les^aEn Brasil se han notificado 4 243 049 casos de dengue entre 1981 y 
2006, de ellos 5 817 casos de dengue hemorrágico/síndrome de choque por dengue (
DH/SCD) y un total de 338 casos mortales. A pesar de que la enfermedad ha afecta
do a todas las regiones brasileñas, el mayor número de casos se ha notificado en
 las regiones nororiental y suroriental. Los virus del dengue (DENV) 1 y 4 se ai
slaron por primera vez en la región amazónica de Brasil en 1981 y 1982. La enfer
medad se convirtió en un problema nacional de salud pública después de los brote
s de DENV-1 y DENV-2 en el Estado de Río de Janeiro en 1986 y 1990, respectivame
nte. La introducción del DENV-3 en 2000, también en el Estado de Río de Janeiro,
 llevó a una grave epidemia con 288 245 casos notificados de dengue y 91 muertes
. Las cepas del virus identificadas durante la epidemia de 2002 demostraron que 
el DENV-3 ha desplazado a los otros serotipos y se ha expandido a nuevas zonas, 
algo que merece una evaluación más profunda. En los pacientes con dengue de al m
enos tres regiones del país se han observado síntomas clínicos atípicos, entre e
llos alteraciones del sistema nervioso central.#^dnd^i2#^tm^les^kDengue^i2#^tm^l
es^kdengue^i2^sepidemiología#^tm^les^kvirus del dengue^i2#^tm^les^kdiagnóstico^i
2#^tm^les^kgenoma viral^i2#^tm^les^kBrasil^i2#Conselho Nacional de Desenvolvimen
to Científico e Tecnológico#501564/03-9#Fundação de Amparo a Pesquisa Científica
 e Tecnológica#E-26/152.490/2002#other#39#20060628#28 June 2006#20070712#12 July
 2007#a09v22n5.htm#Internet^ihttp://www.scielosp.org/scielo.php?script=sci_artte
xt&pid=S1020-49892007001000009##
00341000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704010800074002001300182#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#5#1#article#105#<p align="right"><fon
t size="2" face="Verdana"><b>INFORME ESPECIAL</b> SPECIAL    REPORT</font></p>  
   ^cY#a09v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#6#2#article#105#<p>&nbsp;</p>     ^cY
#a09v22n5.htm##
00348000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704011500074002001300189#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#7#3#article#105#<p><font size="4" fac
e="verdana"><b><a name="tx"></a>Dengue viruses in Brazil,    1986–2006</b></font
></p>     ^cY#a09v22n5.htm##
00255000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704002200074002001300096#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#8#4#article#105#<p>&nbsp;</p>     ^cY
#a09v22n5.htm##
00330000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000800062708000400070704009700074002001300171#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#9#5#article#105#<p><font size="3" fac
e="verdana"><b>Virus del dengue en Brasil, 1986–2006</b></font></p>     ^cY#a09v
22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#10#6#article#105#<p>&nbsp;</p>     ^c
Y#a09v22n5.htm##
00256000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704002200075002001300097#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#11#7#article#105#<p>&nbsp;</p>     ^c
Y#a09v22n5.htm##
00447000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704021300075002001300288#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#12#8#article#105#<p><font size="2" fa
ce="Verdana"><b>Rita Maria Ribeiro Nogueira<a href="#nt"><sup>*</sup></a>;    Jo
s&eacute;lio Maria Galv&atilde;o de Ara&uacute;jo; Hermann Gon&ccedil;alves    S
chatzmayr</b></font></p>     ^cY#a09v22n5.htm##
00431000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000800063708000400071704019700075002001300272#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#13#9#article#105#<p><FONT SIZE="2" fa
ce="Verdana">Flavivirus Laboratory, Department of Virology,    Instituto Oswaldo
 Cruz/ FIOCRUZ, Avenida Brasil 4365, 21040-190, Rio de Janeiro,    RJ, Brasil</f
ont></p>     ^cY#a09v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#14#10#article#105#<p>&nbsp;</p>     ^
cY#a09v22n5.htm##
00279000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704004400076002001300120#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#15#11#article#105#<p>&nbsp;</p> <hr s
ize="1" noshade>     ^cY#a09v22n5.htm##
00303000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006800076002001300144#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#16#12#article#105#<p><font size="2" f
ace="Verdana"><b>ABSTRACT</b></font></p>     ^cY#a09v22n5.htm##
01246000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704101100076002001301087#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#17#13#article#105#<p><font size="2" f
ace="Verdana"> A total of 4 243 049 dengue cases have been    reported in Brazil
 between 1981 and 2006, including 5 817 cases of dengue hemorrhagic    fever/den
gue shock syndrome (DHF/DSS) and a total of 338 fatal cases. Although    all Bra
zilian regions have been affected, the Northeast and Southeast regions    have r
egistered the highest number of notifications. DENV-1 and DENV-4 were    isolate
d for the first time in the Amazon region of Brazil in 1981 and 1982.    The dis
ease became a nationwide public health problem following outbreaks of    DENV-1 
and DENV-2 in the state of Rio de Janeiro in 1986 and 1990, respectively.    The
 introduction of DENV-3 in 2000, also in the state of Rio de Janeiro, led    to 
a severe epidemic with 288 245 reported dengue cases, including 91 deaths.    Vi
rus strains that were typed during the 2002 epidemic show that DENV-3 has    dis
placed other dengue virus serotypes and entered new areas, a finding that    war
rants closer evaluation.    ^cY#a09v22n5.htm##
00417000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018200076002001300258#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#18#14#article#105#<br>   Unusual clin
ical symptoms, including central nervous system involvement, have    been observ
ed in dengue patients in at least three regions of the country.</font></p>     ^
cY#a09v22n5.htm##
00415000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704018000076002001300256#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#19#15#article#105#<p><font size="2" f
ace="Verdana"><b>Key words: </b>Dengue, dengue/epidemiology,    dengue virus/cla
ssification, diagnosis, genome, Brazil.</font></p> <hr size="1" noshade>     ^cY
#a09v22n5.htm##
00302000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704006700076002001300143#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#20#16#article#105#<p><font size="2" f
ace="Verdana"><b>RESUMEN</b></font></p>     ^cY#a09v22n5.htm##
01630000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704139500076002001301471#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#21#17#article#105#<p><font size="2" f
ace="Verdana">En Brasil se han notificado 4 243 049 casos de    dengue entre 198
1 y 2006, de ellos 5 817 casos de dengue hemorr&aacute;gico/s&iacute;ndrome    d
e choque por dengue (DH/SCD) y un total de 338 casos mortales. A pesar de que   
 la enfermedad ha afectado a todas las regiones brasile&ntilde;as, el mayor n&ua
cute;mero    de casos se ha notificado en las regiones nororiental y suroriental
. Los virus    del dengue (DENV) 1 y 4 se aislaron por primera vez en la regi&oa
cute;n amaz&oacute;nica    de Brasil en 1981 y 1982. La enfermedad se convirti&o
acute; en un problema nacional    de salud p&uacute;blica despu&eacute;s de los 
brotes de DENV-1 y DENV-2 en el    Estado de R&iacute;o de Janeiro en 1986 y 199
0, respectivamente. La introducci&oacute;n    del DENV-3 en 2000, tambi&eacute;n
 en el Estado de R&iacute;o de Janeiro, llev&oacute;    a una grave epidemia con
 288 245 casos notificados de dengue y 91 muertes. Las    cepas del virus identi
ficadas durante la epidemia de 2002 demostraron que el    DENV-3 ha desplazado a
 los otros serotipos y se ha expandido a nuevas zonas,    algo que merece una ev
aluaci&oacute;n m&aacute;s profunda. En los pacientes    con dengue de al menos 
tres regiones del pa&iacute;s se han observado s&iacute;ntomas    cl&iacute;nico
s at&iacute;picos, entre ellos alteraciones del sistema nervioso    central.</fo
nt></p>     ^cY#a09v22n5.htm##
00432000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704019700076002001300273#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#22#18#article#105#<p><font size="2" f
ace="Verdana"><b>Palabras clave: </b>Dengue, dengue/epidemiolog&iacute;a,    vir
us del dengue, diagn&oacute;stico, genoma viral, Brasil.</font></p> <hr size="1"
 noshade>     ^cY#a09v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#23#19#article#105#<p>&nbsp;</p>     ^
cY#a09v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#24#20#article#105#<p>&nbsp;</p>     ^
cY#a09v22n5.htm##
00828000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704059300076002001300669#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#25#21#article#105#<p><font size="2" f
ace="Verdana">The high level of dengue virus activity on the    American contine
nt and the reinfestation of Brazil by the <i>Aedes aegypti</i>    vector in 1977
 contributed to the reintroduction of the dengue viruses (DENV)    into Brazil i
n the 1980s (1, 2). Since that time, more than 60% of the reported    cases of d
engue in the Region of the Americas have occurred in Brazil (Figure    1). In th
is article, we describe the introduction of dengue viruses in Brazil,    the vir
us strains, and spread of the disease to different regions of the country.</font
></p>     ^cY#a09v22n5.htm##
01265000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704103000076002001301106#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#26#22#article#105#<p><font size="2" f
ace="Verdana">A dengue outbreak caused by the DENV-1 and DENV-4    viruses (1981
– 1982) occurred in the city of Boa Vista, in the state of Roraima,    in the Am
azon region close to the Venezuelan border (3). This outbreak was contained    b
y local vector control measures and no dengue activity was reported for the    n
ext four years in Brazil. It was only after 1986, with the DENV-1 virus introduc
tion    into the state of Rio de Janeiro (4), that dengue infections became a na
tionwide    public health problem. Difficulties implementing effective vector co
ntrol programs    in large urban communities resulted in the rapid spread of the
 virus and explosive    virgin soil epidemics in several states. The situation w
as aggravated in 1990    by the introduction of DENV-2 virus, also into the stat
e of Rio de Janeiro (5).    With its subsequent spread to other regions of the c
ountry, there were more    severe clinical presentations and the first fatal cas
es due to secondary infections.</font></p>     ^cY#a09v22n5.htm##
00490000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704025500076002001300331#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#27#23#article#105#<p><font size="2" f
ace="Verdana">Absent from the Americas for almost 15 years,    DENV-3 was reintr
oduced in 1994 (6), reaching Brazil by 2000 where it caused    a widespread and 
severe dengue epidemic in the summer of 2001–2002 (7–9).</font></p>     ^cY#a09v
22n5.htm##
00584000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704034900076002001300425#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#28#24#article#105#<p><font size="2" f
ace="Verdana">The three dengue virus serotypes spread successively    throughout
 the country and by the end of 2006, 25 of the 27 Brazilian states    had report
ed dengue epidemics. A total of 4 243 049 reported cases in the last    20 years
 in Brazil were caused by DENV-1, DENV-2, and DENV-3 circulation (10).</font></p
>     ^cY#a09v22n5.htm##
00332000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704009700076002001300173#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#29#25#article#105#<p><font size="2" f
ace="Verdana"><b>Dengue in the State of Rio de Janeiro</b></font></p>     ^cY#a0
9v22n5.htm##
00698000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704046300076002001300539#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#30#26#article#105#<p><font size="2" f
ace="Verdana">The state of Rio de Janeiro was the site of the    introduction an
d dissemination of DENV-3, a new serotype in the country, as    well as DENV-1 a
nd DENV-2, making it obvious that this area is important for    dengue epidemiol
ogy in Brazil. As an important tourist center with high levels    of <i>Ae. aegy
pti</i> infestation, the area merits close attention in terms    of entry of den
gue viruses into Brazil.</font></p>     ^cY#a09v22n5.htm##
01339000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704110400076002001301180#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#31#27#article#105#<p><font size="2" f
ace="Verdana">Dengue infection was first confirmed in the state    of Rio de Jan
eiro by the Flavivirus Laboratory at the Oswaldo Cruz Institute    in April 1986
. The DENV-1 virus was isolated from patients presenting with exanthematic    di
sease during an explosive epidemic in the municipality of Nova Igua&ccedil;u    
(4). This municipality belongs to the Greater Metropolitan Area of the state,   
 which includes the capital Rio de Janeiro and 20 other municipalities, and has 
   a population of over 11 million out of the state’s 14.7 million total. Nova  
  Igua&ccedil;u is located about 25 km from downtown Rio de Janeiro, with a larg
e    population that commutes daily to surrounding areas. This heavy circulation
    of people facilitated the rapid spread of dengue virus to susceptible popula
tions,    causing an epidemic of approximately 92 000 cases reported during the 
1986–1987    period (11). The infections were clinically characterized as classi
c dengue    fever. The only fatality reported as a result of this episode was th
at of a    young patient.</font></p>     ^cY#a09v22n5.htm##
00634000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704039900076002001300475#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#32#28#article#105#<p><font size="2" f
ace="Verdana">From Rio de Janeiro, the virus spread rapidly    along the coast t
o different states, all previously infested with the vector.    Epidemics in the
se areas presented similar characteristics to that of Rio de    Janeiro: only DE
NV-1 was involved and no severe cases of dengue hemorrhagic    fever (DHF) or de
ngue shock syndrome (DSS) were reported.</font></p>     ^cY#a09v22n5.htm##
00831000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704059600076002001300672#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#33#29#article#105#<p><font size="2" f
ace="Verdana">By April 1990, an active surveillance program    established by th
e municipality of Niter&oacute;i in the Rio de Janeiro Greater    Metropolitan A
rea allowed for early identification of DENV-2 during a period    of high DENV-1
 virus activity, exactly four years after the first DENV-1 strain    isolations.
 The epidemic in 1990–1991 presented two waves and a significantly    higher pro
portion of patients with thrombocytopenia and clinical presentations    requirin
g hospitalization were seen in the period when DENV-2 was predominant    (5).</f
ont></p>     ^cY#a09v22n5.htm##
00853000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704061800076002001300694#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#34#30#article#105#<p><font size="2" f
ace="Verdana">Both the DENV-1 and DENV-2 viruses were isolated    during an epid
emic recognized in 1995–1996, with a total of 51 465 reported    cases of dengue
 fever. In January 1998 a new epidemic occurred in the Para&iacute;ba    river v
alley, in the western part of the state of Rio de Janeiro and quickly    spread 
to other municipalities, including an important tourist area on the northern    
coast (11). DENV-2 spread from Rio de Janeiro to different parts of the country,
    showing more severe clinical presentations in comparison with the previous D
ENV-1    outbreaks.</font></p>     ^cY#a09v22n5.htm##
00704000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704046900076002001300545#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#35#31#article#105#<p><font size="2" f
ace="Verdana">Because of the epidemiological importance of    the state of Rio d
e Janeiro, a virological surveillance program was mounted    in the city of Nova
 Igua&ccedil;u over the years, including during periods between    epidemics. Th
is made it possible to isolate a strain of the DENV-3 virus in    2000 from a ca
se of classic dengue fever as well as from the vector <i>Ae. aegypti</i>    coll
ected in the field (7, 8, 12).</font></p>     ^cY#a09v22n5.htm##
00945000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704071000076002001300786#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#36#32#article#105#<p><font size="2" f
ace="Verdana">DENV-3 virus introduction increased the number    of reported case
s to 69 269 in 2001 and during the summer of 2002, DENV-3 caused    the most sev
ere epidemic so far observed in the state of Rio de Janeiro (8,    9). The numbe
r of cases in 2001–2002 exceeded the epidemic of 1990–1991, when    about 100 00
0 cases with 462 DHF/DSS cases and 8 deaths were reported. In the    DENV-3 epid
emic in the summer of 2002, a total of 288 245 cases were reported,    with 1 83
1 cases of DHF/DSS and 91 deaths, corresponding to 1 735 reported cases    per 1
00 000 inhabitants (9). The highest notification of cases was in the Greater    
Metropolitan Area of the state.</font></p>     ^cY#a09v22n5.htm##
00957000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704072200076002001300798#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#37#33#article#105#<p><font size="2" f
ace="Verdana">Laboratory studies carried out in 2000/2001 on    1 478 reported d
engue cases confirmed a 54.5% infection rate by serology and/or    virus isolati
on and polymerase chain reaction (RT-PCR) (8). Three DENV-1, one    DENV-2, and 
320 DENV-3 strains were detected, revealing that DENV-3 represented    98.7% of 
the circulating viruses during the 2002 epidemic in the state of Rio    de Janei
ro. Forty fatal cases were confirmed for DENV-3 by our institution and    at lea
st two different laboratory methodologies were used on 20 of these cases.    DEN
V-3 was the only serotype detected in these fatal cases and virtually all    of 
them were primary infections by DENV-3 (9).</font></p>     ^cY#a09v22n5.htm##
00335000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010000076002001300176#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#38#34#article#105#<p><font size="2" f
ace="Verdana"><b>Dengue viruses in other Brazilian states</b></font></p>     ^cY
#a09v22n5.htm##
00803000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056800076002001300644#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#39#35#article#105#<p><font size="2" f
ace="Verdana">The southeastern and northeastern regions of    Brazil have been t
he most affected by dengue infections, with epidemics occurring    almost yearly
. In the southeastern region, besides Rio de Janeiro, the states    of Minas Ger
ais and Esp&iacute;rito Santo have reported epidemics in both the    state capit
als and inland municipalities. In the state of S&atilde;o Paulo,    dengue virus
 activity was mainly observed in inland municipalities, with some    severe epid
emics and sporadic activity in coastal locations.</font></p>     ^cY#a09v22n5.ht
m##
00882000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704064700076002001300723#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#40#36#article#105#<p><font size="2" f
ace="Verdana">The northeastern region, an important tourist    area comprising s
even states along the coast, has suffered successive dengue    epidemics and was
 responsible for the highest number of dengue notifications    during the late 1
990s. In 1994, the state of Cear&aacute; reported an epidemic    with 47 889 cas
es, including 25 cases of DHF and 12 deaths. An increase in DHF    was observed 
in 2003, when 23 796 dengue cases were reported, including 291    DHF cases and 
20 deaths. This scenario was also observed in 2005 with 22 817    cases reported
, including 195 DHF cases and 20 deaths (13–16).</font></p>     ^cY#a09v22n5.htm
##
00513000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704027800076002001300354#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#41#37#article#105#<p><font size="2" f
ace="Verdana">The midwestern region, which includes the Federal    District and 
the nation’s capital Bras&iacute;lia, confirmed DENV-1 circulation    in 1990. I
n 1995 DENV-2 was isolated and one case of dual infection was reported    (17).<
/font></p>     ^cY#a09v22n5.htm##
00852000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704061700076002001300693#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#42#38#article#105#<p><font size="2" f
ace="Verdana">Dengue epidemics caused by DENV-2 occurred in    the state of Toca
ntins in 1991 (18) and in the state of Par&aacute; in 1995    (19), both in Braz
il’s northern region. The state of Roraima confirmed dengue    activity in 1996,
 14 years after the first outbreak occurred in that area. In    1998, the state 
of Amazonas reported a dengue epidemic with 23 910 cases. In    2001, all the st
ates in the Amazonas region had epidemics of different magnitudes    (10), inclu
ding Acre and Amap&aacute;, confirming the expansion of <i>Ae. aegypti</i>    in
 the Amazon basin.</font></p>     ^cY#a09v22n5.htm##
00501000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704026600076002001300342#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#43#39#article#105#<p><font size="2" f
ace="Verdana">In the southern region, the state of Paran&aacute;    is the only 
one that has reported dengue since 1995. No autochthonous cases    were reported
 in 2006 in the states of Santa Catarina or Rio Grande do Sul (10).</font></p>  
   ^cY#a09v22n5.htm##
00486000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704025100076002001300327#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#44#40#article#105#<p><font size="2" f
ace="Verdana">It should be emphasized that, according to available    epidemiolo
gical data, dengue infections in the country are found in all age    groups in t
he period studied, with no predominance in children.</font></p>     ^cY#a09v22n5
.htm##
00337000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704010200076002001300178#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#45#41#article#105#<p><font size="2" f
ace="Verdana"><b>Genetic characterization of dengue viruses</b></font></p>     ^
cY#a09v22n5.htm##
00716000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704048100076002001300557#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#46#42#article#105#<p><font size="2" f
ace="Verdana">The co-circulation of DENV-1 and DENV-2 in Brazil    began in 1990
 with the subsequent appearance of DHF/ DSS and fatal cases (Figure    2). This 
occurred initially in Rio de Janeiro and later in other states (5,    20–22). An
 increase in the number of more severe cases in Brazil, similar to    other coun
tries of the Americas, coincided with the introduction of the DENV-2    Southeas
t Asian genotype into the conti-nent (23).</font></p>     ^cY#a09v22n5.htm##
00661000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704042600076002001300502#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#47#43#article#105#<p><font size="2" f
ace="Verdana">Analysis by genome sequencing performed on DENV-1    and DENV-2 is
olated in Brazil identified genotypes from the Americas and Southeast    Asia of
 DENV-1 and DENV-2, respectively (24–26). The complete nucleotide sequence    an
alysis in our laboratory of one Brazilian DENV-2 isolated in 1998 confirmed    t
hat the Southeast Asian genotype III is circulating in Brazil (27).</font></p>  
   ^cY#a09v22n5.htm##
00795000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704056000076002001300636#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#48#44#article#105#<p><font size="2" f
ace="Verdana">The DENV-3 genotype introduced into the continent    has been asso
ciated with major DHF/DSS epidemics in Sri Lanka and India and    with DHF/ DSS 
cases and deaths in Mexico and Central American countries (28,    29). DENV-3 st
rains isolated in Rio de Janeiro in 2000, 2001, 2002, and 2003    have been sequ
enced by our group and in one strain the complete genome was detailed    (GenBan
k accession no. AY679147), confirming that this strain corresponds to    genotyp
e III of the Indian subcontinent (30–32).</font></p>     ^cY#a09v22n5.htm##
00654000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704041900076002001300495#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#49#45#article#105#<p><font size="2" f
ace="Verdana">The data on dengue strain typing after introduction    of DENV-3 s
how that this genotype dislodged other serotypes when first introduced    into t
he area, showing its high infection capacity in both humans and vectors.    Thes
e data however, need more careful evaluation and comparison with epidemiological
    data from other countries in the Region of the Americas.</font></p>     ^cY#
a09v22n5.htm##
00312000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007700076002001300153#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#50#46#article#105#<p><font size="2" f
ace="Verdana"><b>Clinical symptoms</b></font></p>     ^cY#a09v22n5.htm##
01106000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704087100076002001300947#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#51#47#article#105#<p><font size="2" f
ace="Verdana">Besides the usual symptoms of dengue observed    in the cases of D
HF/ DSS, unusual manifestations involving the central nervous    system were rep
orted during the 1986–1987 epidemic in Rio de Janeiro and later    in different 
states, including one case in which the dengue antigen was detected    in neuron
al cells by immunohistochemistry (33–36). Neurological manifestations    in 41 p
atients were reported in the state of Pernambuco between March and July    1997 
and February and May 2002. The brain was involved in 5 of 7 of these cases    in
 1997 and 20 of 34 cases in 2002; the spinal cord was involved in 2 of 34    cas
es in 2002; peripheral nerves were involved in 2 of 7 cases in 1997 and 12    of
 34 cases in 2002. Cerebral hemorrhage and acute disseminated encephalomyelitis 
   were also diagnosed (16, 37).</font></p>     ^cY#a09v22n5.htm##
00606000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037100076002001300447#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#52#48#article#105#<p><font size="2" f
ace="Verdana">In the state of Rondonia, acute encephalomyelitis    was observed 
in 51 patients presenting signs and symptoms of dengue from November    2004 to 
March 2005. Anti-dengue IgM antibodies were detected in sera, and one    patient
, in whom the RT-PCR test detected DENV-3, presented IgM in cerebrospinal    flu
id (38, 39).</font></p>     ^cY#a09v22n5.htm##
00501000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704026600076002001300342#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#53#49#article#105#<p><font size="2" f
ace="Verdana">Dengue cases with high levels of serum aminotransferases    have a
lso been observed. Yellow fever infections were occasionally suspected    but no
t confirmed by epidemiologic investigations and laboratory results.</font></p>  
   ^cY#a09v22n5.htm##
00468000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704023300076002001300309#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#54#50#article#105#<p><font size="2" f
ace="Verdana">During the DENV-3 epidemic in Rio de Janeiro    in 2002, viral RNA
 was detected in the cerebrospinal fluid, liver, brain, lung,    spleen, and kid
neys of fatal cases by RT-PCR (9).</font></p>     ^cY#a09v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#55#51#article#105#<p>&nbsp;</p>     ^
cY#a09v22n5.htm##
00306000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007100076002001300147#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#56#52#article#105#<p><font size="3" f
ace="Verdana"><b>CONCLUSIONS</b></font></p>     ^cY#a09v22n5.htm##
00578000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704034300076002001300419#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#57#53#article#105#<p><font size="2" f
ace="Verdana">Dengue virus activity in Brazil during the past    20 years is dem
onstrated by the high number of reported cases and states involved    in epidemi
cs. The co-circulation of three dengue serotypes is responsible for    the incre
ased occurrence of severe forms of the disease, such as DHF/DSS.</font></p>     
^cY#a09v22n5.htm##
00674000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704043900076002001300515#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#58#54#article#105#<p><font size="2" f
ace="Verdana">The presence of <i>Ae. aegypti</i> in about 80%    of the country 
and the difficulties of implementing successful vector control    are well-known
 in Brazil and in many other countries in the region. Barriers    to adequate ve
ctor control include poor urban planning, demographic pressure,    and the short
age of vector surveillance and personnel able to cover huge geographic    areas.
</font></p>     ^cY#a09v22n5.htm##
00609000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704037400076002001300450#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#59#55#article#105#<p><font size="2" f
ace="Verdana">While vector control continues to be difficult,    progress has be
en made in notification of dengue outbreaks in Brazil. A network    of laborator
ies that are capable of diagnosing dengue infections has been established    in 
all states of Brazil, under the supervision of Reference Laboratories at    the 
regional level.</font></p>     ^cY#a09v22n5.htm##
00616000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704038100076002001300457#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#60#56#article#105#<p><font size="2" f
ace="Verdana">Considering the widespread presence of the disease    vector and t
he lack of a vaccine to prevent dengue infections, constant improvement    in th
e rapid identification and correct clinical management of dengue cases    by hea
lth services is crucial in order to reduce the impact of the disease and    the 
number of fatal cases.</font></p>     ^cY#a09v22n5.htm##
00762000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704052700076002001300603#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#61#57#article#105#<p><font size="2" f
ace="Verdana"><b>Acknowledgments.</b> The authors would like    to thank the Con
selho Nacional de Desenvolvimento Cient&iacute;fico e Tecnol&oacute;gico    (gra
nt No. 501564/03-9) and Funda&ccedil;&atilde;o de Amparo a Pesquisa Cient&iacute
;fica    e Tecnol&oacute;gica (grant No. E-26/152.490/2002) for their financial 
support    of this work. We are also grateful to the Brazilian Ministry of Healt
h and the    Rio de Janeiro State Health Secretariat for providing epidemiologic
al data.</font></p>     ^cY#a09v22n5.htm##
00257000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704002200076002001300098#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#62#58#article#105#<p>&nbsp;</p>     ^
cY#a09v22n5.htm##
00305000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072704007000076002001300146#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#63#59#article#105#<p><font size="3" f
ace="Verdana"><b>REFERENCES</b></font></p>     ^cY#a09v22n5.htm##
00466000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704021700078002001300295#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#64#60#article#105#1#<p><f
ont size="2" face="Verdana">1. Pinheiro FP, Corber SJ. Global situation    of de
ngue and dengue hemorrhagic fever and its emergence in the Americas. World    He
alth Stat Q. 1997;50(3–4):161–9.</font></p>     ^cY#a09v22n5.htm##
00646000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704039700078002001300475#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#65#61#article#105#2#<p><f
ont size="2" face="Verdana"> 2. Gubler DJ. Dengue/dengue hemorrhagic fever    in
 the Americas: prospects for the year 2000. In: Halstead SB, Gomez-Dantes    H, 
eds. Dengue, a worldwide problem, a common strategy. Proceedings of an Internati
onal    Conference on dengue and <i>Aedes aegypti</i> community-based control. M
exico    City: Ministry of Health; 1992. Pp. 19–27. </font></p>     ^cY#a09v22n5
.htm##
00484000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704023500078002001300313#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#66#62#article#105#3#<p><f
ont size="2" face="Verdana"> 3. Osanai CH, Travassos da Rosa APA, Tang    AT, do
 Amaral RS, Passos AD, Tauil PL. Surto de dengue em Boa Vista em Roraima.    Rev
 Inst Med Trop S&atilde;o Paulo. 1998;25(1):53–4. </font></p>     ^cY#a09v22n5.h
tm##
00457000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704020800078002001300286#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#67#63#article#105#4#<p><f
ont size="2" face="Verdana"> 4. Schatzmayr HG, Nogueira RMR, Travassos    da Ros
a APA. An outbreak of dengue virus at Rio de Janeiro–1986. Mem Inst Oswaldo    C
ruz. 1986;81(2): 245–6.</font></p>     ^cY#a09v22n5.htm##
00546000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704029700078002001300375#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#68#64#article#105#5#<p><f
ont size="2" face="Verdana"> 5. Nogueira RMR, Miagostovich MP, Lampe E,    Souza
 RW, Zagne SMO, Schatzmayr HG. Dengue epidemic in the state of Rio de Janeiro,  
  Brazil, 1990–1991: co-circulation of dengue 1 and dengue 2 serotypes. Epidemio
l    Infect. 1993;111(1):163–70.</font></p>     ^cY#a09v22n5.htm##
00577000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704032800078002001300406#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#69#65#article#105#6#<p><f
ont size="2" face="Verdana"> 6. U.S. Division of Health and Human Services,    C
enters for Disease Control and Prevention, Division of Vector-Borne Infectious  
  Diseases, Dengue Branch, San Juan, Puerto Rico. Dengue 3 in Central America.  
  Dengue surveillance. Summary. San Juan: CDC; 1995. 70 pages. </font></p>     ^
cY#a09v22n5.htm##
00472000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704022300078002001300301#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#70#66#article#105#7#<p><f
ont size="2" face="Verdana"> 7. Nogueira RMR, Miagostovich MP, Filippis    AMB, 
Pereira MAS, Schatzmayr HG. Dengue virus type 3 in Rio de Janeiro, Brazil.    Me
m Inst Oswaldo Cruz. 2001;96(7):925–6.</font></p>     ^cY#a09v22n5.htm##
00560000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704031100078002001300389#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#71#67#article#105#8#<p><f
ont size="2" face="Verdana"> 8. De Simone TS, Nogueira RMR, Araujo ESM,    Guima
r&atilde;es FR, Santos FB, Schatzmayr HG, et al. Dengue virus surveillance:    t
he co-circulation of DENV-1, DENV-2 and DENV-3 in the state of Rio de Janeiro.  
  Trans R Soc Trop Med Hyg. 2004;98(9):553–62.</font></p>     ^cY#a09v22n5.htm##
00462000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000200076704021300078002001300291#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#72#68#article#105#9#<p><f
ont size="2" face="Verdana"> 9. Nogueira RMR, Schatzmayr HG, Filippis    AMB, Sa
ntos FB, Cunha RV, Coelho JO, et al. Dengue type 3, Brazil, 2002. Emerg    Infec
t Dis. 2005;11(9): 1376–81. </font></p>     ^cY#a09v22n5.htm##
00579000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704032900079002001300408#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#73#69#article#105#10#<p><
font size="2" face="Verdana">10. Brazil. Minist&eacute;rio da Sa&uacute;de.    B
uletim, Situa&ccedil;&atilde;o Epidemiologica do Dengue 2005. Accessed on 10    
December 2005 at <a href="http://portal.saude.gov.br/portal/arquivos/pdf" target
="_blank">http://portal.saude.gov.br/    portal/arquivos/pdf</a>.</font></p>    
 ^cY#a09v22n5.htm##
00510000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704026000079002001300339#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#74#70#article#105#11#<p><
font size="2" face="Verdana">11. Nogueira RMR, Miagostovich MP, Schatzmayr    HG
, Ara&uacute;jo ESM, Santos FB, Filippis AMB, et al. Dengue in the State of    R
io de Janeiro, Brazil, 1986–1998. Mem Inst Oswaldo Cruz. 1999;94(3):297–304.</fo
nt></p>     ^cY#a09v22n5.htm##
00613000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704036300079002001300442#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#75#71#article#105#12#<p><
font size="2" face="Verdana">12. Louren&ccedil;o-de-Oliveira R, Hon&oacute;rio  
  NA, Castro MG, Schatzmayr HG, Miagostovich MP, Alves JCR, et al. Dengue virus 
   type 3 (DEN-3) isolation from <i>Aedes aegypti</i> in the municipality of Nov
a    Igua&ccedil;&uacute;, state of Rio de Janeiro. Mem Inst Oswaldo Cruz. 2002;
97(6):    799–800. </font></p>     ^cY#a09v22n5.htm##
00567000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704031700079002001300396#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#76#72#article#105#13#<p><
font size="2" face="Verdana">13. Nogueira RMR, Miagostovich MP, Schatzmayr    HG
, Morais G, Cardoso FMA, Ferreira J, et al. Dengue type 2 outbreak in the    sou
th of the state of Bahia, Brazil: Laboratorial and epidemiological studies.    R
ev Inst Med Trop S&atilde;o Paulo. 1995;37(6):507–10.</font></p>     ^cY#a09v22n
5.htm##
00508000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704025800079002001300337#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#77#73#article#105#14#<p><
font size="2" face="Verdana">14. Cunha RV, Miagostovich MP, Petrola Z,    Ara&ua
cute;jo ESM, Cortez D, Pombo V, et al. Retrospective study on dengue in    Forta
leza, state of Cear&aacute;. Mem Inst Oswaldo Cruz. 1998;93(2): 155–9.    </font
></p>     ^cY#a09v22n5.htm##
00512000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704026200079002001300341#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#78#74#article#105#15#<p><
font size="2" face="Verdana">15. Cunha RV, Schatzmayr HG, Miagostovich    MP, Ba
rbosa AMA, Paiva FGP, Miranda RMO, et al. Dengue epidemic in the state    of Rio
 Grande do Norte, Brazil, in 1997. Trans R Soc Trop Med Hyg. 1999;93(3):247–9.</
font></p>     ^cY#a09v22n5.htm##
00464000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704021400079002001300293#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#79#75#article#105#16#<p><
font size="2" face="Verdana">16. Cordeiro, MT. Dengue in the state of Pernambuco
,    Brazil: 1995–1997. Virological, clinical and epidemiological aspects. Virus
    Rev Res. 1997;2(2): 112–3.</font></p>     ^cY#a09v22n5.htm##
00471000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704022100079002001300300#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#80#76#article#105#17#<p><
font size="2" face="Verdana">17. Rocco IM, Barbosa ML, Kanomata EHN. Simultaneou
s    infection with dengue 1 and 2 in a Brazilian patient. Rev Inst Med Trop S&a
tilde;o    Paulo. 1998; 40(3):151–4. </font></p>     ^cY#a09v22n5.htm##
00539000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704028900079002001300368#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#81#77#article#105#18#<p><
font size="2" face="Verdana">18. Vasconcelos PFC, Travassos da Rosa ES,    Trava
ssos da Rosa APA. Epidemia de febre cl&aacute;ssica de dengue causada pelo    so
rotipo 2 em Aragua&iacute;na, Tocantins, Brasil. Rev Inst Med Trop S&atilde;o   
 Paulo. 1993;35(2):141–8.</font></p>     ^cY#a09v22n5.htm##
00515000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704026500079002001300344#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#82#78#article#105#19#<p><
font size="2" face="Verdana">19. Travassos da Rosa APA, Vasconcelos PFC,    Trav
assos da Rosa ES, Rodrigues SG, Mondet B, Cruz ACR, et al. Dengue epidemic    in
 Bel&eacute;m, Par&aacute;, Brazil, 1996–97. Emerg Infect Dis. 2000;6(3):298–301
.</font></p>     ^cY#a09v22n5.htm##
00527000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027700079002001300356#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#83#79#article#105#20#<p><
font size="2" face="Verdana">20. Zagne SMO, Alves VGF, Nogueira RMR, Miagostovic
h    MP, Lampe E, Tavares W. Dengue haemorrhagic fever in the state of Rio de Ja
neiro,    Brazil: a study of 56 confirmed cases. Trans R Soc Trop Med Hyg. 1994;
 88(6):677–9.</font></p>     ^cY#a09v22n5.htm##
00521000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027100079002001300350#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#84#80#article#105#21#<p><
font size="2" face="Verdana">21. Souza RW, Cunha RV, Miagostovich MP, Timb&oacut
e;    MJ, Montenegro F, Pessoa ETFP, et al. An outbreak of dengue virus infectio
n    in the state of Cear&aacute;, Brazil. Mem Inst Oswaldo Cruz. 1995;90(3):345
–6.    </font></p>     ^cY#a09v22n5.htm##
00562000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704031200079002001300391#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#85#81#article#105#22#<p><
font size="2" face="Verdana">22. Vasconcelos PF, Menezes DB, Melo LP, Pessoa    
ETF, Rodrigues SG, Travassos da Rosa ES, et al. A large epidemic of dengue fever
    with dengue hemorrhagic cases in Cear&aacute; State, Brazil, 1994. Rev Inst 
   Med Trop S&atilde;o Paulo. 1995;37(3):253–5. </font></p>     ^cY#a09v22n5.htm
##
00509000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704025900079002001300338#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#86#82#article#105#23#<p><
font size="2" face="Verdana">23. Rico-Hesse R, Harrison LM, Alba Salas    R, Tov
ar D, Nisalak A, Ramos C, et al. Origins of dengue type 2 viruses associated    
with increased pathogenicity in the Americas. Virology. 1997;230(2):244–51.</fon
t></p>     ^cY#a09v22n5.htm##
00433000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704018300079002001300262#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#87#83#article#105#24#<p><
font size="2" face="Verdana">24. Rico-Hesse R. Molecular evolution and    distri
bution of dengue viruses type 1 and 2 in nature. Virology. 1990;174(2):479–493.<
/font></p>     ^cY#a09v22n5.htm##
00548000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704029800079002001300377#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#88#84#article#105#25#<p><
font size="2" face="Verdana">25. Deubel V, Nogueira RMR, Drouet MT, Zeller    M,
 Reynes J, Ma DQ. Direct sequencing of genomic cDNA fragment amplified by    the
 polymerase chain reaction for molecular epidemiology of dengue 2 viruses.    Ar
ch Virol. 1993; 129(1-4):197–210. </font></p>     ^cY#a09v22n5.htm##
00457000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704020700079002001300286#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#89#85#article#105#26#<p><
font size="2" face="Verdana">26. Miagostovich MP, Nogueira RMR, Schatzmayr    HG
, Lanciotti RS. Molecular epidemiology of DENV-2 in Brazil. Mem Inst Oswaldo    
Cruz. 1998;93(5):625–6.</font></p>     ^cY#a09v22n5.htm##
00527000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027700079002001300356#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#90#86#article#105#27#<p><
font size="2" face="Verdana">27. Santos FB, Miagostovich MP, Nogueira RMR,    Sc
hatzmayr HG, Riley LW, Harris E. Complete nucleotide sequence analysis of    a B
razilian dengue type 2 virus strain (BR64022/98). Mem Inst Oswaldo Cruz.    2002
;97(7):991–5.</font></p>     ^cY#a09v22n5.htm##
00443000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704019300079002001300272#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#91#87#article#105#28#<p><
font size="2" face="Verdana">28. Lanciotti RS, Lewis JG, Gubler DJ, Trent    DW.
 Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol. 1994;75(
1):65–75.</font></p>     ^cY#a09v22n5.htm##
00458000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704020800079002001300287#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#92#88#article#105#29#<p><
font size="2" face="Verdana">29. Figueroa R, Ramos C. Dengue virus (serotype    
3) circulation in endemic countries and its reappearance in America. Arch Med   
 Res. 2000;31(4):429–30.</font></p>     ^cY#a09v22n5.htm##
00528000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027800079002001300357#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#93#89#article#105#30#<p><
font size="2" face="Verdana">30. Miagostovich MP, Santos FB, De Simone    TS, Co
sta EV, Filippis AMB, Schatzmayr HG, et al. Molecular characterization    of den
gue viruses type 3 isolated in the state of Rio de Janeiro. Braz J Med    Res. 2
000;35(1):1–4.</font></p>     ^cY#a09v22n5.htm##
00521000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704027100079002001300350#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#94#90#article#105#31#<p><
font size="2" face="Verdana">31. Miagostovich MP, Nogueira RMR. Molecular    cha
racterization of dengue virus: studies of Brazilian strains. In: Williams    CR,
 ed. Focus on genome research. New York: Nova Science Publishers; 2004. Pp.    8
1–131. </font></p>     ^cY#a09v22n5.htm##
00556000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704030600079002001300385#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#95#91#article#105#32#<p><
font size="2" face="Verdana">32. Miagostovich MP, Santos FB, Furnian TM,    Guim
ar&atilde;es FR, Costa EV, Tavares FN, et al. Complete genetic characterization 
   of a Brazilian dengue virus type 3 strain isolated from a fatal outcome. Mem 
   Inst Oswaldo Cruz. 2006;101(3):307–13. </font></p>     ^cY#a09v22n5.htm##
00478000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704022800079002001300307#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#96#92#article#105#33#<p><
font size="2" face="Verdana">33. Chimelli L, Dumas HM, Barreto Neto M,    Grande
lle R, Dias M, Gray F. Dengue: neuropathological findings in 5 fatal cases    fr
om Brazil. Clin Neuropath. 1990;9(3):157–62.</font></p>     ^cY#a09v22n5.htm##
00605000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704035500079002001300434#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#97#93#article#105#34#<p><
font size="2" face="Verdana">34. Vasconcelos PFC, Travassos da Rosa APA,    Coel
ho ICB, Menezes DB, Travassos da Rosa EST, Rodrigues SG, et al. Involvement    o
f the central nervous system in dengue fever: three serologically confirmed    c
ases from Fortaleza, Cear&aacute;. Rev Inst Med Trop S&atilde;o Paulo. 1998;    
40(1):35–9.</font></p>     ^cY#a09v22n5.htm##
00476000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704022600079002001300305#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#98#94#article#105#35#<p><
font size="2" face="Verdana">35. Miagostovich MP, Ramos RG, Nicol AF, Nogueira  
  RMR, Cuzzi-Maya T, Oliveira AV, et al. Retrospective study on dengue fatal cas
es.    Clin Neuropathol. 1997;16(4):204–8.</font></p>     ^cY#a09v22n5.htm##
00548000000000157000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000800064708000400072888000300076704029800079002001300377#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#99#95#article#105#36#<p><
font size="2" face="Verdana">36. Nogueira RMR, Filippis AMB, Coelho JMO,    Sequ
eira PC, Schatzmayr HG, Paiva FG, et al. Dengue virus infection of the central  
  nervous system (CNS): a case report from Brazil. Southeast Asian J Trop Med   
 Public Health. 2002;33(1):68–71. </font></p>     ^cY#a09v22n5.htm##
00487000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704023600080002001300316#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#100#96#article#105#37#<p>
<font size="2" face="Verdana">37. Ferreira MLB, Cavalcanti CG, Coelho CA,    Mes
quita SB. Manifesta&ccedil;&otilde;es neurol&oacute;gicas de dengue: estudo    d
e 41 casos. Arq Neuropsiquiatr. 2005;63(2-B): 488–93.</font></p>     ^cY#a09v22n
5.htm##
00737000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704048600080002001300566#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#101#97#article#105#38#<p>
<font size="2" face="Verdana">38. Brazil. Minist&eacute;rio da Sa&uacute;de.    
Nota t&eacute;cnica: Surto de enc&eacute;falo-mielite aguda associada &agrave;  
  infec&ccedil;&atilde;o pelo v&iacute;rus da dengue em munic&iacute;pios do Est
ado    de Rond&ocirc;nia. 2005. Accessed on 10 December 2005 at <a href="http://
portal.saude.gov.br/portal/arquivos/pdf/nota_dengue.pdf" target="_blank">http://
portal.saude.gov.br/    portal/arquivos/pdf/nota_dengue.pdf</a></font></p>     ^
cY#a09v22n5.htm##
00495000000000157000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073888000300077704024400080002001300324#v22
n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#102#98#article#105#39#<p>
<font size="2" face="Verdana">39. Silva JB, Pimenta FG Epidemiologia da    dengu
e. In: de Souza, LJ, ed. Dengue: diagn&oacute;stico, tratamento e preven&ccedil;
&atilde;o.    Rio de Janeiro: Editora Rubio; 2007. Pp. 11–35.</font></p>     ^cY
#a09v22n5.htm##
00258000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000300062709000800065708000400073704002200077002001300099#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#103#99#article#105#<p>&nbsp;</p>     
^cY#a09v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#104#100#article#105#<p>&nbsp;</p>    
 ^cY#a09v22n5.htm##
00314000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704007700078002001300155#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#105#101#article#105#<p><font size="2"
 face="Verdana">Manuscript received on 28 June 2006.    ^cY#a09v22n5.htm##
00321000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704008400078002001300162#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#106#102#article#105#<br>   Revised ve
rsion accepted for publication on 12 July 2007.</font></p>     ^cY#a09v22n5.htm#
#
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#107#103#article#105#<p>&nbsp;</p>    
 ^cY#a09v22n5.htm##
00259000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704002200078002001300100#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#108#104#article#105#<p>&nbsp;</p>    
 ^cY#a09v22n5.htm##
00396000000000145000450000400060000070200480000670500020005470600020005670000040
0058701000400062709000800066708000400074704015900078002001300237#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a09v22n5.htm#S#p#109#105#article#105#<p><FONT SIZE="2"
 face="Verdana"><a name="nt"></a><a href="#tx">*</a> E-mail: <a href="mailto:rit
a@ioc.fiocruz.br">rita@ioc.fiocruz.br</a>.</font></p>     ^cY#a09v22n5.htm##
00557000000000277000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100019000770100017000960120
09400113030002100207710000200228065000900230064000500239031000300244032000400247
014000600251865000900257002001300266#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
9v22n5.htm#S#c#110#1#article#39#1#^rND^sPinheiro^nFP#^rND^sCorber^nSJ#Global sit
uation of dengue and dengue hemorrhagic fever and its emergence in the Americas^
len#World Health Stat Q.#2#19970000#1997#50#3-4#161-9#20071100#a09v22n5.htm##
00722000000000289000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770120081000940160
01900175016002200194018005100216053008000267056001500347052002200362055001200384
054000800396014000600404865000900410002001300419#v22n5#v:\scielo\serial\rpsp\v22
n5\markup\a09v22n5.htm#S#c#111#2#article#39#2#^rND^sGubler^nDJ#Dengue/dengue hem
orrhagic fever in the Americas: prospects for the year 2000^len#^rED^sHalstead^n
SB#^rED^sGomez-Dantes^nH#Dengue, a worldwide problem, a common strategy^len#Inte
rnational Conference on dengue and Aedes aegypti community-based control^i1#Mexi
co City^i1#Ministry of Health^i1#19920000^i1#1992^i1#19-27#20071100#a09v22n5.htm
##
00685000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100017000770100029000940100
01500123010002000138010001700158010001600175012004400191030002800235065000900263
06400050027203100030027703200020028001400050028286500090028700200130029603500100
0309801002800319#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#112#3
#article#39#3#^rND^sOsanai^nCH#^rND^sTravassos da Rosa^nAPA#^rND^sTang^nAT#^rND^
sdo Amaral^nRS#^rND^sPassos^nAD#^rND^sTauil^nPL#Surto de dengue em Boa Vista em 
Roraima^lpt#Rev Inst Med Trop São Paulo#19980000#1998#25#1#53-4#20071100#a09v22n
5.htm#0036-4665#Rev Inst Med Trop São Paulo##
00605000000000301000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100021000770100020000980100
02900118012005500147030002200202065000900224064000500233031000300238032000200241
014000600243865000900249002001300258035001000271801002200281#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a09v22n5.htm#S#c#113#4#article#39#4#^rND^sSchatzmayr^nHG#^
rND^sNogueira^nRMR#^rND^sTravassos da Rosa^nAPA#An outbreak of dengue virus at R
io de Janeiro-1986^len#Mem Inst Oswaldo Cruz#19860000#1986#81#2#245-6#20071100#a
09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00705000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100023000970100
01500120010001600135010001700151010002100168012012100189030001800310710000200328
06500090033006400050033903100040034403200020034801400070035086500090035700200130
0366#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#114#5#article#39#
5#^rND^sNogueira^nRMR#^rND^sMiagostovich^nMP#^rND^sLampe^nE#^rND^sSouza^nRW#^rND
^sZagne^nSMO#^rND^sSchatzmayr^nHG#Dengue epidemic in the state of Rio de Janeiro
, Brazil, 1990-1991: co-circulation of dengue 1 and dengue 2 serotypes^len#Epide
miol Infect.#2#19930000#1993#111#1#163-70#20071100#a09v22n5.htm##
00626000000000265000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750170148000770660009002250670
01200234018006200246066000900308062000400317065000900321064000500330020000300335
865000900338002001300347#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S
#c#115#6#article#39#6#U.S. Division of Health and Human Services^dCenters for Di
sease Control and Prevention, Division of Vector-Borne Infectious Diseases, Deng
ue Branch#San Juan#Puerto Rico#Dengue 3 in Central America: Dengue surveillance.
 Summary^len#San Juan#CDC#19950000#1995#70#20071100#a09v22n5.htm##
00657000000000325000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100023000970100
02000120010001900140010002100159012005000180030002200230065000900252064000500261
03100030026603200020026901400060027186500090027700200130028603500100029980100220
0309#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#116#7#article#39#
7#^rND^sNogueira^nRMR#^rND^sMiagostovich^nMP#^rND^sFilippis^nAMB#^rND^sPereira^n
MAS#^rND^sSchatzmayr^nHG#Dengue virus type 3 in Rio de Janeiro, Brazil^len#Mem I
nst Oswaldo Cruz#20010000#2001#96#7#925-6#20071100#a09v22n5.htm#0074-0276#Mem In
st Oswaldo Cruz##
00723000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100020000970100
01800117010002000135010001700155010002100172810000600193012011000199030002600309
71000020033506500090033706400050034603100030035103200020035401400070035686500090
0363002001300372#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#117#8
#article#39#8#^rND^sDe Simone^nTS#^rND^sNogueira^nRMR#^rND^sAraujo^nESM#^rND^sGu
imarães^nFR#^rND^sSantos^nFB#^rND^sSchatzmayr^nHG#et al#Dengue virus surveillanc
e: the co-circulation of DENV-1, DENV-2 and DENV-3 in the state of Rio de Janeir
o^len#Trans R Soc Trop Med Hyg.#2#20040000#2004#98#9#553-62#20071100#a09v22n5.ht
m##
00633000000000337000450000400060000070200480000670500020005470600020005670000040
00587010002000627090008000647080003000721180002000750100020000770100021000970100
02000118010001700138010001600155010001700171810000600188012003200194030001800226
71000020024406500090024606400050025503100030026003200020026301400080026586500090
0273002001300282#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#118#9
#article#39#9#^rND^sNogueira^nRMR#^rND^sSchatzmayr^nHG#^rND^sFilippis^nAMB#^rND^
sSantos^nFB#^rND^sCunha^nRV#^rND^sCoelho^nJO#et al#Dengue type 3, Brazil, 2002^l
en#Emerg Infect Dis.#2#20050000#2005#11#9#1376-81#20071100#a09v22n5.htm##
00473000000000217000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170028000790180052001071100
00900159109001700168037004800185865000900233002001300242#v22n5#v:\scielo\serial\
rpsp\v22n5\markup\a09v22n5.htm#S#c#119#10#article#39#10#Brazil^dMinistério da Sa
úde#Buletim, Situação Epidemiologica do Dengue 2005^lpt#20051210#10 December 200
5#http://portal.saude.gov.br/ portal/arquivos/pdf#20071100#a09v22n5.htm##
00718000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100023000990100
02100122010001800143010001700161010002000178810000600198012006100204030002200265
06500090028706400050029603100030030103200020030401400080030686500090031400200130
0323035001000336801002200346#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#120#11#article#39#11#^rND^sNogueira^nRMR#^rND^sMiagostovich^nMP#^rND^sSch
atzmayr^nHG#^rND^sAraújo^nESM#^rND^sSantos^nFB#^rND^sFilippis^nAMB#et al#Dengue 
in the State of Rio de Janeiro, Brazil, 1986-1998^len#Mem Inst Oswaldo Cruz#1999
0000#1999#94#3#297-304#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00785000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100030000790100018001090100
01700127010002100144010002300165010001700188810000600205012012100211030002200332
06500090035406400050036303100030036803200020037101400080037386500090038100200130
0390035001000403801002200413#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#121#12#article#39#12#^rND^sLourenço-de-Oliveira^nR#^rND^sHonório^nNA#^rND
^sCastro^nMG#^rND^sSchatzmayr^nHG#^rND^sMiagostovich^nMP#^rND^sAlves^nJCR#et al#
Dengue virus type 3 (DEN-3) isolation from Aedes aegypti in the municipality of 
Nova Iguaçú, state of Rio de Janeiro^len#Mem Inst Oswaldo Cruz#20020000#2002#97#
6#799-800#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00778000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100023000990100
02100122010001600143010001900159010001800178810000600196012011200202030002800314
06500090034206400050035103100030035603200020035901400070036186500090036800200130
0377035001000390801002800400#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#122#13#article#39#13#^rND^sNogueira^nRMR#^rND^sMiagostovich^nMP#^rND^sSch
atzmayr^nHG#^rND^sMorais^nG#^rND^sCardoso^nFMA#^rND^sFerreira^nJ#et al#Dengue ty
pe 2 outbreak in the south of the state of Bahia, Brazil: Laboratorial and epide
miological studies^len#Rev Inst Med Trop São Paulo#19950000#1995#37#6#507-10#200
71100#a09v22n5.htm#0036-4665#Rev Inst Med Trop São Paulo##
00704000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100023000950100
01700118010001800135010001600153010001500169810000600184012006300190030002200253
06500090027506400050028403100030028903200020029201400060029486500090030000200130
0309035001000322801002200332#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#123#14#article#39#14#^rND^sCunha^nRV#^rND^sMiagostovich^nMP#^rND^sPetrola
^nZ#^rND^sAraújo^nESM#^rND^sCortez^nD#^rND^sPombo^nV#et al#Retrospective study o
n dengue in Fortaleza, state of Ceará^len#Mem Inst Oswaldo Cruz#19980000#1998#93
#2#155-9#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00686000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100021000950100
02300116010001900139010001700158010001900175810000600194012007300200030002600273
71000020029906500090030106400050031003100030031503200020031801400060032086500090
0326002001300335#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#124#1
5#article#39#15#^rND^sCunha^nRV#^rND^sSchatzmayr^nHG#^rND^sMiagostovich^nMP#^rND
^sBarbosa^nAMA#^rND^sPaiva^nFGP#^rND^sMiranda^nRMO#et al#Dengue epidemic in the 
state of Rio Grande do Norte, Brazil, in 1997^len#Trans R Soc Trop Med Hyg.#2#19
990000#1999#93#3#247-9#20071100#a09v22n5.htm##
00535000000000265000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100019000790120108000980300
01500206710000200221065000900223064000500232031000200237032000200239014000600241
865000900247002001300256#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S
#c#125#16#article#39#16#^rND^sCordeiro^nMT#Dengue in the state of Pernambuco, Br
azil: 1995-1997. Virological, clinical and epidemiological aspects^len#Virus Rev
 Res.#2#19970000#1997#2#2#112-3#20071100#a09v22n5.htm##
00618000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100018000950100
02000113012007000133030002800203065000900231064000500240031000300245032000200248
014000600250865000900256002001300265035001000278801002800288#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a09v22n5.htm#S#c#126#17#article#39#17#^rND^sRocco^nIM#^rND
^sBarbosa^nML#^rND^sKanomata^nEHN#Simultaneous infection with dengue 1 and 2 in 
a Brazilian patient^len#Rev Inst Med Trop São Paulo#19980000#1998#40#3#151-4#200
71100#a09v22n5.htm#0036-4665#Rev Inst Med Trop São Paulo##
00671000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100028001020100
02900130012009700159030002800256065000900284064000500293031000300298032000200301
014000600303865000900309002001300318035001000331801002800341#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a09v22n5.htm#S#c#127#18#article#39#18#^rND^sVasconcelos^nP
FC#^rND^sTravassos da Rosa^nES#^rND^sTravassos da Rosa^nAPA#Epidemia de febre cl
ássica de dengue causada pelo sorotipo 2 em Araguaína, Tocantins, Brasil^lpt#Rev
 Inst Med Trop São Paulo#19930000#1993#35#2#141-8#20071100#a09v22n5.htm#0036-466
5#Rev Inst Med Trop São Paulo##
00675000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100029000790100023001080100
02800131010002000159010001600179010001600195810000600211012005200217030001800269
71000020028706500090028906400050029803100020030303200020030501400080030786500090
0315002001300324#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#128#1
9#article#39#19#^rND^sTravassos da Rosa^nAPA#^rND^sVasconcelos^nPFC#^rND^sTravas
sos da Rosa^nES#^rND^sRodrigues^nSG#^rND^sMondet^nB#^rND^sCruz^nACR#et al#Dengue
 epidemic in Belém, Pará, Brazil, 1996-97^len#Emerg Infect Dis.#2#20000000#2000#
6#3#298-301#20071100#a09v22n5.htm##
00689000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100017000960100
02000113010002300133010001500156010001700171012010000188030002600288710000200314
06500090031606400050032503100030033003200020033301400060033586500090034100200130
0350#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#129#20#article#39
#20#^rND^sZagne^nSMO#^rND^sAlves^nVGF#^rND^sNogueira^nRMR#^rND^sMiagostovich^nMP
#^rND^sLampe^nE#^rND^sTavares^nW#Dengue haemorrhagic fever in the state of Rio d
e Janeiro, Brazil: a study of 56 confirmed cases^len#Trans R Soc Trop Med Hyg.#2
#19940000#1994#88#6#677-9#20071100#a09v22n5.htm##
00718000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100016000950100
02300111010001600134010002000150010001900170810000600189012007200195030002200267
06500090028906400050029803100030030303200020030601400060030886500090031400200130
0323035001000336801002200346#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#130#21#article#39#21#^rND^sSouza^nRW#^rND^sCunha^nRV#^rND^sMiagostovich^n
MP#^rND^sTimbó^nMJ#^rND^sMontenegro^nF#^rND^sPessoa^nETFP#et al#An outbreak of d
engue virus infection in the state of Ceará, Brazil^len#Mem Inst Oswaldo Cruz#19
950000#1995#90#3#345-6#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00765000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100022000790100018001010100
01500119010001800134010002000152010002800172810000600200012009600206030002800302
06500090033006400050033903100030034403200020034701400060034986500090035500200130
0364035001000377801002800387#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#131#22#article#39#22#^rND^sVasconcelos^nPF#^rND^sMenezes^nDB#^rND^sMelo^n
LP#^rND^sPessoa^nETF#^rND^sRodrigues^nSG#^rND^sTravassos da Rosa^nES#et al#A lar
ge epidemic of dengue fever with dengue hemorrhagic cases in Ceará State, Brazil
, 1994^len#Rev Inst Med Trop São Paulo#19950000#1995#37#3#253-5#20071100#a09v22n
5.htm#0036-4665#Rev Inst Med Trop São Paulo##
00711000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100019000990100
02000118010001500138010001700153010001500170810000600185012009300191030000900284
06500090029306400050030203100040030703200020031101400070031386500090032000200130
0329035001000342801000900352#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#132#23#article#39#23#^rND^sRico-Hesse^nR#^rND^sHarrison^nLM#^rND^sAlba Sa
las^nR#^rND^sTovar^nD#^rND^sNisalak^nA#^rND^sRamos^nC#et al#Origins of dengue ty
pe 2 viruses associated with increased pathogenicity in the Americas^len#Virolog
y#19970000#1997#230#2#244-51#20071100#a09v22n5.htm#0042-6822#Virology##
00537000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790120082000990300
00900181065000900190064000500199031000400204032000200208014000800210865000900218
002001300227035001000240801000900250#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
9v22n5.htm#S#c#133#24#article#39#24#^rND^sRico-Hesse^nR#Molecular evolution and 
distribution of dengue viruses type 1 and 2 in nature^len#Virology#19900000#1990
#174#2#479-493#20071100#a09v22n5.htm#0042-6822#Virology##
00706000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100020000950100
01700115010001600132010001600148010001300164012013700177030001200314710000200326
06500090032806400050033703100040034203200040034601400080035086500090035800200130
0367#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#134#25#article#39
#25#^rND^sDeubel^nV#^rND^sNogueira^nRMR#^rND^sDrouet^nMT#^rND^sZeller^nM#^rND^sR
eynes^nJ#^rND^sMa^nDQ#Direct sequencing of genomic cDNA fragment amplified by th
e polymerase chain reaction for molecular epidemiology of dengue 2 viruses^len#A
rch Virol.#2#19930000#1993#129#1-4#197-210#20071100#a09v22n5.htm##
00625000000000313000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100020001020100
02100122010002000143012004700163030002200210065000900232064000500241031000300246
032000200249014000600251865000900257002001300266035001000279801002200289#v22n5#v
:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#135#26#article#39#26#^rND^sMi
agostovich^nMP#^rND^sNogueira^nRMR#^rND^sSchatzmayr^nHG#^rND^sLanciotti^nRS#Mole
cular epidemiology of DENV-2 in Brazil^len#Mem Inst Oswaldo Cruz#19980000#1998#9
3#5#625-6#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00728000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100017000790100023000960100
02000119010002100139010001600160010001600176012009700192030002200289065000900311
06400050032003100030032503200020032801400060033086500090033600200130034503500100
0358801002200368#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#136#2
7#article#39#27#^rND^sSantos^nFB#^rND^sMiagostovich^nMP#^rND^sNogueira^nRMR#^rND
^sSchatzmayr^nHG#^rND^sRiley^nLW#^rND^sHarris^nE#Complete nucleotide sequence an
alysis of a Brazilian dengue type 2 virus strain (BR64022/98)^len#Mem Inst Oswal
do Cruz#20020000#2002#97#7#991-5#20071100#a09v22n5.htm#0074-0276#Mem Inst Oswald
o Cruz##
00573000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100016000990100
01700115010001600132012006100148030001300209710000200222065000900224064000500233
031000300238032000200241014000600243865000900249002001300258#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a09v22n5.htm#S#c#137#28#article#39#28#^rND^sLanciotti^nRS#
^rND^sLewis^nJG#^rND^sGubler^nDJ#^rND^sTrent^nDW#Molecular evolution and epidemi
ology of dengue-3 viruses^len#J Gen Virol.#2#19940000#1994#75#1#65-75#20071100#a
09v22n5.htm##
00549000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100015000970120
09500112030001400207710000200221065000900223064000500232031000300237032000200240
014000700242865000900249002001300258#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
9v22n5.htm#S#c#138#29#article#39#29#^rND^sFigueroa^nR#^rND^sRamos^nC#Dengue viru
s (serotype 3) circulation in endemic countries and its reappearance in America^
len#Arch Med Res.#2#20000000#2000#31#4#429-30#20071100#a09v22n5.htm##
00699000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100017001020100
02000119010001600139010002000155010002100175810000600196012009600202030001600298
71000020031406500090031606400050032503100030033003200020033301400040033586500090
0339002001300348#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#139#3
0#article#39#30#^rND^sMiagostovich^nMP#^rND^sSantos^nFB#^rND^sDe Simone^nTS#^rND
^sCosta^nEV#^rND^sFilippis^nAMB#^rND^sSchatzmayr^nHG#et al#Molecular characteriz
ation of dengue viruses type 3 isolated in the state of Rio de Janeiro^len#Braz 
J Med Res.#2#20000000#2000#35#1#1-4#20071100#a09v22n5.htm##
00601000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100020001020120
07700122016001900199018002900218066000900247062002400256065000900280064000500289
014000700294865000900301002001300310#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
9v22n5.htm#S#c#140#31#article#39#31#^rND^sMiagostovich^nMP#^rND^sNogueira^nRMR#M
olecular characterization of dengue virus: studies of Brazilian strains^len#^rED
^sWilliams^nCR#Focus on genome research^len#New York#Nova Science Publishers#200
40000#2004#81-131#20071100#a09v22n5.htm##
00760000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100017001020100
01800119010002000137010001600157010001800173810000600191012011000197030002200307
06500090032906400050033803100040034303200020034701400070034986500090035600200130
0365035001000378801002200388#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#141#32#article#39#32#^rND^sMiagostovich^nMP#^rND^sSantos^nFB#^rND^sFurnia
n^nTM#^rND^sGuimarães^nFR#^rND^sCosta^nEV#^rND^sTavares^nFN#et al#Complete genet
ic characterization of a Brazilian dengue virus type 3 strain isolated from a fa
tal outcome^len#Mem Inst Oswaldo Cruz#20060000#2006#101#3#307-13#20071100#a09v22
n5.htm#0074-0276#Mem Inst Oswaldo Cruz##
00641000000000325000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100018000790100016000970100
02200113010001900135010001400154010001400168012006800182030001600250710000200266
06500090026806400050027703100020028203200020028401400070028686500090029300200130
0302#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#142#33#article#39
#33#^rND^sChimelli^nL#^rND^sDumas^nHM#^rND^sBarreto Neto^nM#^rND^sGrandelle^nR#^
rND^sDias^nM#^rND^sGray^nF#Dengue: neuropathological findings in 5 fatal cases f
rom Brazil^len#Clin Neuropath.#2#19900000#1990#9#3#157-62#20071100#a09v22n5.htm#
#
00805000000000349000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100029001020100
01800131010001800149010002900167010002000196810000600216012012100222030002800343
06500090037106400050038003100030038503200020038801400050039086500090039500200130
0404035001000417801002800427#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.h
tm#S#c#143#34#article#39#34#^rND^sVasconcelos^nPFC#^rND^sTravassos da Rosa^nAPA#
^rND^sCoelho^nICB#^rND^sMenezes^nDB#^rND^sTravassos da Rosa^nEST#^rND^sRodrigues
^nSG#et al#Involvement of the central nervous system in dengue fever: three sero
logically confirmed cases from Fortaleza, Ceará^len#Rev Inst Med Trop São Paulo#
19980000#1998#40#1#35-9#20071100#a09v22n5.htm#0036-4665#Rev Inst Med Trop São Pa
ulo##
00650000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100023000790100016001020100
01600118010002000134010002000154010001900174810000600193012004600199030001800245
71000020026306500090026506400050027403100030027903200020028201400060028486500090
0290002001300299#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#144#3
5#article#39#35#^rND^sMiagostovich^nMP#^rND^sRamos^nRG#^rND^sNicol^nAF#^rND^sNog
ueira^nRMR#^rND^sCuzzi-Maya^nT#^rND^sOliveira^nAV#et al#Retrospective study on d
engue fatal cases^len#Clin Neuropathol.#2#19970000#1997#16#4#204-8#20071100#a09v
22n5.htm##
00767000000000337000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100020000990100
01800119010001900137010002100156010001600177810000600193012009000199030004100289
06500090033006400050033903100030034403200090034786500090035600200130036503500100
0378801004100388#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#145#3
6#article#39#36#^rND^sNogueira^nRMR#^rND^sFilippis^nAMB#^rND^sCoelho^nJMO#^rND^s
Sequeira^nPC#^rND^sSchatzmayr^nHG#^rND^sPaiva^nFG#et al#Dengue virus infection o
f the central nervous system (CNS): a case report from Brazil^len#Southeast Asia
n J Trop Med Public Health#20020000#2002#33#1^s68-71#20071100#a09v22n5.htm#0038-
3619#Southeast Asian J Trop Med Public Health##
00591000000000301000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100020000790100021000990100
01700120010001900137012006100156030002000217710000200237065000900239064000500248
031000300253032000400256014000700260865000900267002001300276#v22n5#v:\scielo\ser
ial\rpsp\v22n5\markup\a09v22n5.htm#S#c#146#37#article#39#37#^rND^sFerreira^nMLB#
^rND^sCavalcanti^nCG#^rND^sCoelho^nCA#^rND^sMesquita^nSB#Manifestações neurológi
cas de dengue: estudo de 41 casos^lpt#Arq Neuropsiquiatr.#2#20050000#2005#63#2-B
#488-93#20071100#a09v22n5.htm##
00603000000000241000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760170028000790180128001070650
00900235064000500244110000900249109001700258037006400275865000900339002001300348
#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a09v22n5.htm#S#c#147#38#article#39#38#
Brazil^dMinistério da Saúde#Nota técnica: Surto de encéfalo-mielite aguda associ
ada à infecção pelo vírus da dengue em municípios do Estado de Rondônia^lpt#2005
0000#2005#20051210#10 December 2005#http://portal.saude.gov.br/ portal/arquivos/
pdf/nota_dengue.pdf#20071100#a09v22n5.htm##
00557000000000277000450000400060000070200480000670500020005470600020005670000040
00587010003000627090008000657080003000731180003000760100016000790100018000950120
02800113016001900141018004800160066001500208062001400223065000900237064000500246
014000600251865000900257002001300266#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a0
9v22n5.htm#S#c#148#39#article#39#39#^rND^sSilva^nJB#^rND^sPimenta^nFG#Epidemiolo
gia da dengue^lpt#^rED^sde Souza^nLJ#Dengue: diagnóstico, tratamento e prevenção
^lpt#Rio de Janeiro#Editora Rubio#20070000#2007#11-35#20071100#a09v22n5.htm##
00271000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670910009000690920007000780020013000857030
00300098#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a10v22n5.htm#S#o#1#1#text#1#20
080121#151830#a10v22n5.htm#18##
00609000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301200930
0165002001300258#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a10v22n5.htm#S#h#2#1#t
ext#1#ab#es#br1.1#1#3.1#ND#10#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f364^l365#1020-4989#1#Riesgo de malaria en mujeres embarazadas de zonas de baja 
endemia de la Amazonia Peruana^les#a10v22n5.htm##
00616000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301201000
0165002001300265#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a10v22n5.htm#S#f#3#1#t
ext#1#ab#es#br1.1#1#3.1#ND#10#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f364^l365#1020-4989#1#<B>Riesgo de malaria en mujeres embarazadas de zonas de ba
ja endemia de la Amazonia Peruana</B>^les#a10v22n5.htm##
00725000000000349000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002600114
03100030014003200020014306500090014501400110015403500100016512300020017501200930
0177002001300270008009200283#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a10v22n5.h
tm#S#l#4#1#text#1#^mnov.^a2007#ab#es#br1.1#1#3.1#10#RPSP030#nd#Rev. panam. salud
 pública#22#5#20071100#^f364^l365#1020-4989#1#Riesgo de malaria en mujeres embar
azadas de zonas de baja endemia de la Amazonia Peruana^les#a10v22n5.htm#Internet
^ihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001000
010##
00322000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704009300070002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#5#1#text#14#<p align="right"><font si
ze="2" face="Verdana"><b>INSTANT&Aacute;NEAS</b></font></p>     ^cY#a10v22n5.htm
##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#6#2#text#14#<p>&nbsp;</p>     ^cY#a10
v22n5.htm##
00380000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704015100070002001300221#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#7#3#text#14#<p><font size="4" face="v
erdana"><b>Riesgo de malaria en mujeres embarazadas de    zonas de baja endemia 
de la Amazonia Peruana</b></font></p>     ^cY#a10v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#8#4#text#14#<p>&nbsp;</p>     ^cY#a10
v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#9#5#text#14#<p>&nbsp;</p>     ^cY#a10
v22n5.htm##
01356000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704112600071002001301197#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#10#6#text#14#<p><font size="2" face="
Verdana">Cada a&ntilde;o, m&aacute;s de 24 millones de    mujeres resultan embar
azadas en zonas end&eacute;micas de malaria y se encuentran    en un mayor riesg
o de infecci&oacute;n, con graves consecuencias por las complicaciones    que pu
eden sufrir tanto la madre como el feto. La infecci&oacute;n por malaria    dura
nte el embarazo puede provocar el nacimiento de ni&ntilde;os con bajo peso,    e
l retraso en el crecimiento intrauterino del feto y la anemia materna, entre    
otros trastornos. Las mujeres embarazadas con relativamente baja inmunidad adqui
rida    contra la malaria tienen un mayor riesgo de sufrir las complicaciones m&
aacute;s    graves, entre ellas la anemia grave por malaria, abortos, el nacimie
nto de un    ni&ntilde;o muerto y, finalmente, la muerte de la madre y del reci&
eacute;n    nacido. El grado de endemicidad de la transmisi&oacute;n de la malar
ia, el nivel    de inmunidad adquirida y el n&uacute;mero de embarazos anteriore
s son algunos    de los principales factores que influyen en la epidemiolog&iacu
te;a de la malaria    durante el embarazo.</font></p>     ^cY#a10v22n5.htm##
00720000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704049000071002001300561#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#11#7#text#14#<p><font size="2" face="
Verdana">La mayor&iacute;a de los estudios realizados    sobre la epidemiolog&ia
cute;a y el efecto de la malaria durante el embarazo    se han llevado a cabo en
 zonas de alta endemia, donde <i>Plasmodium falciparum</i>    y <i>P. vivax</i> 
han sido los principales agentes infecciosos. Esos estudios    han demostrado qu
e las mujeres embarazadas tienen una mayor susceptibilidad    a la malaria y a s
us complicaciones que el resto de los adultos.</font></p>     ^cY#a10v22n5.htm##
00535000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704030500071002001300376#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#12#8#text#14#<p><font size="2" face="
Verdana">En este trabajo se estudi&oacute; la epidemiolog&iacute;a    de la mala
ria por <i>P. falciparum</i> y <i>P. vivax</i> durante el embarazo    en una zon
a de baja endemia en la regi&oacute;n amaz&oacute;nica de Iquitos,    Per&uacute
;, durante 2004–2005.</font></p>     ^cY#a10v22n5.htm##
00742000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704051200071002001300583#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#13#9#text#14#<p><font size="2" face="
Verdana">En contraste con la mayor&iacute;a de los estudios    realizados en zon
as de alta prevalencia, la informaci&oacute;n de la vigilancia    pasiva en ocho
 postas sanitarias atendidas por el Ministerio de Salud de ese    pa&iacute;s de
mostr&oacute; que las mujeres embarazadas presentaron una menor    prevalencia d
e malaria que el resto de la poblaci&oacute;n (7,5% en 2004 y 6,6%    en 2005 fr
ente a 20,6% y 22,4% en la poblaci&oacute;n total, respectivamente).</font></p> 
    ^cY#a10v22n5.htm##
01186000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704095500072002001301027#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#14#10#text#14#<p><font size="2" face=
"Verdana">Tambi&eacute;n se compar&oacute; la prevalencia    en mujeres embaraza
das con la encontrada en hombres y en mujeres no embarazadas    de 14 a 45 a&nti
lde;os de edad que participaron en el estudio de seguimiento    activo basado en
 la poblaci&oacute;n en esa misma zona. En este caso, se encontr&oacute;    que 
la mujeres embarazadas ten&iacute;an 2,3 veces mayor probabilidad de estar    in
fectadas con el par&aacute;sito <i>P. falciparum</i> que las mujeres no embaraza
das    del mismo grupo de edad (intervalo de confianza de 95%: 1,32 a 3,95, <i>P
</i>    = 0,04). A pesar de que las mujeres embarazadas no demostraron un mayor 
riesgo    de infecci&oacute;n por P. vivax en comparaci&oacute;n con las no emba
razadas,    la incidencia encontrada de cerca de 20% fue significativamente mayo
r que la    encontrada como resultado de la vigilancia pasiva realizada por las 
postas sanitarias    (6,0–7,5%).</font></p>     ^cY#a10v22n5.htm##
00751000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704052000072002001300592#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#15#11#text#14#<p><font size="2" face=
"Verdana">El an&aacute;lisis de los factores de riesgo    demostr&oacute; que la
s mujeres embarazadas con malaria eran de mayor edad y    hab&iacute;an tenido m
&aacute;s embarazos que las mujeres que no estaban embarazadas.    Esto marca un
a diferencia radical con respecto a los estudios realizados en    zonas end&eacu
te;micas, en los que se encontr&oacute; que la resistencia a la    malaria en es
tas mujeres aumentaba con la edad y el n&uacute;mero de embarazos    previos.</f
ont></p>     ^cY#a10v22n5.htm##
01383000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704115200072002001301224#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#16#12#text#14#<p><font size="2" face=
"Verdana">La mayor frecuencia de infecci&oacute;n, tanto    con <i>P. vivax</i> 
como con <i>P. falciparum</i>, encontrada durante el seguimiento    activo en co
mparaci&oacute;n con la encontrada en las postas sanitarias indica    que las in
fecciones asintom&aacute;ticas pueden ser frecuentes en las mujeres    embarazad
as. La infecci&oacute;n por <i>P. falciparum</i>, incluso si es asintom&aacute;t
ica,    tiene grandes implicaciones para la salud de las mujeres embarazadas y d
e su    feto, ya que causa complicaciones m&aacute;s graves que la infecci&oacut
e;n    por <i>P. vivax</i>, como malaria cerebral, anemia grave por malaria e hi
poglucemia,    entre otras. Adem&aacute;s, los eritrocitos infectados por <i>P. 
falciparum</i>    pueden acumularse en la placenta y afectar a la transferencia 
de ox&iacute;geno    entre la madre y el feto. Las infecciones asintom&aacute;ti
cas pueden tener    consecuencias mucho m&aacute;s graves en las mujeres embaraz
adas que en las    no embarazadas, ya que pueden pasar inadvertidas y continuar 
causando los graves    da&ntilde;os mencionados a la madre y al feto.</font></p>
     ^cY#a10v22n5.htm##
00754000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704052300072002001300595#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#17#13#text#14#<p><font size="2" face=
"Verdana">Este estudio demostr&oacute; que en la vigilancia    pasiva se subesti
m&oacute; la carga de la malaria en esta regi&oacute;n y que    la infecci&oacut
e;n subcl&iacute;nica puede ser frecuente en las mujeres embarazadas.    Adem&aa
cute;s, las mujeres embarazadas en esta zona de bajo nivel de transmisi&oacute;n
,    donde el <i>P. vivax</i> es el agente causal dominante, corren un mayor rie
sgo    por la infecci&oacute;n por <i>P. falciparum</i> que por <i>P. vivax</i>.
</font></p>     ^cY#a10v22n5.htm##
01229000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704099800072002001301070#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a10v22n5.htm#S#p#18#14#text#14#<p><font size="2" face=
"Verdana">La infecci&oacute;n por malaria durante el embarazo,    aun si es asin
tom&aacute;tica, es un grave problema de salud p&uacute;blica    en Iquitos, Per
&uacute;, y sus alrededores. Se deben realizar pruebas de diagn&oacute;stico    
para la malaria a todas las mujeres embarazadas que llegan a las postas de salud
,    incluso si antes reciben el diagn&oacute;stico de otra enfermedad asociada 
con    el embarazo. Estos resultados justifican la realizaci&oacute;n de una inv
estigaci&oacute;n    m&aacute;s detallada de las mujeres en el momento del parto
 para determinar    los posibles desenlaces asociados con la infecci&oacute;n po
r malaria y actuar    en consecuencia. (Parekh FK, Hern&aacute;ndez JN, Krogstad
 DJ, Martin Casapia    W, Branch OH. Prevalence and risk of <i>P. falciparum</i>
 and <i>P. vivax</i>    malaria among pregnant women living in the hypoendemic c
ommunities of the Peruvian    Amazon. Am J Trop Med Hyg. 2007;77(3):451–7.)</fon
t></p>     ^cY#a10v22n5.htm##
00271000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670910009000690920007000780020013000857030
00300098#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a11v22n5.htm#S#o#1#1#text#1#20
080121#151831#a11v22n5.htm#17##
00647000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301201310
0165002001300296#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a11v22n5.htm#S#h#2#1#t
ext#1#ab#es#br1.1#1#3.1#ND#11#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f365^l366#1020-4989#1#Relación entre el colesterol de HDL, los niveles muy bajos
 de colesterol de LDL y los episodios cardiovasculares agudos graves^les#a11v22n
5.htm##
00654000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301201380
0165002001300303#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a11v22n5.htm#S#f#3#1#t
ext#1#ab#es#br1.1#1#3.1#ND#11#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f365^l366#1020-4989#1#<B>Relación entre el colesterol de HDL, los niveles muy ba
jos de colesterol de LDL y los episodios cardiovasculares agudos graves</B>^les#
a11v22n5.htm##
00763000000000349000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002600114
03100030014003200020014306500090014501400110015403500100016512300020017501201310
0177002001300308008009200321#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a11v22n5.h
tm#S#l#4#1#text#1#^mnov.^a2007#ab#es#br1.1#1#3.1#11#RPSP030#nd#Rev. panam. salud
 pública#22#5#20071100#^f365^l366#1020-4989#1#Relación entre el colesterol de HD
L, los niveles muy bajos de colesterol de LDL y los episodios cardiovasculares a
gudos graves^les#a11v22n5.htm#Internet^ihttp://www.scielosp.org/scielo.php?scrip
t=sci_arttext&pid=S1020-49892007001000011##
00322000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704009300070002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#5#1#text#13#<p align="right"><font si
ze="2" face="Verdana"><b>INSTANT&Aacute;NEAS</b></font></p>     ^cY#a11v22n5.htm
##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#6#2#text#13#<p>&nbsp;</p>     ^cY#a11
v22n5.htm##
00428000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704019900070002001300269#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#7#3#text#13#<p><font size="4" face="v
erdana"><b>Relaci&oacute;n entre el colesterol de HDL,    los niveles muy bajos 
de colesterol de LDL y los episodios cardiovasculares    agudos graves</b></font
></p>     ^cY#a11v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#8#4#text#13#<p>&nbsp;</p>     ^cY#a11
v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#9#5#text#13#<p>&nbsp;</p>     ^cY#a11
v22n5.htm##
01100000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704087000071002001300941#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#10#6#text#13#<p><font size="2" face="
Verdana">Los estudios de poblaci&oacute;n han demostrado    de manera consistent
e que el nivel bajo de colesterol de lipoprote&iacute;nas    de alta densidad (H
DL) es un factor predictivo independiente de enfermedades    cardiovasculares. E
l an&aacute;lisis de los resultados de cuatro grandes estudios    demuestran que
 por cada incremento de 1 mg/dL (0,03 mmol/L) de colesterol de    HDL disminuye 
el riesgo de enfermedad coronaria en 2-3%. Por otra parte, el    uso de estatina
s para reducir los niveles de colesterol de lipoprote&iacute;nas    de baja dens
idad (LDL) ha permitido reducir considerablemente los problemas    cardiovascula
res en varios grupos de riesgo. Por cada 40 mg/dL (1,0 mmol/L)    de reducci&oac
ute;n de los niveles de colesterol de LDL, disminuye el riesgo    de enfermedade
s cardiovasculares en 24%.</font></p>     ^cY#a11v22n5.htm##
00693000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704046300071002001300534#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#11#7#text#13#<p><font size="2" face="
Verdana">Estos hallazgos respaldan la idea de que el aumento    de los niveles d
e colesterol de HDL debe ser un objetivo terap&eacute;utico    y de salud p&uacu
te;blica adicional e independiente de la reducci&oacute;n de    los niveles de c
olesterol de LDL. Sin embargo, no est&aacute; claro el valor    que pueden tener
 los niveles de colesterol de HDL cuando el colesterol de LDL    se encuentra en
 niveles muy bajos.</font></p>     ^cY#a11v22n5.htm##
01182000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704095200071002001301023#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#12#8#text#13#<p><font size="2" face="
Verdana">Para aclarar este punto se hizo un an&aacute;lisis    <i>post hoc</i> d
e los datos del ensayo <i>Treating to New Targets</i> (TNT),    recientemente co
ncluido. El objetivo fue analizar la relaci&oacute;n existente    entre la frecu
encia de episodios cardiovasculares agudos graves y los niveles    de colesterol
 de HDL en una poblaci&oacute;n de pacientes con signos cl&iacute;nicos    de en
fermedad card&iacute;aca coronaria que hab&iacute;an recibido tratamiento    con
 estatinas. Tambi&eacute;n se analiz&oacute; si esa posible relaci&oacute;n    s
e manten&iacute;a cuando los niveles de colesterol de LDL se encontraban por    
debajo de 70 mg/dL. Para ello se estratificaron en quintiles los 9 770 participa
ntes    del estudio TNT que contaban con los datos de colesterol de HDL, seg&uac
ute;n    el nivel de colesterol de HDL al tercer mes de la fase de tratamiento c
on doble    enmascaramiento.</font></p>     ^cY#a11v22n5.htm##
01059000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704082900071002001300900#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#13#9#text#13#<p><font size="2" face="
Verdana">Se observ&oacute; que el nivel de colesterol    de HDL en los pacientes
 que tomaron estatinas era un factor predictivo de la    ocurrencia de episodios
 cardiovasculares agudos graves, tanto cuando se tom&oacute;    el colesterol de
 HDL como una variable continua como cuando se analizaron los    pacientes seg&u
acute;n los quintiles de niveles de colesterol de HDL, aunque    en este &uacute
;ltimo caso el nivel de significaci&oacute;n fue bajo (<i>P</i>    = 0,05). Incl
uso en el grupo de pacientes con niveles de colesterol de LDL por    debajo de 7
0 mg/dL, los pacientes ubicados en el quintil m&aacute;s alto (mayores    nivele
s de colesterol de HDL) presentaron menor riesgo de ese tipo de episodios    que
 los que estaban en el quintil m&aacute;s bajo (<i>P</i> = 0,03).</font></p>    
 ^cY#a11v22n5.htm##
01013000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704078200072002001300854#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#14#10#text#13#<p><font size="2" face=
"Verdana">Seg&uacute;n este estudio, el nivel de colesterol    de HDL permaneci&
oacute; siendo un factor predictivo de episodios cardiovasculares    agudos grav
es en la cohorte de estudio, aun despu&eacute;s de tomar en cuenta    todos los 
otros factores de riesgo, en particular los niveles de colesterol    de LDL. Est
e efecto fue m&aacute;s pronunciado cuando los niveles de colesterol    de HDL s
e tomaron como variable continua que cuando se analizaron por quintiles    seg&u
acute;n el nivel de colesterol de LDL a los 3 meses de tratamiento con    estati
nas. Estos resultados indican que los niveles at&iacute;picos de colesterol    d
e HDL en s&iacute; pueden desempe&ntilde;ar un papel importante en la relaci&oac
ute;n    observada.</font></p>     ^cY#a11v22n5.htm##
00935000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704070400072002001300776#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#15#11#text#13#<p><font size="2" face=
"Verdana">El hecho de que despu&eacute;s de ajustar por    las covariables, el v
alor predictivo del nivel de colesterol de HDL fuera bajo,    confirma la hip&oa
cute;tesis de que en los pacientes con enfermedad coronaria,    los niveles alto
s de colesterol de HDL pueden contrarrestar el aumento del riesgo    provocado p
or los niveles altos de colesterol de LDL. Incluso en el grupo con    los nivele
s m&aacute;s bajos de colesterol de LDL, se redujo el riesgo de episodios    car
diovasculares agudos graves en los pacientes con niveles de colesterol de    HDL
 m&aacute;s elevados en comparaci&oacute;n con los que ten&iacute;an los    nive
les m&aacute;s bajos.</font></p>     ^cY#a11v22n5.htm##
00818000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704058700072002001300659#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#16#12#text#13#<p><font size="2" face=
"Verdana">Debido a que seg&uacute;n este an&aacute;lisis,    tanto los niveles d
e colesterol de HDL como los de LDL eran factores predictivos    independientes 
de episodios cardiovasculares agudos graves en todos los niveles    de colestero
l de HDL y de LDL, era de esperar que la raz&oacute;n entre ambos    tipos de co
lesterol tuviera tambi&eacute;n valor predictivo para ese tipo de    episodios. 
Se observ&oacute; tambi&eacute;n un resultado similar con relaci&oacute;n    a l
a raz&oacute;n entre el colesterol total y el colesterol de HDL.</font></p>     
^cY#a11v22n5.htm##
01197000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704096600072002001301038#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a11v22n5.htm#S#p#17#13#text#13#<p><font size="2" face=
"Verdana">En resumen, este an&aacute;lisis secundario de    los datos del estudi
o TNT demostr&oacute; que los niveles de colesterol de HDL    en pacientes con d
iagn&oacute;stico cl&iacute;nico de enfermedad coronaria que    recib&iacute;an 
tratamiento con estatina constituyen un factor predictivo inverso    independien
te de futuros episodios cardiovasculares agudos graves. Cuando se    tom&oacute;
 en cuenta el nivel de colesterol de LDL alcanzado por los pacientes    bajo tra
tamiento, el papel desempe&ntilde;ado por el colesterol de HDL fue menos    marc
ado, aunque mantuvo su significaci&oacute;n. Esta relaci&oacute;n se mantuvo    
significativa incluso en pacientes con niveles de colesterol de LDL por debajo  
  de 70 mg/dL. (Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM,   
 et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular 
   events. N Engl J Med. 2007;357:1301–10.)</font></p>     ^cY#a11v22n5.htm##
00271000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670910009000690920007000780020013000857030
00300098#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a12v22n5.htm#S#o#1#1#text#1#20
080121#151832#a12v22n5.htm#17##
00648000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301201320
0165002001300297#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a12v22n5.htm#S#h#2#1#t
ext#1#ab#es#br1.1#1#3.1#ND#12#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f366^l367#1020-4989#1#Impacto del Seguro Popular y de la disponibilidad de profe
sionales de salud en el control de la hipertensión arterial en México^les#a12v22
n5.htm##
00655000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301201390
0165002001300304#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a12v22n5.htm#S#f#3#1#t
ext#1#ab#es#br1.1#1#3.1#ND#12#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f366^l367#1020-4989#1#<B>Impacto del Seguro Popular y de la disponibilidad de pr
ofesionales de salud en el control de la hipertensión arterial en México</B>^les
#a12v22n5.htm##
00764000000000349000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002600114
03100030014003200020014306500090014501400110015403500100016512300020017501201320
0177002001300309008009200322#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a12v22n5.h
tm#S#l#4#1#text#1#^mnov.^a2007#ab#es#br1.1#1#3.1#12#RPSP030#nd#Rev. panam. salud
 pública#22#5#20071100#^f366^l367#1020-4989#1#Impacto del Seguro Popular y de la
 disponibilidad de profesionales de salud en el control de la hipertensión arter
ial en México^les#a12v22n5.htm#Internet^ihttp://www.scielosp.org/scielo.php?scri
pt=sci_arttext&pid=S1020-49892007001000012##
00322000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704009300070002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#5#1#text#13#<p align="right"><font si
ze="2" face="Verdana"><b>INSTANT&Aacute;NEAS</b></font></p>     ^cY#a12v22n5.htm
##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#6#2#text#13#<p>&nbsp;</p>     ^cY#a12
v22n5.htm##
00436000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704020700070002001300277#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#7#3#text#13#<p><font size="4" face="v
erdana"><b>Impacto del Seguro Popular y de la disponibilidad    de profesionales
 de salud en el control de la hipertensi&oacute;n arterial en    M&eacute;xico</
b></font></p>     ^cY#a12v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#8#4#text#13#<p>&nbsp;</p>     ^cY#a12
v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#9#5#text#13#<p>&nbsp;</p>     ^cY#a12
v22n5.htm##
01149000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704091900071002001300990#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#10#6#text#13#<p><font size="2" face="
Verdana">La hipertensi&oacute;n arterial (HTA) afecta    a m&aacute;s de nueve m
illones de adultos en M&eacute;xico y esta cifra debe    aumentar a medida que a
umentan las tasas de obesidad en la poblaci&oacute;n.    La HTA incrementa consi
derablemente el riesgo de enfermedades cardiovasculares,    como la enfermedad i
squ&eacute;mica y el infarto (segunda y tercera causas de    muerte en M&eacute;
xico, respectivamente). El gasto esperado este a&ntilde;o    para tratar la HTA 
es de m&aacute;s de 275 millones de d&oacute;lares estadounidenses.    Se ha dem
ostrado que la reducci&oacute;n de la HTA reduce significativamente    la incide
ncia de enfermedades cardiovasculares y la mortalidad asociada. A pesar    de di
sponer de medicamentos eficaces, el tratamiento de la HTA no es el &oacute;ptimo
    y su eficacia var&iacute;a de una regi&oacute;n a otra del pa&iacute;s.</fon
t></p>     ^cY#a12v22n5.htm##
01788000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704155800071002001301629#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#11#7#text#13#<p><font size="2" face="
Verdana">La falta de seguro m&eacute;dico ha sido un obst&aacute;culo    clave p
ermanente para el tratamiento antihipertensivo y para el uso de los servicios   
 de salud en general. El reciente programa Seguro Popular, que pretende extender
    legalmente el seguro de salud a todas las personas que no poseen un seguro m
&eacute;dico    en M&eacute;xico para el a&ntilde;o 2010 (alrededor de 50 millon
es de personas),    puede mejorar el acceso al tratamiento de la HTA y, segurame
nte, los resultados    sanitarios del pa&iacute;s. El paquete asegurador cubre 2
49 intervenciones,    entre ellas el diagn&oacute;stico y el tratamiento de la H
TA. La ley, sin embargo,    estipula que la prioridad en la afiliaci&oacute;n la
 tienen los hogares pobres    de zonas con grandes carencias econ&oacute;micas, 
los habitantes de zonas rurales    y los grupos ind&iacute;genas, as&iacute; com
o las familias que tienen necesidades    mayores de atenci&oacute;n sanitaria. P
or ende, la mayor parte de la poblaci&oacute;n    cubierta actualmente por este 
seguro pertenece a los grupos con ingresos m&aacute;s    bajos. Adem&aacute;s, e
l Seguro Popular se dise&ntilde;&oacute; para que se    comenzara a aplicar en l
as comunidades en las que existieran instalaciones de    salud suficientemente e
quipadas para ofrecer los servicios contemplados en el    paquete del seguro. En
 las zonas rurales y de bajos ingresos, la falta de suministros    puede impedir
 la efectividad del programa con respecto al tratamiento antihipertensivo.</font
></p>     ^cY#a12v22n5.htm##
00665000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704043500071002001300506#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#12#8#text#13#<p><font size="2" face="
Verdana">Para investigar si el Seguro Popular es suficiente    por s&iacute; sol
o para aumentar la cobertura de tratamiento antihipertensivo    en adultos de M&
eacute;xico o si su efecto es mayor en las zonas que cuentan    con m&aacute;s r
ecursos humanos, se examinaron las contribuciones independientes    y combinadas
 del estatus de asegurado y de la cantidad de profesionales sanitarios.</font></
p>     ^cY#a12v22n5.htm##
00749000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704051900071002001300590#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#13#9#text#13#<p><font size="2" face="
Verdana">Para ello se estudiaron 2 967 adultos hipertensos    de 20 a&ntilde;os 
o m&aacute;s sin seguro m&eacute;dico, de ellos 1 065 se parearon    por edad co
n igual n&uacute;mero de personas cubiertas por el Seguro Popular,    por lo que
 el estudio abarc&oacute; a un total de 4 032 personas. El n&uacute;mero    de m
&eacute;dicos y enfermeros (<i>n</i> = 12 566) se tom&oacute; del Registro    Na
cional de Infraestructura de Salud de M&eacute;xico correspondiente a 2005.</fon
t></p>     ^cY#a12v22n5.htm##
00655000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704042400072002001300496#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#14#10#text#13#<p><font size="2" face=
"Verdana">Los resultados mostraron una asociaci&oacute;n    significativa entre 
estar cubierto por el Seguro Popular y una mayor tasa de    tratamiento por HTA 
y de control de la tensi&oacute;n arterial. Adem&aacute;s,    el Seguro Popular 
fue m&aacute;s efectivo en las zonas que contaban con una    mejor relaci&oacute
;n entre el n&uacute;mero de profesionales y el de pacientes.</font></p>     ^cY
#a12v22n5.htm##
00932000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704070100072002001300773#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#15#11#text#13#<p><font size="2" face=
"Verdana">En 2005, casi la sexta parte de los adultos de    M&eacute;xico (cerca
 de cinco millones de personas) pod&iacute;an optar por    el Seguro Popular. Se
 espera que para el a&ntilde;o 2010, el Seguro Popular    permita incrementar la
 asignaci&oacute;n de recursos p&uacute;blicos para aumentar    el pago de los s
ervicios de salud de cada familia, de $268,00 en 2001 (de un    gasto medio por 
hogar de $4 032,00) a $677,00. La prevenci&oacute;n secundaria    de las enferme
dades cardiovasculares, como resultado de mayores tasas de tratamiento    y de c
ontrol de la HTA, puede compensar los gastos que ocasione la ampliaci&oacute;n  
  de la cobertura.</font></p>     ^cY#a12v22n5.htm##
00982000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704075100072002001300823#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#16#12#text#13#<p><font size="2" face=
"Verdana">A diferencia de otros estudios, estos resultados    no demostraron que
 la presencia de profesionales sanitarios tenga un efecto    independiente en el
 tratamiento de la HTA. El hecho de haber encontrado una    relaci&oacute;n dire
cta y significativa entre el estar cubierto por el Seguro    Popular y la presen
cia de profesionales sanitarios con respecto a la cobertura    del tratamiento a
ntihipertensivo indica que el Seguro Popular no fue suficiente    por s&iacute; 
solo. En cambio, se comprob&oacute; que se obtiene el mayor impacto    de este s
eguro sobre la cobertura del tratamiento contra la HTA cuando la relaci&oacute;n
    entre el n&uacute;mero de m&eacute;dicos y de pacientes es alta.</font></p> 
    ^cY#a12v22n5.htm##
01325000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704109400072002001301166#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a12v22n5.htm#S#p#17#13#text#13#<p><font size="2" face=
"Verdana">En conclusi&oacute;n, en este trabajo se demuestra    que el Seguro Po
pular est&aacute; teniendo un impacto positivo en la cobertura    del tratamient
o antihipertensivo en M&eacute;xico, especialmente en las zonas    en que la con
centraci&oacute;n de profesionales sanitarios es alta. Adem&aacute;s    de hacer
 esfuerzos adicionales para comprender mejor los factores que inciden    en la f
alta de control de la HTA en M&eacute;xico, se debe ampliar la cobertura    de l
os seguros de salud y aumentar la cantidad de m&eacute;dicos y enfermeros    en 
las zonas en las que a&uacute;n no son suficientes. El &eacute;xito del Seguro  
  Popular debe constituir un ejemplo para otros pa&iacute;ses en desarrollo que 
   aspiran a garantizar la atenci&oacute;n m&eacute;dica a las personas que no  
  cuentan con un seguro de salud. (Bleich SN, Cutler DM, Adams AS, Lozano R, Mur
ray    CJL. Impact of insurance and supply of health professionals on coverage o
f treatment    for hypertension in Mexico: population based study. Br Med J. 200
7;335:875.)</font></p>     ^cY#a12v22n5.htm##
00271000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670910009000690920007000780020013000857030
00300098#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a13v22n5.htm#S#o#1#1#text#1#20
080121#151833#a13v22n5.htm#19##
00585000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301200690
0165002001300234#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a13v22n5.htm#S#h#2#1#t
ext#1#ab#es#br1.1#1#3.1#ND#13#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f367^l368#1020-4989#1#Tendencias en la prevalencia de los síntomas de asma en el
 mundo^les#a13v22n5.htm##
00592000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301200760
0165002001300241#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a13v22n5.htm#S#f#3#1#t
ext#1#ab#es#br1.1#1#3.1#ND#13#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f367^l368#1020-4989#1#<B>Tendencias en la prevalencia de los síntomas de asma en
 el mundo</B>^les#a13v22n5.htm##
00701000000000349000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002600114
03100030014003200020014306500090014501400110015403500100016512300020017501200690
0177002001300246008009200259#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a13v22n5.h
tm#S#l#4#1#text#1#^mnov.^a2007#ab#es#br1.1#1#3.1#13#RPSP030#nd#Rev. panam. salud
 pública#22#5#20071100#^f367^l368#1020-4989#1#Tendencias en la prevalencia de lo
s síntomas de asma en el mundo^les#a13v22n5.htm#Internet^ihttp://www.scielosp.or
g/scielo.php?script=sci_arttext&pid=S1020-49892007001000013##
00322000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704009300070002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#5#1#text#15#<p align="right"><font si
ze="2" face="Verdana"><b>INSTANT&Aacute;NEAS</b></font></p>     ^cY#a13v22n5.htm
##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#6#2#text#15#<p>&nbsp;</p>     ^cY#a13
v22n5.htm##
00363000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704013400070002001300204#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#7#3#text#15#<p><font size="4" face="v
erdana"><b>Tendencias en la prevalencia de los s&iacute;ntomas    de asma en el 
mundo</b></font></p>     ^cY#a13v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#8#4#text#15#<p>&nbsp;</p>     ^cY#a13
v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#9#5#text#15#<p>&nbsp;</p>     ^cY#a13
v22n5.htm##
00746000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704051600071002001300587#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#10#6#text#15#<p><font size="2" face="
Verdana">El Estudio Internacional sobre Asma y Alergias    en la Ni&ntilde;ez (I
SAAC) se dise&ntilde;&oacute; para poder comparar las prevalencias    de asma, r
inoconjuntivitis al&eacute;rgica y eczema de poblaciones de diferentes    pa&iac
ute;ses y analizar sus tendencias en el tiempo. Su objetivo es contribuir    a e
laborar hip&oacute;tesis de trabajo sobre las causas de los patrones observados 
   y, consiguientemente, de las causas del asma, la rinitis y el eczema.</font><
/p>     ^cY#a13v22n5.htm##
00956000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704072600071002001300797#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#11#7#text#15#<p><font size="2" face="
Verdana">En la fase I se estudiaron 463 801 ni&ntilde;os    de 13–14 a&ntilde;os
 de edad en 155 instituciones sanitarias de 56 pa&iacute;ses    y 257 800 ni&nti
lde;os de 6–7 a&ntilde;os en 91 centros de 38 pa&iacute;ses.    Se observaron va
riaciones de hasta 20 veces en la prevalencia de sibilancia    reciente (en los 
12 meses previos) entre los centros estudiados de Australia,    Nueva Zelanda, R
eino Unido y Rep&uacute;blica de Irlanda y de los centros de    la Regi&oacute;n
 de las Am&eacute;ricas. En la fase II se profundiz&oacute;    en la b&uacute;sq
ueda de los posibles factores etiol&oacute;gicos en ni&ntilde;os    de 9–11 a&nt
ilde;os en 30 centros de 22 pa&iacute;ses.</font></p>     ^cY#a13v22n5.htm##
01103000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704087300071002001300944#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#12#8#text#15#<p><font size="2" face="
Verdana">La fase III consisti&oacute; en una repetici&oacute;n    de la encuesta
 de la fase I, realizada 5–10 a&ntilde;os despu&eacute;s para    examinar, entre
 otras cosas, las tendencias de las prevalencia de asma en los    centros y pa&i
acute;ses participantes y examinar las hip&oacute;tesis propuestas    durante la
 fase I, a la luz de los estudios ecol&oacute;gicos subsecuentes y    de otras i
nvestigaciones recientes. En este art&iacute;culo se describen detalladamente   
 los resultados obtenidos, esta vez en 304 679 ni&ntilde;os de 13–14 a&ntilde;os
    en 106 centros de 56 pa&iacute;ses y en 193 404 ni&ntilde;os de 6–7 a&ntilde
;os    en 66 centros de 37 pa&iacute;ses. Se solicit&oacute; a cada centro parti
cipante    que se realizara la fase III del estudio de la misma manera en que se
 realiz&oacute;    la fase I.</font></p>     ^cY#a13v22n5.htm##
01034000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704080400071002001300875#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#13#9#text#15#<p><font size="2" face="
Verdana">Los resultados obtenidos demostraron que la prevalencia    de s&iacute;
ntomas de asma se ha reducido internacionalmente, en particular    en ni&ntilde;
os de 13–14 a&ntilde;os. Por regiones, esta prevalencia ha disminuido    en los 
pa&iacute;ses de habla inglesa y en Europa Occidental, mientras que ha    aument
ado en los pa&iacute;ses en que la prevalencia era baja, como en los de    Am&ea
cute;rica Latina. Aunque se observaron cambios menores en la prevalencia    de l
a sibilancia, el porcentaje de ni&ntilde;os que informaron haber tenido    asma 
aument&oacute; significativamente, lo que posiblemente refleja la mayor    atenc
i&oacute;n que ahora se presta a esta enfermedad o cambios en los criterios    d
e diagn&oacute;stico de esta enfermedad.</font></p>     ^cY#a13v22n5.htm##
01060000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704082900072002001300901#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#14#10#text#15#<p><font size="2" face=
"Verdana">Las conclusiones de este estudio son varias.    Primero, se demostr&oa
cute; que en la mayor&iacute;a de los pa&iacute;ses con    alta prevalencia, par
ticularmente en los pa&iacute;ses angl&oacute;fonos, la    prevalencia de los s&
iacute;ntomas de asma puede haber llegado a su pico y haber    empezado a declin
ar. Este hallazgo es consistente con los resultados de otros    estudios recient
es realizados en ni&ntilde;os y adultos. Hay algunas excepciones    a esta regla
: en Europa, Alemania y Finlandia han mostrado incrementos en la    prevalencia 
de s&iacute;ntomas de asma durante la fase III con respecto a lo    encontrado d
urante la fase I. De los pa&iacute;ses angl&oacute;fonos de las    Am&eacute;ric
as, se observ&oacute; un incremento de la prevalencia en Barbados.</font></p>   
  ^cY#a13v22n5.htm##
00670000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704043900072002001300511#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#15#11#text#15#<p><font size="2" face=
"Verdana">Segundo, algunos pa&iacute;ses que ten&iacute;an    prevalencias inter
medias o altas durante la fase I mostraron incrementos significativos    durante
 la fase III, tanto en Am&eacute;rica Latina —Argentina, Chile, Costa    Rica, M
&eacute;xico y Panam&aacute;— como en Europa Oriental —Ucrania y Rumania—    y &
Aacute;frica —T&uacute;nez, Marruecos y Argelia—, adem&aacute;s de Barbados.</fo
nt></p>     ^cY#a13v22n5.htm##
00572000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704034100072002001300413#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#16#12#text#15#<p><font size="2" face=
"Verdana">Tercero, con la excepci&oacute;n de la India,    todos los pa&iacute;s
es con niveles muy bajos de prevalencia de s&iacute;ntomas    de asma en la fase
 I informaron aumentos durante la fase III, aunque solamente    resultaron signi
ficativos los incrementos observados en China e Indonesia.</font></p>     ^cY#a1
3v22n5.htm##
00797000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704056600072002001300638#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#17#13#text#15#<p><font size="2" face=
"Verdana">Por &uacute;ltimo, pr&aacute;cticamente todos    los pa&iacute;ses —in
dependientemente del nivel de la prevalencia de s&iacute;ntomas—    informaron a
umentos en la prevalencia de toda la vida de asma entre las fases    I y III. De
 hecho, estos aumentos resultaron m&aacute;s pronunciados en los    pa&iacute;se
s con las mayores prevalencias medias entre las dos fases de estudio,    a pesar
 de que muchos de esos pa&iacute;ses informaron reducciones en las prevalencias 
   de s&iacute;ntomas de asma en ese lapso.</font></p>     ^cY#a13v22n5.htm##
00682000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704045100072002001300523#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#18#14#text#15#<p><font size="2" face=
"Verdana">Seg&uacute;n los resultados de la fase III de    este estudio, el cons
iderable incremento en la prevalencia de s&iacute;ntomas    de asma en los pa&ia
cute;ses latinoamericanos puede llevar a que en el futuro,    el asma deje de de
scribirse como una enfermedad propia de los pa&iacute;ses    de habla inglesa pa
ra convertirse en una enfermedad de los pa&iacute;ses de    hablas hispana y por
tuguesa.</font></p>     ^cY#a13v22n5.htm##
01152000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704092100072002001300993#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a13v22n5.htm#S#p#19#15#text#15#<p><font size="2" face=
"Verdana">Esta nueva y abarcadora informaci&oacute;n sobre    la tendencia en el
 tiempo de la prevalencia de s&iacute;ntomas de asma debe    contribuir al an&aa
cute;lisis de las teor&iacute;as actuales acerca de la etiolog&iacute;a    del a
sma y a la elaboraci&oacute;n de nuevas hip&oacute;tesis. Adem&aacute;s,    esto
s resultados del estudio ISAAC indican que, a pesar de que se ha detenido    el 
incremento en la prevalencia de asma en los pa&iacute;ses de habla inglesa    y 
de Europa Occidental, el asma contin&uacute;a siendo un grave problema de    sal
ud p&uacute;blica en el mundo y su carga contin&uacute;a aumentando. (Pearce    
N, A&iuml;t-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide 
   trends in the prevalence of asthma symptoms: phase III of the International  
  Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62;757–65.)</
font></p>     ^cY#a13v22n5.htm##
00271000000000169000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670910009000690920007000780020013000857030
00300098#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a14v22n5.htm#S#o#1#1#text#1#20
080121#151834#a14v22n5.htm#17##
00601000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301200850
0165002001300250#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a14v22n5.htm#S#h#2#1#t
ext#1#ab#es#br1.1#1#3.1#ND#14#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f368^l368#1020-4989#1#Papel de las redes de información y comunicaciones en el d
esenlace de la malaria^les#a14v22n5.htm##
00608000000000337000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670710003000690400003000720010006000750420
00200081120000400083038000300087121000300090049000800093158000300101030002400104
03100030012803200020013106500090013301400110014203500100015312300020016301200920
0165002001300257#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a14v22n5.htm#S#f#3#1#t
ext#1#ab#es#br1.1#1#3.1#ND#14#RPSP030#nd#Rev Panam Salud Publica#22#5#20071100#^
f368^l368#1020-4989#1#<B>Papel de las redes de información y comunicaciones en e
l desenlace de la malaria</B>^les#a14v22n5.htm##
00717000000000349000450000400060000070200480000670500020005470600020005670000020
00587010002000607090005000627080002000670640013000690710003000820400003000850010
00600088042000200094120000400096121000300100049000800103158000300111030002600114
03100030014003200020014306500090014501400110015403500100016512300020017501200850
0177002001300262008009200275#v22n5#v:\scielo\serial\rpsp\v22n5\markup\a14v22n5.h
tm#S#l#4#1#text#1#^mnov.^a2007#ab#es#br1.1#1#3.1#14#RPSP030#nd#Rev. panam. salud
 pública#22#5#20071100#^f368^l368#1020-4989#1#Papel de las redes de información 
y comunicaciones en el desenlace de la malaria^les#a14v22n5.htm#Internet^ihttp:/
/www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007001000014##
00322000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704009300070002001300163#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#5#1#text#13#<p align="right"><font si
ze="2" face="Verdana"><b>INSTANT&Aacute;NEAS</b></font></p>     ^cY#a14v22n5.htm
##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#6#2#text#13#<p>&nbsp;</p>     ^cY#a14
v22n5.htm##
00379000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704015000070002001300220#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#7#3#text#13#<p><font size="4" face="v
erdana"><b>Papel de las redes de informaci&oacute;n y    comunicaciones en el de
senlace de la malaria</b></font></p>     ^cY#a14v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#8#4#text#13#<p>&nbsp;</p>     ^cY#a14
v22n5.htm##
00251000000000145000450000400060000070200480000670500020005470600020005670000020
0058701000200060709000500062708000300067704002200070002001300092#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#9#5#text#13#<p>&nbsp;</p>     ^cY#a14
v22n5.htm##
01106000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704087600071002001300947#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#10#6#text#13#<p><font size="2" face="
Verdana">Cada a&ntilde;o, en el mundo se presentan cinco    mil millones de caso
s de malaria que requieren tratamiento y se registran m&aacute;s    de tres mill
ones de muertes atribuidas a esta enfermedad, de las cuales una    tercera parte
 corresponde a ni&ntilde;os. M&aacute;s de la mitad de las muertes    por malari
a en ni&ntilde;os ocurren en las primeras 48 horas de la enfermedad,    de maner
a que la decisi&oacute;n de tomar aspirina para aliviar la fiebre o    medicamen
tos antimal&aacute;ricos eficaces puede definir si el desenlace ser&aacute;    v
ivir o morir. Por lo tanto, es extremadamente importante contar con un diagn&oac
ute;stico    r&aacute;pido y un tratamiento apropiado para poder reducir la mort
alidad infantil    por esta enfermedad y alcanzar dos de los principales Objetiv
os de Desarrollo    del Milenio.</font></p>     ^cY#a14v22n5.htm##
00699000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704046900071002001300540#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#11#7#text#13#<p><font size="2" face="
Verdana">Con frecuencia, los s&iacute;ntomas de la malaria    pasan inadvertidos
 y no se aplica el tratamiento correspondiente. Seg&uacute;n    la Iniciativa Mu
ltilateral contra la Malaria, 70% de los casos que se tratan    en el hogar no r
eciben el tratamiento apropiado y en algunas regiones, como    en &Aacute;frica 
Subsahariana, m&aacute;s de 80% de los casos de malaria se    atienden fuera del
 sistema formal de salud.</font></p>     ^cY#a14v22n5.htm##
00944000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704071400071002001300785#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#12#8#text#13#<p><font size="2" face="
Verdana">En este sentido, varios investigadores y programas    de acci&oacute;n 
han resaltado la importancia de las redes de informaci&oacute;n    y comunicacio
nes (RIC) para el control de la malaria. La Organizaci&oacute;n    Mundial de la
 Salud (OMS) estableci&oacute; el grupo de trabajo Hacer Retroceder    la Malari
a (<i>Roll Back Malaria</i>) para recomendar iniciativas de comunicaci&oacute;n 
   y promoci&oacute;n apropiadas. La hip&oacute;tesis de trabajo de este grupo  
  es que las RIC pueden constituir un factor clave en la prevenci&oacute;n de   
 las muertes por malaria y que el an&aacute;lisis emp&iacute;rico tiende a respa
ldar    esta hip&oacute;tesis.</font></p>     ^cY#a14v22n5.htm##
00498000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000200061709000500063708000300068704026800071002001300339#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#13#9#text#13#<p><font size="2" face="
Verdana">No obstante, no se hab&iacute;a establecido hasta    ahora una asociaci
&oacute;n significativa entre las RIC y el desenlace de la    enfermedad. El obj
etivo de este art&iacute;culo es precisamente cubrir esa brecha.</font></p>     
^cY#a14v22n5.htm##
01030000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704079900072002001300871#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#14#10#text#13#<p><font size="2" face=
"Verdana">Los datos para investigar el papel que pueden    desempe&ntilde;ar las
 RIC en la reducci&oacute;n del n&uacute;mero de muertes    por malaria se obtuv
ieron de dos fuentes diferentes en dependencia de las variables.    Las variable
s relacionadas con la salud y la enfermedad se obtuvieron de la    base de datos
 de malaria de la OMS que se encuentra disponible en Internet.    La intensidad 
de las RIC —representada por el n&uacute;mero de l&iacute;neas    telef&oacute;n
icas y el n&uacute;mero de televisores, por 1 000 habitantes—    se obtuvo de lo
s Indicadores Mundiales de Desarrollo. Se agruparon los datos    de 70 pa&iacute
;ses para construir el conjunto de variables socioecon&oacute;micas    y de salu
d del per&iacute;odo de 1960 a 2004.</font></p>     ^cY#a14v22n5.htm##
01020000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704078900072002001300861#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#15#11#text#13#<p><font size="2" face=
"Verdana">Los datos brutos mostraron una correlaci&oacute;n    negativa entre la
 intensidad de las RIC y la incidencia de muertes por malaria.    Algunas de las
 mayores tasas de mortalidad por malaria se presentaron en los    pa&iacute;ses 
con menor disponibilidad de l&iacute;neas telef&oacute;nicas y    televisores. N
o obstante esta tendencia, se encontraron pa&iacute;ses como Somalia,    que tie
ne una baja probabilidad de muerte por malaria (0, 00008) y una baja    densidad
 de l&iacute;neas telef&oacute;nicas (9,84 por 1 000 habitantes) y de    televis
ores (14,76 por 1 000 habitantes). Esto implica que las RIC pueden ser    uno de
 los numerosos factores que influyen en la probabilidad de muerte por    malaria
, pero no el &uacute;nico.</font></p>     ^cY#a14v22n5.htm##
01209000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704097800072002001301050#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#16#12#text#13#<p><font size="2" face=
"Verdana">Debido a estos resultados preliminares que indicaban    una correlaci&
oacute;n negativa entre la probabilidad de muerte por malaria    y las RIC, los 
autores procedieron a realizar un an&aacute;lisis cuantitativo    m&aacute;s rig
uroso que permitiera investigar la asociaci&oacute;n entre las    variables de l
as RIC y la probabilidad de muerte por malaria. El an&aacute;lisis    por pa&iac
ute;ses demostr&oacute; que la densidad de las RIC mantiene una correlaci&oacute
;n    significativa inversa con la probabilidad de muerte por malaria. Aunque el
 impacto    de las RIC en la prevenci&oacute;n de la muerte por esta enfermedad 
puede no    ser directo, estas tecnolog&iacute;as pueden contribuir a acelerar l
a entrega    de los servicios y mejorar el acceso a informaci&oacute;n clave y c
on ello aumentar    indirectamente la eficacia de las estrategias de intervenci&
oacute;n y la efectividad    de los recursos empleados.</font></p>     ^cY#a14v2
2n5.htm##
01134000000000145000450000400060000070200480000670500020005470600020005670000030
0058701000300061709000500064708000300069704090300072002001300975#v22n5#v:\scielo
\serial\rpsp\v22n5\markup\a14v22n5.htm#S#p#17#13#text#13#<p><font size="2" face=
"Verdana">El principal hallazgo de esta investigaci&oacute;n    —la asociaci&oac
ute;n inversa entre la intensidad de las RIC y la probabilidad    de muerte de l
as personas con signos y s&iacute;ntomas cl&iacute;nicos de malaria—    son robu
stos, tanto para las redes de comunicaci&oacute;n interpersonal como    para las
 de comunicaci&oacute;n masiva seg&uacute;n todos los modelos empleados.    La o
ptimizaci&oacute;n de la infraestructura de las RIC impulsar&aacute; el    estab
lecimiento de redes locales —entre las comunidades y m&aacute;s all&aacute;    d
e ellas— y a&ntilde;adir&aacute; una reserva de capital social que puede emplear
se    para aumentar la efectividad de los limitados recursos disponibles para co
mbatir    la malaria. (Mozumder P, Marathe A. Role of information and communicat
ion networks    in malaria survival. Malaria J. 2007;6:136.)</font></p>     ^cY#
a14v22n5.htm##
